data_1dfd_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1dfd _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.471 ' HB3' ' HB3' ' A' ' 62' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.566 ' CB ' ' HA ' ' A' ' 61' ' ' TRP . 31.6 p90 179.78 -167.39 0.09 Allowed 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.173 -0.954 . . . . 0.0 109.208 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.505 ' HA ' HG13 ' A' ' 36' ' ' VAL . 39.3 p90 173.5 -166.79 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 106.87 -1.529 . . . . 0.0 106.87 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.568 HG23 ' CZ ' ' A' ' 25' ' ' PHE . 2.5 t -152.14 166.76 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 C-N-CA 117.532 -1.667 . . . . 0.0 112.119 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.468 ' C ' ' H ' ' A' ' 9' ' ' ASP . 0.8 OUTLIER -106.76 68.57 0.74 Allowed 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 178.561 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.505 ' CB ' ' O ' ' A' ' 34' ' ' ALA . 0.6 OUTLIER -47.72 -15.59 0.06 Allowed 'General case' 0 C--N 1.297 -1.701 0 CA-C-O 121.344 0.593 . . . . 0.0 109.495 179.258 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.468 ' H ' ' C ' ' A' ' 7' ' ' ASP . 0.2 OUTLIER -65.17 -33.12 75.25 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.697 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.493 ' HB3' ' HB3' ' A' ' 58' ' ' CYS . 0.3 OUTLIER -93.47 0.74 56.87 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 179.168 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.414 ' HB3' ' O ' ' A' ' 8' ' ' GLN . 10.1 t -66.84 129.32 39.49 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.081 -1.012 . . . . 0.0 110.073 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.505 HG13 ' N ' ' A' ' 13' ' ' ALA . 43.2 pt -88.78 -143.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.486 -0.759 . . . . 0.0 109.639 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.505 ' N ' HG13 ' A' ' 12' ' ' ILE . . . -107.56 52.92 0.7 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.076 -1.015 . . . . 0.0 109.901 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.575 ' SG ' ' OG ' ' A' ' 16' ' ' SER . 0.1 OUTLIER -134.53 155.18 50.86 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.039 -1.038 . . . . 0.0 109.673 179.661 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.42 ' O ' ' C ' ' A' ' 16' ' ' SER . 0.2 OUTLIER -120.46 18.89 12.09 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.319 -0.863 . . . . 0.0 109.798 -179.555 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.575 ' OG ' ' SG ' ' A' ' 14' ' ' CYS . 0.7 OUTLIER -44.15 -51.13 8.34 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.195 -0.941 . . . . 0.0 109.346 179.995 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.826 ' SG ' ' CD2' ' A' ' 25' ' ' PHE . 14.6 p -62.02 -54.93 34.63 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.316 -0.865 . . . . 0.0 109.366 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.626 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 98.7 t -43.92 -34.22 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.279 -0.888 . . . . 0.0 109.501 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.42 -36.78 66.01 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.062 -1.024 . . . . 0.0 109.025 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.518 HG23 ' N ' ' A' ' 50' ' ' ALA . 5.0 mt -87.37 16.13 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 178.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -174.43 63.64 0.26 Allowed Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.344 -0.848 . . . . 0.0 109.672 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -75.36 51.76 3.0 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 124.04 1.547 . . . . 0.0 110.34 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.42 ' C ' ' HA3' ' A' ' 41' ' ' GLY . . . -166.0 -41.63 0.02 OUTLIER Glycine 0 N--CA 1.489 2.213 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.516 ' HB1' ' CB ' ' A' ' 42' ' ' ALA . . . -92.31 -46.8 7.52 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.434 -1.039 . . . . 0.0 108.678 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.826 ' CD2' ' SG ' ' A' ' 17' ' ' CYS . 0.1 OUTLIER -89.7 138.09 31.77 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.387 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.45 ' O ' ' CD1' ' A' ' 35' ' ' TYR . . . -173.57 126.31 0.4 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.103 -0.998 . . . . 0.0 109.58 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' MET . . . . . 0.546 ' HA ' ' C ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -63.82 153.01 37.98 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.166 -0.959 . . . . 0.0 109.841 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.605 ' O ' ' N ' ' A' ' 32' ' ' GLU . 2.2 t0 -129.59 163.67 45.09 Favored Pre-proline 0 C--O 1.209 -1.061 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.456 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 45.7 Cg_endo -83.63 -18.31 5.73 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 124.619 1.852 . . . . 0.0 107.961 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -84.17 -39.17 19.73 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 178.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.635 ' CD1' ' CD1' ' A' ' 35' ' ' TYR . 3.0 pt -101.51 -2.05 9.72 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 177.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.605 ' N ' ' O ' ' A' ' 28' ' ' ASP . 65.4 mt-10 34.66 34.53 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -179.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.556 ' CG ' ' O ' ' A' ' 32' ' ' GLU . 18.5 mttt -163.15 150.3 12.86 Favored 'General case' 0 N--CA 1.499 1.999 0 C-N-CA 119.408 -0.917 . . . . 0.0 110.374 -178.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.535 ' HA ' ' HA ' ' A' ' 27' ' ' MET . . . -62.48 143.88 56.62 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.515 -0.74 . . . . 0.0 110.489 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.667 ' CE2' ' HA ' ' A' ' 37' ' ' LYS . 1.2 p90 -155.25 158.02 38.18 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.55 HG22 ' CE2' ' A' ' 4' ' ' PHE . 14.5 p -67.51 68.44 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.818 -1.176 . . . . 0.0 108.833 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.667 ' HA ' ' CE2' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -49.95 -19.24 0.66 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.445 -0.785 . . . . 0.0 110.295 -179.691 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -165.95 99.72 0.65 Allowed 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.09 -1.006 . . . . 0.0 109.394 -179.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.495 ' HA ' ' CZ ' ' A' ' 4' ' ' PHE . 11.0 m -48.19 -29.65 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.419 -0.801 . . . . 0.0 109.764 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.477 ' N ' HG21 ' A' ' 39' ' ' VAL . 10.5 mt-10 -85.12 -4.98 59.35 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.207 -0.933 . . . . 0.0 109.711 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.42 ' HA3' ' C ' ' A' ' 23' ' ' GLY . . . -67.02 -32.2 80.11 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.516 ' CB ' ' HB1' ' A' ' 24' ' ' ALA . . . -128.24 163.04 25.59 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.212 -1.17 . . . . 0.0 109.279 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.469 ' OG ' ' OE2' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -89.51 171.53 9.64 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.278 -0.889 . . . . 0.0 109.416 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.494 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 17.6 pt20 -68.51 -34.55 76.1 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.326 -0.859 . . . . 0.0 109.38 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -72.4 -23.9 61.17 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.311 -0.868 . . . . 0.0 109.322 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.469 ' OE2' ' OG ' ' A' ' 43' ' ' SER . 33.6 mt-10 -87.55 -41.14 13.69 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 178.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 38.5 t -63.37 -29.33 46.99 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 177.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.494 ' HB2' ' O ' ' A' ' 44' ' ' GLN . 0.5 OUTLIER -69.37 -64.65 0.83 Allowed 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.262 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -52.19 -39.76 60.59 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 119.467 -0.893 . . . . 0.0 108.786 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.518 ' N ' HG23 ' A' ' 20' ' ' ILE . . . -62.78 -27.33 69.22 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.542 ' HG3' ' CG2' ' A' ' 59' ' ' ILE . 3.7 ttm -72.82 -43.57 62.53 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -55.36 -42.88 74.49 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.446 ' CG2' ' HB3' ' A' ' 16' ' ' SER . 0.1 OUTLIER -59.98 -160.23 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.419 -0.801 . . . . 0.0 109.195 179.803 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . 0.583 ' SG ' ' HD2' ' A' ' 55' ' ' PRO . 1.7 t 66.74 144.63 0.09 OUTLIER Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.151 -0.968 . . . . 0.0 109.381 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.583 ' HD2' ' SG ' ' A' ' 54' ' ' CYS . 43.2 Cg_endo -73.57 -61.04 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.97 1.511 . . . . 0.0 109.948 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.456 ' O ' ' N ' ' A' ' 58' ' ' CYS . 12.2 t -102.86 14.73 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.368 -0.833 . . . . 0.0 108.778 179.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.558 ' HA ' ' HB3' ' A' ' 54' ' ' CYS . 0.4 OUTLIER 65.08 -73.31 0.06 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.389 -0.819 . . . . 0.0 109.806 -179.891 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.493 ' HB3' ' HB3' ' A' ' 10' ' ' GLU . 1.8 m 63.95 12.98 7.27 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.95 -1.094 . . . . 0.0 108.544 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.542 ' CG2' ' HG3' ' A' ' 51' ' ' MET . 11.3 tt -119.22 152.25 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.432 -0.792 . . . . 0.0 109.463 -179.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.524 ' CD2' ' O ' ' A' ' 59' ' ' ILE . 18.9 m80 -156.11 170.26 22.6 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.104 -0.998 . . . . 0.0 110.007 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . 0.566 ' HA ' ' CB ' ' A' ' 4' ' ' PHE . 60.6 m95 -94.14 175.1 6.83 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.353 -0.842 . . . . 0.0 109.577 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.471 ' HB3' ' HB3' ' A' ' 3' ' ' LYS . 7.3 tt0 . . . . . 0 N--CA 1.488 1.465 0 O-C-N 121.404 -0.81 . . . . 0.0 109.357 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.51 ' HB3' ' HB3' ' A' ' 62' ' ' GLU . 13.6 tptt . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.554 ' CZ ' ' HB ' ' A' ' 39' ' ' VAL . 49.1 p90 176.39 176.38 0.29 Allowed 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.136 -0.977 . . . . 0.0 109.036 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.519 ' HA ' HG13 ' A' ' 36' ' ' VAL . 23.7 p90 175.66 -157.11 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.662 ' CG2' ' CZ ' ' A' ' 25' ' ' PHE . 0.2 OUTLIER -145.6 -170.57 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 C-N-CA 118.101 -1.439 . . . . 0.0 111.175 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.517 ' O ' ' N ' ' A' ' 9' ' ' ASP . 0.6 OUTLIER -147.41 96.33 2.68 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.121 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.535 ' CG ' ' O ' ' A' ' 34' ' ' ALA . 4.5 mp0 -64.67 40.08 0.02 OUTLIER 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.095 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.517 ' N ' ' O ' ' A' ' 7' ' ' ASP . 0.3 OUTLIER -99.03 -18.05 17.96 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.03 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.429 ' O ' HG13 ' A' ' 56' ' ' VAL . 0.5 OUTLIER -116.32 -9.29 11.56 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.701 -0.624 . . . . 0.0 109.621 -179.739 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.768 ' SG ' ' HG2' ' A' ' 33' ' ' LYS . 42.0 t -60.67 129.52 41.96 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.213 -0.929 . . . . 0.0 109.777 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.523 ' O ' ' CB ' ' A' ' 13' ' ' ALA . 14.3 pt -91.38 -45.32 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.413 -0.805 . . . . 0.0 109.271 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.523 ' CB ' ' O ' ' A' ' 12' ' ' ILE . . . 164.4 -29.9 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.279 -0.888 . . . . 0.0 110.024 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.492 ' SG ' ' HB2' ' A' ' 16' ' ' SER . 0.1 OUTLIER -49.16 154.8 0.75 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.938 -1.101 . . . . 0.0 109.377 -179.669 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.443 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 5.0 mm-40 -116.74 19.2 14.61 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.215 -0.928 . . . . 0.0 109.277 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.492 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 0.6 OUTLIER -43.93 -46.23 8.04 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.264 -0.897 . . . . 0.0 109.269 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.518 ' SG ' ' N ' ' A' ' 18' ' ' VAL . 19.1 p -66.21 -47.56 73.44 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.394 -0.816 . . . . 0.0 109.274 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.518 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 23.7 t -50.65 -38.87 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.261 -0.899 . . . . 0.0 109.305 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -70.19 -37.28 75.08 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.224 -0.922 . . . . 0.0 109.097 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.537 ' O ' ' CG2' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -78.14 5.79 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.316 -0.865 . . . . 0.0 108.696 178.499 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.463 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . . . -179.3 67.55 0.17 Allowed Pre-proline 0 N--CA 1.488 1.426 0 O-C-N 121.116 -0.99 . . . . 0.0 109.292 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -70.78 -2.96 11.74 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.051 1.553 . . . . 0.0 110.49 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.403 ' C ' ' HA3' ' A' ' 41' ' ' GLY . . . -103.52 -33.78 4.07 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.466 ' HB3' ' O ' ' A' ' 38' ' ' ASP . . . -96.95 -51.01 4.41 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.344 -1.092 . . . . 0.0 109.659 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.662 ' CZ ' ' CG2' ' A' ' 6' ' ' VAL . 0.2 OUTLIER -85.54 136.08 33.55 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.307 -0.871 . . . . 0.0 109.572 -179.874 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.435 ' O ' ' CD1' ' A' ' 35' ' ' TYR . . . -163.73 128.83 2.94 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.11 -0.994 . . . . 0.0 109.834 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' MET . . . . . 0.535 ' HG2' ' CA ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -61.89 148.39 43.63 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.191 -0.943 . . . . 0.0 109.952 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.589 ' O ' ' HA ' ' A' ' 32' ' ' GLU . 1.4 t70 -127.51 160.54 59.94 Favored Pre-proline 0 N--CA 1.478 0.966 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 178.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.449 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 44.2 Cg_endo -84.59 -19.24 4.36 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 O-C-N 124.497 1.788 . . . . 0.0 108.653 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -88.94 -33.99 17.06 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 106.452 -1.685 . . . . 0.0 106.452 177.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.632 ' CD1' ' CD1' ' A' ' 35' ' ' TYR . 0.5 OUTLIER -101.78 -0.41 10.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 177.9 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.589 ' HA ' ' O ' ' A' ' 28' ' ' ASP . 17.0 mt-10 27.91 42.41 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.632 0.729 . . . . 0.0 109.654 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.768 ' HG2' ' SG ' ' A' ' 11' ' ' CYS . 0.2 OUTLIER -171.16 157.52 5.15 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -179.135 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.535 ' O ' ' CG ' ' A' ' 8' ' ' GLN . . . -70.27 144.16 51.87 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.118 -0.989 . . . . 0.0 110.719 -178.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.661 ' CE2' ' HA ' ' A' ' 37' ' ' LYS . 2.6 p90 -150.24 159.03 44.74 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.523 ' CG1' ' O ' ' A' ' 36' ' ' VAL . 8.2 p -67.77 67.9 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.814 -1.178 . . . . 0.0 109.219 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.661 ' HA ' ' CE2' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -55.98 -14.8 2.76 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.232 -0.918 . . . . 0.0 110.598 -179.528 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.466 ' O ' ' HB3' ' A' ' 24' ' ' ALA . 26.1 t0 -166.17 92.33 0.49 Allowed 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 119.004 -1.078 . . . . 0.0 109.909 -179.202 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.554 ' HB ' ' CZ ' ' A' ' 4' ' ' PHE . 23.7 m -49.72 -26.13 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.389 -0.819 . . . . 0.0 109.703 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -78.86 -9.96 59.64 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.293 -0.879 . . . . 0.0 109.605 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.403 ' HA3' ' C ' ' A' ' 23' ' ' GLY . . . -79.23 -19.43 72.04 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.463 ' HB3' ' HB3' ' A' ' 21' ' ' ALA . . . -127.39 153.78 45.81 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.191 -1.182 . . . . 0.0 109.45 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.435 ' HB2' ' HG3' ' A' ' 46' ' ' GLU . 0.5 OUTLIER -96.77 -168.15 1.67 Allowed 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.181 -0.949 . . . . 0.0 109.961 -179.738 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.479 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 0.4 OUTLIER -73.89 -57.98 3.61 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.609 -0.682 . . . . 0.0 109.196 179.703 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.403 ' O ' ' HB2' ' A' ' 49' ' ' GLU . 49.0 mm-40 -62.49 -14.43 41.37 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.37 -0.831 . . . . 0.0 109.692 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.435 ' HG3' ' HB2' ' A' ' 43' ' ' SER . 20.3 mt-10 -95.21 -46.48 6.75 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 179.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.48 HG23 ' CE2' ' A' ' 4' ' ' PHE . 5.5 t -59.23 -37.48 69.04 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.317 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.526 ' O ' ' N ' ' A' ' 51' ' ' MET . 0.2 OUTLIER -72.92 -55.49 6.52 Favored 'General case' 0 C--N 1.308 -1.218 0 O-C-N 121.58 -0.7 . . . . 0.0 109.813 179.971 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.481 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . 2.6 tt0 -45.13 -50.57 11.14 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.196 -0.94 . . . . 0.0 108.862 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.516 ' N ' HG22 ' A' ' 20' ' ' ILE . . . -61.69 -28.37 69.36 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.211 -0.931 . . . . 0.0 108.607 179.196 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.526 ' N ' ' O ' ' A' ' 48' ' ' GLU . 43.2 ttm -64.7 -20.1 66.13 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.444 -0.785 . . . . 0.0 109.171 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -107.13 -10.03 15.99 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.374 -0.829 . . . . 0.0 109.432 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.448 ' OG1' ' HA ' ' A' ' 50' ' ' ALA . 23.2 p -97.15 36.12 1.49 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.297 -0.877 . . . . 0.0 110.015 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . 0.784 ' SG ' HG21 ' A' ' 56' ' ' VAL . 49.7 t -126.84 132.82 24.48 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.041 -1.037 . . . . 0.0 109.573 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.87 -32.97 8.42 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 123.835 1.44 . . . . 0.0 109.665 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.784 HG21 ' SG ' ' A' ' 54' ' ' CYS . 7.3 m -98.82 -16.12 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.502 ' N ' ' SG ' ' A' ' 54' ' ' CYS . 6.9 mt-30 42.39 86.71 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.554 -0.716 . . . . 0.0 109.692 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.494 ' O ' ' CE1' ' A' ' 60' ' ' HIS . 8.9 p -120.33 6.17 10.68 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.318 -0.864 . . . . 0.0 109.23 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.526 ' HB ' HG12 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -95.3 127.17 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.268 -0.895 . . . . 0.0 109.931 -179.625 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.494 ' CE1' ' O ' ' A' ' 58' ' ' CYS . 2.4 m80 -131.91 -160.75 1.07 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.376 -0.828 . . . . 0.0 109.041 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . 0.528 ' HA ' ' CB ' ' A' ' 4' ' ' PHE . 49.3 m95 -111.32 174.11 6.02 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.959 -1.088 . . . . 0.0 109.327 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.51 ' HB3' ' HB3' ' A' ' 3' ' ' LYS . 3.1 tt0 . . . . . 0 C--N 1.301 -1.537 0 O-C-N 121.505 -0.747 . . . . 0.0 109.137 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.478 ' HB3' ' HB3' ' A' ' 62' ' ' GLU . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.46 0.648 . . . . 0.0 109.805 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.569 ' CZ ' ' HB ' ' A' ' 39' ' ' VAL . 8.1 p90 168.59 176.87 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.555 ' HA ' ' CG1' ' A' ' 36' ' ' VAL . 18.9 p90 178.52 -174.2 0.17 Allowed 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.672 ' CG2' ' CZ ' ' A' ' 25' ' ' PHE . 0.4 OUTLIER -132.69 168.45 24.16 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.12 0 C-N-CA 117.546 -1.662 . . . . 0.0 111.333 -179.393 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.517 ' C ' ' H ' ' A' ' 9' ' ' ASP . 9.5 t0 -116.07 89.91 3.21 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.587 ' CG ' ' O ' ' A' ' 34' ' ' ALA . 1.4 mp0 -63.24 42.3 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.949 -0.47 . . . . 0.0 111.004 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.517 ' H ' ' C ' ' A' ' 7' ' ' ASP . 0.4 OUTLIER -101.07 -28.32 12.77 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.177 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -119.53 21.74 11.97 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.498 ' HB3' ' CD ' ' A' ' 33' ' ' LYS . 8.7 t -76.77 122.51 24.86 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.186 -0.946 . . . . 0.0 110.055 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.536 ' O ' ' CB ' ' A' ' 13' ' ' ALA . 37.7 pt -73.39 -5.76 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.405 -0.809 . . . . 0.0 109.436 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.536 ' CB ' ' O ' ' A' ' 12' ' ' ILE . . . 79.76 32.78 0.21 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.461 -0.775 . . . . 0.0 110.129 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.785 ' SG ' ' HB2' ' A' ' 16' ' ' SER . 1.3 p -95.78 151.93 18.93 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.097 -1.002 . . . . 0.0 109.178 179.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.472 ' O ' ' HB2' ' A' ' 19' ' ' GLU . 2.1 pt-20 -82.03 5.85 18.05 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.19 -0.944 . . . . 0.0 110.353 -179.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.785 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 3.6 m -43.78 -82.64 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.127 -0.983 . . . . 0.0 109.432 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.751 ' SG ' ' CD2' ' A' ' 25' ' ' PHE . 13.0 p -47.32 -56.83 6.07 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.25 -0.906 . . . . 0.0 109.617 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.666 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 74.1 t -47.29 -27.2 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.394 -0.816 . . . . 0.0 110.186 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 15' ' ' GLU . 0.1 OUTLIER -81.03 -40.14 24.72 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.966 -1.084 . . . . 0.0 109.673 -179.685 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.593 ' CD1' ' CG2' ' A' ' 53' ' ' THR . 2.4 mt -84.18 13.8 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.457 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . . . 177.84 65.92 0.09 OUTLIER Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.378 -0.826 . . . . 0.0 109.333 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -74.23 1.62 7.08 Favored 'Trans proline' 0 C--N 1.303 -1.837 0 O-C-N 124.069 1.563 . . . . 0.0 110.718 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.468 ' O ' ' HB3' ' A' ' 38' ' ' ASP . . . -97.77 -45.07 2.54 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.468 ' HA ' ' O ' ' A' ' 38' ' ' ASP . . . -87.78 -47.1 8.89 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.255 -1.144 . . . . 0.0 109.559 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.751 ' CD2' ' SG ' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -92.62 134.83 34.63 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.263 -0.898 . . . . 0.0 109.121 179.859 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.577 ' O ' ' CD1' ' A' ' 35' ' ' TYR . . . -157.95 118.63 3.44 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.386 -0.821 . . . . 0.0 109.587 179.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' MET . . . . . 0.54 ' HA ' ' C ' ' A' ' 33' ' ' LYS . 14.6 mtm -59.15 149.6 27.64 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.114 -0.991 . . . . 0.0 109.37 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.612 ' O ' ' N ' ' A' ' 32' ' ' GLU . 1.3 t0 -126.95 163.13 43.39 Favored Pre-proline 0 C--N 1.312 -1.031 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 179.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.447 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 43.9 Cg_endo -83.95 -16.76 6.19 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 124.95 2.026 . . . . 0.0 108.086 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.24 -38.83 17.2 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 178.066 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.606 ' CG1' ' CB ' ' A' ' 28' ' ' ASP . 2.6 pt -102.24 -2.2 9.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.612 ' N ' ' O ' ' A' ' 28' ' ' ASP . 3.9 mm-40 34.35 36.23 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 -178.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.54 ' C ' ' HA ' ' A' ' 27' ' ' MET . 11.1 mttm -161.41 148.64 14.81 Favored 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 119.37 -0.932 . . . . 0.0 110.501 -177.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.587 ' O ' ' CG ' ' A' ' 8' ' ' GLN . . . -58.59 143.99 44.41 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.478 -0.764 . . . . 0.0 109.901 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.627 ' CZ ' ' HB3' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -142.31 139.76 31.94 Favored 'General case' 0 N--CA 1.5 2.039 0 CA-C-O 121.803 0.811 . . . . 0.0 110.199 179.461 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.555 ' CG1' ' HA ' ' A' ' 5' ' ' TYR . 7.9 p -74.34 61.61 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.123 -0.986 . . . . 0.0 108.673 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.627 ' HB3' ' CZ ' ' A' ' 35' ' ' TYR . 0.1 OUTLIER -71.4 -18.34 62.35 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.303 -0.873 . . . . 0.0 110.607 -178.992 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.468 ' HB3' ' O ' ' A' ' 23' ' ' GLY . 57.2 t0 -135.21 75.62 1.58 Allowed 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.055 -1.028 . . . . 0.0 109.722 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.569 ' HB ' ' CZ ' ' A' ' 4' ' ' PHE . 6.4 m -51.81 -24.35 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.273 -0.892 . . . . 0.0 108.935 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.427 ' N ' HG21 ' A' ' 39' ' ' VAL . 2.0 mt-10 -90.16 1.81 56.01 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.335 -0.853 . . . . 0.0 109.365 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.43 ' O ' ' HA3' ' A' ' 23' ' ' GLY . . . -96.04 34.75 4.72 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.457 ' HB3' ' HB3' ' A' ' 21' ' ' ALA . . . -179.66 126.65 0.08 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.251 -1.147 . . . . 0.0 109.615 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.529 ' N ' ' HG2' ' A' ' 46' ' ' GLU . 0.3 OUTLIER -59.22 165.67 2.52 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.298 -0.876 . . . . 0.0 109.542 179.768 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.493 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 0.1 OUTLIER -71.67 -37.44 70.76 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.333 -0.854 . . . . 0.0 109.467 179.995 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -71.73 -20.26 61.92 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.075 -1.015 . . . . 0.0 109.286 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.529 ' HG2' ' N ' ' A' ' 43' ' ' SER . 5.3 pt-20 -95.08 -34.08 12.44 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 106.517 -1.661 . . . . 0.0 106.517 178.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.488 ' CG2' ' O ' ' A' ' 43' ' ' SER . 25.1 t -64.25 -46.82 92.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 177.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.493 ' HB2' ' O ' ' A' ' 44' ' ' GLN . 0.2 OUTLIER -64.77 -51.3 63.02 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.615 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -51.74 -40.57 60.46 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.581 ' CB ' ' HB ' ' A' ' 20' ' ' ILE . . . -72.41 -32.73 66.61 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.523 ' HG3' ' CD1' ' A' ' 59' ' ' ILE . 34.6 ttm -74.41 -24.88 59.17 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.645 -0.659 . . . . 0.0 110.103 -179.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -86.3 -26.35 24.97 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.047 -1.033 . . . . 0.0 109.882 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.593 ' CG2' ' CD1' ' A' ' 20' ' ' ILE . 13.8 t -73.01 -5.89 41.84 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.137 -0.977 . . . . 0.0 109.772 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . 0.625 ' SG ' ' HD2' ' A' ' 55' ' ' PRO . 19.4 t -79.09 142.61 59.82 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.163 -0.961 . . . . 0.0 109.743 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.625 ' HD2' ' SG ' ' A' ' 54' ' ' CYS . 42.9 Cg_endo -76.35 -72.38 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.07 1.563 . . . . 0.0 109.945 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.418 ' O ' ' HB2' ' A' ' 57' ' ' GLN . 2.5 t -74.5 -18.18 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.096 -1.003 . . . . 0.0 108.761 179.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.451 ' O ' ' C ' ' A' ' 58' ' ' CYS . 0.0 OUTLIER 71.9 -64.57 0.38 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.431 -0.793 . . . . 0.0 110.139 179.582 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.451 ' C ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER 42.05 37.9 0.95 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.334 -0.854 . . . . 0.0 108.799 -179.467 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.57 ' O ' ' CG ' ' A' ' 60' ' ' HIS . 7.6 tt -121.48 157.46 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.303 -0.873 . . . . 0.0 110.096 -179.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.57 ' CG ' ' O ' ' A' ' 59' ' ' ILE . 23.5 m80 -159.3 132.62 7.14 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.353 -0.842 . . . . 0.0 109.655 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . 0.547 ' HA ' ' CB ' ' A' ' 4' ' ' PHE . 57.3 m95 -71.26 168.72 16.7 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.239 -0.913 . . . . 0.0 109.141 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.494 ' N ' ' HA ' ' A' ' 4' ' ' PHE . 1.4 tt0 . . . . . 0 N--CA 1.488 1.444 0 O-C-N 121.186 -0.946 . . . . 0.0 109.644 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.476 ' HB3' ' HB3' ' A' ' 62' ' ' GLU . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.269 0.557 . . . . 0.0 109.758 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.588 ' CE1' HG13 ' A' ' 39' ' ' VAL . 14.4 p90 167.98 -174.33 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.269 -0.894 . . . . 0.0 109.657 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.509 ' O ' HG13 ' A' ' 59' ' ' ILE . 4.4 p90 176.18 -172.63 0.08 Allowed 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.596 ' CG2' ' CG2' ' A' ' 36' ' ' VAL . 0.2 OUTLIER -135.78 164.89 31.25 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 C-N-CA 118.056 -1.458 . . . . 0.0 111.086 179.685 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.569 ' OD2' ' CE1' ' A' ' 60' ' ' HIS . 5.5 m-20 -109.1 90.88 3.43 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.496 ' HG2' ' HB3' ' A' ' 35' ' ' TYR . 5.2 mp0 -66.22 48.24 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.66 0 CA-C-O 121.884 0.85 . . . . 0.0 110.002 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.527 ' N ' ' O ' ' A' ' 7' ' ' ASP . 11.0 t0 -110.53 -39.96 4.76 Favored 'General case' 0 C--N 1.285 -2.22 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.412 ' HB2' ' SG ' ' A' ' 58' ' ' CYS . 0.0 OUTLIER -101.25 20.49 15.69 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.307 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.475 ' HB3' ' HG2' ' A' ' 33' ' ' LYS . 11.1 t -86.44 134.99 33.65 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.308 -0.87 . . . . 0.0 110.085 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.506 ' O ' ' CB ' ' A' ' 13' ' ' ALA . 30.3 pt -105.09 -6.15 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.353 -0.842 . . . . 0.0 108.78 179.029 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.506 ' CB ' ' O ' ' A' ' 12' ' ' ILE . . . 76.53 70.85 0.07 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.344 -0.848 . . . . 0.0 109.45 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 1.214 ' SG ' ' OG ' ' A' ' 16' ' ' SER . 27.4 p -103.89 -11.45 17.48 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.124 -0.985 . . . . 0.0 109.697 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.52 ' CB ' ' O ' ' A' ' 14' ' ' CYS . 3.1 tt0 76.29 -1.65 2.88 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.212 -0.93 . . . . 0.0 110.253 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 1.214 ' OG ' ' SG ' ' A' ' 14' ' ' CYS . 0.2 OUTLIER -61.76 -67.11 0.44 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.975 -1.078 . . . . 0.0 109.294 179.89 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.723 ' SG ' ' CD2' ' A' ' 25' ' ' PHE . 14.2 p -54.77 -44.12 73.39 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.21 -0.931 . . . . 0.0 109.103 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.463 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 21.2 t -54.31 -19.69 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.304 -0.872 . . . . 0.0 109.16 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.27 -41.54 14.51 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.172 -0.955 . . . . 0.0 109.107 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.556 ' HB ' ' CB ' ' A' ' 50' ' ' ALA . 1.9 mt -85.84 16.23 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 177.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.42 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . . . -177.54 59.95 0.15 Allowed Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.429 -0.795 . . . . 0.0 109.062 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -74.25 -0.11 9.21 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 124.075 1.566 . . . . 0.0 110.402 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.477 ' O ' ' HB3' ' A' ' 38' ' ' ASP . . . -111.43 -26.88 4.37 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.523 ' CB ' ' O ' ' A' ' 38' ' ' ASP . . . -100.34 -47.25 4.99 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.362 -1.081 . . . . 0.0 109.604 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.723 ' CD2' ' SG ' ' A' ' 17' ' ' CYS . 0.1 OUTLIER -90.61 140.4 29.79 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.373 -0.829 . . . . 0.0 109.045 -179.96 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.523 ' O ' ' CD1' ' A' ' 35' ' ' TYR . . . -164.48 119.57 1.45 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.147 -0.97 . . . . 0.0 109.943 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' MET . . . . . 0.513 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 5.7 ttm -60.14 152.22 24.94 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.098 -1.001 . . . . 0.0 109.159 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.606 ' O ' ' N ' ' A' ' 32' ' ' GLU . 2.8 t0 -125.97 160.14 58.33 Favored Pre-proline 0 C--N 1.312 -1.06 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 179.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.445 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 43.9 Cg_endo -84.88 -16.15 5.46 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 O-C-N 124.662 1.875 . . . . 0.0 108.585 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.75 -28.0 16.87 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 177.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.554 HG12 ' CB ' ' A' ' 28' ' ' ASP . 0.8 OUTLIER -108.46 -0.81 9.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 177.905 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.606 ' N ' ' O ' ' A' ' 28' ' ' ASP . 19.6 mt-10 28.73 42.73 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.595 0.712 . . . . 0.0 109.625 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.502 ' C ' ' HA ' ' A' ' 27' ' ' MET . 1.0 OUTLIER -169.44 148.19 3.76 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 119.365 -0.934 . . . . 0.0 110.287 -179.051 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.513 ' HA ' ' HA ' ' A' ' 27' ' ' MET . . . -57.2 143.76 37.88 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.453 -0.779 . . . . 0.0 110.67 -179.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.633 ' O ' ' CD1' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -144.03 143.09 31.03 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.732 0.777 . . . . 0.0 109.607 179.094 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.596 ' CG2' ' CG2' ' A' ' 6' ' ' VAL . 2.1 t -86.2 91.67 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 120.816 -1.178 . . . . 0.0 108.153 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.592 ' HB3' ' CE2' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -104.3 -16.22 15.22 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.343 -0.848 . . . . 0.0 110.605 -178.82 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.523 ' O ' ' CB ' ' A' ' 24' ' ' ALA . 36.9 t70 -129.66 90.92 3.06 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 120.984 -1.072 . . . . 0.0 109.696 -179.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.588 HG13 ' CE1' ' A' ' 4' ' ' PHE . 28.7 m -58.27 -39.77 75.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.22 -0.925 . . . . 0.0 109.578 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.466 ' HG2' ' OD1' ' A' ' 38' ' ' ASP . 1.3 pt-20 -64.6 -16.53 62.86 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.248 -0.907 . . . . 0.0 109.258 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.513 ' N ' ' OD2' ' A' ' 38' ' ' ASP . . . -76.59 0.76 63.86 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.694 -1.363 . . . . 0.0 109.694 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.42 ' HB3' ' HB3' ' A' ' 21' ' ' ALA . . . -160.04 103.91 1.49 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.179 -1.189 . . . . 0.0 109.512 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.472 ' OG ' ' OE2' ' A' ' 46' ' ' GLU . 0.4 OUTLIER -50.19 162.65 0.2 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.27 -0.894 . . . . 0.0 109.69 -179.876 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.475 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 15.1 pt20 -48.97 -50.17 36.99 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.434 -0.791 . . . . 0.0 109.43 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.403 ' N ' ' HG3' ' A' ' 44' ' ' GLN . 25.9 mm-40 -63.21 -13.04 33.04 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.298 -0.876 . . . . 0.0 109.359 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.472 ' OE2' ' OG ' ' A' ' 43' ' ' SER . 7.3 mt-10 -93.48 -52.77 4.35 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 179.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.457 ' O ' ' HB2' ' A' ' 51' ' ' MET . 2.5 t -53.67 -38.7 35.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 178.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' A' ' 44' ' ' GLN . 0.1 OUTLIER -69.08 -55.63 10.19 Favored 'General case' 0 C--N 1.309 -1.173 0 O-C-N 121.499 -0.751 . . . . 0.0 109.776 179.775 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.487 ' CB ' HG23 ' A' ' 20' ' ' ILE . 20.3 mm-40 -53.2 -49.77 66.06 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.143 -0.973 . . . . 0.0 108.765 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.556 ' CB ' ' HB ' ' A' ' 20' ' ' ILE . . . -65.6 -11.1 41.32 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.429 -0.794 . . . . 0.0 108.931 179.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.463 ' SD ' ' CD1' ' A' ' 59' ' ' ILE . 0.0 OUTLIER -83.92 -43.78 14.92 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.453 -0.78 . . . . 0.0 109.938 -179.372 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -76.41 -22.36 54.82 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.335 -0.853 . . . . 0.0 110.205 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.474 HG22 ' CD1' ' A' ' 20' ' ' ILE . 7.6 t -69.95 -6.05 30.43 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.052 -1.03 . . . . 0.0 109.69 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . 0.519 ' SG ' ' HD2' ' A' ' 55' ' ' PRO . 16.1 t -85.95 139.97 34.99 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.152 -0.968 . . . . 0.0 109.557 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.519 ' HD2' ' SG ' ' A' ' 54' ' ' CYS . 46.0 Cg_endo -74.27 -49.52 0.18 Allowed 'Trans proline' 0 C--N 1.303 -1.819 0 O-C-N 124.051 1.553 . . . . 0.0 110.138 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.474 ' O ' ' HB2' ' A' ' 57' ' ' GLN . 5.4 t -97.28 -11.78 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.301 -0.874 . . . . 0.0 109.078 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.477 ' HA ' ' HB3' ' A' ' 54' ' ' CYS . 13.6 mt-30 65.43 -85.43 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.464 -0.773 . . . . 0.0 110.028 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.439 ' SG ' ' HB2' ' A' ' 7' ' ' ASP . 7.2 t 58.79 31.99 21.77 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.067 -1.021 . . . . 0.0 108.823 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.522 HD13 ' CG1' ' A' ' 6' ' ' VAL . 1.2 tt -110.84 156.65 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.354 -0.841 . . . . 0.0 109.724 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.569 ' CE1' ' OD2' ' A' ' 7' ' ' ASP . 13.6 m80 -154.03 136.54 15.07 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.116 -0.99 . . . . 0.0 109.797 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . 0.539 ' HA ' ' CB ' ' A' ' 4' ' ' PHE . 56.8 m95 -78.74 166.88 21.97 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.39 -0.819 . . . . 0.0 109.499 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.515 ' N ' ' HA ' ' A' ' 4' ' ' PHE . 45.2 tt0 . . . . . 0 N--CA 1.489 1.511 0 O-C-N 121.342 -0.849 . . . . 0.0 109.32 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.589 ' CG ' ' CG ' ' A' ' 62' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.041 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.581 ' CE2' HG12 ' A' ' 36' ' ' VAL . 28.6 p90 -173.48 -177.59 1.5 Allowed 'General case' 0 C--N 1.296 -1.747 0 O-C-N 121.205 -0.935 . . . . 0.0 109.496 -179.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.55 ' CD1' ' HB2' ' A' ' 62' ' ' GLU . 14.3 p90 175.1 -172.05 0.06 Allowed 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.595 HG23 ' CZ ' ' A' ' 25' ' ' PHE . 0.2 OUTLIER -134.34 172.33 16.38 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 C-N-CA 117.594 -1.642 . . . . 0.0 111.162 179.565 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.496 ' O ' ' N ' ' A' ' 9' ' ' ASP . 13.5 t70 -122.29 90.18 3.25 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.566 ' CG ' ' O ' ' A' ' 34' ' ' ALA . 6.9 mp0 -66.45 48.92 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.748 0.785 . . . . 0.0 109.81 179.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.496 ' N ' ' O ' ' A' ' 7' ' ' ASP . 0.5 OUTLIER -114.08 -25.7 8.41 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.588 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.457 ' HB3' ' SG ' ' A' ' 58' ' ' CYS . 0.1 OUTLIER -110.22 -19.71 12.92 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.649 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.462 ' O ' ' HD3' ' A' ' 33' ' ' LYS . 42.0 t -46.75 141.92 3.62 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.425 -0.797 . . . . 0.0 109.471 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.582 ' O ' ' CB ' ' A' ' 13' ' ' ALA . 11.8 pt -99.34 -51.93 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.068 -1.02 . . . . 0.0 109.545 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.582 ' CB ' ' O ' ' A' ' 12' ' ' ILE . . . 154.91 35.48 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.543 -0.723 . . . . 0.0 110.276 179.287 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.632 ' SG ' ' HB2' ' A' ' 16' ' ' SER . 0.5 OUTLIER -105.08 158.53 16.5 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.667 -1.271 . . . . 0.0 109.719 179.557 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.455 ' O ' ' N ' ' A' ' 19' ' ' GLU . 11.6 mt-10 -99.07 12.97 34.5 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.306 -0.871 . . . . 0.0 109.833 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.632 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 3.7 m -45.03 -76.34 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.087 -1.008 . . . . 0.0 109.052 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.995 ' SG ' ' CD2' ' A' ' 25' ' ' PHE . 10.6 p -52.6 -49.15 65.62 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.38 -0.825 . . . . 0.0 109.125 179.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.581 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 60.8 t -52.13 -24.7 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.311 -0.868 . . . . 0.0 109.226 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.455 ' N ' ' O ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -83.61 -36.02 24.21 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.219 -0.926 . . . . 0.0 109.173 179.76 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.559 ' HB ' ' CB ' ' A' ' 50' ' ' ALA . 2.7 mp -83.43 10.56 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.529 ' CB ' ' HB3' ' A' ' 42' ' ' ALA . . . 178.08 68.71 0.1 Allowed Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.393 -0.817 . . . . 0.0 108.879 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -69.93 -1.19 8.21 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 124.166 1.614 . . . . 0.0 110.887 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.478 ' O ' ' HB3' ' A' ' 38' ' ' ASP . . . -105.34 -44.44 1.46 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.53 ' CB ' ' O ' ' A' ' 38' ' ' ASP . . . -83.46 -36.42 24.19 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.374 -1.074 . . . . 0.0 109.844 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.995 ' CD2' ' SG ' ' A' ' 17' ' ' CYS . 0.1 OUTLIER -105.73 140.71 38.36 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.342 -0.848 . . . . 0.0 109.23 -179.682 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.522 ' O ' ' CD1' ' A' ' 35' ' ' TYR . . . -171.27 120.37 0.5 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.151 -0.968 . . . . 0.0 109.459 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' MET . . . . . 0.534 ' HA ' ' C ' ' A' ' 33' ' ' LYS . 10.5 mtp -58.41 153.73 15.16 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.08 -1.013 . . . . 0.0 109.232 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.613 ' O ' ' N ' ' A' ' 32' ' ' GLU . 1.4 t0 -132.97 165.07 39.4 Favored Pre-proline 0 C--N 1.312 -1.063 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.479 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 43.8 Cg_endo -84.59 -15.11 6.29 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 124.654 1.871 . . . . 0.0 107.459 178.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.441 ' HB3' HD11 ' A' ' 31' ' ' ILE . 4.4 tt0 -83.54 -39.24 20.66 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 177.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.543 HG12 ' CB ' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -106.2 1.24 10.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.103 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.613 ' N ' ' O ' ' A' ' 28' ' ' ASP . 22.6 mt-10 33.84 36.42 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 -179.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.547 ' CG ' ' O ' ' A' ' 32' ' ' GLU . 17.9 mttm -164.72 149.6 9.61 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 119.203 -0.999 . . . . 0.0 110.565 -177.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.566 ' O ' ' CG ' ' A' ' 8' ' ' GLN . . . -53.07 141.83 21.64 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.574 -0.704 . . . . 0.0 109.658 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.642 ' O ' ' CD1' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -144.69 140.67 28.76 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 122.044 0.926 . . . . 0.0 109.901 179.347 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.59 ' CG2' ' CG2' ' A' ' 6' ' ' VAL . 1.7 t -84.57 97.31 5.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -179.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.568 ' HG2' ' CE1' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -115.87 -10.62 11.65 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.278 -0.889 . . . . 0.0 111.193 -178.604 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.53 ' O ' ' CB ' ' A' ' 24' ' ' ALA . 33.9 t0 -133.03 87.91 2.45 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.792 -1.192 . . . . 0.0 110.098 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 24.0 m -54.08 -34.89 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.258 -0.901 . . . . 0.0 109.343 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 74.3 mt-10 -69.5 -14.03 62.65 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.4 -0.813 . . . . 0.0 109.601 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -76.44 -2.08 73.0 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.529 ' HB3' ' CB ' ' A' ' 21' ' ' ALA . . . -162.5 135.57 5.92 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.209 -1.171 . . . . 0.0 109.46 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.458 ' OG ' ' HG3' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -77.23 166.43 23.22 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.283 -0.886 . . . . 0.0 109.84 -179.75 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.466 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 5.4 pt20 -54.9 -43.2 73.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.45 -0.781 . . . . 0.0 109.633 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.433 ' N ' ' HG3' ' A' ' 44' ' ' GLN . 33.4 mm-40 -69.18 -11.04 60.45 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.235 -0.916 . . . . 0.0 109.163 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.458 ' HG3' ' OG ' ' A' ' 43' ' ' SER . 18.3 mt-10 -94.72 -44.63 7.7 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 178.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.557 HG12 ' CE2' ' A' ' 4' ' ' PHE . 72.6 t -60.83 -37.26 76.01 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 177.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.466 ' HB2' ' O ' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -67.93 -59.65 3.11 Favored 'General case' 0 C--N 1.31 -1.146 0 O-C-N 121.502 -0.749 . . . . 0.0 109.298 179.108 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.405 ' OE1' HG21 ' A' ' 20' ' ' ILE . 8.8 tt0 -51.59 -47.48 63.55 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.441 -0.903 . . . . 0.0 109.101 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.559 ' CB ' ' HB ' ' A' ' 20' ' ' ILE . . . -61.62 -27.42 68.64 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.3 -0.875 . . . . 0.0 109.204 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.591 ' CG ' ' CG2' ' A' ' 59' ' ' ILE . 0.8 OUTLIER -70.97 -27.14 63.51 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.544 -0.723 . . . . 0.0 110.405 -179.21 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -94.68 -8.45 37.82 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.919 -1.113 . . . . 0.0 110.127 -179.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.472 ' CB ' HD12 ' A' ' 20' ' ' ILE . 91.7 m -88.07 -17.96 29.93 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.073 -1.017 . . . . 0.0 110.052 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . 0.814 ' SG ' ' HD2' ' A' ' 55' ' ' PRO . 35.5 t -69.73 147.07 96.24 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.028 -1.045 . . . . 0.0 109.783 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.814 ' HD2' ' SG ' ' A' ' 54' ' ' CYS . 45.0 Cg_endo -77.9 -63.32 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.119 1.589 . . . . 0.0 109.781 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 75.9 t -80.65 -6.02 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.287 -0.883 . . . . 0.0 109.081 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.415 ' HA ' ' HB3' ' A' ' 54' ' ' CYS . 44.9 mt-30 45.8 71.46 0.28 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.315 -0.866 . . . . 0.0 109.545 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.46 ' O ' HG11 ' A' ' 6' ' ' VAL . 2.5 m -94.44 21.1 7.5 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.277 -0.889 . . . . 0.0 109.129 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.591 ' CG2' ' CG ' ' A' ' 51' ' ' MET . 1.9 tt -105.19 142.41 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.453 -0.78 . . . . 0.0 109.833 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.436 ' CG ' ' C ' ' A' ' 59' ' ' ILE . 6.5 m80 -149.83 142.31 24.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.471 -0.768 . . . . 0.0 109.118 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . 0.555 ' HA ' ' CB ' ' A' ' 4' ' ' PHE . 64.5 m95 -59.5 175.28 0.35 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.22 -0.925 . . . . 0.0 109.744 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.589 ' CG ' ' CG ' ' A' ' 3' ' ' LYS . 1.4 tp10 . . . . . 0 C--N 1.302 -1.466 0 O-C-N 121.475 -0.766 . . . . 0.0 109.116 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.482 ' O ' ' HB3' ' A' ' 4' ' ' PHE . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.333 0.587 . . . . 0.0 109.677 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.574 ' CE2' HG12 ' A' ' 36' ' ' VAL . 12.5 p90 177.07 -163.91 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.453 -0.779 . . . . 0.0 109.175 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.56 ' HA ' HG23 ' A' ' 36' ' ' VAL . 52.2 p90 171.44 -178.32 0.05 Allowed 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.574 HG23 ' CE2' ' A' ' 25' ' ' PHE . 3.7 t -143.71 155.58 16.13 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.338 0 C-N-CA 117.205 -1.798 . . . . 0.0 111.301 179.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.525 ' O ' ' N ' ' A' ' 9' ' ' ASP . 0.2 OUTLIER -102.14 74.87 1.46 Allowed 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 178.864 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.507 ' HB3' ' O ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER -40.98 -24.43 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.523 0.678 . . . . 0.0 109.372 179.871 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.525 ' N ' ' O ' ' A' ' 7' ' ' ASP . 0.2 OUTLIER -54.27 -31.22 53.14 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.421 -0.799 . . . . 0.0 109.121 179.816 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.424 ' HB3' ' HB3' ' A' ' 58' ' ' CYS . 1.4 tp10 -100.83 11.27 39.91 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.346 -0.846 . . . . 0.0 109.152 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 6.6 t -76.97 122.03 24.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.242 -0.911 . . . . 0.0 109.905 -179.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.477 HG13 ' N ' ' A' ' 13' ' ' ALA . 16.4 pt -70.96 -145.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.41 -0.806 . . . . 0.0 109.413 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.477 ' N ' HG13 ' A' ' 12' ' ' ILE . . . -111.71 55.77 0.66 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.053 -1.029 . . . . 0.0 109.575 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.443 ' HB3' HD13 ' A' ' 12' ' ' ILE . 0.1 OUTLIER -139.35 155.37 47.72 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.121 -0.987 . . . . 0.0 109.692 179.858 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.43 ' O ' ' C ' ' A' ' 16' ' ' SER . 13.3 pt-20 -118.44 20.36 13.06 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.366 -0.833 . . . . 0.0 109.534 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.43 ' C ' ' O ' ' A' ' 15' ' ' GLU . 0.2 OUTLIER -43.65 -60.95 1.56 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.354 -0.841 . . . . 0.0 109.269 179.899 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.533 ' SG ' ' N ' ' A' ' 18' ' ' VAL . 19.5 p -49.17 -48.59 44.92 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.386 -0.821 . . . . 0.0 109.297 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.533 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 5.0 t -49.6 -36.45 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.355 -0.841 . . . . 0.0 109.578 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.426 ' N ' ' OE1' ' A' ' 19' ' ' GLU . 0.2 OUTLIER -73.77 -35.91 65.03 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.041 -1.037 . . . . 0.0 109.321 -179.949 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.527 ' HB ' ' CB ' ' A' ' 50' ' ' ALA . 2.5 mp -84.84 12.47 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.241 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -171.34 66.48 0.43 Allowed Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.355 -0.84 . . . . 0.0 109.311 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -72.51 56.42 2.77 Favored 'Trans proline' 0 C--N 1.303 -1.842 0 O-C-N 124.091 1.574 . . . . 0.0 110.058 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -179.85 -34.45 0.07 OUTLIER Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.464 ' CB ' ' O ' ' A' ' 38' ' ' ASP . . . -94.72 -25.28 16.77 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.246 -1.149 . . . . 0.0 109.303 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.574 ' CE2' HG23 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -123.83 135.31 53.69 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.31 -0.869 . . . . 0.0 109.287 179.839 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.477 ' O ' ' HA ' ' A' ' 34' ' ' ALA . . . -163.05 145.15 10.16 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' MET . . . . . 0.513 ' HG3' ' CA ' ' A' ' 33' ' ' LYS . 10.7 ttm -77.72 152.7 33.55 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.96 -1.087 . . . . 0.0 109.123 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.636 ' O ' ' N ' ' A' ' 32' ' ' GLU . 1.1 t0 -123.84 162.26 41.98 Favored Pre-proline 0 C--N 1.313 -1.019 0 N-CA-C 106.614 -1.624 . . . . 0.0 106.614 179.067 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.427 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 46.5 Cg_endo -84.29 -15.09 6.67 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 125.06 2.084 . . . . 0.0 108.109 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -88.26 -34.34 17.75 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 178.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.587 ' CG1' ' CB ' ' A' ' 28' ' ' ASP . 1.6 pt -107.72 -2.49 10.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.042 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.636 ' N ' ' O ' ' A' ' 28' ' ' ASP . 0.0 OUTLIER 35.25 35.05 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -178.74 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.522 ' N ' ' O ' ' A' ' 31' ' ' ILE . 23.7 mmtp -157.87 152.92 25.53 Favored 'General case' 0 N--CA 1.499 2.022 0 C-N-CA 119.42 -0.912 . . . . 0.0 110.542 -177.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.507 ' O ' ' HB3' ' A' ' 8' ' ' GLN . . . -61.74 142.75 57.06 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.616 -0.677 . . . . 0.0 110.059 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.634 ' CE2' ' HA ' ' A' ' 37' ' ' LYS . 11.6 p90 -144.0 168.5 19.83 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 178.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.574 HG12 ' CE2' ' A' ' 4' ' ' PHE . 0.2 OUTLIER -85.16 78.39 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.272 0 CA-C-O 121.782 0.801 . . . . 0.0 109.04 -178.079 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.634 ' HA ' ' CE2' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -68.89 -3.74 13.82 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.846 -0.534 . . . . 0.0 110.539 -179.125 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.481 ' HB2' ' O ' ' A' ' 37' ' ' LYS . 36.7 t0 179.87 128.6 0.08 Allowed 'General case' 0 C--N 1.299 -1.611 0 C-N-CA 118.73 -1.188 . . . . 0.0 110.004 -178.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.462 HG11 ' CE1' ' A' ' 4' ' ' PHE . 15.8 m -79.6 -30.66 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.22 -0.925 . . . . 0.0 109.698 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -84.07 -9.75 58.38 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.183 -0.948 . . . . 0.0 109.267 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -61.95 -21.74 61.6 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.46 ' HB1' ' CB ' ' A' ' 24' ' ' ALA . . . -136.21 138.59 42.03 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.235 -1.156 . . . . 0.0 109.737 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.463 ' O ' ' N ' ' A' ' 46' ' ' GLU . 0.1 OUTLIER -71.66 158.32 36.38 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.244 -0.91 . . . . 0.0 109.643 -179.957 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.474 ' HA ' HG22 ' A' ' 47' ' ' VAL . 0.9 OUTLIER -47.53 -46.65 27.8 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.455 -0.778 . . . . 0.0 109.514 179.89 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -67.04 -9.54 40.21 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.292 -0.88 . . . . 0.0 109.449 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.463 ' N ' ' O ' ' A' ' 43' ' ' SER . 27.5 mt-10 -97.91 -41.84 7.82 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 178.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.474 HG22 ' HA ' ' A' ' 44' ' ' GLN . 2.1 t -62.18 -40.59 88.17 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.924 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 178.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.415 ' HB2' ' O ' ' A' ' 44' ' ' GLN . 0.4 OUTLIER -73.17 -56.17 5.46 Favored 'General case' 0 C--N 1.308 -1.211 0 O-C-N 121.673 -0.642 . . . . 0.0 109.648 179.585 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.453 ' HB3' ' CG2' ' A' ' 20' ' ' ILE . 34.0 tt0 -52.94 -45.57 67.74 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.172 -0.955 . . . . 0.0 108.806 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.527 ' CB ' ' HB ' ' A' ' 20' ' ' ILE . . . -64.31 -17.87 64.07 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.32 -0.863 . . . . 0.0 108.93 179.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.573 ' HE2' ' CZ2' ' A' ' 61' ' ' TRP . 2.6 ttm -80.93 -41.61 22.65 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.562 -0.712 . . . . 0.0 109.581 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -69.06 -24.54 64.18 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.282 -0.886 . . . . 0.0 109.704 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.525 ' CG2' HD12 ' A' ' 20' ' ' ILE . 4.9 p -72.5 -33.24 66.8 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.12 -0.988 . . . . 0.0 109.975 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . 0.788 ' SG ' ' HD2' ' A' ' 55' ' ' PRO . 9.4 t -65.19 146.6 98.91 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.056 -1.028 . . . . 0.0 109.864 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.788 ' HD2' ' SG ' ' A' ' 54' ' ' CYS . 45.2 Cg_endo -79.15 -69.49 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 124.099 1.579 . . . . 0.0 110.105 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 9.8 p -75.44 -16.43 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.201 -0.937 . . . . 0.0 108.791 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 63.94 47.81 3.33 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.449 -0.782 . . . . 0.0 109.837 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.494 ' O ' ' CE1' ' A' ' 60' ' ' HIS . 11.5 p -48.61 -23.57 1.05 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.224 -0.923 . . . . 0.0 109.212 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.54 ' CG2' ' HG3' ' A' ' 51' ' ' MET . 6.6 tt -69.32 159.09 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.574 -0.703 . . . . 0.0 110.047 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.527 ' C ' ' CD1' ' A' ' 61' ' ' TRP . 46.9 m80 -149.82 -134.19 0.06 Allowed 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . 0.573 ' CZ2' ' HE2' ' A' ' 51' ' ' MET . 74.4 m95 -151.68 168.74 24.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.835 -1.166 . . . . 0.0 110.062 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.449 ' HB3' ' HB3' ' A' ' 3' ' ' LYS . 2.7 tt0 . . . . . 0 N--CA 1.489 1.512 0 O-C-N 121.431 -0.793 . . . . 0.0 109.404 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.512 ' HB3' ' HB3' ' A' ' 62' ' ' GLU . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.6 ' CZ ' ' HB ' ' A' ' 39' ' ' VAL . 29.3 p90 179.08 173.49 0.77 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.203 -0.936 . . . . 0.0 108.506 -179.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.469 ' HA ' HG13 ' A' ' 36' ' ' VAL . 6.4 p90 178.43 -161.63 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.606 HG22 ' CE1' ' A' ' 25' ' ' PHE . 0.2 OUTLIER -139.3 -177.74 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 C-N-CA 117.545 -1.662 . . . . 0.0 112.076 -179.883 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.517 ' C ' ' H ' ' A' ' 9' ' ' ASP . 5.6 m-20 -143.3 94.44 2.62 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.073 178.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.551 ' CD ' ' O ' ' A' ' 34' ' ' ALA . 31.2 mm-40 -65.11 42.54 0.02 OUTLIER 'General case' 0 C--N 1.291 -1.942 0 CA-C-O 121.444 0.64 . . . . 0.0 111.293 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.517 ' H ' ' C ' ' A' ' 7' ' ' ASP . 0.3 OUTLIER -93.57 -16.87 23.95 Favored 'General case' 0 C--N 1.288 -2.094 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.548 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.471 ' HB3' ' CG1' ' A' ' 56' ' ' VAL . 0.9 OUTLIER -127.15 -1.16 6.44 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.505 -0.747 . . . . 0.0 110.472 -178.944 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.49 ' HB2' ' OE1' ' A' ' 8' ' ' GLN . 49.9 t -63.92 119.11 9.43 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.755 -1.216 . . . . 0.0 109.706 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.527 ' O ' ' CB ' ' A' ' 13' ' ' ALA . 11.8 pt -83.46 -45.1 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 O-C-N 121.364 -0.835 . . . . 0.0 109.481 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.527 ' CB ' ' O ' ' A' ' 12' ' ' ILE . . . 163.92 -27.95 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.163 -0.96 . . . . 0.0 110.033 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.504 ' SG ' ' HB2' ' A' ' 16' ' ' SER . 0.1 OUTLIER -48.24 154.44 0.59 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.011 -1.056 . . . . 0.0 110.041 -179.298 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.426 ' O ' ' C ' ' A' ' 16' ' ' SER . 6.9 mt-10 -113.35 18.25 17.91 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.404 -0.81 . . . . 0.0 109.193 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.504 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 1.6 m -42.54 -60.17 1.62 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.424 -0.798 . . . . 0.0 109.5 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.682 ' SG ' ' CD2' ' A' ' 25' ' ' PHE . 18.1 p -51.05 -53.88 29.76 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.331 -0.856 . . . . 0.0 109.25 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.575 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 65.7 t -46.33 -37.7 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.334 -0.854 . . . . 0.0 109.207 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.05 -33.16 65.5 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.111 -0.993 . . . . 0.0 109.267 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.545 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 2.4 mp -85.1 11.99 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 179.08 62.83 0.1 Allowed Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.429 -0.795 . . . . 0.0 109.49 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -73.34 54.73 2.88 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 124.134 1.597 . . . . 0.0 110.268 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -161.68 -40.57 0.02 OUTLIER Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.756 -1.737 . . . . 0.0 108.756 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.433 ' HB1' ' HB2' ' A' ' 42' ' ' ALA . . . -96.41 -36.71 10.73 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.407 -1.055 . . . . 0.0 108.908 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.682 ' CD2' ' SG ' ' A' ' 17' ' ' CYS . 0.1 OUTLIER -95.17 138.01 33.45 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.301 -0.874 . . . . 0.0 108.835 179.624 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.477 ' C ' ' HA ' ' A' ' 34' ' ' ALA . . . -162.87 121.69 2.13 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.027 -1.046 . . . . 0.0 110.197 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' MET . . . . . 0.542 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 6.8 tmm? -62.0 147.81 45.9 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.175 -0.953 . . . . 0.0 109.506 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.624 ' O ' ' N ' ' A' ' 32' ' ' GLU . 0.8 OUTLIER -125.67 161.78 48.8 Favored Pre-proline 0 C--N 1.315 -0.907 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 179.083 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.42 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 46.4 Cg_endo -84.0 -15.79 6.66 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 124.96 2.032 . . . . 0.0 107.958 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.39 -35.89 18.08 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 178.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.588 ' CG1' ' CB ' ' A' ' 28' ' ' ASP . 2.7 pt -105.58 -1.99 9.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.008 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.624 ' N ' ' O ' ' A' ' 28' ' ' ASP . 2.1 mt-10 34.75 34.97 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -178.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.543 ' CD ' ' HB3' ' A' ' 8' ' ' GLN . 34.2 mttp -160.49 151.67 19.14 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.213 -178.058 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.551 ' O ' ' CD ' ' A' ' 8' ' ' GLN . . . -70.09 151.0 45.98 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.249 -0.907 . . . . 0.0 110.658 -179.026 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.65 ' CZ ' ' CB ' ' A' ' 37' ' ' LYS . 4.3 p90 -148.07 150.41 33.85 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 178.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.479 ' CG2' HG11 ' A' ' 39' ' ' VAL . 10.6 p -69.59 63.39 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 C-N-CA 119.055 -1.058 . . . . 0.0 108.205 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.65 ' CB ' ' CZ ' ' A' ' 35' ' ' TYR . 13.7 pttp -47.98 -27.49 2.24 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.265 0.555 . . . . 0.0 110.481 -179.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -157.33 92.27 1.23 Allowed 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 119.207 -0.997 . . . . 0.0 109.753 -178.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.6 ' HB ' ' CZ ' ' A' ' 4' ' ' PHE . 26.8 m -49.11 -21.99 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.425 -0.797 . . . . 0.0 109.773 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.44 -16.79 57.2 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.149 -0.969 . . . . 0.0 109.476 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -77.45 1.38 66.05 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.433 ' HB2' ' HB1' ' A' ' 24' ' ' ALA . . . -157.27 124.0 5.03 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.14 -1.212 . . . . 0.0 109.781 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.542 ' N ' ' HG2' ' A' ' 46' ' ' GLU . 0.3 OUTLIER -53.86 163.0 0.79 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.375 -0.828 . . . . 0.0 109.754 179.708 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.442 ' CG ' ' N ' ' A' ' 45' ' ' GLU . 11.1 pt20 -67.95 -40.34 83.26 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.351 -0.843 . . . . 0.0 109.853 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.483 ' HA ' ' CD ' ' A' ' 48' ' ' GLU . 1.6 mm-40 -72.45 -26.23 61.75 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.075 -1.016 . . . . 0.0 109.53 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.542 ' HG2' ' N ' ' A' ' 43' ' ' SER . 5.3 pt-20 -85.0 -31.5 23.45 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 105.476 -2.046 . . . . 0.0 105.476 177.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.57 HG12 ' CD1' ' A' ' 4' ' ' PHE . 2.5 t -65.28 -34.64 71.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.059 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.517 ' O ' ' N ' ' A' ' 51' ' ' MET . 8.4 pt-20 -74.45 -56.84 4.4 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.16 -0.962 . . . . 0.0 109.417 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 48' ' ' GLU . 61.8 tt0 -41.3 -38.32 1.15 Allowed 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.545 ' N ' ' CG2' ' A' ' 20' ' ' ILE . . . -67.95 -41.63 82.21 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.521 ' CE ' HG23 ' A' ' 59' ' ' ILE . 3.7 ttm -62.93 -47.72 82.04 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.94 -31.61 71.15 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.16 -0.963 . . . . 0.0 109.329 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.466 ' HB ' HD12 ' A' ' 20' ' ' ILE . 70.0 m -98.29 88.22 4.11 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.313 -0.867 . . . . 0.0 109.173 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . 0.54 ' SG ' ' HD2' ' A' ' 55' ' ' PRO . 21.6 t -161.15 145.82 10.38 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.198 -0.939 . . . . 0.0 109.334 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.54 ' HD2' ' SG ' ' A' ' 54' ' ' CYS . 43.3 Cg_endo -71.21 101.3 1.09 Allowed 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 123.858 1.452 . . . . 0.0 109.425 179.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.531 ' CG1' ' O ' ' A' ' 55' ' ' PRO . 0.4 OUTLIER 82.41 -9.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 -178.624 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.536 ' HA ' ' HB3' ' A' ' 54' ' ' CYS . 0.1 OUTLIER 63.04 148.38 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.441 -0.787 . . . . 0.0 110.641 179.393 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.585 ' O ' ' CE1' ' A' ' 60' ' ' HIS . 2.4 p -148.87 -34.81 0.2 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.72 -0.613 . . . . 0.0 109.403 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.556 ' O ' ' CD2' ' A' ' 60' ' ' HIS . 17.1 mt -58.12 153.67 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.026 -1.046 . . . . 0.0 109.418 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.585 ' CE1' ' O ' ' A' ' 58' ' ' CYS . 45.6 m80 -159.06 125.0 4.41 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . 0.557 ' HA ' ' CB ' ' A' ' 4' ' ' PHE . 87.8 m95 -55.22 171.11 0.17 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.121 -0.987 . . . . 0.0 109.108 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.512 ' HB3' ' HB3' ' A' ' 3' ' ' LYS . 1.3 tt0 . . . . . 0 C--N 1.302 -1.461 0 O-C-N 121.248 -0.907 . . . . 0.0 109.245 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.464 ' O ' ' HB3' ' A' ' 4' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.263 0.554 . . . . 0.0 109.602 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.558 ' CB ' ' HA ' ' A' ' 61' ' ' TRP . 6.1 p90 177.43 -172.12 0.1 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.321 -0.862 . . . . 0.0 109.262 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.574 ' HA ' ' CG1' ' A' ' 36' ' ' VAL . 46.8 p90 169.2 -177.77 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.649 ' CG2' ' CZ ' ' A' ' 25' ' ' PHE . 3.1 t -139.39 159.5 28.45 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.4 0 C-N-CA 116.962 -1.895 . . . . 0.0 111.417 179.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.516 ' O ' ' N ' ' A' ' 9' ' ' ASP . 1.2 m-20 -106.9 72.52 0.89 Allowed 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.494 ' HB3' ' O ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER -41.8 -23.87 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 179.486 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 7' ' ' ASP . 19.5 t0 -50.92 -38.54 50.71 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.549 ' HB3' ' CB ' ' A' ' 58' ' ' CYS . 20.8 tt0 -82.02 -19.99 39.28 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.369 -0.832 . . . . 0.0 108.942 179.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.471 ' HB3' ' HG2' ' A' ' 33' ' ' LYS . 36.9 t -51.15 123.92 10.47 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.477 -0.764 . . . . 0.0 109.806 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.496 ' O ' ' CB ' ' A' ' 13' ' ' ALA . 10.0 pt -75.32 -48.7 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.376 -0.827 . . . . 0.0 109.541 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.496 ' CB ' ' O ' ' A' ' 12' ' ' ILE . . . 166.13 -33.03 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.028 -1.045 . . . . 0.0 110.132 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -52.32 159.6 0.95 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.073 -1.017 . . . . 0.0 109.519 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.407 ' O ' ' C ' ' A' ' 16' ' ' SER . 13.6 pt-20 -123.75 21.85 9.1 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.31 -0.869 . . . . 0.0 109.505 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.407 ' C ' ' O ' ' A' ' 15' ' ' GLU . 0.6 OUTLIER -44.53 -58.57 2.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.175 -0.953 . . . . 0.0 109.023 179.797 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.674 ' SG ' ' N ' ' A' ' 18' ' ' VAL . 17.6 p -49.96 -58.77 4.76 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.433 -0.792 . . . . 0.0 109.166 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.674 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 59.4 t -45.26 -34.41 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.224 -0.922 . . . . 0.0 109.044 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.39 -39.53 71.13 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.162 -0.961 . . . . 0.0 108.897 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.59 ' HB ' ' CB ' ' A' ' 50' ' ' ALA . 1.9 mt -87.1 17.77 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 177.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.473 ' CB ' ' HB3' ' A' ' 42' ' ' ALA . . . 172.31 65.42 0.03 OUTLIER Pre-proline 0 N--CA 1.489 1.482 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.503 ' N ' ' O ' ' A' ' 18' ' ' VAL . 43.8 Cg_endo -72.14 -2.09 11.07 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.108 1.583 . . . . 0.0 110.65 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.484 ' O ' ' HB3' ' A' ' 38' ' ' ASP . . . -92.2 -71.85 1.2 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.547 ' CB ' ' O ' ' A' ' 38' ' ' ASP . . . -66.82 -30.15 70.26 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.353 -1.087 . . . . 0.0 109.364 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.649 ' CZ ' ' CG2' ' A' ' 6' ' ' VAL . 0.1 OUTLIER -105.42 133.75 49.66 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 118.821 -1.152 . . . . 0.0 109.904 -179.734 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.553 ' O ' ' CD1' ' A' ' 35' ' ' TYR . . . -166.27 123.97 1.42 Allowed 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.478 -0.764 . . . . 0.0 109.156 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' MET . . . . . 0.528 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER -62.17 155.63 23.91 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.169 -0.957 . . . . 0.0 109.092 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.593 ' O ' ' HA ' ' A' ' 32' ' ' GLU . 4.0 t0 -128.2 161.99 53.02 Favored Pre-proline 0 C--N 1.309 -1.166 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.444 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 43.9 Cg_endo -85.0 -18.16 4.42 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 124.428 1.752 . . . . 0.0 108.562 -179.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -89.32 -32.75 17.19 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 177.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.55 HG12 ' CB ' ' A' ' 28' ' ' ASP . 0.8 OUTLIER -104.79 2.19 10.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 178.071 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.593 ' HA ' ' O ' ' A' ' 28' ' ' ASP . 9.9 mt-10 26.34 43.68 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.51 0.672 . . . . 0.0 110.212 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.523 ' N ' ' O ' ' A' ' 31' ' ' ILE . 6.2 mttt -172.13 148.46 2.2 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 119.134 -1.027 . . . . 0.0 110.653 -179.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.528 ' HA ' ' HA ' ' A' ' 27' ' ' MET . . . -54.71 142.21 29.44 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.684 -0.635 . . . . 0.0 110.634 -179.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.666 ' CE2' ' HG3' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -143.91 151.01 39.26 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-O 121.764 0.792 . . . . 0.0 109.95 179.156 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.574 ' CG1' ' HA ' ' A' ' 5' ' ' TYR . 0.9 OUTLIER -91.04 109.19 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.424 -1.422 . . . . 0.0 109.563 -178.637 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.666 ' HG3' ' CE2' ' A' ' 35' ' ' TYR . 23.5 mmtt -125.75 -53.25 1.56 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.423 -0.798 . . . . 0.0 110.445 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.547 ' O ' ' CB ' ' A' ' 24' ' ' ALA . 61.6 t0 -86.98 71.94 10.17 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.599 -0.688 . . . . 0.0 110.462 -177.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.468 HG13 ' CZ ' ' A' ' 4' ' ' PHE . 24.8 m -46.58 -40.59 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.322 -0.861 . . . . 0.0 109.194 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -66.33 -17.71 64.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.352 -0.842 . . . . 0.0 109.499 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' A' ' 38' ' ' ASP . . . -72.43 -21.13 79.58 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.473 ' HB3' ' CB ' ' A' ' 21' ' ' ALA . . . -132.02 134.67 45.83 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.277 -1.131 . . . . 0.0 109.296 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.465 ' O ' ' CG2' ' A' ' 47' ' ' VAL . 0.4 OUTLIER -79.29 -166.99 1.04 Allowed 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.224 -0.922 . . . . 0.0 109.775 -179.8 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.473 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 1.9 mt-30 -71.44 -49.58 40.27 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.664 -0.647 . . . . 0.0 109.56 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.472 ' O ' ' HB2' ' A' ' 49' ' ' GLU . 1.8 pm0 -72.77 -12.84 61.16 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.175 -0.953 . . . . 0.0 109.298 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.462 ' HG3' ' HB2' ' A' ' 43' ' ' SER . 29.9 mt-10 -90.71 -42.01 10.96 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 178.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.475 ' O ' ' HB2' ' A' ' 51' ' ' MET . 24.2 t -63.95 -47.53 90.12 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 CA-C-N 114.789 -1.096 . . . . 0.0 108.093 178.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.526 ' O ' ' N ' ' A' ' 51' ' ' MET . 0.3 OUTLIER -67.97 -62.23 1.5 Allowed 'General case' 0 C--N 1.307 -1.243 0 O-C-N 121.584 -0.697 . . . . 0.0 109.591 179.583 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 45' ' ' GLU . 34.6 mt-10 -43.23 -52.01 5.86 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 119.44 -0.904 . . . . 0.0 108.918 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.59 ' CB ' ' HB ' ' A' ' 20' ' ' ILE . . . -65.53 -27.86 68.76 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.57 ' HE2' ' CE2' ' A' ' 61' ' ' TRP . 22.5 ttm -76.88 -21.68 54.58 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.627 -0.67 . . . . 0.0 110.35 -179.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.81 -15.78 26.11 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.085 -1.009 . . . . 0.0 109.759 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.527 ' OG1' ' CD1' ' A' ' 20' ' ' ILE . 76.2 p -91.91 73.63 5.66 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.189 -0.944 . . . . 0.0 109.455 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 19.0 t -151.65 128.49 5.43 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.219 -0.926 . . . . 0.0 109.684 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.514 ' O ' ' CB ' ' A' ' 56' ' ' VAL . 47.1 Cg_endo -75.48 53.73 3.64 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 123.857 1.451 . . . . 0.0 109.912 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.514 ' CB ' ' O ' ' A' ' 55' ' ' PRO . 1.5 p 160.42 -26.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 60.19 72.96 0.5 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.569 -0.707 . . . . 0.0 109.933 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.549 ' CB ' ' HB3' ' A' ' 10' ' ' GLU . 29.7 p -84.6 7.98 18.31 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.108 -0.995 . . . . 0.0 109.198 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.56 ' O ' ' CD2' ' A' ' 60' ' ' HIS . 1.0 OUTLIER -75.87 155.62 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.348 -0.845 . . . . 0.0 110.505 -179.232 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.56 ' CD2' ' O ' ' A' ' 59' ' ' ILE . 39.7 m80 -155.52 125.36 6.51 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . 0.57 ' CE2' ' HE2' ' A' ' 51' ' ' MET . 62.5 m95 -73.05 173.89 8.69 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.194 -0.941 . . . . 0.0 109.652 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.457 ' HB3' ' HB3' ' A' ' 3' ' ' LYS . 9.6 tp10 . . . . . 0 N--CA 1.49 1.526 0 O-C-N 121.327 -0.858 . . . . 0.0 109.333 -179.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.48 ' O ' ' HB3' ' A' ' 4' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.566 ' CE2' HG12 ' A' ' 36' ' ' VAL . 2.5 p90 177.9 -178.73 0.24 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.293 -0.879 . . . . 0.0 110.007 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.46 ' O ' HD12 ' A' ' 59' ' ' ILE . 20.3 p90 174.68 -167.0 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.647 ' CG2' ' CZ ' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -137.03 -166.36 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 C-N-CA 118.406 -1.318 . . . . 0.0 111.066 179.713 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.532 ' O ' ' N ' ' A' ' 9' ' ' ASP . 0.3 OUTLIER -151.65 98.98 2.55 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 114.413 -1.267 . . . . 0.0 108.056 177.784 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.57 ' CG ' ' HB3' ' A' ' 33' ' ' LYS . 2.9 mp0 -65.15 43.3 0.02 OUTLIER 'General case' 0 C--N 1.29 -2.001 0 CA-C-O 121.367 0.603 . . . . 0.0 110.392 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.532 ' N ' ' O ' ' A' ' 7' ' ' ASP . 0.5 OUTLIER -99.42 -29.68 12.62 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.265 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.455 ' HB2' ' SG ' ' A' ' 58' ' ' CYS . 0.0 OUTLIER -118.31 25.59 10.2 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.859 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.706 ' SG ' ' HG2' ' A' ' 33' ' ' LYS . 14.3 t -90.22 119.07 30.22 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.225 -0.922 . . . . 0.0 110.432 -179.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 12.2 pt -88.61 5.01 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 61.76 65.26 0.94 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.367 -0.833 . . . . 0.0 109.665 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.788 ' SG ' ' OG ' ' A' ' 16' ' ' SER . 31.7 p -102.22 -9.89 20.06 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.082 -1.011 . . . . 0.0 109.678 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.439 ' OE1' ' HG3' ' A' ' 19' ' ' GLU . 0.0 OUTLIER 70.7 4.29 4.93 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.24 -0.913 . . . . 0.0 109.84 179.591 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.788 ' OG ' ' SG ' ' A' ' 14' ' ' CYS . 29.6 p -62.15 -69.77 0.23 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.068 -1.02 . . . . 0.0 109.335 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.634 ' SG ' ' N ' ' A' ' 18' ' ' VAL . 19.4 p -49.33 -55.87 11.43 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.328 -0.857 . . . . 0.0 109.385 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.634 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 59.6 t -46.32 -33.14 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.199 -0.938 . . . . 0.0 109.012 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.439 ' HG3' ' OE1' ' A' ' 15' ' ' GLU . 5.3 mt-10 -71.05 -34.78 71.57 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.999 -1.063 . . . . 0.0 108.592 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.536 ' O ' ' CG2' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -81.16 6.05 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.252 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.422 ' HB3' ' O ' ' A' ' 20' ' ' ILE . . . 176.82 65.47 0.07 OUTLIER Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.274 -0.891 . . . . 0.0 109.009 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.54 ' N ' ' O ' ' A' ' 18' ' ' VAL . 46.0 Cg_endo -71.92 0.12 7.62 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.039 1.547 . . . . 0.0 110.783 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -96.3 -31.66 7.09 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.589 ' HA ' ' HB3' ' A' ' 38' ' ' ASP . . . -109.4 -53.65 2.63 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.333 -1.098 . . . . 0.0 109.99 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.647 ' CZ ' ' CG2' ' A' ' 6' ' ' VAL . 0.3 OUTLIER -75.22 139.43 42.59 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 118.561 -1.256 . . . . 0.0 107.689 179.727 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.574 ' O ' ' CD1' ' A' ' 35' ' ' TYR . . . -172.13 140.84 1.22 Allowed 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.263 -0.898 . . . . 0.0 109.561 -179.217 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' MET . . . . . 0.536 ' HA ' ' C ' ' A' ' 33' ' ' LYS . 5.1 mtp -71.55 158.35 36.39 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.292 -0.88 . . . . 0.0 109.94 -179.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.613 ' O ' ' N ' ' A' ' 32' ' ' GLU . 3.9 t0 -126.31 161.52 51.74 Favored Pre-proline 0 C--N 1.309 -1.154 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.457 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 44.3 Cg_endo -85.19 -16.13 5.15 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 O-C-N 124.691 1.89 . . . . 0.0 108.626 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -91.53 -29.7 16.83 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 178.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.566 ' CD1' ' HB3' ' A' ' 35' ' ' TYR . 1.0 OUTLIER -106.2 -5.25 10.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.25 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.613 ' N ' ' O ' ' A' ' 28' ' ' ASP . 6.9 mm-40 33.59 41.52 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 121.433 0.635 . . . . 0.0 109.303 -179.054 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.706 ' HG2' ' SG ' ' A' ' 11' ' ' CYS . 0.2 OUTLIER -169.74 146.3 3.22 Favored 'General case' 0 N--CA 1.501 2.109 0 C-N-CA 119.601 -0.839 . . . . 0.0 110.365 -179.176 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.54 ' O ' ' CG ' ' A' ' 8' ' ' GLN . . . -47.99 146.54 2.47 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.425 -0.797 . . . . 0.0 111.564 -178.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.676 ' CE2' ' CG ' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -135.83 -174.29 3.61 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.965 -1.085 . . . . 0.0 110.086 179.075 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.62 ' CG2' ' CG2' ' A' ' 6' ' ' VAL . 2.5 t -125.98 92.44 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.676 ' CG ' ' CE2' ' A' ' 35' ' ' TYR . 18.5 mmtt -103.87 -46.07 4.59 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 119.567 -0.853 . . . . 0.0 111.286 -178.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.589 ' HB3' ' HA ' ' A' ' 24' ' ' ALA . 62.8 t0 -93.59 118.24 31.11 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 119.207 -0.997 . . . . 0.0 110.564 -177.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.2 m -80.52 -17.11 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.338 -0.851 . . . . 0.0 109.268 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.424 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -103.01 2.39 34.87 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.355 -0.841 . . . . 0.0 109.558 -179.994 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.436 ' HA3' ' HB3' ' A' ' 24' ' ' ALA . . . -78.24 -7.64 87.71 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.674 -1.371 . . . . 0.0 109.674 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -149.08 127.84 12.51 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.229 -1.159 . . . . 0.0 109.566 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.421 ' OG ' ' OE2' ' A' ' 46' ' ' GLU . 0.1 OUTLIER -67.61 166.79 14.28 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.235 -0.916 . . . . 0.0 109.43 179.951 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.465 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -51.66 -45.28 63.32 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.412 -0.805 . . . . 0.0 109.438 179.979 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.414 ' O ' ' CG ' ' A' ' 49' ' ' GLU . 50.0 mm-40 -67.54 -8.4 33.63 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.362 -0.836 . . . . 0.0 109.646 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.421 ' OE2' ' OG ' ' A' ' 43' ' ' SER . 11.9 mt-10 -100.32 -43.88 6.11 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 179.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.444 ' O ' ' HB2' ' A' ' 51' ' ' MET . 1.9 t -60.49 -40.54 84.63 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 178.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.465 ' HB2' ' O ' ' A' ' 44' ' ' GLN . 0.2 OUTLIER -74.86 -48.43 25.0 Favored 'General case' 0 C--N 1.308 -1.227 0 O-C-N 121.527 -0.733 . . . . 0.0 109.198 179.293 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.507 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . 34.1 mt-10 -53.5 -54.01 43.26 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.189 -0.944 . . . . 0.0 109.096 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.402 ' HB1' ' CG2' ' A' ' 20' ' ' ILE . . . -63.83 -18.04 63.73 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.143 -0.973 . . . . 0.0 108.945 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.527 ' HG3' ' CG2' ' A' ' 59' ' ' ILE . 38.6 ttm -77.87 -18.31 56.37 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.416 -0.802 . . . . 0.0 109.208 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -105.35 -23.73 12.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.32 -0.863 . . . . 0.0 109.599 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.467 HG23 ' HB2' ' A' ' 16' ' ' SER . 0.3 OUTLIER -62.39 -48.02 81.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.23 -0.919 . . . . 0.0 109.768 -179.684 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . 0.781 ' SG ' ' HD2' ' A' ' 55' ' ' PRO . 4.6 t -48.88 147.41 4.62 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.139 -0.975 . . . . 0.0 109.606 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.781 ' HD2' ' SG ' ' A' ' 54' ' ' CYS . 44.1 Cg_endo -73.91 -64.65 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.986 1.519 . . . . 0.0 110.509 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.421 ' O ' ' HB2' ' A' ' 57' ' ' GLN . 38.4 t -79.08 -25.02 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.115 -0.99 . . . . 0.0 109.098 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.426 ' CG ' ' O ' ' A' ' 51' ' ' MET . 0.0 OUTLIER 67.38 72.04 0.35 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.277 -0.889 . . . . 0.0 109.755 179.719 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.455 ' SG ' ' HB2' ' A' ' 10' ' ' GLU . 0.7 OUTLIER -89.87 21.89 3.4 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.188 -0.945 . . . . 0.0 109.155 179.571 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.534 ' CD1' ' N ' ' A' ' 60' ' ' HIS . 0.0 OUTLIER -108.65 140.69 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.341 -0.85 . . . . 0.0 109.564 -179.651 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.534 ' N ' ' CD1' ' A' ' 59' ' ' ILE . 2.7 m80 -142.48 -177.47 5.29 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.279 -0.888 . . . . 0.0 109.532 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . 0.55 ' HA ' ' CB ' ' A' ' 4' ' ' PHE . 36.0 m95 -97.84 -179.25 4.36 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.014 -1.054 . . . . 0.0 109.697 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.2 tp10 . . . . . 0 N--CA 1.49 1.541 0 O-C-N 121.267 -0.896 . . . . 0.0 109.621 -179.561 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.503 ' O ' ' HB3' ' A' ' 4' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.464 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.573 ' CE2' HG22 ' A' ' 36' ' ' VAL . 53.8 p90 173.06 -176.06 0.06 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.357 -0.839 . . . . 0.0 108.895 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.665 ' CZ ' ' CD2' ' A' ' 60' ' ' HIS . 51.6 p90 175.84 -173.28 0.08 Allowed 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 179.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.589 HG23 ' CZ ' ' A' ' 25' ' ' PHE . 2.9 t -145.57 166.37 10.0 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.428 0 C-N-CA 117.397 -1.721 . . . . 0.0 112.094 -179.194 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.441 ' C ' ' H ' ' A' ' 9' ' ' ASP . 8.5 t0 -105.22 74.56 1.11 Allowed 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.537 ' O ' ' CD ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -53.72 -11.51 0.39 Allowed 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.362 179.576 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.441 ' H ' ' C ' ' A' ' 7' ' ' ASP . 0.1 OUTLIER -65.61 -32.8 74.57 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.634 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.542 ' HB3' ' CB ' ' A' ' 58' ' ' CYS . 0.1 OUTLIER -91.16 -16.3 27.97 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.09 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.4 ' C ' ' O ' ' A' ' 10' ' ' GLU . 7.2 t -43.46 128.41 4.97 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.432 -0.793 . . . . 0.0 110.075 -179.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 4.5 pt -79.25 -134.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.444 -0.785 . . . . 0.0 109.066 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -119.67 43.55 2.61 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.762 -1.211 . . . . 0.0 110.017 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 1.012 ' SG ' ' OG ' ' A' ' 16' ' ' SER . 0.1 OUTLIER -124.91 156.83 37.33 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.075 -1.016 . . . . 0.0 109.594 179.557 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.437 ' O ' ' C ' ' A' ' 16' ' ' SER . 14.3 mt-10 -117.26 17.75 14.64 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.299 -0.876 . . . . 0.0 109.685 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 1.012 ' OG ' ' SG ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -44.42 -70.57 0.1 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.245 -0.909 . . . . 0.0 108.996 179.722 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.645 ' SG ' ' N ' ' A' ' 18' ' ' VAL . 8.3 p -44.17 -51.51 8.06 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.262 -0.898 . . . . 0.0 109.325 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.645 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 41.5 t -50.15 -33.31 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.362 -0.836 . . . . 0.0 109.61 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -84.74 -30.93 24.31 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.129 -0.982 . . . . 0.0 109.414 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.574 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 2.7 mp -81.76 9.12 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.206 -0.934 . . . . 0.0 108.646 178.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.481 ' HB3' ' CB ' ' A' ' 42' ' ' ALA . . . -169.86 69.41 0.62 Allowed Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.17 -0.956 . . . . 0.0 109.309 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -71.72 76.83 1.9 Allowed 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 124.206 1.635 . . . . 0.0 110.181 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.441 ' C ' ' HA3' ' A' ' 41' ' ' GLY . . . 165.02 -42.55 0.29 Allowed Glycine 0 N--CA 1.488 2.117 0 N-CA-C 108.672 -1.771 . . . . 0.0 108.672 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' A' ' 38' ' ' ASP . . . -92.99 -49.3 6.09 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.415 -1.05 . . . . 0.0 109.046 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.589 ' CZ ' HG23 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -96.06 137.84 34.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.269 -0.894 . . . . 0.0 108.818 179.582 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.45 ' HA ' HG12 ' A' ' 18' ' ' VAL . . . -174.77 126.66 0.3 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.025 -1.047 . . . . 0.0 109.609 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' MET . . . . . 0.572 ' HA ' ' C ' ' A' ' 33' ' ' LYS . 29.3 mtp -58.56 150.86 21.85 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.315 -0.865 . . . . 0.0 109.365 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.615 ' O ' ' N ' ' A' ' 32' ' ' GLU . 1.6 t0 -130.26 163.99 44.03 Favored Pre-proline 0 C--N 1.311 -1.085 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.455 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 43.9 Cg_endo -83.29 -16.44 7.1 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 124.803 1.949 . . . . 0.0 107.571 179.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -82.84 -42.38 17.9 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 177.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.554 HG12 ' CB ' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -102.14 0.26 10.26 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 178.098 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.615 ' N ' ' O ' ' A' ' 28' ' ' ASP . 2.9 mm-40 35.33 34.55 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -179.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.572 ' C ' ' HA ' ' A' ' 27' ' ' MET . 59.4 mttp -163.55 151.16 12.83 Favored 'General case' 0 N--CA 1.499 2.0 0 C-N-CA 119.556 -0.858 . . . . 0.0 110.183 -177.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.53 ' O ' ' CB ' ' A' ' 8' ' ' GLN . . . -59.18 139.97 56.38 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.444 -0.785 . . . . 0.0 110.206 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.643 ' CE2' ' HA ' ' A' ' 37' ' ' LYS . 1.5 p90 -154.06 155.89 36.31 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.573 HG22 ' CE2' ' A' ' 4' ' ' PHE . 14.9 p -67.01 67.19 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 120.905 -1.122 . . . . 0.0 108.933 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.643 ' HA ' ' CE2' ' A' ' 35' ' ' TYR . 0.1 OUTLIER -51.01 -19.05 0.92 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.533 -0.729 . . . . 0.0 110.391 -179.664 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.486 ' N ' ' HG3' ' A' ' 37' ' ' LYS . 11.5 t70 -167.21 103.42 0.53 Allowed 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.996 -1.065 . . . . 0.0 109.674 -179.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.534 ' HB ' ' CE1' ' A' ' 4' ' ' PHE . 1.8 m -55.39 -24.39 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.378 -0.826 . . . . 0.0 109.835 -179.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.501 ' N ' HG21 ' A' ' 39' ' ' VAL . 63.6 mm-40 -90.89 -0.6 57.77 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.168 -0.958 . . . . 0.0 109.601 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.45 ' N ' ' OD2' ' A' ' 38' ' ' ASP . . . -76.36 -16.05 81.02 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.481 ' CB ' ' HB3' ' A' ' 21' ' ' ALA . . . -141.92 161.74 37.21 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.192 -1.181 . . . . 0.0 109.333 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.07 173.89 9.56 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.263 -0.898 . . . . 0.0 109.571 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.46 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 1.0 OUTLIER -70.09 -38.56 75.7 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.363 -0.836 . . . . 0.0 109.233 179.895 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 36.0 mm-40 -66.91 -21.87 65.97 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.143 -0.973 . . . . 0.0 108.875 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -90.2 -43.1 10.65 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 178.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 4.0 t -58.25 -38.11 66.77 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 178.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.46 ' HB2' ' O ' ' A' ' 44' ' ' GLN . 0.1 OUTLIER -70.22 -65.93 0.66 Allowed 'General case' 0 C--N 1.308 -1.229 0 O-C-N 121.562 -0.712 . . . . 0.0 109.584 179.715 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.43 ' C ' HG22 ' A' ' 20' ' ' ILE . 16.1 mt-10 -47.5 -42.45 23.0 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.259 -0.9 . . . . 0.0 109.052 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.574 ' N ' ' CG2' ' A' ' 20' ' ' ILE . . . -68.59 -27.08 65.73 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.356 -0.84 . . . . 0.0 109.024 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.517 ' HG3' ' CG2' ' A' ' 59' ' ' ILE . 6.6 ttm -83.92 -17.63 40.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.482 -0.761 . . . . 0.0 109.904 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -95.02 -10.36 31.11 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.048 -1.032 . . . . 0.0 109.795 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.527 ' CG2' HD12 ' A' ' 20' ' ' ILE . 12.0 p -91.08 8.05 37.42 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.242 -0.911 . . . . 0.0 109.642 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . 0.513 ' SG ' ' HD2' ' A' ' 55' ' ' PRO . 8.7 t -95.35 140.74 22.51 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.22 -0.925 . . . . 0.0 109.399 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.513 ' HD2' ' SG ' ' A' ' 54' ' ' CYS . 46.1 Cg_endo -75.16 -58.18 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.942 1.496 . . . . 0.0 109.931 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.503 ' O ' ' CB ' ' A' ' 57' ' ' GLN . 7.6 p -84.63 -23.19 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.319 -0.863 . . . . 0.0 108.898 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.503 ' CB ' ' O ' ' A' ' 56' ' ' VAL . 1.9 tt0 77.71 -66.44 0.22 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.495 -0.753 . . . . 0.0 110.459 179.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.542 ' CB ' ' HB3' ' A' ' 10' ' ' GLU . 2.5 p 43.57 26.41 0.11 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.225 -0.922 . . . . 0.0 109.156 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.533 ' HA ' HG11 ' A' ' 6' ' ' VAL . 9.4 tt -125.77 164.1 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.466 -0.771 . . . . 0.0 110.304 -178.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.665 ' CD2' ' CZ ' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -172.64 173.61 3.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.337 -0.852 . . . . 0.0 109.245 179.987 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . 0.543 ' HA ' ' CB ' ' A' ' 4' ' ' PHE . 50.9 m95 -98.66 164.3 12.29 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.152 -0.968 . . . . 0.0 109.767 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.473 ' N ' ' HA ' ' A' ' 4' ' ' PHE . 20.6 tt0 . . . . . 0 N--CA 1.489 1.524 0 O-C-N 121.362 -0.836 . . . . 0.0 109.469 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.501 ' HB3' ' HB3' ' A' ' 62' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.596 ' CE1' ' HA ' ' A' ' 39' ' ' VAL . 20.7 p90 179.2 -159.05 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.166 -0.959 . . . . 0.0 109.768 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.606 ' HA ' ' CG2' ' A' ' 36' ' ' VAL . 4.6 p90 168.04 -178.75 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 -179.448 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.657 ' CG2' ' CE1' ' A' ' 25' ' ' PHE . 1.6 t -121.64 145.07 28.82 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.251 0 C-N-CA 116.914 -1.914 . . . . 0.0 111.954 -179.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.495 ' O ' ' N ' ' A' ' 9' ' ' ASP . 0.2 OUTLIER -96.7 38.9 1.19 Allowed 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.718 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.515 ' HG3' ' CG2' ' A' ' 31' ' ' ILE . 0.0 OUTLIER -38.6 -27.94 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.125 0.488 . . . . 0.0 110.15 -179.689 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.495 ' N ' ' O ' ' A' ' 7' ' ' ASP . 4.8 t0 -46.62 -25.3 0.68 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.159 -0.963 . . . . 0.0 108.822 179.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.465 ' HB3' ' HB3' ' A' ' 58' ' ' CYS . 14.7 tt0 -108.04 -15.48 14.51 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.465 -0.772 . . . . 0.0 109.577 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.648 ' SG ' ' HG2' ' A' ' 33' ' ' LYS . 40.6 t -43.37 141.72 1.27 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.17 -0.956 . . . . 0.0 109.661 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.542 ' CG1' ' N ' ' A' ' 13' ' ' ALA . 8.0 pt -98.59 -47.49 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.242 -0.911 . . . . 0.0 109.826 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.542 ' N ' ' CG1' ' A' ' 12' ' ' ILE . . . 166.0 -34.9 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.059 -1.026 . . . . 0.0 110.157 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -47.61 159.86 0.14 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.085 -1.01 . . . . 0.0 109.614 -179.488 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -122.13 22.23 10.27 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.321 -0.862 . . . . 0.0 109.854 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -46.26 -58.33 3.77 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.218 -0.926 . . . . 0.0 109.039 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.944 ' SG ' ' HD2' ' A' ' 25' ' ' PHE . 19.8 p -52.17 -57.26 10.16 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.37 -0.831 . . . . 0.0 109.239 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.644 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 98.2 t -45.15 -28.14 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.277 -0.89 . . . . 0.0 109.164 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.97 -37.7 23.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.187 -0.946 . . . . 0.0 108.914 179.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.53 ' HB ' ' CB ' ' A' ' 50' ' ' ALA . 1.8 mt -88.33 18.06 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 177.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.427 ' HB3' ' O ' ' A' ' 20' ' ' ILE . . . 172.56 64.6 0.03 OUTLIER Pre-proline 0 N--CA 1.488 1.451 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -74.25 2.29 6.35 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 124.073 1.565 . . . . 0.0 110.62 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.464 ' O ' ' HB3' ' A' ' 37' ' ' LYS . . . -113.86 -22.7 5.25 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.534 ' O ' ' N ' ' A' ' 37' ' ' LYS . . . -110.66 -30.25 7.68 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.249 -1.147 . . . . 0.0 109.624 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.944 ' HD2' ' SG ' ' A' ' 17' ' ' CYS . 0.8 OUTLIER -114.62 129.84 56.72 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.21 -0.931 . . . . 0.0 108.564 179.762 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.526 ' O ' ' N ' ' A' ' 35' ' ' TYR . . . -158.76 146.83 18.13 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.874 -1.141 . . . . 0.0 110.36 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' MET . . . . . 0.528 ' HG2' ' N ' ' A' ' 28' ' ' ASP . 1.3 ttm -74.22 152.38 39.76 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.275 -0.891 . . . . 0.0 109.004 179.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.589 ' O ' ' N ' ' A' ' 32' ' ' GLU . 1.2 t0 -133.5 165.77 34.23 Favored Pre-proline 0 C--O 1.211 -0.948 0 O-C-N 120.197 -1.564 . . . . 0.0 108.071 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.473 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 44.8 Cg_endo -84.44 -16.56 5.75 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 124.507 1.793 . . . . 0.0 107.725 179.022 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.476 ' HB3' HD12 ' A' ' 31' ' ' ILE . 0.3 OUTLIER -85.18 -38.95 18.39 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 178.122 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.562 HG12 ' CB ' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -104.29 0.47 10.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 178.068 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.589 ' N ' ' O ' ' A' ' 28' ' ' ASP . 5.2 mt-10 34.97 35.91 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -179.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.648 ' HG2' ' SG ' ' A' ' 11' ' ' CYS . 0.1 OUTLIER -172.95 167.26 5.07 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 119.82 -0.752 . . . . 0.0 109.228 -178.367 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.496 ' O ' ' HB3' ' A' ' 8' ' ' GLN . . . -37.45 157.45 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.515 0.674 . . . . 0.0 110.318 -179.139 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.637 ' CZ ' ' HA ' ' A' ' 37' ' ' LYS . 0.2 OUTLIER -162.41 150.26 14.18 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 179.729 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.628 ' N ' HG22 ' A' ' 6' ' ' VAL . 4.3 t -64.76 88.04 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 120.963 -1.086 . . . . 0.0 109.907 -178.04 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.637 ' HA ' ' CZ ' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -55.56 -26.54 44.01 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.459 -0.776 . . . . 0.0 109.528 179.589 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 39' ' ' VAL . 9.9 t0 175.43 157.99 0.21 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.255 -0.903 . . . . 0.0 109.625 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.596 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 11.6 m -78.22 -21.98 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.321 -0.862 . . . . 0.0 110.111 -179.275 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -117.11 18.95 14.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.12 -0.987 . . . . 0.0 109.422 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.436 ' HA3' ' C ' ' A' ' 23' ' ' GLY . . . -67.7 -15.8 67.04 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 -179.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.449 ' HB1' ' HB1' ' A' ' 24' ' ' ALA . . . -148.93 153.72 38.4 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.035 -1.273 . . . . 0.0 109.692 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.471 ' OG ' ' HG3' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -77.12 156.6 31.55 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.349 -0.844 . . . . 0.0 109.944 -179.775 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.496 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -48.47 -48.41 37.83 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.402 -0.811 . . . . 0.0 109.151 179.768 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -57.63 -36.8 72.3 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.209 -0.932 . . . . 0.0 108.979 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.471 ' HG3' ' OG ' ' A' ' 43' ' ' SER . 14.4 mt-10 -73.06 -57.04 4.31 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.275 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.627 ' CG1' ' CH2' ' A' ' 61' ' ' TRP . 1.2 t -50.87 -32.15 11.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 179.226 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.496 ' HB2' ' O ' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -65.66 -72.89 0.14 Allowed 'General case' 0 C--N 1.309 -1.193 0 O-C-N 121.264 -0.898 . . . . 0.0 109.866 179.966 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.459 ' HB3' HG22 ' A' ' 20' ' ' ILE . 1.9 mm-40 -47.22 -39.67 14.63 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.273 -0.892 . . . . 0.0 109.233 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.53 ' CB ' ' HB ' ' A' ' 20' ' ' ILE . . . -61.03 -39.62 90.49 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.281 -0.887 . . . . 0.0 108.918 179.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.527 ' CE ' HG13 ' A' ' 59' ' ' ILE . 45.0 ttm -74.53 -29.8 61.52 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.443 -0.785 . . . . 0.0 109.169 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -60.99 -45.99 92.57 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.296 -0.877 . . . . 0.0 109.141 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.479 ' O ' ' HB3' ' A' ' 54' ' ' CYS . 65.9 p -68.25 -152.68 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.336 -0.852 . . . . 0.0 109.072 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . 0.941 ' SG ' ' CA ' ' A' ' 57' ' ' GLN . 10.3 t 73.41 122.28 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.268 -0.895 . . . . 0.0 109.779 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -73.51 -44.08 0.58 Allowed 'Trans proline' 0 C--N 1.308 -1.562 0 O-C-N 123.863 1.454 . . . . 0.0 109.083 179.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.509 ' O ' ' CB ' ' A' ' 57' ' ' GLN . 1.9 m -96.37 -17.65 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.941 ' CA ' ' SG ' ' A' ' 54' ' ' CYS . 0.9 OUTLIER 81.34 -59.77 0.24 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.724 -0.61 . . . . 0.0 110.569 179.542 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.508 ' C ' ' O ' ' A' ' 57' ' ' GLN . 11.9 p 35.88 41.6 0.12 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.641 -0.662 . . . . 0.0 109.51 -179.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.554 ' CD1' ' N ' ' A' ' 60' ' ' HIS . 0.1 OUTLIER -148.56 137.44 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.501 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.588 ' HB2' ' CE1' ' A' ' 5' ' ' TYR . 31.0 m80 -155.7 163.56 39.74 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.708 -1.245 . . . . 0.0 110.469 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . 0.627 ' CH2' ' CG1' ' A' ' 47' ' ' VAL . 72.2 m95 -87.63 -176.15 5.45 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.381 -0.824 . . . . 0.0 109.216 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.501 ' HB3' ' HB3' ' A' ' 3' ' ' LYS . 7.4 tt0 . . . . . 0 N--CA 1.489 1.5 0 O-C-N 121.332 -0.855 . . . . 0.0 109.208 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.467 ' O ' ' HB3' ' A' ' 4' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.54 ' C ' ' CD1' ' A' ' 4' ' ' PHE . 11.5 p90 176.81 174.49 0.39 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.282 -0.886 . . . . 0.0 109.864 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.543 ' HA ' ' CG1' ' A' ' 36' ' ' VAL . 1.3 p90 177.15 -171.6 0.09 Allowed 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 179.237 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.604 ' CG2' ' CG2' ' A' ' 36' ' ' VAL . 0.2 OUTLIER -135.44 177.18 7.01 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 C-N-CA 117.693 -1.603 . . . . 0.0 111.651 179.869 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.521 ' C ' ' H ' ' A' ' 9' ' ' ASP . 0.3 OUTLIER -129.35 92.45 3.36 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.786 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.567 ' CG ' ' O ' ' A' ' 34' ' ' ALA . 3.7 mp0 -65.36 45.2 0.02 OUTLIER 'General case' 0 C--N 1.291 -1.945 0 CA-C-O 121.617 0.722 . . . . 0.0 110.669 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.521 ' H ' ' C ' ' A' ' 7' ' ' ASP . 1.0 OUTLIER -110.93 -44.89 3.54 Favored 'General case' 0 C--N 1.285 -2.202 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.214 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -89.85 -7.35 54.48 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.664 ' SG ' ' HG2' ' A' ' 33' ' ' LYS . 39.6 t -62.95 144.2 57.02 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.453 -0.779 . . . . 0.0 110.195 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.7 pt -102.0 -113.16 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.293 -0.88 . . . . 0.0 108.798 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -135.27 26.61 3.5 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.778 -1.201 . . . . 0.0 109.043 179.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -102.1 149.6 24.11 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.28 -0.888 . . . . 0.0 109.905 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.463 ' HB2' ' HB ' ' A' ' 18' ' ' VAL . 0.7 OUTLIER -109.13 20.03 18.81 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.468 -0.77 . . . . 0.0 109.645 -179.856 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 15' ' ' GLU . 56.7 m -43.86 -66.78 0.34 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.262 -0.898 . . . . 0.0 109.34 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.969 ' SG ' ' CD2' ' A' ' 25' ' ' PHE . 19.0 p -48.52 -46.49 38.62 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.323 -0.86 . . . . 0.0 109.328 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.475 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 59.0 t -50.24 -31.28 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.276 -0.89 . . . . 0.0 109.329 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -77.52 -34.56 53.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.244 -0.91 . . . . 0.0 109.395 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.523 ' HB ' ' CB ' ' A' ' 50' ' ' ALA . 2.5 mp -79.95 5.36 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 178.318 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -172.8 65.15 0.34 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.351 -0.843 . . . . 0.0 109.045 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.37 70.13 2.53 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 O-C-N 124.286 1.677 . . . . 0.0 110.266 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.471 ' O ' ' HB3' ' A' ' 38' ' ' ASP . . . 177.72 -43.51 0.09 OUTLIER Glycine 0 N--CA 1.488 2.105 0 N-CA-C 108.737 -1.745 . . . . 0.0 108.737 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.532 ' CB ' ' O ' ' A' ' 38' ' ' ASP . . . -93.17 -32.25 14.47 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.555 -0.968 . . . . 0.0 109.029 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.969 ' CD2' ' SG ' ' A' ' 17' ' ' CYS . 0.1 OUTLIER -105.58 141.73 36.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.333 -0.855 . . . . 0.0 108.878 179.905 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.49 ' O ' ' CD1' ' A' ' 35' ' ' TYR . . . -174.96 125.32 0.27 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.115 -0.991 . . . . 0.0 109.286 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' MET . . . . . 0.558 ' HA ' ' C ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -58.5 154.3 14.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.165 -0.96 . . . . 0.0 109.558 -179.769 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.604 ' O ' ' N ' ' A' ' 32' ' ' GLU . 0.7 OUTLIER -126.18 163.29 40.87 Favored Pre-proline 0 C--N 1.313 -1.005 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 179.295 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.428 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 47.7 Cg_endo -84.19 -16.67 5.98 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 125.055 2.081 . . . . 0.0 108.279 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -88.07 -35.78 17.32 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 178.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.589 ' CG1' ' CB ' ' A' ' 28' ' ' ASP . 1.3 pt -105.28 -1.32 9.94 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 177.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.604 ' N ' ' O ' ' A' ' 28' ' ' ASP . 0.5 OUTLIER 34.78 36.86 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -179.244 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.664 ' HG2' ' SG ' ' A' ' 11' ' ' CYS . 1.8 mtmt -162.27 148.44 13.13 Favored 'General case' 0 N--CA 1.501 2.083 0 C-N-CA 119.012 -1.075 . . . . 0.0 110.755 -178.187 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.567 ' O ' ' CG ' ' A' ' 8' ' ' GLN . . . -52.76 146.09 11.09 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.548 -0.72 . . . . 0.0 110.201 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.613 ' O ' ' CD1' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -149.33 147.54 28.45 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-O 121.77 0.795 . . . . 0.0 109.51 179.219 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.604 ' CG2' ' CG2' ' A' ' 6' ' ' VAL . 1.3 t -88.84 96.09 5.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.097 -1.002 . . . . 0.0 108.34 -179.376 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.588 ' HG2' ' CE1' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -107.17 -28.12 10.15 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.418 -0.801 . . . . 0.0 110.966 -178.687 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.54 ' N ' ' HG3' ' A' ' 37' ' ' LYS . 22.1 t70 -122.21 78.8 1.53 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.799 -1.188 . . . . 0.0 110.16 -179.1 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.441 ' HB ' ' CZ ' ' A' ' 4' ' ' PHE . 27.2 m -45.25 -46.71 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.248 -0.908 . . . . 0.0 109.266 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.408 ' N ' ' CG2' ' A' ' 39' ' ' VAL . 6.5 mt-10 -58.51 -24.72 61.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.302 -0.874 . . . . 0.0 109.486 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 38' ' ' ASP . . . -54.08 -26.05 33.73 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.421 ' HB2' HG21 ' A' ' 47' ' ' VAL . . . -144.69 144.76 31.39 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.23 -1.159 . . . . 0.0 109.443 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.424 ' OG ' ' CD ' ' A' ' 46' ' ' GLU . 0.1 OUTLIER -67.95 169.14 10.45 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.177 -0.952 . . . . 0.0 109.504 179.988 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.479 ' O ' ' HG2' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -66.15 -47.72 73.11 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.49 -0.756 . . . . 0.0 109.247 179.802 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.68 ' HA ' ' HG2' ' A' ' 48' ' ' GLU . 5.8 mm-40 -61.4 -17.26 53.36 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.284 -0.885 . . . . 0.0 109.185 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.473 ' O ' HG23 ' A' ' 20' ' ' ILE . 76.9 mt-10 -91.92 -45.79 8.17 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 178.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.587 HG13 ' CH2' ' A' ' 61' ' ' TRP . 6.8 t -55.04 -38.24 45.34 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 178.014 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.68 ' HG2' ' HA ' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -68.14 -56.9 7.13 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.64 -0.663 . . . . 0.0 109.345 178.954 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.485 ' H ' ' HG3' ' A' ' 48' ' ' GLU . 0.3 OUTLIER -43.04 -48.14 6.02 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.167 -0.958 . . . . 0.0 109.085 179.883 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.523 ' CB ' ' HB ' ' A' ' 20' ' ' ILE . . . -60.41 -40.0 89.41 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.213 -0.929 . . . . 0.0 108.65 179.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.559 ' HE1' ' CZ3' ' A' ' 61' ' ' TRP . 21.2 ttm -58.7 -37.74 76.76 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.429 -0.794 . . . . 0.0 109.342 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -79.26 -8.07 58.76 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.282 -0.886 . . . . 0.0 109.244 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.502 ' CB ' HD12 ' A' ' 20' ' ' ILE . 0.3 OUTLIER -115.21 78.36 1.16 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.258 -0.901 . . . . 0.0 109.908 -179.897 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . 0.798 ' SG ' ' HD2' ' A' ' 55' ' ' PRO . 44.2 t -151.08 148.18 22.16 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.284 -0.885 . . . . 0.0 108.914 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.798 ' HD2' ' SG ' ' A' ' 54' ' ' CYS . 44.1 Cg_endo -72.1 -37.09 5.04 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 123.863 1.454 . . . . 0.0 110.333 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.9 m -111.83 -29.59 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.27 -0.894 . . . . 0.0 109.232 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.618 ' N ' ' SG ' ' A' ' 54' ' ' CYS . 0.0 OUTLIER 66.57 76.65 0.3 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.305 -0.872 . . . . 0.0 109.722 179.763 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 22.5 p -112.3 17.24 19.59 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.279 -0.888 . . . . 0.0 109.12 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.534 ' CG2' ' HG3' ' A' ' 51' ' ' MET . 0.1 OUTLIER -104.09 129.69 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.332 -0.855 . . . . 0.0 109.51 -179.687 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.525 ' N ' HD12 ' A' ' 59' ' ' ILE . 1.8 m80 -136.99 160.42 38.96 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.181 -0.949 . . . . 0.0 109.393 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . 0.587 ' CH2' HG13 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -68.13 -169.68 0.15 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.331 -0.856 . . . . 0.0 109.222 179.884 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.456 ' HB3' ' HB3' ' A' ' 3' ' ' LYS . 26.0 tt0 . . . . . 0 N--CA 1.489 1.521 0 O-C-N 121.287 -0.883 . . . . 0.0 109.318 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.505 ' O ' ' HB3' ' A' ' 4' ' ' PHE . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.518 ' HA ' ' HA ' ' A' ' 61' ' ' TRP . 39.3 p90 168.8 170.32 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.709 -0.619 . . . . 0.0 109.486 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.503 ' CE1' ' HB2' ' A' ' 62' ' ' GLU . 20.5 p90 176.75 -167.61 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 179.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.613 HG22 ' CZ ' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -136.52 -165.36 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 118.44 -1.304 . . . . 0.0 111.517 -179.57 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.537 ' C ' ' H ' ' A' ' 9' ' ' ASP . 1.5 m-20 -151.23 98.31 2.53 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 114.209 -1.36 . . . . 0.0 107.478 178.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.519 ' HG3' ' O ' ' A' ' 34' ' ' ALA . 5.7 mp0 -64.85 43.19 0.02 OUTLIER 'General case' 0 C--N 1.291 -1.939 0 CA-C-O 121.624 0.726 . . . . 0.0 110.664 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.537 ' H ' ' C ' ' A' ' 7' ' ' ASP . 0.2 OUTLIER -99.95 -24.52 14.61 Favored 'General case' 0 C--N 1.287 -2.116 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 179.438 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.432 ' HG2' ' HB ' ' A' ' 56' ' ' VAL . 0.6 OUTLIER -115.55 13.13 16.32 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.495 -0.753 . . . . 0.0 109.353 -179.977 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.453 ' HB3' ' HD3' ' A' ' 33' ' ' LYS . 41.9 t -84.23 129.67 34.87 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.155 -0.966 . . . . 0.0 109.7 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.514 ' O ' ' CB ' ' A' ' 13' ' ' ALA . 21.8 pt -102.24 -41.95 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.365 -0.834 . . . . 0.0 109.389 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.514 ' CB ' ' O ' ' A' ' 12' ' ' ILE . . . 163.85 -22.33 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.35 -0.844 . . . . 0.0 109.899 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.494 ' SG ' ' OG ' ' A' ' 16' ' ' SER . 0.1 OUTLIER -51.23 139.9 17.79 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.037 -1.04 . . . . 0.0 109.443 -179.75 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.47 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 4.0 mp0 -102.51 20.4 17.14 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.107 -0.996 . . . . 0.0 109.501 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.494 ' OG ' ' SG ' ' A' ' 14' ' ' CYS . 7.1 m -44.18 -65.48 0.51 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.25 -0.906 . . . . 0.0 109.063 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.608 ' SG ' ' N ' ' A' ' 18' ' ' VAL . 16.4 p -53.16 -52.16 59.67 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.42 -0.8 . . . . 0.0 109.026 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.608 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 38.5 t -48.32 -24.42 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.354 -0.841 . . . . 0.0 109.161 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -86.22 -33.47 20.73 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.299 -0.876 . . . . 0.0 109.004 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.531 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 2.7 mp -85.01 12.05 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.27 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.537 ' HB3' ' CB ' ' A' ' 42' ' ' ALA . . . 169.69 65.22 0.02 OUTLIER Pre-proline 0 N--CA 1.486 1.345 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -69.23 -4.85 14.49 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 O-C-N 124.143 1.602 . . . . 0.0 110.298 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.459 ' O ' ' HB3' ' A' ' 38' ' ' ASP . . . -100.44 -39.94 3.1 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.494 ' HA ' ' HB3' ' A' ' 38' ' ' ASP . . . -85.72 -33.76 21.41 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.321 -1.105 . . . . 0.0 109.299 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.613 ' CZ ' HG22 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -103.69 144.25 31.7 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.795 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.487 ' O ' ' CD1' ' A' ' 35' ' ' TYR . . . -170.84 126.48 0.71 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.991 -1.068 . . . . 0.0 109.793 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' MET . . . . . 0.531 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 3.7 ppp? -59.91 153.86 20.07 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.082 -1.011 . . . . 0.0 109.323 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.633 ' O ' ' N ' ' A' ' 32' ' ' GLU . 3.0 t0 -123.99 160.21 52.94 Favored Pre-proline 0 C--N 1.31 -1.135 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 179.217 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.432 ' CD ' ' OD1' ' A' ' 28' ' ' ASP . 47.2 Cg_endo -84.7 -16.48 5.49 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 124.973 2.039 . . . . 0.0 108.682 -179.28 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.35 -28.21 17.06 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 178.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.559 HG12 ' CB ' ' A' ' 28' ' ' ASP . 0.9 OUTLIER -108.83 -2.67 10.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 177.974 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.633 ' N ' ' O ' ' A' ' 28' ' ' ASP . 2.7 mm-40 31.33 38.56 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -179.006 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.544 ' CG ' ' O ' ' A' ' 32' ' ' GLU . 70.7 mttt -162.39 148.11 12.76 Favored 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 119.723 -0.791 . . . . 0.0 110.296 -178.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.553 ' HB2' ' CE1' ' A' ' 25' ' ' PHE . . . -56.79 147.57 22.83 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.468 -0.77 . . . . 0.0 110.863 -179.423 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.595 ' O ' ' CD1' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -152.44 153.36 33.4 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.576 -0.703 . . . . 0.0 109.316 178.806 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.602 HG21 ' CE2' ' A' ' 25' ' ' PHE . 36.5 t -92.62 103.54 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 120.926 -1.108 . . . . 0.0 109.095 -179.452 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.579 ' HB3' ' CE2' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -119.3 -23.48 6.71 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 119.469 -0.892 . . . . 0.0 110.616 -179.286 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.517 ' N ' ' HG3' ' A' ' 37' ' ' LYS . 45.1 t0 -112.31 98.45 7.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.997 -1.064 . . . . 0.0 109.821 -179.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.426 HG22 ' OE1' ' A' ' 40' ' ' GLU . 27.7 m -63.9 -29.21 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.139 -0.976 . . . . 0.0 109.578 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.426 ' OE1' HG22 ' A' ' 39' ' ' VAL . 0.7 OUTLIER -81.86 -14.26 56.49 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.228 -0.92 . . . . 0.0 109.53 -179.804 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.413 ' HA3' ' C ' ' A' ' 23' ' ' GLY . . . -67.08 -17.85 68.33 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.211 -1.556 . . . . 0.0 109.211 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.537 ' CB ' ' HB3' ' A' ' 21' ' ' ALA . . . -151.34 131.42 13.47 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.431 -1.041 . . . . 0.0 109.278 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.86 167.61 5.92 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.217 -0.927 . . . . 0.0 109.487 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -58.04 -49.01 78.36 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.506 -0.746 . . . . 0.0 109.409 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.692 ' HA ' ' HG2' ' A' ' 48' ' ' GLU . 1.0 OUTLIER -62.77 -14.72 48.33 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.182 -0.949 . . . . 0.0 108.943 179.908 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.433 ' OE1' ' HA ' ' A' ' 42' ' ' ALA . 43.0 mt-10 -90.52 -44.3 9.67 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 178.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.404 HG23 ' CE1' ' A' ' 4' ' ' PHE . 8.5 t -57.84 -38.71 67.37 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.343 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.692 ' HG2' ' HA ' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -68.77 -58.21 4.53 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.518 -0.739 . . . . 0.0 109.662 179.672 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.488 ' H ' ' HG3' ' A' ' 48' ' ' GLU . 29.0 tt0 -44.13 -53.58 6.32 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.013 -1.054 . . . . 0.0 108.819 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.531 ' N ' ' CG2' ' A' ' 20' ' ' ILE . . . -54.0 -42.3 68.91 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.057 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.509 ' HE3' ' CD1' ' A' ' 61' ' ' TRP . 30.3 ttm -61.05 -29.87 69.99 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.052 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -63.56 -32.59 74.09 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.517 ' CG2' HD12 ' A' ' 20' ' ' ILE . 76.4 p -77.52 -155.03 0.07 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.402 -0.811 . . . . 0.0 109.201 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . 0.502 ' SG ' ' HD2' ' A' ' 55' ' ' PRO . 2.3 t 64.99 140.46 0.06 OUTLIER Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.11 -0.994 . . . . 0.0 109.391 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.502 ' HD2' ' SG ' ' A' ' 54' ' ' CYS . 42.1 Cg_endo -71.37 -86.89 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.006 1.529 . . . . 0.0 110.061 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.432 ' HB ' ' HG2' ' A' ' 10' ' ' GLU . 11.1 t -63.34 -12.68 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.179 -0.951 . . . . 0.0 108.935 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.488 ' HA ' ' HB3' ' A' ' 54' ' ' CYS . 0.0 OUTLIER 58.55 81.08 0.16 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.244 -0.91 . . . . 0.0 109.431 179.863 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.468 ' O ' HG11 ' A' ' 6' ' ' VAL . 28.0 p -86.64 16.14 4.98 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.2 -0.937 . . . . 0.0 109.399 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.475 ' HA ' HG11 ' A' ' 6' ' ' VAL . 7.9 tt -106.16 154.38 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.168 -0.957 . . . . 0.0 109.81 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.423 ' ND1' ' C ' ' A' ' 59' ' ' ILE . 0.2 OUTLIER -166.95 -174.62 2.75 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.49 -0.756 . . . . 0.0 108.986 179.981 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . 0.518 ' HA ' ' HA ' ' A' ' 4' ' ' PHE . 47.1 m95 -104.54 155.16 19.06 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.041 -1.037 . . . . 0.0 109.704 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.503 ' HB2' ' CE1' ' A' ' 5' ' ' TYR . 6.4 tt0 . . . . . 0 N--CA 1.49 1.548 0 O-C-N 121.465 -0.772 . . . . 0.0 109.454 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.537 ' HB3' ' HB3' ' A' ' 62' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.36 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.574 ' CB ' ' HA ' ' A' ' 61' ' ' TRP . 24.4 p90 168.54 -179.3 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.508 -0.745 . . . . 0.0 109.551 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.474 ' O ' HG13 ' A' ' 59' ' ' ILE . 30.0 p90 176.71 -175.95 0.13 Allowed 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 179.23 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.626 ' CG2' ' CZ ' ' A' ' 25' ' ' PHE . 0.2 OUTLIER -131.4 169.77 21.08 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.018 0 C-N-CA 117.389 -1.724 . . . . 0.0 111.413 -179.661 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.508 ' O ' ' N ' ' A' ' 9' ' ' ASP . 9.3 t0 -108.99 89.58 3.04 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 178.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.559 ' CG ' ' O ' ' A' ' 34' ' ' ALA . 8.4 mp0 -65.36 46.09 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.859 0 CA-C-O 121.578 0.704 . . . . 0.0 110.3 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.508 ' N ' ' O ' ' A' ' 7' ' ' ASP . 0.3 OUTLIER -113.32 -44.65 3.21 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.395 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.464 ' HB2' ' SG ' ' A' ' 58' ' ' CYS . 0.3 OUTLIER -91.45 17.62 8.33 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.087 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.428 ' HB3' ' HG2' ' A' ' 33' ' ' LYS . 37.4 t -83.26 111.95 19.43 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.359 -0.838 . . . . 0.0 110.373 -179.169 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.498 ' O ' ' CB ' ' A' ' 13' ' ' ALA . 30.6 pt -78.53 0.59 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.47 -0.768 . . . . 0.0 109.047 179.344 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.498 ' CB ' ' O ' ' A' ' 12' ' ' ILE . . . 78.81 50.58 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.452 -0.78 . . . . 0.0 110.294 179.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.839 ' SG ' ' OG ' ' A' ' 16' ' ' SER . 3.2 p -105.67 161.51 14.33 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.866 -1.146 . . . . 0.0 109.436 179.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.466 ' O ' ' HB2' ' A' ' 19' ' ' GLU . 63.3 mt-10 -87.88 18.38 4.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.277 -0.889 . . . . 0.0 109.832 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.839 ' OG ' ' SG ' ' A' ' 14' ' ' CYS . 52.4 p -60.73 -91.06 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.22 -0.925 . . . . 0.0 109.636 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.523 ' SG ' ' N ' ' A' ' 18' ' ' VAL . 10.8 p -45.34 -47.77 13.3 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.22 -0.925 . . . . 0.0 110.034 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.523 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 78.6 t -53.03 -30.74 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.165 -0.96 . . . . 0.0 109.981 -179.503 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.466 ' HB2' ' O ' ' A' ' 15' ' ' GLU . 2.8 mm-40 -77.35 -41.97 38.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.932 -1.105 . . . . 0.0 109.603 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.562 ' HB ' ' CB ' ' A' ' 50' ' ' ALA . 1.6 mt -84.81 15.57 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.248 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 20' ' ' ILE . . . 170.54 63.14 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.452 -0.78 . . . . 0.0 109.281 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.487 ' N ' ' O ' ' A' ' 18' ' ' VAL . 45.9 Cg_endo -74.07 -18.56 21.12 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.08 1.569 . . . . 0.0 110.882 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -79.44 -41.48 13.28 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.484 ' HA ' ' HB3' ' A' ' 38' ' ' ASP . . . -87.32 -34.2 18.93 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.215 -1.168 . . . . 0.0 109.71 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.626 ' CZ ' ' CG2' ' A' ' 6' ' ' VAL . 0.1 OUTLIER -106.04 141.21 37.8 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.324 -0.86 . . . . 0.0 109.326 -179.716 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.49 ' O ' ' CD1' ' A' ' 35' ' ' TYR . . . -170.45 128.69 0.83 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.069 -1.019 . . . . 0.0 109.948 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' MET . . . . . 0.55 ' HA ' ' C ' ' A' ' 33' ' ' LYS . 2.7 ptm -62.65 153.98 30.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.917 -1.114 . . . . 0.0 109.222 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.574 ' O ' ' HA ' ' A' ' 32' ' ' GLU . 1.7 t0 -135.22 165.26 37.82 Favored Pre-proline 0 C--N 1.311 -1.085 0 O-C-N 120.663 -1.273 . . . . 0.0 107.572 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.469 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 43.4 Cg_endo -84.01 -17.1 5.95 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 O-C-N 124.528 1.804 . . . . 0.0 107.867 179.265 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.72 -38.96 19.07 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 177.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.551 HG12 ' CB ' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -104.13 3.07 10.58 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 177.885 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.574 ' HA ' ' O ' ' A' ' 28' ' ' ASP . 2.5 mm-40 31.62 39.33 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.795 0.807 . . . . 0.0 108.879 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.55 ' C ' ' HA ' ' A' ' 27' ' ' MET . 0.0 OUTLIER -173.7 153.55 2.27 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 119.191 -1.004 . . . . 0.0 110.131 -178.537 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.559 ' O ' ' CG ' ' A' ' 8' ' ' GLN . . . -52.52 149.32 5.95 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.475 -0.766 . . . . 0.0 109.66 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.617 ' O ' ' CD1' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -154.16 146.5 23.9 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.614 0.721 . . . . 0.0 109.267 179.266 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.598 ' CG2' ' CG2' ' A' ' 6' ' ' VAL . 2.1 t -87.44 99.75 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.103 -0.998 . . . . 0.0 108.49 -179.411 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.587 ' HG2' ' CE1' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -115.56 -27.11 7.24 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.23 -0.919 . . . . 0.0 111.057 -178.699 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.556 ' N ' ' HG3' ' A' ' 37' ' ' LYS . 39.5 t0 -113.21 92.46 4.01 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.897 -1.127 . . . . 0.0 110.026 -179.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.541 HG13 ' CZ ' ' A' ' 4' ' ' PHE . 25.5 m -61.16 -23.28 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.36 -0.837 . . . . 0.0 109.248 179.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.48 ' N ' HG21 ' A' ' 39' ' ' VAL . 3.1 mt-10 -93.13 1.39 57.19 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.418 -0.801 . . . . 0.0 109.561 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -87.2 -0.09 85.37 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.444 ' HA ' ' OE2' ' A' ' 46' ' ' GLU . . . -162.91 131.41 3.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.167 -1.196 . . . . 0.0 109.718 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.514 ' N ' ' HG2' ' A' ' 46' ' ' GLU . 0.1 OUTLIER -61.52 170.93 1.65 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.348 -0.845 . . . . 0.0 109.943 -179.823 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.468 ' HA ' ' HB ' ' A' ' 47' ' ' VAL . 6.0 tt0 -72.0 -41.05 68.04 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.572 -0.705 . . . . 0.0 109.743 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -67.22 -25.92 66.34 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.108 -0.995 . . . . 0.0 109.41 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.514 ' HG2' ' N ' ' A' ' 43' ' ' SER . 5.1 pt-20 -90.02 -35.29 15.59 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 178.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.468 ' HB ' ' HA ' ' A' ' 44' ' ' GLN . 4.0 t -64.37 -32.7 58.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 177.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.459 ' HB2' ' O ' ' A' ' 44' ' ' GLN . 0.5 OUTLIER -71.15 -59.35 2.82 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.131 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.494 ' CB ' HG23 ' A' ' 20' ' ' ILE . 0.4 OUTLIER -53.2 -39.22 63.52 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.113 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.562 ' CB ' ' HB ' ' A' ' 20' ' ' ILE . . . -71.59 -17.83 62.27 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.365 -0.834 . . . . 0.0 109.049 179.413 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.531 ' CG ' HG23 ' A' ' 59' ' ' ILE . 33.4 ttm -92.11 -17.84 24.41 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.483 -0.761 . . . . 0.0 109.939 -179.328 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -100.93 -17.15 16.93 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.054 -1.029 . . . . 0.0 109.784 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.485 ' CG2' ' CD1' ' A' ' 20' ' ' ILE . 9.6 t -72.58 -11.22 60.56 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.061 -1.025 . . . . 0.0 109.448 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . 1.227 ' SG ' ' HD2' ' A' ' 55' ' ' PRO . 9.4 t -71.04 158.61 87.78 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.248 -0.907 . . . . 0.0 109.486 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 1.227 ' HD2' ' SG ' ' A' ' 54' ' ' CYS . 42.1 Cg_endo -72.79 -85.28 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.92 1.484 . . . . 0.0 109.929 179.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.462 ' CG1' ' HB3' ' A' ' 10' ' ' GLU . 4.2 p -68.41 -22.91 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.111 -0.993 . . . . 0.0 108.926 179.358 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.454 ' O ' ' N ' ' A' ' 59' ' ' ILE . 0.6 OUTLIER 69.34 46.63 0.75 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.474 -0.767 . . . . 0.0 109.635 179.741 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.464 ' SG ' ' HB2' ' A' ' 10' ' ' GLU . 0.1 OUTLIER -68.28 62.41 0.09 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.158 -0.964 . . . . 0.0 109.296 179.732 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.582 ' O ' ' CG ' ' A' ' 60' ' ' HIS . 12.0 tt -132.22 160.29 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.297 -0.877 . . . . 0.0 109.418 -179.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.582 ' CG ' ' O ' ' A' ' 59' ' ' ILE . 15.7 m80 -159.83 147.54 16.87 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.02 -1.05 . . . . 0.0 109.915 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . 0.574 ' HA ' ' CB ' ' A' ' 4' ' ' PHE . 58.2 m95 -83.74 -175.38 5.78 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.321 -0.862 . . . . 0.0 108.861 179.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.537 ' HB3' ' HB3' ' A' ' 3' ' ' LYS . 0.5 OUTLIER . . . . . 0 C--N 1.301 -1.53 0 O-C-N 121.089 -1.007 . . . . 0.0 109.586 -179.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.426 ' HB3' ' HB3' ' A' ' 62' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.581 ' CE2' HG12 ' A' ' 36' ' ' VAL . 30.9 p90 -178.12 -178.83 0.68 Allowed 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.253 -0.905 . . . . 0.0 109.613 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.577 ' HA ' HG23 ' A' ' 36' ' ' VAL . 45.6 p90 -179.89 -178.15 0.42 Allowed 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 106.012 -1.848 . . . . 0.0 106.012 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.586 HG22 ' CZ ' ' A' ' 25' ' ' PHE . 2.6 t -142.41 160.95 19.41 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.32 0 C-N-CA 117.487 -1.685 . . . . 0.0 111.228 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.526 ' O ' ' N ' ' A' ' 9' ' ' ASP . 4.8 m-20 -114.52 79.26 1.24 Allowed 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.518 ' HB2' ' CB ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -42.07 -22.76 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.564 0.697 . . . . 0.0 109.285 179.359 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.526 ' N ' ' O ' ' A' ' 7' ' ' ASP . 0.5 OUTLIER -48.99 -42.58 38.3 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.545 -0.722 . . . . 0.0 109.332 -179.782 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.489 ' CG ' ' SG ' ' A' ' 58' ' ' CYS . 7.8 tp10 -84.1 -14.53 50.14 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.308 -0.87 . . . . 0.0 109.179 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 42.8 t -56.68 139.79 49.26 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.243 -0.91 . . . . 0.0 109.492 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.586 ' O ' ' CB ' ' A' ' 13' ' ' ALA . 1.6 pp -101.35 -33.69 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.219 -0.925 . . . . 0.0 109.783 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.586 ' CB ' ' O ' ' A' ' 12' ' ' ILE . . . 155.99 -40.5 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.543 -0.723 . . . . 0.0 109.769 179.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.43 ' C ' ' O ' ' A' ' 13' ' ' ALA . 0.1 OUTLIER -43.84 153.2 0.13 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.146 -0.971 . . . . 0.0 109.735 -179.39 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.427 ' O ' ' C ' ' A' ' 16' ' ' SER . 3.5 pt-20 -117.49 21.88 12.76 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.277 -0.889 . . . . 0.0 109.559 -179.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.427 ' C ' ' O ' ' A' ' 15' ' ' GLU . 0.1 OUTLIER -44.43 -55.19 5.23 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.148 -0.97 . . . . 0.0 109.18 179.856 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.49 ' SG ' ' CD1' ' A' ' 25' ' ' PHE . 21.5 p -54.46 -45.31 73.1 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.376 -0.827 . . . . 0.0 109.3 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.461 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 4.8 t -52.26 -26.48 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.34 -0.85 . . . . 0.0 109.466 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -89.82 -32.08 17.08 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.166 -0.959 . . . . 0.0 109.541 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.512 HG22 ' N ' ' A' ' 50' ' ' ALA . 2.7 mp -84.65 11.8 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.473 ' CB ' ' HB3' ' A' ' 42' ' ' ALA . . . -168.58 66.28 0.67 Allowed Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.357 -0.84 . . . . 0.0 109.293 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -71.74 83.28 1.12 Allowed 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 123.981 1.516 . . . . 0.0 110.287 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 147.57 -21.01 1.5 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.546 ' CB ' ' O ' ' A' ' 38' ' ' ASP . . . -113.01 -30.68 6.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.314 -1.109 . . . . 0.0 109.102 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.586 ' CZ ' HG22 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -112.86 140.57 47.54 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.439 -0.788 . . . . 0.0 109.408 -179.972 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.458 ' O ' ' HA ' ' A' ' 34' ' ' ALA . . . -171.59 149.65 2.65 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' MET . . . . . 0.511 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 0.2 OUTLIER -82.76 156.51 23.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.874 -1.141 . . . . 0.0 108.652 -179.979 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.622 ' O ' ' N ' ' A' ' 32' ' ' GLU . 1.7 t0 -121.13 160.95 43.16 Favored Pre-proline 0 C--N 1.31 -1.148 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 179.26 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.437 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 48.1 Cg_endo -83.42 -15.97 7.24 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 125.051 2.08 . . . . 0.0 108.157 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -88.56 -35.35 16.96 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 178.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.591 ' CG1' ' CB ' ' A' ' 28' ' ' ASP . 3.8 pt -106.86 0.48 10.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.622 ' N ' ' O ' ' A' ' 28' ' ' ASP . 51.6 mt-10 32.18 38.34 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -179.247 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.535 ' N ' ' O ' ' A' ' 31' ' ' ILE . 83.1 mttt -157.83 146.87 19.55 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 119.262 -0.975 . . . . 0.0 110.93 -177.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.512 ' O ' ' HB3' ' A' ' 8' ' ' GLN . . . -53.31 143.91 17.55 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.737 -0.602 . . . . 0.0 110.634 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.693 ' CE2' ' HA ' ' A' ' 37' ' ' LYS . 6.9 p90 -149.37 169.19 21.4 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.581 HG12 ' CE2' ' A' ' 4' ' ' PHE . 0.2 OUTLIER -86.59 85.09 2.35 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.084 0 CA-C-O 121.624 0.726 . . . . 0.0 109.433 -178.26 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.693 ' HA ' ' CE2' ' A' ' 35' ' ' TYR . 13.4 ptmt -68.89 -10.39 56.79 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.558 -0.714 . . . . 0.0 110.511 -179.344 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.546 ' O ' ' CB ' ' A' ' 24' ' ' ALA . 11.7 t0 178.55 141.07 0.1 Allowed 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 118.611 -1.235 . . . . 0.0 110.424 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.1 m -84.38 -33.54 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.289 -0.882 . . . . 0.0 109.351 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -71.78 -16.08 62.18 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.247 -0.908 . . . . 0.0 109.21 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -69.39 -26.85 74.18 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.473 ' HB3' ' CB ' ' A' ' 21' ' ' ALA . . . -130.7 144.74 51.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.294 -1.121 . . . . 0.0 109.252 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.452 ' OG ' ' HG3' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -89.11 158.24 18.02 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.199 -0.938 . . . . 0.0 109.996 -179.613 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.525 ' HG2' ' N ' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -53.03 -23.06 6.69 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.45 -0.781 . . . . 0.0 109.147 179.811 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.525 ' N ' ' HG2' ' A' ' 44' ' ' GLN . 53.8 mm-40 -85.06 -23.1 28.72 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.4 -0.813 . . . . 0.0 108.837 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.454 ' O ' HG23 ' A' ' 20' ' ' ILE . 48.5 mt-10 -88.5 -55.8 3.57 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 106.263 -1.755 . . . . 0.0 106.263 178.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.505 HG23 ' CE2' ' A' ' 4' ' ' PHE . 2.9 t -48.06 -29.35 2.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 177.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.523 ' HB2' ' O ' ' A' ' 44' ' ' GLN . 0.3 OUTLIER -70.25 -69.27 0.37 Allowed 'General case' 0 C--N 1.311 -1.083 0 O-C-N 121.565 -0.709 . . . . 0.0 109.41 179.161 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -46.15 -46.72 17.44 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.381 -0.825 . . . . 0.0 109.11 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.512 ' N ' HG22 ' A' ' 20' ' ' ILE . . . -55.02 -32.49 61.88 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.289 -0.882 . . . . 0.0 109.088 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.537 ' HG3' ' CG2' ' A' ' 59' ' ' ILE . 34.9 ttm -66.7 -60.2 2.91 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.414 -0.803 . . . . 0.0 109.426 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -46.69 -28.19 1.42 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.223 -0.923 . . . . 0.0 109.689 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.432 ' O ' ' HB2' ' A' ' 54' ' ' CYS . 0.2 OUTLIER -102.08 99.9 10.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.176 -0.953 . . . . 0.0 109.827 -179.763 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . 0.812 ' SG ' ' HD2' ' A' ' 55' ' ' PRO . 53.2 t 176.64 146.43 0.27 Allowed Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.214 -0.929 . . . . 0.0 109.868 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.812 ' HD2' ' SG ' ' A' ' 54' ' ' CYS . 45.1 Cg_endo -75.14 104.04 1.84 Allowed 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 124.061 1.558 . . . . 0.0 109.279 179.178 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.527 ' CB ' ' O ' ' A' ' 55' ' ' PRO . 3.7 t 77.71 3.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.441 -0.787 . . . . 0.0 109.003 -178.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.483 ' HA ' ' HB3' ' A' ' 54' ' ' CYS . 15.5 mt-30 44.72 82.65 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.284 -0.885 . . . . 0.0 109.413 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.538 ' O ' ' CE1' ' A' ' 60' ' ' HIS . 2.3 m -79.93 -12.54 59.72 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.242 -0.911 . . . . 0.0 109.224 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.537 ' CG2' ' HG3' ' A' ' 51' ' ' MET . 16.4 tt -83.77 144.19 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.383 -0.823 . . . . 0.0 110.145 -179.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.538 ' CE1' ' O ' ' A' ' 58' ' ' CYS . 14.0 m80 -144.37 172.43 12.94 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.365 -0.834 . . . . 0.0 108.902 179.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . 0.524 ' HA ' ' CB ' ' A' ' 4' ' ' PHE . 68.4 m95 -94.69 179.55 5.22 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.029 -1.045 . . . . 0.0 110.037 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.426 ' HB3' ' HB3' ' A' ' 3' ' ' LYS . 13.6 tt0 . . . . . 0 N--CA 1.49 1.53 0 O-C-N 121.42 -0.8 . . . . 0.0 109.261 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.482 ' HB3' ' HB3' ' A' ' 62' ' ' GLU . 1.2 ttmt . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.557 ' HA ' ' N ' ' A' ' 62' ' ' GLU . 51.2 p90 175.55 175.69 0.24 Allowed 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.399 -0.813 . . . . 0.0 110.082 179.606 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.527 ' O ' ' CD1' ' A' ' 59' ' ' ILE . 41.0 p90 179.7 -176.34 0.31 Allowed 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.668 ' CG2' ' CZ ' ' A' ' 25' ' ' PHE . 0.2 OUTLIER -135.48 171.95 16.59 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 C-N-CA 117.816 -1.553 . . . . 0.0 110.94 -179.859 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.516 ' C ' ' H ' ' A' ' 9' ' ' ASP . 2.5 t0 -117.98 92.56 3.86 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.555 ' CG ' ' O ' ' A' ' 34' ' ' ALA . 4.0 mp0 -62.89 42.37 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.93 0 CA-C-O 121.399 0.619 . . . . 0.0 111.039 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.516 ' H ' ' C ' ' A' ' 7' ' ' ASP . 0.4 OUTLIER -104.13 -31.68 9.53 Favored 'General case' 0 C--N 1.287 -2.11 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.432 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.432 ' HB2' ' SG ' ' A' ' 58' ' ' CYS . 0.6 OUTLIER -111.42 22.06 15.53 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.632 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 14.4 t -83.76 126.04 32.51 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.292 -0.88 . . . . 0.0 109.988 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.536 ' O ' ' CB ' ' A' ' 13' ' ' ALA . 23.1 pt -86.21 1.31 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.363 -0.836 . . . . 0.0 109.431 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.536 ' CB ' ' O ' ' A' ' 12' ' ' ILE . . . 78.49 32.59 0.32 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.333 -0.854 . . . . 0.0 110.612 179.207 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.6 p -88.86 151.52 22.3 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.905 -1.122 . . . . 0.0 109.076 179.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.431 ' O ' ' HB2' ' A' ' 19' ' ' GLU . 1.5 mt-10 -88.54 33.97 0.76 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.179 -0.951 . . . . 0.0 110.115 -179.336 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.495 ' OG ' ' N ' ' A' ' 17' ' ' CYS . 75.5 p -75.83 -69.95 0.46 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.086 -1.009 . . . . 0.0 109.326 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.59 ' SG ' ' CG ' ' A' ' 25' ' ' PHE . 12.4 p -58.25 -46.55 85.77 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.226 -0.922 . . . . 0.0 109.519 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.533 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 68.7 t -52.69 -41.73 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.364 -0.835 . . . . 0.0 109.916 -179.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.431 ' HB2' ' O ' ' A' ' 15' ' ' GLU . 7.4 tm-20 -66.49 -42.7 87.01 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.099 -1.001 . . . . 0.0 109.662 -179.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.593 ' HB ' ' CB ' ' A' ' 50' ' ' ALA . 2.7 mp -82.06 11.76 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.294 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -176.18 68.67 0.25 Allowed Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.29 -0.881 . . . . 0.0 109.237 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -74.09 -0.32 9.4 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 124.076 1.566 . . . . 0.0 110.381 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.451 ' O ' ' HB3' ' A' ' 38' ' ' ASP . . . -112.98 -33.12 2.06 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.44 ' HA ' ' HB3' ' A' ' 38' ' ' ASP . . . -90.1 -46.46 8.46 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.147 -1.208 . . . . 0.0 109.449 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.668 ' CZ ' ' CG2' ' A' ' 6' ' ' VAL . 0.1 OUTLIER -99.26 146.97 25.65 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.273 -0.892 . . . . 0.0 108.901 179.829 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.469 ' O ' ' CD1' ' A' ' 35' ' ' TYR . . . -169.86 125.02 0.8 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.105 -0.997 . . . . 0.0 109.946 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' MET . . . . . 0.537 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 6.3 ttp -58.43 152.87 16.94 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.174 -0.954 . . . . 0.0 109.289 179.557 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.637 ' O ' ' N ' ' A' ' 32' ' ' GLU . 0.6 OUTLIER -128.21 163.56 43.25 Favored Pre-proline 0 C--N 1.311 -1.092 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 179.181 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -85.43 -15.62 5.15 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 O-C-N 125.148 2.131 . . . . 0.0 108.513 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -92.41 -29.34 16.34 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 178.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.546 HG12 ' HB3' ' A' ' 28' ' ' ASP . 0.2 OUTLIER -103.31 -15.66 7.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 177.557 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.637 ' N ' ' O ' ' A' ' 28' ' ' ASP . 14.1 mt-10 44.08 31.7 0.56 Allowed 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 -177.111 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.519 ' C ' ' HA ' ' A' ' 27' ' ' MET . 2.5 mttp -158.26 152.82 24.64 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 119.344 -0.942 . . . . 0.0 110.483 -177.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.555 ' O ' ' CG ' ' A' ' 8' ' ' GLN . . . -59.66 148.97 31.89 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.487 -0.758 . . . . 0.0 109.768 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.632 ' O ' ' CD1' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -150.75 146.85 26.69 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.624 0.726 . . . . 0.0 109.519 179.296 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.607 ' CG2' ' CG2' ' A' ' 6' ' ' VAL . 2.4 t -89.57 97.82 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.077 -1.014 . . . . 0.0 108.448 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.619 ' HB3' ' CE2' ' A' ' 35' ' ' TYR . 1.3 pttp -108.08 -23.71 11.87 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.337 -0.852 . . . . 0.0 110.296 -179.26 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.519 ' N ' ' HG3' ' A' ' 37' ' ' LYS . 55.2 t0 -118.36 124.54 47.98 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.125 -0.984 . . . . 0.0 109.884 -179.334 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.488 HG21 ' N ' ' A' ' 40' ' ' GLU . 15.5 m -86.22 -34.53 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.272 -0.892 . . . . 0.0 109.451 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.488 ' N ' HG21 ' A' ' 39' ' ' VAL . 8.1 pm0 -81.9 -10.31 59.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.198 -0.938 . . . . 0.0 109.519 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -63.54 -18.55 61.41 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -151.93 132.28 13.72 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.248 -1.148 . . . . 0.0 109.521 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.45 155.09 19.05 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.26 -0.9 . . . . 0.0 109.727 -179.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.463 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 4.2 pt20 -49.46 -44.94 46.17 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.479 -0.763 . . . . 0.0 109.565 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.415 ' O ' ' HG3' ' A' ' 49' ' ' GLU . 7.6 mm-40 -64.12 -17.96 63.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.215 -0.928 . . . . 0.0 109.019 179.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -90.73 -46.99 7.91 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 179.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.52 ' CG1' ' HE3' ' A' ' 51' ' ' MET . 2.3 t -57.85 -38.6 66.81 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.438 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.463 ' HB2' ' O ' ' A' ' 44' ' ' GLN . 0.1 OUTLIER -68.19 -60.99 2.06 Favored 'General case' 0 C--N 1.307 -1.257 0 O-C-N 121.534 -0.729 . . . . 0.0 109.629 179.721 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.415 ' HG3' ' O ' ' A' ' 45' ' ' GLU . 2.3 mt-10 -51.5 -40.67 60.01 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.172 -0.955 . . . . 0.0 108.877 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.593 ' CB ' ' HB ' ' A' ' 20' ' ' ILE . . . -69.28 -20.91 63.91 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.521 -0.737 . . . . 0.0 109.024 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.52 ' HE3' ' CG1' ' A' ' 47' ' ' VAL . 0.7 OUTLIER -82.86 -51.03 8.0 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.522 -0.736 . . . . 0.0 109.522 -179.482 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -57.32 -32.11 66.36 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.308 -0.87 . . . . 0.0 109.444 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.495 ' CG2' HD12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -60.61 -32.05 71.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.341 -0.849 . . . . 0.0 109.804 -179.834 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . 0.459 ' HB3' ' HA ' ' A' ' 57' ' ' GLN . 11.4 t -58.28 128.75 82.7 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.18 -0.95 . . . . 0.0 109.429 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -72.26 -53.94 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 123.931 1.49 . . . . 0.0 109.621 179.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 27.9 t -79.63 -15.18 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.459 ' HA ' ' HB3' ' A' ' 54' ' ' CYS . 0.5 OUTLIER 45.84 79.4 0.05 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.413 -0.804 . . . . 0.0 109.789 179.783 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.432 ' SG ' ' HB2' ' A' ' 10' ' ' GLU . 0.9 OUTLIER -92.58 15.86 13.35 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.354 -0.841 . . . . 0.0 109.043 179.517 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.527 ' CD1' ' O ' ' A' ' 5' ' ' TYR . 4.0 tp -64.33 159.21 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.34 -0.85 . . . . 0.0 109.448 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.519 ' O ' ' HB2' ' A' ' 61' ' ' TRP . 6.5 m80 -135.73 -32.05 0.92 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.227 -0.921 . . . . 0.0 110.358 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . 0.552 ' HA ' ' HA ' ' A' ' 4' ' ' PHE . 55.7 m95 67.51 163.75 0.2 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.477 -0.764 . . . . 0.0 109.244 -179.025 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.557 ' N ' ' HA ' ' A' ' 4' ' ' PHE . 14.8 tt0 . . . . . 0 N--CA 1.488 1.441 0 O-C-N 121.35 -0.844 . . . . 0.0 109.342 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.504 ' O ' ' HB3' ' A' ' 4' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.505 ' HA ' ' HA ' ' A' ' 61' ' ' TRP . 33.6 p90 168.0 -175.56 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.469 -0.769 . . . . 0.0 109.323 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.48 ' HB3' ' O ' ' A' ' 4' ' ' PHE . 28.0 p90 167.6 -175.62 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 106.541 -1.652 . . . . 0.0 106.541 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.663 ' CG2' ' CZ ' ' A' ' 25' ' ' PHE . 0.6 OUTLIER -131.25 176.31 9.2 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.073 0 C-N-CA 117.467 -1.693 . . . . 0.0 110.952 -179.945 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.486 ' C ' ' H ' ' A' ' 9' ' ' ASP . 1.1 m-20 -127.1 90.52 3.16 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-O 121.845 0.831 . . . . 0.0 109.118 179.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.561 ' CG ' ' O ' ' A' ' 34' ' ' ALA . 1.5 mp0 -63.63 44.1 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.704 179.266 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.486 ' H ' ' C ' ' A' ' 7' ' ' ASP . 0.2 OUTLIER -99.93 -20.75 15.97 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 179.369 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.507 ' CG ' HG12 ' A' ' 56' ' ' VAL . 2.8 mm-40 -121.49 -7.49 9.18 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.663 -0.648 . . . . 0.0 109.468 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.652 ' SG ' ' HG2' ' A' ' 33' ' ' LYS . 45.0 t -54.1 112.41 0.96 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.19 -0.944 . . . . 0.0 109.692 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.531 ' O ' ' CB ' ' A' ' 13' ' ' ALA . 13.8 pt -73.65 -47.61 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.241 -0.912 . . . . 0.0 109.601 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.531 ' CB ' ' O ' ' A' ' 12' ' ' ILE . . . 164.77 -28.92 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.095 -1.003 . . . . 0.0 110.147 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -46.33 156.52 0.17 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.966 -1.084 . . . . 0.0 109.727 -179.534 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.421 ' O ' ' C ' ' A' ' 16' ' ' SER . 0.7 OUTLIER -120.02 20.45 12.12 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.406 -0.809 . . . . 0.0 109.858 -179.643 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.435 ' O ' ' CD1' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -43.89 -52.22 7.0 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.199 -0.938 . . . . 0.0 109.414 179.943 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.554 ' SG ' ' N ' ' A' ' 18' ' ' VAL . 19.8 p -59.34 -52.67 64.65 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.308 -0.87 . . . . 0.0 109.453 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.554 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 5.7 t -47.17 -34.92 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.128 -0.983 . . . . 0.0 109.414 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -73.53 -34.67 65.33 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.125 -0.984 . . . . 0.0 109.324 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.537 ' HB ' ' CB ' ' A' ' 50' ' ' ALA . 2.7 mp -84.9 10.96 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 178.313 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.434 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . . . -174.75 65.71 0.27 Allowed Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 121.377 -0.827 . . . . 0.0 109.2 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -71.81 56.15 2.33 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 O-C-N 124.171 1.616 . . . . 0.0 110.371 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.477 ' O ' ' HB3' ' A' ' 38' ' ' ASP . . . -167.47 -55.09 0.03 OUTLIER Glycine 0 N--CA 1.488 2.109 0 N-CA-C 108.543 -1.823 . . . . 0.0 108.543 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.526 ' CB ' ' O ' ' A' ' 38' ' ' ASP . . . -78.29 -38.87 41.46 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.439 -1.036 . . . . 0.0 109.112 179.402 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.663 ' CZ ' ' CG2' ' A' ' 6' ' ' VAL . 0.1 OUTLIER -97.14 134.23 40.74 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.136 -0.978 . . . . 0.0 108.88 179.693 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.502 ' O ' ' CD1' ' A' ' 35' ' ' TYR . . . -163.55 122.63 2.04 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.173 -0.954 . . . . 0.0 109.8 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' MET . . . . . 0.534 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 30.5 ttm -60.32 149.52 33.33 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.187 -0.946 . . . . 0.0 109.235 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.602 ' O ' ' N ' ' A' ' 32' ' ' GLU . 2.4 t0 -126.47 160.73 56.59 Favored Pre-proline 0 C--N 1.311 -1.073 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 179.533 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.452 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 43.9 Cg_endo -84.82 -17.12 5.06 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 O-C-N 124.765 1.929 . . . . 0.0 108.49 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -90.78 -30.45 17.01 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 178.009 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.55 HG12 ' CB ' ' A' ' 28' ' ' ASP . 0.8 OUTLIER -106.74 -0.18 9.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.092 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.602 ' N ' ' O ' ' A' ' 28' ' ' ASP . 8.2 mt-10 27.85 43.43 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.506 0.67 . . . . 0.0 109.983 -179.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.652 ' HG2' ' SG ' ' A' ' 11' ' ' CYS . 2.0 mttt -169.19 146.14 3.52 Favored 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 119.475 -0.89 . . . . 0.0 110.273 -179.31 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.561 ' O ' ' CG ' ' A' ' 8' ' ' GLN . . . -58.01 140.87 51.48 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.436 -0.79 . . . . 0.0 109.183 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.619 ' O ' ' CD1' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -146.26 146.49 30.76 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-O 121.902 0.858 . . . . 0.0 110.084 179.742 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.596 ' CG2' ' CG2' ' A' ' 6' ' ' VAL . 2.7 t -85.67 100.82 9.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -179.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.583 ' HG2' ' CZ ' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -116.63 -34.26 4.59 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.456 -0.777 . . . . 0.0 110.103 -179.083 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.526 ' O ' ' CB ' ' A' ' 24' ' ' ALA . 17.0 t0 -104.58 85.56 2.35 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.217 -0.927 . . . . 0.0 109.801 -179.263 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 14.5 m -53.52 -29.21 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.293 -0.879 . . . . 0.0 109.288 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -73.02 -14.45 61.43 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.338 -0.851 . . . . 0.0 109.375 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.439 ' HA3' ' N ' ' A' ' 24' ' ' ALA . . . -71.88 -25.4 74.94 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.434 ' HB3' ' HB3' ' A' ' 21' ' ' ALA . . . -142.24 155.43 45.25 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.317 -1.107 . . . . 0.0 109.2 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -96.05 -166.73 1.47 Allowed 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.064 -1.022 . . . . 0.0 109.875 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.488 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 22.0 tt0 -72.66 -53.7 11.08 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.423 ' OE2' ' NE2' ' A' ' 44' ' ' GLN . 18.7 mm-40 -62.98 -19.63 64.51 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.397 -0.814 . . . . 0.0 109.252 179.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.445 ' O ' HG23 ' A' ' 20' ' ' ILE . 23.4 mt-10 -88.25 -45.85 9.72 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 178.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.3 t -62.94 -27.23 42.75 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 178.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.488 ' HB2' ' O ' ' A' ' 44' ' ' GLN . 0.2 OUTLIER -71.15 -66.1 0.66 Allowed 'General case' 0 C--N 1.309 -1.192 0 O-C-N 121.635 -0.666 . . . . 0.0 109.302 179.406 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.489 ' HB3' HG22 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -47.29 -49.0 24.7 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.367 -0.833 . . . . 0.0 109.022 179.703 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.537 ' CB ' ' HB ' ' A' ' 20' ' ' ILE . . . -57.44 -40.18 77.89 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.251 -0.905 . . . . 0.0 108.761 179.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.536 ' HG3' ' CG2' ' A' ' 59' ' ' ILE . 22.4 ttm -69.05 -14.15 62.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.413 -0.804 . . . . 0.0 109.186 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -99.77 -3.99 31.57 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.341 -0.849 . . . . 0.0 109.465 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.418 ' O ' ' HB3' ' A' ' 16' ' ' SER . 2.4 m -113.67 46.01 1.35 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.15 -0.969 . . . . 0.0 109.784 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . 0.789 ' SG ' ' N ' ' A' ' 57' ' ' GLN . 53.6 t -123.05 143.1 39.88 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.225 -0.922 . . . . 0.0 109.142 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.607 ' HD2' ' SG ' ' A' ' 54' ' ' CYS . 44.1 Cg_endo -71.35 -35.33 8.51 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.936 1.493 . . . . 0.0 110.037 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.507 HG12 ' CG ' ' A' ' 10' ' ' GLU . 43.5 t -124.45 -0.98 5.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.426 -0.796 . . . . 0.0 109.185 179.488 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.789 ' N ' ' SG ' ' A' ' 54' ' ' CYS . 6.4 mt-30 60.94 -80.41 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.266 -0.896 . . . . 0.0 109.459 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.482 ' N ' ' O ' ' A' ' 56' ' ' VAL . 0.3 OUTLIER 55.59 23.4 6.03 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.075 -1.016 . . . . 0.0 108.825 179.985 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.536 ' CG2' ' HG3' ' A' ' 51' ' ' MET . 7.8 tt -124.12 154.31 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.213 -0.929 . . . . 0.0 110.051 -179.313 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.53 ' CG ' ' C ' ' A' ' 59' ' ' ILE . 10.5 m80 -157.36 157.55 34.29 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.426 -0.796 . . . . 0.0 109.241 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . 0.505 ' HA ' ' HA ' ' A' ' 4' ' ' PHE . 40.1 m95 -83.32 179.53 7.66 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.095 -1.003 . . . . 0.0 109.394 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.485 ' O ' ' CB ' ' A' ' 3' ' ' LYS . 1.1 tt0 . . . . . 0 N--CA 1.489 1.476 0 O-C-N 121.288 -0.883 . . . . 0.0 109.408 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.495 ' O ' ' HB3' ' A' ' 4' ' ' PHE . 1.1 tttt . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.548 ' HA ' ' HA ' ' A' ' 61' ' ' TRP . 9.3 p90 167.57 179.56 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.283 -0.886 . . . . 0.0 109.307 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.469 ' HB3' ' O ' ' A' ' 4' ' ' PHE . 55.3 p90 176.16 -171.63 0.08 Allowed 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.354 -0.841 . . . . 0.0 109.272 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.628 ' CG2' ' CZ ' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -140.09 152.23 21.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 179.718 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.609 ' O ' ' N ' ' A' ' 9' ' ' ASP . 53.6 t0 -99.56 0.01 41.4 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 118.628 -1.229 . . . . 0.0 111.692 -178.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.475 ' CB ' ' O ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER 42.56 14.92 0.01 OUTLIER 'General case' 0 C--N 1.273 -2.753 0 CA-C-O 121.29 0.567 . . . . 0.0 110.935 179.143 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.609 ' N ' ' O ' ' A' ' 7' ' ' ASP . 0.8 OUTLIER -75.98 -50.66 14.25 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.315 -0.866 . . . . 0.0 109.142 -179.295 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.529 ' HG2' ' CB ' ' A' ' 56' ' ' VAL . 1.1 tp10 -85.66 11.93 9.85 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.457 -0.777 . . . . 0.0 109.041 179.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 31.4 t -66.04 111.4 3.35 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.246 -0.909 . . . . 0.0 110.003 -179.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.524 HG13 ' N ' ' A' ' 13' ' ' ALA . 11.9 pt -73.53 -139.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.443 -0.786 . . . . 0.0 109.221 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.524 ' N ' HG13 ' A' ' 12' ' ' ILE . . . -102.99 28.34 6.32 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.942 -1.099 . . . . 0.0 110.003 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -112.0 159.49 18.39 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.922 -1.111 . . . . 0.0 109.78 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.442 ' O ' ' C ' ' A' ' 16' ' ' SER . 0.0 OUTLIER -136.25 20.4 3.19 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.401 -0.812 . . . . 0.0 109.374 -179.995 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.442 ' C ' ' O ' ' A' ' 15' ' ' GLU . 59.6 p -41.83 -44.33 3.29 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.521 -0.737 . . . . 0.0 109.387 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.615 ' SG ' ' CD2' ' A' ' 25' ' ' PHE . 17.4 p -58.33 -42.86 87.75 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.307 -0.871 . . . . 0.0 109.095 179.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.444 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 39.8 t -56.8 -30.5 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.33 -0.856 . . . . 0.0 109.493 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -81.58 -38.43 26.13 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.171 -0.955 . . . . 0.0 109.293 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.54 ' CG2' ' HB3' ' A' ' 50' ' ' ALA . 0.3 OUTLIER -74.64 2.98 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.152 -0.967 . . . . 0.0 108.827 178.565 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.525 ' HB3' ' CB ' ' A' ' 42' ' ' ALA . . . -161.86 70.71 2.38 Favored Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.185 -0.947 . . . . 0.0 109.381 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -71.0 68.09 2.42 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 124.133 1.596 . . . . 0.0 110.277 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 165.66 -35.85 0.26 Allowed Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.989 -1.644 . . . . 0.0 108.989 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.525 ' CB ' ' O ' ' A' ' 38' ' ' ASP . . . -91.81 -46.97 7.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.454 -1.027 . . . . 0.0 109.176 179.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.628 ' CZ ' ' CG2' ' A' ' 6' ' ' VAL . 0.1 OUTLIER -100.63 139.05 36.86 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.368 -0.832 . . . . 0.0 108.885 179.768 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.499 ' O ' ' CD1' ' A' ' 35' ' ' TYR . . . -169.34 124.03 0.83 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.152 -0.967 . . . . 0.0 109.759 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' MET . . . . . 0.528 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER -61.17 152.55 28.34 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.007 -1.058 . . . . 0.0 108.881 179.665 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.6 ' O ' ' N ' ' A' ' 32' ' ' GLU . 2.5 t0 -128.63 159.82 66.01 Favored Pre-proline 0 C--N 1.308 -1.204 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.448 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 44.9 Cg_endo -84.6 -16.23 5.73 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 O-C-N 124.562 1.822 . . . . 0.0 108.346 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -91.96 -27.81 17.63 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 177.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.556 ' CD1' ' HB3' ' A' ' 35' ' ' TYR . 0.7 OUTLIER -110.46 2.41 9.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.151 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.6 ' N ' ' O ' ' A' ' 28' ' ' ASP . 2.6 mm-40 26.22 44.01 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.466 0.651 . . . . 0.0 110.14 -179.543 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.532 ' CG ' ' O ' ' A' ' 32' ' ' GLU . 0.2 OUTLIER -172.23 149.19 2.24 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 119.175 -1.01 . . . . 0.0 109.999 -179.186 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.528 ' HA ' ' HA ' ' A' ' 27' ' ' MET . . . -56.8 144.67 32.1 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.433 -0.792 . . . . 0.0 110.158 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.649 ' O ' ' CD1' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -148.78 140.79 23.85 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.839 0.828 . . . . 0.0 110.173 178.932 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.562 ' CG2' ' CG2' ' A' ' 6' ' ' VAL . 2.8 t -87.44 90.19 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 120.98 -1.075 . . . . 0.0 108.112 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.587 ' HB3' ' CE2' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -101.28 -7.79 22.7 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.333 -0.854 . . . . 0.0 110.588 -178.75 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.525 ' O ' ' CB ' ' A' ' 24' ' ' ALA . 59.6 t0 -138.16 93.6 2.78 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.991 -1.068 . . . . 0.0 109.952 -179.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.42 ' HB ' ' CZ ' ' A' ' 4' ' ' PHE . 17.7 m -58.48 -29.5 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.298 -0.877 . . . . 0.0 109.017 179.459 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -76.28 -17.6 59.38 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.303 -0.873 . . . . 0.0 109.251 179.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -69.55 -8.65 60.28 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.525 ' CB ' ' HB3' ' A' ' 21' ' ' ALA . . . -155.09 119.56 4.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.286 -1.126 . . . . 0.0 109.289 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.403 ' O ' ' O ' ' A' ' 42' ' ' ALA . 0.1 OUTLIER -49.39 174.99 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.319 -0.863 . . . . 0.0 109.812 -179.747 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.426 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 6.3 tm0? -68.16 -42.48 79.98 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.558 -0.714 . . . . 0.0 109.478 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.411 ' O ' ' HG3' ' A' ' 49' ' ' GLU . 42.6 mm-40 -66.7 -13.8 61.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.101 -0.999 . . . . 0.0 108.963 179.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -96.49 -43.48 7.6 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 178.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.444 HG21 ' O ' ' A' ' 42' ' ' ALA . 55.5 t -58.2 -51.61 69.0 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 178.31 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.434 ' O ' ' N ' ' A' ' 51' ' ' MET . 0.2 OUTLIER -65.46 -52.6 51.88 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.615 -0.678 . . . . 0.0 109.57 179.387 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.411 ' HG3' ' O ' ' A' ' 45' ' ' GLU . 19.3 mt-10 -47.73 -48.63 29.59 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.207 -0.933 . . . . 0.0 109.234 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.54 ' HB3' ' CG2' ' A' ' 20' ' ' ILE . . . -65.94 -23.64 66.65 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.199 -0.938 . . . . 0.0 109.001 179.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.513 ' CG ' HG23 ' A' ' 59' ' ' ILE . 35.0 ttm -76.16 -14.83 60.15 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.345 -0.847 . . . . 0.0 109.509 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -98.15 -25.32 14.95 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.218 -0.926 . . . . 0.0 109.71 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.75 -19.17 60.33 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.18 -0.95 . . . . 0.0 109.948 -179.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . 0.744 ' SG ' ' HD2' ' A' ' 55' ' ' PRO . 9.2 t -70.57 145.03 92.17 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.071 -1.018 . . . . 0.0 109.702 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.744 ' HD2' ' SG ' ' A' ' 54' ' ' CYS . 43.4 Cg_endo -73.44 -86.9 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.004 1.529 . . . . 0.0 109.505 179.247 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.529 ' CB ' ' HG2' ' A' ' 10' ' ' GLU . 27.8 m -56.03 -31.28 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 120.981 -1.074 . . . . 0.0 108.168 178.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.497 ' O ' ' N ' ' A' ' 59' ' ' ILE . 4.1 tt0 68.97 52.41 0.51 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.566 -0.709 . . . . 0.0 110.361 179.146 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.46 ' O ' HG13 ' A' ' 6' ' ' VAL . 0.5 OUTLIER -68.26 65.5 0.11 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.055 -1.028 . . . . 0.0 108.804 179.166 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.513 HG23 ' CG ' ' A' ' 51' ' ' MET . 0.5 OUTLIER -131.59 148.1 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.229 -0.919 . . . . 0.0 110.219 -179.262 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.495 ' N ' HG13 ' A' ' 59' ' ' ILE . 1.1 m80 -148.74 129.46 14.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.324 -0.86 . . . . 0.0 109.431 179.705 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . 0.548 ' HA ' ' HA ' ' A' ' 4' ' ' PHE . 54.3 m95 -68.27 161.15 27.88 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.266 -0.896 . . . . 0.0 109.256 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.505 ' N ' ' HA ' ' A' ' 4' ' ' PHE . 24.2 tt0 . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.204 -0.935 . . . . 0.0 109.696 -179.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.482 ' O ' ' HB3' ' A' ' 4' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.48 0 CA-C-O 121.346 0.593 . . . . 0.0 109.645 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.566 ' CZ ' ' CG1' ' A' ' 39' ' ' VAL . 23.4 p90 175.82 176.67 0.23 Allowed 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.506 ' CE1' ' HB2' ' A' ' 62' ' ' GLU . 17.4 p90 172.45 -168.42 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 105.747 -1.946 . . . . 0.0 105.747 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.609 HG22 ' CZ ' ' A' ' 25' ' ' PHE . 4.4 t -146.54 159.72 10.42 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.236 0 C-N-CA 116.724 -1.99 . . . . 0.0 111.739 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.525 ' O ' ' N ' ' A' ' 9' ' ' ASP . 39.1 t70 -106.16 78.44 1.31 Allowed 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.563 ' CG ' ' O ' ' A' ' 34' ' ' ALA . 5.3 mp0 -43.34 -19.24 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.984 179.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.525 ' N ' ' O ' ' A' ' 7' ' ' ASP . 0.1 OUTLIER -56.51 -35.56 68.17 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.163 -0.96 . . . . 0.0 108.828 -179.898 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.478 ' HB3' ' HB3' ' A' ' 58' ' ' CYS . 0.6 OUTLIER -81.96 -31.5 31.17 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.656 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.434 ' C ' ' O ' ' A' ' 10' ' ' GLU . 36.5 t -42.65 143.09 0.73 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.362 -0.836 . . . . 0.0 109.503 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.525 ' O ' ' CB ' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -98.14 -45.25 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.27 -0.893 . . . . 0.0 109.675 -179.603 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.525 ' CB ' ' O ' ' A' ' 12' ' ' ILE . . . 162.41 -28.84 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.24 -0.912 . . . . 0.0 109.571 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -56.09 156.34 5.58 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.16 -0.962 . . . . 0.0 109.499 -179.725 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.436 ' O ' ' C ' ' A' ' 16' ' ' SER . 31.3 mt-10 -116.97 20.94 13.59 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.276 -0.89 . . . . 0.0 109.68 -179.591 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.436 ' C ' ' O ' ' A' ' 15' ' ' GLU . 70.1 m -44.45 -63.79 0.82 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.226 -0.921 . . . . 0.0 109.073 179.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.647 ' SG ' ' N ' ' A' ' 18' ' ' VAL . 17.8 p -49.13 -54.33 16.75 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.32 -0.862 . . . . 0.0 109.151 179.585 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.647 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 48.4 t -43.43 -46.1 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.442 -0.786 . . . . 0.0 109.199 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -63.65 -34.5 77.99 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.155 -0.966 . . . . 0.0 109.146 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.502 HD13 ' CG2' ' A' ' 53' ' ' THR . 5.6 mt -87.51 14.42 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.137 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -171.03 65.25 0.43 Allowed Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.486 -0.759 . . . . 0.0 109.257 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -71.15 56.51 2.01 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 124.161 1.611 . . . . 0.0 110.147 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.472 ' C ' ' HB3' ' A' ' 38' ' ' ASP . . . -177.86 -63.35 0.07 OUTLIER Glycine 0 N--CA 1.488 2.148 0 N-CA-C 108.832 -1.707 . . . . 0.0 108.832 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.548 ' CB ' ' O ' ' A' ' 38' ' ' ASP . . . -66.56 -42.04 87.7 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.298 -1.119 . . . . 0.0 108.453 179.443 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.609 ' CZ ' HG22 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -101.23 132.79 46.57 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 118.757 -1.177 . . . . 0.0 108.949 179.45 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.486 ' O ' ' CD1' ' A' ' 35' ' ' TYR . . . -161.49 130.87 4.64 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.434 -0.791 . . . . 0.0 109.358 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' MET . . . . . 0.517 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 4.0 ptt? -71.68 152.2 43.02 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.193 -0.942 . . . . 0.0 109.46 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.632 ' O ' ' N ' ' A' ' 32' ' ' GLU . 2.0 t0 -126.0 161.21 52.88 Favored Pre-proline 0 C--N 1.31 -1.118 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 179.002 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.449 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 45.0 Cg_endo -85.18 -17.9 4.4 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 O-C-N 124.814 1.955 . . . . 0.0 108.596 -179.468 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.3 -28.62 18.64 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 177.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.539 HG12 ' CB ' ' A' ' 28' ' ' ASP . 0.9 OUTLIER -107.17 -3.92 10.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 177.687 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.632 ' N ' ' O ' ' A' ' 28' ' ' ASP . 1.6 mt-10 31.41 37.47 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -179.271 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.536 ' HG2' ' O ' ' A' ' 32' ' ' GLU . 19.4 mmtp -161.91 148.22 13.68 Favored 'General case' 0 N--CA 1.502 2.17 0 C-N-CA 119.499 -0.881 . . . . 0.0 110.753 -178.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.563 ' O ' ' CG ' ' A' ' 8' ' ' GLN . . . -61.58 138.45 58.29 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.416 -0.802 . . . . 0.0 110.167 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.711 ' CE2' ' HG3' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -132.58 144.57 50.48 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-O 122.262 1.029 . . . . 0.0 110.511 179.881 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.588 ' CG2' ' CG2' ' A' ' 6' ' ' VAL . 2.4 t -86.4 92.26 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 120.303 -1.498 . . . . 0.0 109.242 -178.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.711 ' HG3' ' CE2' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -107.55 -53.31 2.64 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.436 -0.79 . . . . 0.0 111.013 -179.006 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.548 ' O ' ' CB ' ' A' ' 24' ' ' ALA . 46.9 t0 -85.77 76.07 9.97 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 119.746 -0.781 . . . . 0.0 110.782 -177.224 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.566 ' CG1' ' CZ ' ' A' ' 4' ' ' PHE . 27.5 m -49.94 -31.36 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.327 -0.858 . . . . 0.0 109.34 179.279 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -79.55 -6.92 58.02 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.327 -0.858 . . . . 0.0 109.476 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -85.85 5.38 84.01 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -153.35 116.46 4.58 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.179 -1.189 . . . . 0.0 109.644 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.457 ' OG ' ' OE2' ' A' ' 46' ' ' GLU . 0.1 OUTLIER -64.5 163.88 12.65 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.243 -0.911 . . . . 0.0 109.599 179.971 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.46 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 3.4 tt0 -49.8 -44.14 48.89 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.356 -0.84 . . . . 0.0 109.381 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.423 ' O ' ' HB2' ' A' ' 49' ' ' GLU . 72.7 mm-40 -67.87 -8.9 40.29 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.18 -0.95 . . . . 0.0 109.187 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.457 ' OE2' ' OG ' ' A' ' 43' ' ' SER . 14.3 mt-10 -99.58 -43.12 6.62 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 106.66 -1.608 . . . . 0.0 106.66 179.112 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.437 HG22 ' HA ' ' A' ' 44' ' ' GLN . 1.9 t -61.92 -42.73 95.84 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.398 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.46 ' HB2' ' O ' ' A' ' 44' ' ' GLN . 0.2 OUTLIER -73.49 -50.1 23.25 Favored 'General case' 0 C--N 1.308 -1.236 0 O-C-N 121.59 -0.694 . . . . 0.0 109.282 179.383 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.423 ' HB2' ' O ' ' A' ' 45' ' ' GLU . 13.3 mm-40 -53.23 -45.95 68.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.224 -0.923 . . . . 0.0 108.77 179.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.473 ' HA ' ' OG1' ' A' ' 53' ' ' THR . . . -70.29 -13.45 62.17 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.37 -0.831 . . . . 0.0 108.785 179.231 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.495 ' CG ' HG22 ' A' ' 59' ' ' ILE . 0.4 OUTLIER -80.72 -21.9 40.76 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.434 -0.791 . . . . 0.0 109.492 179.98 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -96.37 -34.34 11.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.197 -0.94 . . . . 0.0 109.605 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.502 ' CG2' HD13 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -50.71 -54.82 20.11 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.252 -0.905 . . . . 0.0 109.747 179.975 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . 0.523 ' SG ' ' HD2' ' A' ' 55' ' ' PRO . 3.8 t -46.36 140.86 5.21 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.192 -0.943 . . . . 0.0 109.912 -179.61 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.523 ' HD2' ' SG ' ' A' ' 54' ' ' CYS . 44.8 Cg_endo -77.03 -62.99 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 124.123 1.591 . . . . 0.0 109.843 179.33 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 33.0 t -74.4 -20.74 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.335 -0.853 . . . . 0.0 108.868 179.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.481 ' NE2' ' O ' ' A' ' 51' ' ' MET . 3.5 mt-30 64.78 94.24 0.06 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.343 -0.848 . . . . 0.0 109.586 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.478 ' HB3' ' HB3' ' A' ' 10' ' ' GLU . 0.1 OUTLIER -100.42 -28.0 13.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.304 -0.872 . . . . 0.0 108.821 179.795 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.495 HG22 ' CG ' ' A' ' 51' ' ' MET . 5.7 tt -60.88 151.06 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.458 -0.776 . . . . 0.0 109.976 -179.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.496 ' NE2' ' CE2' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -159.92 -178.55 7.11 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.454 -0.779 . . . . 0.0 108.9 179.509 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . 0.487 ' HA ' ' HA ' ' A' ' 4' ' ' PHE . 66.7 m95 -101.3 165.02 11.49 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.118 -0.989 . . . . 0.0 109.768 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.506 ' HB2' ' CE1' ' A' ' 5' ' ' TYR . 41.2 tt0 . . . . . 0 N--CA 1.489 1.491 0 O-C-N 121.431 -0.793 . . . . 0.0 109.169 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.7 tpt180 -137.03 114.31 10.83 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.231 -0.918 . . . . 0.0 109.451 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.471 ' HB3' ' HB3' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -101.19 -156.47 0.56 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.165 -0.959 . . . . 0.0 109.522 -179.884 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.566 ' CB ' ' HA ' ' A' ' 61' ' ' TRP . 31.6 p90 179.78 -167.39 0.09 Allowed 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.173 -0.954 . . . . 0.0 109.208 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.505 ' HA ' HG13 ' A' ' 36' ' ' VAL . 39.3 p90 173.5 -166.79 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 106.87 -1.529 . . . . 0.0 106.87 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.568 HG23 ' CZ ' ' A' ' 25' ' ' PHE . 2.5 t -152.14 166.76 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 C-N-CA 117.532 -1.667 . . . . 0.0 112.119 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.468 ' C ' ' H ' ' A' ' 9' ' ' ASP . 0.8 OUTLIER -106.76 68.57 0.74 Allowed 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 178.561 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.505 ' CB ' ' O ' ' A' ' 34' ' ' ALA . 0.6 OUTLIER -47.72 -15.59 0.06 Allowed 'General case' 0 C--N 1.297 -1.701 0 CA-C-O 121.344 0.593 . . . . 0.0 109.495 179.258 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.468 ' H ' ' C ' ' A' ' 7' ' ' ASP . 0.2 OUTLIER -65.17 -33.12 75.25 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.697 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.493 ' HB3' ' HB3' ' A' ' 58' ' ' CYS . 0.3 OUTLIER -93.47 0.74 56.87 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 179.168 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.414 ' HB3' ' O ' ' A' ' 8' ' ' GLN . 10.1 t -66.84 129.32 39.49 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.081 -1.012 . . . . 0.0 110.073 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.754 HG12 ' S3 ' ' A' ' 65' ' ' SF4 . 43.2 pt -88.78 -143.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.486 -0.759 . . . . 0.0 109.639 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.505 ' N ' HG13 ' A' ' 12' ' ' ILE . . . -107.56 52.92 0.7 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.076 -1.015 . . . . 0.0 109.901 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.947 ' O ' ' S2 ' ' A' ' 65' ' ' SF4 . 0.1 OUTLIER -134.53 155.18 50.86 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.039 -1.038 . . . . 0.0 109.673 179.661 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.42 ' O ' ' C ' ' A' ' 16' ' ' SER . 0.2 OUTLIER -120.46 18.89 12.09 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.319 -0.863 . . . . 0.0 109.798 -179.555 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.575 ' OG ' ' SG ' ' A' ' 14' ' ' CYS . 0.7 OUTLIER -44.15 -51.13 8.34 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.195 -0.941 . . . . 0.0 109.346 179.995 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.826 ' SG ' ' CD2' ' A' ' 25' ' ' PHE . 14.6 p -62.02 -54.93 34.63 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.316 -0.865 . . . . 0.0 109.366 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.626 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 98.7 t -43.92 -34.22 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.279 -0.888 . . . . 0.0 109.501 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.42 -36.78 66.01 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.062 -1.024 . . . . 0.0 109.025 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.518 HG23 ' N ' ' A' ' 50' ' ' ALA . 5.0 mt -87.37 16.13 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 178.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -174.43 63.64 0.26 Allowed Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.344 -0.848 . . . . 0.0 109.672 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -75.36 51.76 3.0 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 124.04 1.547 . . . . 0.0 110.34 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.42 ' C ' ' HA3' ' A' ' 41' ' ' GLY . . . -166.0 -41.63 0.02 OUTLIER Glycine 0 N--CA 1.489 2.213 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.516 ' HB1' ' CB ' ' A' ' 42' ' ' ALA . . . -92.31 -46.8 7.52 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.434 -1.039 . . . . 0.0 108.678 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.826 ' CD2' ' SG ' ' A' ' 17' ' ' CYS . 0.1 OUTLIER -89.7 138.09 31.77 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.387 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.45 ' O ' ' CD1' ' A' ' 35' ' ' TYR . . . -173.57 126.31 0.4 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.103 -0.998 . . . . 0.0 109.58 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.546 ' HA ' ' C ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -63.82 153.01 37.98 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.166 -0.959 . . . . 0.0 109.841 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.605 ' O ' ' N ' ' A' ' 32' ' ' GLU . 2.2 t0 -129.59 163.67 45.09 Favored Pre-proline 0 C--O 1.209 -1.061 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.456 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 45.7 Cg_endo -83.63 -18.31 5.73 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 124.619 1.852 . . . . 0.0 107.961 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -84.17 -39.17 19.73 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 178.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.635 ' CD1' ' CD1' ' A' ' 35' ' ' TYR . 3.0 pt -101.51 -2.05 9.72 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 177.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.605 ' N ' ' O ' ' A' ' 28' ' ' ASP . 65.4 mt-10 34.66 34.53 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -179.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.556 ' CG ' ' O ' ' A' ' 32' ' ' GLU . 18.5 mttt -163.15 150.3 12.86 Favored 'General case' 0 N--CA 1.499 1.999 0 C-N-CA 119.408 -0.917 . . . . 0.0 110.374 -178.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.535 ' HA ' ' HA ' ' A' ' 27' ' ' MET . . . -62.48 143.88 56.62 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.515 -0.74 . . . . 0.0 110.489 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.667 ' CE2' ' HA ' ' A' ' 37' ' ' LYS . 1.2 p90 -155.25 158.02 38.18 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.55 HG22 ' CE2' ' A' ' 4' ' ' PHE . 14.5 p -67.51 68.44 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.818 -1.176 . . . . 0.0 108.833 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.667 ' HA ' ' CE2' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -49.95 -19.24 0.66 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.445 -0.785 . . . . 0.0 110.295 -179.691 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -165.95 99.72 0.65 Allowed 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.09 -1.006 . . . . 0.0 109.394 -179.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.495 ' HA ' ' CZ ' ' A' ' 4' ' ' PHE . 11.0 m -48.19 -29.65 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.419 -0.801 . . . . 0.0 109.764 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.477 ' N ' HG21 ' A' ' 39' ' ' VAL . 10.5 mt-10 -85.12 -4.98 59.35 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.207 -0.933 . . . . 0.0 109.711 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.42 ' HA3' ' C ' ' A' ' 23' ' ' GLY . . . -67.02 -32.2 80.11 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.516 ' CB ' ' HB1' ' A' ' 24' ' ' ALA . . . -128.24 163.04 25.59 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.212 -1.17 . . . . 0.0 109.279 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.469 ' OG ' ' OE2' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -89.51 171.53 9.64 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.278 -0.889 . . . . 0.0 109.416 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.494 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 17.6 pt20 -68.51 -34.55 76.1 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.326 -0.859 . . . . 0.0 109.38 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -72.4 -23.9 61.17 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.311 -0.868 . . . . 0.0 109.322 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.469 ' OE2' ' OG ' ' A' ' 43' ' ' SER . 33.6 mt-10 -87.55 -41.14 13.69 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 178.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 38.5 t -63.37 -29.33 46.99 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 177.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.494 ' HB2' ' O ' ' A' ' 44' ' ' GLN . 0.5 OUTLIER -69.37 -64.65 0.83 Allowed 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.262 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -52.19 -39.76 60.59 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 119.467 -0.893 . . . . 0.0 108.786 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.518 ' N ' HG23 ' A' ' 20' ' ' ILE . . . -62.78 -27.33 69.22 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.542 ' HG3' ' CG2' ' A' ' 59' ' ' ILE . 3.7 ttm -72.82 -43.57 62.53 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -55.36 -42.88 74.49 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.446 ' CG2' ' HB3' ' A' ' 16' ' ' SER . 0.1 OUTLIER -59.98 -160.23 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.419 -0.801 . . . . 0.0 109.195 179.803 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.583 ' SG ' ' HD2' ' A' ' 55' ' ' PRO . 1.7 t 66.74 144.63 0.09 OUTLIER Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.151 -0.968 . . . . 0.0 109.381 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.583 ' HD2' ' SG ' ' A' ' 54' ' ' CYS . 43.2 Cg_endo -73.57 -61.04 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.97 1.511 . . . . 0.0 109.948 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.456 ' O ' ' N ' ' A' ' 58' ' ' CYS . 12.2 t -102.86 14.73 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.368 -0.833 . . . . 0.0 108.778 179.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.558 ' HA ' ' HB3' ' A' ' 54' ' ' CYS . 0.4 OUTLIER 65.08 -73.31 0.06 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.389 -0.819 . . . . 0.0 109.806 -179.891 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.493 ' HB3' ' HB3' ' A' ' 10' ' ' GLU . 1.8 m 63.95 12.98 7.27 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.95 -1.094 . . . . 0.0 108.544 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.542 ' CG2' ' HG3' ' A' ' 51' ' ' MET . 11.3 tt -119.22 152.25 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.432 -0.792 . . . . 0.0 109.463 -179.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.524 ' CD2' ' O ' ' A' ' 59' ' ' ILE . 18.9 m80 -156.11 170.26 22.6 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.104 -0.998 . . . . 0.0 110.007 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.566 ' HA ' ' CB ' ' A' ' 4' ' ' PHE . 60.6 m95 -94.14 175.1 6.83 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.353 -0.842 . . . . 0.0 109.577 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.471 ' HB3' ' HB3' ' A' ' 3' ' ' LYS . 7.3 tt0 -136.8 89.23 2.43 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.404 -0.81 . . . . 0.0 109.357 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.41 ' O ' ' C ' ' A' ' 64' ' ' GLU . 22.2 p-10 -54.93 155.41 4.46 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.317 -0.864 . . . . 0.0 109.666 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 63' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.363 -0.835 . . . . 0.0 109.571 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SF4 . . . . . 0.947 ' S2 ' ' O ' ' A' ' 14' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.505 ' O ' ' CB ' ' A' ' 2' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.2 0.524 . . . . 0.0 109.614 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.505 ' CB ' ' O ' ' A' ' 1' ' ' ALA . 10.6 tpp85 79.0 37.85 0.14 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.407 -0.808 . . . . 0.0 109.723 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.51 ' HB3' ' HB3' ' A' ' 62' ' ' GLU . 13.6 tptt -99.25 -154.37 0.47 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.246 -0.909 . . . . 0.0 109.286 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.554 ' CZ ' ' HB ' ' A' ' 39' ' ' VAL . 49.1 p90 176.39 176.38 0.29 Allowed 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.136 -0.977 . . . . 0.0 109.036 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.519 ' HA ' HG13 ' A' ' 36' ' ' VAL . 23.7 p90 175.66 -157.11 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.662 ' CG2' ' CZ ' ' A' ' 25' ' ' PHE . 0.2 OUTLIER -145.6 -170.57 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 C-N-CA 118.101 -1.439 . . . . 0.0 111.175 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.517 ' O ' ' N ' ' A' ' 9' ' ' ASP . 0.6 OUTLIER -147.41 96.33 2.68 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.121 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.535 ' CG ' ' O ' ' A' ' 34' ' ' ALA . 4.5 mp0 -64.67 40.08 0.02 OUTLIER 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.095 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.517 ' N ' ' O ' ' A' ' 7' ' ' ASP . 0.3 OUTLIER -99.03 -18.05 17.96 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.03 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.429 ' O ' HG13 ' A' ' 56' ' ' VAL . 0.5 OUTLIER -116.32 -9.29 11.56 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.701 -0.624 . . . . 0.0 109.621 -179.739 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.768 ' SG ' ' HG2' ' A' ' 33' ' ' LYS . 42.0 t -60.67 129.52 41.96 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.213 -0.929 . . . . 0.0 109.777 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.523 ' O ' ' CB ' ' A' ' 13' ' ' ALA . 14.3 pt -91.38 -45.32 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.413 -0.805 . . . . 0.0 109.271 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.523 ' CB ' ' O ' ' A' ' 12' ' ' ILE . . . 164.4 -29.9 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.279 -0.888 . . . . 0.0 110.024 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 1.164 ' O ' ' S2 ' ' A' ' 65' ' ' SF4 . 0.1 OUTLIER -49.16 154.8 0.75 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.938 -1.101 . . . . 0.0 109.377 -179.669 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.443 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 5.0 mm-40 -116.74 19.2 14.61 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.215 -0.928 . . . . 0.0 109.277 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.492 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 0.6 OUTLIER -43.93 -46.23 8.04 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.264 -0.897 . . . . 0.0 109.269 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.573 ' HB3' ' S1 ' ' A' ' 65' ' ' SF4 . 19.1 p -66.21 -47.56 73.44 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.394 -0.816 . . . . 0.0 109.274 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.518 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 23.7 t -50.65 -38.87 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.261 -0.899 . . . . 0.0 109.305 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -70.19 -37.28 75.08 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.224 -0.922 . . . . 0.0 109.097 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.537 ' O ' ' CG2' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -78.14 5.79 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.316 -0.865 . . . . 0.0 108.696 178.499 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.463 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . . . -179.3 67.55 0.17 Allowed Pre-proline 0 N--CA 1.488 1.426 0 O-C-N 121.116 -0.99 . . . . 0.0 109.292 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -70.78 -2.96 11.74 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.051 1.553 . . . . 0.0 110.49 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.403 ' C ' ' HA3' ' A' ' 41' ' ' GLY . . . -103.52 -33.78 4.07 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.466 ' HB3' ' O ' ' A' ' 38' ' ' ASP . . . -96.95 -51.01 4.41 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.344 -1.092 . . . . 0.0 109.659 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.662 ' CZ ' ' CG2' ' A' ' 6' ' ' VAL . 0.2 OUTLIER -85.54 136.08 33.55 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.307 -0.871 . . . . 0.0 109.572 -179.874 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.435 ' O ' ' CD1' ' A' ' 35' ' ' TYR . . . -163.73 128.83 2.94 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.11 -0.994 . . . . 0.0 109.834 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.535 ' HG2' ' CA ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -61.89 148.39 43.63 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.191 -0.943 . . . . 0.0 109.952 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.589 ' O ' ' HA ' ' A' ' 32' ' ' GLU . 1.4 t70 -127.51 160.54 59.94 Favored Pre-proline 0 N--CA 1.478 0.966 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 178.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.449 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 44.2 Cg_endo -84.59 -19.24 4.36 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 O-C-N 124.497 1.788 . . . . 0.0 108.653 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -88.94 -33.99 17.06 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 106.452 -1.685 . . . . 0.0 106.452 177.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.632 ' CD1' ' CD1' ' A' ' 35' ' ' TYR . 0.5 OUTLIER -101.78 -0.41 10.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 177.9 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.589 ' HA ' ' O ' ' A' ' 28' ' ' ASP . 17.0 mt-10 27.91 42.41 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.632 0.729 . . . . 0.0 109.654 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.768 ' HG2' ' SG ' ' A' ' 11' ' ' CYS . 0.2 OUTLIER -171.16 157.52 5.15 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -179.135 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.535 ' O ' ' CG ' ' A' ' 8' ' ' GLN . . . -70.27 144.16 51.87 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.118 -0.989 . . . . 0.0 110.719 -178.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.661 ' CE2' ' HA ' ' A' ' 37' ' ' LYS . 2.6 p90 -150.24 159.03 44.74 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.523 ' CG1' ' O ' ' A' ' 36' ' ' VAL . 8.2 p -67.77 67.9 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.814 -1.178 . . . . 0.0 109.219 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.661 ' HA ' ' CE2' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -55.98 -14.8 2.76 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.232 -0.918 . . . . 0.0 110.598 -179.528 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.466 ' O ' ' HB3' ' A' ' 24' ' ' ALA . 26.1 t0 -166.17 92.33 0.49 Allowed 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 119.004 -1.078 . . . . 0.0 109.909 -179.202 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.554 ' HB ' ' CZ ' ' A' ' 4' ' ' PHE . 23.7 m -49.72 -26.13 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.389 -0.819 . . . . 0.0 109.703 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -78.86 -9.96 59.64 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.293 -0.879 . . . . 0.0 109.605 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.403 ' HA3' ' C ' ' A' ' 23' ' ' GLY . . . -79.23 -19.43 72.04 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.463 ' HB3' ' HB3' ' A' ' 21' ' ' ALA . . . -127.39 153.78 45.81 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.191 -1.182 . . . . 0.0 109.45 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.435 ' HB2' ' HG3' ' A' ' 46' ' ' GLU . 0.5 OUTLIER -96.77 -168.15 1.67 Allowed 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.181 -0.949 . . . . 0.0 109.961 -179.738 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.479 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 0.4 OUTLIER -73.89 -57.98 3.61 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.609 -0.682 . . . . 0.0 109.196 179.703 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.403 ' O ' ' HB2' ' A' ' 49' ' ' GLU . 49.0 mm-40 -62.49 -14.43 41.37 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.37 -0.831 . . . . 0.0 109.692 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.435 ' HG3' ' HB2' ' A' ' 43' ' ' SER . 20.3 mt-10 -95.21 -46.48 6.75 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 179.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.48 HG23 ' CE2' ' A' ' 4' ' ' PHE . 5.5 t -59.23 -37.48 69.04 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.317 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.526 ' O ' ' N ' ' A' ' 51' ' ' MET . 0.2 OUTLIER -72.92 -55.49 6.52 Favored 'General case' 0 C--N 1.308 -1.218 0 O-C-N 121.58 -0.7 . . . . 0.0 109.813 179.971 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.481 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . 2.6 tt0 -45.13 -50.57 11.14 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.196 -0.94 . . . . 0.0 108.862 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.516 ' N ' HG22 ' A' ' 20' ' ' ILE . . . -61.69 -28.37 69.36 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.211 -0.931 . . . . 0.0 108.607 179.196 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.526 ' N ' ' O ' ' A' ' 48' ' ' GLU . 43.2 ttm -64.7 -20.1 66.13 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.444 -0.785 . . . . 0.0 109.171 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -107.13 -10.03 15.99 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.374 -0.829 . . . . 0.0 109.432 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.448 ' OG1' ' HA ' ' A' ' 50' ' ' ALA . 23.2 p -97.15 36.12 1.49 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.297 -0.877 . . . . 0.0 110.015 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.784 ' SG ' HG21 ' A' ' 56' ' ' VAL . 49.7 t -126.84 132.82 24.48 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.041 -1.037 . . . . 0.0 109.573 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.87 -32.97 8.42 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 123.835 1.44 . . . . 0.0 109.665 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.784 HG21 ' SG ' ' A' ' 54' ' ' CYS . 7.3 m -98.82 -16.12 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.502 ' N ' ' SG ' ' A' ' 54' ' ' CYS . 6.9 mt-30 42.39 86.71 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.554 -0.716 . . . . 0.0 109.692 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.494 ' O ' ' CE1' ' A' ' 60' ' ' HIS . 8.9 p -120.33 6.17 10.68 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.318 -0.864 . . . . 0.0 109.23 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.526 ' HB ' HG12 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -95.3 127.17 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.268 -0.895 . . . . 0.0 109.931 -179.625 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.494 ' CE1' ' O ' ' A' ' 58' ' ' CYS . 2.4 m80 -131.91 -160.75 1.07 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.376 -0.828 . . . . 0.0 109.041 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.528 ' HA ' ' CB ' ' A' ' 4' ' ' PHE . 49.3 m95 -111.32 174.11 6.02 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.959 -1.088 . . . . 0.0 109.327 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.51 ' HB3' ' HB3' ' A' ' 3' ' ' LYS . 3.1 tt0 -136.43 78.78 1.73 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.505 -0.747 . . . . 0.0 109.137 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -92.21 -19.02 22.65 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.43 -0.794 . . . . 0.0 109.442 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.29 -0.881 . . . . 0.0 109.442 179.98 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' SF4 . . . . . 1.164 ' S2 ' ' O ' ' A' ' 14' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.42 ' O ' ' HG2' ' A' ' 2' ' ' ARG . 0.0 OUTLIER -86.63 101.38 13.19 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.358 -0.839 . . . . 0.0 109.407 179.998 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.478 ' HB3' ' HB3' ' A' ' 62' ' ' GLU . 0.6 OUTLIER -96.82 -153.41 0.41 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.182 -0.949 . . . . 0.0 109.805 -179.739 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.569 ' CZ ' ' HB ' ' A' ' 39' ' ' VAL . 8.1 p90 168.59 176.87 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.555 ' HA ' ' CG1' ' A' ' 36' ' ' VAL . 18.9 p90 178.52 -174.2 0.17 Allowed 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.672 ' CG2' ' CZ ' ' A' ' 25' ' ' PHE . 0.4 OUTLIER -132.69 168.45 24.16 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.12 0 C-N-CA 117.546 -1.662 . . . . 0.0 111.333 -179.393 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.517 ' C ' ' H ' ' A' ' 9' ' ' ASP . 9.5 t0 -116.07 89.91 3.21 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.587 ' CG ' ' O ' ' A' ' 34' ' ' ALA . 1.4 mp0 -63.24 42.3 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.949 -0.47 . . . . 0.0 111.004 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.517 ' H ' ' C ' ' A' ' 7' ' ' ASP . 0.4 OUTLIER -101.07 -28.32 12.77 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.177 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -119.53 21.74 11.97 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.498 ' HB3' ' CD ' ' A' ' 33' ' ' LYS . 8.7 t -76.77 122.51 24.86 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.186 -0.946 . . . . 0.0 110.055 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.89 HG12 ' S3 ' ' A' ' 65' ' ' SF4 . 37.7 pt -73.39 -5.76 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.405 -0.809 . . . . 0.0 109.436 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.536 ' CB ' ' O ' ' A' ' 12' ' ' ILE . . . 79.76 32.78 0.21 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.461 -0.775 . . . . 0.0 110.129 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.785 ' SG ' ' HB2' ' A' ' 16' ' ' SER . 1.3 p -95.78 151.93 18.93 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.097 -1.002 . . . . 0.0 109.178 179.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.472 ' O ' ' HB2' ' A' ' 19' ' ' GLU . 2.1 pt-20 -82.03 5.85 18.05 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.19 -0.944 . . . . 0.0 110.353 -179.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.785 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 3.6 m -43.78 -82.64 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.127 -0.983 . . . . 0.0 109.432 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.751 ' SG ' ' CD2' ' A' ' 25' ' ' PHE . 13.0 p -47.32 -56.83 6.07 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.25 -0.906 . . . . 0.0 109.617 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.666 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 74.1 t -47.29 -27.2 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.394 -0.816 . . . . 0.0 110.186 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 15' ' ' GLU . 0.1 OUTLIER -81.03 -40.14 24.72 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.966 -1.084 . . . . 0.0 109.673 -179.685 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.593 ' CD1' ' CG2' ' A' ' 53' ' ' THR . 2.4 mt -84.18 13.8 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.457 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . . . 177.84 65.92 0.09 OUTLIER Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.378 -0.826 . . . . 0.0 109.333 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -74.23 1.62 7.08 Favored 'Trans proline' 0 C--N 1.303 -1.837 0 O-C-N 124.069 1.563 . . . . 0.0 110.718 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.468 ' O ' ' HB3' ' A' ' 38' ' ' ASP . . . -97.77 -45.07 2.54 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.468 ' HA ' ' O ' ' A' ' 38' ' ' ASP . . . -87.78 -47.1 8.89 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.255 -1.144 . . . . 0.0 109.559 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.751 ' CD2' ' SG ' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -92.62 134.83 34.63 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.263 -0.898 . . . . 0.0 109.121 179.859 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.577 ' O ' ' CD1' ' A' ' 35' ' ' TYR . . . -157.95 118.63 3.44 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.386 -0.821 . . . . 0.0 109.587 179.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.54 ' HA ' ' C ' ' A' ' 33' ' ' LYS . 14.6 mtm -59.15 149.6 27.64 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.114 -0.991 . . . . 0.0 109.37 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.612 ' O ' ' N ' ' A' ' 32' ' ' GLU . 1.3 t0 -126.95 163.13 43.39 Favored Pre-proline 0 C--N 1.312 -1.031 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 179.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.447 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 43.9 Cg_endo -83.95 -16.76 6.19 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 124.95 2.026 . . . . 0.0 108.086 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.24 -38.83 17.2 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 178.066 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.606 ' CG1' ' CB ' ' A' ' 28' ' ' ASP . 2.6 pt -102.24 -2.2 9.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.612 ' N ' ' O ' ' A' ' 28' ' ' ASP . 3.9 mm-40 34.35 36.23 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 -178.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.54 ' C ' ' HA ' ' A' ' 27' ' ' MET . 11.1 mttm -161.41 148.64 14.81 Favored 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 119.37 -0.932 . . . . 0.0 110.501 -177.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.587 ' O ' ' CG ' ' A' ' 8' ' ' GLN . . . -58.59 143.99 44.41 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.478 -0.764 . . . . 0.0 109.901 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.627 ' CZ ' ' HB3' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -142.31 139.76 31.94 Favored 'General case' 0 N--CA 1.5 2.039 0 CA-C-O 121.803 0.811 . . . . 0.0 110.199 179.461 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.555 ' CG1' ' HA ' ' A' ' 5' ' ' TYR . 7.9 p -74.34 61.61 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.123 -0.986 . . . . 0.0 108.673 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.627 ' HB3' ' CZ ' ' A' ' 35' ' ' TYR . 0.1 OUTLIER -71.4 -18.34 62.35 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.303 -0.873 . . . . 0.0 110.607 -178.992 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.468 ' HB3' ' O ' ' A' ' 23' ' ' GLY . 57.2 t0 -135.21 75.62 1.58 Allowed 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.055 -1.028 . . . . 0.0 109.722 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.569 ' HB ' ' CZ ' ' A' ' 4' ' ' PHE . 6.4 m -51.81 -24.35 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.273 -0.892 . . . . 0.0 108.935 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.427 ' N ' HG21 ' A' ' 39' ' ' VAL . 2.0 mt-10 -90.16 1.81 56.01 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.335 -0.853 . . . . 0.0 109.365 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.43 ' O ' ' HA3' ' A' ' 23' ' ' GLY . . . -96.04 34.75 4.72 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.457 ' HB3' ' HB3' ' A' ' 21' ' ' ALA . . . -179.66 126.65 0.08 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.251 -1.147 . . . . 0.0 109.615 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.529 ' N ' ' HG2' ' A' ' 46' ' ' GLU . 0.3 OUTLIER -59.22 165.67 2.52 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.298 -0.876 . . . . 0.0 109.542 179.768 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.493 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 0.1 OUTLIER -71.67 -37.44 70.76 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.333 -0.854 . . . . 0.0 109.467 179.995 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -71.73 -20.26 61.92 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.075 -1.015 . . . . 0.0 109.286 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.529 ' HG2' ' N ' ' A' ' 43' ' ' SER . 5.3 pt-20 -95.08 -34.08 12.44 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 106.517 -1.661 . . . . 0.0 106.517 178.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.488 ' CG2' ' O ' ' A' ' 43' ' ' SER . 25.1 t -64.25 -46.82 92.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 177.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.493 ' HB2' ' O ' ' A' ' 44' ' ' GLN . 0.2 OUTLIER -64.77 -51.3 63.02 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.615 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -51.74 -40.57 60.46 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.581 ' CB ' ' HB ' ' A' ' 20' ' ' ILE . . . -72.41 -32.73 66.61 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.523 ' HG3' ' CD1' ' A' ' 59' ' ' ILE . 34.6 ttm -74.41 -24.88 59.17 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.645 -0.659 . . . . 0.0 110.103 -179.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -86.3 -26.35 24.97 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.047 -1.033 . . . . 0.0 109.882 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.593 ' CG2' ' CD1' ' A' ' 20' ' ' ILE . 13.8 t -73.01 -5.89 41.84 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.137 -0.977 . . . . 0.0 109.772 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.625 ' SG ' ' HD2' ' A' ' 55' ' ' PRO . 19.4 t -79.09 142.61 59.82 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.163 -0.961 . . . . 0.0 109.743 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.625 ' HD2' ' SG ' ' A' ' 54' ' ' CYS . 42.9 Cg_endo -76.35 -72.38 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.07 1.563 . . . . 0.0 109.945 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.418 ' O ' ' HB2' ' A' ' 57' ' ' GLN . 2.5 t -74.5 -18.18 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.096 -1.003 . . . . 0.0 108.761 179.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.451 ' O ' ' C ' ' A' ' 58' ' ' CYS . 0.0 OUTLIER 71.9 -64.57 0.38 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.431 -0.793 . . . . 0.0 110.139 179.582 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.451 ' C ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER 42.05 37.9 0.95 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.334 -0.854 . . . . 0.0 108.799 -179.467 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.57 ' O ' ' CG ' ' A' ' 60' ' ' HIS . 7.6 tt -121.48 157.46 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.303 -0.873 . . . . 0.0 110.096 -179.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.57 ' CG ' ' O ' ' A' ' 59' ' ' ILE . 23.5 m80 -159.3 132.62 7.14 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.353 -0.842 . . . . 0.0 109.655 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.547 ' HA ' ' CB ' ' A' ' 4' ' ' PHE . 57.3 m95 -71.26 168.72 16.7 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.239 -0.913 . . . . 0.0 109.141 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.494 ' N ' ' HA ' ' A' ' 4' ' ' PHE . 1.4 tt0 -135.5 112.57 10.37 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.186 -0.946 . . . . 0.0 109.644 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -106.04 36.52 2.54 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.335 -0.853 . . . . 0.0 109.375 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 O-C-N 121.21 -0.931 . . . . 0.0 109.457 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' SF4 . . . . . 0.89 ' S3 ' HG12 ' A' ' 12' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 23.9 mtm180 -150.56 153.63 36.1 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.171 -0.956 . . . . 0.0 109.602 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.476 ' HB3' ' HB3' ' A' ' 62' ' ' GLU . 0.2 OUTLIER -101.55 -163.25 1.0 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.226 -0.921 . . . . 0.0 109.758 -179.968 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.588 ' CE1' HG13 ' A' ' 39' ' ' VAL . 14.4 p90 167.98 -174.33 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.269 -0.894 . . . . 0.0 109.657 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.509 ' O ' HG13 ' A' ' 59' ' ' ILE . 4.4 p90 176.18 -172.63 0.08 Allowed 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.596 ' CG2' ' CG2' ' A' ' 36' ' ' VAL . 0.2 OUTLIER -135.78 164.89 31.25 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 C-N-CA 118.056 -1.458 . . . . 0.0 111.086 179.685 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.569 ' OD2' ' CE1' ' A' ' 60' ' ' HIS . 5.5 m-20 -109.1 90.88 3.43 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.496 ' HG2' ' HB3' ' A' ' 35' ' ' TYR . 5.2 mp0 -66.22 48.24 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.66 0 CA-C-O 121.884 0.85 . . . . 0.0 110.002 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.527 ' N ' ' O ' ' A' ' 7' ' ' ASP . 11.0 t0 -110.53 -39.96 4.76 Favored 'General case' 0 C--N 1.285 -2.22 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.412 ' HB2' ' SG ' ' A' ' 58' ' ' CYS . 0.0 OUTLIER -101.25 20.49 15.69 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.307 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.475 ' HB3' ' HG2' ' A' ' 33' ' ' LYS . 11.1 t -86.44 134.99 33.65 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.308 -0.87 . . . . 0.0 110.085 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.506 ' O ' ' CB ' ' A' ' 13' ' ' ALA . 30.3 pt -105.09 -6.15 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.353 -0.842 . . . . 0.0 108.78 179.029 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.506 ' CB ' ' O ' ' A' ' 12' ' ' ILE . . . 76.53 70.85 0.07 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.344 -0.848 . . . . 0.0 109.45 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 1.214 ' SG ' ' OG ' ' A' ' 16' ' ' SER . 27.4 p -103.89 -11.45 17.48 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.124 -0.985 . . . . 0.0 109.697 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.52 ' CB ' ' O ' ' A' ' 14' ' ' CYS . 3.1 tt0 76.29 -1.65 2.88 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.212 -0.93 . . . . 0.0 110.253 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 1.214 ' OG ' ' SG ' ' A' ' 14' ' ' CYS . 0.2 OUTLIER -61.76 -67.11 0.44 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.975 -1.078 . . . . 0.0 109.294 179.89 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.723 ' SG ' ' CD2' ' A' ' 25' ' ' PHE . 14.2 p -54.77 -44.12 73.39 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.21 -0.931 . . . . 0.0 109.103 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.463 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 21.2 t -54.31 -19.69 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.304 -0.872 . . . . 0.0 109.16 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.27 -41.54 14.51 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.172 -0.955 . . . . 0.0 109.107 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.556 ' HB ' ' CB ' ' A' ' 50' ' ' ALA . 1.9 mt -85.84 16.23 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 177.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.42 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . . . -177.54 59.95 0.15 Allowed Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.429 -0.795 . . . . 0.0 109.062 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -74.25 -0.11 9.21 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 124.075 1.566 . . . . 0.0 110.402 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.477 ' O ' ' HB3' ' A' ' 38' ' ' ASP . . . -111.43 -26.88 4.37 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.523 ' CB ' ' O ' ' A' ' 38' ' ' ASP . . . -100.34 -47.25 4.99 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.362 -1.081 . . . . 0.0 109.604 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.723 ' CD2' ' SG ' ' A' ' 17' ' ' CYS . 0.1 OUTLIER -90.61 140.4 29.79 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.373 -0.829 . . . . 0.0 109.045 -179.96 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.523 ' O ' ' CD1' ' A' ' 35' ' ' TYR . . . -164.48 119.57 1.45 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.147 -0.97 . . . . 0.0 109.943 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.513 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 5.7 ttm -60.14 152.22 24.94 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.098 -1.001 . . . . 0.0 109.159 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.606 ' O ' ' N ' ' A' ' 32' ' ' GLU . 2.8 t0 -125.97 160.14 58.33 Favored Pre-proline 0 C--N 1.312 -1.06 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 179.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.445 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 43.9 Cg_endo -84.88 -16.15 5.46 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 O-C-N 124.662 1.875 . . . . 0.0 108.585 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.75 -28.0 16.87 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 177.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.554 HG12 ' CB ' ' A' ' 28' ' ' ASP . 0.8 OUTLIER -108.46 -0.81 9.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 177.905 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.606 ' N ' ' O ' ' A' ' 28' ' ' ASP . 19.6 mt-10 28.73 42.73 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.595 0.712 . . . . 0.0 109.625 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.502 ' C ' ' HA ' ' A' ' 27' ' ' MET . 1.0 OUTLIER -169.44 148.19 3.76 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 119.365 -0.934 . . . . 0.0 110.287 -179.051 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.619 ' HB1' ' S2 ' ' A' ' 65' ' ' SF4 . . . -57.2 143.76 37.88 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.453 -0.779 . . . . 0.0 110.67 -179.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.633 ' O ' ' CD1' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -144.03 143.09 31.03 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.732 0.777 . . . . 0.0 109.607 179.094 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.596 ' CG2' ' CG2' ' A' ' 6' ' ' VAL . 2.1 t -86.2 91.67 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 120.816 -1.178 . . . . 0.0 108.153 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.592 ' HB3' ' CE2' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -104.3 -16.22 15.22 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.343 -0.848 . . . . 0.0 110.605 -178.82 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.523 ' O ' ' CB ' ' A' ' 24' ' ' ALA . 36.9 t70 -129.66 90.92 3.06 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 120.984 -1.072 . . . . 0.0 109.696 -179.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.588 HG13 ' CE1' ' A' ' 4' ' ' PHE . 28.7 m -58.27 -39.77 75.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.22 -0.925 . . . . 0.0 109.578 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.466 ' HG2' ' OD1' ' A' ' 38' ' ' ASP . 1.3 pt-20 -64.6 -16.53 62.86 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.248 -0.907 . . . . 0.0 109.258 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.513 ' N ' ' OD2' ' A' ' 38' ' ' ASP . . . -76.59 0.76 63.86 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.694 -1.363 . . . . 0.0 109.694 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.42 ' HB3' ' HB3' ' A' ' 21' ' ' ALA . . . -160.04 103.91 1.49 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.179 -1.189 . . . . 0.0 109.512 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.472 ' OG ' ' OE2' ' A' ' 46' ' ' GLU . 0.4 OUTLIER -50.19 162.65 0.2 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.27 -0.894 . . . . 0.0 109.69 -179.876 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.475 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 15.1 pt20 -48.97 -50.17 36.99 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.434 -0.791 . . . . 0.0 109.43 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.403 ' N ' ' HG3' ' A' ' 44' ' ' GLN . 25.9 mm-40 -63.21 -13.04 33.04 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.298 -0.876 . . . . 0.0 109.359 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.472 ' OE2' ' OG ' ' A' ' 43' ' ' SER . 7.3 mt-10 -93.48 -52.77 4.35 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 179.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.457 ' O ' ' HB2' ' A' ' 51' ' ' MET . 2.5 t -53.67 -38.7 35.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 178.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' A' ' 44' ' ' GLN . 0.1 OUTLIER -69.08 -55.63 10.19 Favored 'General case' 0 C--N 1.309 -1.173 0 O-C-N 121.499 -0.751 . . . . 0.0 109.776 179.775 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.487 ' CB ' HG23 ' A' ' 20' ' ' ILE . 20.3 mm-40 -53.2 -49.77 66.06 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.143 -0.973 . . . . 0.0 108.765 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.556 ' CB ' ' HB ' ' A' ' 20' ' ' ILE . . . -65.6 -11.1 41.32 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.429 -0.794 . . . . 0.0 108.931 179.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.463 ' SD ' ' CD1' ' A' ' 59' ' ' ILE . 0.0 OUTLIER -83.92 -43.78 14.92 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.453 -0.78 . . . . 0.0 109.938 -179.372 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -76.41 -22.36 54.82 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.335 -0.853 . . . . 0.0 110.205 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.474 HG22 ' CD1' ' A' ' 20' ' ' ILE . 7.6 t -69.95 -6.05 30.43 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.052 -1.03 . . . . 0.0 109.69 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.519 ' SG ' ' HD2' ' A' ' 55' ' ' PRO . 16.1 t -85.95 139.97 34.99 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.152 -0.968 . . . . 0.0 109.557 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.519 ' HD2' ' SG ' ' A' ' 54' ' ' CYS . 46.0 Cg_endo -74.27 -49.52 0.18 Allowed 'Trans proline' 0 C--N 1.303 -1.819 0 O-C-N 124.051 1.553 . . . . 0.0 110.138 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.474 ' O ' ' HB2' ' A' ' 57' ' ' GLN . 5.4 t -97.28 -11.78 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.301 -0.874 . . . . 0.0 109.078 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.477 ' HA ' ' HB3' ' A' ' 54' ' ' CYS . 13.6 mt-30 65.43 -85.43 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.464 -0.773 . . . . 0.0 110.028 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.439 ' SG ' ' HB2' ' A' ' 7' ' ' ASP . 7.2 t 58.79 31.99 21.77 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.067 -1.021 . . . . 0.0 108.823 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.522 HD13 ' CG1' ' A' ' 6' ' ' VAL . 1.2 tt -110.84 156.65 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.354 -0.841 . . . . 0.0 109.724 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.569 ' CE1' ' OD2' ' A' ' 7' ' ' ASP . 13.6 m80 -154.03 136.54 15.07 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.116 -0.99 . . . . 0.0 109.797 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.539 ' HA ' ' CB ' ' A' ' 4' ' ' PHE . 56.8 m95 -78.74 166.88 21.97 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.39 -0.819 . . . . 0.0 109.499 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.515 ' N ' ' HA ' ' A' ' 4' ' ' PHE . 45.2 tt0 -132.65 116.83 17.13 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.342 -0.849 . . . . 0.0 109.32 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -106.14 -39.14 6.05 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.285 -0.885 . . . . 0.0 109.611 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 . . . . . 0 N--CA 1.49 1.548 0 O-C-N 121.207 -0.933 . . . . 0.0 109.507 179.984 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' SF4 . . . . . 0.619 ' S2 ' ' HB1' ' A' ' 34' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.433 ' O ' ' C ' ' A' ' 2' ' ' ARG . . . . . . . . 0 N--CA 1.492 1.627 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.433 ' C ' ' O ' ' A' ' 1' ' ' ALA . 18.9 mtm180 43.9 33.06 0.69 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.267 -0.895 . . . . 0.0 109.159 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.589 ' CG ' ' CG ' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -81.44 -145.01 0.05 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.506 -0.746 . . . . 0.0 109.538 -179.82 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.581 ' CE2' HG12 ' A' ' 36' ' ' VAL . 28.6 p90 -173.48 -177.59 1.5 Allowed 'General case' 0 C--N 1.296 -1.747 0 O-C-N 121.205 -0.935 . . . . 0.0 109.496 -179.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.55 ' CD1' ' HB2' ' A' ' 62' ' ' GLU . 14.3 p90 175.1 -172.05 0.06 Allowed 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.595 HG23 ' CZ ' ' A' ' 25' ' ' PHE . 0.2 OUTLIER -134.34 172.33 16.38 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 C-N-CA 117.594 -1.642 . . . . 0.0 111.162 179.565 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.496 ' O ' ' N ' ' A' ' 9' ' ' ASP . 13.5 t70 -122.29 90.18 3.25 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.566 ' CG ' ' O ' ' A' ' 34' ' ' ALA . 6.9 mp0 -66.45 48.92 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.748 0.785 . . . . 0.0 109.81 179.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.496 ' N ' ' O ' ' A' ' 7' ' ' ASP . 0.5 OUTLIER -114.08 -25.7 8.41 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.588 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.457 ' HB3' ' SG ' ' A' ' 58' ' ' CYS . 0.1 OUTLIER -110.22 -19.71 12.92 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.649 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.462 ' O ' ' HD3' ' A' ' 33' ' ' LYS . 42.0 t -46.75 141.92 3.62 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.425 -0.797 . . . . 0.0 109.471 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.582 ' O ' ' CB ' ' A' ' 13' ' ' ALA . 11.8 pt -99.34 -51.93 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.068 -1.02 . . . . 0.0 109.545 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.582 ' CB ' ' O ' ' A' ' 12' ' ' ILE . . . 154.91 35.48 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.543 -0.723 . . . . 0.0 110.276 179.287 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.673 ' O ' ' S2 ' ' A' ' 65' ' ' SF4 . 0.5 OUTLIER -105.08 158.53 16.5 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.667 -1.271 . . . . 0.0 109.719 179.557 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.455 ' O ' ' N ' ' A' ' 19' ' ' GLU . 11.6 mt-10 -99.07 12.97 34.5 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.306 -0.871 . . . . 0.0 109.833 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.632 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 3.7 m -45.03 -76.34 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.087 -1.008 . . . . 0.0 109.052 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.995 ' SG ' ' CD2' ' A' ' 25' ' ' PHE . 10.6 p -52.6 -49.15 65.62 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.38 -0.825 . . . . 0.0 109.125 179.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.581 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 60.8 t -52.13 -24.7 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.311 -0.868 . . . . 0.0 109.226 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.455 ' N ' ' O ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -83.61 -36.02 24.21 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.219 -0.926 . . . . 0.0 109.173 179.76 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.559 ' HB ' ' CB ' ' A' ' 50' ' ' ALA . 2.7 mp -83.43 10.56 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.529 ' CB ' ' HB3' ' A' ' 42' ' ' ALA . . . 178.08 68.71 0.1 Allowed Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.393 -0.817 . . . . 0.0 108.879 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -69.93 -1.19 8.21 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 124.166 1.614 . . . . 0.0 110.887 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.478 ' O ' ' HB3' ' A' ' 38' ' ' ASP . . . -105.34 -44.44 1.46 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.53 ' CB ' ' O ' ' A' ' 38' ' ' ASP . . . -83.46 -36.42 24.19 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.374 -1.074 . . . . 0.0 109.844 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.995 ' CD2' ' SG ' ' A' ' 17' ' ' CYS . 0.1 OUTLIER -105.73 140.71 38.36 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.342 -0.848 . . . . 0.0 109.23 -179.682 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.522 ' O ' ' CD1' ' A' ' 35' ' ' TYR . . . -171.27 120.37 0.5 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.151 -0.968 . . . . 0.0 109.459 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.534 ' HA ' ' C ' ' A' ' 33' ' ' LYS . 10.5 mtp -58.41 153.73 15.16 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.08 -1.013 . . . . 0.0 109.232 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.613 ' O ' ' N ' ' A' ' 32' ' ' GLU . 1.4 t0 -132.97 165.07 39.4 Favored Pre-proline 0 C--N 1.312 -1.063 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.479 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 43.8 Cg_endo -84.59 -15.11 6.29 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 124.654 1.871 . . . . 0.0 107.459 178.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.441 ' HB3' HD11 ' A' ' 31' ' ' ILE . 4.4 tt0 -83.54 -39.24 20.66 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 177.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.543 HG12 ' CB ' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -106.2 1.24 10.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.103 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.613 ' N ' ' O ' ' A' ' 28' ' ' ASP . 22.6 mt-10 33.84 36.42 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 -179.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.547 ' CG ' ' O ' ' A' ' 32' ' ' GLU . 17.9 mttm -164.72 149.6 9.61 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 119.203 -0.999 . . . . 0.0 110.565 -177.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.76 ' HB1' ' S2 ' ' A' ' 65' ' ' SF4 . . . -53.07 141.83 21.64 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.574 -0.704 . . . . 0.0 109.658 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.642 ' O ' ' CD1' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -144.69 140.67 28.76 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 122.044 0.926 . . . . 0.0 109.901 179.347 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.59 ' CG2' ' CG2' ' A' ' 6' ' ' VAL . 1.7 t -84.57 97.31 5.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -179.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.568 ' HG2' ' CE1' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -115.87 -10.62 11.65 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.278 -0.889 . . . . 0.0 111.193 -178.604 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.53 ' O ' ' CB ' ' A' ' 24' ' ' ALA . 33.9 t0 -133.03 87.91 2.45 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.792 -1.192 . . . . 0.0 110.098 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 24.0 m -54.08 -34.89 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.258 -0.901 . . . . 0.0 109.343 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 74.3 mt-10 -69.5 -14.03 62.65 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.4 -0.813 . . . . 0.0 109.601 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -76.44 -2.08 73.0 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.529 ' HB3' ' CB ' ' A' ' 21' ' ' ALA . . . -162.5 135.57 5.92 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.209 -1.171 . . . . 0.0 109.46 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.458 ' OG ' ' HG3' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -77.23 166.43 23.22 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.283 -0.886 . . . . 0.0 109.84 -179.75 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.466 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 5.4 pt20 -54.9 -43.2 73.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.45 -0.781 . . . . 0.0 109.633 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.433 ' N ' ' HG3' ' A' ' 44' ' ' GLN . 33.4 mm-40 -69.18 -11.04 60.45 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.235 -0.916 . . . . 0.0 109.163 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.458 ' HG3' ' OG ' ' A' ' 43' ' ' SER . 18.3 mt-10 -94.72 -44.63 7.7 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 178.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.557 HG12 ' CE2' ' A' ' 4' ' ' PHE . 72.6 t -60.83 -37.26 76.01 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 177.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.466 ' HB2' ' O ' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -67.93 -59.65 3.11 Favored 'General case' 0 C--N 1.31 -1.146 0 O-C-N 121.502 -0.749 . . . . 0.0 109.298 179.108 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.405 ' OE1' HG21 ' A' ' 20' ' ' ILE . 8.8 tt0 -51.59 -47.48 63.55 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.441 -0.903 . . . . 0.0 109.101 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.559 ' CB ' ' HB ' ' A' ' 20' ' ' ILE . . . -61.62 -27.42 68.64 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.3 -0.875 . . . . 0.0 109.204 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.591 ' CG ' ' CG2' ' A' ' 59' ' ' ILE . 0.8 OUTLIER -70.97 -27.14 63.51 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.544 -0.723 . . . . 0.0 110.405 -179.21 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -94.68 -8.45 37.82 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.919 -1.113 . . . . 0.0 110.127 -179.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.472 ' CB ' HD12 ' A' ' 20' ' ' ILE . 91.7 m -88.07 -17.96 29.93 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.073 -1.017 . . . . 0.0 110.052 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.814 ' SG ' ' HD2' ' A' ' 55' ' ' PRO . 35.5 t -69.73 147.07 96.24 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.028 -1.045 . . . . 0.0 109.783 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.814 ' HD2' ' SG ' ' A' ' 54' ' ' CYS . 45.0 Cg_endo -77.9 -63.32 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.119 1.589 . . . . 0.0 109.781 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 75.9 t -80.65 -6.02 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.287 -0.883 . . . . 0.0 109.081 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.415 ' HA ' ' HB3' ' A' ' 54' ' ' CYS . 44.9 mt-30 45.8 71.46 0.28 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.315 -0.866 . . . . 0.0 109.545 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.46 ' O ' HG11 ' A' ' 6' ' ' VAL . 2.5 m -94.44 21.1 7.5 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.277 -0.889 . . . . 0.0 109.129 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.591 ' CG2' ' CG ' ' A' ' 51' ' ' MET . 1.9 tt -105.19 142.41 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.453 -0.78 . . . . 0.0 109.833 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.436 ' CG ' ' C ' ' A' ' 59' ' ' ILE . 6.5 m80 -149.83 142.31 24.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.471 -0.768 . . . . 0.0 109.118 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.555 ' HA ' ' CB ' ' A' ' 4' ' ' PHE . 64.5 m95 -59.5 175.28 0.35 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.22 -0.925 . . . . 0.0 109.744 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.589 ' CG ' ' CG ' ' A' ' 3' ' ' LYS . 1.4 tp10 -127.81 103.74 7.44 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.475 -0.766 . . . . 0.0 109.116 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -108.36 104.04 13.33 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.0 -1.063 . . . . 0.0 109.485 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.5 0 O-C-N 121.274 -0.891 . . . . 0.0 109.486 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' SF4 . . . . . 0.76 ' S2 ' ' HB1' ' A' ' 34' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.5 ptt-85 -74.01 114.18 12.04 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.165 -0.959 . . . . 0.0 109.379 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.482 ' O ' ' HB3' ' A' ' 4' ' ' PHE . 0.5 OUTLIER -111.58 -168.01 1.25 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.279 -0.888 . . . . 0.0 109.677 -179.882 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.574 ' CE2' HG12 ' A' ' 36' ' ' VAL . 12.5 p90 177.07 -163.91 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.453 -0.779 . . . . 0.0 109.175 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.56 ' HA ' HG23 ' A' ' 36' ' ' VAL . 52.2 p90 171.44 -178.32 0.05 Allowed 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.574 HG23 ' CE2' ' A' ' 25' ' ' PHE . 3.7 t -143.71 155.58 16.13 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.338 0 C-N-CA 117.205 -1.798 . . . . 0.0 111.301 179.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.525 ' O ' ' N ' ' A' ' 9' ' ' ASP . 0.2 OUTLIER -102.14 74.87 1.46 Allowed 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 178.864 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.507 ' HB3' ' O ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER -40.98 -24.43 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.523 0.678 . . . . 0.0 109.372 179.871 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.525 ' N ' ' O ' ' A' ' 7' ' ' ASP . 0.2 OUTLIER -54.27 -31.22 53.14 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.421 -0.799 . . . . 0.0 109.121 179.816 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.424 ' HB3' ' HB3' ' A' ' 58' ' ' CYS . 1.4 tp10 -100.83 11.27 39.91 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.346 -0.846 . . . . 0.0 109.152 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 6.6 t -76.97 122.03 24.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.242 -0.911 . . . . 0.0 109.905 -179.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.98 HG12 ' S3 ' ' A' ' 65' ' ' SF4 . 16.4 pt -70.96 -145.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.41 -0.806 . . . . 0.0 109.413 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.477 ' N ' HG13 ' A' ' 12' ' ' ILE . . . -111.71 55.77 0.66 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.053 -1.029 . . . . 0.0 109.575 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 1.044 ' O ' ' S2 ' ' A' ' 65' ' ' SF4 . 0.1 OUTLIER -139.35 155.37 47.72 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.121 -0.987 . . . . 0.0 109.692 179.858 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.43 ' O ' ' C ' ' A' ' 16' ' ' SER . 13.3 pt-20 -118.44 20.36 13.06 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.366 -0.833 . . . . 0.0 109.534 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.43 ' C ' ' O ' ' A' ' 15' ' ' GLU . 0.2 OUTLIER -43.65 -60.95 1.56 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.354 -0.841 . . . . 0.0 109.269 179.899 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.533 ' SG ' ' N ' ' A' ' 18' ' ' VAL . 19.5 p -49.17 -48.59 44.92 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.386 -0.821 . . . . 0.0 109.297 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.533 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 5.0 t -49.6 -36.45 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.355 -0.841 . . . . 0.0 109.578 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.426 ' N ' ' OE1' ' A' ' 19' ' ' GLU . 0.2 OUTLIER -73.77 -35.91 65.03 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.041 -1.037 . . . . 0.0 109.321 -179.949 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.527 ' HB ' ' CB ' ' A' ' 50' ' ' ALA . 2.5 mp -84.84 12.47 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.241 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -171.34 66.48 0.43 Allowed Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.355 -0.84 . . . . 0.0 109.311 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -72.51 56.42 2.77 Favored 'Trans proline' 0 C--N 1.303 -1.842 0 O-C-N 124.091 1.574 . . . . 0.0 110.058 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -179.85 -34.45 0.07 OUTLIER Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.464 ' CB ' ' O ' ' A' ' 38' ' ' ASP . . . -94.72 -25.28 16.77 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.246 -1.149 . . . . 0.0 109.303 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.574 ' CE2' HG23 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -123.83 135.31 53.69 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.31 -0.869 . . . . 0.0 109.287 179.839 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.477 ' O ' ' HA ' ' A' ' 34' ' ' ALA . . . -163.05 145.15 10.16 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.513 ' HG3' ' CA ' ' A' ' 33' ' ' LYS . 10.7 ttm -77.72 152.7 33.55 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.96 -1.087 . . . . 0.0 109.123 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.636 ' O ' ' N ' ' A' ' 32' ' ' GLU . 1.1 t0 -123.84 162.26 41.98 Favored Pre-proline 0 C--N 1.313 -1.019 0 N-CA-C 106.614 -1.624 . . . . 0.0 106.614 179.067 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.427 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 46.5 Cg_endo -84.29 -15.09 6.67 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 125.06 2.084 . . . . 0.0 108.109 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -88.26 -34.34 17.75 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 178.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.587 ' CG1' ' CB ' ' A' ' 28' ' ' ASP . 1.6 pt -107.72 -2.49 10.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.042 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.636 ' N ' ' O ' ' A' ' 28' ' ' ASP . 0.0 OUTLIER 35.25 35.05 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -178.74 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.522 ' N ' ' O ' ' A' ' 31' ' ' ILE . 23.7 mmtp -157.87 152.92 25.53 Favored 'General case' 0 N--CA 1.499 2.022 0 C-N-CA 119.42 -0.912 . . . . 0.0 110.542 -177.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.507 ' O ' ' HB3' ' A' ' 8' ' ' GLN . . . -61.74 142.75 57.06 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.616 -0.677 . . . . 0.0 110.059 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.634 ' CE2' ' HA ' ' A' ' 37' ' ' LYS . 11.6 p90 -144.0 168.5 19.83 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 178.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.574 HG12 ' CE2' ' A' ' 4' ' ' PHE . 0.2 OUTLIER -85.16 78.39 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.272 0 CA-C-O 121.782 0.801 . . . . 0.0 109.04 -178.079 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.634 ' HA ' ' CE2' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -68.89 -3.74 13.82 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.846 -0.534 . . . . 0.0 110.539 -179.125 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.481 ' HB2' ' O ' ' A' ' 37' ' ' LYS . 36.7 t0 179.87 128.6 0.08 Allowed 'General case' 0 C--N 1.299 -1.611 0 C-N-CA 118.73 -1.188 . . . . 0.0 110.004 -178.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.462 HG11 ' CE1' ' A' ' 4' ' ' PHE . 15.8 m -79.6 -30.66 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.22 -0.925 . . . . 0.0 109.698 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -84.07 -9.75 58.38 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.183 -0.948 . . . . 0.0 109.267 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -61.95 -21.74 61.6 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.46 ' HB1' ' CB ' ' A' ' 24' ' ' ALA . . . -136.21 138.59 42.03 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.235 -1.156 . . . . 0.0 109.737 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.463 ' O ' ' N ' ' A' ' 46' ' ' GLU . 0.1 OUTLIER -71.66 158.32 36.38 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.244 -0.91 . . . . 0.0 109.643 -179.957 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.474 ' HA ' HG22 ' A' ' 47' ' ' VAL . 0.9 OUTLIER -47.53 -46.65 27.8 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.455 -0.778 . . . . 0.0 109.514 179.89 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -67.04 -9.54 40.21 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.292 -0.88 . . . . 0.0 109.449 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.463 ' N ' ' O ' ' A' ' 43' ' ' SER . 27.5 mt-10 -97.91 -41.84 7.82 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 178.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.474 HG22 ' HA ' ' A' ' 44' ' ' GLN . 2.1 t -62.18 -40.59 88.17 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.924 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 178.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.415 ' HB2' ' O ' ' A' ' 44' ' ' GLN . 0.4 OUTLIER -73.17 -56.17 5.46 Favored 'General case' 0 C--N 1.308 -1.211 0 O-C-N 121.673 -0.642 . . . . 0.0 109.648 179.585 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.453 ' HB3' ' CG2' ' A' ' 20' ' ' ILE . 34.0 tt0 -52.94 -45.57 67.74 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.172 -0.955 . . . . 0.0 108.806 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.527 ' CB ' ' HB ' ' A' ' 20' ' ' ILE . . . -64.31 -17.87 64.07 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.32 -0.863 . . . . 0.0 108.93 179.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.573 ' HE2' ' CZ2' ' A' ' 61' ' ' TRP . 2.6 ttm -80.93 -41.61 22.65 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.562 -0.712 . . . . 0.0 109.581 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -69.06 -24.54 64.18 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.282 -0.886 . . . . 0.0 109.704 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.525 ' CG2' HD12 ' A' ' 20' ' ' ILE . 4.9 p -72.5 -33.24 66.8 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.12 -0.988 . . . . 0.0 109.975 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.788 ' SG ' ' HD2' ' A' ' 55' ' ' PRO . 9.4 t -65.19 146.6 98.91 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.056 -1.028 . . . . 0.0 109.864 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.788 ' HD2' ' SG ' ' A' ' 54' ' ' CYS . 45.2 Cg_endo -79.15 -69.49 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 124.099 1.579 . . . . 0.0 110.105 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 9.8 p -75.44 -16.43 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.201 -0.937 . . . . 0.0 108.791 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 63.94 47.81 3.33 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.449 -0.782 . . . . 0.0 109.837 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.541 ' SG ' ' S4 ' ' A' ' 65' ' ' SF4 . 11.5 p -48.61 -23.57 1.05 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.224 -0.923 . . . . 0.0 109.212 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.54 ' CG2' ' HG3' ' A' ' 51' ' ' MET . 6.6 tt -69.32 159.09 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.574 -0.703 . . . . 0.0 110.047 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.527 ' C ' ' CD1' ' A' ' 61' ' ' TRP . 46.9 m80 -149.82 -134.19 0.06 Allowed 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.573 ' CZ2' ' HE2' ' A' ' 51' ' ' MET . 74.4 m95 -151.68 168.74 24.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.835 -1.166 . . . . 0.0 110.062 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.449 ' HB3' ' HB3' ' A' ' 3' ' ' LYS . 2.7 tt0 -147.83 114.5 6.03 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.431 -0.793 . . . . 0.0 109.404 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -137.79 -67.12 0.49 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.222 -0.924 . . . . 0.0 109.395 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 . . . . . 0 N--CA 1.489 1.513 0 O-C-N 121.254 -0.904 . . . . 0.0 109.423 -179.986 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' SF4 . . . . . 1.044 ' S2 ' ' O ' ' A' ' 14' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 15.4 mmm-85 58.94 90.75 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.173 -0.954 . . . . 0.0 109.403 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.512 ' HB3' ' HB3' ' A' ' 62' ' ' GLU . 0.5 OUTLIER -110.28 -158.34 0.64 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.142 -0.974 . . . . 0.0 109.606 -179.925 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.6 ' CZ ' ' HB ' ' A' ' 39' ' ' VAL . 29.3 p90 179.08 173.49 0.77 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.203 -0.936 . . . . 0.0 108.506 -179.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.469 ' HA ' HG13 ' A' ' 36' ' ' VAL . 6.4 p90 178.43 -161.63 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.606 HG22 ' CE1' ' A' ' 25' ' ' PHE . 0.2 OUTLIER -139.3 -177.74 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 C-N-CA 117.545 -1.662 . . . . 0.0 112.076 -179.883 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.517 ' C ' ' H ' ' A' ' 9' ' ' ASP . 5.6 m-20 -143.3 94.44 2.62 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.073 178.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.551 ' CD ' ' O ' ' A' ' 34' ' ' ALA . 31.2 mm-40 -65.11 42.54 0.02 OUTLIER 'General case' 0 C--N 1.291 -1.942 0 CA-C-O 121.444 0.64 . . . . 0.0 111.293 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.517 ' H ' ' C ' ' A' ' 7' ' ' ASP . 0.3 OUTLIER -93.57 -16.87 23.95 Favored 'General case' 0 C--N 1.288 -2.094 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.548 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.471 ' HB3' ' CG1' ' A' ' 56' ' ' VAL . 0.9 OUTLIER -127.15 -1.16 6.44 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.505 -0.747 . . . . 0.0 110.472 -178.944 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.49 ' HB2' ' OE1' ' A' ' 8' ' ' GLN . 49.9 t -63.92 119.11 9.43 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.755 -1.216 . . . . 0.0 109.706 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.527 ' O ' ' CB ' ' A' ' 13' ' ' ALA . 11.8 pt -83.46 -45.1 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 O-C-N 121.364 -0.835 . . . . 0.0 109.481 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.527 ' CB ' ' O ' ' A' ' 12' ' ' ILE . . . 163.92 -27.95 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.163 -0.96 . . . . 0.0 110.033 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 1.079 ' O ' ' S2 ' ' A' ' 65' ' ' SF4 . 0.1 OUTLIER -48.24 154.44 0.59 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.011 -1.056 . . . . 0.0 110.041 -179.298 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.426 ' O ' ' C ' ' A' ' 16' ' ' SER . 6.9 mt-10 -113.35 18.25 17.91 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.404 -0.81 . . . . 0.0 109.193 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.504 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 1.6 m -42.54 -60.17 1.62 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.424 -0.798 . . . . 0.0 109.5 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.682 ' SG ' ' CD2' ' A' ' 25' ' ' PHE . 18.1 p -51.05 -53.88 29.76 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.331 -0.856 . . . . 0.0 109.25 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.575 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 65.7 t -46.33 -37.7 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.334 -0.854 . . . . 0.0 109.207 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.05 -33.16 65.5 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.111 -0.993 . . . . 0.0 109.267 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.545 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 2.4 mp -85.1 11.99 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 179.08 62.83 0.1 Allowed Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.429 -0.795 . . . . 0.0 109.49 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -73.34 54.73 2.88 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 124.134 1.597 . . . . 0.0 110.268 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -161.68 -40.57 0.02 OUTLIER Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.756 -1.737 . . . . 0.0 108.756 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.433 ' HB1' ' HB2' ' A' ' 42' ' ' ALA . . . -96.41 -36.71 10.73 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.407 -1.055 . . . . 0.0 108.908 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.682 ' CD2' ' SG ' ' A' ' 17' ' ' CYS . 0.1 OUTLIER -95.17 138.01 33.45 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.301 -0.874 . . . . 0.0 108.835 179.624 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.477 ' C ' ' HA ' ' A' ' 34' ' ' ALA . . . -162.87 121.69 2.13 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.027 -1.046 . . . . 0.0 110.197 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.542 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 6.8 tmm? -62.0 147.81 45.9 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.175 -0.953 . . . . 0.0 109.506 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.624 ' O ' ' N ' ' A' ' 32' ' ' GLU . 0.8 OUTLIER -125.67 161.78 48.8 Favored Pre-proline 0 C--N 1.315 -0.907 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 179.083 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.42 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 46.4 Cg_endo -84.0 -15.79 6.66 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 124.96 2.032 . . . . 0.0 107.958 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.39 -35.89 18.08 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 178.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.588 ' CG1' ' CB ' ' A' ' 28' ' ' ASP . 2.7 pt -105.58 -1.99 9.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.008 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.624 ' N ' ' O ' ' A' ' 28' ' ' ASP . 2.1 mt-10 34.75 34.97 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -178.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.543 ' CD ' ' HB3' ' A' ' 8' ' ' GLN . 34.2 mttp -160.49 151.67 19.14 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.213 -178.058 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.551 ' O ' ' CD ' ' A' ' 8' ' ' GLN . . . -70.09 151.0 45.98 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.249 -0.907 . . . . 0.0 110.658 -179.026 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.65 ' CZ ' ' CB ' ' A' ' 37' ' ' LYS . 4.3 p90 -148.07 150.41 33.85 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 178.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.479 ' CG2' HG11 ' A' ' 39' ' ' VAL . 10.6 p -69.59 63.39 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 C-N-CA 119.055 -1.058 . . . . 0.0 108.205 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.65 ' CB ' ' CZ ' ' A' ' 35' ' ' TYR . 13.7 pttp -47.98 -27.49 2.24 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.265 0.555 . . . . 0.0 110.481 -179.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -157.33 92.27 1.23 Allowed 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 119.207 -0.997 . . . . 0.0 109.753 -178.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.6 ' HB ' ' CZ ' ' A' ' 4' ' ' PHE . 26.8 m -49.11 -21.99 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.425 -0.797 . . . . 0.0 109.773 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.44 -16.79 57.2 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.149 -0.969 . . . . 0.0 109.476 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -77.45 1.38 66.05 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.433 ' HB2' ' HB1' ' A' ' 24' ' ' ALA . . . -157.27 124.0 5.03 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.14 -1.212 . . . . 0.0 109.781 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.542 ' N ' ' HG2' ' A' ' 46' ' ' GLU . 0.3 OUTLIER -53.86 163.0 0.79 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.375 -0.828 . . . . 0.0 109.754 179.708 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.442 ' CG ' ' N ' ' A' ' 45' ' ' GLU . 11.1 pt20 -67.95 -40.34 83.26 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.351 -0.843 . . . . 0.0 109.853 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.483 ' HA ' ' CD ' ' A' ' 48' ' ' GLU . 1.6 mm-40 -72.45 -26.23 61.75 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.075 -1.016 . . . . 0.0 109.53 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.542 ' HG2' ' N ' ' A' ' 43' ' ' SER . 5.3 pt-20 -85.0 -31.5 23.45 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 105.476 -2.046 . . . . 0.0 105.476 177.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.57 HG12 ' CD1' ' A' ' 4' ' ' PHE . 2.5 t -65.28 -34.64 71.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.059 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.517 ' O ' ' N ' ' A' ' 51' ' ' MET . 8.4 pt-20 -74.45 -56.84 4.4 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.16 -0.962 . . . . 0.0 109.417 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 48' ' ' GLU . 61.8 tt0 -41.3 -38.32 1.15 Allowed 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.545 ' N ' ' CG2' ' A' ' 20' ' ' ILE . . . -67.95 -41.63 82.21 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.521 ' CE ' HG23 ' A' ' 59' ' ' ILE . 3.7 ttm -62.93 -47.72 82.04 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.94 -31.61 71.15 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.16 -0.963 . . . . 0.0 109.329 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.466 ' HB ' HD12 ' A' ' 20' ' ' ILE . 70.0 m -98.29 88.22 4.11 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.313 -0.867 . . . . 0.0 109.173 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.54 ' SG ' ' HD2' ' A' ' 55' ' ' PRO . 21.6 t -161.15 145.82 10.38 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.198 -0.939 . . . . 0.0 109.334 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.758 ' CG ' ' S3 ' ' A' ' 65' ' ' SF4 . 43.3 Cg_endo -71.21 101.3 1.09 Allowed 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 123.858 1.452 . . . . 0.0 109.425 179.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.531 ' CG1' ' O ' ' A' ' 55' ' ' PRO . 0.4 OUTLIER 82.41 -9.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 -178.624 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.536 ' HA ' ' HB3' ' A' ' 54' ' ' CYS . 0.1 OUTLIER 63.04 148.38 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.441 -0.787 . . . . 0.0 110.641 179.393 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.749 ' SG ' ' S4 ' ' A' ' 65' ' ' SF4 . 2.4 p -148.87 -34.81 0.2 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.72 -0.613 . . . . 0.0 109.403 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.556 ' O ' ' CD2' ' A' ' 60' ' ' HIS . 17.1 mt -58.12 153.67 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.026 -1.046 . . . . 0.0 109.418 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.585 ' CE1' ' O ' ' A' ' 58' ' ' CYS . 45.6 m80 -159.06 125.0 4.41 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.557 ' HA ' ' CB ' ' A' ' 4' ' ' PHE . 87.8 m95 -55.22 171.11 0.17 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.121 -0.987 . . . . 0.0 109.108 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.512 ' HB3' ' HB3' ' A' ' 3' ' ' LYS . 1.3 tt0 -136.22 93.55 2.92 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.248 -0.907 . . . . 0.0 109.245 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -90.23 135.26 33.78 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.189 -0.945 . . . . 0.0 109.424 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 O-C-N 121.23 -0.919 . . . . 0.0 109.479 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' SF4 . . . . . 1.079 ' S2 ' ' O ' ' A' ' 14' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.276 0.56 . . . . 0.0 109.529 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 17.0 mtt180 -63.52 172.04 2.26 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.263 -0.898 . . . . 0.0 109.35 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.464 ' O ' ' HB3' ' A' ' 4' ' ' PHE . 0.2 OUTLIER -132.26 -164.36 1.45 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.132 -0.98 . . . . 0.0 109.602 -179.955 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.558 ' CB ' ' HA ' ' A' ' 61' ' ' TRP . 6.1 p90 177.43 -172.12 0.1 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.321 -0.862 . . . . 0.0 109.262 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.574 ' HA ' ' CG1' ' A' ' 36' ' ' VAL . 46.8 p90 169.2 -177.77 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.649 ' CG2' ' CZ ' ' A' ' 25' ' ' PHE . 3.1 t -139.39 159.5 28.45 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.4 0 C-N-CA 116.962 -1.895 . . . . 0.0 111.417 179.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.516 ' O ' ' N ' ' A' ' 9' ' ' ASP . 1.2 m-20 -106.9 72.52 0.89 Allowed 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.494 ' HB3' ' O ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER -41.8 -23.87 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 179.486 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 7' ' ' ASP . 19.5 t0 -50.92 -38.54 50.71 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.549 ' HB3' ' CB ' ' A' ' 58' ' ' CYS . 20.8 tt0 -82.02 -19.99 39.28 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.369 -0.832 . . . . 0.0 108.942 179.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.471 ' HB3' ' HG2' ' A' ' 33' ' ' LYS . 36.9 t -51.15 123.92 10.47 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.477 -0.764 . . . . 0.0 109.806 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.5 HG12 ' S3 ' ' A' ' 65' ' ' SF4 . 10.0 pt -75.32 -48.7 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.376 -0.827 . . . . 0.0 109.541 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.496 ' CB ' ' O ' ' A' ' 12' ' ' ILE . . . 166.13 -33.03 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.028 -1.045 . . . . 0.0 110.132 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 1.119 ' O ' ' S2 ' ' A' ' 65' ' ' SF4 . 0.1 OUTLIER -52.32 159.6 0.95 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.073 -1.017 . . . . 0.0 109.519 -179.59 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.467 ' HA ' ' S2 ' ' A' ' 65' ' ' SF4 . 13.6 pt-20 -123.75 21.85 9.1 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.31 -0.869 . . . . 0.0 109.505 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.407 ' C ' ' O ' ' A' ' 15' ' ' GLU . 0.6 OUTLIER -44.53 -58.57 2.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.175 -0.953 . . . . 0.0 109.023 179.797 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.674 ' SG ' ' N ' ' A' ' 18' ' ' VAL . 17.6 p -49.96 -58.77 4.76 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.433 -0.792 . . . . 0.0 109.166 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.674 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 59.4 t -45.26 -34.41 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.224 -0.922 . . . . 0.0 109.044 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.39 -39.53 71.13 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.162 -0.961 . . . . 0.0 108.897 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.59 ' HB ' ' CB ' ' A' ' 50' ' ' ALA . 1.9 mt -87.1 17.77 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 177.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.473 ' CB ' ' HB3' ' A' ' 42' ' ' ALA . . . 172.31 65.42 0.03 OUTLIER Pre-proline 0 N--CA 1.489 1.482 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.503 ' N ' ' O ' ' A' ' 18' ' ' VAL . 43.8 Cg_endo -72.14 -2.09 11.07 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.108 1.583 . . . . 0.0 110.65 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.484 ' O ' ' HB3' ' A' ' 38' ' ' ASP . . . -92.2 -71.85 1.2 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.547 ' CB ' ' O ' ' A' ' 38' ' ' ASP . . . -66.82 -30.15 70.26 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.353 -1.087 . . . . 0.0 109.364 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.649 ' CZ ' ' CG2' ' A' ' 6' ' ' VAL . 0.1 OUTLIER -105.42 133.75 49.66 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 118.821 -1.152 . . . . 0.0 109.904 -179.734 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.553 ' O ' ' CD1' ' A' ' 35' ' ' TYR . . . -166.27 123.97 1.42 Allowed 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.478 -0.764 . . . . 0.0 109.156 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.528 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER -62.17 155.63 23.91 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.169 -0.957 . . . . 0.0 109.092 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.593 ' O ' ' HA ' ' A' ' 32' ' ' GLU . 4.0 t0 -128.2 161.99 53.02 Favored Pre-proline 0 C--N 1.309 -1.166 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.444 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 43.9 Cg_endo -85.0 -18.16 4.42 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 124.428 1.752 . . . . 0.0 108.562 -179.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -89.32 -32.75 17.19 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 177.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.55 HG12 ' CB ' ' A' ' 28' ' ' ASP . 0.8 OUTLIER -104.79 2.19 10.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 178.071 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.593 ' HA ' ' O ' ' A' ' 28' ' ' ASP . 9.9 mt-10 26.34 43.68 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.51 0.672 . . . . 0.0 110.212 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.523 ' N ' ' O ' ' A' ' 31' ' ' ILE . 6.2 mttt -172.13 148.46 2.2 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 119.134 -1.027 . . . . 0.0 110.653 -179.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.577 ' HB1' ' S2 ' ' A' ' 65' ' ' SF4 . . . -54.71 142.21 29.44 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.684 -0.635 . . . . 0.0 110.634 -179.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.666 ' CE2' ' HG3' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -143.91 151.01 39.26 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-O 121.764 0.792 . . . . 0.0 109.95 179.156 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.574 ' CG1' ' HA ' ' A' ' 5' ' ' TYR . 0.9 OUTLIER -91.04 109.19 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.424 -1.422 . . . . 0.0 109.563 -178.637 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.666 ' HG3' ' CE2' ' A' ' 35' ' ' TYR . 23.5 mmtt -125.75 -53.25 1.56 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.423 -0.798 . . . . 0.0 110.445 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.547 ' O ' ' CB ' ' A' ' 24' ' ' ALA . 61.6 t0 -86.98 71.94 10.17 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.599 -0.688 . . . . 0.0 110.462 -177.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.468 HG13 ' CZ ' ' A' ' 4' ' ' PHE . 24.8 m -46.58 -40.59 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.322 -0.861 . . . . 0.0 109.194 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -66.33 -17.71 64.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.352 -0.842 . . . . 0.0 109.499 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' A' ' 38' ' ' ASP . . . -72.43 -21.13 79.58 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.473 ' HB3' ' CB ' ' A' ' 21' ' ' ALA . . . -132.02 134.67 45.83 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.277 -1.131 . . . . 0.0 109.296 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.465 ' O ' ' CG2' ' A' ' 47' ' ' VAL . 0.4 OUTLIER -79.29 -166.99 1.04 Allowed 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.224 -0.922 . . . . 0.0 109.775 -179.8 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.473 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 1.9 mt-30 -71.44 -49.58 40.27 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.664 -0.647 . . . . 0.0 109.56 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.472 ' O ' ' HB2' ' A' ' 49' ' ' GLU . 1.8 pm0 -72.77 -12.84 61.16 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.175 -0.953 . . . . 0.0 109.298 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.462 ' HG3' ' HB2' ' A' ' 43' ' ' SER . 29.9 mt-10 -90.71 -42.01 10.96 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 178.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.475 ' O ' ' HB2' ' A' ' 51' ' ' MET . 24.2 t -63.95 -47.53 90.12 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 CA-C-N 114.789 -1.096 . . . . 0.0 108.093 178.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.526 ' O ' ' N ' ' A' ' 51' ' ' MET . 0.3 OUTLIER -67.97 -62.23 1.5 Allowed 'General case' 0 C--N 1.307 -1.243 0 O-C-N 121.584 -0.697 . . . . 0.0 109.591 179.583 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 45' ' ' GLU . 34.6 mt-10 -43.23 -52.01 5.86 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 119.44 -0.904 . . . . 0.0 108.918 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.59 ' CB ' ' HB ' ' A' ' 20' ' ' ILE . . . -65.53 -27.86 68.76 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.57 ' HE2' ' CE2' ' A' ' 61' ' ' TRP . 22.5 ttm -76.88 -21.68 54.58 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.627 -0.67 . . . . 0.0 110.35 -179.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.81 -15.78 26.11 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.085 -1.009 . . . . 0.0 109.759 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.527 ' OG1' ' CD1' ' A' ' 20' ' ' ILE . 76.2 p -91.91 73.63 5.66 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.189 -0.944 . . . . 0.0 109.455 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 19.0 t -151.65 128.49 5.43 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.219 -0.926 . . . . 0.0 109.684 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.514 ' O ' ' CB ' ' A' ' 56' ' ' VAL . 47.1 Cg_endo -75.48 53.73 3.64 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 123.857 1.451 . . . . 0.0 109.912 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.514 ' CB ' ' O ' ' A' ' 55' ' ' PRO . 1.5 p 160.42 -26.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 60.19 72.96 0.5 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.569 -0.707 . . . . 0.0 109.933 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.549 ' CB ' ' HB3' ' A' ' 10' ' ' GLU . 29.7 p -84.6 7.98 18.31 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.108 -0.995 . . . . 0.0 109.198 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.56 ' O ' ' CD2' ' A' ' 60' ' ' HIS . 1.0 OUTLIER -75.87 155.62 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.348 -0.845 . . . . 0.0 110.505 -179.232 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.56 ' CD2' ' O ' ' A' ' 59' ' ' ILE . 39.7 m80 -155.52 125.36 6.51 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.57 ' CE2' ' HE2' ' A' ' 51' ' ' MET . 62.5 m95 -73.05 173.89 8.69 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.194 -0.941 . . . . 0.0 109.652 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.457 ' HB3' ' HB3' ' A' ' 3' ' ' LYS . 9.6 tp10 -145.1 106.25 4.18 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.327 -0.858 . . . . 0.0 109.333 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -118.97 99.29 6.64 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.379 -0.825 . . . . 0.0 109.301 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 . . . . . 0 N--CA 1.489 1.503 0 O-C-N 121.325 -0.86 . . . . 0.0 109.379 -179.99 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' SF4 . . . . . 1.119 ' S2 ' ' O ' ' A' ' 14' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -94.08 102.39 14.44 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.228 -0.92 . . . . 0.0 109.41 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.48 ' O ' ' HB3' ' A' ' 4' ' ' PHE . 0.2 OUTLIER -101.9 -154.9 0.5 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.181 -0.949 . . . . 0.0 109.441 -179.999 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.566 ' CE2' HG12 ' A' ' 36' ' ' VAL . 2.5 p90 177.9 -178.73 0.24 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.293 -0.879 . . . . 0.0 110.007 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.46 ' O ' HD12 ' A' ' 59' ' ' ILE . 20.3 p90 174.68 -167.0 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.647 ' CG2' ' CZ ' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -137.03 -166.36 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 C-N-CA 118.406 -1.318 . . . . 0.0 111.066 179.713 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.532 ' O ' ' N ' ' A' ' 9' ' ' ASP . 0.3 OUTLIER -151.65 98.98 2.55 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 114.413 -1.267 . . . . 0.0 108.056 177.784 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.57 ' CG ' ' HB3' ' A' ' 33' ' ' LYS . 2.9 mp0 -65.15 43.3 0.02 OUTLIER 'General case' 0 C--N 1.29 -2.001 0 CA-C-O 121.367 0.603 . . . . 0.0 110.392 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.532 ' N ' ' O ' ' A' ' 7' ' ' ASP . 0.5 OUTLIER -99.42 -29.68 12.62 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.265 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.455 ' HB2' ' SG ' ' A' ' 58' ' ' CYS . 0.0 OUTLIER -118.31 25.59 10.2 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.859 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.706 ' SG ' ' HG2' ' A' ' 33' ' ' LYS . 14.3 t -90.22 119.07 30.22 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.225 -0.922 . . . . 0.0 110.432 -179.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 12.2 pt -88.61 5.01 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 61.76 65.26 0.94 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.367 -0.833 . . . . 0.0 109.665 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.788 ' SG ' ' OG ' ' A' ' 16' ' ' SER . 31.7 p -102.22 -9.89 20.06 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.082 -1.011 . . . . 0.0 109.678 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.439 ' OE1' ' HG3' ' A' ' 19' ' ' GLU . 0.0 OUTLIER 70.7 4.29 4.93 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.24 -0.913 . . . . 0.0 109.84 179.591 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.792 ' OG ' ' S1 ' ' A' ' 65' ' ' SF4 . 29.6 p -62.15 -69.77 0.23 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.068 -1.02 . . . . 0.0 109.335 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.634 ' SG ' ' N ' ' A' ' 18' ' ' VAL . 19.4 p -49.33 -55.87 11.43 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.328 -0.857 . . . . 0.0 109.385 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.634 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 59.6 t -46.32 -33.14 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.199 -0.938 . . . . 0.0 109.012 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.439 ' HG3' ' OE1' ' A' ' 15' ' ' GLU . 5.3 mt-10 -71.05 -34.78 71.57 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.999 -1.063 . . . . 0.0 108.592 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.536 ' O ' ' CG2' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -81.16 6.05 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.252 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.422 ' HB3' ' O ' ' A' ' 20' ' ' ILE . . . 176.82 65.47 0.07 OUTLIER Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.274 -0.891 . . . . 0.0 109.009 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.54 ' N ' ' O ' ' A' ' 18' ' ' VAL . 46.0 Cg_endo -71.92 0.12 7.62 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.039 1.547 . . . . 0.0 110.783 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -96.3 -31.66 7.09 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.589 ' HA ' ' HB3' ' A' ' 38' ' ' ASP . . . -109.4 -53.65 2.63 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.333 -1.098 . . . . 0.0 109.99 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.647 ' CZ ' ' CG2' ' A' ' 6' ' ' VAL . 0.3 OUTLIER -75.22 139.43 42.59 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 118.561 -1.256 . . . . 0.0 107.689 179.727 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.574 ' O ' ' CD1' ' A' ' 35' ' ' TYR . . . -172.13 140.84 1.22 Allowed 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.263 -0.898 . . . . 0.0 109.561 -179.217 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.536 ' HA ' ' C ' ' A' ' 33' ' ' LYS . 5.1 mtp -71.55 158.35 36.39 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.292 -0.88 . . . . 0.0 109.94 -179.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.613 ' O ' ' N ' ' A' ' 32' ' ' GLU . 3.9 t0 -126.31 161.52 51.74 Favored Pre-proline 0 C--N 1.309 -1.154 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.457 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 44.3 Cg_endo -85.19 -16.13 5.15 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 O-C-N 124.691 1.89 . . . . 0.0 108.626 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -91.53 -29.7 16.83 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 178.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.566 ' CD1' ' HB3' ' A' ' 35' ' ' TYR . 1.0 OUTLIER -106.2 -5.25 10.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.25 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.613 ' N ' ' O ' ' A' ' 28' ' ' ASP . 6.9 mm-40 33.59 41.52 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 121.433 0.635 . . . . 0.0 109.303 -179.054 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.706 ' HG2' ' SG ' ' A' ' 11' ' ' CYS . 0.2 OUTLIER -169.74 146.3 3.22 Favored 'General case' 0 N--CA 1.501 2.109 0 C-N-CA 119.601 -0.839 . . . . 0.0 110.365 -179.176 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.54 ' O ' ' CG ' ' A' ' 8' ' ' GLN . . . -47.99 146.54 2.47 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.425 -0.797 . . . . 0.0 111.564 -178.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.676 ' CE2' ' CG ' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -135.83 -174.29 3.61 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.965 -1.085 . . . . 0.0 110.086 179.075 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.62 ' CG2' ' CG2' ' A' ' 6' ' ' VAL . 2.5 t -125.98 92.44 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.676 ' CG ' ' CE2' ' A' ' 35' ' ' TYR . 18.5 mmtt -103.87 -46.07 4.59 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 119.567 -0.853 . . . . 0.0 111.286 -178.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.589 ' HB3' ' HA ' ' A' ' 24' ' ' ALA . 62.8 t0 -93.59 118.24 31.11 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 119.207 -0.997 . . . . 0.0 110.564 -177.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.2 m -80.52 -17.11 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.338 -0.851 . . . . 0.0 109.268 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.424 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -103.01 2.39 34.87 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.355 -0.841 . . . . 0.0 109.558 -179.994 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.436 ' HA3' ' HB3' ' A' ' 24' ' ' ALA . . . -78.24 -7.64 87.71 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.674 -1.371 . . . . 0.0 109.674 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -149.08 127.84 12.51 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.229 -1.159 . . . . 0.0 109.566 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.421 ' OG ' ' OE2' ' A' ' 46' ' ' GLU . 0.1 OUTLIER -67.61 166.79 14.28 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.235 -0.916 . . . . 0.0 109.43 179.951 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.465 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -51.66 -45.28 63.32 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.412 -0.805 . . . . 0.0 109.438 179.979 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.414 ' O ' ' CG ' ' A' ' 49' ' ' GLU . 50.0 mm-40 -67.54 -8.4 33.63 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.362 -0.836 . . . . 0.0 109.646 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.421 ' OE2' ' OG ' ' A' ' 43' ' ' SER . 11.9 mt-10 -100.32 -43.88 6.11 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 179.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.444 ' O ' ' HB2' ' A' ' 51' ' ' MET . 1.9 t -60.49 -40.54 84.63 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 178.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.465 ' HB2' ' O ' ' A' ' 44' ' ' GLN . 0.2 OUTLIER -74.86 -48.43 25.0 Favored 'General case' 0 C--N 1.308 -1.227 0 O-C-N 121.527 -0.733 . . . . 0.0 109.198 179.293 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.507 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . 34.1 mt-10 -53.5 -54.01 43.26 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.189 -0.944 . . . . 0.0 109.096 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.402 ' HB1' ' CG2' ' A' ' 20' ' ' ILE . . . -63.83 -18.04 63.73 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.143 -0.973 . . . . 0.0 108.945 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.527 ' HG3' ' CG2' ' A' ' 59' ' ' ILE . 38.6 ttm -77.87 -18.31 56.37 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.416 -0.802 . . . . 0.0 109.208 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -105.35 -23.73 12.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.32 -0.863 . . . . 0.0 109.599 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.467 HG23 ' HB2' ' A' ' 16' ' ' SER . 0.3 OUTLIER -62.39 -48.02 81.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.23 -0.919 . . . . 0.0 109.768 -179.684 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.781 ' SG ' ' HD2' ' A' ' 55' ' ' PRO . 4.6 t -48.88 147.41 4.62 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.139 -0.975 . . . . 0.0 109.606 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.781 ' HD2' ' SG ' ' A' ' 54' ' ' CYS . 44.1 Cg_endo -73.91 -64.65 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.986 1.519 . . . . 0.0 110.509 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.421 ' O ' ' HB2' ' A' ' 57' ' ' GLN . 38.4 t -79.08 -25.02 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.115 -0.99 . . . . 0.0 109.098 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.426 ' CG ' ' O ' ' A' ' 51' ' ' MET . 0.0 OUTLIER 67.38 72.04 0.35 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.277 -0.889 . . . . 0.0 109.755 179.719 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.455 ' SG ' ' HB2' ' A' ' 10' ' ' GLU . 0.7 OUTLIER -89.87 21.89 3.4 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.188 -0.945 . . . . 0.0 109.155 179.571 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.534 ' CD1' ' N ' ' A' ' 60' ' ' HIS . 0.0 OUTLIER -108.65 140.69 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.341 -0.85 . . . . 0.0 109.564 -179.651 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.534 ' N ' ' CD1' ' A' ' 59' ' ' ILE . 2.7 m80 -142.48 -177.47 5.29 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.279 -0.888 . . . . 0.0 109.532 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.55 ' HA ' ' CB ' ' A' ' 4' ' ' PHE . 36.0 m95 -97.84 -179.25 4.36 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.014 -1.054 . . . . 0.0 109.697 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.2 tp10 -150.32 97.15 2.5 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.267 -0.896 . . . . 0.0 109.621 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.439 ' N ' ' OD1' ' A' ' 63' ' ' ASP . 29.7 p-10 -111.77 14.16 21.07 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.225 -0.922 . . . . 0.0 109.338 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 O-C-N 121.268 -0.895 . . . . 0.0 109.546 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' SF4 . . . . . 0.792 ' S1 ' ' OG ' ' A' ' 16' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.215 0.531 . . . . 0.0 109.647 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.73 108.38 13.45 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.295 -0.878 . . . . 0.0 109.533 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.503 ' O ' ' HB3' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -98.17 -155.8 0.51 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.262 -0.899 . . . . 0.0 109.313 -179.99 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.573 ' CE2' HG22 ' A' ' 36' ' ' VAL . 53.8 p90 173.06 -176.06 0.06 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.357 -0.839 . . . . 0.0 108.895 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.665 ' CZ ' ' CD2' ' A' ' 60' ' ' HIS . 51.6 p90 175.84 -173.28 0.08 Allowed 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 179.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.589 HG23 ' CZ ' ' A' ' 25' ' ' PHE . 2.9 t -145.57 166.37 10.0 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.428 0 C-N-CA 117.397 -1.721 . . . . 0.0 112.094 -179.194 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.441 ' C ' ' H ' ' A' ' 9' ' ' ASP . 8.5 t0 -105.22 74.56 1.11 Allowed 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.537 ' O ' ' CD ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -53.72 -11.51 0.39 Allowed 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.362 179.576 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.441 ' H ' ' C ' ' A' ' 7' ' ' ASP . 0.1 OUTLIER -65.61 -32.8 74.57 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.634 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.542 ' HB3' ' CB ' ' A' ' 58' ' ' CYS . 0.1 OUTLIER -91.16 -16.3 27.97 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.09 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.4 ' C ' ' O ' ' A' ' 10' ' ' GLU . 7.2 t -43.46 128.41 4.97 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.432 -0.793 . . . . 0.0 110.075 -179.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.753 HG12 ' S3 ' ' A' ' 65' ' ' SF4 . 4.5 pt -79.25 -134.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.444 -0.785 . . . . 0.0 109.066 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -119.67 43.55 2.61 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.762 -1.211 . . . . 0.0 110.017 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 1.012 ' SG ' ' OG ' ' A' ' 16' ' ' SER . 0.1 OUTLIER -124.91 156.83 37.33 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.075 -1.016 . . . . 0.0 109.594 179.557 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.437 ' O ' ' C ' ' A' ' 16' ' ' SER . 14.3 mt-10 -117.26 17.75 14.64 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.299 -0.876 . . . . 0.0 109.685 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 1.012 ' OG ' ' SG ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -44.42 -70.57 0.1 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.245 -0.909 . . . . 0.0 108.996 179.722 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.645 ' SG ' ' N ' ' A' ' 18' ' ' VAL . 8.3 p -44.17 -51.51 8.06 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.262 -0.898 . . . . 0.0 109.325 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.645 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 41.5 t -50.15 -33.31 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.362 -0.836 . . . . 0.0 109.61 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -84.74 -30.93 24.31 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.129 -0.982 . . . . 0.0 109.414 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.574 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 2.7 mp -81.76 9.12 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.206 -0.934 . . . . 0.0 108.646 178.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.481 ' HB3' ' CB ' ' A' ' 42' ' ' ALA . . . -169.86 69.41 0.62 Allowed Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.17 -0.956 . . . . 0.0 109.309 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -71.72 76.83 1.9 Allowed 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 124.206 1.635 . . . . 0.0 110.181 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.441 ' C ' ' HA3' ' A' ' 41' ' ' GLY . . . 165.02 -42.55 0.29 Allowed Glycine 0 N--CA 1.488 2.117 0 N-CA-C 108.672 -1.771 . . . . 0.0 108.672 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' A' ' 38' ' ' ASP . . . -92.99 -49.3 6.09 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.415 -1.05 . . . . 0.0 109.046 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.589 ' CZ ' HG23 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -96.06 137.84 34.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.269 -0.894 . . . . 0.0 108.818 179.582 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.45 ' HA ' HG12 ' A' ' 18' ' ' VAL . . . -174.77 126.66 0.3 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.025 -1.047 . . . . 0.0 109.609 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.572 ' HA ' ' C ' ' A' ' 33' ' ' LYS . 29.3 mtp -58.56 150.86 21.85 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.315 -0.865 . . . . 0.0 109.365 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.615 ' O ' ' N ' ' A' ' 32' ' ' GLU . 1.6 t0 -130.26 163.99 44.03 Favored Pre-proline 0 C--N 1.311 -1.085 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.455 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 43.9 Cg_endo -83.29 -16.44 7.1 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 124.803 1.949 . . . . 0.0 107.571 179.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -82.84 -42.38 17.9 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 177.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.554 HG12 ' CB ' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -102.14 0.26 10.26 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 178.098 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.615 ' N ' ' O ' ' A' ' 28' ' ' ASP . 2.9 mm-40 35.33 34.55 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -179.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.572 ' C ' ' HA ' ' A' ' 27' ' ' MET . 59.4 mttp -163.55 151.16 12.83 Favored 'General case' 0 N--CA 1.499 2.0 0 C-N-CA 119.556 -0.858 . . . . 0.0 110.183 -177.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.53 ' O ' ' CB ' ' A' ' 8' ' ' GLN . . . -59.18 139.97 56.38 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.444 -0.785 . . . . 0.0 110.206 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.643 ' CE2' ' HA ' ' A' ' 37' ' ' LYS . 1.5 p90 -154.06 155.89 36.31 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.573 HG22 ' CE2' ' A' ' 4' ' ' PHE . 14.9 p -67.01 67.19 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 120.905 -1.122 . . . . 0.0 108.933 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.643 ' HA ' ' CE2' ' A' ' 35' ' ' TYR . 0.1 OUTLIER -51.01 -19.05 0.92 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.533 -0.729 . . . . 0.0 110.391 -179.664 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.486 ' N ' ' HG3' ' A' ' 37' ' ' LYS . 11.5 t70 -167.21 103.42 0.53 Allowed 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.996 -1.065 . . . . 0.0 109.674 -179.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.534 ' HB ' ' CE1' ' A' ' 4' ' ' PHE . 1.8 m -55.39 -24.39 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.378 -0.826 . . . . 0.0 109.835 -179.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.501 ' N ' HG21 ' A' ' 39' ' ' VAL . 63.6 mm-40 -90.89 -0.6 57.77 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.168 -0.958 . . . . 0.0 109.601 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.45 ' N ' ' OD2' ' A' ' 38' ' ' ASP . . . -76.36 -16.05 81.02 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.481 ' CB ' ' HB3' ' A' ' 21' ' ' ALA . . . -141.92 161.74 37.21 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.192 -1.181 . . . . 0.0 109.333 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.07 173.89 9.56 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.263 -0.898 . . . . 0.0 109.571 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.46 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 1.0 OUTLIER -70.09 -38.56 75.7 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.363 -0.836 . . . . 0.0 109.233 179.895 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 36.0 mm-40 -66.91 -21.87 65.97 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.143 -0.973 . . . . 0.0 108.875 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -90.2 -43.1 10.65 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 178.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 4.0 t -58.25 -38.11 66.77 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 178.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.46 ' HB2' ' O ' ' A' ' 44' ' ' GLN . 0.1 OUTLIER -70.22 -65.93 0.66 Allowed 'General case' 0 C--N 1.308 -1.229 0 O-C-N 121.562 -0.712 . . . . 0.0 109.584 179.715 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.43 ' C ' HG22 ' A' ' 20' ' ' ILE . 16.1 mt-10 -47.5 -42.45 23.0 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.259 -0.9 . . . . 0.0 109.052 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.574 ' N ' ' CG2' ' A' ' 20' ' ' ILE . . . -68.59 -27.08 65.73 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.356 -0.84 . . . . 0.0 109.024 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.517 ' HG3' ' CG2' ' A' ' 59' ' ' ILE . 6.6 ttm -83.92 -17.63 40.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.482 -0.761 . . . . 0.0 109.904 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -95.02 -10.36 31.11 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.048 -1.032 . . . . 0.0 109.795 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.527 ' CG2' HD12 ' A' ' 20' ' ' ILE . 12.0 p -91.08 8.05 37.42 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.242 -0.911 . . . . 0.0 109.642 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.513 ' SG ' ' HD2' ' A' ' 55' ' ' PRO . 8.7 t -95.35 140.74 22.51 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.22 -0.925 . . . . 0.0 109.399 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.513 ' HD2' ' SG ' ' A' ' 54' ' ' CYS . 46.1 Cg_endo -75.16 -58.18 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.942 1.496 . . . . 0.0 109.931 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.503 ' O ' ' CB ' ' A' ' 57' ' ' GLN . 7.6 p -84.63 -23.19 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.319 -0.863 . . . . 0.0 108.898 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.503 ' CB ' ' O ' ' A' ' 56' ' ' VAL . 1.9 tt0 77.71 -66.44 0.22 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.495 -0.753 . . . . 0.0 110.459 179.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.542 ' CB ' ' HB3' ' A' ' 10' ' ' GLU . 2.5 p 43.57 26.41 0.11 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.225 -0.922 . . . . 0.0 109.156 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.533 ' HA ' HG11 ' A' ' 6' ' ' VAL . 9.4 tt -125.77 164.1 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.466 -0.771 . . . . 0.0 110.304 -178.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.665 ' CD2' ' CZ ' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -172.64 173.61 3.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.337 -0.852 . . . . 0.0 109.245 179.987 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.543 ' HA ' ' CB ' ' A' ' 4' ' ' PHE . 50.9 m95 -98.66 164.3 12.29 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.152 -0.968 . . . . 0.0 109.767 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.473 ' N ' ' HA ' ' A' ' 4' ' ' PHE . 20.6 tt0 -121.87 107.25 12.06 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.362 -0.836 . . . . 0.0 109.469 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -110.51 110.87 21.78 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.282 -0.886 . . . . 0.0 109.56 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 . . . . . 0 N--CA 1.491 1.582 0 O-C-N 121.298 -0.876 . . . . 0.0 109.47 179.941 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' SF4 . . . . . 0.914 ' S2 ' ' O ' ' A' ' 14' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.64 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.1 tpp180 -148.0 105.5 3.67 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.21 -0.931 . . . . 0.0 109.652 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.501 ' HB3' ' HB3' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -86.35 -157.8 0.37 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.205 -0.935 . . . . 0.0 109.137 179.8 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.596 ' CE1' ' HA ' ' A' ' 39' ' ' VAL . 20.7 p90 179.2 -159.05 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.166 -0.959 . . . . 0.0 109.768 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.606 ' HA ' ' CG2' ' A' ' 36' ' ' VAL . 4.6 p90 168.04 -178.75 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 -179.448 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.657 ' CG2' ' CE1' ' A' ' 25' ' ' PHE . 1.6 t -121.64 145.07 28.82 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.251 0 C-N-CA 116.914 -1.914 . . . . 0.0 111.954 -179.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.495 ' O ' ' N ' ' A' ' 9' ' ' ASP . 0.2 OUTLIER -96.7 38.9 1.19 Allowed 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.718 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.515 ' HG3' ' CG2' ' A' ' 31' ' ' ILE . 0.0 OUTLIER -38.6 -27.94 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.125 0.488 . . . . 0.0 110.15 -179.689 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.495 ' N ' ' O ' ' A' ' 7' ' ' ASP . 4.8 t0 -46.62 -25.3 0.68 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.159 -0.963 . . . . 0.0 108.822 179.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.465 ' HB3' ' HB3' ' A' ' 58' ' ' CYS . 14.7 tt0 -108.04 -15.48 14.51 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.465 -0.772 . . . . 0.0 109.577 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.648 ' SG ' ' HG2' ' A' ' 33' ' ' LYS . 40.6 t -43.37 141.72 1.27 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.17 -0.956 . . . . 0.0 109.661 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.542 ' CG1' ' N ' ' A' ' 13' ' ' ALA . 8.0 pt -98.59 -47.49 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.242 -0.911 . . . . 0.0 109.826 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.542 ' N ' ' CG1' ' A' ' 12' ' ' ILE . . . 166.0 -34.9 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.059 -1.026 . . . . 0.0 110.157 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.956 ' O ' ' S2 ' ' A' ' 65' ' ' SF4 . 0.1 OUTLIER -47.61 159.86 0.14 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.085 -1.01 . . . . 0.0 109.614 -179.488 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -122.13 22.23 10.27 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.321 -0.862 . . . . 0.0 109.854 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -46.26 -58.33 3.77 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.218 -0.926 . . . . 0.0 109.039 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.944 ' SG ' ' HD2' ' A' ' 25' ' ' PHE . 19.8 p -52.17 -57.26 10.16 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.37 -0.831 . . . . 0.0 109.239 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.644 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 98.2 t -45.15 -28.14 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.277 -0.89 . . . . 0.0 109.164 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.97 -37.7 23.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.187 -0.946 . . . . 0.0 108.914 179.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.53 ' HB ' ' CB ' ' A' ' 50' ' ' ALA . 1.8 mt -88.33 18.06 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 177.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.427 ' HB3' ' O ' ' A' ' 20' ' ' ILE . . . 172.56 64.6 0.03 OUTLIER Pre-proline 0 N--CA 1.488 1.451 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -74.25 2.29 6.35 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 124.073 1.565 . . . . 0.0 110.62 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.464 ' O ' ' HB3' ' A' ' 37' ' ' LYS . . . -113.86 -22.7 5.25 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.534 ' O ' ' N ' ' A' ' 37' ' ' LYS . . . -110.66 -30.25 7.68 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.249 -1.147 . . . . 0.0 109.624 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.944 ' HD2' ' SG ' ' A' ' 17' ' ' CYS . 0.8 OUTLIER -114.62 129.84 56.72 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.21 -0.931 . . . . 0.0 108.564 179.762 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.526 ' O ' ' N ' ' A' ' 35' ' ' TYR . . . -158.76 146.83 18.13 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.874 -1.141 . . . . 0.0 110.36 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.528 ' HG2' ' N ' ' A' ' 28' ' ' ASP . 1.3 ttm -74.22 152.38 39.76 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.275 -0.891 . . . . 0.0 109.004 179.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.589 ' O ' ' N ' ' A' ' 32' ' ' GLU . 1.2 t0 -133.5 165.77 34.23 Favored Pre-proline 0 C--O 1.211 -0.948 0 O-C-N 120.197 -1.564 . . . . 0.0 108.071 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.473 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 44.8 Cg_endo -84.44 -16.56 5.75 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 124.507 1.793 . . . . 0.0 107.725 179.022 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.476 ' HB3' HD12 ' A' ' 31' ' ' ILE . 0.3 OUTLIER -85.18 -38.95 18.39 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 178.122 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.562 HG12 ' CB ' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -104.29 0.47 10.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 178.068 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.589 ' N ' ' O ' ' A' ' 28' ' ' ASP . 5.2 mt-10 34.97 35.91 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -179.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.648 ' HG2' ' SG ' ' A' ' 11' ' ' CYS . 0.1 OUTLIER -172.95 167.26 5.07 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 119.82 -0.752 . . . . 0.0 109.228 -178.367 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.496 ' O ' ' HB3' ' A' ' 8' ' ' GLN . . . -37.45 157.45 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.515 0.674 . . . . 0.0 110.318 -179.139 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.637 ' CZ ' ' HA ' ' A' ' 37' ' ' LYS . 0.2 OUTLIER -162.41 150.26 14.18 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 179.729 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.628 ' N ' HG22 ' A' ' 6' ' ' VAL . 4.3 t -64.76 88.04 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 120.963 -1.086 . . . . 0.0 109.907 -178.04 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.637 ' HA ' ' CZ ' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -55.56 -26.54 44.01 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.459 -0.776 . . . . 0.0 109.528 179.589 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 39' ' ' VAL . 9.9 t0 175.43 157.99 0.21 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.255 -0.903 . . . . 0.0 109.625 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.596 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 11.6 m -78.22 -21.98 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.321 -0.862 . . . . 0.0 110.111 -179.275 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -117.11 18.95 14.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.12 -0.987 . . . . 0.0 109.422 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.436 ' HA3' ' C ' ' A' ' 23' ' ' GLY . . . -67.7 -15.8 67.04 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 -179.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.449 ' HB1' ' HB1' ' A' ' 24' ' ' ALA . . . -148.93 153.72 38.4 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.035 -1.273 . . . . 0.0 109.692 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.471 ' OG ' ' HG3' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -77.12 156.6 31.55 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.349 -0.844 . . . . 0.0 109.944 -179.775 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.496 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -48.47 -48.41 37.83 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.402 -0.811 . . . . 0.0 109.151 179.768 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -57.63 -36.8 72.3 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.209 -0.932 . . . . 0.0 108.979 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.471 ' HG3' ' OG ' ' A' ' 43' ' ' SER . 14.4 mt-10 -73.06 -57.04 4.31 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.275 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.627 ' CG1' ' CH2' ' A' ' 61' ' ' TRP . 1.2 t -50.87 -32.15 11.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 179.226 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.496 ' HB2' ' O ' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -65.66 -72.89 0.14 Allowed 'General case' 0 C--N 1.309 -1.193 0 O-C-N 121.264 -0.898 . . . . 0.0 109.866 179.966 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.459 ' HB3' HG22 ' A' ' 20' ' ' ILE . 1.9 mm-40 -47.22 -39.67 14.63 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.273 -0.892 . . . . 0.0 109.233 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.53 ' CB ' ' HB ' ' A' ' 20' ' ' ILE . . . -61.03 -39.62 90.49 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.281 -0.887 . . . . 0.0 108.918 179.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.527 ' CE ' HG13 ' A' ' 59' ' ' ILE . 45.0 ttm -74.53 -29.8 61.52 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.443 -0.785 . . . . 0.0 109.169 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -60.99 -45.99 92.57 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.296 -0.877 . . . . 0.0 109.141 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.479 ' O ' ' HB3' ' A' ' 54' ' ' CYS . 65.9 p -68.25 -152.68 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.336 -0.852 . . . . 0.0 109.072 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.941 ' SG ' ' CA ' ' A' ' 57' ' ' GLN . 10.3 t 73.41 122.28 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.268 -0.895 . . . . 0.0 109.779 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -73.51 -44.08 0.58 Allowed 'Trans proline' 0 C--N 1.308 -1.562 0 O-C-N 123.863 1.454 . . . . 0.0 109.083 179.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.509 ' O ' ' CB ' ' A' ' 57' ' ' GLN . 1.9 m -96.37 -17.65 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.941 ' CA ' ' SG ' ' A' ' 54' ' ' CYS . 0.9 OUTLIER 81.34 -59.77 0.24 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.724 -0.61 . . . . 0.0 110.569 179.542 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.962 ' SG ' ' S4 ' ' A' ' 65' ' ' SF4 . 11.9 p 35.88 41.6 0.12 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.641 -0.662 . . . . 0.0 109.51 -179.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.554 ' CD1' ' N ' ' A' ' 60' ' ' HIS . 0.1 OUTLIER -148.56 137.44 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.501 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.588 ' HB2' ' CE1' ' A' ' 5' ' ' TYR . 31.0 m80 -155.7 163.56 39.74 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.708 -1.245 . . . . 0.0 110.469 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.627 ' CH2' ' CG1' ' A' ' 47' ' ' VAL . 72.2 m95 -87.63 -176.15 5.45 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.381 -0.824 . . . . 0.0 109.216 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.501 ' HB3' ' HB3' ' A' ' 3' ' ' LYS . 7.4 tt0 -150.72 99.8 2.77 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.332 -0.855 . . . . 0.0 109.208 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -90.31 -68.59 0.78 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.264 -0.897 . . . . 0.0 109.557 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.507 0 O-C-N 121.209 -0.932 . . . . 0.0 109.593 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' SF4 . . . . . 0.962 ' S4 ' ' SG ' ' A' ' 58' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 121.331 0.586 . . . . 0.0 109.488 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 67.13 96.46 0.06 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.251 -0.905 . . . . 0.0 109.515 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.467 ' O ' ' HB3' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -114.11 -156.41 0.6 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.32 -0.863 . . . . 0.0 109.524 179.946 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.54 ' C ' ' CD1' ' A' ' 4' ' ' PHE . 11.5 p90 176.81 174.49 0.39 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.282 -0.886 . . . . 0.0 109.864 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.543 ' HA ' ' CG1' ' A' ' 36' ' ' VAL . 1.3 p90 177.15 -171.6 0.09 Allowed 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 179.237 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.604 ' CG2' ' CG2' ' A' ' 36' ' ' VAL . 0.2 OUTLIER -135.44 177.18 7.01 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 C-N-CA 117.693 -1.603 . . . . 0.0 111.651 179.869 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.521 ' C ' ' H ' ' A' ' 9' ' ' ASP . 0.3 OUTLIER -129.35 92.45 3.36 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.786 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.567 ' CG ' ' O ' ' A' ' 34' ' ' ALA . 3.7 mp0 -65.36 45.2 0.02 OUTLIER 'General case' 0 C--N 1.291 -1.945 0 CA-C-O 121.617 0.722 . . . . 0.0 110.669 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.521 ' H ' ' C ' ' A' ' 7' ' ' ASP . 1.0 OUTLIER -110.93 -44.89 3.54 Favored 'General case' 0 C--N 1.285 -2.202 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.214 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -89.85 -7.35 54.48 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.664 ' SG ' ' HG2' ' A' ' 33' ' ' LYS . 39.6 t -62.95 144.2 57.02 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.453 -0.779 . . . . 0.0 110.195 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.7 pt -102.0 -113.16 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.293 -0.88 . . . . 0.0 108.798 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -135.27 26.61 3.5 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.778 -1.201 . . . . 0.0 109.043 179.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.892 ' O ' ' S2 ' ' A' ' 65' ' ' SF4 . 0.1 OUTLIER -102.1 149.6 24.11 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.28 -0.888 . . . . 0.0 109.905 -179.741 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.463 ' HB2' ' HB ' ' A' ' 18' ' ' VAL . 0.7 OUTLIER -109.13 20.03 18.81 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.468 -0.77 . . . . 0.0 109.645 -179.856 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 15' ' ' GLU . 56.7 m -43.86 -66.78 0.34 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.262 -0.898 . . . . 0.0 109.34 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.969 ' SG ' ' CD2' ' A' ' 25' ' ' PHE . 19.0 p -48.52 -46.49 38.62 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.323 -0.86 . . . . 0.0 109.328 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.475 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 59.0 t -50.24 -31.28 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.276 -0.89 . . . . 0.0 109.329 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -77.52 -34.56 53.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.244 -0.91 . . . . 0.0 109.395 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.523 ' HB ' ' CB ' ' A' ' 50' ' ' ALA . 2.5 mp -79.95 5.36 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 178.318 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -172.8 65.15 0.34 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.351 -0.843 . . . . 0.0 109.045 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.37 70.13 2.53 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 O-C-N 124.286 1.677 . . . . 0.0 110.266 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.471 ' O ' ' HB3' ' A' ' 38' ' ' ASP . . . 177.72 -43.51 0.09 OUTLIER Glycine 0 N--CA 1.488 2.105 0 N-CA-C 108.737 -1.745 . . . . 0.0 108.737 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.532 ' CB ' ' O ' ' A' ' 38' ' ' ASP . . . -93.17 -32.25 14.47 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.555 -0.968 . . . . 0.0 109.029 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.969 ' CD2' ' SG ' ' A' ' 17' ' ' CYS . 0.1 OUTLIER -105.58 141.73 36.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.333 -0.855 . . . . 0.0 108.878 179.905 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.49 ' O ' ' CD1' ' A' ' 35' ' ' TYR . . . -174.96 125.32 0.27 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.115 -0.991 . . . . 0.0 109.286 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.558 ' HA ' ' C ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -58.5 154.3 14.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.165 -0.96 . . . . 0.0 109.558 -179.769 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.604 ' O ' ' N ' ' A' ' 32' ' ' GLU . 0.7 OUTLIER -126.18 163.29 40.87 Favored Pre-proline 0 C--N 1.313 -1.005 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 179.295 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.428 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 47.7 Cg_endo -84.19 -16.67 5.98 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 125.055 2.081 . . . . 0.0 108.279 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -88.07 -35.78 17.32 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 178.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.589 ' CG1' ' CB ' ' A' ' 28' ' ' ASP . 1.3 pt -105.28 -1.32 9.94 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 177.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.604 ' N ' ' O ' ' A' ' 28' ' ' ASP . 0.5 OUTLIER 34.78 36.86 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -179.244 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.664 ' HG2' ' SG ' ' A' ' 11' ' ' CYS . 1.8 mtmt -162.27 148.44 13.13 Favored 'General case' 0 N--CA 1.501 2.083 0 C-N-CA 119.012 -1.075 . . . . 0.0 110.755 -178.187 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.977 ' HB1' ' S2 ' ' A' ' 65' ' ' SF4 . . . -52.76 146.09 11.09 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.548 -0.72 . . . . 0.0 110.201 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.613 ' O ' ' CD1' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -149.33 147.54 28.45 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-O 121.77 0.795 . . . . 0.0 109.51 179.219 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.604 ' CG2' ' CG2' ' A' ' 6' ' ' VAL . 1.3 t -88.84 96.09 5.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.097 -1.002 . . . . 0.0 108.34 -179.376 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.588 ' HG2' ' CE1' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -107.17 -28.12 10.15 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.418 -0.801 . . . . 0.0 110.966 -178.687 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.54 ' N ' ' HG3' ' A' ' 37' ' ' LYS . 22.1 t70 -122.21 78.8 1.53 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.799 -1.188 . . . . 0.0 110.16 -179.1 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.441 ' HB ' ' CZ ' ' A' ' 4' ' ' PHE . 27.2 m -45.25 -46.71 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.248 -0.908 . . . . 0.0 109.266 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.408 ' N ' ' CG2' ' A' ' 39' ' ' VAL . 6.5 mt-10 -58.51 -24.72 61.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.302 -0.874 . . . . 0.0 109.486 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 38' ' ' ASP . . . -54.08 -26.05 33.73 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.421 ' HB2' HG21 ' A' ' 47' ' ' VAL . . . -144.69 144.76 31.39 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.23 -1.159 . . . . 0.0 109.443 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.424 ' OG ' ' CD ' ' A' ' 46' ' ' GLU . 0.1 OUTLIER -67.95 169.14 10.45 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.177 -0.952 . . . . 0.0 109.504 179.988 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.479 ' O ' ' HG2' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -66.15 -47.72 73.11 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.49 -0.756 . . . . 0.0 109.247 179.802 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.68 ' HA ' ' HG2' ' A' ' 48' ' ' GLU . 5.8 mm-40 -61.4 -17.26 53.36 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.284 -0.885 . . . . 0.0 109.185 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.473 ' O ' HG23 ' A' ' 20' ' ' ILE . 76.9 mt-10 -91.92 -45.79 8.17 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 178.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.587 HG13 ' CH2' ' A' ' 61' ' ' TRP . 6.8 t -55.04 -38.24 45.34 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 178.014 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.68 ' HG2' ' HA ' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -68.14 -56.9 7.13 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.64 -0.663 . . . . 0.0 109.345 178.954 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.485 ' H ' ' HG3' ' A' ' 48' ' ' GLU . 0.3 OUTLIER -43.04 -48.14 6.02 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.167 -0.958 . . . . 0.0 109.085 179.883 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.523 ' CB ' ' HB ' ' A' ' 20' ' ' ILE . . . -60.41 -40.0 89.41 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.213 -0.929 . . . . 0.0 108.65 179.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.559 ' HE1' ' CZ3' ' A' ' 61' ' ' TRP . 21.2 ttm -58.7 -37.74 76.76 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.429 -0.794 . . . . 0.0 109.342 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -79.26 -8.07 58.76 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.282 -0.886 . . . . 0.0 109.244 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.502 ' CB ' HD12 ' A' ' 20' ' ' ILE . 0.3 OUTLIER -115.21 78.36 1.16 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.258 -0.901 . . . . 0.0 109.908 -179.897 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.798 ' SG ' ' HD2' ' A' ' 55' ' ' PRO . 44.2 t -151.08 148.18 22.16 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.284 -0.885 . . . . 0.0 108.914 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.798 ' HD2' ' SG ' ' A' ' 54' ' ' CYS . 44.1 Cg_endo -72.1 -37.09 5.04 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 123.863 1.454 . . . . 0.0 110.333 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.9 m -111.83 -29.59 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.27 -0.894 . . . . 0.0 109.232 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.618 ' N ' ' SG ' ' A' ' 54' ' ' CYS . 0.0 OUTLIER 66.57 76.65 0.3 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.305 -0.872 . . . . 0.0 109.722 179.763 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 22.5 p -112.3 17.24 19.59 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.279 -0.888 . . . . 0.0 109.12 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.534 ' CG2' ' HG3' ' A' ' 51' ' ' MET . 0.1 OUTLIER -104.09 129.69 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.332 -0.855 . . . . 0.0 109.51 -179.687 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.525 ' N ' HD12 ' A' ' 59' ' ' ILE . 1.8 m80 -136.99 160.42 38.96 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.181 -0.949 . . . . 0.0 109.393 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.587 ' CH2' HG13 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -68.13 -169.68 0.15 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.331 -0.856 . . . . 0.0 109.222 179.884 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.456 ' HB3' ' HB3' ' A' ' 3' ' ' LYS . 26.0 tt0 -159.57 120.37 3.14 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.287 -0.883 . . . . 0.0 109.318 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -66.38 -58.94 4.23 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.31 -0.869 . . . . 0.0 109.321 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 51.2 tt0 . . . . . 0 N--CA 1.489 1.49 0 O-C-N 121.307 -0.871 . . . . 0.0 109.457 179.956 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' SF4 . . . . . 0.977 ' S2 ' ' HB1' ' A' ' 34' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 6.5 ptt180 -69.82 166.2 19.88 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.276 -0.89 . . . . 0.0 109.312 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.505 ' O ' ' HB3' ' A' ' 4' ' ' PHE . 0.5 OUTLIER -103.04 -152.58 0.45 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.321 -0.862 . . . . 0.0 109.518 -179.865 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.518 ' HA ' ' HA ' ' A' ' 61' ' ' TRP . 39.3 p90 168.8 170.32 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.709 -0.619 . . . . 0.0 109.486 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.503 ' CE1' ' HB2' ' A' ' 62' ' ' GLU . 20.5 p90 176.75 -167.61 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 179.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.613 HG22 ' CZ ' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -136.52 -165.36 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 118.44 -1.304 . . . . 0.0 111.517 -179.57 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.537 ' C ' ' H ' ' A' ' 9' ' ' ASP . 1.5 m-20 -151.23 98.31 2.53 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 114.209 -1.36 . . . . 0.0 107.478 178.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.519 ' HG3' ' O ' ' A' ' 34' ' ' ALA . 5.7 mp0 -64.85 43.19 0.02 OUTLIER 'General case' 0 C--N 1.291 -1.939 0 CA-C-O 121.624 0.726 . . . . 0.0 110.664 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.537 ' H ' ' C ' ' A' ' 7' ' ' ASP . 0.2 OUTLIER -99.95 -24.52 14.61 Favored 'General case' 0 C--N 1.287 -2.116 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 179.438 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.432 ' HG2' ' HB ' ' A' ' 56' ' ' VAL . 0.6 OUTLIER -115.55 13.13 16.32 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.495 -0.753 . . . . 0.0 109.353 -179.977 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.453 ' HB3' ' HD3' ' A' ' 33' ' ' LYS . 41.9 t -84.23 129.67 34.87 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.155 -0.966 . . . . 0.0 109.7 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.514 ' O ' ' CB ' ' A' ' 13' ' ' ALA . 21.8 pt -102.24 -41.95 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.365 -0.834 . . . . 0.0 109.389 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.514 ' CB ' ' O ' ' A' ' 12' ' ' ILE . . . 163.85 -22.33 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.35 -0.844 . . . . 0.0 109.899 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 1.015 ' O ' ' S2 ' ' A' ' 65' ' ' SF4 . 0.1 OUTLIER -51.23 139.9 17.79 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.037 -1.04 . . . . 0.0 109.443 -179.75 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.47 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 4.0 mp0 -102.51 20.4 17.14 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.107 -0.996 . . . . 0.0 109.501 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.494 ' OG ' ' SG ' ' A' ' 14' ' ' CYS . 7.1 m -44.18 -65.48 0.51 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.25 -0.906 . . . . 0.0 109.063 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.608 ' SG ' ' N ' ' A' ' 18' ' ' VAL . 16.4 p -53.16 -52.16 59.67 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.42 -0.8 . . . . 0.0 109.026 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.608 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 38.5 t -48.32 -24.42 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.354 -0.841 . . . . 0.0 109.161 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -86.22 -33.47 20.73 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.299 -0.876 . . . . 0.0 109.004 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.531 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 2.7 mp -85.01 12.05 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.27 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.537 ' HB3' ' CB ' ' A' ' 42' ' ' ALA . . . 169.69 65.22 0.02 OUTLIER Pre-proline 0 N--CA 1.486 1.345 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -69.23 -4.85 14.49 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 O-C-N 124.143 1.602 . . . . 0.0 110.298 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.459 ' O ' ' HB3' ' A' ' 38' ' ' ASP . . . -100.44 -39.94 3.1 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.494 ' HA ' ' HB3' ' A' ' 38' ' ' ASP . . . -85.72 -33.76 21.41 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.321 -1.105 . . . . 0.0 109.299 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.613 ' CZ ' HG22 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -103.69 144.25 31.7 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.795 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.487 ' O ' ' CD1' ' A' ' 35' ' ' TYR . . . -170.84 126.48 0.71 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.991 -1.068 . . . . 0.0 109.793 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.531 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 3.7 ppp? -59.91 153.86 20.07 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.082 -1.011 . . . . 0.0 109.323 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.633 ' O ' ' N ' ' A' ' 32' ' ' GLU . 3.0 t0 -123.99 160.21 52.94 Favored Pre-proline 0 C--N 1.31 -1.135 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 179.217 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.432 ' CD ' ' OD1' ' A' ' 28' ' ' ASP . 47.2 Cg_endo -84.7 -16.48 5.49 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 124.973 2.039 . . . . 0.0 108.682 -179.28 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.35 -28.21 17.06 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 178.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.559 HG12 ' CB ' ' A' ' 28' ' ' ASP . 0.9 OUTLIER -108.83 -2.67 10.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 177.974 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.633 ' N ' ' O ' ' A' ' 28' ' ' ASP . 2.7 mm-40 31.33 38.56 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -179.006 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.544 ' CG ' ' O ' ' A' ' 32' ' ' GLU . 70.7 mttt -162.39 148.11 12.76 Favored 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 119.723 -0.791 . . . . 0.0 110.296 -178.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.553 ' HB2' ' CE1' ' A' ' 25' ' ' PHE . . . -56.79 147.57 22.83 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.468 -0.77 . . . . 0.0 110.863 -179.423 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.595 ' O ' ' CD1' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -152.44 153.36 33.4 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.576 -0.703 . . . . 0.0 109.316 178.806 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.602 HG21 ' CE2' ' A' ' 25' ' ' PHE . 36.5 t -92.62 103.54 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 120.926 -1.108 . . . . 0.0 109.095 -179.452 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.579 ' HB3' ' CE2' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -119.3 -23.48 6.71 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 119.469 -0.892 . . . . 0.0 110.616 -179.286 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.517 ' N ' ' HG3' ' A' ' 37' ' ' LYS . 45.1 t0 -112.31 98.45 7.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.997 -1.064 . . . . 0.0 109.821 -179.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.426 HG22 ' OE1' ' A' ' 40' ' ' GLU . 27.7 m -63.9 -29.21 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.139 -0.976 . . . . 0.0 109.578 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.426 ' OE1' HG22 ' A' ' 39' ' ' VAL . 0.7 OUTLIER -81.86 -14.26 56.49 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.228 -0.92 . . . . 0.0 109.53 -179.804 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.413 ' HA3' ' C ' ' A' ' 23' ' ' GLY . . . -67.08 -17.85 68.33 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.211 -1.556 . . . . 0.0 109.211 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.537 ' CB ' ' HB3' ' A' ' 21' ' ' ALA . . . -151.34 131.42 13.47 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.431 -1.041 . . . . 0.0 109.278 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.86 167.61 5.92 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.217 -0.927 . . . . 0.0 109.487 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -58.04 -49.01 78.36 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.506 -0.746 . . . . 0.0 109.409 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.692 ' HA ' ' HG2' ' A' ' 48' ' ' GLU . 1.0 OUTLIER -62.77 -14.72 48.33 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.182 -0.949 . . . . 0.0 108.943 179.908 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.433 ' OE1' ' HA ' ' A' ' 42' ' ' ALA . 43.0 mt-10 -90.52 -44.3 9.67 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 178.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.404 HG23 ' CE1' ' A' ' 4' ' ' PHE . 8.5 t -57.84 -38.71 67.37 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.343 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.692 ' HG2' ' HA ' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -68.77 -58.21 4.53 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.518 -0.739 . . . . 0.0 109.662 179.672 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.488 ' H ' ' HG3' ' A' ' 48' ' ' GLU . 29.0 tt0 -44.13 -53.58 6.32 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.013 -1.054 . . . . 0.0 108.819 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.531 ' N ' ' CG2' ' A' ' 20' ' ' ILE . . . -54.0 -42.3 68.91 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.057 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.509 ' HE3' ' CD1' ' A' ' 61' ' ' TRP . 30.3 ttm -61.05 -29.87 69.99 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.052 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -63.56 -32.59 74.09 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.517 ' CG2' HD12 ' A' ' 20' ' ' ILE . 76.4 p -77.52 -155.03 0.07 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.402 -0.811 . . . . 0.0 109.201 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.502 ' SG ' ' HD2' ' A' ' 55' ' ' PRO . 2.3 t 64.99 140.46 0.06 OUTLIER Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.11 -0.994 . . . . 0.0 109.391 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.502 ' HD2' ' SG ' ' A' ' 54' ' ' CYS . 42.1 Cg_endo -71.37 -86.89 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.006 1.529 . . . . 0.0 110.061 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.432 ' HB ' ' HG2' ' A' ' 10' ' ' GLU . 11.1 t -63.34 -12.68 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.179 -0.951 . . . . 0.0 108.935 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.488 ' HA ' ' HB3' ' A' ' 54' ' ' CYS . 0.0 OUTLIER 58.55 81.08 0.16 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.244 -0.91 . . . . 0.0 109.431 179.863 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.468 ' O ' HG11 ' A' ' 6' ' ' VAL . 28.0 p -86.64 16.14 4.98 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.2 -0.937 . . . . 0.0 109.399 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.475 ' HA ' HG11 ' A' ' 6' ' ' VAL . 7.9 tt -106.16 154.38 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.168 -0.957 . . . . 0.0 109.81 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.423 ' ND1' ' C ' ' A' ' 59' ' ' ILE . 0.2 OUTLIER -166.95 -174.62 2.75 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.49 -0.756 . . . . 0.0 108.986 179.981 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.518 ' HA ' ' HA ' ' A' ' 4' ' ' PHE . 47.1 m95 -104.54 155.16 19.06 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.041 -1.037 . . . . 0.0 109.704 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.503 ' HB2' ' CE1' ' A' ' 5' ' ' TYR . 6.4 tt0 -122.28 96.5 5.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.465 -0.772 . . . . 0.0 109.454 -179.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.57 84.49 1.14 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.161 -0.962 . . . . 0.0 109.409 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 . . . . . 0 N--CA 1.489 1.502 0 O-C-N 121.196 -0.94 . . . . 0.0 109.395 -179.998 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' SF4 . . . . . 1.015 ' S2 ' ' O ' ' A' ' 14' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.461 ' O ' ' HG3' ' A' ' 2' ' ' ARG . 9.6 ptt85 -51.27 120.7 5.27 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.224 -0.923 . . . . 0.0 109.45 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.537 ' HB3' ' HB3' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -122.81 -150.18 0.44 Allowed 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.145 -0.972 . . . . 0.0 109.446 -179.965 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.574 ' CB ' ' HA ' ' A' ' 61' ' ' TRP . 24.4 p90 168.54 -179.3 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.508 -0.745 . . . . 0.0 109.551 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.474 ' O ' HG13 ' A' ' 59' ' ' ILE . 30.0 p90 176.71 -175.95 0.13 Allowed 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 179.23 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.626 ' CG2' ' CZ ' ' A' ' 25' ' ' PHE . 0.2 OUTLIER -131.4 169.77 21.08 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.018 0 C-N-CA 117.389 -1.724 . . . . 0.0 111.413 -179.661 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.508 ' O ' ' N ' ' A' ' 9' ' ' ASP . 9.3 t0 -108.99 89.58 3.04 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 178.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.559 ' CG ' ' O ' ' A' ' 34' ' ' ALA . 8.4 mp0 -65.36 46.09 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.859 0 CA-C-O 121.578 0.704 . . . . 0.0 110.3 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.508 ' N ' ' O ' ' A' ' 7' ' ' ASP . 0.3 OUTLIER -113.32 -44.65 3.21 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.395 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.464 ' HB2' ' SG ' ' A' ' 58' ' ' CYS . 0.3 OUTLIER -91.45 17.62 8.33 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.087 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.428 ' HB3' ' HG2' ' A' ' 33' ' ' LYS . 37.4 t -83.26 111.95 19.43 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.359 -0.838 . . . . 0.0 110.373 -179.169 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.498 ' O ' ' CB ' ' A' ' 13' ' ' ALA . 30.6 pt -78.53 0.59 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.47 -0.768 . . . . 0.0 109.047 179.344 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.498 ' CB ' ' O ' ' A' ' 12' ' ' ILE . . . 78.81 50.58 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.452 -0.78 . . . . 0.0 110.294 179.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.839 ' SG ' ' OG ' ' A' ' 16' ' ' SER . 3.2 p -105.67 161.51 14.33 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.866 -1.146 . . . . 0.0 109.436 179.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.466 ' O ' ' HB2' ' A' ' 19' ' ' GLU . 63.3 mt-10 -87.88 18.38 4.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.277 -0.889 . . . . 0.0 109.832 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 1.09 ' OG ' ' S1 ' ' A' ' 65' ' ' SF4 . 52.4 p -60.73 -91.06 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.22 -0.925 . . . . 0.0 109.636 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.523 ' HB3' ' S1 ' ' A' ' 65' ' ' SF4 . 10.8 p -45.34 -47.77 13.3 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.22 -0.925 . . . . 0.0 110.034 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.523 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 78.6 t -53.03 -30.74 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.165 -0.96 . . . . 0.0 109.981 -179.503 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.466 ' HB2' ' O ' ' A' ' 15' ' ' GLU . 2.8 mm-40 -77.35 -41.97 38.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.932 -1.105 . . . . 0.0 109.603 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.562 ' HB ' ' CB ' ' A' ' 50' ' ' ALA . 1.6 mt -84.81 15.57 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.248 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 20' ' ' ILE . . . 170.54 63.14 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.452 -0.78 . . . . 0.0 109.281 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.487 ' N ' ' O ' ' A' ' 18' ' ' VAL . 45.9 Cg_endo -74.07 -18.56 21.12 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.08 1.569 . . . . 0.0 110.882 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -79.44 -41.48 13.28 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.484 ' HA ' ' HB3' ' A' ' 38' ' ' ASP . . . -87.32 -34.2 18.93 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.215 -1.168 . . . . 0.0 109.71 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.626 ' CZ ' ' CG2' ' A' ' 6' ' ' VAL . 0.1 OUTLIER -106.04 141.21 37.8 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.324 -0.86 . . . . 0.0 109.326 -179.716 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.49 ' O ' ' CD1' ' A' ' 35' ' ' TYR . . . -170.45 128.69 0.83 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.069 -1.019 . . . . 0.0 109.948 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.55 ' HA ' ' C ' ' A' ' 33' ' ' LYS . 2.7 ptm -62.65 153.98 30.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.917 -1.114 . . . . 0.0 109.222 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.574 ' O ' ' HA ' ' A' ' 32' ' ' GLU . 1.7 t0 -135.22 165.26 37.82 Favored Pre-proline 0 C--N 1.311 -1.085 0 O-C-N 120.663 -1.273 . . . . 0.0 107.572 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.469 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 43.4 Cg_endo -84.01 -17.1 5.95 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 O-C-N 124.528 1.804 . . . . 0.0 107.867 179.265 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.72 -38.96 19.07 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 177.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.551 HG12 ' CB ' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -104.13 3.07 10.58 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 177.885 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.574 ' HA ' ' O ' ' A' ' 28' ' ' ASP . 2.5 mm-40 31.62 39.33 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.795 0.807 . . . . 0.0 108.879 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.55 ' C ' ' HA ' ' A' ' 27' ' ' MET . 0.0 OUTLIER -173.7 153.55 2.27 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 119.191 -1.004 . . . . 0.0 110.131 -178.537 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.559 ' O ' ' CG ' ' A' ' 8' ' ' GLN . . . -52.52 149.32 5.95 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.475 -0.766 . . . . 0.0 109.66 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.617 ' O ' ' CD1' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -154.16 146.5 23.9 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.614 0.721 . . . . 0.0 109.267 179.266 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.598 ' CG2' ' CG2' ' A' ' 6' ' ' VAL . 2.1 t -87.44 99.75 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.103 -0.998 . . . . 0.0 108.49 -179.411 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.587 ' HG2' ' CE1' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -115.56 -27.11 7.24 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.23 -0.919 . . . . 0.0 111.057 -178.699 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.556 ' N ' ' HG3' ' A' ' 37' ' ' LYS . 39.5 t0 -113.21 92.46 4.01 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.897 -1.127 . . . . 0.0 110.026 -179.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.541 HG13 ' CZ ' ' A' ' 4' ' ' PHE . 25.5 m -61.16 -23.28 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.36 -0.837 . . . . 0.0 109.248 179.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.48 ' N ' HG21 ' A' ' 39' ' ' VAL . 3.1 mt-10 -93.13 1.39 57.19 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.418 -0.801 . . . . 0.0 109.561 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -87.2 -0.09 85.37 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.444 ' HA ' ' OE2' ' A' ' 46' ' ' GLU . . . -162.91 131.41 3.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.167 -1.196 . . . . 0.0 109.718 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.514 ' N ' ' HG2' ' A' ' 46' ' ' GLU . 0.1 OUTLIER -61.52 170.93 1.65 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.348 -0.845 . . . . 0.0 109.943 -179.823 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.468 ' HA ' ' HB ' ' A' ' 47' ' ' VAL . 6.0 tt0 -72.0 -41.05 68.04 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.572 -0.705 . . . . 0.0 109.743 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -67.22 -25.92 66.34 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.108 -0.995 . . . . 0.0 109.41 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.514 ' HG2' ' N ' ' A' ' 43' ' ' SER . 5.1 pt-20 -90.02 -35.29 15.59 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 178.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.468 ' HB ' ' HA ' ' A' ' 44' ' ' GLN . 4.0 t -64.37 -32.7 58.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 177.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.459 ' HB2' ' O ' ' A' ' 44' ' ' GLN . 0.5 OUTLIER -71.15 -59.35 2.82 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.131 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.494 ' CB ' HG23 ' A' ' 20' ' ' ILE . 0.4 OUTLIER -53.2 -39.22 63.52 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.113 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.562 ' CB ' ' HB ' ' A' ' 20' ' ' ILE . . . -71.59 -17.83 62.27 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.365 -0.834 . . . . 0.0 109.049 179.413 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.531 ' CG ' HG23 ' A' ' 59' ' ' ILE . 33.4 ttm -92.11 -17.84 24.41 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.483 -0.761 . . . . 0.0 109.939 -179.328 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -100.93 -17.15 16.93 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.054 -1.029 . . . . 0.0 109.784 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.485 ' CG2' ' CD1' ' A' ' 20' ' ' ILE . 9.6 t -72.58 -11.22 60.56 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.061 -1.025 . . . . 0.0 109.448 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 1.227 ' SG ' ' HD2' ' A' ' 55' ' ' PRO . 9.4 t -71.04 158.61 87.78 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.248 -0.907 . . . . 0.0 109.486 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 1.227 ' HD2' ' SG ' ' A' ' 54' ' ' CYS . 42.1 Cg_endo -72.79 -85.28 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.92 1.484 . . . . 0.0 109.929 179.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.462 ' CG1' ' HB3' ' A' ' 10' ' ' GLU . 4.2 p -68.41 -22.91 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.111 -0.993 . . . . 0.0 108.926 179.358 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.454 ' O ' ' N ' ' A' ' 59' ' ' ILE . 0.6 OUTLIER 69.34 46.63 0.75 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.474 -0.767 . . . . 0.0 109.635 179.741 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.464 ' SG ' ' HB2' ' A' ' 10' ' ' GLU . 0.1 OUTLIER -68.28 62.41 0.09 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.158 -0.964 . . . . 0.0 109.296 179.732 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.582 ' O ' ' CG ' ' A' ' 60' ' ' HIS . 12.0 tt -132.22 160.29 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.297 -0.877 . . . . 0.0 109.418 -179.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.582 ' CG ' ' O ' ' A' ' 59' ' ' ILE . 15.7 m80 -159.83 147.54 16.87 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.02 -1.05 . . . . 0.0 109.915 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.574 ' HA ' ' CB ' ' A' ' 4' ' ' PHE . 58.2 m95 -83.74 -175.38 5.78 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.321 -0.862 . . . . 0.0 108.861 179.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.537 ' HB3' ' HB3' ' A' ' 3' ' ' LYS . 0.5 OUTLIER -139.47 81.92 1.86 Allowed 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.089 -1.007 . . . . 0.0 109.586 -179.587 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.446 ' O ' ' CB ' ' A' ' 64' ' ' GLU . 11.0 t0 -92.7 90.02 6.9 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.379 -0.825 . . . . 0.0 109.285 179.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.446 ' CB ' ' O ' ' A' ' 63' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.244 -0.91 . . . . 0.0 109.48 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' SF4 . . . . . 1.09 ' S1 ' ' OG ' ' A' ' 16' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' A' ' 2' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 121.258 0.551 . . . . 0.0 109.537 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.46 ' HB2' ' O ' ' A' ' 1' ' ' ALA . 10.2 mtt180 64.37 82.14 0.19 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.31 -0.869 . . . . 0.0 109.648 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.426 ' HB3' ' HB3' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -103.3 -153.46 0.47 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.306 -0.871 . . . . 0.0 109.039 179.713 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.581 ' CE2' HG12 ' A' ' 36' ' ' VAL . 30.9 p90 -178.12 -178.83 0.68 Allowed 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.253 -0.905 . . . . 0.0 109.613 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.577 ' HA ' HG23 ' A' ' 36' ' ' VAL . 45.6 p90 -179.89 -178.15 0.42 Allowed 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 106.012 -1.848 . . . . 0.0 106.012 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.586 HG22 ' CZ ' ' A' ' 25' ' ' PHE . 2.6 t -142.41 160.95 19.41 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.32 0 C-N-CA 117.487 -1.685 . . . . 0.0 111.228 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.526 ' O ' ' N ' ' A' ' 9' ' ' ASP . 4.8 m-20 -114.52 79.26 1.24 Allowed 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.518 ' HB2' ' CB ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -42.07 -22.76 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.564 0.697 . . . . 0.0 109.285 179.359 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.526 ' N ' ' O ' ' A' ' 7' ' ' ASP . 0.5 OUTLIER -48.99 -42.58 38.3 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.545 -0.722 . . . . 0.0 109.332 -179.782 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.489 ' CG ' ' SG ' ' A' ' 58' ' ' CYS . 7.8 tp10 -84.1 -14.53 50.14 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.308 -0.87 . . . . 0.0 109.179 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 42.8 t -56.68 139.79 49.26 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.243 -0.91 . . . . 0.0 109.492 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.586 ' O ' ' CB ' ' A' ' 13' ' ' ALA . 1.6 pp -101.35 -33.69 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.219 -0.925 . . . . 0.0 109.783 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.586 ' CB ' ' O ' ' A' ' 12' ' ' ILE . . . 155.99 -40.5 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.543 -0.723 . . . . 0.0 109.769 179.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 1.154 ' O ' ' S2 ' ' A' ' 65' ' ' SF4 . 0.1 OUTLIER -43.84 153.2 0.13 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.146 -0.971 . . . . 0.0 109.735 -179.39 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.427 ' O ' ' C ' ' A' ' 16' ' ' SER . 3.5 pt-20 -117.49 21.88 12.76 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.277 -0.889 . . . . 0.0 109.559 -179.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.427 ' C ' ' O ' ' A' ' 15' ' ' GLU . 0.1 OUTLIER -44.43 -55.19 5.23 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.148 -0.97 . . . . 0.0 109.18 179.856 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.49 ' SG ' ' CD1' ' A' ' 25' ' ' PHE . 21.5 p -54.46 -45.31 73.1 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.376 -0.827 . . . . 0.0 109.3 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.461 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 4.8 t -52.26 -26.48 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.34 -0.85 . . . . 0.0 109.466 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -89.82 -32.08 17.08 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.166 -0.959 . . . . 0.0 109.541 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.512 HG22 ' N ' ' A' ' 50' ' ' ALA . 2.7 mp -84.65 11.8 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.473 ' CB ' ' HB3' ' A' ' 42' ' ' ALA . . . -168.58 66.28 0.67 Allowed Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.357 -0.84 . . . . 0.0 109.293 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -71.74 83.28 1.12 Allowed 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 123.981 1.516 . . . . 0.0 110.287 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 147.57 -21.01 1.5 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.546 ' CB ' ' O ' ' A' ' 38' ' ' ASP . . . -113.01 -30.68 6.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.314 -1.109 . . . . 0.0 109.102 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.586 ' CZ ' HG22 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -112.86 140.57 47.54 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.439 -0.788 . . . . 0.0 109.408 -179.972 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.458 ' O ' ' HA ' ' A' ' 34' ' ' ALA . . . -171.59 149.65 2.65 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.511 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 0.2 OUTLIER -82.76 156.51 23.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.874 -1.141 . . . . 0.0 108.652 -179.979 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.622 ' O ' ' N ' ' A' ' 32' ' ' GLU . 1.7 t0 -121.13 160.95 43.16 Favored Pre-proline 0 C--N 1.31 -1.148 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 179.26 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.437 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 48.1 Cg_endo -83.42 -15.97 7.24 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 125.051 2.08 . . . . 0.0 108.157 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -88.56 -35.35 16.96 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 178.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.591 ' CG1' ' CB ' ' A' ' 28' ' ' ASP . 3.8 pt -106.86 0.48 10.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.622 ' N ' ' O ' ' A' ' 28' ' ' ASP . 51.6 mt-10 32.18 38.34 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -179.247 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.535 ' N ' ' O ' ' A' ' 31' ' ' ILE . 83.1 mttt -157.83 146.87 19.55 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 119.262 -0.975 . . . . 0.0 110.93 -177.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.512 ' O ' ' HB3' ' A' ' 8' ' ' GLN . . . -53.31 143.91 17.55 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.737 -0.602 . . . . 0.0 110.634 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.693 ' CE2' ' HA ' ' A' ' 37' ' ' LYS . 6.9 p90 -149.37 169.19 21.4 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.581 HG12 ' CE2' ' A' ' 4' ' ' PHE . 0.2 OUTLIER -86.59 85.09 2.35 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.084 0 CA-C-O 121.624 0.726 . . . . 0.0 109.433 -178.26 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.693 ' HA ' ' CE2' ' A' ' 35' ' ' TYR . 13.4 ptmt -68.89 -10.39 56.79 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.558 -0.714 . . . . 0.0 110.511 -179.344 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.546 ' O ' ' CB ' ' A' ' 24' ' ' ALA . 11.7 t0 178.55 141.07 0.1 Allowed 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 118.611 -1.235 . . . . 0.0 110.424 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.1 m -84.38 -33.54 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.289 -0.882 . . . . 0.0 109.351 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -71.78 -16.08 62.18 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.247 -0.908 . . . . 0.0 109.21 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -69.39 -26.85 74.18 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.473 ' HB3' ' CB ' ' A' ' 21' ' ' ALA . . . -130.7 144.74 51.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.294 -1.121 . . . . 0.0 109.252 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.452 ' OG ' ' HG3' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -89.11 158.24 18.02 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.199 -0.938 . . . . 0.0 109.996 -179.613 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.525 ' HG2' ' N ' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -53.03 -23.06 6.69 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.45 -0.781 . . . . 0.0 109.147 179.811 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.525 ' N ' ' HG2' ' A' ' 44' ' ' GLN . 53.8 mm-40 -85.06 -23.1 28.72 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.4 -0.813 . . . . 0.0 108.837 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.454 ' O ' HG23 ' A' ' 20' ' ' ILE . 48.5 mt-10 -88.5 -55.8 3.57 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 106.263 -1.755 . . . . 0.0 106.263 178.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.505 HG23 ' CE2' ' A' ' 4' ' ' PHE . 2.9 t -48.06 -29.35 2.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 177.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.523 ' HB2' ' O ' ' A' ' 44' ' ' GLN . 0.3 OUTLIER -70.25 -69.27 0.37 Allowed 'General case' 0 C--N 1.311 -1.083 0 O-C-N 121.565 -0.709 . . . . 0.0 109.41 179.161 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -46.15 -46.72 17.44 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.381 -0.825 . . . . 0.0 109.11 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.512 ' N ' HG22 ' A' ' 20' ' ' ILE . . . -55.02 -32.49 61.88 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.289 -0.882 . . . . 0.0 109.088 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.537 ' HG3' ' CG2' ' A' ' 59' ' ' ILE . 34.9 ttm -66.7 -60.2 2.91 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.414 -0.803 . . . . 0.0 109.426 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -46.69 -28.19 1.42 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.223 -0.923 . . . . 0.0 109.689 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.432 ' O ' ' HB2' ' A' ' 54' ' ' CYS . 0.2 OUTLIER -102.08 99.9 10.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.176 -0.953 . . . . 0.0 109.827 -179.763 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.812 ' SG ' ' HD2' ' A' ' 55' ' ' PRO . 53.2 t 176.64 146.43 0.27 Allowed Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.214 -0.929 . . . . 0.0 109.868 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.812 ' HD2' ' SG ' ' A' ' 54' ' ' CYS . 45.1 Cg_endo -75.14 104.04 1.84 Allowed 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 124.061 1.558 . . . . 0.0 109.279 179.178 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.527 ' CB ' ' O ' ' A' ' 55' ' ' PRO . 3.7 t 77.71 3.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.441 -0.787 . . . . 0.0 109.003 -178.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.483 ' HA ' ' HB3' ' A' ' 54' ' ' CYS . 15.5 mt-30 44.72 82.65 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.284 -0.885 . . . . 0.0 109.413 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.538 ' O ' ' CE1' ' A' ' 60' ' ' HIS . 2.3 m -79.93 -12.54 59.72 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.242 -0.911 . . . . 0.0 109.224 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.537 ' CG2' ' HG3' ' A' ' 51' ' ' MET . 16.4 tt -83.77 144.19 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.383 -0.823 . . . . 0.0 110.145 -179.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.538 ' CE1' ' O ' ' A' ' 58' ' ' CYS . 14.0 m80 -144.37 172.43 12.94 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.365 -0.834 . . . . 0.0 108.902 179.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.524 ' HA ' ' CB ' ' A' ' 4' ' ' PHE . 68.4 m95 -94.69 179.55 5.22 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.029 -1.045 . . . . 0.0 110.037 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.426 ' HB3' ' HB3' ' A' ' 3' ' ' LYS . 13.6 tt0 -155.97 94.36 1.53 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.42 -0.8 . . . . 0.0 109.261 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.88 107.08 0.78 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.189 -0.944 . . . . 0.0 109.413 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 . . . . . 0 N--CA 1.492 1.639 0 O-C-N 121.323 -0.861 . . . . 0.0 109.574 -179.913 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' SF4 . . . . . 1.154 ' S2 ' ' O ' ' A' ' 14' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.271 0.558 . . . . 0.0 109.586 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.2 ttp180 46.56 75.11 0.13 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.187 -0.945 . . . . 0.0 109.715 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.482 ' HB3' ' HB3' ' A' ' 62' ' ' GLU . 1.2 ttmt -80.22 -152.88 0.08 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.216 -0.928 . . . . 0.0 109.188 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.557 ' HA ' ' N ' ' A' ' 62' ' ' GLU . 51.2 p90 175.55 175.69 0.24 Allowed 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.399 -0.813 . . . . 0.0 110.082 179.606 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.527 ' O ' ' CD1' ' A' ' 59' ' ' ILE . 41.0 p90 179.7 -176.34 0.31 Allowed 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.668 ' CG2' ' CZ ' ' A' ' 25' ' ' PHE . 0.2 OUTLIER -135.48 171.95 16.59 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 C-N-CA 117.816 -1.553 . . . . 0.0 110.94 -179.859 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.516 ' C ' ' H ' ' A' ' 9' ' ' ASP . 2.5 t0 -117.98 92.56 3.86 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.555 ' CG ' ' O ' ' A' ' 34' ' ' ALA . 4.0 mp0 -62.89 42.37 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.93 0 CA-C-O 121.399 0.619 . . . . 0.0 111.039 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.516 ' H ' ' C ' ' A' ' 7' ' ' ASP . 0.4 OUTLIER -104.13 -31.68 9.53 Favored 'General case' 0 C--N 1.287 -2.11 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.432 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.432 ' HB2' ' SG ' ' A' ' 58' ' ' CYS . 0.6 OUTLIER -111.42 22.06 15.53 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.632 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 14.4 t -83.76 126.04 32.51 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.292 -0.88 . . . . 0.0 109.988 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.536 ' O ' ' CB ' ' A' ' 13' ' ' ALA . 23.1 pt -86.21 1.31 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.363 -0.836 . . . . 0.0 109.431 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.536 ' CB ' ' O ' ' A' ' 12' ' ' ILE . . . 78.49 32.59 0.32 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.333 -0.854 . . . . 0.0 110.612 179.207 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.494 ' O ' ' S2 ' ' A' ' 65' ' ' SF4 . 1.6 p -88.86 151.52 22.3 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.905 -1.122 . . . . 0.0 109.076 179.216 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.431 ' O ' ' HB2' ' A' ' 19' ' ' GLU . 1.5 mt-10 -88.54 33.97 0.76 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.179 -0.951 . . . . 0.0 110.115 -179.336 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.908 ' OG ' ' S1 ' ' A' ' 65' ' ' SF4 . 75.5 p -75.83 -69.95 0.46 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.086 -1.009 . . . . 0.0 109.326 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.686 ' HB3' ' S1 ' ' A' ' 65' ' ' SF4 . 12.4 p -58.25 -46.55 85.77 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.226 -0.922 . . . . 0.0 109.519 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.533 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 68.7 t -52.69 -41.73 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.364 -0.835 . . . . 0.0 109.916 -179.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.431 ' HB2' ' O ' ' A' ' 15' ' ' GLU . 7.4 tm-20 -66.49 -42.7 87.01 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.099 -1.001 . . . . 0.0 109.662 -179.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.593 ' HB ' ' CB ' ' A' ' 50' ' ' ALA . 2.7 mp -82.06 11.76 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.294 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -176.18 68.67 0.25 Allowed Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.29 -0.881 . . . . 0.0 109.237 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -74.09 -0.32 9.4 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 124.076 1.566 . . . . 0.0 110.381 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.451 ' O ' ' HB3' ' A' ' 38' ' ' ASP . . . -112.98 -33.12 2.06 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.44 ' HA ' ' HB3' ' A' ' 38' ' ' ASP . . . -90.1 -46.46 8.46 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.147 -1.208 . . . . 0.0 109.449 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.668 ' CZ ' ' CG2' ' A' ' 6' ' ' VAL . 0.1 OUTLIER -99.26 146.97 25.65 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.273 -0.892 . . . . 0.0 108.901 179.829 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.469 ' O ' ' CD1' ' A' ' 35' ' ' TYR . . . -169.86 125.02 0.8 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.105 -0.997 . . . . 0.0 109.946 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.537 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 6.3 ttp -58.43 152.87 16.94 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.174 -0.954 . . . . 0.0 109.289 179.557 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.637 ' O ' ' N ' ' A' ' 32' ' ' GLU . 0.6 OUTLIER -128.21 163.56 43.25 Favored Pre-proline 0 C--N 1.311 -1.092 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 179.181 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -85.43 -15.62 5.15 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 O-C-N 125.148 2.131 . . . . 0.0 108.513 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -92.41 -29.34 16.34 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 178.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.546 HG12 ' HB3' ' A' ' 28' ' ' ASP . 0.2 OUTLIER -103.31 -15.66 7.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 177.557 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.637 ' N ' ' O ' ' A' ' 28' ' ' ASP . 14.1 mt-10 44.08 31.7 0.56 Allowed 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 -177.111 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.519 ' C ' ' HA ' ' A' ' 27' ' ' MET . 2.5 mttp -158.26 152.82 24.64 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 119.344 -0.942 . . . . 0.0 110.483 -177.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.962 ' HB1' ' S2 ' ' A' ' 65' ' ' SF4 . . . -59.66 148.97 31.89 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.487 -0.758 . . . . 0.0 109.768 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.632 ' O ' ' CD1' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -150.75 146.85 26.69 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.624 0.726 . . . . 0.0 109.519 179.296 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.607 ' CG2' ' CG2' ' A' ' 6' ' ' VAL . 2.4 t -89.57 97.82 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.077 -1.014 . . . . 0.0 108.448 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.619 ' HB3' ' CE2' ' A' ' 35' ' ' TYR . 1.3 pttp -108.08 -23.71 11.87 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.337 -0.852 . . . . 0.0 110.296 -179.26 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.519 ' N ' ' HG3' ' A' ' 37' ' ' LYS . 55.2 t0 -118.36 124.54 47.98 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.125 -0.984 . . . . 0.0 109.884 -179.334 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.488 HG21 ' N ' ' A' ' 40' ' ' GLU . 15.5 m -86.22 -34.53 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.272 -0.892 . . . . 0.0 109.451 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.488 ' N ' HG21 ' A' ' 39' ' ' VAL . 8.1 pm0 -81.9 -10.31 59.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.198 -0.938 . . . . 0.0 109.519 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -63.54 -18.55 61.41 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -151.93 132.28 13.72 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.248 -1.148 . . . . 0.0 109.521 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.45 155.09 19.05 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.26 -0.9 . . . . 0.0 109.727 -179.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.463 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 4.2 pt20 -49.46 -44.94 46.17 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.479 -0.763 . . . . 0.0 109.565 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.415 ' O ' ' HG3' ' A' ' 49' ' ' GLU . 7.6 mm-40 -64.12 -17.96 63.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.215 -0.928 . . . . 0.0 109.019 179.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -90.73 -46.99 7.91 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 179.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.52 ' CG1' ' HE3' ' A' ' 51' ' ' MET . 2.3 t -57.85 -38.6 66.81 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.438 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.463 ' HB2' ' O ' ' A' ' 44' ' ' GLN . 0.1 OUTLIER -68.19 -60.99 2.06 Favored 'General case' 0 C--N 1.307 -1.257 0 O-C-N 121.534 -0.729 . . . . 0.0 109.629 179.721 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.415 ' HG3' ' O ' ' A' ' 45' ' ' GLU . 2.3 mt-10 -51.5 -40.67 60.01 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.172 -0.955 . . . . 0.0 108.877 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.593 ' CB ' ' HB ' ' A' ' 20' ' ' ILE . . . -69.28 -20.91 63.91 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.521 -0.737 . . . . 0.0 109.024 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.52 ' HE3' ' CG1' ' A' ' 47' ' ' VAL . 0.7 OUTLIER -82.86 -51.03 8.0 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.522 -0.736 . . . . 0.0 109.522 -179.482 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -57.32 -32.11 66.36 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.308 -0.87 . . . . 0.0 109.444 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.495 ' CG2' HD12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -60.61 -32.05 71.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.341 -0.849 . . . . 0.0 109.804 -179.834 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.459 ' HB3' ' HA ' ' A' ' 57' ' ' GLN . 11.4 t -58.28 128.75 82.7 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.18 -0.95 . . . . 0.0 109.429 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -72.26 -53.94 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 123.931 1.49 . . . . 0.0 109.621 179.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 27.9 t -79.63 -15.18 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.459 ' HA ' ' HB3' ' A' ' 54' ' ' CYS . 0.5 OUTLIER 45.84 79.4 0.05 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.413 -0.804 . . . . 0.0 109.789 179.783 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.432 ' SG ' ' HB2' ' A' ' 10' ' ' GLU . 0.9 OUTLIER -92.58 15.86 13.35 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.354 -0.841 . . . . 0.0 109.043 179.517 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.527 ' CD1' ' O ' ' A' ' 5' ' ' TYR . 4.0 tp -64.33 159.21 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.34 -0.85 . . . . 0.0 109.448 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.519 ' O ' ' HB2' ' A' ' 61' ' ' TRP . 6.5 m80 -135.73 -32.05 0.92 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.227 -0.921 . . . . 0.0 110.358 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.552 ' HA ' ' HA ' ' A' ' 4' ' ' PHE . 55.7 m95 67.51 163.75 0.2 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.477 -0.764 . . . . 0.0 109.244 -179.025 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.557 ' N ' ' HA ' ' A' ' 4' ' ' PHE . 14.8 tt0 -142.8 95.72 2.82 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.35 -0.844 . . . . 0.0 109.342 -179.462 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -57.99 -42.5 85.3 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.298 -0.876 . . . . 0.0 109.361 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 . . . . . 0 N--CA 1.491 1.578 0 O-C-N 121.316 -0.865 . . . . 0.0 109.388 -179.937 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' SF4 . . . . . 0.962 ' S2 ' ' HB1' ' A' ' 34' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.212 0.53 . . . . 0.0 109.622 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 9.1 ttm180 -92.27 176.85 6.33 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.185 -0.947 . . . . 0.0 109.614 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.504 ' O ' ' HB3' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -140.85 -158.01 0.82 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.215 -0.928 . . . . 0.0 109.443 -179.98 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.505 ' HA ' ' HA ' ' A' ' 61' ' ' TRP . 33.6 p90 168.0 -175.56 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.469 -0.769 . . . . 0.0 109.323 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.48 ' HB3' ' O ' ' A' ' 4' ' ' PHE . 28.0 p90 167.6 -175.62 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 106.541 -1.652 . . . . 0.0 106.541 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.663 ' CG2' ' CZ ' ' A' ' 25' ' ' PHE . 0.6 OUTLIER -131.25 176.31 9.2 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.073 0 C-N-CA 117.467 -1.693 . . . . 0.0 110.952 -179.945 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.486 ' C ' ' H ' ' A' ' 9' ' ' ASP . 1.1 m-20 -127.1 90.52 3.16 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-O 121.845 0.831 . . . . 0.0 109.118 179.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.561 ' CG ' ' O ' ' A' ' 34' ' ' ALA . 1.5 mp0 -63.63 44.1 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.704 179.266 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.486 ' H ' ' C ' ' A' ' 7' ' ' ASP . 0.2 OUTLIER -99.93 -20.75 15.97 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 179.369 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.507 ' CG ' HG12 ' A' ' 56' ' ' VAL . 2.8 mm-40 -121.49 -7.49 9.18 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.663 -0.648 . . . . 0.0 109.468 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.652 ' SG ' ' HG2' ' A' ' 33' ' ' LYS . 45.0 t -54.1 112.41 0.96 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.19 -0.944 . . . . 0.0 109.692 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.531 ' O ' ' CB ' ' A' ' 13' ' ' ALA . 13.8 pt -73.65 -47.61 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.241 -0.912 . . . . 0.0 109.601 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.531 ' CB ' ' O ' ' A' ' 12' ' ' ILE . . . 164.77 -28.92 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.095 -1.003 . . . . 0.0 110.147 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 1.023 ' O ' ' S2 ' ' A' ' 65' ' ' SF4 . 0.1 OUTLIER -46.33 156.52 0.17 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.966 -1.084 . . . . 0.0 109.727 -179.534 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.421 ' O ' ' C ' ' A' ' 16' ' ' SER . 0.7 OUTLIER -120.02 20.45 12.12 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.406 -0.809 . . . . 0.0 109.858 -179.643 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.435 ' O ' ' CD1' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -43.89 -52.22 7.0 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.199 -0.938 . . . . 0.0 109.414 179.943 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.554 ' SG ' ' N ' ' A' ' 18' ' ' VAL . 19.8 p -59.34 -52.67 64.65 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.308 -0.87 . . . . 0.0 109.453 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.554 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 5.7 t -47.17 -34.92 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.128 -0.983 . . . . 0.0 109.414 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -73.53 -34.67 65.33 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.125 -0.984 . . . . 0.0 109.324 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.537 ' HB ' ' CB ' ' A' ' 50' ' ' ALA . 2.7 mp -84.9 10.96 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 178.313 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.434 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . . . -174.75 65.71 0.27 Allowed Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 121.377 -0.827 . . . . 0.0 109.2 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -71.81 56.15 2.33 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 O-C-N 124.171 1.616 . . . . 0.0 110.371 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.477 ' O ' ' HB3' ' A' ' 38' ' ' ASP . . . -167.47 -55.09 0.03 OUTLIER Glycine 0 N--CA 1.488 2.109 0 N-CA-C 108.543 -1.823 . . . . 0.0 108.543 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.526 ' CB ' ' O ' ' A' ' 38' ' ' ASP . . . -78.29 -38.87 41.46 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.439 -1.036 . . . . 0.0 109.112 179.402 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.663 ' CZ ' ' CG2' ' A' ' 6' ' ' VAL . 0.1 OUTLIER -97.14 134.23 40.74 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.136 -0.978 . . . . 0.0 108.88 179.693 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.502 ' O ' ' CD1' ' A' ' 35' ' ' TYR . . . -163.55 122.63 2.04 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.173 -0.954 . . . . 0.0 109.8 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.534 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 30.5 ttm -60.32 149.52 33.33 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.187 -0.946 . . . . 0.0 109.235 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.602 ' O ' ' N ' ' A' ' 32' ' ' GLU . 2.4 t0 -126.47 160.73 56.59 Favored Pre-proline 0 C--N 1.311 -1.073 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 179.533 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.452 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 43.9 Cg_endo -84.82 -17.12 5.06 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 O-C-N 124.765 1.929 . . . . 0.0 108.49 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -90.78 -30.45 17.01 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 178.009 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.55 HG12 ' CB ' ' A' ' 28' ' ' ASP . 0.8 OUTLIER -106.74 -0.18 9.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.092 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.602 ' N ' ' O ' ' A' ' 28' ' ' ASP . 8.2 mt-10 27.85 43.43 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.506 0.67 . . . . 0.0 109.983 -179.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.652 ' HG2' ' SG ' ' A' ' 11' ' ' CYS . 2.0 mttt -169.19 146.14 3.52 Favored 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 119.475 -0.89 . . . . 0.0 110.273 -179.31 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.616 ' HB1' ' S2 ' ' A' ' 65' ' ' SF4 . . . -58.01 140.87 51.48 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.436 -0.79 . . . . 0.0 109.183 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.619 ' O ' ' CD1' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -146.26 146.49 30.76 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-O 121.902 0.858 . . . . 0.0 110.084 179.742 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.596 ' CG2' ' CG2' ' A' ' 6' ' ' VAL . 2.7 t -85.67 100.82 9.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -179.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.583 ' HG2' ' CZ ' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -116.63 -34.26 4.59 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.456 -0.777 . . . . 0.0 110.103 -179.083 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.526 ' O ' ' CB ' ' A' ' 24' ' ' ALA . 17.0 t0 -104.58 85.56 2.35 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.217 -0.927 . . . . 0.0 109.801 -179.263 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 14.5 m -53.52 -29.21 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.293 -0.879 . . . . 0.0 109.288 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -73.02 -14.45 61.43 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.338 -0.851 . . . . 0.0 109.375 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.439 ' HA3' ' N ' ' A' ' 24' ' ' ALA . . . -71.88 -25.4 74.94 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.434 ' HB3' ' HB3' ' A' ' 21' ' ' ALA . . . -142.24 155.43 45.25 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.317 -1.107 . . . . 0.0 109.2 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -96.05 -166.73 1.47 Allowed 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.064 -1.022 . . . . 0.0 109.875 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.488 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 22.0 tt0 -72.66 -53.7 11.08 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.423 ' OE2' ' NE2' ' A' ' 44' ' ' GLN . 18.7 mm-40 -62.98 -19.63 64.51 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.397 -0.814 . . . . 0.0 109.252 179.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.445 ' O ' HG23 ' A' ' 20' ' ' ILE . 23.4 mt-10 -88.25 -45.85 9.72 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 178.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.3 t -62.94 -27.23 42.75 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 178.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.488 ' HB2' ' O ' ' A' ' 44' ' ' GLN . 0.2 OUTLIER -71.15 -66.1 0.66 Allowed 'General case' 0 C--N 1.309 -1.192 0 O-C-N 121.635 -0.666 . . . . 0.0 109.302 179.406 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.489 ' HB3' HG22 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -47.29 -49.0 24.7 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.367 -0.833 . . . . 0.0 109.022 179.703 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.537 ' CB ' ' HB ' ' A' ' 20' ' ' ILE . . . -57.44 -40.18 77.89 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.251 -0.905 . . . . 0.0 108.761 179.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.536 ' HG3' ' CG2' ' A' ' 59' ' ' ILE . 22.4 ttm -69.05 -14.15 62.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.413 -0.804 . . . . 0.0 109.186 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -99.77 -3.99 31.57 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.341 -0.849 . . . . 0.0 109.465 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.418 ' O ' ' HB3' ' A' ' 16' ' ' SER . 2.4 m -113.67 46.01 1.35 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.15 -0.969 . . . . 0.0 109.784 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.789 ' SG ' ' N ' ' A' ' 57' ' ' GLN . 53.6 t -123.05 143.1 39.88 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.225 -0.922 . . . . 0.0 109.142 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.607 ' HD2' ' SG ' ' A' ' 54' ' ' CYS . 44.1 Cg_endo -71.35 -35.33 8.51 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.936 1.493 . . . . 0.0 110.037 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.507 HG12 ' CG ' ' A' ' 10' ' ' GLU . 43.5 t -124.45 -0.98 5.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.426 -0.796 . . . . 0.0 109.185 179.488 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.789 ' N ' ' SG ' ' A' ' 54' ' ' CYS . 6.4 mt-30 60.94 -80.41 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.266 -0.896 . . . . 0.0 109.459 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.482 ' N ' ' O ' ' A' ' 56' ' ' VAL . 0.3 OUTLIER 55.59 23.4 6.03 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.075 -1.016 . . . . 0.0 108.825 179.985 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.536 ' CG2' ' HG3' ' A' ' 51' ' ' MET . 7.8 tt -124.12 154.31 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.213 -0.929 . . . . 0.0 110.051 -179.313 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.53 ' CG ' ' C ' ' A' ' 59' ' ' ILE . 10.5 m80 -157.36 157.55 34.29 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.426 -0.796 . . . . 0.0 109.241 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.505 ' HA ' ' HA ' ' A' ' 4' ' ' PHE . 40.1 m95 -83.32 179.53 7.66 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.095 -1.003 . . . . 0.0 109.394 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.485 ' O ' ' CB ' ' A' ' 3' ' ' LYS . 1.1 tt0 -149.5 108.04 3.81 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.288 -0.883 . . . . 0.0 109.408 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -104.68 -56.88 2.11 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.178 -0.951 . . . . 0.0 109.546 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 O-C-N 121.328 -0.858 . . . . 0.0 109.508 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' SF4 . . . . . 1.023 ' S2 ' ' O ' ' A' ' 14' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.436 ' O ' ' OD1' ' A' ' 63' ' ' ASP . . . . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.15 76.18 1.53 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.272 -0.893 . . . . 0.0 109.676 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.495 ' O ' ' HB3' ' A' ' 4' ' ' PHE . 1.1 tttt -97.85 -161.81 0.9 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.297 -0.877 . . . . 0.0 109.08 179.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.548 ' HA ' ' HA ' ' A' ' 61' ' ' TRP . 9.3 p90 167.57 179.56 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.283 -0.886 . . . . 0.0 109.307 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.469 ' HB3' ' O ' ' A' ' 4' ' ' PHE . 55.3 p90 176.16 -171.63 0.08 Allowed 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.354 -0.841 . . . . 0.0 109.272 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.628 ' CG2' ' CZ ' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -140.09 152.23 21.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 179.718 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.609 ' O ' ' N ' ' A' ' 9' ' ' ASP . 53.6 t0 -99.56 0.01 41.4 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 118.628 -1.229 . . . . 0.0 111.692 -178.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.475 ' CB ' ' O ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER 42.56 14.92 0.01 OUTLIER 'General case' 0 C--N 1.273 -2.753 0 CA-C-O 121.29 0.567 . . . . 0.0 110.935 179.143 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.609 ' N ' ' O ' ' A' ' 7' ' ' ASP . 0.8 OUTLIER -75.98 -50.66 14.25 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.315 -0.866 . . . . 0.0 109.142 -179.295 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.529 ' HG2' ' CB ' ' A' ' 56' ' ' VAL . 1.1 tp10 -85.66 11.93 9.85 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.457 -0.777 . . . . 0.0 109.041 179.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 31.4 t -66.04 111.4 3.35 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.246 -0.909 . . . . 0.0 110.003 -179.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.524 HG13 ' N ' ' A' ' 13' ' ' ALA . 11.9 pt -73.53 -139.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.443 -0.786 . . . . 0.0 109.221 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.524 ' N ' HG13 ' A' ' 12' ' ' ILE . . . -102.99 28.34 6.32 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.942 -1.099 . . . . 0.0 110.003 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 1.038 ' O ' ' S2 ' ' A' ' 65' ' ' SF4 . 0.0 OUTLIER -112.0 159.49 18.39 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.922 -1.111 . . . . 0.0 109.78 179.67 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.856 ' HA ' ' S2 ' ' A' ' 65' ' ' SF4 . 0.0 OUTLIER -136.25 20.4 3.19 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.401 -0.812 . . . . 0.0 109.374 -179.995 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.442 ' C ' ' O ' ' A' ' 15' ' ' GLU . 59.6 p -41.83 -44.33 3.29 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.521 -0.737 . . . . 0.0 109.387 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.615 ' SG ' ' CD2' ' A' ' 25' ' ' PHE . 17.4 p -58.33 -42.86 87.75 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.307 -0.871 . . . . 0.0 109.095 179.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.444 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 39.8 t -56.8 -30.5 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.33 -0.856 . . . . 0.0 109.493 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -81.58 -38.43 26.13 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.171 -0.955 . . . . 0.0 109.293 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.54 ' CG2' ' HB3' ' A' ' 50' ' ' ALA . 0.3 OUTLIER -74.64 2.98 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.152 -0.967 . . . . 0.0 108.827 178.565 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.525 ' HB3' ' CB ' ' A' ' 42' ' ' ALA . . . -161.86 70.71 2.38 Favored Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.185 -0.947 . . . . 0.0 109.381 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -71.0 68.09 2.42 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 124.133 1.596 . . . . 0.0 110.277 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 165.66 -35.85 0.26 Allowed Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.989 -1.644 . . . . 0.0 108.989 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.525 ' CB ' ' O ' ' A' ' 38' ' ' ASP . . . -91.81 -46.97 7.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.454 -1.027 . . . . 0.0 109.176 179.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.628 ' CZ ' ' CG2' ' A' ' 6' ' ' VAL . 0.1 OUTLIER -100.63 139.05 36.86 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.368 -0.832 . . . . 0.0 108.885 179.768 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.499 ' O ' ' CD1' ' A' ' 35' ' ' TYR . . . -169.34 124.03 0.83 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.152 -0.967 . . . . 0.0 109.759 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.528 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER -61.17 152.55 28.34 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.007 -1.058 . . . . 0.0 108.881 179.665 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.6 ' O ' ' N ' ' A' ' 32' ' ' GLU . 2.5 t0 -128.63 159.82 66.01 Favored Pre-proline 0 C--N 1.308 -1.204 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.448 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 44.9 Cg_endo -84.6 -16.23 5.73 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 O-C-N 124.562 1.822 . . . . 0.0 108.346 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -91.96 -27.81 17.63 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 177.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.556 ' CD1' ' HB3' ' A' ' 35' ' ' TYR . 0.7 OUTLIER -110.46 2.41 9.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.151 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.6 ' N ' ' O ' ' A' ' 28' ' ' ASP . 2.6 mm-40 26.22 44.01 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.466 0.651 . . . . 0.0 110.14 -179.543 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.532 ' CG ' ' O ' ' A' ' 32' ' ' GLU . 0.2 OUTLIER -172.23 149.19 2.24 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 119.175 -1.01 . . . . 0.0 109.999 -179.186 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.627 ' HB1' ' S2 ' ' A' ' 65' ' ' SF4 . . . -56.8 144.67 32.1 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.433 -0.792 . . . . 0.0 110.158 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.649 ' O ' ' CD1' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -148.78 140.79 23.85 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.839 0.828 . . . . 0.0 110.173 178.932 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.562 ' CG2' ' CG2' ' A' ' 6' ' ' VAL . 2.8 t -87.44 90.19 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 120.98 -1.075 . . . . 0.0 108.112 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.587 ' HB3' ' CE2' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -101.28 -7.79 22.7 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.333 -0.854 . . . . 0.0 110.588 -178.75 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.525 ' O ' ' CB ' ' A' ' 24' ' ' ALA . 59.6 t0 -138.16 93.6 2.78 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.991 -1.068 . . . . 0.0 109.952 -179.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.42 ' HB ' ' CZ ' ' A' ' 4' ' ' PHE . 17.7 m -58.48 -29.5 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.298 -0.877 . . . . 0.0 109.017 179.459 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -76.28 -17.6 59.38 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.303 -0.873 . . . . 0.0 109.251 179.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -69.55 -8.65 60.28 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.525 ' CB ' ' HB3' ' A' ' 21' ' ' ALA . . . -155.09 119.56 4.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.286 -1.126 . . . . 0.0 109.289 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.403 ' O ' ' O ' ' A' ' 42' ' ' ALA . 0.1 OUTLIER -49.39 174.99 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.319 -0.863 . . . . 0.0 109.812 -179.747 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.426 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 6.3 tm0? -68.16 -42.48 79.98 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.558 -0.714 . . . . 0.0 109.478 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.411 ' O ' ' HG3' ' A' ' 49' ' ' GLU . 42.6 mm-40 -66.7 -13.8 61.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.101 -0.999 . . . . 0.0 108.963 179.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -96.49 -43.48 7.6 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 178.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.444 HG21 ' O ' ' A' ' 42' ' ' ALA . 55.5 t -58.2 -51.61 69.0 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 178.31 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.434 ' O ' ' N ' ' A' ' 51' ' ' MET . 0.2 OUTLIER -65.46 -52.6 51.88 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.615 -0.678 . . . . 0.0 109.57 179.387 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.411 ' HG3' ' O ' ' A' ' 45' ' ' GLU . 19.3 mt-10 -47.73 -48.63 29.59 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.207 -0.933 . . . . 0.0 109.234 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.54 ' HB3' ' CG2' ' A' ' 20' ' ' ILE . . . -65.94 -23.64 66.65 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.199 -0.938 . . . . 0.0 109.001 179.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.513 ' CG ' HG23 ' A' ' 59' ' ' ILE . 35.0 ttm -76.16 -14.83 60.15 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.345 -0.847 . . . . 0.0 109.509 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -98.15 -25.32 14.95 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.218 -0.926 . . . . 0.0 109.71 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.75 -19.17 60.33 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.18 -0.95 . . . . 0.0 109.948 -179.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.744 ' SG ' ' HD2' ' A' ' 55' ' ' PRO . 9.2 t -70.57 145.03 92.17 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.071 -1.018 . . . . 0.0 109.702 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.744 ' HD2' ' SG ' ' A' ' 54' ' ' CYS . 43.4 Cg_endo -73.44 -86.9 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.004 1.529 . . . . 0.0 109.505 179.247 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.529 ' CB ' ' HG2' ' A' ' 10' ' ' GLU . 27.8 m -56.03 -31.28 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 120.981 -1.074 . . . . 0.0 108.168 178.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.497 ' O ' ' N ' ' A' ' 59' ' ' ILE . 4.1 tt0 68.97 52.41 0.51 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.566 -0.709 . . . . 0.0 110.361 179.146 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.46 ' O ' HG13 ' A' ' 6' ' ' VAL . 0.5 OUTLIER -68.26 65.5 0.11 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.055 -1.028 . . . . 0.0 108.804 179.166 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.513 HG23 ' CG ' ' A' ' 51' ' ' MET . 0.5 OUTLIER -131.59 148.1 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.229 -0.919 . . . . 0.0 110.219 -179.262 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.495 ' N ' HG13 ' A' ' 59' ' ' ILE . 1.1 m80 -148.74 129.46 14.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.324 -0.86 . . . . 0.0 109.431 179.705 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.548 ' HA ' ' HA ' ' A' ' 4' ' ' PHE . 54.3 m95 -68.27 161.15 27.88 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.266 -0.896 . . . . 0.0 109.256 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.505 ' N ' ' HA ' ' A' ' 4' ' ' PHE . 24.2 tt0 -129.71 119.83 24.13 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.204 -0.935 . . . . 0.0 109.696 -179.262 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 1' ' ' ALA . 4.9 m-20 -112.65 30.47 7.1 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.277 -0.89 . . . . 0.0 109.343 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.337 -0.852 . . . . 0.0 109.452 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' SF4 . . . . . 1.038 ' S2 ' ' O ' ' A' ' 14' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.29 0.566 . . . . 0.0 109.478 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 13.3 mtm180 -59.56 104.01 0.24 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.258 -0.901 . . . . 0.0 109.424 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.482 ' O ' ' HB3' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -126.28 -152.8 0.53 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.234 -0.916 . . . . 0.0 109.645 -179.879 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.566 ' CZ ' ' CG1' ' A' ' 39' ' ' VAL . 23.4 p90 175.82 176.67 0.23 Allowed 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.506 ' CE1' ' HB2' ' A' ' 62' ' ' GLU . 17.4 p90 172.45 -168.42 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 105.747 -1.946 . . . . 0.0 105.747 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.609 HG22 ' CZ ' ' A' ' 25' ' ' PHE . 4.4 t -146.54 159.72 10.42 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.236 0 C-N-CA 116.724 -1.99 . . . . 0.0 111.739 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.525 ' O ' ' N ' ' A' ' 9' ' ' ASP . 39.1 t70 -106.16 78.44 1.31 Allowed 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.563 ' CG ' ' O ' ' A' ' 34' ' ' ALA . 5.3 mp0 -43.34 -19.24 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.984 179.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.525 ' N ' ' O ' ' A' ' 7' ' ' ASP . 0.1 OUTLIER -56.51 -35.56 68.17 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.163 -0.96 . . . . 0.0 108.828 -179.898 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.478 ' HB3' ' HB3' ' A' ' 58' ' ' CYS . 0.6 OUTLIER -81.96 -31.5 31.17 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.656 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.434 ' C ' ' O ' ' A' ' 10' ' ' GLU . 36.5 t -42.65 143.09 0.73 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.362 -0.836 . . . . 0.0 109.503 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.878 HD12 ' S3 ' ' A' ' 65' ' ' SF4 . 0.0 OUTLIER -98.14 -45.25 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.27 -0.893 . . . . 0.0 109.675 -179.603 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.525 ' CB ' ' O ' ' A' ' 12' ' ' ILE . . . 162.41 -28.84 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.24 -0.912 . . . . 0.0 109.571 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 1.082 ' O ' ' S2 ' ' A' ' 65' ' ' SF4 . 0.1 OUTLIER -56.09 156.34 5.58 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.16 -0.962 . . . . 0.0 109.499 -179.725 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.436 ' O ' ' C ' ' A' ' 16' ' ' SER . 31.3 mt-10 -116.97 20.94 13.59 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.276 -0.89 . . . . 0.0 109.68 -179.591 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.436 ' C ' ' O ' ' A' ' 15' ' ' GLU . 70.1 m -44.45 -63.79 0.82 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.226 -0.921 . . . . 0.0 109.073 179.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.647 ' SG ' ' N ' ' A' ' 18' ' ' VAL . 17.8 p -49.13 -54.33 16.75 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.32 -0.862 . . . . 0.0 109.151 179.585 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.647 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 48.4 t -43.43 -46.1 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.442 -0.786 . . . . 0.0 109.199 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -63.65 -34.5 77.99 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.155 -0.966 . . . . 0.0 109.146 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.502 HD13 ' CG2' ' A' ' 53' ' ' THR . 5.6 mt -87.51 14.42 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.137 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -171.03 65.25 0.43 Allowed Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.486 -0.759 . . . . 0.0 109.257 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -71.15 56.51 2.01 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 124.161 1.611 . . . . 0.0 110.147 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.472 ' C ' ' HB3' ' A' ' 38' ' ' ASP . . . -177.86 -63.35 0.07 OUTLIER Glycine 0 N--CA 1.488 2.148 0 N-CA-C 108.832 -1.707 . . . . 0.0 108.832 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.548 ' CB ' ' O ' ' A' ' 38' ' ' ASP . . . -66.56 -42.04 87.7 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.298 -1.119 . . . . 0.0 108.453 179.443 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.609 ' CZ ' HG22 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -101.23 132.79 46.57 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 118.757 -1.177 . . . . 0.0 108.949 179.45 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.486 ' O ' ' CD1' ' A' ' 35' ' ' TYR . . . -161.49 130.87 4.64 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.434 -0.791 . . . . 0.0 109.358 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.517 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 4.0 ptt? -71.68 152.2 43.02 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.193 -0.942 . . . . 0.0 109.46 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.632 ' O ' ' N ' ' A' ' 32' ' ' GLU . 2.0 t0 -126.0 161.21 52.88 Favored Pre-proline 0 C--N 1.31 -1.118 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 179.002 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.449 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 45.0 Cg_endo -85.18 -17.9 4.4 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 O-C-N 124.814 1.955 . . . . 0.0 108.596 -179.468 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.3 -28.62 18.64 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 177.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.539 HG12 ' CB ' ' A' ' 28' ' ' ASP . 0.9 OUTLIER -107.17 -3.92 10.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 177.687 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.632 ' N ' ' O ' ' A' ' 28' ' ' ASP . 1.6 mt-10 31.41 37.47 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -179.271 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.536 ' HG2' ' O ' ' A' ' 32' ' ' GLU . 19.4 mmtp -161.91 148.22 13.68 Favored 'General case' 0 N--CA 1.502 2.17 0 C-N-CA 119.499 -0.881 . . . . 0.0 110.753 -178.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.563 ' O ' ' CG ' ' A' ' 8' ' ' GLN . . . -61.58 138.45 58.29 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.416 -0.802 . . . . 0.0 110.167 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.711 ' CE2' ' HG3' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -132.58 144.57 50.48 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-O 122.262 1.029 . . . . 0.0 110.511 179.881 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.588 ' CG2' ' CG2' ' A' ' 6' ' ' VAL . 2.4 t -86.4 92.26 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 120.303 -1.498 . . . . 0.0 109.242 -178.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.711 ' HG3' ' CE2' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -107.55 -53.31 2.64 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.436 -0.79 . . . . 0.0 111.013 -179.006 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.548 ' O ' ' CB ' ' A' ' 24' ' ' ALA . 46.9 t0 -85.77 76.07 9.97 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 119.746 -0.781 . . . . 0.0 110.782 -177.224 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.566 ' CG1' ' CZ ' ' A' ' 4' ' ' PHE . 27.5 m -49.94 -31.36 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.327 -0.858 . . . . 0.0 109.34 179.279 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -79.55 -6.92 58.02 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.327 -0.858 . . . . 0.0 109.476 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -85.85 5.38 84.01 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -153.35 116.46 4.58 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.179 -1.189 . . . . 0.0 109.644 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.457 ' OG ' ' OE2' ' A' ' 46' ' ' GLU . 0.1 OUTLIER -64.5 163.88 12.65 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.243 -0.911 . . . . 0.0 109.599 179.971 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.46 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 3.4 tt0 -49.8 -44.14 48.89 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.356 -0.84 . . . . 0.0 109.381 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.423 ' O ' ' HB2' ' A' ' 49' ' ' GLU . 72.7 mm-40 -67.87 -8.9 40.29 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.18 -0.95 . . . . 0.0 109.187 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.457 ' OE2' ' OG ' ' A' ' 43' ' ' SER . 14.3 mt-10 -99.58 -43.12 6.62 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 106.66 -1.608 . . . . 0.0 106.66 179.112 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.437 HG22 ' HA ' ' A' ' 44' ' ' GLN . 1.9 t -61.92 -42.73 95.84 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.398 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.46 ' HB2' ' O ' ' A' ' 44' ' ' GLN . 0.2 OUTLIER -73.49 -50.1 23.25 Favored 'General case' 0 C--N 1.308 -1.236 0 O-C-N 121.59 -0.694 . . . . 0.0 109.282 179.383 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.423 ' HB2' ' O ' ' A' ' 45' ' ' GLU . 13.3 mm-40 -53.23 -45.95 68.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.224 -0.923 . . . . 0.0 108.77 179.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.473 ' HA ' ' OG1' ' A' ' 53' ' ' THR . . . -70.29 -13.45 62.17 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.37 -0.831 . . . . 0.0 108.785 179.231 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.495 ' CG ' HG22 ' A' ' 59' ' ' ILE . 0.4 OUTLIER -80.72 -21.9 40.76 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.434 -0.791 . . . . 0.0 109.492 179.98 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -96.37 -34.34 11.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.197 -0.94 . . . . 0.0 109.605 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.502 ' CG2' HD13 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -50.71 -54.82 20.11 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.252 -0.905 . . . . 0.0 109.747 179.975 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.523 ' SG ' ' HD2' ' A' ' 55' ' ' PRO . 3.8 t -46.36 140.86 5.21 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.192 -0.943 . . . . 0.0 109.912 -179.61 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.523 ' HD2' ' SG ' ' A' ' 54' ' ' CYS . 44.8 Cg_endo -77.03 -62.99 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 124.123 1.591 . . . . 0.0 109.843 179.33 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 33.0 t -74.4 -20.74 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.335 -0.853 . . . . 0.0 108.868 179.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.481 ' NE2' ' O ' ' A' ' 51' ' ' MET . 3.5 mt-30 64.78 94.24 0.06 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.343 -0.848 . . . . 0.0 109.586 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.478 ' HB3' ' HB3' ' A' ' 10' ' ' GLU . 0.1 OUTLIER -100.42 -28.0 13.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.304 -0.872 . . . . 0.0 108.821 179.795 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.495 HG22 ' CG ' ' A' ' 51' ' ' MET . 5.7 tt -60.88 151.06 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.458 -0.776 . . . . 0.0 109.976 -179.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.496 ' NE2' ' CE2' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -159.92 -178.55 7.11 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.454 -0.779 . . . . 0.0 108.9 179.509 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.487 ' HA ' ' HA ' ' A' ' 4' ' ' PHE . 66.7 m95 -101.3 165.02 11.49 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.118 -0.989 . . . . 0.0 109.768 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.506 ' HB2' ' CE1' ' A' ' 5' ' ' TYR . 41.2 tt0 -128.83 107.82 9.95 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.431 -0.793 . . . . 0.0 109.169 -179.629 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -103.07 62.91 0.8 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.263 -0.898 . . . . 0.0 109.508 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 . . . . . 0 N--CA 1.491 1.614 0 O-C-N 121.203 -0.936 . . . . 0.0 109.405 -179.973 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' SF4 . . . . . 1.082 ' S2 ' ' O ' ' A' ' 14' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.479 ' HB3' ' HB3' ' A' ' 62' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.576 ' CB ' ' HA ' ' A' ' 61' ' ' TRP . 31.6 p90 179.78 -167.39 0.09 Allowed 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.173 -0.954 . . . . 0.0 109.208 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.735 ' HA ' HG11 ' A' ' 36' ' ' VAL . 39.3 p90 173.5 -166.79 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 106.87 -1.529 . . . . 0.0 106.87 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.909 HG11 ' HZ ' ' A' ' 25' ' ' PHE . 2.5 t -152.14 166.76 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 C-N-CA 117.532 -1.667 . . . . 0.0 112.119 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.582 ' H ' HG12 ' A' ' 6' ' ' VAL . 0.8 OUTLIER -106.76 68.57 0.74 Allowed 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 178.561 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.531 ' HB3' ' O ' ' A' ' 34' ' ' ALA . 0.6 OUTLIER -47.72 -15.59 0.06 Allowed 'General case' 0 C--N 1.297 -1.701 0 CA-C-O 121.344 0.593 . . . . 0.0 109.495 179.258 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.465 ' N ' ' O ' ' A' ' 7' ' ' ASP . 0.2 OUTLIER -65.17 -33.12 75.25 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.697 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.53 ' HB3' ' HB3' ' A' ' 58' ' ' CYS . 0.3 OUTLIER -93.47 0.74 56.87 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 179.168 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.449 ' HB3' ' O ' ' A' ' 8' ' ' GLN . 10.1 t -66.84 129.32 39.49 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.081 -1.012 . . . . 0.0 110.073 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.493 HG13 ' N ' ' A' ' 13' ' ' ALA . 43.2 pt -88.78 -143.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.486 -0.759 . . . . 0.0 109.639 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.493 ' N ' HG13 ' A' ' 12' ' ' ILE . . . -107.56 52.92 0.7 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.076 -1.015 . . . . 0.0 109.901 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.453 ' SG ' ' OG ' ' A' ' 16' ' ' SER . 0.1 OUTLIER -134.53 155.18 50.86 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.039 -1.038 . . . . 0.0 109.673 179.661 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.42 ' O ' ' C ' ' A' ' 16' ' ' SER . 0.2 OUTLIER -120.46 18.89 12.09 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.319 -0.863 . . . . 0.0 109.798 -179.555 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.671 ' HB3' HG21 ' A' ' 53' ' ' THR . 0.7 OUTLIER -44.15 -51.13 8.34 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.195 -0.941 . . . . 0.0 109.346 179.995 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.823 ' SG ' ' CD2' ' A' ' 25' ' ' PHE . 14.6 p -62.02 -54.93 34.63 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.316 -0.865 . . . . 0.0 109.366 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.626 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 98.7 t -43.92 -34.22 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.279 -0.888 . . . . 0.0 109.501 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.42 -36.78 66.01 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.062 -1.024 . . . . 0.0 109.025 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.572 HD13 ' HB3' ' A' ' 49' ' ' GLU . 5.0 mt -87.37 16.13 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 178.198 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -174.43 63.64 0.26 Allowed Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.344 -0.848 . . . . 0.0 109.672 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -75.36 51.76 3.0 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 124.04 1.547 . . . . 0.0 110.34 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.428 ' C ' ' HA3' ' A' ' 41' ' ' GLY . . . -166.0 -41.63 0.02 OUTLIER Glycine 0 N--CA 1.489 2.213 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.574 ' HB2' ' H ' ' A' ' 42' ' ' ALA . . . -92.31 -46.8 7.52 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.434 -1.039 . . . . 0.0 108.678 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.909 ' HZ ' HG11 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -89.7 138.09 31.77 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.387 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.45 ' O ' ' CD1' ' A' ' 35' ' ' TYR . . . -173.57 126.31 0.4 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.103 -0.998 . . . . 0.0 109.58 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.565 ' HA ' ' C ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -63.82 153.01 37.98 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.166 -0.959 . . . . 0.0 109.841 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.605 ' O ' ' N ' ' A' ' 32' ' ' GLU . 2.2 t0 -129.59 163.67 45.09 Favored Pre-proline 0 C--O 1.209 -1.061 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.49 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 45.7 Cg_endo -83.63 -18.31 5.73 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 124.619 1.852 . . . . 0.0 107.961 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -84.17 -39.17 19.73 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 178.146 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.877 HD11 ' CD1' ' A' ' 35' ' ' TYR . 3.0 pt -101.51 -2.05 9.72 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 177.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.605 ' N ' ' O ' ' A' ' 28' ' ' ASP . 65.4 mt-10 34.66 34.53 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -179.273 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.578 ' O ' HD12 ' A' ' 31' ' ' ILE . 18.5 mttt -163.15 150.3 12.86 Favored 'General case' 0 N--CA 1.499 1.999 0 C-N-CA 119.408 -0.917 . . . . 0.0 110.374 -178.148 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.562 ' HA ' ' HA ' ' A' ' 27' ' ' MET . . . -62.48 143.88 56.62 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.515 -0.74 . . . . 0.0 110.489 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.877 ' CD1' HD11 ' A' ' 31' ' ' ILE . 1.2 p90 -155.25 158.02 38.18 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.735 HG11 ' HA ' ' A' ' 5' ' ' TYR . 14.5 p -67.51 68.44 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.818 -1.176 . . . . 0.0 108.833 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.679 ' HA ' ' CE2' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -49.95 -19.24 0.66 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.445 -0.785 . . . . 0.0 110.295 -179.691 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -165.95 99.72 0.65 Allowed 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.09 -1.006 . . . . 0.0 109.394 -179.541 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.503 ' HA ' ' CZ ' ' A' ' 4' ' ' PHE . 11.0 m -48.19 -29.65 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.419 -0.801 . . . . 0.0 109.764 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -85.12 -4.98 59.35 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.207 -0.933 . . . . 0.0 109.711 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.428 ' HA3' ' C ' ' A' ' 23' ' ' GLY . . . -67.02 -32.2 80.11 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.574 ' H ' ' HB2' ' A' ' 24' ' ' ALA . . . -128.24 163.04 25.59 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.212 -1.17 . . . . 0.0 109.279 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.557 ' O ' HG23 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -89.51 171.53 9.64 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.278 -0.889 . . . . 0.0 109.416 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.481 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 17.6 pt20 -68.51 -34.55 76.1 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.326 -0.859 . . . . 0.0 109.38 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -72.4 -23.9 61.17 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.311 -0.868 . . . . 0.0 109.322 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.469 ' OE2' ' OG ' ' A' ' 43' ' ' SER . 33.6 mt-10 -87.55 -41.14 13.69 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 178.481 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 43' ' ' SER . 38.5 t -63.37 -29.33 46.99 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 177.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.481 ' HB2' ' O ' ' A' ' 44' ' ' GLN . 0.5 OUTLIER -69.37 -64.65 0.83 Allowed 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.262 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.572 ' HB3' HD13 ' A' ' 20' ' ' ILE . 43.1 mt-10 -52.19 -39.76 60.59 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 119.467 -0.893 . . . . 0.0 108.786 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.515 ' HB2' ' HB ' ' A' ' 20' ' ' ILE . . . -62.78 -27.33 69.22 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.571 ' HG3' ' CG2' ' A' ' 59' ' ' ILE . 3.7 ttm -72.82 -43.57 62.53 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.408 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -55.36 -42.88 74.49 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.671 HG21 ' HB3' ' A' ' 16' ' ' SER . 0.1 OUTLIER -59.98 -160.23 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.419 -0.801 . . . . 0.0 109.195 179.803 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 54' ' ' CYS . . . . . 0.593 ' SG ' ' HD2' ' A' ' 55' ' ' PRO . 1.7 t 66.74 144.63 0.09 OUTLIER Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.151 -0.968 . . . . 0.0 109.381 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.593 ' HD2' ' SG ' ' A' ' 54' ' ' CYS . 43.2 Cg_endo -73.57 -61.04 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.97 1.511 . . . . 0.0 109.948 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.456 HG12 ' O ' ' A' ' 56' ' ' VAL . 12.2 t -102.86 14.73 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.368 -0.833 . . . . 0.0 108.778 179.217 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.578 ' HA ' ' HB3' ' A' ' 54' ' ' CYS . 0.4 OUTLIER 65.08 -73.31 0.06 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.389 -0.819 . . . . 0.0 109.806 -179.891 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.53 ' HB3' ' HB3' ' A' ' 10' ' ' GLU . 1.8 m 63.95 12.98 7.27 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.95 -1.094 . . . . 0.0 108.544 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.571 ' CG2' ' HG3' ' A' ' 51' ' ' MET . 11.3 tt -119.22 152.25 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.432 -0.792 . . . . 0.0 109.463 -179.409 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.524 ' CD2' ' O ' ' A' ' 59' ' ' ILE . 18.9 m80 -156.11 170.26 22.6 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.104 -0.998 . . . . 0.0 110.007 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.576 ' HA ' ' CB ' ' A' ' 4' ' ' PHE . 60.6 m95 -94.14 175.1 6.83 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.353 -0.842 . . . . 0.0 109.577 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.479 ' HB3' ' HB3' ' A' ' 3' ' ' LYS . 7.3 tt0 . . . . . 0 N--CA 1.488 1.465 0 O-C-N 121.404 -0.81 . . . . 0.0 109.357 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.522 ' HB3' ' HB3' ' A' ' 62' ' ' GLU . 13.6 tptt . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.561 ' CZ ' ' HB ' ' A' ' 39' ' ' VAL . 49.1 p90 176.39 176.38 0.29 Allowed 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.136 -0.977 . . . . 0.0 109.036 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.624 ' HA ' HG11 ' A' ' 36' ' ' VAL . 23.7 p90 175.66 -157.11 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 1.127 HG21 ' CZ ' ' A' ' 25' ' ' PHE . 0.2 OUTLIER -145.6 -170.57 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 C-N-CA 118.101 -1.439 . . . . 0.0 111.175 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.623 ' H ' HG12 ' A' ' 6' ' ' VAL . 0.6 OUTLIER -147.41 96.33 2.68 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.121 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.559 ' CG ' ' HB3' ' A' ' 33' ' ' LYS . 4.5 mp0 -64.67 40.08 0.02 OUTLIER 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.095 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.517 ' N ' ' O ' ' A' ' 7' ' ' ASP . 0.3 OUTLIER -99.03 -18.05 17.96 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.03 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.639 ' O ' HG11 ' A' ' 56' ' ' VAL . 0.5 OUTLIER -116.32 -9.29 11.56 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.701 -0.624 . . . . 0.0 109.621 -179.739 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.777 ' SG ' ' HG2' ' A' ' 33' ' ' LYS . 42.0 t -60.67 129.52 41.96 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.213 -0.929 . . . . 0.0 109.777 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.701 ' O ' ' HB2' ' A' ' 13' ' ' ALA . 14.3 pt -91.38 -45.32 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.413 -0.805 . . . . 0.0 109.271 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.701 ' HB2' ' O ' ' A' ' 12' ' ' ILE . . . 164.4 -29.9 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.279 -0.888 . . . . 0.0 110.024 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.491 ' SG ' ' HB2' ' A' ' 16' ' ' SER . 0.1 OUTLIER -49.16 154.8 0.75 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.938 -1.101 . . . . 0.0 109.377 -179.669 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.593 ' OE1' HG21 ' A' ' 18' ' ' VAL . 5.0 mm-40 -116.74 19.2 14.61 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.215 -0.928 . . . . 0.0 109.277 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.491 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 0.6 OUTLIER -43.93 -46.23 8.04 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.264 -0.897 . . . . 0.0 109.269 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.518 ' SG ' ' N ' ' A' ' 18' ' ' VAL . 19.1 p -66.21 -47.56 73.44 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.394 -0.816 . . . . 0.0 109.274 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.593 HG21 ' OE1' ' A' ' 15' ' ' GLU . 23.7 t -50.65 -38.87 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.261 -0.899 . . . . 0.0 109.305 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -70.19 -37.28 75.08 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.224 -0.922 . . . . 0.0 109.097 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.624 HG22 ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -78.14 5.79 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.316 -0.865 . . . . 0.0 108.696 178.499 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.698 ' HB1' ' HB2' ' A' ' 42' ' ' ALA . . . -179.3 67.55 0.17 Allowed Pre-proline 0 N--CA 1.488 1.426 0 O-C-N 121.116 -0.99 . . . . 0.0 109.292 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -70.78 -2.96 11.74 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.051 1.553 . . . . 0.0 110.49 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.413 ' C ' ' HA3' ' A' ' 41' ' ' GLY . . . -103.52 -33.78 4.07 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.569 ' HB2' ' N ' ' A' ' 42' ' ' ALA . . . -96.95 -51.01 4.41 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.344 -1.092 . . . . 0.0 109.659 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 1.127 ' CZ ' HG21 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -85.54 136.08 33.55 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.307 -0.871 . . . . 0.0 109.572 -179.874 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.435 ' O ' ' CD1' ' A' ' 35' ' ' TYR . . . -163.73 128.83 2.94 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.11 -0.994 . . . . 0.0 109.834 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.56 ' HG2' ' CA ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -61.89 148.39 43.63 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.191 -0.943 . . . . 0.0 109.952 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.584 ' O ' ' N ' ' A' ' 32' ' ' GLU . 1.4 t70 -127.51 160.54 59.94 Favored Pre-proline 0 N--CA 1.478 0.966 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 178.723 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.48 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 44.2 Cg_endo -84.59 -19.24 4.36 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 O-C-N 124.497 1.788 . . . . 0.0 108.653 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -88.94 -33.99 17.06 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 106.452 -1.685 . . . . 0.0 106.452 177.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.663 HD11 ' CD1' ' A' ' 35' ' ' TYR . 0.5 OUTLIER -101.78 -0.41 10.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 177.9 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.584 ' N ' ' O ' ' A' ' 28' ' ' ASP . 17.0 mt-10 27.91 42.41 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.632 0.729 . . . . 0.0 109.654 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.777 ' HG2' ' SG ' ' A' ' 11' ' ' CYS . 0.2 OUTLIER -171.16 157.52 5.15 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -179.135 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.854 ' HB1' ' HD1' ' A' ' 25' ' ' PHE . . . -70.27 144.16 51.87 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.118 -0.989 . . . . 0.0 110.719 -178.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.665 ' CE2' ' HA ' ' A' ' 37' ' ' LYS . 2.6 p90 -150.24 159.03 44.74 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.319 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.801 ' O ' HG13 ' A' ' 36' ' ' VAL . 8.2 p -67.77 67.9 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.814 -1.178 . . . . 0.0 109.219 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.665 ' HA ' ' CE2' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -55.98 -14.8 2.76 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.232 -0.918 . . . . 0.0 110.598 -179.528 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -166.17 92.33 0.49 Allowed 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 119.004 -1.078 . . . . 0.0 109.909 -179.202 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.6 HG12 HG21 ' A' ' 36' ' ' VAL . 23.7 m -49.72 -26.13 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.389 -0.819 . . . . 0.0 109.703 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -78.86 -9.96 59.64 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.293 -0.879 . . . . 0.0 109.605 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.413 ' HA3' ' C ' ' A' ' 23' ' ' GLY . . . -79.23 -19.43 72.04 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.698 ' HB2' ' HB1' ' A' ' 21' ' ' ALA . . . -127.39 153.78 45.81 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.191 -1.182 . . . . 0.0 109.45 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.455 ' O ' HG23 ' A' ' 47' ' ' VAL . 0.5 OUTLIER -96.77 -168.15 1.67 Allowed 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.181 -0.949 . . . . 0.0 109.961 -179.738 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.481 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 0.4 OUTLIER -73.89 -57.98 3.61 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.609 -0.682 . . . . 0.0 109.196 179.703 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.404 ' O ' ' HB2' ' A' ' 49' ' ' GLU . 49.0 mm-40 -62.49 -14.43 41.37 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.37 -0.831 . . . . 0.0 109.692 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.453 ' HG3' ' HB2' ' A' ' 43' ' ' SER . 20.3 mt-10 -95.21 -46.48 6.75 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 179.305 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.491 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 5.5 t -59.23 -37.48 69.04 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.317 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.526 ' O ' ' N ' ' A' ' 51' ' ' MET . 0.2 OUTLIER -72.92 -55.49 6.52 Favored 'General case' 0 C--N 1.308 -1.218 0 O-C-N 121.58 -0.7 . . . . 0.0 109.813 179.971 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.827 ' O ' HG23 ' A' ' 53' ' ' THR . 2.6 tt0 -45.13 -50.57 11.14 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.196 -0.94 . . . . 0.0 108.862 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.614 ' N ' HG21 ' A' ' 20' ' ' ILE . . . -61.69 -28.37 69.36 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.211 -0.931 . . . . 0.0 108.607 179.196 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.764 ' HE2' HG23 ' A' ' 59' ' ' ILE . 43.2 ttm -64.7 -20.1 66.13 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.444 -0.785 . . . . 0.0 109.171 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -107.13 -10.03 15.99 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.374 -0.829 . . . . 0.0 109.432 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.827 HG23 ' O ' ' A' ' 49' ' ' GLU . 23.2 p -97.15 36.12 1.49 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.297 -0.877 . . . . 0.0 110.015 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' CYS . . . . . 0.547 ' SG ' HG22 ' A' ' 56' ' ' VAL . 49.7 t -126.84 132.82 24.48 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.041 -1.037 . . . . 0.0 109.573 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.87 -32.97 8.42 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 123.835 1.44 . . . . 0.0 109.665 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.639 HG11 ' O ' ' A' ' 10' ' ' GLU . 7.3 m -98.82 -16.12 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.223 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.502 ' N ' ' SG ' ' A' ' 54' ' ' CYS . 6.9 mt-30 42.39 86.71 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.554 -0.716 . . . . 0.0 109.692 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 8.9 p -120.33 6.17 10.68 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.318 -0.864 . . . . 0.0 109.23 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.87 HD13 ' N ' ' A' ' 60' ' ' HIS . 0.0 OUTLIER -95.3 127.17 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.268 -0.895 . . . . 0.0 109.931 -179.625 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.87 ' N ' HD13 ' A' ' 59' ' ' ILE . 5.3 m-70 -131.91 -160.75 1.07 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.376 -0.828 . . . . 0.0 109.041 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.535 ' HA ' ' CB ' ' A' ' 4' ' ' PHE . 49.3 m95 -111.32 174.11 6.02 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.959 -1.088 . . . . 0.0 109.327 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.522 ' HB3' ' HB3' ' A' ' 3' ' ' LYS . 3.1 tt0 . . . . . 0 C--N 1.301 -1.537 0 O-C-N 121.505 -0.747 . . . . 0.0 109.137 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.486 ' HB3' ' HB3' ' A' ' 62' ' ' GLU . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.46 0.648 . . . . 0.0 109.805 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.578 ' CZ ' ' HB ' ' A' ' 39' ' ' VAL . 8.1 p90 168.59 176.87 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 1.005 ' HA ' HG11 ' A' ' 36' ' ' VAL . 18.9 p90 178.52 -174.2 0.17 Allowed 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 1.14 HG21 ' CZ ' ' A' ' 25' ' ' PHE . 0.4 OUTLIER -132.69 168.45 24.16 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.12 0 C-N-CA 117.546 -1.662 . . . . 0.0 111.333 -179.393 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.541 ' O ' ' N ' ' A' ' 9' ' ' ASP . 9.5 t0 -116.07 89.91 3.21 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.587 ' CG ' ' O ' ' A' ' 34' ' ' ALA . 1.4 mp0 -63.24 42.3 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.949 -0.47 . . . . 0.0 111.004 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.541 ' N ' ' O ' ' A' ' 7' ' ' ASP . 0.4 OUTLIER -101.07 -28.32 12.77 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.177 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -119.53 21.74 11.97 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.485 ' HB3' ' CD ' ' A' ' 33' ' ' LYS . 8.7 t -76.77 122.51 24.86 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.186 -0.946 . . . . 0.0 110.055 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.711 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 37.7 pt -73.39 -5.76 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.405 -0.809 . . . . 0.0 109.436 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.711 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . 79.76 32.78 0.21 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.461 -0.775 . . . . 0.0 110.129 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.776 ' SG ' ' HB2' ' A' ' 16' ' ' SER . 1.3 p -95.78 151.93 18.93 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.097 -1.002 . . . . 0.0 109.178 179.394 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.468 ' O ' ' HB2' ' A' ' 19' ' ' GLU . 2.1 pt-20 -82.03 5.85 18.05 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.19 -0.944 . . . . 0.0 110.353 -179.079 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.776 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 3.6 m -43.78 -82.64 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.127 -0.983 . . . . 0.0 109.432 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.75 ' SG ' ' CD2' ' A' ' 25' ' ' PHE . 13.0 p -47.32 -56.83 6.07 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.25 -0.906 . . . . 0.0 109.617 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.666 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 74.1 t -47.29 -27.2 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.394 -0.816 . . . . 0.0 110.186 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.468 ' HB2' ' O ' ' A' ' 15' ' ' GLU . 0.1 OUTLIER -81.03 -40.14 24.72 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.966 -1.084 . . . . 0.0 109.673 -179.685 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.957 ' CD1' HG21 ' A' ' 53' ' ' THR . 2.4 mt -84.18 13.8 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.403 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.433 ' HB2' ' O ' ' A' ' 20' ' ' ILE . . . 177.84 65.92 0.09 OUTLIER Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.378 -0.826 . . . . 0.0 109.333 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -74.23 1.62 7.08 Favored 'Trans proline' 0 C--N 1.303 -1.837 0 O-C-N 124.069 1.563 . . . . 0.0 110.718 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.485 ' O ' ' HB3' ' A' ' 38' ' ' ASP . . . -97.77 -45.07 2.54 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' A' ' 38' ' ' ASP . . . -87.78 -47.1 8.89 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.255 -1.144 . . . . 0.0 109.559 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 1.14 ' CZ ' HG21 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -92.62 134.83 34.63 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.263 -0.898 . . . . 0.0 109.121 179.859 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.67 ' HB3' ' HE1' ' A' ' 35' ' ' TYR . . . -157.95 118.63 3.44 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.386 -0.821 . . . . 0.0 109.587 179.501 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.559 ' HA ' ' C ' ' A' ' 33' ' ' LYS . 14.6 mtm -59.15 149.6 27.64 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.114 -0.991 . . . . 0.0 109.37 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.612 ' O ' ' N ' ' A' ' 32' ' ' GLU . 1.3 t0 -126.95 163.13 43.39 Favored Pre-proline 0 C--N 1.312 -1.031 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 179.02 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.479 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 43.9 Cg_endo -83.95 -16.76 6.19 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 124.95 2.026 . . . . 0.0 108.086 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.24 -38.83 17.2 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 178.066 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.606 ' CG1' ' CB ' ' A' ' 28' ' ' ASP . 2.6 pt -102.24 -2.2 9.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.148 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.612 ' N ' ' O ' ' A' ' 28' ' ' ASP . 3.9 mm-40 34.35 36.23 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 -178.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.559 ' C ' ' HA ' ' A' ' 27' ' ' MET . 11.1 mttm -161.41 148.64 14.81 Favored 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 119.37 -0.932 . . . . 0.0 110.501 -177.509 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.587 ' O ' ' CG ' ' A' ' 8' ' ' GLN . . . -58.59 143.99 44.41 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.478 -0.764 . . . . 0.0 109.901 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.67 ' HE1' ' HB3' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -142.31 139.76 31.94 Favored 'General case' 0 N--CA 1.5 2.039 0 CA-C-O 121.803 0.811 . . . . 0.0 110.199 179.461 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 1.005 HG11 ' HA ' ' A' ' 5' ' ' TYR . 7.9 p -74.34 61.61 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.123 -0.986 . . . . 0.0 108.673 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.646 ' HB3' ' CZ ' ' A' ' 35' ' ' TYR . 0.1 OUTLIER -71.4 -18.34 62.35 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.303 -0.873 . . . . 0.0 110.607 -178.992 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.485 ' HB3' ' O ' ' A' ' 23' ' ' GLY . 57.2 t0 -135.21 75.62 1.58 Allowed 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.055 -1.028 . . . . 0.0 109.722 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.578 ' HB ' ' CZ ' ' A' ' 4' ' ' PHE . 6.4 m -51.81 -24.35 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.273 -0.892 . . . . 0.0 108.935 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.521 ' HG3' HG23 ' A' ' 39' ' ' VAL . 2.0 mt-10 -90.16 1.81 56.01 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.335 -0.853 . . . . 0.0 109.365 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.408 ' O ' ' HA3' ' A' ' 23' ' ' GLY . . . -96.04 34.75 4.72 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.435 ' HA ' ' OE2' ' A' ' 46' ' ' GLU . . . -179.66 126.65 0.08 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.251 -1.147 . . . . 0.0 109.615 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.77 ' O ' HG23 ' A' ' 47' ' ' VAL . 0.3 OUTLIER -59.22 165.67 2.52 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.298 -0.876 . . . . 0.0 109.542 179.768 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.496 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 0.1 OUTLIER -71.67 -37.44 70.76 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.333 -0.854 . . . . 0.0 109.467 179.995 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -71.73 -20.26 61.92 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.075 -1.015 . . . . 0.0 109.286 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.531 ' HG2' ' N ' ' A' ' 43' ' ' SER . 5.3 pt-20 -95.08 -34.08 12.44 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 106.517 -1.661 . . . . 0.0 106.517 178.764 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.77 HG23 ' O ' ' A' ' 43' ' ' SER . 25.1 t -64.25 -46.82 92.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 177.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.496 ' HB2' ' O ' ' A' ' 44' ' ' GLN . 0.2 OUTLIER -64.77 -51.3 63.02 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.615 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.652 ' HB3' HG21 ' A' ' 20' ' ' ILE . 6.6 mt-10 -51.74 -40.57 60.46 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 178.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.769 ' HA ' HD13 ' A' ' 20' ' ' ILE . . . -72.41 -32.73 66.61 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.126 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.993 ' HG3' HD13 ' A' ' 59' ' ' ILE . 34.6 ttm -74.41 -24.88 59.17 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.645 -0.659 . . . . 0.0 110.103 -179.304 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -86.3 -26.35 24.97 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.047 -1.033 . . . . 0.0 109.882 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.957 HG21 ' CD1' ' A' ' 20' ' ' ILE . 13.8 t -73.01 -5.89 41.84 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.137 -0.977 . . . . 0.0 109.772 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' CYS . . . . . 0.633 ' SG ' ' HD2' ' A' ' 55' ' ' PRO . 19.4 t -79.09 142.61 59.82 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.163 -0.961 . . . . 0.0 109.743 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.633 ' HD2' ' SG ' ' A' ' 54' ' ' CYS . 42.9 Cg_endo -76.35 -72.38 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.07 1.563 . . . . 0.0 109.945 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.424 ' O ' ' HB2' ' A' ' 57' ' ' GLN . 2.5 t -74.5 -18.18 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.096 -1.003 . . . . 0.0 108.761 179.337 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.451 ' O ' ' C ' ' A' ' 58' ' ' CYS . 1.4 mt-30 71.9 -64.57 0.38 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.431 -0.793 . . . . 0.0 110.139 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.451 ' C ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER 42.05 37.9 0.95 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.334 -0.854 . . . . 0.0 108.799 -179.467 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.993 HD13 ' HG3' ' A' ' 51' ' ' MET . 7.6 tt -121.48 157.46 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.303 -0.873 . . . . 0.0 110.096 -179.27 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.57 ' CG ' ' O ' ' A' ' 59' ' ' ILE . 23.5 m80 -159.3 132.62 7.14 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.353 -0.842 . . . . 0.0 109.655 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.569 ' HA ' ' HA ' ' A' ' 4' ' ' PHE . 57.3 m95 -71.26 168.72 16.7 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.239 -0.913 . . . . 0.0 109.141 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.505 ' N ' ' HA ' ' A' ' 4' ' ' PHE . 1.4 tt0 . . . . . 0 N--CA 1.488 1.444 0 O-C-N 121.186 -0.946 . . . . 0.0 109.644 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.465 ' HB3' ' HB3' ' A' ' 62' ' ' GLU . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.269 0.557 . . . . 0.0 109.758 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.638 ' CE1' HG21 ' A' ' 47' ' ' VAL . 14.4 p90 167.98 -174.33 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.269 -0.894 . . . . 0.0 109.657 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.527 ' O ' HG13 ' A' ' 59' ' ' ILE . 4.4 p90 176.18 -172.63 0.08 Allowed 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.953 HG21 ' CZ ' ' A' ' 25' ' ' PHE . 0.2 OUTLIER -135.78 164.89 31.25 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 C-N-CA 118.056 -1.458 . . . . 0.0 111.086 179.685 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.569 ' OD2' ' CE1' ' A' ' 60' ' ' HIS . 5.5 m-20 -109.1 90.88 3.43 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.105 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.519 ' HG2' ' O ' ' A' ' 34' ' ' ALA . 5.2 mp0 -66.22 48.24 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.66 0 CA-C-O 121.884 0.85 . . . . 0.0 110.002 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.527 ' N ' ' O ' ' A' ' 7' ' ' ASP . 11.0 t0 -110.53 -39.96 4.76 Favored 'General case' 0 C--N 1.285 -2.22 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.426 ' HB2' ' SG ' ' A' ' 58' ' ' CYS . 0.0 OUTLIER -101.25 20.49 15.69 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.307 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.447 ' HB3' ' HG2' ' A' ' 33' ' ' LYS . 11.1 t -86.44 134.99 33.65 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.308 -0.87 . . . . 0.0 110.085 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.692 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 30.3 pt -105.09 -6.15 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.353 -0.842 . . . . 0.0 108.78 179.029 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.692 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . 76.53 70.85 0.07 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.344 -0.848 . . . . 0.0 109.45 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 1.208 ' SG ' ' OG ' ' A' ' 16' ' ' SER . 27.4 p -103.89 -11.45 17.48 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.124 -0.985 . . . . 0.0 109.697 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.52 ' CB ' ' O ' ' A' ' 14' ' ' CYS . 3.1 tt0 76.29 -1.65 2.88 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.212 -0.93 . . . . 0.0 110.253 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' SER . . . . . 1.208 ' OG ' ' SG ' ' A' ' 14' ' ' CYS . 0.2 OUTLIER -61.76 -67.11 0.44 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.975 -1.078 . . . . 0.0 109.294 179.89 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.722 ' SG ' ' CD2' ' A' ' 25' ' ' PHE . 14.2 p -54.77 -44.12 73.39 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.21 -0.931 . . . . 0.0 109.103 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.463 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 21.2 t -54.31 -19.69 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.304 -0.872 . . . . 0.0 109.16 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.27 -41.54 14.51 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.172 -0.955 . . . . 0.0 109.107 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.837 HG21 ' HB3' ' A' ' 49' ' ' GLU . 1.9 mt -85.84 16.23 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 177.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.401 ' N ' ' HD3' ' A' ' 22' ' ' PRO . . . -177.54 59.95 0.15 Allowed Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.429 -0.795 . . . . 0.0 109.062 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.401 ' HD3' ' N ' ' A' ' 21' ' ' ALA . 45.4 Cg_endo -74.25 -0.11 9.21 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 124.075 1.566 . . . . 0.0 110.402 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.491 ' O ' ' HB3' ' A' ' 38' ' ' ASP . . . -111.43 -26.88 4.37 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.523 ' CB ' ' O ' ' A' ' 38' ' ' ASP . . . -100.34 -47.25 4.99 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.362 -1.081 . . . . 0.0 109.604 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.953 ' CZ ' HG21 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -90.61 140.4 29.79 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.373 -0.829 . . . . 0.0 109.045 -179.96 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.523 ' O ' ' CD1' ' A' ' 35' ' ' TYR . . . -164.48 119.57 1.45 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.147 -0.97 . . . . 0.0 109.943 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.542 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 5.7 ttm -60.14 152.22 24.94 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.098 -1.001 . . . . 0.0 109.159 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.606 ' O ' ' N ' ' A' ' 32' ' ' GLU . 2.8 t0 -125.97 160.14 58.33 Favored Pre-proline 0 C--N 1.312 -1.06 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 179.395 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.48 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 43.9 Cg_endo -84.88 -16.15 5.46 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 O-C-N 124.662 1.875 . . . . 0.0 108.585 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.75 -28.0 16.87 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 177.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.596 HD12 ' HB3' ' A' ' 35' ' ' TYR . 0.8 OUTLIER -108.46 -0.81 9.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 177.905 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.606 ' N ' ' O ' ' A' ' 28' ' ' ASP . 19.6 mt-10 28.73 42.73 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.595 0.712 . . . . 0.0 109.625 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.523 ' C ' ' HA ' ' A' ' 27' ' ' MET . 1.0 OUTLIER -169.44 148.19 3.76 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 119.365 -0.934 . . . . 0.0 110.287 -179.051 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.542 ' HA ' ' HA ' ' A' ' 27' ' ' MET . . . -57.2 143.76 37.88 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.453 -0.779 . . . . 0.0 110.67 -179.449 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.633 ' O ' ' CD1' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -144.03 143.09 31.03 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.732 0.777 . . . . 0.0 109.607 179.094 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.927 ' HB ' HG23 ' A' ' 6' ' ' VAL . 2.1 t -86.2 91.67 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 120.816 -1.178 . . . . 0.0 108.153 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.611 ' HB3' ' CE2' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -104.3 -16.22 15.22 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.343 -0.848 . . . . 0.0 110.605 -178.82 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.523 ' O ' ' CB ' ' A' ' 24' ' ' ALA . 36.9 t70 -129.66 90.92 3.06 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 120.984 -1.072 . . . . 0.0 109.696 -179.531 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.515 HG12 ' CE1' ' A' ' 4' ' ' PHE . 28.7 m -58.27 -39.77 75.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.22 -0.925 . . . . 0.0 109.578 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.486 ' HG2' ' OD1' ' A' ' 38' ' ' ASP . 1.3 pt-20 -64.6 -16.53 62.86 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.248 -0.907 . . . . 0.0 109.258 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.513 ' N ' ' OD2' ' A' ' 38' ' ' ASP . . . -76.59 0.76 63.86 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.694 -1.363 . . . . 0.0 109.694 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -160.04 103.91 1.49 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.179 -1.189 . . . . 0.0 109.512 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.472 ' OG ' ' OE2' ' A' ' 46' ' ' GLU . 0.4 OUTLIER -50.19 162.65 0.2 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.27 -0.894 . . . . 0.0 109.69 -179.876 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.479 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 15.1 pt20 -48.97 -50.17 36.99 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.434 -0.791 . . . . 0.0 109.43 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.42 ' N ' ' HG3' ' A' ' 44' ' ' GLN . 25.9 mm-40 -63.21 -13.04 33.04 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.298 -0.876 . . . . 0.0 109.359 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.472 ' OE2' ' OG ' ' A' ' 43' ' ' SER . 7.3 mt-10 -93.48 -52.77 4.35 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 179.017 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.638 HG21 ' CE1' ' A' ' 4' ' ' PHE . 2.5 t -53.67 -38.7 35.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 178.371 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.479 ' HB2' ' O ' ' A' ' 44' ' ' GLN . 0.1 OUTLIER -69.08 -55.63 10.19 Favored 'General case' 0 C--N 1.309 -1.173 0 O-C-N 121.499 -0.751 . . . . 0.0 109.776 179.775 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.837 ' HB3' HG21 ' A' ' 20' ' ' ILE . 20.3 mm-40 -53.2 -49.77 66.06 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.143 -0.973 . . . . 0.0 108.765 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.72 ' HB2' ' HB ' ' A' ' 20' ' ' ILE . . . -65.6 -11.1 41.32 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.429 -0.794 . . . . 0.0 108.931 179.194 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.643 ' CG ' HG21 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -83.92 -43.78 14.92 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.453 -0.78 . . . . 0.0 109.938 -179.372 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -76.41 -22.36 54.82 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.335 -0.853 . . . . 0.0 110.205 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.617 HG21 ' CD1' ' A' ' 20' ' ' ILE . 7.6 t -69.95 -6.05 30.43 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.052 -1.03 . . . . 0.0 109.69 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' CYS . . . . . 0.521 ' SG ' ' HD2' ' A' ' 55' ' ' PRO . 16.1 t -85.95 139.97 34.99 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.152 -0.968 . . . . 0.0 109.557 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.521 ' HD2' ' SG ' ' A' ' 54' ' ' CYS . 46.0 Cg_endo -74.27 -49.52 0.18 Allowed 'Trans proline' 0 C--N 1.303 -1.819 0 O-C-N 124.051 1.553 . . . . 0.0 110.138 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.476 ' O ' ' HB2' ' A' ' 57' ' ' GLN . 5.4 t -97.28 -11.78 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.301 -0.874 . . . . 0.0 109.078 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.476 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 13.6 mt-30 65.43 -85.43 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.464 -0.773 . . . . 0.0 110.028 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.465 ' SG ' ' HB2' ' A' ' 7' ' ' ASP . 7.2 t 58.79 31.99 21.77 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.067 -1.021 . . . . 0.0 108.823 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.845 HD12 HG13 ' A' ' 6' ' ' VAL . 1.2 tt -110.84 156.65 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.354 -0.841 . . . . 0.0 109.724 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.569 ' CE1' ' OD2' ' A' ' 7' ' ' ASP . 13.6 m80 -154.03 136.54 15.07 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.116 -0.99 . . . . 0.0 109.797 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.547 ' HA ' ' CB ' ' A' ' 4' ' ' PHE . 56.8 m95 -78.74 166.88 21.97 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.39 -0.819 . . . . 0.0 109.499 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.526 ' N ' ' HA ' ' A' ' 4' ' ' PHE . 45.2 tt0 . . . . . 0 N--CA 1.489 1.511 0 O-C-N 121.342 -0.849 . . . . 0.0 109.32 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.589 ' CG ' ' CG ' ' A' ' 62' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.041 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.562 ' CB ' ' HA ' ' A' ' 61' ' ' TRP . 28.6 p90 -173.48 -177.59 1.5 Allowed 'General case' 0 C--N 1.296 -1.747 0 O-C-N 121.205 -0.935 . . . . 0.0 109.496 -179.066 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.609 ' HA ' HG11 ' A' ' 36' ' ' VAL . 14.3 p90 175.1 -172.05 0.06 Allowed 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 1.053 HG21 ' CZ ' ' A' ' 25' ' ' PHE . 0.2 OUTLIER -134.34 172.33 16.38 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 C-N-CA 117.594 -1.642 . . . . 0.0 111.162 179.565 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.567 ' O ' ' N ' ' A' ' 9' ' ' ASP . 13.5 t70 -122.29 90.18 3.25 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.566 ' CG ' ' O ' ' A' ' 34' ' ' ALA . 6.9 mp0 -66.45 48.92 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.748 0.785 . . . . 0.0 109.81 179.28 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.567 ' N ' ' O ' ' A' ' 7' ' ' ASP . 0.5 OUTLIER -114.08 -25.7 8.41 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.588 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.481 ' HB3' ' SG ' ' A' ' 58' ' ' CYS . 0.1 OUTLIER -110.22 -19.71 12.92 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.649 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.466 ' O ' ' HD3' ' A' ' 33' ' ' LYS . 42.0 t -46.75 141.92 3.62 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.425 -0.797 . . . . 0.0 109.471 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.749 ' O ' ' HB2' ' A' ' 13' ' ' ALA . 11.8 pt -99.34 -51.93 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.068 -1.02 . . . . 0.0 109.545 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.749 ' HB2' ' O ' ' A' ' 12' ' ' ILE . . . 154.91 35.48 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.543 -0.723 . . . . 0.0 110.276 179.287 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.618 ' SG ' ' HB2' ' A' ' 16' ' ' SER . 0.5 OUTLIER -105.08 158.53 16.5 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.667 -1.271 . . . . 0.0 109.719 179.557 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.455 ' O ' ' N ' ' A' ' 19' ' ' GLU . 11.6 mt-10 -99.07 12.97 34.5 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.306 -0.871 . . . . 0.0 109.833 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.631 ' O ' HD12 ' A' ' 20' ' ' ILE . 3.7 m -45.03 -76.34 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.087 -1.008 . . . . 0.0 109.052 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.984 ' SG ' ' CD2' ' A' ' 25' ' ' PHE . 10.6 p -52.6 -49.15 65.62 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.38 -0.825 . . . . 0.0 109.125 179.421 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.581 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 60.8 t -52.13 -24.7 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.311 -0.868 . . . . 0.0 109.226 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.455 ' N ' ' O ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -83.61 -36.02 24.21 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.219 -0.926 . . . . 0.0 109.173 179.76 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 1.012 HD13 ' HA ' ' A' ' 50' ' ' ALA . 2.7 mp -83.43 10.56 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.242 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.67 ' HB1' ' HB2' ' A' ' 42' ' ' ALA . . . 178.08 68.71 0.1 Allowed Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.393 -0.817 . . . . 0.0 108.879 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -69.93 -1.19 8.21 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 124.166 1.614 . . . . 0.0 110.887 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.497 ' O ' ' HB3' ' A' ' 38' ' ' ASP . . . -105.34 -44.44 1.46 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.53 ' CB ' ' O ' ' A' ' 38' ' ' ASP . . . -83.46 -36.42 24.19 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.374 -1.074 . . . . 0.0 109.844 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 1.053 ' CZ ' HG21 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -105.73 140.71 38.36 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.342 -0.848 . . . . 0.0 109.23 -179.682 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.522 ' O ' ' CD1' ' A' ' 35' ' ' TYR . . . -171.27 120.37 0.5 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.151 -0.968 . . . . 0.0 109.459 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.558 ' HA ' ' C ' ' A' ' 33' ' ' LYS . 10.5 mtp -58.41 153.73 15.16 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.08 -1.013 . . . . 0.0 109.232 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.613 ' O ' ' N ' ' A' ' 32' ' ' GLU . 1.4 t0 -132.97 165.07 39.4 Favored Pre-proline 0 C--N 1.312 -1.063 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.516 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 43.8 Cg_endo -84.59 -15.11 6.29 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 124.654 1.871 . . . . 0.0 107.459 178.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.687 ' HB3' HD13 ' A' ' 31' ' ' ILE . 4.4 tt0 -83.54 -39.24 20.66 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 177.843 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.7 ' N ' HD13 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -106.2 1.24 10.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.103 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.613 ' N ' ' O ' ' A' ' 28' ' ' ASP . 22.6 mt-10 33.84 36.42 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 -179.242 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.558 ' C ' ' HA ' ' A' ' 27' ' ' MET . 17.9 mttm -164.72 149.6 9.61 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 119.203 -0.999 . . . . 0.0 110.565 -177.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.566 ' O ' ' CG ' ' A' ' 8' ' ' GLN . . . -53.07 141.83 21.64 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.574 -0.704 . . . . 0.0 109.658 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.642 ' O ' ' CD1' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -144.69 140.67 28.76 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 122.044 0.926 . . . . 0.0 109.901 179.347 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.967 ' HB ' HG23 ' A' ' 6' ' ' VAL . 1.7 t -84.57 97.31 5.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -179.41 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.564 ' HG2' ' CE1' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -115.87 -10.62 11.65 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.278 -0.889 . . . . 0.0 111.193 -178.604 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.53 ' O ' ' CB ' ' A' ' 24' ' ' ALA . 33.9 t0 -133.03 87.91 2.45 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.792 -1.192 . . . . 0.0 110.098 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.408 HG23 ' N ' ' A' ' 40' ' ' GLU . 24.0 m -54.08 -34.89 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.258 -0.901 . . . . 0.0 109.343 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.408 ' N ' HG23 ' A' ' 39' ' ' VAL . 74.3 mt-10 -69.5 -14.03 62.65 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.4 -0.813 . . . . 0.0 109.601 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.4 ' HA3' ' C ' ' A' ' 23' ' ' GLY . . . -76.44 -2.08 73.0 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.67 ' HB2' ' HB1' ' A' ' 21' ' ' ALA . . . -162.5 135.57 5.92 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.209 -1.171 . . . . 0.0 109.46 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.456 ' OG ' ' HG3' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -77.23 166.43 23.22 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.283 -0.886 . . . . 0.0 109.84 -179.75 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.465 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 5.4 pt20 -54.9 -43.2 73.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.45 -0.781 . . . . 0.0 109.633 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.446 ' N ' ' HG3' ' A' ' 44' ' ' GLN . 33.4 mm-40 -69.18 -11.04 60.45 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.235 -0.916 . . . . 0.0 109.163 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.456 ' HG3' ' OG ' ' A' ' 43' ' ' SER . 18.3 mt-10 -94.72 -44.63 7.7 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 178.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.431 ' O ' ' HB2' ' A' ' 51' ' ' MET . 72.6 t -60.83 -37.26 76.01 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 177.803 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.465 ' HB2' ' O ' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -67.93 -59.65 3.11 Favored 'General case' 0 C--N 1.31 -1.146 0 O-C-N 121.502 -0.749 . . . . 0.0 109.298 179.108 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.644 ' OE1' HG23 ' A' ' 20' ' ' ILE . 8.8 tt0 -51.59 -47.48 63.55 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.441 -0.903 . . . . 0.0 109.101 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 1.012 ' HA ' HD13 ' A' ' 20' ' ' ILE . . . -61.62 -27.42 68.64 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.3 -0.875 . . . . 0.0 109.204 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.591 ' CG ' ' CG2' ' A' ' 59' ' ' ILE . 0.8 OUTLIER -70.97 -27.14 63.51 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.544 -0.723 . . . . 0.0 110.405 -179.21 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -94.68 -8.45 37.82 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.919 -1.113 . . . . 0.0 110.127 -179.408 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.474 HG22 ' HB3' ' A' ' 16' ' ' SER . 91.7 m -88.07 -17.96 29.93 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.073 -1.017 . . . . 0.0 110.052 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' CYS . . . . . 0.818 ' SG ' ' HD2' ' A' ' 55' ' ' PRO . 35.5 t -69.73 147.07 96.24 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.028 -1.045 . . . . 0.0 109.783 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.818 ' HD2' ' SG ' ' A' ' 54' ' ' CYS . 45.0 Cg_endo -77.9 -63.32 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.119 1.589 . . . . 0.0 109.781 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.527 HG12 ' O ' ' A' ' 56' ' ' VAL . 75.9 t -80.65 -6.02 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.287 -0.883 . . . . 0.0 109.081 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.402 ' HA ' ' HB3' ' A' ' 54' ' ' CYS . 44.9 mt-30 45.8 71.46 0.28 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.315 -0.866 . . . . 0.0 109.545 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.481 ' SG ' ' HB3' ' A' ' 10' ' ' GLU . 2.5 m -94.44 21.1 7.5 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.277 -0.889 . . . . 0.0 109.129 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.658 HD12 HG22 ' A' ' 6' ' ' VAL . 1.9 tt -105.19 142.41 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.453 -0.78 . . . . 0.0 109.833 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.436 ' CG ' ' C ' ' A' ' 59' ' ' ILE . 10.1 m-70 -149.83 142.31 24.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.471 -0.768 . . . . 0.0 109.118 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.562 ' HA ' ' CB ' ' A' ' 4' ' ' PHE . 64.5 m95 -59.5 175.28 0.35 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.22 -0.925 . . . . 0.0 109.744 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.589 ' CG ' ' CG ' ' A' ' 3' ' ' LYS . 1.4 tp10 . . . . . 0 C--N 1.302 -1.466 0 O-C-N 121.475 -0.766 . . . . 0.0 109.116 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.477 ' O ' ' HB3' ' A' ' 4' ' ' PHE . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.333 0.587 . . . . 0.0 109.677 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.544 ' CB ' ' HA ' ' A' ' 61' ' ' TRP . 12.5 p90 177.07 -163.91 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.453 -0.779 . . . . 0.0 109.175 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.796 ' HA ' HG21 ' A' ' 36' ' ' VAL . 52.2 p90 171.44 -178.32 0.05 Allowed 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.95 HG21 ' CZ ' ' A' ' 25' ' ' PHE . 3.7 t -143.71 155.58 16.13 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.338 0 C-N-CA 117.205 -1.798 . . . . 0.0 111.301 179.273 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.525 ' O ' ' N ' ' A' ' 9' ' ' ASP . 0.2 OUTLIER -102.14 74.87 1.46 Allowed 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 178.864 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.532 ' HB3' ' O ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER -40.98 -24.43 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.523 0.678 . . . . 0.0 109.372 179.871 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.525 ' N ' ' O ' ' A' ' 7' ' ' ASP . 0.2 OUTLIER -54.27 -31.22 53.14 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.421 -0.799 . . . . 0.0 109.121 179.816 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.484 ' HG2' HG11 ' A' ' 56' ' ' VAL . 1.4 tp10 -100.83 11.27 39.91 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.346 -0.846 . . . . 0.0 109.152 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 6.6 t -76.97 122.03 24.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.242 -0.911 . . . . 0.0 109.905 -179.552 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.469 HG13 ' N ' ' A' ' 13' ' ' ALA . 16.4 pt -70.96 -145.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.41 -0.806 . . . . 0.0 109.413 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.469 ' N ' HG13 ' A' ' 12' ' ' ILE . . . -111.71 55.77 0.66 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.053 -1.029 . . . . 0.0 109.575 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.414 ' HB3' HD11 ' A' ' 12' ' ' ILE . 0.1 OUTLIER -139.35 155.37 47.72 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.121 -0.987 . . . . 0.0 109.692 179.858 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.43 ' O ' ' C ' ' A' ' 16' ' ' SER . 13.3 pt-20 -118.44 20.36 13.06 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.366 -0.833 . . . . 0.0 109.534 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.64 ' O ' HD12 ' A' ' 20' ' ' ILE . 0.2 OUTLIER -43.65 -60.95 1.56 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.354 -0.841 . . . . 0.0 109.269 179.899 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.533 ' SG ' ' N ' ' A' ' 18' ' ' VAL . 19.5 p -49.17 -48.59 44.92 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.386 -0.821 . . . . 0.0 109.297 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.533 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 5.0 t -49.6 -36.45 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.355 -0.841 . . . . 0.0 109.578 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.426 ' N ' ' OE1' ' A' ' 19' ' ' GLU . 0.2 OUTLIER -73.77 -35.91 65.03 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.041 -1.037 . . . . 0.0 109.321 -179.949 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.942 HD11 HG21 ' A' ' 53' ' ' THR . 2.5 mp -84.84 12.47 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.241 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.537 ' HB1' ' HB2' ' A' ' 42' ' ' ALA . . . -171.34 66.48 0.43 Allowed Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.355 -0.84 . . . . 0.0 109.311 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -72.51 56.42 2.77 Favored 'Trans proline' 0 C--N 1.303 -1.842 0 O-C-N 124.091 1.574 . . . . 0.0 110.058 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -179.85 -34.45 0.07 OUTLIER Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.476 ' O ' ' HA ' ' A' ' 36' ' ' VAL . . . -94.72 -25.28 16.77 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.246 -1.149 . . . . 0.0 109.303 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.95 ' CZ ' HG21 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -123.83 135.31 53.69 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.31 -0.869 . . . . 0.0 109.287 179.839 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.49 ' O ' ' HA ' ' A' ' 34' ' ' ALA . . . -163.05 145.15 10.16 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.537 ' HG3' ' CA ' ' A' ' 33' ' ' LYS . 10.7 ttm -77.72 152.7 33.55 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.96 -1.087 . . . . 0.0 109.123 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.636 ' O ' ' N ' ' A' ' 32' ' ' GLU . 1.1 t0 -123.84 162.26 41.98 Favored Pre-proline 0 C--N 1.313 -1.019 0 N-CA-C 106.614 -1.624 . . . . 0.0 106.614 179.067 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.456 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 46.5 Cg_endo -84.29 -15.09 6.67 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 125.06 2.084 . . . . 0.0 108.109 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -88.26 -34.34 17.75 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 178.369 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.596 ' CG1' ' HB3' ' A' ' 28' ' ' ASP . 1.6 pt -107.72 -2.49 10.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.042 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.636 ' N ' ' O ' ' A' ' 28' ' ' ASP . 0.0 OUTLIER 35.25 35.05 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -178.74 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.537 ' CA ' ' HG3' ' A' ' 27' ' ' MET . 23.7 mmtp -157.87 152.92 25.53 Favored 'General case' 0 N--CA 1.499 2.022 0 C-N-CA 119.42 -0.912 . . . . 0.0 110.542 -177.547 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.532 ' O ' ' HB3' ' A' ' 8' ' ' GLN . . . -61.74 142.75 57.06 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.616 -0.677 . . . . 0.0 110.059 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.651 ' CZ ' ' HB3' ' A' ' 37' ' ' LYS . 11.6 p90 -144.0 168.5 19.83 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 178.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.827 HG22 HG23 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -85.16 78.39 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.272 0 CA-C-O 121.782 0.801 . . . . 0.0 109.04 -178.079 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.651 ' HB3' ' CZ ' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -68.89 -3.74 13.82 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.846 -0.534 . . . . 0.0 110.539 -179.125 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.477 ' HB2' ' O ' ' A' ' 37' ' ' LYS . 36.7 t0 179.87 128.6 0.08 Allowed 'General case' 0 C--N 1.299 -1.611 0 C-N-CA 118.73 -1.188 . . . . 0.0 110.004 -178.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.529 HG12 ' CE1' ' A' ' 4' ' ' PHE . 15.8 m -79.6 -30.66 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.22 -0.925 . . . . 0.0 109.698 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -84.07 -9.75 58.38 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.183 -0.948 . . . . 0.0 109.267 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -61.95 -21.74 61.6 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.537 ' HB2' ' HB1' ' A' ' 21' ' ' ALA . . . -136.21 138.59 42.03 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.235 -1.156 . . . . 0.0 109.737 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.847 ' O ' HG23 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -71.66 158.32 36.38 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.244 -0.91 . . . . 0.0 109.643 -179.957 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.408 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 0.9 OUTLIER -47.53 -46.65 27.8 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.455 -0.778 . . . . 0.0 109.514 179.89 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -67.04 -9.54 40.21 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.292 -0.88 . . . . 0.0 109.449 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.468 ' HB2' ' HB1' ' A' ' 42' ' ' ALA . 27.5 mt-10 -97.91 -41.84 7.82 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 178.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.847 HG23 ' O ' ' A' ' 43' ' ' SER . 2.1 t -62.18 -40.59 88.17 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.924 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 178.139 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.408 ' HB2' ' O ' ' A' ' 44' ' ' GLN . 0.4 OUTLIER -73.17 -56.17 5.46 Favored 'General case' 0 C--N 1.308 -1.211 0 O-C-N 121.673 -0.642 . . . . 0.0 109.648 179.585 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.543 ' HB3' HG21 ' A' ' 20' ' ' ILE . 34.0 tt0 -52.94 -45.57 67.74 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.172 -0.955 . . . . 0.0 108.806 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.917 ' HA ' HD13 ' A' ' 20' ' ' ILE . . . -64.31 -17.87 64.07 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.32 -0.863 . . . . 0.0 108.93 179.328 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.79 ' HG3' HG21 ' A' ' 59' ' ' ILE . 2.6 ttm -80.93 -41.61 22.65 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.562 -0.712 . . . . 0.0 109.581 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -69.06 -24.54 64.18 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.282 -0.886 . . . . 0.0 109.704 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.942 HG21 HD11 ' A' ' 20' ' ' ILE . 4.9 p -72.5 -33.24 66.8 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.12 -0.988 . . . . 0.0 109.975 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' CYS . . . . . 0.798 ' SG ' ' HD2' ' A' ' 55' ' ' PRO . 9.4 t -65.19 146.6 98.91 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.056 -1.028 . . . . 0.0 109.864 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.798 ' HD2' ' SG ' ' A' ' 54' ' ' CYS . 45.2 Cg_endo -79.15 -69.49 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 124.099 1.579 . . . . 0.0 110.105 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.484 HG11 ' HG2' ' A' ' 10' ' ' GLU . 9.8 p -75.44 -16.43 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.201 -0.937 . . . . 0.0 108.791 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 63.94 47.81 3.33 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.449 -0.782 . . . . 0.0 109.837 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.491 ' SG ' ' CG1' ' A' ' 6' ' ' VAL . 11.5 p -48.61 -23.57 1.05 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.224 -0.923 . . . . 0.0 109.212 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.869 ' CA ' HG13 ' A' ' 6' ' ' VAL . 6.6 tt -69.32 159.09 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.574 -0.703 . . . . 0.0 110.047 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.527 ' C ' ' CD1' ' A' ' 61' ' ' TRP . 98.0 m-70 -149.82 -134.19 0.06 Allowed 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.666 ' CZ2' ' HE3' ' A' ' 51' ' ' MET . 74.4 m95 -151.68 168.74 24.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.835 -1.166 . . . . 0.0 110.062 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.451 ' O ' ' HB3' ' A' ' 3' ' ' LYS . 2.7 tt0 . . . . . 0 N--CA 1.489 1.512 0 O-C-N 121.431 -0.793 . . . . 0.0 109.404 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.513 ' HB3' ' HB3' ' A' ' 62' ' ' GLU . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.608 ' CZ ' ' HB ' ' A' ' 39' ' ' VAL . 29.3 p90 179.08 173.49 0.77 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.203 -0.936 . . . . 0.0 108.506 -179.632 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.577 ' HA ' HG11 ' A' ' 36' ' ' VAL . 6.4 p90 178.43 -161.63 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 1.051 HG21 ' CZ ' ' A' ' 25' ' ' PHE . 0.2 OUTLIER -139.3 -177.74 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 C-N-CA 117.545 -1.662 . . . . 0.0 112.076 -179.883 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.638 ' H ' HG12 ' A' ' 6' ' ' VAL . 5.6 m-20 -143.3 94.44 2.62 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.073 178.695 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.566 ' HB3' ' CD ' ' A' ' 33' ' ' LYS . 31.2 mm-40 -65.11 42.54 0.02 OUTLIER 'General case' 0 C--N 1.291 -1.942 0 CA-C-O 121.444 0.64 . . . . 0.0 111.293 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.495 ' N ' ' O ' ' A' ' 7' ' ' ASP . 0.3 OUTLIER -93.57 -16.87 23.95 Favored 'General case' 0 C--N 1.288 -2.094 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.548 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.806 ' CG ' HG11 ' A' ' 56' ' ' VAL . 0.9 OUTLIER -127.15 -1.16 6.44 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.505 -0.747 . . . . 0.0 110.472 -178.944 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.494 ' HB2' ' OE1' ' A' ' 8' ' ' GLN . 49.9 t -63.92 119.11 9.43 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.755 -1.216 . . . . 0.0 109.706 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.713 ' O ' ' HB2' ' A' ' 13' ' ' ALA . 11.8 pt -83.46 -45.1 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 O-C-N 121.364 -0.835 . . . . 0.0 109.481 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.713 ' HB2' ' O ' ' A' ' 12' ' ' ILE . . . 163.92 -27.95 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.163 -0.96 . . . . 0.0 110.033 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.496 ' SG ' ' HB2' ' A' ' 16' ' ' SER . 0.1 OUTLIER -48.24 154.44 0.59 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.011 -1.056 . . . . 0.0 110.041 -179.298 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.426 ' O ' ' C ' ' A' ' 16' ' ' SER . 6.9 mt-10 -113.35 18.25 17.91 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.404 -0.81 . . . . 0.0 109.193 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.8 ' O ' HD12 ' A' ' 20' ' ' ILE . 1.6 m -42.54 -60.17 1.62 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.424 -0.798 . . . . 0.0 109.5 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.682 ' SG ' ' CD2' ' A' ' 25' ' ' PHE . 18.1 p -51.05 -53.88 29.76 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.331 -0.856 . . . . 0.0 109.25 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.575 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 65.7 t -46.33 -37.7 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.334 -0.854 . . . . 0.0 109.207 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.05 -33.16 65.5 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.111 -0.993 . . . . 0.0 109.267 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.942 HG21 ' N ' ' A' ' 50' ' ' ALA . 2.4 mp -85.1 11.99 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.267 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.506 ' HB1' ' CB ' ' A' ' 42' ' ' ALA . . . 179.08 62.83 0.1 Allowed Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.429 -0.795 . . . . 0.0 109.49 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -73.34 54.73 2.88 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 124.134 1.597 . . . . 0.0 110.268 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -161.68 -40.57 0.02 OUTLIER Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.756 -1.737 . . . . 0.0 108.756 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.42 ' O ' ' HA ' ' A' ' 36' ' ' VAL . . . -96.41 -36.71 10.73 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.407 -1.055 . . . . 0.0 108.908 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 1.051 ' CZ ' HG21 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -95.17 138.01 33.45 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.301 -0.874 . . . . 0.0 108.835 179.624 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.486 ' C ' ' HA ' ' A' ' 34' ' ' ALA . . . -162.87 121.69 2.13 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.027 -1.046 . . . . 0.0 110.197 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.576 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 6.8 tmm? -62.0 147.81 45.9 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.175 -0.953 . . . . 0.0 109.506 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.624 ' O ' ' N ' ' A' ' 32' ' ' GLU . 0.8 OUTLIER -125.67 161.78 48.8 Favored Pre-proline 0 C--N 1.315 -0.907 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 179.083 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.45 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 46.4 Cg_endo -84.0 -15.79 6.66 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 124.96 2.032 . . . . 0.0 107.958 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.39 -35.89 18.08 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 178.329 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.639 HD12 ' O ' ' A' ' 33' ' ' LYS . 2.7 pt -105.58 -1.99 9.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.008 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.624 ' N ' ' O ' ' A' ' 28' ' ' ASP . 2.1 mt-10 34.75 34.97 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -178.51 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.639 ' O ' HD12 ' A' ' 31' ' ' ILE . 34.2 mttp -160.49 151.67 19.14 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.213 -178.058 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.594 ' HB1' ' CD1' ' A' ' 25' ' ' PHE . . . -70.09 151.0 45.98 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.249 -0.907 . . . . 0.0 110.658 -179.026 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.651 ' CZ ' ' HB3' ' A' ' 37' ' ' LYS . 4.3 p90 -148.07 150.41 33.85 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 178.528 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.724 HG21 HG12 ' A' ' 39' ' ' VAL . 10.6 p -69.59 63.39 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 C-N-CA 119.055 -1.058 . . . . 0.0 108.205 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.651 ' HB3' ' CZ ' ' A' ' 35' ' ' TYR . 13.7 pttp -47.98 -27.49 2.24 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.265 0.555 . . . . 0.0 110.481 -179.188 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -157.33 92.27 1.23 Allowed 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 119.207 -0.997 . . . . 0.0 109.753 -178.13 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.724 HG12 HG21 ' A' ' 36' ' ' VAL . 26.8 m -49.11 -21.99 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.425 -0.797 . . . . 0.0 109.773 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.44 -16.79 57.2 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.149 -0.969 . . . . 0.0 109.476 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -77.45 1.38 66.05 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.506 ' CB ' ' HB1' ' A' ' 21' ' ' ALA . . . -157.27 124.0 5.03 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.14 -1.212 . . . . 0.0 109.781 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.554 ' N ' ' HG2' ' A' ' 46' ' ' GLU . 0.3 OUTLIER -53.86 163.0 0.79 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.375 -0.828 . . . . 0.0 109.754 179.708 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.448 ' HG3' ' HG2' ' A' ' 45' ' ' GLU . 11.1 pt20 -67.95 -40.34 83.26 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.351 -0.843 . . . . 0.0 109.853 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.504 ' O ' ' HG2' ' A' ' 48' ' ' GLU . 1.6 mm-40 -72.45 -26.23 61.75 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.075 -1.016 . . . . 0.0 109.53 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.56 ' O ' HG22 ' A' ' 20' ' ' ILE . 5.3 pt-20 -85.0 -31.5 23.45 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 105.476 -2.046 . . . . 0.0 105.476 177.508 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 43' ' ' SER . 2.5 t -65.28 -34.64 71.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.059 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.517 ' O ' ' N ' ' A' ' 51' ' ' MET . 8.4 pt-20 -74.45 -56.84 4.4 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.16 -0.962 . . . . 0.0 109.417 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.581 ' C ' HG21 ' A' ' 20' ' ' ILE . 61.8 tt0 -41.3 -38.32 1.15 Allowed 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.942 ' N ' HG21 ' A' ' 20' ' ' ILE . . . -67.95 -41.63 82.21 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.043 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.573 ' HE2' HG22 ' A' ' 59' ' ' ILE . 3.7 ttm -62.93 -47.72 82.04 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.94 -31.61 71.15 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.16 -0.963 . . . . 0.0 109.329 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 70.0 m -98.29 88.22 4.11 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.313 -0.867 . . . . 0.0 109.173 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' CYS . . . . . 0.536 ' SG ' ' HD2' ' A' ' 55' ' ' PRO . 21.6 t -161.15 145.82 10.38 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.198 -0.939 . . . . 0.0 109.334 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.712 ' O ' HG12 ' A' ' 56' ' ' VAL . 43.3 Cg_endo -71.21 101.3 1.09 Allowed 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 123.858 1.452 . . . . 0.0 109.425 179.347 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.806 HG11 ' CG ' ' A' ' 10' ' ' GLU . 0.4 OUTLIER 82.41 -9.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 -178.624 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.529 ' HA ' ' HB3' ' A' ' 54' ' ' CYS . 0.1 OUTLIER 63.04 148.38 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.441 -0.787 . . . . 0.0 110.641 179.393 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.585 ' O ' ' CE1' ' A' ' 60' ' ' HIS . 2.4 p -148.87 -34.81 0.2 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.72 -0.613 . . . . 0.0 109.403 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.881 ' HA ' HG13 ' A' ' 6' ' ' VAL . 17.1 mt -58.12 153.67 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.026 -1.046 . . . . 0.0 109.418 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.585 ' CE1' ' O ' ' A' ' 58' ' ' CYS . 45.6 m80 -159.06 125.0 4.41 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.345 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.565 ' HA ' ' CB ' ' A' ' 4' ' ' PHE . 87.8 m95 -55.22 171.11 0.17 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.121 -0.987 . . . . 0.0 109.108 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.513 ' HB3' ' HB3' ' A' ' 3' ' ' LYS . 1.3 tt0 . . . . . 0 C--N 1.302 -1.461 0 O-C-N 121.248 -0.907 . . . . 0.0 109.245 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.457 ' O ' ' HB3' ' A' ' 4' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.263 0.554 . . . . 0.0 109.602 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.565 ' CB ' ' HA ' ' A' ' 61' ' ' TRP . 6.1 p90 177.43 -172.12 0.1 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.321 -0.862 . . . . 0.0 109.262 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.623 ' HA ' HG11 ' A' ' 36' ' ' VAL . 46.8 p90 169.2 -177.77 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 1.086 HG21 ' CZ ' ' A' ' 25' ' ' PHE . 3.1 t -139.39 159.5 28.45 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.4 0 C-N-CA 116.962 -1.895 . . . . 0.0 111.417 179.307 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.544 ' N ' HG12 ' A' ' 6' ' ' VAL . 1.2 m-20 -106.9 72.52 0.89 Allowed 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.521 ' HB3' ' O ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER -41.8 -23.87 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 179.486 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 7' ' ' ASP . 19.5 t0 -50.92 -38.54 50.71 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.562 ' HB3' ' CB ' ' A' ' 58' ' ' CYS . 20.8 tt0 -82.02 -19.99 39.28 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.369 -0.832 . . . . 0.0 108.942 179.274 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.512 ' HB3' ' O ' ' A' ' 8' ' ' GLN . 36.9 t -51.15 123.92 10.47 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.477 -0.764 . . . . 0.0 109.806 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.683 ' O ' ' HB2' ' A' ' 13' ' ' ALA . 10.0 pt -75.32 -48.7 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.376 -0.827 . . . . 0.0 109.541 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.683 ' HB2' ' O ' ' A' ' 12' ' ' ILE . . . 166.13 -33.03 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.028 -1.045 . . . . 0.0 110.132 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -52.32 159.6 0.95 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.073 -1.017 . . . . 0.0 109.519 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.407 ' O ' ' C ' ' A' ' 16' ' ' SER . 13.6 pt-20 -123.75 21.85 9.1 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.31 -0.869 . . . . 0.0 109.505 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.428 ' O ' HD12 ' A' ' 20' ' ' ILE . 0.6 OUTLIER -44.53 -58.57 2.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.175 -0.953 . . . . 0.0 109.023 179.797 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.674 ' SG ' ' N ' ' A' ' 18' ' ' VAL . 17.6 p -49.96 -58.77 4.76 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.433 -0.792 . . . . 0.0 109.166 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.674 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 59.4 t -45.26 -34.41 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.224 -0.922 . . . . 0.0 109.044 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.39 -39.53 71.13 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.162 -0.961 . . . . 0.0 108.897 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.728 ' HB ' ' HB2' ' A' ' 50' ' ' ALA . 1.9 mt -87.1 17.77 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 177.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.639 ' HB1' ' HB2' ' A' ' 42' ' ' ALA . . . 172.31 65.42 0.03 OUTLIER Pre-proline 0 N--CA 1.489 1.482 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.503 ' N ' ' O ' ' A' ' 18' ' ' VAL . 43.8 Cg_endo -72.14 -2.09 11.07 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.108 1.583 . . . . 0.0 110.65 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.506 ' O ' ' HB3' ' A' ' 38' ' ' ASP . . . -92.2 -71.85 1.2 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.763 ' HB2' ' O ' ' A' ' 38' ' ' ASP . . . -66.82 -30.15 70.26 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.353 -1.087 . . . . 0.0 109.364 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 1.086 ' CZ ' HG21 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -105.42 133.75 49.66 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 118.821 -1.152 . . . . 0.0 109.904 -179.734 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.553 ' O ' ' CD1' ' A' ' 35' ' ' TYR . . . -166.27 123.97 1.42 Allowed 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.478 -0.764 . . . . 0.0 109.156 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.56 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER -62.17 155.63 23.91 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.169 -0.957 . . . . 0.0 109.092 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.589 ' O ' ' HA ' ' A' ' 32' ' ' GLU . 4.0 t0 -128.2 161.99 53.02 Favored Pre-proline 0 C--N 1.309 -1.166 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.477 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 43.9 Cg_endo -85.0 -18.16 4.42 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 124.428 1.752 . . . . 0.0 108.562 -179.422 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -89.32 -32.75 17.19 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 177.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.635 HD12 ' HB3' ' A' ' 35' ' ' TYR . 0.8 OUTLIER -104.79 2.19 10.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 178.071 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.589 ' HA ' ' O ' ' A' ' 28' ' ' ASP . 9.9 mt-10 26.34 43.68 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.51 0.672 . . . . 0.0 110.212 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.53 ' O ' ' HA ' ' A' ' 27' ' ' MET . 6.2 mttt -172.13 148.46 2.2 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 119.134 -1.027 . . . . 0.0 110.653 -179.525 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.56 ' HA ' ' HA ' ' A' ' 27' ' ' MET . . . -54.71 142.21 29.44 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.684 -0.635 . . . . 0.0 110.634 -179.451 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.71 ' CE2' ' HG3' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -143.91 151.01 39.26 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-O 121.764 0.792 . . . . 0.0 109.95 179.156 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.805 ' HB ' HG23 ' A' ' 6' ' ' VAL . 0.9 OUTLIER -91.04 109.19 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.424 -1.422 . . . . 0.0 109.563 -178.637 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.71 ' HG3' ' CE2' ' A' ' 35' ' ' TYR . 23.5 mmtt -125.75 -53.25 1.56 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.423 -0.798 . . . . 0.0 110.445 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.763 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 61.6 t0 -86.98 71.94 10.17 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.599 -0.688 . . . . 0.0 110.462 -177.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.523 HG23 ' N ' ' A' ' 40' ' ' GLU . 24.8 m -46.58 -40.59 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.322 -0.861 . . . . 0.0 109.194 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.523 ' N ' HG23 ' A' ' 39' ' ' VAL . 11.0 mm-40 -66.33 -17.71 64.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.352 -0.842 . . . . 0.0 109.499 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' A' ' 38' ' ' ASP . . . -72.43 -21.13 79.58 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.639 ' HB2' ' HB1' ' A' ' 21' ' ' ALA . . . -132.02 134.67 45.83 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.277 -1.131 . . . . 0.0 109.296 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.692 ' O ' HG23 ' A' ' 47' ' ' VAL . 0.4 OUTLIER -79.29 -166.99 1.04 Allowed 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.224 -0.922 . . . . 0.0 109.775 -179.8 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.477 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 3.9 mt-30 -71.44 -49.58 40.27 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.664 -0.647 . . . . 0.0 109.56 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.459 ' O ' ' HB2' ' A' ' 49' ' ' GLU . 1.8 pm0 -72.77 -12.84 61.16 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.175 -0.953 . . . . 0.0 109.298 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.476 ' HG3' ' HB2' ' A' ' 43' ' ' SER . 29.9 mt-10 -90.71 -42.01 10.96 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 178.491 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.692 HG23 ' O ' ' A' ' 43' ' ' SER . 24.2 t -63.95 -47.53 90.12 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 CA-C-N 114.789 -1.096 . . . . 0.0 108.093 178.076 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.526 ' O ' ' N ' ' A' ' 51' ' ' MET . 0.3 OUTLIER -67.97 -62.23 1.5 Allowed 'General case' 0 C--N 1.307 -1.243 0 O-C-N 121.584 -0.697 . . . . 0.0 109.591 179.583 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.628 ' HB3' HG21 ' A' ' 20' ' ' ILE . 34.6 mt-10 -43.23 -52.01 5.86 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 119.44 -0.904 . . . . 0.0 108.918 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.728 ' HB2' ' HB ' ' A' ' 20' ' ' ILE . . . -65.53 -27.86 68.76 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.212 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' MET . . . . . 1.029 ' CG ' HG21 ' A' ' 59' ' ' ILE . 22.5 ttm -76.88 -21.68 54.58 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.627 -0.67 . . . . 0.0 110.35 -179.158 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.81 -15.78 26.11 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.085 -1.009 . . . . 0.0 109.759 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.527 ' OG1' ' CD1' ' A' ' 20' ' ' ILE . 76.2 p -91.91 73.63 5.66 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.189 -0.944 . . . . 0.0 109.455 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 19.0 t -151.65 128.49 5.43 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.219 -0.926 . . . . 0.0 109.684 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.596 ' C ' HG12 ' A' ' 56' ' ' VAL . 47.1 Cg_endo -75.48 53.73 3.64 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 123.857 1.451 . . . . 0.0 109.912 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.596 HG12 ' C ' ' A' ' 55' ' ' PRO . 1.5 p 160.42 -26.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 60.19 72.96 0.5 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.569 -0.707 . . . . 0.0 109.933 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.562 ' CB ' ' HB3' ' A' ' 10' ' ' GLU . 29.7 p -84.6 7.98 18.31 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.108 -0.995 . . . . 0.0 109.198 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 1.029 HG21 ' CG ' ' A' ' 51' ' ' MET . 1.0 OUTLIER -75.87 155.62 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.348 -0.845 . . . . 0.0 110.505 -179.232 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.454 ' CG ' ' O ' ' A' ' 59' ' ' ILE . 89.9 m-70 -155.52 125.36 6.51 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.565 ' HA ' ' CB ' ' A' ' 4' ' ' PHE . 62.5 m95 -73.05 173.89 8.69 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.194 -0.941 . . . . 0.0 109.652 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.453 ' HB3' ' HB3' ' A' ' 3' ' ' LYS . 9.6 tp10 . . . . . 0 N--CA 1.49 1.526 0 O-C-N 121.327 -0.858 . . . . 0.0 109.333 -179.65 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.475 ' O ' ' HB3' ' A' ' 4' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.562 ' CB ' ' HA ' ' A' ' 61' ' ' TRP . 2.5 p90 177.9 -178.73 0.24 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.293 -0.879 . . . . 0.0 110.007 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.463 ' HA ' HG11 ' A' ' 36' ' ' VAL . 20.3 p90 174.68 -167.0 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 1.088 HG21 ' CZ ' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -137.03 -166.36 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 C-N-CA 118.406 -1.318 . . . . 0.0 111.066 179.713 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.532 ' O ' ' N ' ' A' ' 9' ' ' ASP . 0.3 OUTLIER -151.65 98.98 2.55 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 114.413 -1.267 . . . . 0.0 108.056 177.784 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.6 ' CG ' ' HB3' ' A' ' 33' ' ' LYS . 2.9 mp0 -65.15 43.3 0.02 OUTLIER 'General case' 0 C--N 1.29 -2.001 0 CA-C-O 121.367 0.603 . . . . 0.0 110.392 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.532 ' N ' ' O ' ' A' ' 7' ' ' ASP . 0.5 OUTLIER -99.42 -29.68 12.62 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.265 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.471 ' HB2' ' SG ' ' A' ' 58' ' ' CYS . 0.0 OUTLIER -118.31 25.59 10.2 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.859 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.712 ' SG ' ' HG2' ' A' ' 33' ' ' LYS . 14.3 t -90.22 119.07 30.22 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.225 -0.922 . . . . 0.0 110.432 -179.327 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.439 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 12.2 pt -88.61 5.01 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.293 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . 61.76 65.26 0.94 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.367 -0.833 . . . . 0.0 109.665 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.783 ' SG ' ' OG ' ' A' ' 16' ' ' SER . 31.7 p -102.22 -9.89 20.06 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.082 -1.011 . . . . 0.0 109.678 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.447 ' OE1' ' HG3' ' A' ' 19' ' ' GLU . 0.0 OUTLIER 70.7 4.29 4.93 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.24 -0.913 . . . . 0.0 109.84 179.591 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.783 ' OG ' ' SG ' ' A' ' 14' ' ' CYS . 29.6 p -62.15 -69.77 0.23 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.068 -1.02 . . . . 0.0 109.335 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.634 ' SG ' ' N ' ' A' ' 18' ' ' VAL . 19.4 p -49.33 -55.87 11.43 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.328 -0.857 . . . . 0.0 109.385 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.634 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 59.6 t -46.32 -33.14 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.199 -0.938 . . . . 0.0 109.012 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.447 ' HG3' ' OE1' ' A' ' 15' ' ' GLU . 5.3 mt-10 -71.05 -34.78 71.57 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.999 -1.063 . . . . 0.0 108.592 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.633 HG22 ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -81.16 6.05 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.252 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.59 ' HB1' ' HB2' ' A' ' 42' ' ' ALA . . . 176.82 65.47 0.07 OUTLIER Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.274 -0.891 . . . . 0.0 109.009 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.54 ' N ' ' O ' ' A' ' 18' ' ' VAL . 46.0 Cg_endo -71.92 0.12 7.62 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.039 1.547 . . . . 0.0 110.783 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -96.3 -31.66 7.09 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.679 ' HB1' ' O ' ' A' ' 38' ' ' ASP . . . -109.4 -53.65 2.63 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.333 -1.098 . . . . 0.0 109.99 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 1.088 ' CZ ' HG21 ' A' ' 6' ' ' VAL . 0.3 OUTLIER -75.22 139.43 42.59 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 118.561 -1.256 . . . . 0.0 107.689 179.727 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.574 ' O ' ' CD1' ' A' ' 35' ' ' TYR . . . -172.13 140.84 1.22 Allowed 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.263 -0.898 . . . . 0.0 109.561 -179.217 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.554 ' HA ' ' C ' ' A' ' 33' ' ' LYS . 5.1 mtp -71.55 158.35 36.39 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.292 -0.88 . . . . 0.0 109.94 -179.381 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.613 ' O ' ' N ' ' A' ' 32' ' ' GLU . 3.9 t0 -126.31 161.52 51.74 Favored Pre-proline 0 C--N 1.309 -1.154 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.489 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 44.3 Cg_endo -85.19 -16.13 5.15 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 O-C-N 124.691 1.89 . . . . 0.0 108.626 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -91.53 -29.7 16.83 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 178.06 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.575 ' CD1' ' HB3' ' A' ' 35' ' ' TYR . 1.0 OUTLIER -106.2 -5.25 10.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.25 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.613 ' N ' ' O ' ' A' ' 28' ' ' ASP . 6.9 mm-40 33.59 41.52 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 121.433 0.635 . . . . 0.0 109.303 -179.054 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.712 ' HG2' ' SG ' ' A' ' 11' ' ' CYS . 0.2 OUTLIER -169.74 146.3 3.22 Favored 'General case' 0 N--CA 1.501 2.109 0 C-N-CA 119.601 -0.839 . . . . 0.0 110.365 -179.176 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.742 ' HB1' ' CD1' ' A' ' 25' ' ' PHE . . . -47.99 146.54 2.47 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.425 -0.797 . . . . 0.0 111.564 -178.715 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.676 ' CE2' ' CG ' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -135.83 -174.29 3.61 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.965 -1.085 . . . . 0.0 110.086 179.075 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.784 HG23 ' CG2' ' A' ' 6' ' ' VAL . 2.5 t -125.98 92.44 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.676 ' CG ' ' CE2' ' A' ' 35' ' ' TYR . 18.5 mmtt -103.87 -46.07 4.59 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 119.567 -0.853 . . . . 0.0 111.286 -178.407 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.679 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 62.8 t0 -93.59 118.24 31.11 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 119.207 -0.997 . . . . 0.0 110.564 -177.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.2 m -80.52 -17.11 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.338 -0.851 . . . . 0.0 109.268 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.424 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -103.01 2.39 34.87 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.355 -0.841 . . . . 0.0 109.558 -179.994 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.569 ' HA3' ' HB2' ' A' ' 24' ' ' ALA . . . -78.24 -7.64 87.71 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.674 -1.371 . . . . 0.0 109.674 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.59 ' HB2' ' HB1' ' A' ' 21' ' ' ALA . . . -149.08 127.84 12.51 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.229 -1.159 . . . . 0.0 109.566 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.927 ' O ' HG23 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -67.61 166.79 14.28 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.235 -0.916 . . . . 0.0 109.43 179.951 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.463 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -51.66 -45.28 63.32 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.412 -0.805 . . . . 0.0 109.438 179.979 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.414 ' O ' ' CG ' ' A' ' 49' ' ' GLU . 50.0 mm-40 -67.54 -8.4 33.63 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.362 -0.836 . . . . 0.0 109.646 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.528 ' HB2' ' HB1' ' A' ' 42' ' ' ALA . 11.9 mt-10 -100.32 -43.88 6.11 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 179.022 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.927 HG23 ' O ' ' A' ' 43' ' ' SER . 1.9 t -60.49 -40.54 84.63 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 178.238 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.463 ' HB2' ' O ' ' A' ' 44' ' ' GLN . 0.2 OUTLIER -74.86 -48.43 25.0 Favored 'General case' 0 C--N 1.308 -1.227 0 O-C-N 121.527 -0.733 . . . . 0.0 109.198 179.293 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.527 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . 34.1 mt-10 -53.5 -54.01 43.26 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.189 -0.944 . . . . 0.0 109.096 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.522 ' HB2' ' CG2' ' A' ' 20' ' ' ILE . . . -63.83 -18.04 63.73 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.143 -0.973 . . . . 0.0 108.945 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.595 ' HE3' HD12 ' A' ' 59' ' ' ILE . 38.6 ttm -77.87 -18.31 56.37 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.416 -0.802 . . . . 0.0 109.208 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -105.35 -23.73 12.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.32 -0.863 . . . . 0.0 109.599 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -62.39 -48.02 81.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.23 -0.919 . . . . 0.0 109.768 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' CYS . . . . . 0.79 ' SG ' ' HD2' ' A' ' 55' ' ' PRO . 4.6 t -48.88 147.41 4.62 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.139 -0.975 . . . . 0.0 109.606 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.79 ' HD2' ' SG ' ' A' ' 54' ' ' CYS . 44.1 Cg_endo -73.91 -64.65 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.986 1.519 . . . . 0.0 110.509 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.427 ' O ' ' HB2' ' A' ' 57' ' ' GLN . 38.4 t -79.08 -25.02 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.115 -0.99 . . . . 0.0 109.098 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.427 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER 67.38 72.04 0.35 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.277 -0.889 . . . . 0.0 109.755 179.719 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.471 ' SG ' ' HB2' ' A' ' 10' ' ' GLU . 0.7 OUTLIER -89.87 21.89 3.4 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.188 -0.945 . . . . 0.0 109.155 179.571 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 1.038 HD13 ' N ' ' A' ' 60' ' ' HIS . 0.0 OUTLIER -108.65 140.69 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.341 -0.85 . . . . 0.0 109.564 -179.651 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 1.038 ' N ' HD13 ' A' ' 59' ' ' ILE . 2.7 m80 -142.48 -177.47 5.29 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.279 -0.888 . . . . 0.0 109.532 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.562 ' HA ' ' CB ' ' A' ' 4' ' ' PHE . 36.0 m95 -97.84 -179.25 4.36 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.014 -1.054 . . . . 0.0 109.697 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.2 tp10 . . . . . 0 N--CA 1.49 1.541 0 O-C-N 121.267 -0.896 . . . . 0.0 109.621 -179.561 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.495 ' O ' ' HB3' ' A' ' 4' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.464 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.553 ' CB ' ' HA ' ' A' ' 61' ' ' TRP . 53.8 p90 173.06 -176.06 0.06 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.357 -0.839 . . . . 0.0 108.895 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.79 ' HA ' HG11 ' A' ' 36' ' ' VAL . 51.6 p90 175.84 -173.28 0.08 Allowed 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 179.258 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.789 HG13 ' HB ' ' A' ' 59' ' ' ILE . 2.9 t -145.57 166.37 10.0 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.428 0 C-N-CA 117.397 -1.721 . . . . 0.0 112.094 -179.194 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.57 ' H ' HG12 ' A' ' 6' ' ' VAL . 8.5 t0 -105.22 74.56 1.11 Allowed 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.564 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.537 ' O ' ' CD ' ' A' ' 33' ' ' LYS . 3.1 pm0 -53.72 -11.51 0.39 Allowed 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.362 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.42 ' N ' ' C ' ' A' ' 7' ' ' ASP . 0.1 OUTLIER -65.61 -32.8 74.57 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.634 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.578 ' HB3' ' CB ' ' A' ' 58' ' ' CYS . 0.1 OUTLIER -91.16 -16.3 27.97 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.09 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.409 ' HB3' ' O ' ' A' ' 8' ' ' GLN . 7.2 t -43.46 128.41 4.97 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.432 -0.793 . . . . 0.0 110.075 -179.288 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.585 HD11 ' HB3' ' A' ' 14' ' ' CYS . 4.5 pt -79.25 -134.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.444 -0.785 . . . . 0.0 109.066 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -119.67 43.55 2.61 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.762 -1.211 . . . . 0.0 110.017 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 1.009 ' SG ' ' OG ' ' A' ' 16' ' ' SER . 0.1 OUTLIER -124.91 156.83 37.33 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.075 -1.016 . . . . 0.0 109.594 179.557 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.437 ' O ' ' C ' ' A' ' 16' ' ' SER . 14.3 mt-10 -117.26 17.75 14.64 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.299 -0.876 . . . . 0.0 109.685 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' SER . . . . . 1.009 ' OG ' ' SG ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -44.42 -70.57 0.1 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.245 -0.909 . . . . 0.0 108.996 179.722 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.645 ' SG ' ' N ' ' A' ' 18' ' ' VAL . 8.3 p -44.17 -51.51 8.06 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.262 -0.898 . . . . 0.0 109.325 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.645 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 41.5 t -50.15 -33.31 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.362 -0.836 . . . . 0.0 109.61 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -84.74 -30.93 24.31 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.129 -0.982 . . . . 0.0 109.414 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.841 HD12 ' O ' ' A' ' 16' ' ' SER . 2.7 mp -81.76 9.12 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.206 -0.934 . . . . 0.0 108.646 178.709 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -169.86 69.41 0.62 Allowed Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.17 -0.956 . . . . 0.0 109.309 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -71.72 76.83 1.9 Allowed 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 124.206 1.635 . . . . 0.0 110.181 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.444 ' C ' ' HA3' ' A' ' 41' ' ' GLY . . . 165.02 -42.55 0.29 Allowed Glycine 0 N--CA 1.488 2.117 0 N-CA-C 108.672 -1.771 . . . . 0.0 108.672 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.487 ' HA ' ' O ' ' A' ' 38' ' ' ASP . . . -92.99 -49.3 6.09 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.415 -1.05 . . . . 0.0 109.046 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.782 ' CZ ' HG21 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -96.06 137.84 34.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.269 -0.894 . . . . 0.0 108.818 179.582 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.445 ' O ' ' CD1' ' A' ' 35' ' ' TYR . . . -174.77 126.66 0.3 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.025 -1.047 . . . . 0.0 109.609 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.596 ' HA ' ' C ' ' A' ' 33' ' ' LYS . 29.3 mtp -58.56 150.86 21.85 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.315 -0.865 . . . . 0.0 109.365 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.615 ' O ' ' N ' ' A' ' 32' ' ' GLU . 1.6 t0 -130.26 163.99 44.03 Favored Pre-proline 0 C--N 1.311 -1.085 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.487 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 43.9 Cg_endo -83.29 -16.44 7.1 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 124.803 1.949 . . . . 0.0 107.571 179.096 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.713 ' HB3' HD13 ' A' ' 31' ' ' ILE . 8.1 tt0 -82.84 -42.38 17.9 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 177.819 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.745 ' N ' HD13 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -102.14 0.26 10.26 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 178.098 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.615 ' N ' ' O ' ' A' ' 28' ' ' ASP . 2.9 mm-40 35.33 34.55 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -179.016 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.596 ' C ' ' HA ' ' A' ' 27' ' ' MET . 59.4 mttp -163.55 151.16 12.83 Favored 'General case' 0 N--CA 1.499 2.0 0 C-N-CA 119.556 -0.858 . . . . 0.0 110.183 -177.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.539 ' HA ' ' HA ' ' A' ' 27' ' ' MET . . . -59.18 139.97 56.38 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.444 -0.785 . . . . 0.0 110.206 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.647 ' CE2' ' HA ' ' A' ' 37' ' ' LYS . 1.5 p90 -154.06 155.89 36.31 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.79 HG11 ' HA ' ' A' ' 5' ' ' TYR . 14.9 p -67.01 67.19 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 120.905 -1.122 . . . . 0.0 108.933 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.647 ' HA ' ' CE2' ' A' ' 35' ' ' TYR . 0.1 OUTLIER -51.01 -19.05 0.92 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.533 -0.729 . . . . 0.0 110.391 -179.664 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.492 ' N ' ' HG3' ' A' ' 37' ' ' LYS . 11.5 t70 -167.21 103.42 0.53 Allowed 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.996 -1.065 . . . . 0.0 109.674 -179.082 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.543 ' HB ' ' CE1' ' A' ' 4' ' ' PHE . 1.8 m -55.39 -24.39 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.378 -0.826 . . . . 0.0 109.835 -179.475 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -90.89 -0.6 57.77 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.168 -0.958 . . . . 0.0 109.601 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.45 ' N ' ' OD2' ' A' ' 38' ' ' ASP . . . -76.36 -16.05 81.02 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -141.92 161.74 37.21 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.192 -1.181 . . . . 0.0 109.333 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.07 173.89 9.56 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.263 -0.898 . . . . 0.0 109.571 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.457 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 1.0 OUTLIER -70.09 -38.56 75.7 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.363 -0.836 . . . . 0.0 109.233 179.895 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 36.0 mm-40 -66.91 -21.87 65.97 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.143 -0.973 . . . . 0.0 108.875 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -90.2 -43.1 10.65 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 178.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 4.0 t -58.25 -38.11 66.77 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 178.336 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.457 ' HB2' ' O ' ' A' ' 44' ' ' GLN . 0.1 OUTLIER -70.22 -65.93 0.66 Allowed 'General case' 0 C--N 1.308 -1.229 0 O-C-N 121.562 -0.712 . . . . 0.0 109.584 179.715 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.645 ' C ' HG21 ' A' ' 20' ' ' ILE . 16.1 mt-10 -47.5 -42.45 23.0 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.259 -0.9 . . . . 0.0 109.052 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.824 ' N ' HG21 ' A' ' 20' ' ' ILE . . . -68.59 -27.08 65.73 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.356 -0.84 . . . . 0.0 109.024 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.712 ' HG3' HG21 ' A' ' 59' ' ' ILE . 6.6 ttm -83.92 -17.63 40.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.482 -0.761 . . . . 0.0 109.904 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -95.02 -10.36 31.11 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.048 -1.032 . . . . 0.0 109.795 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.745 ' OG1' HD13 ' A' ' 20' ' ' ILE . 12.0 p -91.08 8.05 37.42 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.242 -0.911 . . . . 0.0 109.642 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' CYS . . . . . 0.518 ' SG ' ' HD2' ' A' ' 55' ' ' PRO . 8.7 t -95.35 140.74 22.51 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.22 -0.925 . . . . 0.0 109.399 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.518 ' HD2' ' SG ' ' A' ' 54' ' ' CYS . 46.1 Cg_endo -75.16 -58.18 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.942 1.496 . . . . 0.0 109.931 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.524 HG21 ' HG2' ' A' ' 10' ' ' GLU . 7.6 p -84.63 -23.19 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.319 -0.863 . . . . 0.0 108.898 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.503 ' CB ' ' O ' ' A' ' 56' ' ' VAL . 1.9 tt0 77.71 -66.44 0.22 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.495 -0.753 . . . . 0.0 110.459 179.557 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.578 ' CB ' ' HB3' ' A' ' 10' ' ' GLU . 2.5 p 43.57 26.41 0.11 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.225 -0.922 . . . . 0.0 109.156 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.789 ' HB ' HG13 ' A' ' 6' ' ' VAL . 9.4 tt -125.77 164.1 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.466 -0.771 . . . . 0.0 110.304 -178.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.665 ' CD2' ' CZ ' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -172.64 173.61 3.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.337 -0.852 . . . . 0.0 109.245 179.987 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.553 ' HA ' ' CB ' ' A' ' 4' ' ' PHE . 50.9 m95 -98.66 164.3 12.29 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.152 -0.968 . . . . 0.0 109.767 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.485 ' N ' ' HA ' ' A' ' 4' ' ' PHE . 20.6 tt0 . . . . . 0 N--CA 1.489 1.524 0 O-C-N 121.362 -0.836 . . . . 0.0 109.469 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.509 ' HB3' ' HB3' ' A' ' 62' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.604 ' CE1' ' HA ' ' A' ' 39' ' ' VAL . 20.7 p90 179.2 -159.05 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.166 -0.959 . . . . 0.0 109.768 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.7 ' HA ' HG21 ' A' ' 36' ' ' VAL . 4.6 p90 168.04 -178.75 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 -179.448 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 1.104 HG23 HG22 ' A' ' 36' ' ' VAL . 1.6 t -121.64 145.07 28.82 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.251 0 C-N-CA 116.914 -1.914 . . . . 0.0 111.954 -179.48 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.495 ' O ' ' N ' ' A' ' 9' ' ' ASP . 0.2 OUTLIER -96.7 38.9 1.19 Allowed 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.718 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.67 ' HG3' HG21 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -38.6 -27.94 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.125 0.488 . . . . 0.0 110.15 -179.689 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.495 ' N ' ' O ' ' A' ' 7' ' ' ASP . 4.8 t0 -46.62 -25.3 0.68 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.159 -0.963 . . . . 0.0 108.822 179.577 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.477 ' HB3' ' HB3' ' A' ' 58' ' ' CYS . 14.7 tt0 -108.04 -15.48 14.51 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.465 -0.772 . . . . 0.0 109.577 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.654 ' SG ' ' HG2' ' A' ' 33' ' ' LYS . 40.6 t -43.37 141.72 1.27 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.17 -0.956 . . . . 0.0 109.661 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.694 ' O ' ' HB2' ' A' ' 13' ' ' ALA . 8.0 pt -98.59 -47.49 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.242 -0.911 . . . . 0.0 109.826 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.694 ' HB2' ' O ' ' A' ' 12' ' ' ILE . . . 166.0 -34.9 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.059 -1.026 . . . . 0.0 110.157 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -47.61 159.86 0.14 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.085 -1.01 . . . . 0.0 109.614 -179.488 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -122.13 22.23 10.27 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.321 -0.862 . . . . 0.0 109.854 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.571 ' O ' HD12 ' A' ' 20' ' ' ILE . 0.3 OUTLIER -46.26 -58.33 3.77 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.218 -0.926 . . . . 0.0 109.039 179.728 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.945 ' SG ' ' HD2' ' A' ' 25' ' ' PHE . 19.8 p -52.17 -57.26 10.16 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.37 -0.831 . . . . 0.0 109.239 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.644 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 98.2 t -45.15 -28.14 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.277 -0.89 . . . . 0.0 109.164 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.97 -37.7 23.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.187 -0.946 . . . . 0.0 108.914 179.491 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.841 HD13 ' HA ' ' A' ' 50' ' ' ALA . 1.8 mt -88.33 18.06 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 177.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.522 ' HB2' ' O ' ' A' ' 20' ' ' ILE . . . 172.56 64.6 0.03 OUTLIER Pre-proline 0 N--CA 1.488 1.451 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.65 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -74.25 2.29 6.35 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 124.073 1.565 . . . . 0.0 110.62 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.482 ' O ' ' HB3' ' A' ' 37' ' ' LYS . . . -113.86 -22.7 5.25 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.534 ' O ' ' N ' ' A' ' 37' ' ' LYS . . . -110.66 -30.25 7.68 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.249 -1.147 . . . . 0.0 109.624 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 1.093 ' CE1' HG22 ' A' ' 6' ' ' VAL . 0.8 OUTLIER -114.62 129.84 56.72 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.21 -0.931 . . . . 0.0 108.564 179.762 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.587 ' HA ' HG22 ' A' ' 18' ' ' VAL . . . -158.76 146.83 18.13 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.874 -1.141 . . . . 0.0 110.36 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.55 ' HA ' ' C ' ' A' ' 33' ' ' LYS . 1.3 ttm -74.22 152.38 39.76 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.275 -0.891 . . . . 0.0 109.004 179.637 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.589 ' O ' ' N ' ' A' ' 32' ' ' GLU . 1.2 t0 -133.5 165.77 34.23 Favored Pre-proline 0 C--O 1.211 -0.948 0 O-C-N 120.197 -1.564 . . . . 0.0 108.071 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.508 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 44.8 Cg_endo -84.44 -16.56 5.75 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 124.507 1.793 . . . . 0.0 107.725 179.022 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.491 ' HB3' HD13 ' A' ' 31' ' ' ILE . 0.3 OUTLIER -85.18 -38.95 18.39 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 178.122 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.67 HG21 ' HG3' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -104.29 0.47 10.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 178.068 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.589 ' N ' ' O ' ' A' ' 28' ' ' ASP . 5.2 mt-10 34.97 35.91 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -179.248 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.654 ' HG2' ' SG ' ' A' ' 11' ' ' CYS . 0.1 OUTLIER -172.95 167.26 5.07 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 119.82 -0.752 . . . . 0.0 109.228 -178.367 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.529 ' O ' ' HB3' ' A' ' 8' ' ' GLN . . . -37.45 157.45 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.515 0.674 . . . . 0.0 110.318 -179.139 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.65 ' CZ ' ' HA ' ' A' ' 37' ' ' LYS . 0.2 OUTLIER -162.41 150.26 14.18 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 179.729 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 1.104 HG22 HG23 ' A' ' 6' ' ' VAL . 4.3 t -64.76 88.04 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 120.963 -1.086 . . . . 0.0 109.907 -178.04 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.65 ' HA ' ' CZ ' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -55.56 -26.54 44.01 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.459 -0.776 . . . . 0.0 109.528 179.589 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 39' ' ' VAL . 9.9 t0 175.43 157.99 0.21 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.255 -0.903 . . . . 0.0 109.625 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.604 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 11.6 m -78.22 -21.98 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.321 -0.862 . . . . 0.0 110.111 -179.275 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -117.11 18.95 14.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.12 -0.987 . . . . 0.0 109.422 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.448 ' HA3' ' C ' ' A' ' 23' ' ' GLY . . . -67.7 -15.8 67.04 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 -179.601 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.483 ' HB1' ' HB2' ' A' ' 46' ' ' GLU . . . -148.93 153.72 38.4 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.035 -1.273 . . . . 0.0 109.692 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.469 ' OG ' ' HG3' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -77.12 156.6 31.55 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.349 -0.844 . . . . 0.0 109.944 -179.775 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.489 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -48.47 -48.41 37.83 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.402 -0.811 . . . . 0.0 109.151 179.768 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -57.63 -36.8 72.3 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.209 -0.932 . . . . 0.0 108.979 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.483 ' HB2' ' HB1' ' A' ' 42' ' ' ALA . 14.4 mt-10 -73.06 -57.04 4.31 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.275 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.627 ' CG1' ' CH2' ' A' ' 61' ' ' TRP . 1.2 t -50.87 -32.15 11.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 179.226 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.489 ' HB2' ' O ' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -65.66 -72.89 0.14 Allowed 'General case' 0 C--N 1.309 -1.193 0 O-C-N 121.264 -0.898 . . . . 0.0 109.866 179.966 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -47.22 -39.67 14.63 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.273 -0.892 . . . . 0.0 109.233 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.841 ' HA ' HD13 ' A' ' 20' ' ' ILE . . . -61.03 -39.62 90.49 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.281 -0.887 . . . . 0.0 108.918 179.578 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' MET . . . . . 1.025 ' HE2' HG13 ' A' ' 59' ' ' ILE . 45.0 ttm -74.53 -29.8 61.52 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.443 -0.785 . . . . 0.0 109.169 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -60.99 -45.99 92.57 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.296 -0.877 . . . . 0.0 109.141 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.517 ' O ' ' HB3' ' A' ' 54' ' ' CYS . 65.9 p -68.25 -152.68 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.336 -0.852 . . . . 0.0 109.072 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' CYS . . . . . 0.941 ' SG ' ' CA ' ' A' ' 57' ' ' GLN . 10.3 t 73.41 122.28 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.268 -0.895 . . . . 0.0 109.779 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -73.51 -44.08 0.58 Allowed 'Trans proline' 0 C--N 1.308 -1.562 0 O-C-N 123.863 1.454 . . . . 0.0 109.083 179.05 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.509 ' O ' ' CB ' ' A' ' 57' ' ' GLN . 1.9 m -96.37 -17.65 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.568 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.998 ' O ' HG22 ' A' ' 59' ' ' ILE . 0.9 OUTLIER 81.34 -59.77 0.24 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.724 -0.61 . . . . 0.0 110.569 179.542 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.523 ' O ' HG12 ' A' ' 6' ' ' VAL . 11.9 p 35.88 41.6 0.12 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.641 -0.662 . . . . 0.0 109.51 -179.499 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 1.027 HD12 ' N ' ' A' ' 60' ' ' HIS . 0.1 OUTLIER -148.56 137.44 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.501 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 1.027 ' N ' HD12 ' A' ' 59' ' ' ILE . 31.0 m80 -155.7 163.56 39.74 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.708 -1.245 . . . . 0.0 110.469 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.627 ' CH2' ' CG1' ' A' ' 47' ' ' VAL . 72.2 m95 -87.63 -176.15 5.45 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.381 -0.824 . . . . 0.0 109.216 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.509 ' HB3' ' HB3' ' A' ' 3' ' ' LYS . 7.4 tt0 . . . . . 0 N--CA 1.489 1.5 0 O-C-N 121.332 -0.855 . . . . 0.0 109.208 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.459 ' O ' ' HB3' ' A' ' 4' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.829 ' CE1' HG12 ' A' ' 39' ' ' VAL . 11.5 p90 176.81 174.49 0.39 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.282 -0.886 . . . . 0.0 109.864 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.8 ' HA ' HG11 ' A' ' 36' ' ' VAL . 1.3 p90 177.15 -171.6 0.09 Allowed 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 179.237 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.982 HG23 ' HB ' ' A' ' 36' ' ' VAL . 0.2 OUTLIER -135.44 177.18 7.01 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 C-N-CA 117.693 -1.603 . . . . 0.0 111.651 179.869 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.583 ' H ' HG12 ' A' ' 6' ' ' VAL . 0.3 OUTLIER -129.35 92.45 3.36 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.786 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.567 ' CG ' ' O ' ' A' ' 34' ' ' ALA . 3.7 mp0 -65.36 45.2 0.02 OUTLIER 'General case' 0 C--N 1.291 -1.945 0 CA-C-O 121.617 0.722 . . . . 0.0 110.669 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.555 ' N ' ' O ' ' A' ' 7' ' ' ASP . 1.0 OUTLIER -110.93 -44.89 3.54 Favored 'General case' 0 C--N 1.285 -2.202 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.214 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.681 ' O ' HG21 ' A' ' 56' ' ' VAL . 0.3 OUTLIER -89.85 -7.35 54.48 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.741 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.671 ' SG ' ' HG2' ' A' ' 33' ' ' LYS . 39.6 t -62.95 144.2 57.02 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.453 -0.779 . . . . 0.0 110.195 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.7 pt -102.0 -113.16 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.293 -0.88 . . . . 0.0 108.798 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -135.27 26.61 3.5 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.778 -1.201 . . . . 0.0 109.043 179.441 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -102.1 149.6 24.11 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.28 -0.888 . . . . 0.0 109.905 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.48 ' HB2' ' HB ' ' A' ' 18' ' ' VAL . 0.7 OUTLIER -109.13 20.03 18.81 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.468 -0.77 . . . . 0.0 109.645 -179.856 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 15' ' ' GLU . 56.7 m -43.86 -66.78 0.34 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.262 -0.898 . . . . 0.0 109.34 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.969 ' SG ' ' CD2' ' A' ' 25' ' ' PHE . 19.0 p -48.52 -46.49 38.62 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.323 -0.86 . . . . 0.0 109.328 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.48 ' HB ' ' HB2' ' A' ' 15' ' ' GLU . 59.0 t -50.24 -31.28 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.276 -0.89 . . . . 0.0 109.329 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -77.52 -34.56 53.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.244 -0.91 . . . . 0.0 109.395 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.915 HG21 ' N ' ' A' ' 50' ' ' ALA . 2.5 mp -79.95 5.36 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 178.318 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.498 ' HB1' ' HB2' ' A' ' 42' ' ' ALA . . . -172.8 65.15 0.34 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.351 -0.843 . . . . 0.0 109.045 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.37 70.13 2.53 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 O-C-N 124.286 1.677 . . . . 0.0 110.266 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.49 ' O ' ' HB3' ' A' ' 38' ' ' ASP . . . 177.72 -43.51 0.09 OUTLIER Glycine 0 N--CA 1.488 2.105 0 N-CA-C 108.737 -1.745 . . . . 0.0 108.737 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.585 ' HB2' ' O ' ' A' ' 38' ' ' ASP . . . -93.17 -32.25 14.47 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.555 -0.968 . . . . 0.0 109.029 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.969 ' CD2' ' SG ' ' A' ' 17' ' ' CYS . 0.1 OUTLIER -105.58 141.73 36.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.333 -0.855 . . . . 0.0 108.878 179.905 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.49 ' O ' ' CD1' ' A' ' 35' ' ' TYR . . . -174.96 125.32 0.27 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.115 -0.991 . . . . 0.0 109.286 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.579 ' HA ' ' C ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -58.5 154.3 14.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.165 -0.96 . . . . 0.0 109.558 -179.769 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.604 ' O ' ' N ' ' A' ' 32' ' ' GLU . 0.7 OUTLIER -126.18 163.29 40.87 Favored Pre-proline 0 C--N 1.313 -1.005 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 179.295 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.458 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 47.7 Cg_endo -84.19 -16.67 5.98 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 125.055 2.081 . . . . 0.0 108.279 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -88.07 -35.78 17.32 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 178.394 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.639 HD12 ' HB3' ' A' ' 35' ' ' TYR . 1.3 pt -105.28 -1.32 9.94 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 177.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.604 ' N ' ' O ' ' A' ' 28' ' ' ASP . 0.5 OUTLIER 34.78 36.86 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -179.244 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.671 ' HG2' ' SG ' ' A' ' 11' ' ' CYS . 1.8 mtmt -162.27 148.44 13.13 Favored 'General case' 0 N--CA 1.501 2.083 0 C-N-CA 119.012 -1.075 . . . . 0.0 110.755 -178.187 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.567 ' O ' ' CG ' ' A' ' 8' ' ' GLN . . . -52.76 146.09 11.09 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.548 -0.72 . . . . 0.0 110.201 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.639 ' HB3' HD12 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -149.33 147.54 28.45 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-O 121.77 0.795 . . . . 0.0 109.51 179.219 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.982 ' HB ' HG23 ' A' ' 6' ' ' VAL . 1.3 t -88.84 96.09 5.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.097 -1.002 . . . . 0.0 108.34 -179.376 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.601 ' HB3' ' CE2' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -107.17 -28.12 10.15 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.418 -0.801 . . . . 0.0 110.966 -178.687 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.585 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 22.1 t70 -122.21 78.8 1.53 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.799 -1.188 . . . . 0.0 110.16 -179.1 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.829 HG12 ' CE1' ' A' ' 4' ' ' PHE . 27.2 m -45.25 -46.71 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.248 -0.908 . . . . 0.0 109.266 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.587 ' N ' HG23 ' A' ' 39' ' ' VAL . 6.5 mt-10 -58.51 -24.72 61.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.302 -0.874 . . . . 0.0 109.486 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 38' ' ' ASP . . . -54.08 -26.05 33.73 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.498 ' HB2' ' HB1' ' A' ' 21' ' ' ALA . . . -144.69 144.76 31.39 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.23 -1.159 . . . . 0.0 109.443 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.424 ' OG ' ' CD ' ' A' ' 46' ' ' GLU . 0.1 OUTLIER -67.95 169.14 10.45 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.177 -0.952 . . . . 0.0 109.504 179.988 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.503 ' O ' ' HG2' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -66.15 -47.72 73.11 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.49 -0.756 . . . . 0.0 109.247 179.802 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.721 ' HA ' ' HG2' ' A' ' 48' ' ' GLU . 5.8 mm-40 -61.4 -17.26 53.36 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.284 -0.885 . . . . 0.0 109.185 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.424 ' CD ' ' OG ' ' A' ' 43' ' ' SER . 76.9 mt-10 -91.92 -45.79 8.17 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 178.522 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.811 HG12 ' CH2' ' A' ' 61' ' ' TRP . 6.8 t -55.04 -38.24 45.34 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 178.014 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.721 ' HG2' ' HA ' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -68.14 -56.9 7.13 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.64 -0.663 . . . . 0.0 109.345 178.954 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.457 ' H ' ' HG3' ' A' ' 48' ' ' GLU . 0.3 OUTLIER -43.04 -48.14 6.02 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.167 -0.958 . . . . 0.0 109.085 179.883 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.915 ' N ' HG21 ' A' ' 20' ' ' ILE . . . -60.41 -40.0 89.41 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.213 -0.929 . . . . 0.0 108.65 179.286 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.55 ' CE ' ' CZ3' ' A' ' 61' ' ' TRP . 21.2 ttm -58.7 -37.74 76.76 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.429 -0.794 . . . . 0.0 109.342 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -79.26 -8.07 58.76 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.282 -0.886 . . . . 0.0 109.244 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -115.21 78.36 1.16 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.258 -0.901 . . . . 0.0 109.908 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' CYS . . . . . 0.792 ' SG ' ' HD2' ' A' ' 55' ' ' PRO . 44.2 t -151.08 148.18 22.16 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.284 -0.885 . . . . 0.0 108.914 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.792 ' HD2' ' SG ' ' A' ' 54' ' ' CYS . 44.1 Cg_endo -72.1 -37.09 5.04 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 123.863 1.454 . . . . 0.0 110.333 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.681 HG21 ' O ' ' A' ' 10' ' ' GLU . 2.9 m -111.83 -29.59 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.27 -0.894 . . . . 0.0 109.232 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.552 ' N ' ' SG ' ' A' ' 54' ' ' CYS . 0.0 OUTLIER 66.57 76.65 0.3 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.305 -0.872 . . . . 0.0 109.722 179.763 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 22.5 p -112.3 17.24 19.59 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.279 -0.888 . . . . 0.0 109.12 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.87 ' CB ' HG13 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -104.09 129.69 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.332 -0.855 . . . . 0.0 109.51 -179.687 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.588 ' N ' HD13 ' A' ' 59' ' ' ILE . 1.8 m80 -136.99 160.42 38.96 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.181 -0.949 . . . . 0.0 109.393 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.811 ' CH2' HG12 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -68.13 -169.68 0.15 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.331 -0.856 . . . . 0.0 109.222 179.884 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.446 ' HB3' ' HB3' ' A' ' 3' ' ' LYS . 26.0 tt0 . . . . . 0 N--CA 1.489 1.521 0 O-C-N 121.287 -0.883 . . . . 0.0 109.318 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.497 ' O ' ' HB3' ' A' ' 4' ' ' PHE . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.687 ' CZ ' HG12 ' A' ' 39' ' ' VAL . 39.3 p90 168.8 170.32 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.709 -0.619 . . . . 0.0 109.486 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.508 ' CE1' ' HB2' ' A' ' 62' ' ' GLU . 20.5 p90 176.75 -167.61 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 179.557 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.973 HG21 ' CZ ' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -136.52 -165.36 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 118.44 -1.304 . . . . 0.0 111.517 -179.57 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' A' ' 9' ' ' ASP . 1.5 m-20 -151.23 98.31 2.53 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 114.209 -1.36 . . . . 0.0 107.478 178.317 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.553 ' HG3' ' O ' ' A' ' 34' ' ' ALA . 5.7 mp0 -64.85 43.19 0.02 OUTLIER 'General case' 0 C--N 1.291 -1.939 0 CA-C-O 121.624 0.726 . . . . 0.0 110.664 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 7' ' ' ASP . 0.2 OUTLIER -99.95 -24.52 14.61 Favored 'General case' 0 C--N 1.287 -2.116 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 179.438 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.445 ' HG2' ' HB ' ' A' ' 56' ' ' VAL . 0.6 OUTLIER -115.55 13.13 16.32 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.495 -0.753 . . . . 0.0 109.353 -179.977 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.474 ' HB3' ' HD3' ' A' ' 33' ' ' LYS . 41.9 t -84.23 129.67 34.87 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.155 -0.966 . . . . 0.0 109.7 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.711 ' O ' ' HB2' ' A' ' 13' ' ' ALA . 21.8 pt -102.24 -41.95 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.365 -0.834 . . . . 0.0 109.389 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.711 ' HB2' ' O ' ' A' ' 12' ' ' ILE . . . 163.85 -22.33 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.35 -0.844 . . . . 0.0 109.899 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -51.23 139.9 17.79 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.037 -1.04 . . . . 0.0 109.443 -179.75 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.487 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 4.0 mp0 -102.51 20.4 17.14 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.107 -0.996 . . . . 0.0 109.501 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.712 ' O ' HD12 ' A' ' 20' ' ' ILE . 7.1 m -44.18 -65.48 0.51 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.25 -0.906 . . . . 0.0 109.063 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.608 ' SG ' ' N ' ' A' ' 18' ' ' VAL . 16.4 p -53.16 -52.16 59.67 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.42 -0.8 . . . . 0.0 109.026 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.608 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 38.5 t -48.32 -24.42 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.354 -0.841 . . . . 0.0 109.161 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -86.22 -33.47 20.73 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.299 -0.876 . . . . 0.0 109.004 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.948 HG21 ' N ' ' A' ' 50' ' ' ALA . 2.7 mp -85.01 12.05 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.27 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.627 ' HB1' ' HB2' ' A' ' 42' ' ' ALA . . . 169.69 65.22 0.02 OUTLIER Pre-proline 0 N--CA 1.486 1.345 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -69.23 -4.85 14.49 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 O-C-N 124.143 1.602 . . . . 0.0 110.298 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.475 ' O ' ' HB3' ' A' ' 38' ' ' ASP . . . -100.44 -39.94 3.1 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.493 ' HA ' ' HB3' ' A' ' 38' ' ' ASP . . . -85.72 -33.76 21.41 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.321 -1.105 . . . . 0.0 109.299 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.973 ' CZ ' HG21 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -103.69 144.25 31.7 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.795 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.487 ' O ' ' CD1' ' A' ' 35' ' ' TYR . . . -170.84 126.48 0.71 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.991 -1.068 . . . . 0.0 109.793 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.57 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 3.7 ppp? -59.91 153.86 20.07 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.082 -1.011 . . . . 0.0 109.323 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.633 ' O ' ' N ' ' A' ' 32' ' ' GLU . 3.0 t0 -123.99 160.21 52.94 Favored Pre-proline 0 C--N 1.31 -1.135 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 179.217 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.461 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 47.2 Cg_endo -84.7 -16.48 5.49 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 124.973 2.039 . . . . 0.0 108.682 -179.28 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.35 -28.21 17.06 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 178.17 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.56 HG12 ' CB ' ' A' ' 28' ' ' ASP . 0.9 OUTLIER -108.83 -2.67 10.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 177.974 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.633 ' N ' ' O ' ' A' ' 28' ' ' ASP . 2.7 mm-40 31.33 38.56 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -179.006 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.546 ' C ' ' HA ' ' A' ' 27' ' ' MET . 70.7 mttt -162.39 148.11 12.76 Favored 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 119.723 -0.791 . . . . 0.0 110.296 -178.432 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.763 ' HB1' ' CD1' ' A' ' 25' ' ' PHE . . . -56.79 147.57 22.83 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.468 -0.77 . . . . 0.0 110.863 -179.423 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.595 ' O ' ' CD1' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -152.44 153.36 33.4 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.576 -0.703 . . . . 0.0 109.316 178.806 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.827 HG23 ' CG2' ' A' ' 6' ' ' VAL . 36.5 t -92.62 103.54 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 120.926 -1.108 . . . . 0.0 109.095 -179.452 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.594 ' HB3' ' CE2' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -119.3 -23.48 6.71 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 119.469 -0.892 . . . . 0.0 110.616 -179.286 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.516 ' N ' ' HG3' ' A' ' 37' ' ' LYS . 45.1 t0 -112.31 98.45 7.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.997 -1.064 . . . . 0.0 109.821 -179.683 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.687 HG12 ' CZ ' ' A' ' 4' ' ' PHE . 27.7 m -63.9 -29.21 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.139 -0.976 . . . . 0.0 109.578 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.534 ' OE1' HG23 ' A' ' 39' ' ' VAL . 0.7 OUTLIER -81.86 -14.26 56.49 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.228 -0.92 . . . . 0.0 109.53 -179.804 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.426 ' HA3' ' C ' ' A' ' 23' ' ' GLY . . . -67.08 -17.85 68.33 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.211 -1.556 . . . . 0.0 109.211 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.627 ' HB2' ' HB1' ' A' ' 21' ' ' ALA . . . -151.34 131.42 13.47 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.431 -1.041 . . . . 0.0 109.278 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.86 167.61 5.92 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.217 -0.927 . . . . 0.0 109.487 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -58.04 -49.01 78.36 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.506 -0.746 . . . . 0.0 109.409 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.742 ' HA ' ' HG2' ' A' ' 48' ' ' GLU . 1.0 OUTLIER -62.77 -14.72 48.33 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.182 -0.949 . . . . 0.0 108.943 179.908 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.439 ' OE1' ' HA ' ' A' ' 42' ' ' ALA . 43.0 mt-10 -90.52 -44.3 9.67 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 178.779 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 8.5 t -57.84 -38.71 67.37 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.343 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.742 ' HG2' ' HA ' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -68.77 -58.21 4.53 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.518 -0.739 . . . . 0.0 109.662 179.672 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.49 ' OE2' HG12 ' A' ' 20' ' ' ILE . 29.0 tt0 -44.13 -53.58 6.32 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.013 -1.054 . . . . 0.0 108.819 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.948 ' N ' HG21 ' A' ' 20' ' ' ILE . . . -54.0 -42.3 68.91 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.057 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.841 ' HA ' HG21 ' A' ' 59' ' ' ILE . 30.3 ttm -61.05 -29.87 69.99 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.052 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -63.56 -32.59 74.09 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.827 HG21 HD11 ' A' ' 20' ' ' ILE . 76.4 p -77.52 -155.03 0.07 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.402 -0.811 . . . . 0.0 109.201 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' CYS . . . . . 0.507 ' SG ' ' HD2' ' A' ' 55' ' ' PRO . 2.3 t 64.99 140.46 0.06 OUTLIER Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.11 -0.994 . . . . 0.0 109.391 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.507 ' HD2' ' SG ' ' A' ' 54' ' ' CYS . 42.1 Cg_endo -71.37 -86.89 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.006 1.529 . . . . 0.0 110.061 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.445 ' HB ' ' HG2' ' A' ' 10' ' ' GLU . 11.1 t -63.34 -12.68 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.179 -0.951 . . . . 0.0 108.935 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.478 ' HA ' ' HB3' ' A' ' 54' ' ' CYS . 0.0 OUTLIER 58.55 81.08 0.16 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.244 -0.91 . . . . 0.0 109.431 179.863 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.434 ' SG ' HG12 ' A' ' 6' ' ' VAL . 28.0 p -86.64 16.14 4.98 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.2 -0.937 . . . . 0.0 109.399 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.841 HG21 ' HA ' ' A' ' 51' ' ' MET . 7.9 tt -106.16 154.38 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.168 -0.957 . . . . 0.0 109.81 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.425 ' HA ' ' HE1' ' A' ' 51' ' ' MET . 0.2 OUTLIER -166.95 -174.62 2.75 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.49 -0.756 . . . . 0.0 108.986 179.981 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.535 ' HA ' ' HA ' ' A' ' 4' ' ' PHE . 47.1 m95 -104.54 155.16 19.06 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.041 -1.037 . . . . 0.0 109.704 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.508 ' HB2' ' CE1' ' A' ' 5' ' ' TYR . 6.4 tt0 . . . . . 0 N--CA 1.49 1.548 0 O-C-N 121.465 -0.772 . . . . 0.0 109.454 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.553 ' HB3' ' HB3' ' A' ' 62' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.36 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.584 ' CB ' ' HA ' ' A' ' 61' ' ' TRP . 24.4 p90 168.54 -179.3 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.508 -0.745 . . . . 0.0 109.551 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.496 ' O ' HG13 ' A' ' 59' ' ' ILE . 30.0 p90 176.71 -175.95 0.13 Allowed 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 179.23 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 1.083 HG21 ' CZ ' ' A' ' 25' ' ' PHE . 0.2 OUTLIER -131.4 169.77 21.08 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.018 0 C-N-CA 117.389 -1.724 . . . . 0.0 111.413 -179.661 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.515 ' O ' ' N ' ' A' ' 9' ' ' ASP . 9.3 t0 -108.99 89.58 3.04 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 178.661 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.559 ' CG ' ' O ' ' A' ' 34' ' ' ALA . 8.4 mp0 -65.36 46.09 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.859 0 CA-C-O 121.578 0.704 . . . . 0.0 110.3 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.515 ' N ' ' O ' ' A' ' 7' ' ' ASP . 0.3 OUTLIER -113.32 -44.65 3.21 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.395 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.657 ' CG ' HG11 ' A' ' 56' ' ' VAL . 0.3 OUTLIER -91.45 17.62 8.33 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.087 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 37.4 t -83.26 111.95 19.43 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.359 -0.838 . . . . 0.0 110.373 -179.169 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.708 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 30.6 pt -78.53 0.59 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.47 -0.768 . . . . 0.0 109.047 179.344 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.708 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . 78.81 50.58 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.452 -0.78 . . . . 0.0 110.294 179.561 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.82 ' SG ' ' OG ' ' A' ' 16' ' ' SER . 3.2 p -105.67 161.51 14.33 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.866 -1.146 . . . . 0.0 109.436 179.297 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.456 ' O ' ' HB2' ' A' ' 19' ' ' GLU . 63.3 mt-10 -87.88 18.38 4.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.277 -0.889 . . . . 0.0 109.832 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.82 ' OG ' ' SG ' ' A' ' 14' ' ' CYS . 52.4 p -60.73 -91.06 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.22 -0.925 . . . . 0.0 109.636 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.523 ' SG ' ' N ' ' A' ' 18' ' ' VAL . 10.8 p -45.34 -47.77 13.3 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.22 -0.925 . . . . 0.0 110.034 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.523 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 78.6 t -53.03 -30.74 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.165 -0.96 . . . . 0.0 109.981 -179.503 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.456 ' HB2' ' O ' ' A' ' 15' ' ' GLU . 2.8 mm-40 -77.35 -41.97 38.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.932 -1.105 . . . . 0.0 109.603 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.768 ' CD1' HG21 ' A' ' 53' ' ' THR . 1.6 mt -84.81 15.57 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.248 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.585 ' HB2' ' O ' ' A' ' 20' ' ' ILE . . . 170.54 63.14 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.452 -0.78 . . . . 0.0 109.281 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.487 ' N ' ' O ' ' A' ' 18' ' ' VAL . 45.9 Cg_endo -74.07 -18.56 21.12 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.08 1.569 . . . . 0.0 110.882 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.401 ' O ' ' HB3' ' A' ' 38' ' ' ASP . . . -79.44 -41.48 13.28 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.489 ' HA ' ' HB3' ' A' ' 38' ' ' ASP . . . -87.32 -34.2 18.93 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.215 -1.168 . . . . 0.0 109.71 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 1.083 ' CZ ' HG21 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -106.04 141.21 37.8 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.324 -0.86 . . . . 0.0 109.326 -179.716 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.49 ' O ' ' CD1' ' A' ' 35' ' ' TYR . . . -170.45 128.69 0.83 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.069 -1.019 . . . . 0.0 109.948 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.572 ' HA ' ' C ' ' A' ' 33' ' ' LYS . 2.7 ptm -62.65 153.98 30.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.917 -1.114 . . . . 0.0 109.222 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.578 ' HB3' ' CD1' ' A' ' 31' ' ' ILE . 1.7 t0 -135.22 165.26 37.82 Favored Pre-proline 0 C--N 1.311 -1.085 0 O-C-N 120.663 -1.273 . . . . 0.0 107.572 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.505 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 43.4 Cg_endo -84.01 -17.1 5.95 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 O-C-N 124.528 1.804 . . . . 0.0 107.867 179.265 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.72 -38.96 19.07 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 177.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.578 ' CD1' ' HB3' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -104.13 3.07 10.58 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 177.885 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.565 ' N ' ' O ' ' A' ' 28' ' ' ASP . 2.5 mm-40 31.62 39.33 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.795 0.807 . . . . 0.0 108.879 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.572 ' C ' ' HA ' ' A' ' 27' ' ' MET . 0.0 OUTLIER -173.7 153.55 2.27 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 119.191 -1.004 . . . . 0.0 110.131 -178.537 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.559 ' O ' ' CG ' ' A' ' 8' ' ' GLN . . . -52.52 149.32 5.95 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.475 -0.766 . . . . 0.0 109.66 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.617 ' O ' ' CD1' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -154.16 146.5 23.9 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.614 0.721 . . . . 0.0 109.267 179.266 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.873 ' HB ' HG23 ' A' ' 6' ' ' VAL . 2.1 t -87.44 99.75 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.103 -0.998 . . . . 0.0 108.49 -179.411 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.597 ' HB3' ' CE2' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -115.56 -27.11 7.24 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.23 -0.919 . . . . 0.0 111.057 -178.699 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.554 ' N ' ' HG3' ' A' ' 37' ' ' LYS . 39.5 t0 -113.21 92.46 4.01 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.897 -1.127 . . . . 0.0 110.026 -179.343 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.457 HG12 ' CE1' ' A' ' 4' ' ' PHE . 25.5 m -61.16 -23.28 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.36 -0.837 . . . . 0.0 109.248 179.657 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -93.13 1.39 57.19 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.418 -0.801 . . . . 0.0 109.561 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -87.2 -0.09 85.37 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.451 ' HA ' ' OE2' ' A' ' 46' ' ' GLU . . . -162.91 131.41 3.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.167 -1.196 . . . . 0.0 109.718 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.609 ' O ' HG23 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -61.52 170.93 1.65 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.348 -0.845 . . . . 0.0 109.943 -179.823 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.486 ' HA ' ' HB ' ' A' ' 47' ' ' VAL . 6.0 tt0 -72.0 -41.05 68.04 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.572 -0.705 . . . . 0.0 109.743 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -67.22 -25.92 66.34 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.108 -0.995 . . . . 0.0 109.41 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.52 ' HG2' ' N ' ' A' ' 43' ' ' SER . 5.1 pt-20 -90.02 -35.29 15.59 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 178.722 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.609 HG23 ' O ' ' A' ' 43' ' ' SER . 4.0 t -64.37 -32.7 58.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 177.834 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.447 ' HB2' ' O ' ' A' ' 44' ' ' GLN . 0.5 OUTLIER -71.15 -59.35 2.82 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.131 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.687 ' HB3' HG21 ' A' ' 20' ' ' ILE . 0.4 OUTLIER -53.2 -39.22 63.52 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.113 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.709 ' HB2' ' HB ' ' A' ' 20' ' ' ILE . . . -71.59 -17.83 62.27 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.365 -0.834 . . . . 0.0 109.049 179.413 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' MET . . . . . 1.0 ' HG3' HD13 ' A' ' 59' ' ' ILE . 33.4 ttm -92.11 -17.84 24.41 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.483 -0.761 . . . . 0.0 109.939 -179.328 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -100.93 -17.15 16.93 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.054 -1.029 . . . . 0.0 109.784 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.768 HG21 ' CD1' ' A' ' 20' ' ' ILE . 9.6 t -72.58 -11.22 60.56 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.061 -1.025 . . . . 0.0 109.448 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' CYS . . . . . 1.242 ' SG ' ' HD2' ' A' ' 55' ' ' PRO . 9.4 t -71.04 158.61 87.78 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.248 -0.907 . . . . 0.0 109.486 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 1.242 ' HD2' ' SG ' ' A' ' 54' ' ' CYS . 42.1 Cg_endo -72.79 -85.28 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.92 1.484 . . . . 0.0 109.929 179.452 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.657 HG11 ' CG ' ' A' ' 10' ' ' GLU . 4.2 p -68.41 -22.91 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.111 -0.993 . . . . 0.0 108.926 179.358 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.5 ' O ' ' N ' ' A' ' 59' ' ' ILE . 0.6 OUTLIER 69.34 46.63 0.75 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.474 -0.767 . . . . 0.0 109.635 179.741 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.484 ' HB2' ' HB2' ' A' ' 10' ' ' GLU . 0.1 OUTLIER -68.28 62.41 0.09 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.158 -0.964 . . . . 0.0 109.296 179.732 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 1.0 HD13 ' HG3' ' A' ' 51' ' ' MET . 12.0 tt -132.22 160.29 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.297 -0.877 . . . . 0.0 109.418 -179.681 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.582 ' CG ' ' O ' ' A' ' 59' ' ' ILE . 15.7 m80 -159.83 147.54 16.87 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.02 -1.05 . . . . 0.0 109.915 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.584 ' HA ' ' CB ' ' A' ' 4' ' ' PHE . 58.2 m95 -83.74 -175.38 5.78 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.321 -0.862 . . . . 0.0 108.861 179.198 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.553 ' HB3' ' HB3' ' A' ' 3' ' ' LYS . 0.5 OUTLIER . . . . . 0 C--N 1.301 -1.53 0 O-C-N 121.089 -1.007 . . . . 0.0 109.586 -179.587 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.42 ' HB3' ' HB3' ' A' ' 62' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.654 ' CZ ' HG21 ' A' ' 47' ' ' VAL . 30.9 p90 -178.12 -178.83 0.68 Allowed 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.253 -0.905 . . . . 0.0 109.613 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.759 ' HA ' HG21 ' A' ' 36' ' ' VAL . 45.6 p90 -179.89 -178.15 0.42 Allowed 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 106.012 -1.848 . . . . 0.0 106.012 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 1.104 HG21 ' CE2' ' A' ' 25' ' ' PHE . 2.6 t -142.41 160.95 19.41 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.32 0 C-N-CA 117.487 -1.685 . . . . 0.0 111.228 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.531 ' N ' HG12 ' A' ' 6' ' ' VAL . 4.8 m-20 -114.52 79.26 1.24 Allowed 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.624 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.683 ' OE1' HD13 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -42.07 -22.76 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.564 0.697 . . . . 0.0 109.285 179.359 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.526 ' N ' ' O ' ' A' ' 7' ' ' ASP . 0.5 OUTLIER -48.99 -42.58 38.3 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.545 -0.722 . . . . 0.0 109.332 -179.782 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.489 ' CG ' ' SG ' ' A' ' 58' ' ' CYS . 7.8 tp10 -84.1 -14.53 50.14 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.308 -0.87 . . . . 0.0 109.179 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.415 ' HB3' ' O ' ' A' ' 8' ' ' GLN . 42.8 t -56.68 139.79 49.26 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.243 -0.91 . . . . 0.0 109.492 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.748 ' O ' ' HB2' ' A' ' 13' ' ' ALA . 1.6 pp -101.35 -33.69 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.219 -0.925 . . . . 0.0 109.783 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.748 ' HB2' ' O ' ' A' ' 12' ' ' ILE . . . 155.99 -40.5 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.543 -0.723 . . . . 0.0 109.769 179.544 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.43 ' C ' ' O ' ' A' ' 13' ' ' ALA . 0.1 OUTLIER -43.84 153.2 0.13 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.146 -0.971 . . . . 0.0 109.735 -179.39 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.427 ' O ' ' C ' ' A' ' 16' ' ' SER . 3.5 pt-20 -117.49 21.88 12.76 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.277 -0.889 . . . . 0.0 109.559 -179.575 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.825 ' O ' HD12 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -44.43 -55.19 5.23 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.148 -0.97 . . . . 0.0 109.18 179.856 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.461 ' SG ' ' N ' ' A' ' 18' ' ' VAL . 21.5 p -54.46 -45.31 73.1 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.376 -0.827 . . . . 0.0 109.3 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.461 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 4.8 t -52.26 -26.48 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.34 -0.85 . . . . 0.0 109.466 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -89.82 -32.08 17.08 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.166 -0.959 . . . . 0.0 109.541 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.932 HD13 ' HA ' ' A' ' 50' ' ' ALA . 2.7 mp -84.65 11.8 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.449 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.707 ' HB1' ' HB2' ' A' ' 42' ' ' ALA . . . -168.58 66.28 0.67 Allowed Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.357 -0.84 . . . . 0.0 109.293 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -71.74 83.28 1.12 Allowed 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 123.981 1.516 . . . . 0.0 110.287 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 147.57 -21.01 1.5 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.546 ' CB ' ' O ' ' A' ' 38' ' ' ASP . . . -113.01 -30.68 6.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.314 -1.109 . . . . 0.0 109.102 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 1.104 ' CE2' HG21 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -112.86 140.57 47.54 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.439 -0.788 . . . . 0.0 109.408 -179.972 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.479 ' O ' ' HA ' ' A' ' 34' ' ' ALA . . . -171.59 149.65 2.65 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.544 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 0.2 OUTLIER -82.76 156.51 23.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.874 -1.141 . . . . 0.0 108.652 -179.979 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.622 ' O ' ' N ' ' A' ' 32' ' ' GLU . 1.7 t0 -121.13 160.95 43.16 Favored Pre-proline 0 C--N 1.31 -1.148 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 179.26 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.467 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 48.1 Cg_endo -83.42 -15.97 7.24 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 125.051 2.08 . . . . 0.0 108.157 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -88.56 -35.35 16.96 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 178.31 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.683 HD13 ' OE1' ' A' ' 8' ' ' GLN . 3.8 pt -106.86 0.48 10.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.245 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.622 ' N ' ' O ' ' A' ' 28' ' ' ASP . 51.6 mt-10 32.18 38.34 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -179.247 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.605 ' O ' HD12 ' A' ' 31' ' ' ILE . 83.1 mttt -157.83 146.87 19.55 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 119.262 -0.975 . . . . 0.0 110.93 -177.445 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.76 ' HB1' ' CD1' ' A' ' 25' ' ' PHE . . . -53.31 143.91 17.55 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.737 -0.602 . . . . 0.0 110.634 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.708 ' CE2' ' HA ' ' A' ' 37' ' ' LYS . 6.9 p90 -149.37 169.19 21.4 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 1.062 HG22 HG23 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -86.59 85.09 2.35 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.084 0 CA-C-O 121.624 0.726 . . . . 0.0 109.433 -178.26 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.708 ' HA ' ' CE2' ' A' ' 35' ' ' TYR . 13.4 ptmt -68.89 -10.39 56.79 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.558 -0.714 . . . . 0.0 110.511 -179.344 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.546 ' O ' ' CB ' ' A' ' 24' ' ' ALA . 11.7 t0 178.55 141.07 0.1 Allowed 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 118.611 -1.235 . . . . 0.0 110.424 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.1 m -84.38 -33.54 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.289 -0.882 . . . . 0.0 109.351 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -71.78 -16.08 62.18 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.247 -0.908 . . . . 0.0 109.21 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -69.39 -26.85 74.18 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.707 ' HB2' ' HB1' ' A' ' 21' ' ' ALA . . . -130.7 144.74 51.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.294 -1.121 . . . . 0.0 109.252 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.451 ' OG ' ' OE2' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -89.11 158.24 18.02 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.199 -0.938 . . . . 0.0 109.996 -179.613 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.528 ' HG2' ' N ' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -53.03 -23.06 6.69 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.45 -0.781 . . . . 0.0 109.147 179.811 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.528 ' N ' ' HG2' ' A' ' 44' ' ' GLN . 53.8 mm-40 -85.06 -23.1 28.72 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.4 -0.813 . . . . 0.0 108.837 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.463 ' HB3' ' O ' ' A' ' 20' ' ' ILE . 48.5 mt-10 -88.5 -55.8 3.57 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 106.263 -1.755 . . . . 0.0 106.263 178.44 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.654 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 2.9 t -48.06 -29.35 2.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 177.605 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.519 ' HB2' ' O ' ' A' ' 44' ' ' GLN . 0.3 OUTLIER -70.25 -69.27 0.37 Allowed 'General case' 0 C--N 1.311 -1.083 0 O-C-N 121.565 -0.709 . . . . 0.0 109.41 179.161 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -46.15 -46.72 17.44 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.381 -0.825 . . . . 0.0 109.11 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.932 ' HA ' HD13 ' A' ' 20' ' ' ILE . . . -55.02 -32.49 61.88 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.289 -0.882 . . . . 0.0 109.088 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.679 ' HE2' HG23 ' A' ' 59' ' ' ILE . 34.9 ttm -66.7 -60.2 2.91 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.414 -0.803 . . . . 0.0 109.426 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -46.69 -28.19 1.42 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.223 -0.923 . . . . 0.0 109.689 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.459 ' O ' ' HB2' ' A' ' 54' ' ' CYS . 0.2 OUTLIER -102.08 99.9 10.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.176 -0.953 . . . . 0.0 109.827 -179.763 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 54' ' ' CYS . . . . . 0.813 ' SG ' ' HD2' ' A' ' 55' ' ' PRO . 53.2 t 176.64 146.43 0.27 Allowed Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.214 -0.929 . . . . 0.0 109.868 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.813 ' HD2' ' SG ' ' A' ' 54' ' ' CYS . 45.1 Cg_endo -75.14 104.04 1.84 Allowed 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 124.061 1.558 . . . . 0.0 109.279 179.178 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.535 HG23 ' C ' ' A' ' 55' ' ' PRO . 3.7 t 77.71 3.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.441 -0.787 . . . . 0.0 109.003 -178.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.489 ' HG2' ' O ' ' A' ' 51' ' ' MET . 41.4 mt-30 44.72 82.65 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.284 -0.885 . . . . 0.0 109.413 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.489 ' SG ' ' CG ' ' A' ' 10' ' ' GLU . 2.3 m -79.93 -12.54 59.72 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.242 -0.911 . . . . 0.0 109.224 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.848 ' HA ' HG13 ' A' ' 6' ' ' VAL . 16.4 tt -83.77 144.19 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.383 -0.823 . . . . 0.0 110.145 -179.588 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.474 ' O ' ' HB2' ' A' ' 4' ' ' PHE . 39.6 m-70 -144.37 172.43 12.94 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.365 -0.834 . . . . 0.0 108.902 179.586 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.532 ' HA ' ' CB ' ' A' ' 4' ' ' PHE . 68.4 m95 -94.69 179.55 5.22 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.029 -1.045 . . . . 0.0 110.037 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.42 ' HB3' ' HB3' ' A' ' 3' ' ' LYS . 13.6 tt0 . . . . . 0 N--CA 1.49 1.53 0 O-C-N 121.42 -0.8 . . . . 0.0 109.261 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.49 ' HB3' ' HB3' ' A' ' 62' ' ' GLU . 1.2 ttmt . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.573 ' HA ' ' N ' ' A' ' 62' ' ' GLU . 51.2 p90 175.55 175.69 0.24 Allowed 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.399 -0.813 . . . . 0.0 110.082 179.606 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.845 ' O ' HD12 ' A' ' 59' ' ' ILE . 41.0 p90 179.7 -176.34 0.31 Allowed 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 1.148 HG21 ' CZ ' ' A' ' 25' ' ' PHE . 0.2 OUTLIER -135.48 171.95 16.59 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 C-N-CA 117.816 -1.553 . . . . 0.0 110.94 -179.859 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.58 ' O ' ' N ' ' A' ' 9' ' ' ASP . 2.5 t0 -117.98 92.56 3.86 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.529 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.569 ' CB ' HG21 ' A' ' 31' ' ' ILE . 4.0 mp0 -62.89 42.37 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.93 0 CA-C-O 121.399 0.619 . . . . 0.0 111.039 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.58 ' N ' ' O ' ' A' ' 7' ' ' ASP . 0.4 OUTLIER -104.13 -31.68 9.53 Favored 'General case' 0 C--N 1.287 -2.11 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.432 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.448 ' HB2' ' SG ' ' A' ' 58' ' ' CYS . 0.6 OUTLIER -111.42 22.06 15.53 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.632 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 14.4 t -83.76 126.04 32.51 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.292 -0.88 . . . . 0.0 109.988 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.719 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 23.1 pt -86.21 1.31 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.363 -0.836 . . . . 0.0 109.431 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.719 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . 78.49 32.59 0.32 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.333 -0.854 . . . . 0.0 110.612 179.207 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.6 p -88.86 151.52 22.3 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.905 -1.122 . . . . 0.0 109.076 179.216 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.448 ' O ' ' HB2' ' A' ' 19' ' ' GLU . 1.5 mt-10 -88.54 33.97 0.76 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.179 -0.951 . . . . 0.0 110.115 -179.336 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.786 ' O ' HD12 ' A' ' 20' ' ' ILE . 75.5 p -75.83 -69.95 0.46 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.086 -1.009 . . . . 0.0 109.326 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.576 ' SG ' ' CD2' ' A' ' 25' ' ' PHE . 12.4 p -58.25 -46.55 85.77 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.226 -0.922 . . . . 0.0 109.519 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.533 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 68.7 t -52.69 -41.73 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.364 -0.835 . . . . 0.0 109.916 -179.679 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.448 ' HB2' ' O ' ' A' ' 15' ' ' GLU . 7.4 tm-20 -66.49 -42.7 87.01 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.099 -1.001 . . . . 0.0 109.662 -179.634 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.888 HD11 HG21 ' A' ' 53' ' ' THR . 2.7 mp -82.06 11.76 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.294 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -176.18 68.67 0.25 Allowed Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.29 -0.881 . . . . 0.0 109.237 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -74.09 -0.32 9.4 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 124.076 1.566 . . . . 0.0 110.381 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.468 ' O ' ' HB3' ' A' ' 38' ' ' ASP . . . -112.98 -33.12 2.06 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.442 ' HA ' ' HB3' ' A' ' 38' ' ' ASP . . . -90.1 -46.46 8.46 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.147 -1.208 . . . . 0.0 109.449 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 1.148 ' CZ ' HG21 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -99.26 146.97 25.65 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.273 -0.892 . . . . 0.0 108.901 179.829 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.469 ' O ' ' CD1' ' A' ' 35' ' ' TYR . . . -169.86 125.02 0.8 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.105 -0.997 . . . . 0.0 109.946 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.562 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 6.3 ttp -58.43 152.87 16.94 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.174 -0.954 . . . . 0.0 109.289 179.557 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.637 ' O ' ' N ' ' A' ' 32' ' ' GLU . 0.6 OUTLIER -128.21 163.56 43.25 Favored Pre-proline 0 C--N 1.311 -1.092 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 179.181 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -85.43 -15.62 5.15 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 O-C-N 125.148 2.131 . . . . 0.0 108.513 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -92.41 -29.34 16.34 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 178.359 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.598 HG12 ' HB3' ' A' ' 28' ' ' ASP . 0.2 OUTLIER -103.31 -15.66 7.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 177.557 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.637 ' N ' ' O ' ' A' ' 28' ' ' ASP . 14.1 mt-10 44.08 31.7 0.56 Allowed 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 -177.111 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.537 ' C ' ' HA ' ' A' ' 27' ' ' MET . 2.5 mttp -158.26 152.82 24.64 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 119.344 -0.942 . . . . 0.0 110.483 -177.626 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.562 ' HA ' ' HA ' ' A' ' 27' ' ' MET . . . -59.66 148.97 31.89 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.487 -0.758 . . . . 0.0 109.768 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.635 ' CE2' ' HB3' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -150.75 146.85 26.69 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.624 0.726 . . . . 0.0 109.519 179.296 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.981 ' HB ' HG23 ' A' ' 6' ' ' VAL . 2.4 t -89.57 97.82 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.077 -1.014 . . . . 0.0 108.448 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.635 ' HB3' ' CE2' ' A' ' 35' ' ' TYR . 1.3 pttp -108.08 -23.71 11.87 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.337 -0.852 . . . . 0.0 110.296 -179.26 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.52 ' N ' ' HG3' ' A' ' 37' ' ' LYS . 55.2 t0 -118.36 124.54 47.98 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.125 -0.984 . . . . 0.0 109.884 -179.334 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 15.5 m -86.22 -34.53 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.272 -0.892 . . . . 0.0 109.451 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.439 ' HG2' ' OD1' ' A' ' 38' ' ' ASP . 8.1 pm0 -81.9 -10.31 59.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.198 -0.938 . . . . 0.0 109.519 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -63.54 -18.55 61.41 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.418 ' HB1' ' HB2' ' A' ' 46' ' ' GLU . . . -151.93 132.28 13.72 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.248 -1.148 . . . . 0.0 109.521 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.45 155.09 19.05 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.26 -0.9 . . . . 0.0 109.727 -179.724 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.455 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 4.2 pt20 -49.46 -44.94 46.17 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.479 -0.763 . . . . 0.0 109.565 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.431 ' O ' ' HG3' ' A' ' 49' ' ' GLU . 7.6 mm-40 -64.12 -17.96 63.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.215 -0.928 . . . . 0.0 109.019 179.718 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.418 ' HB2' ' HB1' ' A' ' 42' ' ' ALA . 47.9 mt-10 -90.73 -46.99 7.91 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 179.03 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.459 ' O ' ' HB2' ' A' ' 51' ' ' MET . 2.3 t -57.85 -38.6 66.81 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.438 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.455 ' HB2' ' O ' ' A' ' 44' ' ' GLN . 0.1 OUTLIER -68.19 -60.99 2.06 Favored 'General case' 0 C--N 1.307 -1.257 0 O-C-N 121.534 -0.729 . . . . 0.0 109.629 179.721 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.431 ' HG3' ' O ' ' A' ' 45' ' ' GLU . 2.3 mt-10 -51.5 -40.67 60.01 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.172 -0.955 . . . . 0.0 108.877 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.662 ' HA ' HD13 ' A' ' 20' ' ' ILE . . . -69.28 -20.91 63.91 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.521 -0.737 . . . . 0.0 109.024 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.747 ' HE3' HG12 ' A' ' 59' ' ' ILE . 0.7 OUTLIER -82.86 -51.03 8.0 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.522 -0.736 . . . . 0.0 109.522 -179.482 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -57.32 -32.11 66.36 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.308 -0.87 . . . . 0.0 109.444 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.888 HG21 HD11 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -60.61 -32.05 71.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.341 -0.849 . . . . 0.0 109.804 -179.834 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 54' ' ' CYS . . . . . 0.478 ' HB3' ' HG3' ' A' ' 57' ' ' GLN . 11.4 t -58.28 128.75 82.7 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.18 -0.95 . . . . 0.0 109.429 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -72.26 -53.94 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 123.931 1.49 . . . . 0.0 109.621 179.589 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 27.9 t -79.63 -15.18 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.478 ' HG3' ' HB3' ' A' ' 54' ' ' CYS . 0.5 OUTLIER 45.84 79.4 0.05 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.413 -0.804 . . . . 0.0 109.789 179.783 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.448 ' SG ' ' HB2' ' A' ' 10' ' ' GLU . 0.9 OUTLIER -92.58 15.86 13.35 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.354 -0.841 . . . . 0.0 109.043 179.517 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.908 ' HA ' HG13 ' A' ' 6' ' ' VAL . 4.0 tp -64.33 159.21 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.34 -0.85 . . . . 0.0 109.448 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.53 ' O ' ' HB2' ' A' ' 61' ' ' TRP . 6.5 m80 -135.73 -32.05 0.92 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.227 -0.921 . . . . 0.0 110.358 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.555 ' HA ' ' CB ' ' A' ' 4' ' ' PHE . 55.7 m95 67.51 163.75 0.2 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.477 -0.764 . . . . 0.0 109.244 -179.025 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.573 ' N ' ' HA ' ' A' ' 4' ' ' PHE . 14.8 tt0 . . . . . 0 N--CA 1.488 1.441 0 O-C-N 121.35 -0.844 . . . . 0.0 109.342 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.501 ' O ' ' HB3' ' A' ' 4' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.644 ' CE1' HG12 ' A' ' 39' ' ' VAL . 33.6 p90 168.0 -175.56 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.469 -0.769 . . . . 0.0 109.323 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.489 ' O ' HG13 ' A' ' 59' ' ' ILE . 28.0 p90 167.6 -175.62 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 106.541 -1.652 . . . . 0.0 106.541 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 1.179 HG21 ' CZ ' ' A' ' 25' ' ' PHE . 0.6 OUTLIER -131.25 176.31 9.2 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.073 0 C-N-CA 117.467 -1.693 . . . . 0.0 110.952 -179.945 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.625 ' H ' HG12 ' A' ' 6' ' ' VAL . 1.1 m-20 -127.1 90.52 3.16 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-O 121.845 0.831 . . . . 0.0 109.118 179.333 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.561 ' CG ' ' O ' ' A' ' 34' ' ' ALA . 1.5 mp0 -63.63 44.1 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.704 179.266 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.541 ' N ' ' O ' ' A' ' 7' ' ' ASP . 0.2 OUTLIER -99.93 -20.75 15.97 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 179.369 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.816 ' OE1' HG21 ' A' ' 56' ' ' VAL . 2.8 mm-40 -121.49 -7.49 9.18 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.663 -0.648 . . . . 0.0 109.468 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.659 ' SG ' ' HG2' ' A' ' 33' ' ' LYS . 45.0 t -54.1 112.41 0.96 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.19 -0.944 . . . . 0.0 109.692 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.699 ' O ' ' HB2' ' A' ' 13' ' ' ALA . 13.8 pt -73.65 -47.61 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.241 -0.912 . . . . 0.0 109.601 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.699 ' HB2' ' O ' ' A' ' 12' ' ' ILE . . . 164.77 -28.92 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.095 -1.003 . . . . 0.0 110.147 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -46.33 156.52 0.17 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.966 -1.084 . . . . 0.0 109.727 -179.534 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.421 ' O ' ' C ' ' A' ' 16' ' ' SER . 0.7 OUTLIER -120.02 20.45 12.12 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.406 -0.809 . . . . 0.0 109.858 -179.643 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.923 ' O ' HD12 ' A' ' 20' ' ' ILE . 0.5 OUTLIER -43.89 -52.22 7.0 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.199 -0.938 . . . . 0.0 109.414 179.943 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.554 ' SG ' ' N ' ' A' ' 18' ' ' VAL . 19.8 p -59.34 -52.67 64.65 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.308 -0.87 . . . . 0.0 109.453 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.554 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 5.7 t -47.17 -34.92 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.128 -0.983 . . . . 0.0 109.414 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -73.53 -34.67 65.33 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.125 -0.984 . . . . 0.0 109.324 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.929 HD13 ' HA ' ' A' ' 50' ' ' ALA . 2.7 mp -84.9 10.96 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 178.313 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.681 ' HB1' ' HB2' ' A' ' 42' ' ' ALA . . . -174.75 65.71 0.27 Allowed Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 121.377 -0.827 . . . . 0.0 109.2 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -71.81 56.15 2.33 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 O-C-N 124.171 1.616 . . . . 0.0 110.371 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.495 ' O ' ' HB3' ' A' ' 38' ' ' ASP . . . -167.47 -55.09 0.03 OUTLIER Glycine 0 N--CA 1.488 2.109 0 N-CA-C 108.543 -1.823 . . . . 0.0 108.543 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.549 ' HB2' ' O ' ' A' ' 38' ' ' ASP . . . -78.29 -38.87 41.46 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.439 -1.036 . . . . 0.0 109.112 179.402 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 1.179 ' CZ ' HG21 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -97.14 134.23 40.74 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.136 -0.978 . . . . 0.0 108.88 179.693 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.502 ' O ' ' CD1' ' A' ' 35' ' ' TYR . . . -163.55 122.63 2.04 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.173 -0.954 . . . . 0.0 109.8 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.55 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 30.5 ttm -60.32 149.52 33.33 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.187 -0.946 . . . . 0.0 109.235 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.602 ' O ' ' N ' ' A' ' 32' ' ' GLU . 2.4 t0 -126.47 160.73 56.59 Favored Pre-proline 0 C--N 1.311 -1.073 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 179.533 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.489 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 43.9 Cg_endo -84.82 -17.12 5.06 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 O-C-N 124.765 1.929 . . . . 0.0 108.49 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -90.78 -30.45 17.01 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 178.009 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.566 HD12 ' HB3' ' A' ' 35' ' ' TYR . 0.8 OUTLIER -106.74 -0.18 9.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.092 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.602 ' N ' ' O ' ' A' ' 28' ' ' ASP . 8.2 mt-10 27.85 43.43 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.506 0.67 . . . . 0.0 109.983 -179.582 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.659 ' HG2' ' SG ' ' A' ' 11' ' ' CYS . 2.0 mttt -169.19 146.14 3.52 Favored 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 119.475 -0.89 . . . . 0.0 110.273 -179.31 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.561 ' O ' ' CG ' ' A' ' 8' ' ' GLN . . . -58.01 140.87 51.48 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.436 -0.79 . . . . 0.0 109.183 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.619 ' O ' ' CD1' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -146.26 146.49 30.76 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-O 121.902 0.858 . . . . 0.0 110.084 179.742 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.962 ' HB ' HG23 ' A' ' 6' ' ' VAL . 2.7 t -85.67 100.82 9.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -179.581 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.584 ' HG2' ' CZ ' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -116.63 -34.26 4.59 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.456 -0.777 . . . . 0.0 110.103 -179.083 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.549 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 17.0 t0 -104.58 85.56 2.35 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.217 -0.927 . . . . 0.0 109.801 -179.263 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.644 HG12 ' CE1' ' A' ' 4' ' ' PHE . 14.5 m -53.52 -29.21 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.293 -0.879 . . . . 0.0 109.288 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -73.02 -14.45 61.43 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.338 -0.851 . . . . 0.0 109.375 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.435 ' HA3' ' N ' ' A' ' 24' ' ' ALA . . . -71.88 -25.4 74.94 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.681 ' HB2' ' HB1' ' A' ' 21' ' ' ALA . . . -142.24 155.43 45.25 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.317 -1.107 . . . . 0.0 109.2 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -96.05 -166.73 1.47 Allowed 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.064 -1.022 . . . . 0.0 109.875 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.478 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 22.0 tt0 -72.66 -53.7 11.08 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.423 ' OE2' ' NE2' ' A' ' 44' ' ' GLN . 18.7 mm-40 -62.98 -19.63 64.51 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.397 -0.814 . . . . 0.0 109.252 179.581 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -88.25 -45.85 9.72 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 178.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.3 t -62.94 -27.23 42.75 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 178.17 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.478 ' HB2' ' O ' ' A' ' 44' ' ' GLN . 0.2 OUTLIER -71.15 -66.1 0.66 Allowed 'General case' 0 C--N 1.309 -1.192 0 O-C-N 121.635 -0.666 . . . . 0.0 109.302 179.406 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -47.29 -49.0 24.7 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.367 -0.833 . . . . 0.0 109.022 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.929 ' HA ' HD13 ' A' ' 20' ' ' ILE . . . -57.44 -40.18 77.89 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.251 -0.905 . . . . 0.0 108.761 179.429 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.633 ' HE2' HD13 ' A' ' 59' ' ' ILE . 22.4 ttm -69.05 -14.15 62.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.413 -0.804 . . . . 0.0 109.186 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -99.77 -3.99 31.57 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.341 -0.849 . . . . 0.0 109.465 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.437 ' O ' ' HB3' ' A' ' 16' ' ' SER . 2.4 m -113.67 46.01 1.35 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.15 -0.969 . . . . 0.0 109.784 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' CYS . . . . . 0.789 ' SG ' ' N ' ' A' ' 57' ' ' GLN . 53.6 t -123.05 143.1 39.88 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.225 -0.922 . . . . 0.0 109.142 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.603 ' HD2' ' SG ' ' A' ' 54' ' ' CYS . 44.1 Cg_endo -71.35 -35.33 8.51 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.936 1.493 . . . . 0.0 110.037 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.816 HG21 ' OE1' ' A' ' 10' ' ' GLU . 43.5 t -124.45 -0.98 5.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.426 -0.796 . . . . 0.0 109.185 179.488 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.789 ' N ' ' SG ' ' A' ' 54' ' ' CYS . 6.4 mt-30 60.94 -80.41 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.266 -0.896 . . . . 0.0 109.459 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.5 ' SG ' ' HB3' ' A' ' 10' ' ' GLU . 0.3 OUTLIER 55.59 23.4 6.03 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.075 -1.016 . . . . 0.0 108.825 179.985 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.87 ' CB ' HG13 ' A' ' 6' ' ' VAL . 7.8 tt -124.12 154.31 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.213 -0.929 . . . . 0.0 110.051 -179.313 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.53 ' CG ' ' C ' ' A' ' 59' ' ' ILE . 10.5 m80 -157.36 157.55 34.29 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.426 -0.796 . . . . 0.0 109.241 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.511 ' HA ' ' HA ' ' A' ' 4' ' ' PHE . 40.1 m95 -83.32 179.53 7.66 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.095 -1.003 . . . . 0.0 109.394 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.485 ' O ' ' CB ' ' A' ' 3' ' ' LYS . 1.1 tt0 . . . . . 0 N--CA 1.489 1.476 0 O-C-N 121.288 -0.883 . . . . 0.0 109.408 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.483 ' O ' ' HB3' ' A' ' 4' ' ' PHE . 1.1 tttt . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.651 ' CE1' HG12 ' A' ' 39' ' ' VAL . 9.3 p90 167.57 179.56 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.283 -0.886 . . . . 0.0 109.307 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.46 ' HB3' ' O ' ' A' ' 4' ' ' PHE . 55.3 p90 176.16 -171.63 0.08 Allowed 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.354 -0.841 . . . . 0.0 109.272 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 1.046 HG21 ' CZ ' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -140.09 152.23 21.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 179.718 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.609 ' O ' ' N ' ' A' ' 9' ' ' ASP . 53.6 t0 -99.56 0.01 41.4 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 118.628 -1.229 . . . . 0.0 111.692 -178.746 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.583 ' NE2' ' O ' ' A' ' 7' ' ' ASP . 1.7 pm0 42.56 14.92 0.01 OUTLIER 'General case' 0 C--N 1.273 -2.753 0 CA-C-O 121.29 0.567 . . . . 0.0 110.935 179.143 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.609 ' N ' ' O ' ' A' ' 7' ' ' ASP . 0.8 OUTLIER -75.98 -50.66 14.25 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.315 -0.866 . . . . 0.0 109.142 -179.295 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.724 ' HB3' HG21 ' A' ' 56' ' ' VAL . 1.1 tp10 -85.66 11.93 9.85 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.457 -0.777 . . . . 0.0 109.041 179.528 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 31.4 t -66.04 111.4 3.35 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.246 -0.909 . . . . 0.0 110.003 -179.482 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.523 HG13 ' N ' ' A' ' 13' ' ' ALA . 11.9 pt -73.53 -139.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.443 -0.786 . . . . 0.0 109.221 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.523 ' N ' HG13 ' A' ' 12' ' ' ILE . . . -102.99 28.34 6.32 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.942 -1.099 . . . . 0.0 110.003 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -112.0 159.49 18.39 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.922 -1.111 . . . . 0.0 109.78 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.442 ' O ' ' C ' ' A' ' 16' ' ' SER . 0.0 OUTLIER -136.25 20.4 3.19 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.401 -0.812 . . . . 0.0 109.374 -179.995 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.442 ' C ' ' O ' ' A' ' 15' ' ' GLU . 59.6 p -41.83 -44.33 3.29 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.521 -0.737 . . . . 0.0 109.387 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.605 ' SG ' ' CD2' ' A' ' 25' ' ' PHE . 17.4 p -58.33 -42.86 87.75 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.307 -0.871 . . . . 0.0 109.095 179.466 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.444 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 39.8 t -56.8 -30.5 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.33 -0.856 . . . . 0.0 109.493 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -81.58 -38.43 26.13 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.171 -0.955 . . . . 0.0 109.293 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.606 HG21 ' N ' ' A' ' 50' ' ' ALA . 0.3 OUTLIER -74.64 2.98 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.152 -0.967 . . . . 0.0 108.827 178.565 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.79 ' HB1' ' HB2' ' A' ' 42' ' ' ALA . . . -161.86 70.71 2.38 Favored Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.185 -0.947 . . . . 0.0 109.381 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -71.0 68.09 2.42 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 124.133 1.596 . . . . 0.0 110.277 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 165.66 -35.85 0.26 Allowed Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.989 -1.644 . . . . 0.0 108.989 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.525 ' CB ' ' O ' ' A' ' 38' ' ' ASP . . . -91.81 -46.97 7.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.454 -1.027 . . . . 0.0 109.176 179.553 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 1.046 ' CZ ' HG21 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -100.63 139.05 36.86 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.368 -0.832 . . . . 0.0 108.885 179.768 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.499 ' O ' ' CD1' ' A' ' 35' ' ' TYR . . . -169.34 124.03 0.83 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.152 -0.967 . . . . 0.0 109.759 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.554 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER -61.17 152.55 28.34 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.007 -1.058 . . . . 0.0 108.881 179.665 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.6 ' O ' ' N ' ' A' ' 32' ' ' GLU . 2.5 t0 -128.63 159.82 66.01 Favored Pre-proline 0 C--N 1.308 -1.204 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.479 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 44.9 Cg_endo -84.6 -16.23 5.73 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 O-C-N 124.562 1.822 . . . . 0.0 108.346 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -91.96 -27.81 17.63 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 177.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.684 HD12 ' HB3' ' A' ' 35' ' ' TYR . 0.7 OUTLIER -110.46 2.41 9.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.151 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.6 ' N ' ' O ' ' A' ' 28' ' ' ASP . 2.6 mm-40 26.22 44.01 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.466 0.651 . . . . 0.0 110.14 -179.543 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.532 ' CG ' ' O ' ' A' ' 32' ' ' GLU . 0.2 OUTLIER -172.23 149.19 2.24 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 119.175 -1.01 . . . . 0.0 109.999 -179.186 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.554 ' HA ' ' HA ' ' A' ' 27' ' ' MET . . . -56.8 144.67 32.1 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.433 -0.792 . . . . 0.0 110.158 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.684 ' HB3' HD12 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -148.78 140.79 23.85 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.839 0.828 . . . . 0.0 110.173 178.932 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.887 ' HB ' HG23 ' A' ' 6' ' ' VAL . 2.8 t -87.44 90.19 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 120.98 -1.075 . . . . 0.0 108.112 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.606 ' HB3' ' CE2' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -101.28 -7.79 22.7 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.333 -0.854 . . . . 0.0 110.588 -178.75 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.525 ' O ' ' CB ' ' A' ' 24' ' ' ALA . 59.6 t0 -138.16 93.6 2.78 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.991 -1.068 . . . . 0.0 109.952 -179.6 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.651 HG12 ' CE1' ' A' ' 4' ' ' PHE . 17.7 m -58.48 -29.5 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.298 -0.877 . . . . 0.0 109.017 179.459 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -76.28 -17.6 59.38 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.303 -0.873 . . . . 0.0 109.251 179.794 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -69.55 -8.65 60.28 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.79 ' HB2' ' HB1' ' A' ' 21' ' ' ALA . . . -155.09 119.56 4.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.286 -1.126 . . . . 0.0 109.289 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.659 ' O ' HG23 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -49.39 174.99 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.319 -0.863 . . . . 0.0 109.812 -179.747 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.427 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 6.3 tm0? -68.16 -42.48 79.98 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.558 -0.714 . . . . 0.0 109.478 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.6 mm-40 -66.7 -13.8 61.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.101 -0.999 . . . . 0.0 108.963 179.562 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -96.49 -43.48 7.6 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 178.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.67 HG23 ' O ' ' A' ' 42' ' ' ALA . 55.5 t -58.2 -51.61 69.0 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 178.31 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.427 ' HB2' ' O ' ' A' ' 44' ' ' GLN . 0.2 OUTLIER -65.46 -52.6 51.88 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.615 -0.678 . . . . 0.0 109.57 179.387 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -47.73 -48.63 29.59 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.207 -0.933 . . . . 0.0 109.234 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.606 ' N ' HG21 ' A' ' 20' ' ' ILE . . . -65.94 -23.64 66.65 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.199 -0.938 . . . . 0.0 109.001 179.591 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.995 ' CG ' HG21 ' A' ' 59' ' ' ILE . 35.0 ttm -76.16 -14.83 60.15 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.345 -0.847 . . . . 0.0 109.509 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -98.15 -25.32 14.95 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.218 -0.926 . . . . 0.0 109.71 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.75 -19.17 60.33 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.18 -0.95 . . . . 0.0 109.948 -179.617 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' CYS . . . . . 0.747 ' SG ' ' HD2' ' A' ' 55' ' ' PRO . 9.2 t -70.57 145.03 92.17 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.071 -1.018 . . . . 0.0 109.702 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.747 ' HD2' ' SG ' ' A' ' 54' ' ' CYS . 43.4 Cg_endo -73.44 -86.9 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.004 1.529 . . . . 0.0 109.505 179.247 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.724 HG21 ' HB3' ' A' ' 10' ' ' GLU . 27.8 m -56.03 -31.28 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 120.981 -1.074 . . . . 0.0 108.168 178.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.497 ' O ' ' N ' ' A' ' 59' ' ' ILE . 4.1 tt0 68.97 52.41 0.51 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.566 -0.709 . . . . 0.0 110.361 179.146 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.784 ' O ' HG12 ' A' ' 6' ' ' VAL . 0.5 OUTLIER -68.26 65.5 0.11 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.055 -1.028 . . . . 0.0 108.804 179.166 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.995 HG21 ' CG ' ' A' ' 51' ' ' MET . 0.5 OUTLIER -131.59 148.1 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.229 -0.919 . . . . 0.0 110.219 -179.262 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.505 ' N ' HG13 ' A' ' 59' ' ' ILE . 1.1 m80 -148.74 129.46 14.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.324 -0.86 . . . . 0.0 109.431 179.705 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.57 ' HA ' ' HA ' ' A' ' 4' ' ' PHE . 54.3 m95 -68.27 161.15 27.88 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.266 -0.896 . . . . 0.0 109.256 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.517 ' N ' ' HA ' ' A' ' 4' ' ' PHE . 24.2 tt0 . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.204 -0.935 . . . . 0.0 109.696 -179.262 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.48 ' HB3' ' HB3' ' A' ' 62' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.48 0 CA-C-O 121.346 0.593 . . . . 0.0 109.645 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.919 ' CZ ' HG12 ' A' ' 39' ' ' VAL . 23.4 p90 175.82 176.67 0.23 Allowed 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.514 ' CE1' ' HB2' ' A' ' 62' ' ' GLU . 17.4 p90 172.45 -168.42 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 105.747 -1.946 . . . . 0.0 105.747 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.854 HG13 ' HA ' ' A' ' 59' ' ' ILE . 4.4 t -146.54 159.72 10.42 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.236 0 C-N-CA 116.724 -1.99 . . . . 0.0 111.739 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.531 ' N ' HG12 ' A' ' 6' ' ' VAL . 39.1 t70 -106.16 78.44 1.31 Allowed 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.342 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.563 ' CG ' ' O ' ' A' ' 34' ' ' ALA . 5.3 mp0 -43.34 -19.24 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.984 179.67 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.525 ' N ' ' O ' ' A' ' 7' ' ' ASP . 0.1 OUTLIER -56.51 -35.56 68.17 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.163 -0.96 . . . . 0.0 108.828 -179.898 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.5 ' HB3' ' HB3' ' A' ' 58' ' ' CYS . 0.6 OUTLIER -81.96 -31.5 31.17 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.656 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.434 ' C ' ' O ' ' A' ' 10' ' ' GLU . 36.5 t -42.65 143.09 0.73 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.362 -0.836 . . . . 0.0 109.503 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.705 ' O ' ' HB2' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -98.14 -45.25 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.27 -0.893 . . . . 0.0 109.675 -179.603 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.705 ' HB2' ' O ' ' A' ' 12' ' ' ILE . . . 162.41 -28.84 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.24 -0.912 . . . . 0.0 109.571 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -56.09 156.34 5.58 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.16 -0.962 . . . . 0.0 109.499 -179.725 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.436 ' O ' ' C ' ' A' ' 16' ' ' SER . 31.3 mt-10 -116.97 20.94 13.59 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.276 -0.89 . . . . 0.0 109.68 -179.591 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.436 ' C ' ' O ' ' A' ' 15' ' ' GLU . 70.1 m -44.45 -63.79 0.82 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.226 -0.921 . . . . 0.0 109.073 179.755 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.647 ' SG ' ' N ' ' A' ' 18' ' ' VAL . 17.8 p -49.13 -54.33 16.75 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.32 -0.862 . . . . 0.0 109.151 179.585 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.647 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 48.4 t -43.43 -46.1 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.442 -0.786 . . . . 0.0 109.199 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -63.65 -34.5 77.99 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.155 -0.966 . . . . 0.0 109.146 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.592 HG22 ' O ' ' A' ' 20' ' ' ILE . 5.6 mt -87.51 14.42 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.137 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -171.03 65.25 0.43 Allowed Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.486 -0.759 . . . . 0.0 109.257 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -71.15 56.51 2.01 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 124.161 1.611 . . . . 0.0 110.147 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.491 ' C ' ' HB3' ' A' ' 38' ' ' ASP . . . -177.86 -63.35 0.07 OUTLIER Glycine 0 N--CA 1.488 2.148 0 N-CA-C 108.832 -1.707 . . . . 0.0 108.832 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.758 ' HB2' ' O ' ' A' ' 38' ' ' ASP . . . -66.56 -42.04 87.7 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.298 -1.119 . . . . 0.0 108.453 179.443 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.621 ' HZ ' HG11 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -101.23 132.79 46.57 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 118.757 -1.177 . . . . 0.0 108.949 179.45 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.624 ' HB3' ' HE1' ' A' ' 35' ' ' TYR . . . -161.49 130.87 4.64 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.434 -0.791 . . . . 0.0 109.358 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.535 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 4.0 ptt? -71.68 152.2 43.02 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.193 -0.942 . . . . 0.0 109.46 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.632 ' O ' ' N ' ' A' ' 32' ' ' GLU . 2.0 t0 -126.0 161.21 52.88 Favored Pre-proline 0 C--N 1.31 -1.118 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 179.002 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.483 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 45.0 Cg_endo -85.18 -17.9 4.4 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 O-C-N 124.814 1.955 . . . . 0.0 108.596 -179.468 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.3 -28.62 18.64 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 177.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.536 HG12 ' CB ' ' A' ' 28' ' ' ASP . 0.9 OUTLIER -107.17 -3.92 10.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 177.687 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.632 ' N ' ' O ' ' A' ' 28' ' ' ASP . 1.6 mt-10 31.41 37.47 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -179.271 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.548 ' CB ' ' HB3' ' A' ' 8' ' ' GLN . 19.4 mmtp -161.91 148.22 13.68 Favored 'General case' 0 N--CA 1.502 2.17 0 C-N-CA 119.499 -0.881 . . . . 0.0 110.753 -178.673 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.563 ' O ' ' CG ' ' A' ' 8' ' ' GLN . . . -61.58 138.45 58.29 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.416 -0.802 . . . . 0.0 110.167 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.76 ' CE2' ' HG3' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -132.58 144.57 50.48 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-O 122.262 1.029 . . . . 0.0 110.511 179.881 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.655 ' CG2' HG23 ' A' ' 6' ' ' VAL . 2.4 t -86.4 92.26 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 120.303 -1.498 . . . . 0.0 109.242 -178.81 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.76 ' HG3' ' CE2' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -107.55 -53.31 2.64 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.436 -0.79 . . . . 0.0 111.013 -179.006 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.758 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 46.9 t0 -85.77 76.07 9.97 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 119.746 -0.781 . . . . 0.0 110.782 -177.224 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.919 HG12 ' CZ ' ' A' ' 4' ' ' PHE . 27.5 m -49.94 -31.36 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.327 -0.858 . . . . 0.0 109.34 179.279 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -79.55 -6.92 58.02 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.327 -0.858 . . . . 0.0 109.476 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -85.85 5.38 84.01 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -153.35 116.46 4.58 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.179 -1.189 . . . . 0.0 109.644 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.869 ' O ' HG23 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -64.5 163.88 12.65 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.243 -0.911 . . . . 0.0 109.599 179.971 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.46 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 3.4 tt0 -49.8 -44.14 48.89 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.356 -0.84 . . . . 0.0 109.381 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.412 ' O ' ' HB2' ' A' ' 49' ' ' GLU . 72.7 mm-40 -67.87 -8.9 40.29 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.18 -0.95 . . . . 0.0 109.187 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.457 ' OE2' ' OG ' ' A' ' 43' ' ' SER . 14.3 mt-10 -99.58 -43.12 6.62 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 106.66 -1.608 . . . . 0.0 106.66 179.112 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.869 HG23 ' O ' ' A' ' 43' ' ' SER . 1.9 t -61.92 -42.73 95.84 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.398 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.46 ' HB2' ' O ' ' A' ' 44' ' ' GLN . 0.2 OUTLIER -73.49 -50.1 23.25 Favored 'General case' 0 C--N 1.308 -1.236 0 O-C-N 121.59 -0.694 . . . . 0.0 109.282 179.383 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.476 ' HB3' HD13 ' A' ' 20' ' ' ILE . 13.3 mm-40 -53.23 -45.95 68.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.224 -0.923 . . . . 0.0 108.77 179.475 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.554 ' HB2' ' HB ' ' A' ' 20' ' ' ILE . . . -70.29 -13.45 62.17 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.37 -0.831 . . . . 0.0 108.785 179.231 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.53 ' HA ' HG21 ' A' ' 59' ' ' ILE . 0.4 OUTLIER -80.72 -21.9 40.76 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.434 -0.791 . . . . 0.0 109.492 179.98 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -96.37 -34.34 11.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.197 -0.94 . . . . 0.0 109.605 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.477 ' OG1' ' HA ' ' A' ' 50' ' ' ALA . 0.1 OUTLIER -50.71 -54.82 20.11 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.252 -0.905 . . . . 0.0 109.747 179.975 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 54' ' ' CYS . . . . . 0.535 ' SG ' ' HD2' ' A' ' 55' ' ' PRO . 3.8 t -46.36 140.86 5.21 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.192 -0.943 . . . . 0.0 109.912 -179.61 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.535 ' HD2' ' SG ' ' A' ' 54' ' ' CYS . 44.8 Cg_endo -77.03 -62.99 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 124.123 1.591 . . . . 0.0 109.843 179.33 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 33.0 t -74.4 -20.74 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.335 -0.853 . . . . 0.0 108.868 179.377 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.481 ' NE2' ' O ' ' A' ' 51' ' ' MET . 3.5 mt-30 64.78 94.24 0.06 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.343 -0.848 . . . . 0.0 109.586 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.5 ' HB3' ' HB3' ' A' ' 10' ' ' GLU . 0.1 OUTLIER -100.42 -28.0 13.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.304 -0.872 . . . . 0.0 108.821 179.795 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.854 ' HA ' HG13 ' A' ' 6' ' ' VAL . 5.7 tt -60.88 151.06 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.458 -0.776 . . . . 0.0 109.976 -179.654 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.49 ' NE2' ' CE2' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -159.92 -178.55 7.11 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.454 -0.779 . . . . 0.0 108.9 179.509 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.506 ' HA ' ' HA ' ' A' ' 4' ' ' PHE . 66.7 m95 -101.3 165.02 11.49 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.118 -0.989 . . . . 0.0 109.768 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.514 ' HB2' ' CE1' ' A' ' 5' ' ' TYR . 41.2 tt0 . . . . . 0 N--CA 1.489 1.491 0 O-C-N 121.431 -0.793 . . . . 0.0 109.169 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.7 tpt180 -137.03 114.31 10.83 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.231 -0.918 . . . . 0.0 109.451 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.479 ' HB3' ' HB3' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -101.19 -156.47 0.56 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.165 -0.959 . . . . 0.0 109.522 -179.884 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.576 ' CB ' ' HA ' ' A' ' 61' ' ' TRP . 31.6 p90 179.78 -167.39 0.09 Allowed 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.173 -0.954 . . . . 0.0 109.208 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.735 ' HA ' HG11 ' A' ' 36' ' ' VAL . 39.3 p90 173.5 -166.79 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 106.87 -1.529 . . . . 0.0 106.87 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.909 HG11 ' HZ ' ' A' ' 25' ' ' PHE . 2.5 t -152.14 166.76 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 C-N-CA 117.532 -1.667 . . . . 0.0 112.119 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.582 ' H ' HG12 ' A' ' 6' ' ' VAL . 0.8 OUTLIER -106.76 68.57 0.74 Allowed 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 178.561 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.531 ' HB3' ' O ' ' A' ' 34' ' ' ALA . 0.6 OUTLIER -47.72 -15.59 0.06 Allowed 'General case' 0 C--N 1.297 -1.701 0 CA-C-O 121.344 0.593 . . . . 0.0 109.495 179.258 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.465 ' N ' ' O ' ' A' ' 7' ' ' ASP . 0.2 OUTLIER -65.17 -33.12 75.25 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.697 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.53 ' HB3' ' HB3' ' A' ' 58' ' ' CYS . 0.3 OUTLIER -93.47 0.74 56.87 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 179.168 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.449 ' HB3' ' O ' ' A' ' 8' ' ' GLN . 10.1 t -66.84 129.32 39.49 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.081 -1.012 . . . . 0.0 110.073 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.773 HG12 ' S3 ' ' A' ' 65' ' ' SF4 . 43.2 pt -88.78 -143.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.486 -0.759 . . . . 0.0 109.639 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.493 ' N ' HG13 ' A' ' 12' ' ' ILE . . . -107.56 52.92 0.7 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.076 -1.015 . . . . 0.0 109.901 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.947 ' O ' ' S2 ' ' A' ' 65' ' ' SF4 . 0.1 OUTLIER -134.53 155.18 50.86 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.039 -1.038 . . . . 0.0 109.673 179.661 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.42 ' O ' ' C ' ' A' ' 16' ' ' SER . 0.2 OUTLIER -120.46 18.89 12.09 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.319 -0.863 . . . . 0.0 109.798 -179.555 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.671 ' HB3' HG21 ' A' ' 53' ' ' THR . 0.7 OUTLIER -44.15 -51.13 8.34 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.195 -0.941 . . . . 0.0 109.346 179.995 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.826 ' SG ' ' CD2' ' A' ' 25' ' ' PHE . 14.6 p -62.02 -54.93 34.63 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.316 -0.865 . . . . 0.0 109.366 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.626 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 98.7 t -43.92 -34.22 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.279 -0.888 . . . . 0.0 109.501 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.42 -36.78 66.01 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.062 -1.024 . . . . 0.0 109.025 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.572 HD13 ' HB3' ' A' ' 49' ' ' GLU . 5.0 mt -87.37 16.13 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 178.198 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -174.43 63.64 0.26 Allowed Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.344 -0.848 . . . . 0.0 109.672 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -75.36 51.76 3.0 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 124.04 1.547 . . . . 0.0 110.34 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.428 ' C ' ' HA3' ' A' ' 41' ' ' GLY . . . -166.0 -41.63 0.02 OUTLIER Glycine 0 N--CA 1.489 2.213 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.574 ' HB2' ' H ' ' A' ' 42' ' ' ALA . . . -92.31 -46.8 7.52 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.434 -1.039 . . . . 0.0 108.678 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.909 ' HZ ' HG11 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -89.7 138.09 31.77 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.387 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.45 ' O ' ' CD1' ' A' ' 35' ' ' TYR . . . -173.57 126.31 0.4 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.103 -0.998 . . . . 0.0 109.58 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.565 ' HA ' ' C ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -63.82 153.01 37.98 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.166 -0.959 . . . . 0.0 109.841 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.605 ' O ' ' N ' ' A' ' 32' ' ' GLU . 2.2 t0 -129.59 163.67 45.09 Favored Pre-proline 0 C--O 1.209 -1.061 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.49 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 45.7 Cg_endo -83.63 -18.31 5.73 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 124.619 1.852 . . . . 0.0 107.961 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -84.17 -39.17 19.73 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 178.146 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.877 HD11 ' CD1' ' A' ' 35' ' ' TYR . 3.0 pt -101.51 -2.05 9.72 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 177.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.605 ' N ' ' O ' ' A' ' 28' ' ' ASP . 65.4 mt-10 34.66 34.53 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -179.273 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.578 ' O ' HD12 ' A' ' 31' ' ' ILE . 18.5 mttt -163.15 150.3 12.86 Favored 'General case' 0 N--CA 1.499 1.999 0 C-N-CA 119.408 -0.917 . . . . 0.0 110.374 -178.148 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.562 ' HA ' ' HA ' ' A' ' 27' ' ' MET . . . -62.48 143.88 56.62 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.515 -0.74 . . . . 0.0 110.489 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.877 ' CD1' HD11 ' A' ' 31' ' ' ILE . 1.2 p90 -155.25 158.02 38.18 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.735 HG11 ' HA ' ' A' ' 5' ' ' TYR . 14.5 p -67.51 68.44 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.818 -1.176 . . . . 0.0 108.833 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.679 ' HA ' ' CE2' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -49.95 -19.24 0.66 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.445 -0.785 . . . . 0.0 110.295 -179.691 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -165.95 99.72 0.65 Allowed 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.09 -1.006 . . . . 0.0 109.394 -179.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.503 ' HA ' ' CZ ' ' A' ' 4' ' ' PHE . 11.0 m -48.19 -29.65 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.419 -0.801 . . . . 0.0 109.764 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -85.12 -4.98 59.35 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.207 -0.933 . . . . 0.0 109.711 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.428 ' HA3' ' C ' ' A' ' 23' ' ' GLY . . . -67.02 -32.2 80.11 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.574 ' H ' ' HB2' ' A' ' 24' ' ' ALA . . . -128.24 163.04 25.59 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.212 -1.17 . . . . 0.0 109.279 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.557 ' O ' HG23 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -89.51 171.53 9.64 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.278 -0.889 . . . . 0.0 109.416 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.481 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 17.6 pt20 -68.51 -34.55 76.1 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.326 -0.859 . . . . 0.0 109.38 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -72.4 -23.9 61.17 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.311 -0.868 . . . . 0.0 109.322 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.469 ' OE2' ' OG ' ' A' ' 43' ' ' SER . 33.6 mt-10 -87.55 -41.14 13.69 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 178.481 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 43' ' ' SER . 38.5 t -63.37 -29.33 46.99 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 177.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.481 ' HB2' ' O ' ' A' ' 44' ' ' GLN . 0.5 OUTLIER -69.37 -64.65 0.83 Allowed 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.262 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.572 ' HB3' HD13 ' A' ' 20' ' ' ILE . 43.1 mt-10 -52.19 -39.76 60.59 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 119.467 -0.893 . . . . 0.0 108.786 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.515 ' HB2' ' HB ' ' A' ' 20' ' ' ILE . . . -62.78 -27.33 69.22 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.571 ' HG3' ' CG2' ' A' ' 59' ' ' ILE . 3.7 ttm -72.82 -43.57 62.53 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.408 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -55.36 -42.88 74.49 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.671 HG21 ' HB3' ' A' ' 16' ' ' SER . 0.1 OUTLIER -59.98 -160.23 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.419 -0.801 . . . . 0.0 109.195 179.803 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.593 ' SG ' ' HD2' ' A' ' 55' ' ' PRO . 1.7 t 66.74 144.63 0.09 OUTLIER Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.151 -0.968 . . . . 0.0 109.381 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.593 ' HD2' ' SG ' ' A' ' 54' ' ' CYS . 43.2 Cg_endo -73.57 -61.04 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.97 1.511 . . . . 0.0 109.948 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.456 HG12 ' O ' ' A' ' 56' ' ' VAL . 12.2 t -102.86 14.73 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.368 -0.833 . . . . 0.0 108.778 179.217 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.578 ' HA ' ' HB3' ' A' ' 54' ' ' CYS . 0.4 OUTLIER 65.08 -73.31 0.06 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.389 -0.819 . . . . 0.0 109.806 -179.891 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.53 ' HB3' ' HB3' ' A' ' 10' ' ' GLU . 1.8 m 63.95 12.98 7.27 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.95 -1.094 . . . . 0.0 108.544 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.571 ' CG2' ' HG3' ' A' ' 51' ' ' MET . 11.3 tt -119.22 152.25 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.432 -0.792 . . . . 0.0 109.463 -179.409 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.524 ' CD2' ' O ' ' A' ' 59' ' ' ILE . 18.9 m80 -156.11 170.26 22.6 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.104 -0.998 . . . . 0.0 110.007 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.576 ' HA ' ' CB ' ' A' ' 4' ' ' PHE . 60.6 m95 -94.14 175.1 6.83 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.353 -0.842 . . . . 0.0 109.577 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.479 ' HB3' ' HB3' ' A' ' 3' ' ' LYS . 7.3 tt0 -136.8 89.23 2.43 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.404 -0.81 . . . . 0.0 109.357 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.41 ' O ' ' C ' ' A' ' 64' ' ' GLU . 22.2 p-10 -54.93 155.41 4.46 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.317 -0.864 . . . . 0.0 109.666 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 63' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.363 -0.835 . . . . 0.0 109.571 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SF4 . . . . . 0.947 ' S2 ' ' O ' ' A' ' 14' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.505 ' O ' ' CB ' ' A' ' 2' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.2 0.524 . . . . 0.0 109.614 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.505 ' CB ' ' O ' ' A' ' 1' ' ' ALA . 10.6 tpp85 79.0 37.85 0.14 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.407 -0.808 . . . . 0.0 109.723 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.522 ' HB3' ' HB3' ' A' ' 62' ' ' GLU . 13.6 tptt -99.25 -154.37 0.47 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.246 -0.909 . . . . 0.0 109.286 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.561 ' CZ ' ' HB ' ' A' ' 39' ' ' VAL . 49.1 p90 176.39 176.38 0.29 Allowed 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.136 -0.977 . . . . 0.0 109.036 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.624 ' HA ' HG11 ' A' ' 36' ' ' VAL . 23.7 p90 175.66 -157.11 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 1.127 HG21 ' CZ ' ' A' ' 25' ' ' PHE . 0.2 OUTLIER -145.6 -170.57 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 C-N-CA 118.101 -1.439 . . . . 0.0 111.175 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.623 ' H ' HG12 ' A' ' 6' ' ' VAL . 0.6 OUTLIER -147.41 96.33 2.68 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.121 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.559 ' CG ' ' HB3' ' A' ' 33' ' ' LYS . 4.5 mp0 -64.67 40.08 0.02 OUTLIER 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.095 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.517 ' N ' ' O ' ' A' ' 7' ' ' ASP . 0.3 OUTLIER -99.03 -18.05 17.96 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.03 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.639 ' O ' HG11 ' A' ' 56' ' ' VAL . 0.5 OUTLIER -116.32 -9.29 11.56 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.701 -0.624 . . . . 0.0 109.621 -179.739 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.777 ' SG ' ' HG2' ' A' ' 33' ' ' LYS . 42.0 t -60.67 129.52 41.96 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.213 -0.929 . . . . 0.0 109.777 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.701 ' O ' ' HB2' ' A' ' 13' ' ' ALA . 14.3 pt -91.38 -45.32 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.413 -0.805 . . . . 0.0 109.271 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.701 ' HB2' ' O ' ' A' ' 12' ' ' ILE . . . 164.4 -29.9 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.279 -0.888 . . . . 0.0 110.024 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 1.164 ' O ' ' S2 ' ' A' ' 65' ' ' SF4 . 0.1 OUTLIER -49.16 154.8 0.75 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.938 -1.101 . . . . 0.0 109.377 -179.669 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.593 ' OE1' HG21 ' A' ' 18' ' ' VAL . 5.0 mm-40 -116.74 19.2 14.61 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.215 -0.928 . . . . 0.0 109.277 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.491 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 0.6 OUTLIER -43.93 -46.23 8.04 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.264 -0.897 . . . . 0.0 109.269 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.562 ' HB3' ' S1 ' ' A' ' 65' ' ' SF4 . 19.1 p -66.21 -47.56 73.44 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.394 -0.816 . . . . 0.0 109.274 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.593 HG21 ' OE1' ' A' ' 15' ' ' GLU . 23.7 t -50.65 -38.87 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.261 -0.899 . . . . 0.0 109.305 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -70.19 -37.28 75.08 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.224 -0.922 . . . . 0.0 109.097 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.624 HG22 ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -78.14 5.79 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.316 -0.865 . . . . 0.0 108.696 178.499 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.698 ' HB1' ' HB2' ' A' ' 42' ' ' ALA . . . -179.3 67.55 0.17 Allowed Pre-proline 0 N--CA 1.488 1.426 0 O-C-N 121.116 -0.99 . . . . 0.0 109.292 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -70.78 -2.96 11.74 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.051 1.553 . . . . 0.0 110.49 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.413 ' C ' ' HA3' ' A' ' 41' ' ' GLY . . . -103.52 -33.78 4.07 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.569 ' HB2' ' N ' ' A' ' 42' ' ' ALA . . . -96.95 -51.01 4.41 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.344 -1.092 . . . . 0.0 109.659 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 1.127 ' CZ ' HG21 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -85.54 136.08 33.55 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.307 -0.871 . . . . 0.0 109.572 -179.874 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.435 ' O ' ' CD1' ' A' ' 35' ' ' TYR . . . -163.73 128.83 2.94 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.11 -0.994 . . . . 0.0 109.834 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.56 ' HG2' ' CA ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -61.89 148.39 43.63 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.191 -0.943 . . . . 0.0 109.952 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.584 ' O ' ' N ' ' A' ' 32' ' ' GLU . 1.4 t70 -127.51 160.54 59.94 Favored Pre-proline 0 N--CA 1.478 0.966 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 178.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.48 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 44.2 Cg_endo -84.59 -19.24 4.36 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 O-C-N 124.497 1.788 . . . . 0.0 108.653 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -88.94 -33.99 17.06 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 106.452 -1.685 . . . . 0.0 106.452 177.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.663 HD11 ' CD1' ' A' ' 35' ' ' TYR . 0.5 OUTLIER -101.78 -0.41 10.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 177.9 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.584 ' N ' ' O ' ' A' ' 28' ' ' ASP . 17.0 mt-10 27.91 42.41 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.632 0.729 . . . . 0.0 109.654 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.777 ' HG2' ' SG ' ' A' ' 11' ' ' CYS . 0.2 OUTLIER -171.16 157.52 5.15 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -179.135 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.854 ' HB1' ' HD1' ' A' ' 25' ' ' PHE . . . -70.27 144.16 51.87 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.118 -0.989 . . . . 0.0 110.719 -178.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.665 ' CE2' ' HA ' ' A' ' 37' ' ' LYS . 2.6 p90 -150.24 159.03 44.74 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.319 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.801 ' O ' HG13 ' A' ' 36' ' ' VAL . 8.2 p -67.77 67.9 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.814 -1.178 . . . . 0.0 109.219 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.665 ' HA ' ' CE2' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -55.98 -14.8 2.76 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.232 -0.918 . . . . 0.0 110.598 -179.528 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -166.17 92.33 0.49 Allowed 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 119.004 -1.078 . . . . 0.0 109.909 -179.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.6 HG12 HG21 ' A' ' 36' ' ' VAL . 23.7 m -49.72 -26.13 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.389 -0.819 . . . . 0.0 109.703 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -78.86 -9.96 59.64 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.293 -0.879 . . . . 0.0 109.605 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.413 ' HA3' ' C ' ' A' ' 23' ' ' GLY . . . -79.23 -19.43 72.04 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.698 ' HB2' ' HB1' ' A' ' 21' ' ' ALA . . . -127.39 153.78 45.81 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.191 -1.182 . . . . 0.0 109.45 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.455 ' O ' HG23 ' A' ' 47' ' ' VAL . 0.5 OUTLIER -96.77 -168.15 1.67 Allowed 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.181 -0.949 . . . . 0.0 109.961 -179.738 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.481 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 0.4 OUTLIER -73.89 -57.98 3.61 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.609 -0.682 . . . . 0.0 109.196 179.703 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.404 ' O ' ' HB2' ' A' ' 49' ' ' GLU . 49.0 mm-40 -62.49 -14.43 41.37 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.37 -0.831 . . . . 0.0 109.692 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.453 ' HG3' ' HB2' ' A' ' 43' ' ' SER . 20.3 mt-10 -95.21 -46.48 6.75 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 179.305 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.491 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 5.5 t -59.23 -37.48 69.04 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.317 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.526 ' O ' ' N ' ' A' ' 51' ' ' MET . 0.2 OUTLIER -72.92 -55.49 6.52 Favored 'General case' 0 C--N 1.308 -1.218 0 O-C-N 121.58 -0.7 . . . . 0.0 109.813 179.971 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.827 ' O ' HG23 ' A' ' 53' ' ' THR . 2.6 tt0 -45.13 -50.57 11.14 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.196 -0.94 . . . . 0.0 108.862 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.614 ' N ' HG21 ' A' ' 20' ' ' ILE . . . -61.69 -28.37 69.36 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.211 -0.931 . . . . 0.0 108.607 179.196 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.764 ' HE2' HG23 ' A' ' 59' ' ' ILE . 43.2 ttm -64.7 -20.1 66.13 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.444 -0.785 . . . . 0.0 109.171 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -107.13 -10.03 15.99 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.374 -0.829 . . . . 0.0 109.432 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.827 HG23 ' O ' ' A' ' 49' ' ' GLU . 23.2 p -97.15 36.12 1.49 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.297 -0.877 . . . . 0.0 110.015 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.547 ' SG ' HG22 ' A' ' 56' ' ' VAL . 49.7 t -126.84 132.82 24.48 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.041 -1.037 . . . . 0.0 109.573 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.87 -32.97 8.42 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 123.835 1.44 . . . . 0.0 109.665 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.639 HG11 ' O ' ' A' ' 10' ' ' GLU . 7.3 m -98.82 -16.12 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.223 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.502 ' N ' ' SG ' ' A' ' 54' ' ' CYS . 6.9 mt-30 42.39 86.71 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.554 -0.716 . . . . 0.0 109.692 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 8.9 p -120.33 6.17 10.68 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.318 -0.864 . . . . 0.0 109.23 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.87 HD13 ' N ' ' A' ' 60' ' ' HIS . 0.0 OUTLIER -95.3 127.17 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.268 -0.895 . . . . 0.0 109.931 -179.625 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.87 ' N ' HD13 ' A' ' 59' ' ' ILE . 5.3 m-70 -131.91 -160.75 1.07 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.376 -0.828 . . . . 0.0 109.041 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.535 ' HA ' ' CB ' ' A' ' 4' ' ' PHE . 49.3 m95 -111.32 174.11 6.02 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.959 -1.088 . . . . 0.0 109.327 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.522 ' HB3' ' HB3' ' A' ' 3' ' ' LYS . 3.1 tt0 -136.43 78.78 1.73 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.505 -0.747 . . . . 0.0 109.137 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -92.21 -19.02 22.65 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.43 -0.794 . . . . 0.0 109.442 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.29 -0.881 . . . . 0.0 109.442 179.98 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 65' ' ' SF4 . . . . . 1.164 ' S2 ' ' O ' ' A' ' 14' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.426 ' O ' ' HG2' ' A' ' 2' ' ' ARG . 0.0 OUTLIER -86.63 101.38 13.19 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.358 -0.839 . . . . 0.0 109.407 179.998 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.486 ' HB3' ' HB3' ' A' ' 62' ' ' GLU . 0.6 OUTLIER -96.82 -153.41 0.41 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.182 -0.949 . . . . 0.0 109.805 -179.739 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.578 ' CZ ' ' HB ' ' A' ' 39' ' ' VAL . 8.1 p90 168.59 176.87 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 1.005 ' HA ' HG11 ' A' ' 36' ' ' VAL . 18.9 p90 178.52 -174.2 0.17 Allowed 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 1.14 HG21 ' CZ ' ' A' ' 25' ' ' PHE . 0.4 OUTLIER -132.69 168.45 24.16 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.12 0 C-N-CA 117.546 -1.662 . . . . 0.0 111.333 -179.393 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.541 ' O ' ' N ' ' A' ' 9' ' ' ASP . 9.5 t0 -116.07 89.91 3.21 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.587 ' CG ' ' O ' ' A' ' 34' ' ' ALA . 1.4 mp0 -63.24 42.3 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.949 -0.47 . . . . 0.0 111.004 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.541 ' N ' ' O ' ' A' ' 7' ' ' ASP . 0.4 OUTLIER -101.07 -28.32 12.77 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.177 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -119.53 21.74 11.97 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.485 ' HB3' ' CD ' ' A' ' 33' ' ' LYS . 8.7 t -76.77 122.51 24.86 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.186 -0.946 . . . . 0.0 110.055 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.913 HG12 ' S3 ' ' A' ' 65' ' ' SF4 . 37.7 pt -73.39 -5.76 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.405 -0.809 . . . . 0.0 109.436 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.711 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . 79.76 32.78 0.21 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.461 -0.775 . . . . 0.0 110.129 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.782 ' O ' ' S2 ' ' A' ' 65' ' ' SF4 . 1.3 p -95.78 151.93 18.93 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.097 -1.002 . . . . 0.0 109.178 179.394 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.468 ' O ' ' HB2' ' A' ' 19' ' ' GLU . 2.1 pt-20 -82.03 5.85 18.05 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.19 -0.944 . . . . 0.0 110.353 -179.079 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.776 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 3.6 m -43.78 -82.64 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.127 -0.983 . . . . 0.0 109.432 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.751 ' SG ' ' CD2' ' A' ' 25' ' ' PHE . 13.0 p -47.32 -56.83 6.07 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.25 -0.906 . . . . 0.0 109.617 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.666 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 74.1 t -47.29 -27.2 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.394 -0.816 . . . . 0.0 110.186 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.468 ' HB2' ' O ' ' A' ' 15' ' ' GLU . 0.1 OUTLIER -81.03 -40.14 24.72 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.966 -1.084 . . . . 0.0 109.673 -179.685 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.957 ' CD1' HG21 ' A' ' 53' ' ' THR . 2.4 mt -84.18 13.8 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.403 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.433 ' HB2' ' O ' ' A' ' 20' ' ' ILE . . . 177.84 65.92 0.09 OUTLIER Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.378 -0.826 . . . . 0.0 109.333 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -74.23 1.62 7.08 Favored 'Trans proline' 0 C--N 1.303 -1.837 0 O-C-N 124.069 1.563 . . . . 0.0 110.718 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.485 ' O ' ' HB3' ' A' ' 38' ' ' ASP . . . -97.77 -45.07 2.54 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' A' ' 38' ' ' ASP . . . -87.78 -47.1 8.89 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.255 -1.144 . . . . 0.0 109.559 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 1.14 ' CZ ' HG21 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -92.62 134.83 34.63 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.263 -0.898 . . . . 0.0 109.121 179.859 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.67 ' HB3' ' HE1' ' A' ' 35' ' ' TYR . . . -157.95 118.63 3.44 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.386 -0.821 . . . . 0.0 109.587 179.501 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.559 ' HA ' ' C ' ' A' ' 33' ' ' LYS . 14.6 mtm -59.15 149.6 27.64 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.114 -0.991 . . . . 0.0 109.37 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.612 ' O ' ' N ' ' A' ' 32' ' ' GLU . 1.3 t0 -126.95 163.13 43.39 Favored Pre-proline 0 C--N 1.312 -1.031 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 179.02 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.479 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 43.9 Cg_endo -83.95 -16.76 6.19 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 124.95 2.026 . . . . 0.0 108.086 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.24 -38.83 17.2 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 178.066 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.606 ' CG1' ' CB ' ' A' ' 28' ' ' ASP . 2.6 pt -102.24 -2.2 9.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.148 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.612 ' N ' ' O ' ' A' ' 28' ' ' ASP . 3.9 mm-40 34.35 36.23 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 -178.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.559 ' C ' ' HA ' ' A' ' 27' ' ' MET . 11.1 mttm -161.41 148.64 14.81 Favored 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 119.37 -0.932 . . . . 0.0 110.501 -177.509 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.587 ' O ' ' CG ' ' A' ' 8' ' ' GLN . . . -58.59 143.99 44.41 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.478 -0.764 . . . . 0.0 109.901 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.67 ' HE1' ' HB3' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -142.31 139.76 31.94 Favored 'General case' 0 N--CA 1.5 2.039 0 CA-C-O 121.803 0.811 . . . . 0.0 110.199 179.461 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 1.005 HG11 ' HA ' ' A' ' 5' ' ' TYR . 7.9 p -74.34 61.61 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.123 -0.986 . . . . 0.0 108.673 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.646 ' HB3' ' CZ ' ' A' ' 35' ' ' TYR . 0.1 OUTLIER -71.4 -18.34 62.35 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.303 -0.873 . . . . 0.0 110.607 -178.992 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.485 ' HB3' ' O ' ' A' ' 23' ' ' GLY . 57.2 t0 -135.21 75.62 1.58 Allowed 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.055 -1.028 . . . . 0.0 109.722 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.578 ' HB ' ' CZ ' ' A' ' 4' ' ' PHE . 6.4 m -51.81 -24.35 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.273 -0.892 . . . . 0.0 108.935 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.521 ' HG3' HG23 ' A' ' 39' ' ' VAL . 2.0 mt-10 -90.16 1.81 56.01 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.335 -0.853 . . . . 0.0 109.365 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.408 ' O ' ' HA3' ' A' ' 23' ' ' GLY . . . -96.04 34.75 4.72 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.435 ' HA ' ' OE2' ' A' ' 46' ' ' GLU . . . -179.66 126.65 0.08 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.251 -1.147 . . . . 0.0 109.615 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.77 ' O ' HG23 ' A' ' 47' ' ' VAL . 0.3 OUTLIER -59.22 165.67 2.52 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.298 -0.876 . . . . 0.0 109.542 179.768 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.496 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 0.1 OUTLIER -71.67 -37.44 70.76 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.333 -0.854 . . . . 0.0 109.467 179.995 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -71.73 -20.26 61.92 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.075 -1.015 . . . . 0.0 109.286 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.531 ' HG2' ' N ' ' A' ' 43' ' ' SER . 5.3 pt-20 -95.08 -34.08 12.44 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 106.517 -1.661 . . . . 0.0 106.517 178.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.77 HG23 ' O ' ' A' ' 43' ' ' SER . 25.1 t -64.25 -46.82 92.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 177.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.496 ' HB2' ' O ' ' A' ' 44' ' ' GLN . 0.2 OUTLIER -64.77 -51.3 63.02 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.615 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.652 ' HB3' HG21 ' A' ' 20' ' ' ILE . 6.6 mt-10 -51.74 -40.57 60.46 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 178.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.769 ' HA ' HD13 ' A' ' 20' ' ' ILE . . . -72.41 -32.73 66.61 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.126 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.993 ' HG3' HD13 ' A' ' 59' ' ' ILE . 34.6 ttm -74.41 -24.88 59.17 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.645 -0.659 . . . . 0.0 110.103 -179.304 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -86.3 -26.35 24.97 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.047 -1.033 . . . . 0.0 109.882 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.957 HG21 ' CD1' ' A' ' 20' ' ' ILE . 13.8 t -73.01 -5.89 41.84 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.137 -0.977 . . . . 0.0 109.772 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.633 ' SG ' ' HD2' ' A' ' 55' ' ' PRO . 19.4 t -79.09 142.61 59.82 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.163 -0.961 . . . . 0.0 109.743 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.633 ' HD2' ' SG ' ' A' ' 54' ' ' CYS . 42.9 Cg_endo -76.35 -72.38 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.07 1.563 . . . . 0.0 109.945 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.424 ' O ' ' HB2' ' A' ' 57' ' ' GLN . 2.5 t -74.5 -18.18 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.096 -1.003 . . . . 0.0 108.761 179.337 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.451 ' O ' ' C ' ' A' ' 58' ' ' CYS . 1.4 mt-30 71.9 -64.57 0.38 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.431 -0.793 . . . . 0.0 110.139 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.451 ' C ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER 42.05 37.9 0.95 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.334 -0.854 . . . . 0.0 108.799 -179.467 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.993 HD13 ' HG3' ' A' ' 51' ' ' MET . 7.6 tt -121.48 157.46 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.303 -0.873 . . . . 0.0 110.096 -179.27 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.57 ' CG ' ' O ' ' A' ' 59' ' ' ILE . 23.5 m80 -159.3 132.62 7.14 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.353 -0.842 . . . . 0.0 109.655 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.569 ' HA ' ' HA ' ' A' ' 4' ' ' PHE . 57.3 m95 -71.26 168.72 16.7 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.239 -0.913 . . . . 0.0 109.141 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.505 ' N ' ' HA ' ' A' ' 4' ' ' PHE . 1.4 tt0 -135.5 112.57 10.37 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.186 -0.946 . . . . 0.0 109.644 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -106.04 36.52 2.54 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.335 -0.853 . . . . 0.0 109.375 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 O-C-N 121.21 -0.931 . . . . 0.0 109.457 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' SF4 . . . . . 0.913 ' S3 ' HG12 ' A' ' 12' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 23.9 mtm180 -150.56 153.63 36.1 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.171 -0.956 . . . . 0.0 109.602 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.465 ' HB3' ' HB3' ' A' ' 62' ' ' GLU . 0.2 OUTLIER -101.55 -163.25 1.0 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.226 -0.921 . . . . 0.0 109.758 -179.968 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.638 ' CE1' HG21 ' A' ' 47' ' ' VAL . 14.4 p90 167.98 -174.33 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.269 -0.894 . . . . 0.0 109.657 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.527 ' O ' HG13 ' A' ' 59' ' ' ILE . 4.4 p90 176.18 -172.63 0.08 Allowed 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.953 HG21 ' CZ ' ' A' ' 25' ' ' PHE . 0.2 OUTLIER -135.78 164.89 31.25 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 C-N-CA 118.056 -1.458 . . . . 0.0 111.086 179.685 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.569 ' OD2' ' CE1' ' A' ' 60' ' ' HIS . 5.5 m-20 -109.1 90.88 3.43 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.105 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.519 ' HG2' ' O ' ' A' ' 34' ' ' ALA . 5.2 mp0 -66.22 48.24 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.66 0 CA-C-O 121.884 0.85 . . . . 0.0 110.002 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.527 ' N ' ' O ' ' A' ' 7' ' ' ASP . 11.0 t0 -110.53 -39.96 4.76 Favored 'General case' 0 C--N 1.285 -2.22 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.426 ' HB2' ' SG ' ' A' ' 58' ' ' CYS . 0.0 OUTLIER -101.25 20.49 15.69 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.307 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.447 ' HB3' ' HG2' ' A' ' 33' ' ' LYS . 11.1 t -86.44 134.99 33.65 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.308 -0.87 . . . . 0.0 110.085 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.692 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 30.3 pt -105.09 -6.15 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.353 -0.842 . . . . 0.0 108.78 179.029 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.692 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . 76.53 70.85 0.07 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.344 -0.848 . . . . 0.0 109.45 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 1.214 ' SG ' ' OG ' ' A' ' 16' ' ' SER . 27.4 p -103.89 -11.45 17.48 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.124 -0.985 . . . . 0.0 109.697 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.52 ' CB ' ' O ' ' A' ' 14' ' ' CYS . 3.1 tt0 76.29 -1.65 2.88 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.212 -0.93 . . . . 0.0 110.253 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . 1.214 ' OG ' ' SG ' ' A' ' 14' ' ' CYS . 0.2 OUTLIER -61.76 -67.11 0.44 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.975 -1.078 . . . . 0.0 109.294 179.89 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.723 ' SG ' ' CD2' ' A' ' 25' ' ' PHE . 14.2 p -54.77 -44.12 73.39 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.21 -0.931 . . . . 0.0 109.103 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.463 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 21.2 t -54.31 -19.69 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.304 -0.872 . . . . 0.0 109.16 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.27 -41.54 14.51 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.172 -0.955 . . . . 0.0 109.107 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.837 HG21 ' HB3' ' A' ' 49' ' ' GLU . 1.9 mt -85.84 16.23 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 177.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.401 ' N ' ' HD3' ' A' ' 22' ' ' PRO . . . -177.54 59.95 0.15 Allowed Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.429 -0.795 . . . . 0.0 109.062 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.401 ' HD3' ' N ' ' A' ' 21' ' ' ALA . 45.4 Cg_endo -74.25 -0.11 9.21 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 124.075 1.566 . . . . 0.0 110.402 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.491 ' O ' ' HB3' ' A' ' 38' ' ' ASP . . . -111.43 -26.88 4.37 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.523 ' CB ' ' O ' ' A' ' 38' ' ' ASP . . . -100.34 -47.25 4.99 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.362 -1.081 . . . . 0.0 109.604 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.953 ' CZ ' HG21 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -90.61 140.4 29.79 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.373 -0.829 . . . . 0.0 109.045 -179.96 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.523 ' O ' ' CD1' ' A' ' 35' ' ' TYR . . . -164.48 119.57 1.45 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.147 -0.97 . . . . 0.0 109.943 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.542 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 5.7 ttm -60.14 152.22 24.94 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.098 -1.001 . . . . 0.0 109.159 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.606 ' O ' ' N ' ' A' ' 32' ' ' GLU . 2.8 t0 -125.97 160.14 58.33 Favored Pre-proline 0 C--N 1.312 -1.06 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 179.395 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.48 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 43.9 Cg_endo -84.88 -16.15 5.46 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 O-C-N 124.662 1.875 . . . . 0.0 108.585 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.75 -28.0 16.87 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 177.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.596 HD12 ' HB3' ' A' ' 35' ' ' TYR . 0.8 OUTLIER -108.46 -0.81 9.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 177.905 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.606 ' N ' ' O ' ' A' ' 28' ' ' ASP . 19.6 mt-10 28.73 42.73 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.595 0.712 . . . . 0.0 109.625 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.523 ' C ' ' HA ' ' A' ' 27' ' ' MET . 1.0 OUTLIER -169.44 148.19 3.76 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 119.365 -0.934 . . . . 0.0 110.287 -179.051 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.542 ' HA ' ' HA ' ' A' ' 27' ' ' MET . . . -57.2 143.76 37.88 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.453 -0.779 . . . . 0.0 110.67 -179.449 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.633 ' O ' ' CD1' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -144.03 143.09 31.03 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.732 0.777 . . . . 0.0 109.607 179.094 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.927 ' HB ' HG23 ' A' ' 6' ' ' VAL . 2.1 t -86.2 91.67 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 120.816 -1.178 . . . . 0.0 108.153 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.611 ' HB3' ' CE2' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -104.3 -16.22 15.22 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.343 -0.848 . . . . 0.0 110.605 -178.82 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.523 ' O ' ' CB ' ' A' ' 24' ' ' ALA . 36.9 t70 -129.66 90.92 3.06 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 120.984 -1.072 . . . . 0.0 109.696 -179.531 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.515 HG12 ' CE1' ' A' ' 4' ' ' PHE . 28.7 m -58.27 -39.77 75.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.22 -0.925 . . . . 0.0 109.578 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.486 ' HG2' ' OD1' ' A' ' 38' ' ' ASP . 1.3 pt-20 -64.6 -16.53 62.86 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.248 -0.907 . . . . 0.0 109.258 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.513 ' N ' ' OD2' ' A' ' 38' ' ' ASP . . . -76.59 0.76 63.86 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.694 -1.363 . . . . 0.0 109.694 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -160.04 103.91 1.49 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.179 -1.189 . . . . 0.0 109.512 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.472 ' OG ' ' OE2' ' A' ' 46' ' ' GLU . 0.4 OUTLIER -50.19 162.65 0.2 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.27 -0.894 . . . . 0.0 109.69 -179.876 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.479 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 15.1 pt20 -48.97 -50.17 36.99 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.434 -0.791 . . . . 0.0 109.43 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.42 ' N ' ' HG3' ' A' ' 44' ' ' GLN . 25.9 mm-40 -63.21 -13.04 33.04 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.298 -0.876 . . . . 0.0 109.359 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.472 ' OE2' ' OG ' ' A' ' 43' ' ' SER . 7.3 mt-10 -93.48 -52.77 4.35 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 179.017 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.638 HG21 ' CE1' ' A' ' 4' ' ' PHE . 2.5 t -53.67 -38.7 35.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 178.371 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.479 ' HB2' ' O ' ' A' ' 44' ' ' GLN . 0.1 OUTLIER -69.08 -55.63 10.19 Favored 'General case' 0 C--N 1.309 -1.173 0 O-C-N 121.499 -0.751 . . . . 0.0 109.776 179.775 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.837 ' HB3' HG21 ' A' ' 20' ' ' ILE . 20.3 mm-40 -53.2 -49.77 66.06 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.143 -0.973 . . . . 0.0 108.765 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.72 ' HB2' ' HB ' ' A' ' 20' ' ' ILE . . . -65.6 -11.1 41.32 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.429 -0.794 . . . . 0.0 108.931 179.194 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.643 ' CG ' HG21 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -83.92 -43.78 14.92 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.453 -0.78 . . . . 0.0 109.938 -179.372 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -76.41 -22.36 54.82 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.335 -0.853 . . . . 0.0 110.205 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.617 HG21 ' CD1' ' A' ' 20' ' ' ILE . 7.6 t -69.95 -6.05 30.43 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.052 -1.03 . . . . 0.0 109.69 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.521 ' SG ' ' HD2' ' A' ' 55' ' ' PRO . 16.1 t -85.95 139.97 34.99 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.152 -0.968 . . . . 0.0 109.557 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.521 ' HD2' ' SG ' ' A' ' 54' ' ' CYS . 46.0 Cg_endo -74.27 -49.52 0.18 Allowed 'Trans proline' 0 C--N 1.303 -1.819 0 O-C-N 124.051 1.553 . . . . 0.0 110.138 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.476 ' O ' ' HB2' ' A' ' 57' ' ' GLN . 5.4 t -97.28 -11.78 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.301 -0.874 . . . . 0.0 109.078 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.476 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 13.6 mt-30 65.43 -85.43 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.464 -0.773 . . . . 0.0 110.028 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.465 ' SG ' ' HB2' ' A' ' 7' ' ' ASP . 7.2 t 58.79 31.99 21.77 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.067 -1.021 . . . . 0.0 108.823 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.845 HD12 HG13 ' A' ' 6' ' ' VAL . 1.2 tt -110.84 156.65 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.354 -0.841 . . . . 0.0 109.724 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.569 ' CE1' ' OD2' ' A' ' 7' ' ' ASP . 13.6 m80 -154.03 136.54 15.07 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.116 -0.99 . . . . 0.0 109.797 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.547 ' HA ' ' CB ' ' A' ' 4' ' ' PHE . 56.8 m95 -78.74 166.88 21.97 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.39 -0.819 . . . . 0.0 109.499 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.526 ' N ' ' HA ' ' A' ' 4' ' ' PHE . 45.2 tt0 -132.65 116.83 17.13 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.342 -0.849 . . . . 0.0 109.32 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -106.14 -39.14 6.05 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.285 -0.885 . . . . 0.0 109.611 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 . . . . . 0 N--CA 1.49 1.548 0 O-C-N 121.207 -0.933 . . . . 0.0 109.507 179.984 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 65' ' ' SF4 . . . . . 0.595 ' S1 ' ' HB3' ' A' ' 17' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.433 ' O ' ' C ' ' A' ' 2' ' ' ARG . . . . . . . . 0 N--CA 1.492 1.627 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.433 ' C ' ' O ' ' A' ' 1' ' ' ALA . 18.9 mtm180 43.9 33.06 0.69 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.267 -0.895 . . . . 0.0 109.159 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.589 ' CG ' ' CG ' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -81.44 -145.01 0.05 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.506 -0.746 . . . . 0.0 109.538 -179.82 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.562 ' CB ' ' HA ' ' A' ' 61' ' ' TRP . 28.6 p90 -173.48 -177.59 1.5 Allowed 'General case' 0 C--N 1.296 -1.747 0 O-C-N 121.205 -0.935 . . . . 0.0 109.496 -179.066 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.609 ' HA ' HG11 ' A' ' 36' ' ' VAL . 14.3 p90 175.1 -172.05 0.06 Allowed 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 1.053 HG21 ' CZ ' ' A' ' 25' ' ' PHE . 0.2 OUTLIER -134.34 172.33 16.38 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 C-N-CA 117.594 -1.642 . . . . 0.0 111.162 179.565 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.567 ' O ' ' N ' ' A' ' 9' ' ' ASP . 13.5 t70 -122.29 90.18 3.25 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.566 ' CG ' ' O ' ' A' ' 34' ' ' ALA . 6.9 mp0 -66.45 48.92 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.748 0.785 . . . . 0.0 109.81 179.28 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.567 ' N ' ' O ' ' A' ' 7' ' ' ASP . 0.5 OUTLIER -114.08 -25.7 8.41 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.588 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.481 ' HB3' ' SG ' ' A' ' 58' ' ' CYS . 0.1 OUTLIER -110.22 -19.71 12.92 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.649 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.466 ' O ' ' HD3' ' A' ' 33' ' ' LYS . 42.0 t -46.75 141.92 3.62 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.425 -0.797 . . . . 0.0 109.471 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.749 ' O ' ' HB2' ' A' ' 13' ' ' ALA . 11.8 pt -99.34 -51.93 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.068 -1.02 . . . . 0.0 109.545 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.749 ' HB2' ' O ' ' A' ' 12' ' ' ILE . . . 154.91 35.48 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.543 -0.723 . . . . 0.0 110.276 179.287 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.673 ' O ' ' S2 ' ' A' ' 65' ' ' SF4 . 0.5 OUTLIER -105.08 158.53 16.5 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.667 -1.271 . . . . 0.0 109.719 179.557 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.455 ' O ' ' N ' ' A' ' 19' ' ' GLU . 11.6 mt-10 -99.07 12.97 34.5 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.306 -0.871 . . . . 0.0 109.833 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.631 ' O ' HD12 ' A' ' 20' ' ' ILE . 3.7 m -45.03 -76.34 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.087 -1.008 . . . . 0.0 109.052 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.995 ' SG ' ' CD2' ' A' ' 25' ' ' PHE . 10.6 p -52.6 -49.15 65.62 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.38 -0.825 . . . . 0.0 109.125 179.421 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.581 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 60.8 t -52.13 -24.7 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.311 -0.868 . . . . 0.0 109.226 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.455 ' N ' ' O ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -83.61 -36.02 24.21 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.219 -0.926 . . . . 0.0 109.173 179.76 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 1.012 HD13 ' HA ' ' A' ' 50' ' ' ALA . 2.7 mp -83.43 10.56 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.242 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.67 ' HB1' ' HB2' ' A' ' 42' ' ' ALA . . . 178.08 68.71 0.1 Allowed Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.393 -0.817 . . . . 0.0 108.879 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -69.93 -1.19 8.21 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 124.166 1.614 . . . . 0.0 110.887 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.497 ' O ' ' HB3' ' A' ' 38' ' ' ASP . . . -105.34 -44.44 1.46 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.53 ' CB ' ' O ' ' A' ' 38' ' ' ASP . . . -83.46 -36.42 24.19 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.374 -1.074 . . . . 0.0 109.844 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 1.053 ' CZ ' HG21 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -105.73 140.71 38.36 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.342 -0.848 . . . . 0.0 109.23 -179.682 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.522 ' O ' ' CD1' ' A' ' 35' ' ' TYR . . . -171.27 120.37 0.5 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.151 -0.968 . . . . 0.0 109.459 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.558 ' HA ' ' C ' ' A' ' 33' ' ' LYS . 10.5 mtp -58.41 153.73 15.16 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.08 -1.013 . . . . 0.0 109.232 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.613 ' O ' ' N ' ' A' ' 32' ' ' GLU . 1.4 t0 -132.97 165.07 39.4 Favored Pre-proline 0 C--N 1.312 -1.063 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.516 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 43.8 Cg_endo -84.59 -15.11 6.29 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 124.654 1.871 . . . . 0.0 107.459 178.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.687 ' HB3' HD13 ' A' ' 31' ' ' ILE . 4.4 tt0 -83.54 -39.24 20.66 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 177.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.7 ' N ' HD13 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -106.2 1.24 10.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.103 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.613 ' N ' ' O ' ' A' ' 28' ' ' ASP . 22.6 mt-10 33.84 36.42 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 -179.242 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.558 ' C ' ' HA ' ' A' ' 27' ' ' MET . 17.9 mttm -164.72 149.6 9.61 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 119.203 -0.999 . . . . 0.0 110.565 -177.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.566 ' O ' ' CG ' ' A' ' 8' ' ' GLN . . . -53.07 141.83 21.64 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.574 -0.704 . . . . 0.0 109.658 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.642 ' O ' ' CD1' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -144.69 140.67 28.76 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 122.044 0.926 . . . . 0.0 109.901 179.347 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.967 ' HB ' HG23 ' A' ' 6' ' ' VAL . 1.7 t -84.57 97.31 5.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -179.41 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.564 ' HG2' ' CE1' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -115.87 -10.62 11.65 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.278 -0.889 . . . . 0.0 111.193 -178.604 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.53 ' O ' ' CB ' ' A' ' 24' ' ' ALA . 33.9 t0 -133.03 87.91 2.45 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.792 -1.192 . . . . 0.0 110.098 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.408 HG23 ' N ' ' A' ' 40' ' ' GLU . 24.0 m -54.08 -34.89 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.258 -0.901 . . . . 0.0 109.343 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.408 ' N ' HG23 ' A' ' 39' ' ' VAL . 74.3 mt-10 -69.5 -14.03 62.65 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.4 -0.813 . . . . 0.0 109.601 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.4 ' HA3' ' C ' ' A' ' 23' ' ' GLY . . . -76.44 -2.08 73.0 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.67 ' HB2' ' HB1' ' A' ' 21' ' ' ALA . . . -162.5 135.57 5.92 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.209 -1.171 . . . . 0.0 109.46 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.456 ' OG ' ' HG3' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -77.23 166.43 23.22 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.283 -0.886 . . . . 0.0 109.84 -179.75 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.465 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 5.4 pt20 -54.9 -43.2 73.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.45 -0.781 . . . . 0.0 109.633 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.446 ' N ' ' HG3' ' A' ' 44' ' ' GLN . 33.4 mm-40 -69.18 -11.04 60.45 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.235 -0.916 . . . . 0.0 109.163 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.456 ' HG3' ' OG ' ' A' ' 43' ' ' SER . 18.3 mt-10 -94.72 -44.63 7.7 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 178.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.431 ' O ' ' HB2' ' A' ' 51' ' ' MET . 72.6 t -60.83 -37.26 76.01 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 177.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.465 ' HB2' ' O ' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -67.93 -59.65 3.11 Favored 'General case' 0 C--N 1.31 -1.146 0 O-C-N 121.502 -0.749 . . . . 0.0 109.298 179.108 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.644 ' OE1' HG23 ' A' ' 20' ' ' ILE . 8.8 tt0 -51.59 -47.48 63.55 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.441 -0.903 . . . . 0.0 109.101 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 1.012 ' HA ' HD13 ' A' ' 20' ' ' ILE . . . -61.62 -27.42 68.64 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.3 -0.875 . . . . 0.0 109.204 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.591 ' CG ' ' CG2' ' A' ' 59' ' ' ILE . 0.8 OUTLIER -70.97 -27.14 63.51 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.544 -0.723 . . . . 0.0 110.405 -179.21 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -94.68 -8.45 37.82 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.919 -1.113 . . . . 0.0 110.127 -179.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.474 HG22 ' HB3' ' A' ' 16' ' ' SER . 91.7 m -88.07 -17.96 29.93 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.073 -1.017 . . . . 0.0 110.052 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.818 ' SG ' ' HD2' ' A' ' 55' ' ' PRO . 35.5 t -69.73 147.07 96.24 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.028 -1.045 . . . . 0.0 109.783 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.818 ' HD2' ' SG ' ' A' ' 54' ' ' CYS . 45.0 Cg_endo -77.9 -63.32 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.119 1.589 . . . . 0.0 109.781 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.527 HG12 ' O ' ' A' ' 56' ' ' VAL . 75.9 t -80.65 -6.02 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.287 -0.883 . . . . 0.0 109.081 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.402 ' HA ' ' HB3' ' A' ' 54' ' ' CYS . 44.9 mt-30 45.8 71.46 0.28 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.315 -0.866 . . . . 0.0 109.545 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.481 ' SG ' ' HB3' ' A' ' 10' ' ' GLU . 2.5 m -94.44 21.1 7.5 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.277 -0.889 . . . . 0.0 109.129 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.658 HD12 HG22 ' A' ' 6' ' ' VAL . 1.9 tt -105.19 142.41 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.453 -0.78 . . . . 0.0 109.833 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.436 ' CG ' ' C ' ' A' ' 59' ' ' ILE . 10.1 m-70 -149.83 142.31 24.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.471 -0.768 . . . . 0.0 109.118 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.562 ' HA ' ' CB ' ' A' ' 4' ' ' PHE . 64.5 m95 -59.5 175.28 0.35 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.22 -0.925 . . . . 0.0 109.744 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.589 ' CG ' ' CG ' ' A' ' 3' ' ' LYS . 1.4 tp10 -127.81 103.74 7.44 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.475 -0.766 . . . . 0.0 109.116 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -108.36 104.04 13.33 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.0 -1.063 . . . . 0.0 109.485 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.5 0 O-C-N 121.274 -0.891 . . . . 0.0 109.486 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' SF4 . . . . . 0.673 ' S2 ' ' O ' ' A' ' 14' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.5 ptt-85 -74.01 114.18 12.04 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.165 -0.959 . . . . 0.0 109.379 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.477 ' O ' ' HB3' ' A' ' 4' ' ' PHE . 0.5 OUTLIER -111.58 -168.01 1.25 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.279 -0.888 . . . . 0.0 109.677 -179.882 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.544 ' CB ' ' HA ' ' A' ' 61' ' ' TRP . 12.5 p90 177.07 -163.91 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.453 -0.779 . . . . 0.0 109.175 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.796 ' HA ' HG21 ' A' ' 36' ' ' VAL . 52.2 p90 171.44 -178.32 0.05 Allowed 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.95 HG21 ' CZ ' ' A' ' 25' ' ' PHE . 3.7 t -143.71 155.58 16.13 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.338 0 C-N-CA 117.205 -1.798 . . . . 0.0 111.301 179.273 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.525 ' O ' ' N ' ' A' ' 9' ' ' ASP . 0.2 OUTLIER -102.14 74.87 1.46 Allowed 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 178.864 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.532 ' HB3' ' O ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER -40.98 -24.43 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.523 0.678 . . . . 0.0 109.372 179.871 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.525 ' N ' ' O ' ' A' ' 7' ' ' ASP . 0.2 OUTLIER -54.27 -31.22 53.14 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.421 -0.799 . . . . 0.0 109.121 179.816 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.484 ' HG2' HG11 ' A' ' 56' ' ' VAL . 1.4 tp10 -100.83 11.27 39.91 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.346 -0.846 . . . . 0.0 109.152 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 6.6 t -76.97 122.03 24.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.242 -0.911 . . . . 0.0 109.905 -179.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 1.001 HG12 ' S3 ' ' A' ' 65' ' ' SF4 . 16.4 pt -70.96 -145.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.41 -0.806 . . . . 0.0 109.413 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.469 ' N ' HG13 ' A' ' 12' ' ' ILE . . . -111.71 55.77 0.66 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.053 -1.029 . . . . 0.0 109.575 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 1.044 ' O ' ' S2 ' ' A' ' 65' ' ' SF4 . 0.1 OUTLIER -139.35 155.37 47.72 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.121 -0.987 . . . . 0.0 109.692 179.858 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.43 ' O ' ' C ' ' A' ' 16' ' ' SER . 13.3 pt-20 -118.44 20.36 13.06 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.366 -0.833 . . . . 0.0 109.534 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.64 ' O ' HD12 ' A' ' 20' ' ' ILE . 0.2 OUTLIER -43.65 -60.95 1.56 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.354 -0.841 . . . . 0.0 109.269 179.899 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.533 ' SG ' ' N ' ' A' ' 18' ' ' VAL . 19.5 p -49.17 -48.59 44.92 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.386 -0.821 . . . . 0.0 109.297 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.533 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 5.0 t -49.6 -36.45 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.355 -0.841 . . . . 0.0 109.578 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.426 ' N ' ' OE1' ' A' ' 19' ' ' GLU . 0.2 OUTLIER -73.77 -35.91 65.03 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.041 -1.037 . . . . 0.0 109.321 -179.949 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.942 HD11 HG21 ' A' ' 53' ' ' THR . 2.5 mp -84.84 12.47 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.241 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.537 ' HB1' ' HB2' ' A' ' 42' ' ' ALA . . . -171.34 66.48 0.43 Allowed Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.355 -0.84 . . . . 0.0 109.311 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -72.51 56.42 2.77 Favored 'Trans proline' 0 C--N 1.303 -1.842 0 O-C-N 124.091 1.574 . . . . 0.0 110.058 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -179.85 -34.45 0.07 OUTLIER Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.476 ' O ' ' HA ' ' A' ' 36' ' ' VAL . . . -94.72 -25.28 16.77 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.246 -1.149 . . . . 0.0 109.303 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.95 ' CZ ' HG21 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -123.83 135.31 53.69 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.31 -0.869 . . . . 0.0 109.287 179.839 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.49 ' O ' ' HA ' ' A' ' 34' ' ' ALA . . . -163.05 145.15 10.16 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.537 ' HG3' ' CA ' ' A' ' 33' ' ' LYS . 10.7 ttm -77.72 152.7 33.55 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.96 -1.087 . . . . 0.0 109.123 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.636 ' O ' ' N ' ' A' ' 32' ' ' GLU . 1.1 t0 -123.84 162.26 41.98 Favored Pre-proline 0 C--N 1.313 -1.019 0 N-CA-C 106.614 -1.624 . . . . 0.0 106.614 179.067 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.456 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 46.5 Cg_endo -84.29 -15.09 6.67 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 125.06 2.084 . . . . 0.0 108.109 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -88.26 -34.34 17.75 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 178.369 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.596 ' CG1' ' HB3' ' A' ' 28' ' ' ASP . 1.6 pt -107.72 -2.49 10.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.042 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.636 ' N ' ' O ' ' A' ' 28' ' ' ASP . 0.0 OUTLIER 35.25 35.05 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -178.74 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.537 ' CA ' ' HG3' ' A' ' 27' ' ' MET . 23.7 mmtp -157.87 152.92 25.53 Favored 'General case' 0 N--CA 1.499 2.022 0 C-N-CA 119.42 -0.912 . . . . 0.0 110.542 -177.547 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.532 ' O ' ' HB3' ' A' ' 8' ' ' GLN . . . -61.74 142.75 57.06 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.616 -0.677 . . . . 0.0 110.059 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.651 ' CZ ' ' HB3' ' A' ' 37' ' ' LYS . 11.6 p90 -144.0 168.5 19.83 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 178.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.827 HG22 HG23 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -85.16 78.39 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.272 0 CA-C-O 121.782 0.801 . . . . 0.0 109.04 -178.079 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.651 ' HB3' ' CZ ' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -68.89 -3.74 13.82 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.846 -0.534 . . . . 0.0 110.539 -179.125 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.477 ' HB2' ' O ' ' A' ' 37' ' ' LYS . 36.7 t0 179.87 128.6 0.08 Allowed 'General case' 0 C--N 1.299 -1.611 0 C-N-CA 118.73 -1.188 . . . . 0.0 110.004 -178.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.529 HG12 ' CE1' ' A' ' 4' ' ' PHE . 15.8 m -79.6 -30.66 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.22 -0.925 . . . . 0.0 109.698 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -84.07 -9.75 58.38 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.183 -0.948 . . . . 0.0 109.267 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -61.95 -21.74 61.6 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.537 ' HB2' ' HB1' ' A' ' 21' ' ' ALA . . . -136.21 138.59 42.03 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.235 -1.156 . . . . 0.0 109.737 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.847 ' O ' HG23 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -71.66 158.32 36.38 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.244 -0.91 . . . . 0.0 109.643 -179.957 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.408 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 0.9 OUTLIER -47.53 -46.65 27.8 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.455 -0.778 . . . . 0.0 109.514 179.89 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -67.04 -9.54 40.21 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.292 -0.88 . . . . 0.0 109.449 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.468 ' HB2' ' HB1' ' A' ' 42' ' ' ALA . 27.5 mt-10 -97.91 -41.84 7.82 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 178.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.847 HG23 ' O ' ' A' ' 43' ' ' SER . 2.1 t -62.18 -40.59 88.17 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.924 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 178.139 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.408 ' HB2' ' O ' ' A' ' 44' ' ' GLN . 0.4 OUTLIER -73.17 -56.17 5.46 Favored 'General case' 0 C--N 1.308 -1.211 0 O-C-N 121.673 -0.642 . . . . 0.0 109.648 179.585 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.543 ' HB3' HG21 ' A' ' 20' ' ' ILE . 34.0 tt0 -52.94 -45.57 67.74 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.172 -0.955 . . . . 0.0 108.806 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.917 ' HA ' HD13 ' A' ' 20' ' ' ILE . . . -64.31 -17.87 64.07 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.32 -0.863 . . . . 0.0 108.93 179.328 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.79 ' HG3' HG21 ' A' ' 59' ' ' ILE . 2.6 ttm -80.93 -41.61 22.65 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.562 -0.712 . . . . 0.0 109.581 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -69.06 -24.54 64.18 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.282 -0.886 . . . . 0.0 109.704 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.942 HG21 HD11 ' A' ' 20' ' ' ILE . 4.9 p -72.5 -33.24 66.8 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.12 -0.988 . . . . 0.0 109.975 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.798 ' SG ' ' HD2' ' A' ' 55' ' ' PRO . 9.4 t -65.19 146.6 98.91 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.056 -1.028 . . . . 0.0 109.864 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.798 ' HD2' ' SG ' ' A' ' 54' ' ' CYS . 45.2 Cg_endo -79.15 -69.49 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 124.099 1.579 . . . . 0.0 110.105 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.484 HG11 ' HG2' ' A' ' 10' ' ' GLU . 9.8 p -75.44 -16.43 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.201 -0.937 . . . . 0.0 108.791 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 63.94 47.81 3.33 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.449 -0.782 . . . . 0.0 109.837 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.541 ' SG ' ' S4 ' ' A' ' 65' ' ' SF4 . 11.5 p -48.61 -23.57 1.05 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.224 -0.923 . . . . 0.0 109.212 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.869 ' CA ' HG13 ' A' ' 6' ' ' VAL . 6.6 tt -69.32 159.09 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.574 -0.703 . . . . 0.0 110.047 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.527 ' C ' ' CD1' ' A' ' 61' ' ' TRP . 98.0 m-70 -149.82 -134.19 0.06 Allowed 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.666 ' CZ2' ' HE3' ' A' ' 51' ' ' MET . 74.4 m95 -151.68 168.74 24.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.835 -1.166 . . . . 0.0 110.062 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.451 ' O ' ' HB3' ' A' ' 3' ' ' LYS . 2.7 tt0 -147.83 114.5 6.03 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.431 -0.793 . . . . 0.0 109.404 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -137.79 -67.12 0.49 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.222 -0.924 . . . . 0.0 109.395 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 . . . . . 0 N--CA 1.489 1.513 0 O-C-N 121.254 -0.904 . . . . 0.0 109.423 -179.986 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 65' ' ' SF4 . . . . . 1.044 ' S2 ' ' O ' ' A' ' 14' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 15.4 mmm-85 58.94 90.75 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.173 -0.954 . . . . 0.0 109.403 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.513 ' HB3' ' HB3' ' A' ' 62' ' ' GLU . 0.5 OUTLIER -110.28 -158.34 0.64 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.142 -0.974 . . . . 0.0 109.606 -179.925 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.608 ' CZ ' ' HB ' ' A' ' 39' ' ' VAL . 29.3 p90 179.08 173.49 0.77 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.203 -0.936 . . . . 0.0 108.506 -179.632 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.577 ' HA ' HG11 ' A' ' 36' ' ' VAL . 6.4 p90 178.43 -161.63 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 1.051 HG21 ' CZ ' ' A' ' 25' ' ' PHE . 0.2 OUTLIER -139.3 -177.74 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 C-N-CA 117.545 -1.662 . . . . 0.0 112.076 -179.883 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.638 ' H ' HG12 ' A' ' 6' ' ' VAL . 5.6 m-20 -143.3 94.44 2.62 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.073 178.695 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.566 ' HB3' ' CD ' ' A' ' 33' ' ' LYS . 31.2 mm-40 -65.11 42.54 0.02 OUTLIER 'General case' 0 C--N 1.291 -1.942 0 CA-C-O 121.444 0.64 . . . . 0.0 111.293 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.495 ' N ' ' O ' ' A' ' 7' ' ' ASP . 0.3 OUTLIER -93.57 -16.87 23.95 Favored 'General case' 0 C--N 1.288 -2.094 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.548 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.806 ' CG ' HG11 ' A' ' 56' ' ' VAL . 0.9 OUTLIER -127.15 -1.16 6.44 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.505 -0.747 . . . . 0.0 110.472 -178.944 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.494 ' HB2' ' OE1' ' A' ' 8' ' ' GLN . 49.9 t -63.92 119.11 9.43 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.755 -1.216 . . . . 0.0 109.706 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.713 ' O ' ' HB2' ' A' ' 13' ' ' ALA . 11.8 pt -83.46 -45.1 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 O-C-N 121.364 -0.835 . . . . 0.0 109.481 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.713 ' HB2' ' O ' ' A' ' 12' ' ' ILE . . . 163.92 -27.95 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.163 -0.96 . . . . 0.0 110.033 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 1.079 ' O ' ' S2 ' ' A' ' 65' ' ' SF4 . 0.1 OUTLIER -48.24 154.44 0.59 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.011 -1.056 . . . . 0.0 110.041 -179.298 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.426 ' O ' ' C ' ' A' ' 16' ' ' SER . 6.9 mt-10 -113.35 18.25 17.91 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.404 -0.81 . . . . 0.0 109.193 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.8 ' O ' HD12 ' A' ' 20' ' ' ILE . 1.6 m -42.54 -60.17 1.62 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.424 -0.798 . . . . 0.0 109.5 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.682 ' SG ' ' CD2' ' A' ' 25' ' ' PHE . 18.1 p -51.05 -53.88 29.76 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.331 -0.856 . . . . 0.0 109.25 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.575 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 65.7 t -46.33 -37.7 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.334 -0.854 . . . . 0.0 109.207 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.05 -33.16 65.5 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.111 -0.993 . . . . 0.0 109.267 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.942 HG21 ' N ' ' A' ' 50' ' ' ALA . 2.4 mp -85.1 11.99 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.267 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.506 ' HB1' ' CB ' ' A' ' 42' ' ' ALA . . . 179.08 62.83 0.1 Allowed Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.429 -0.795 . . . . 0.0 109.49 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -73.34 54.73 2.88 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 124.134 1.597 . . . . 0.0 110.268 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -161.68 -40.57 0.02 OUTLIER Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.756 -1.737 . . . . 0.0 108.756 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.42 ' O ' ' HA ' ' A' ' 36' ' ' VAL . . . -96.41 -36.71 10.73 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.407 -1.055 . . . . 0.0 108.908 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 1.051 ' CZ ' HG21 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -95.17 138.01 33.45 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.301 -0.874 . . . . 0.0 108.835 179.624 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.486 ' C ' ' HA ' ' A' ' 34' ' ' ALA . . . -162.87 121.69 2.13 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.027 -1.046 . . . . 0.0 110.197 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.576 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 6.8 tmm? -62.0 147.81 45.9 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.175 -0.953 . . . . 0.0 109.506 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.624 ' O ' ' N ' ' A' ' 32' ' ' GLU . 0.8 OUTLIER -125.67 161.78 48.8 Favored Pre-proline 0 C--N 1.315 -0.907 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 179.083 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.45 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 46.4 Cg_endo -84.0 -15.79 6.66 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 124.96 2.032 . . . . 0.0 107.958 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.39 -35.89 18.08 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 178.329 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.639 HD12 ' O ' ' A' ' 33' ' ' LYS . 2.7 pt -105.58 -1.99 9.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.008 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.624 ' N ' ' O ' ' A' ' 28' ' ' ASP . 2.1 mt-10 34.75 34.97 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -178.51 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.639 ' O ' HD12 ' A' ' 31' ' ' ILE . 34.2 mttp -160.49 151.67 19.14 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.213 -178.058 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.594 ' HB1' ' CD1' ' A' ' 25' ' ' PHE . . . -70.09 151.0 45.98 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.249 -0.907 . . . . 0.0 110.658 -179.026 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.651 ' CZ ' ' HB3' ' A' ' 37' ' ' LYS . 4.3 p90 -148.07 150.41 33.85 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 178.528 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.724 HG21 HG12 ' A' ' 39' ' ' VAL . 10.6 p -69.59 63.39 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 C-N-CA 119.055 -1.058 . . . . 0.0 108.205 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.651 ' HB3' ' CZ ' ' A' ' 35' ' ' TYR . 13.7 pttp -47.98 -27.49 2.24 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.265 0.555 . . . . 0.0 110.481 -179.188 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -157.33 92.27 1.23 Allowed 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 119.207 -0.997 . . . . 0.0 109.753 -178.13 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.724 HG12 HG21 ' A' ' 36' ' ' VAL . 26.8 m -49.11 -21.99 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.425 -0.797 . . . . 0.0 109.773 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.44 -16.79 57.2 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.149 -0.969 . . . . 0.0 109.476 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -77.45 1.38 66.05 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.506 ' CB ' ' HB1' ' A' ' 21' ' ' ALA . . . -157.27 124.0 5.03 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.14 -1.212 . . . . 0.0 109.781 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.554 ' N ' ' HG2' ' A' ' 46' ' ' GLU . 0.3 OUTLIER -53.86 163.0 0.79 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.375 -0.828 . . . . 0.0 109.754 179.708 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.448 ' HG3' ' HG2' ' A' ' 45' ' ' GLU . 11.1 pt20 -67.95 -40.34 83.26 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.351 -0.843 . . . . 0.0 109.853 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.504 ' O ' ' HG2' ' A' ' 48' ' ' GLU . 1.6 mm-40 -72.45 -26.23 61.75 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.075 -1.016 . . . . 0.0 109.53 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.56 ' O ' HG22 ' A' ' 20' ' ' ILE . 5.3 pt-20 -85.0 -31.5 23.45 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 105.476 -2.046 . . . . 0.0 105.476 177.508 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 43' ' ' SER . 2.5 t -65.28 -34.64 71.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.059 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.517 ' O ' ' N ' ' A' ' 51' ' ' MET . 8.4 pt-20 -74.45 -56.84 4.4 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.16 -0.962 . . . . 0.0 109.417 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.581 ' C ' HG21 ' A' ' 20' ' ' ILE . 61.8 tt0 -41.3 -38.32 1.15 Allowed 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.942 ' N ' HG21 ' A' ' 20' ' ' ILE . . . -67.95 -41.63 82.21 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.043 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.573 ' HE2' HG22 ' A' ' 59' ' ' ILE . 3.7 ttm -62.93 -47.72 82.04 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.94 -31.61 71.15 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.16 -0.963 . . . . 0.0 109.329 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 70.0 m -98.29 88.22 4.11 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.313 -0.867 . . . . 0.0 109.173 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.536 ' SG ' ' HD2' ' A' ' 55' ' ' PRO . 21.6 t -161.15 145.82 10.38 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.198 -0.939 . . . . 0.0 109.334 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.758 ' CG ' ' S3 ' ' A' ' 65' ' ' SF4 . 43.3 Cg_endo -71.21 101.3 1.09 Allowed 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 123.858 1.452 . . . . 0.0 109.425 179.347 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.806 HG11 ' CG ' ' A' ' 10' ' ' GLU . 0.4 OUTLIER 82.41 -9.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 -178.624 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.529 ' HA ' ' HB3' ' A' ' 54' ' ' CYS . 0.1 OUTLIER 63.04 148.38 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.441 -0.787 . . . . 0.0 110.641 179.393 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.749 ' SG ' ' S4 ' ' A' ' 65' ' ' SF4 . 2.4 p -148.87 -34.81 0.2 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.72 -0.613 . . . . 0.0 109.403 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.881 ' HA ' HG13 ' A' ' 6' ' ' VAL . 17.1 mt -58.12 153.67 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.026 -1.046 . . . . 0.0 109.418 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.585 ' CE1' ' O ' ' A' ' 58' ' ' CYS . 45.6 m80 -159.06 125.0 4.41 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.345 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.565 ' HA ' ' CB ' ' A' ' 4' ' ' PHE . 87.8 m95 -55.22 171.11 0.17 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.121 -0.987 . . . . 0.0 109.108 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.513 ' HB3' ' HB3' ' A' ' 3' ' ' LYS . 1.3 tt0 -136.22 93.55 2.92 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.248 -0.907 . . . . 0.0 109.245 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -90.23 135.26 33.78 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.189 -0.945 . . . . 0.0 109.424 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 O-C-N 121.23 -0.919 . . . . 0.0 109.479 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' SF4 . . . . . 1.079 ' S2 ' ' O ' ' A' ' 14' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.276 0.56 . . . . 0.0 109.529 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 17.0 mtt180 -63.52 172.04 2.26 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.263 -0.898 . . . . 0.0 109.35 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.457 ' O ' ' HB3' ' A' ' 4' ' ' PHE . 0.2 OUTLIER -132.26 -164.36 1.45 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.132 -0.98 . . . . 0.0 109.602 -179.955 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.565 ' CB ' ' HA ' ' A' ' 61' ' ' TRP . 6.1 p90 177.43 -172.12 0.1 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.321 -0.862 . . . . 0.0 109.262 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.623 ' HA ' HG11 ' A' ' 36' ' ' VAL . 46.8 p90 169.2 -177.77 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 1.086 HG21 ' CZ ' ' A' ' 25' ' ' PHE . 3.1 t -139.39 159.5 28.45 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.4 0 C-N-CA 116.962 -1.895 . . . . 0.0 111.417 179.307 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.544 ' N ' HG12 ' A' ' 6' ' ' VAL . 1.2 m-20 -106.9 72.52 0.89 Allowed 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.521 ' HB3' ' O ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER -41.8 -23.87 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 179.486 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 7' ' ' ASP . 19.5 t0 -50.92 -38.54 50.71 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.562 ' HB3' ' CB ' ' A' ' 58' ' ' CYS . 20.8 tt0 -82.02 -19.99 39.28 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.369 -0.832 . . . . 0.0 108.942 179.274 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.512 ' HB3' ' O ' ' A' ' 8' ' ' GLN . 36.9 t -51.15 123.92 10.47 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.477 -0.764 . . . . 0.0 109.806 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.683 ' O ' ' HB2' ' A' ' 13' ' ' ALA . 10.0 pt -75.32 -48.7 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.376 -0.827 . . . . 0.0 109.541 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.683 ' HB2' ' O ' ' A' ' 12' ' ' ILE . . . 166.13 -33.03 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.028 -1.045 . . . . 0.0 110.132 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 1.119 ' O ' ' S2 ' ' A' ' 65' ' ' SF4 . 0.1 OUTLIER -52.32 159.6 0.95 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.073 -1.017 . . . . 0.0 109.519 -179.59 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.476 ' HA ' ' S2 ' ' A' ' 65' ' ' SF4 . 13.6 pt-20 -123.75 21.85 9.1 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.31 -0.869 . . . . 0.0 109.505 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.428 ' O ' HD12 ' A' ' 20' ' ' ILE . 0.6 OUTLIER -44.53 -58.57 2.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.175 -0.953 . . . . 0.0 109.023 179.797 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.674 ' SG ' ' N ' ' A' ' 18' ' ' VAL . 17.6 p -49.96 -58.77 4.76 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.433 -0.792 . . . . 0.0 109.166 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.674 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 59.4 t -45.26 -34.41 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.224 -0.922 . . . . 0.0 109.044 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.39 -39.53 71.13 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.162 -0.961 . . . . 0.0 108.897 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.728 ' HB ' ' HB2' ' A' ' 50' ' ' ALA . 1.9 mt -87.1 17.77 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 177.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.639 ' HB1' ' HB2' ' A' ' 42' ' ' ALA . . . 172.31 65.42 0.03 OUTLIER Pre-proline 0 N--CA 1.489 1.482 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.503 ' N ' ' O ' ' A' ' 18' ' ' VAL . 43.8 Cg_endo -72.14 -2.09 11.07 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.108 1.583 . . . . 0.0 110.65 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.506 ' O ' ' HB3' ' A' ' 38' ' ' ASP . . . -92.2 -71.85 1.2 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.763 ' HB2' ' O ' ' A' ' 38' ' ' ASP . . . -66.82 -30.15 70.26 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.353 -1.087 . . . . 0.0 109.364 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 1.086 ' CZ ' HG21 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -105.42 133.75 49.66 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 118.821 -1.152 . . . . 0.0 109.904 -179.734 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.553 ' O ' ' CD1' ' A' ' 35' ' ' TYR . . . -166.27 123.97 1.42 Allowed 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.478 -0.764 . . . . 0.0 109.156 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.56 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER -62.17 155.63 23.91 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.169 -0.957 . . . . 0.0 109.092 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.589 ' O ' ' HA ' ' A' ' 32' ' ' GLU . 4.0 t0 -128.2 161.99 53.02 Favored Pre-proline 0 C--N 1.309 -1.166 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.477 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 43.9 Cg_endo -85.0 -18.16 4.42 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 124.428 1.752 . . . . 0.0 108.562 -179.422 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -89.32 -32.75 17.19 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 177.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.635 HD12 ' HB3' ' A' ' 35' ' ' TYR . 0.8 OUTLIER -104.79 2.19 10.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 178.071 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.589 ' HA ' ' O ' ' A' ' 28' ' ' ASP . 9.9 mt-10 26.34 43.68 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.51 0.672 . . . . 0.0 110.212 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.53 ' O ' ' HA ' ' A' ' 27' ' ' MET . 6.2 mttt -172.13 148.46 2.2 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 119.134 -1.027 . . . . 0.0 110.653 -179.525 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.56 ' HA ' ' HA ' ' A' ' 27' ' ' MET . . . -54.71 142.21 29.44 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.684 -0.635 . . . . 0.0 110.634 -179.451 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.71 ' CE2' ' HG3' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -143.91 151.01 39.26 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-O 121.764 0.792 . . . . 0.0 109.95 179.156 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.805 ' HB ' HG23 ' A' ' 6' ' ' VAL . 0.9 OUTLIER -91.04 109.19 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.424 -1.422 . . . . 0.0 109.563 -178.637 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.71 ' HG3' ' CE2' ' A' ' 35' ' ' TYR . 23.5 mmtt -125.75 -53.25 1.56 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.423 -0.798 . . . . 0.0 110.445 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.763 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 61.6 t0 -86.98 71.94 10.17 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.599 -0.688 . . . . 0.0 110.462 -177.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.523 HG23 ' N ' ' A' ' 40' ' ' GLU . 24.8 m -46.58 -40.59 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.322 -0.861 . . . . 0.0 109.194 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.523 ' N ' HG23 ' A' ' 39' ' ' VAL . 11.0 mm-40 -66.33 -17.71 64.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.352 -0.842 . . . . 0.0 109.499 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' A' ' 38' ' ' ASP . . . -72.43 -21.13 79.58 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.639 ' HB2' ' HB1' ' A' ' 21' ' ' ALA . . . -132.02 134.67 45.83 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.277 -1.131 . . . . 0.0 109.296 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.692 ' O ' HG23 ' A' ' 47' ' ' VAL . 0.4 OUTLIER -79.29 -166.99 1.04 Allowed 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.224 -0.922 . . . . 0.0 109.775 -179.8 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.477 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 3.9 mt-30 -71.44 -49.58 40.27 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.664 -0.647 . . . . 0.0 109.56 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.459 ' O ' ' HB2' ' A' ' 49' ' ' GLU . 1.8 pm0 -72.77 -12.84 61.16 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.175 -0.953 . . . . 0.0 109.298 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.476 ' HG3' ' HB2' ' A' ' 43' ' ' SER . 29.9 mt-10 -90.71 -42.01 10.96 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 178.491 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.692 HG23 ' O ' ' A' ' 43' ' ' SER . 24.2 t -63.95 -47.53 90.12 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 CA-C-N 114.789 -1.096 . . . . 0.0 108.093 178.076 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.526 ' O ' ' N ' ' A' ' 51' ' ' MET . 0.3 OUTLIER -67.97 -62.23 1.5 Allowed 'General case' 0 C--N 1.307 -1.243 0 O-C-N 121.584 -0.697 . . . . 0.0 109.591 179.583 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.628 ' HB3' HG21 ' A' ' 20' ' ' ILE . 34.6 mt-10 -43.23 -52.01 5.86 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 119.44 -0.904 . . . . 0.0 108.918 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.728 ' HB2' ' HB ' ' A' ' 20' ' ' ILE . . . -65.53 -27.86 68.76 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.212 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' MET . . . . . 1.029 ' CG ' HG21 ' A' ' 59' ' ' ILE . 22.5 ttm -76.88 -21.68 54.58 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.627 -0.67 . . . . 0.0 110.35 -179.158 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.81 -15.78 26.11 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.085 -1.009 . . . . 0.0 109.759 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.527 ' OG1' ' CD1' ' A' ' 20' ' ' ILE . 76.2 p -91.91 73.63 5.66 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.189 -0.944 . . . . 0.0 109.455 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 19.0 t -151.65 128.49 5.43 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.219 -0.926 . . . . 0.0 109.684 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.596 ' C ' HG12 ' A' ' 56' ' ' VAL . 47.1 Cg_endo -75.48 53.73 3.64 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 123.857 1.451 . . . . 0.0 109.912 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.596 HG12 ' C ' ' A' ' 55' ' ' PRO . 1.5 p 160.42 -26.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 60.19 72.96 0.5 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.569 -0.707 . . . . 0.0 109.933 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.562 ' CB ' ' HB3' ' A' ' 10' ' ' GLU . 29.7 p -84.6 7.98 18.31 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.108 -0.995 . . . . 0.0 109.198 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 1.029 HG21 ' CG ' ' A' ' 51' ' ' MET . 1.0 OUTLIER -75.87 155.62 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.348 -0.845 . . . . 0.0 110.505 -179.232 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.454 ' CG ' ' O ' ' A' ' 59' ' ' ILE . 89.9 m-70 -155.52 125.36 6.51 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.565 ' HA ' ' CB ' ' A' ' 4' ' ' PHE . 62.5 m95 -73.05 173.89 8.69 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.194 -0.941 . . . . 0.0 109.652 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.453 ' HB3' ' HB3' ' A' ' 3' ' ' LYS . 9.6 tp10 -145.1 106.25 4.18 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.327 -0.858 . . . . 0.0 109.333 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -118.97 99.29 6.64 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.379 -0.825 . . . . 0.0 109.301 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 . . . . . 0 N--CA 1.489 1.503 0 O-C-N 121.325 -0.86 . . . . 0.0 109.379 -179.99 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 65' ' ' SF4 . . . . . 1.119 ' S2 ' ' O ' ' A' ' 14' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -94.08 102.39 14.44 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.228 -0.92 . . . . 0.0 109.41 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.475 ' O ' ' HB3' ' A' ' 4' ' ' PHE . 0.2 OUTLIER -101.9 -154.9 0.5 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.181 -0.949 . . . . 0.0 109.441 -179.999 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.562 ' CB ' ' HA ' ' A' ' 61' ' ' TRP . 2.5 p90 177.9 -178.73 0.24 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.293 -0.879 . . . . 0.0 110.007 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.463 ' HA ' HG11 ' A' ' 36' ' ' VAL . 20.3 p90 174.68 -167.0 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 1.088 HG21 ' CZ ' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -137.03 -166.36 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 C-N-CA 118.406 -1.318 . . . . 0.0 111.066 179.713 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.532 ' O ' ' N ' ' A' ' 9' ' ' ASP . 0.3 OUTLIER -151.65 98.98 2.55 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 114.413 -1.267 . . . . 0.0 108.056 177.784 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.6 ' CG ' ' HB3' ' A' ' 33' ' ' LYS . 2.9 mp0 -65.15 43.3 0.02 OUTLIER 'General case' 0 C--N 1.29 -2.001 0 CA-C-O 121.367 0.603 . . . . 0.0 110.392 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.532 ' N ' ' O ' ' A' ' 7' ' ' ASP . 0.5 OUTLIER -99.42 -29.68 12.62 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.265 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.471 ' HB2' ' SG ' ' A' ' 58' ' ' CYS . 0.0 OUTLIER -118.31 25.59 10.2 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.859 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.712 ' SG ' ' HG2' ' A' ' 33' ' ' LYS . 14.3 t -90.22 119.07 30.22 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.225 -0.922 . . . . 0.0 110.432 -179.327 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.439 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 12.2 pt -88.61 5.01 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.293 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . 61.76 65.26 0.94 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.367 -0.833 . . . . 0.0 109.665 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.783 ' SG ' ' OG ' ' A' ' 16' ' ' SER . 31.7 p -102.22 -9.89 20.06 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.082 -1.011 . . . . 0.0 109.678 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.447 ' OE1' ' HG3' ' A' ' 19' ' ' GLU . 0.0 OUTLIER 70.7 4.29 4.93 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.24 -0.913 . . . . 0.0 109.84 179.591 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.792 ' OG ' ' S1 ' ' A' ' 65' ' ' SF4 . 29.6 p -62.15 -69.77 0.23 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.068 -1.02 . . . . 0.0 109.335 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.634 ' SG ' ' N ' ' A' ' 18' ' ' VAL . 19.4 p -49.33 -55.87 11.43 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.328 -0.857 . . . . 0.0 109.385 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.634 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 59.6 t -46.32 -33.14 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.199 -0.938 . . . . 0.0 109.012 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.447 ' HG3' ' OE1' ' A' ' 15' ' ' GLU . 5.3 mt-10 -71.05 -34.78 71.57 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.999 -1.063 . . . . 0.0 108.592 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.633 HG22 ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -81.16 6.05 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.252 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.59 ' HB1' ' HB2' ' A' ' 42' ' ' ALA . . . 176.82 65.47 0.07 OUTLIER Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.274 -0.891 . . . . 0.0 109.009 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.54 ' N ' ' O ' ' A' ' 18' ' ' VAL . 46.0 Cg_endo -71.92 0.12 7.62 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.039 1.547 . . . . 0.0 110.783 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -96.3 -31.66 7.09 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.679 ' HB1' ' O ' ' A' ' 38' ' ' ASP . . . -109.4 -53.65 2.63 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.333 -1.098 . . . . 0.0 109.99 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 1.088 ' CZ ' HG21 ' A' ' 6' ' ' VAL . 0.3 OUTLIER -75.22 139.43 42.59 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 118.561 -1.256 . . . . 0.0 107.689 179.727 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.574 ' O ' ' CD1' ' A' ' 35' ' ' TYR . . . -172.13 140.84 1.22 Allowed 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.263 -0.898 . . . . 0.0 109.561 -179.217 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.554 ' HA ' ' C ' ' A' ' 33' ' ' LYS . 5.1 mtp -71.55 158.35 36.39 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.292 -0.88 . . . . 0.0 109.94 -179.381 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.613 ' O ' ' N ' ' A' ' 32' ' ' GLU . 3.9 t0 -126.31 161.52 51.74 Favored Pre-proline 0 C--N 1.309 -1.154 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.489 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 44.3 Cg_endo -85.19 -16.13 5.15 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 O-C-N 124.691 1.89 . . . . 0.0 108.626 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -91.53 -29.7 16.83 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 178.06 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.575 ' CD1' ' HB3' ' A' ' 35' ' ' TYR . 1.0 OUTLIER -106.2 -5.25 10.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.25 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.613 ' N ' ' O ' ' A' ' 28' ' ' ASP . 6.9 mm-40 33.59 41.52 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 121.433 0.635 . . . . 0.0 109.303 -179.054 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.712 ' HG2' ' SG ' ' A' ' 11' ' ' CYS . 0.2 OUTLIER -169.74 146.3 3.22 Favored 'General case' 0 N--CA 1.501 2.109 0 C-N-CA 119.601 -0.839 . . . . 0.0 110.365 -179.176 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.742 ' HB1' ' CD1' ' A' ' 25' ' ' PHE . . . -47.99 146.54 2.47 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.425 -0.797 . . . . 0.0 111.564 -178.715 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.676 ' CE2' ' CG ' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -135.83 -174.29 3.61 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.965 -1.085 . . . . 0.0 110.086 179.075 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.784 HG23 ' CG2' ' A' ' 6' ' ' VAL . 2.5 t -125.98 92.44 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.676 ' CG ' ' CE2' ' A' ' 35' ' ' TYR . 18.5 mmtt -103.87 -46.07 4.59 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 119.567 -0.853 . . . . 0.0 111.286 -178.407 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.679 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 62.8 t0 -93.59 118.24 31.11 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 119.207 -0.997 . . . . 0.0 110.564 -177.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.2 m -80.52 -17.11 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.338 -0.851 . . . . 0.0 109.268 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.424 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -103.01 2.39 34.87 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.355 -0.841 . . . . 0.0 109.558 -179.994 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.569 ' HA3' ' HB2' ' A' ' 24' ' ' ALA . . . -78.24 -7.64 87.71 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.674 -1.371 . . . . 0.0 109.674 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.59 ' HB2' ' HB1' ' A' ' 21' ' ' ALA . . . -149.08 127.84 12.51 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.229 -1.159 . . . . 0.0 109.566 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.927 ' O ' HG23 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -67.61 166.79 14.28 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.235 -0.916 . . . . 0.0 109.43 179.951 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.463 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -51.66 -45.28 63.32 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.412 -0.805 . . . . 0.0 109.438 179.979 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.414 ' O ' ' CG ' ' A' ' 49' ' ' GLU . 50.0 mm-40 -67.54 -8.4 33.63 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.362 -0.836 . . . . 0.0 109.646 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.528 ' HB2' ' HB1' ' A' ' 42' ' ' ALA . 11.9 mt-10 -100.32 -43.88 6.11 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 179.022 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.927 HG23 ' O ' ' A' ' 43' ' ' SER . 1.9 t -60.49 -40.54 84.63 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 178.238 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.463 ' HB2' ' O ' ' A' ' 44' ' ' GLN . 0.2 OUTLIER -74.86 -48.43 25.0 Favored 'General case' 0 C--N 1.308 -1.227 0 O-C-N 121.527 -0.733 . . . . 0.0 109.198 179.293 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.527 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . 34.1 mt-10 -53.5 -54.01 43.26 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.189 -0.944 . . . . 0.0 109.096 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.522 ' HB2' ' CG2' ' A' ' 20' ' ' ILE . . . -63.83 -18.04 63.73 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.143 -0.973 . . . . 0.0 108.945 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.595 ' HE3' HD12 ' A' ' 59' ' ' ILE . 38.6 ttm -77.87 -18.31 56.37 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.416 -0.802 . . . . 0.0 109.208 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -105.35 -23.73 12.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.32 -0.863 . . . . 0.0 109.599 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -62.39 -48.02 81.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.23 -0.919 . . . . 0.0 109.768 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.79 ' SG ' ' HD2' ' A' ' 55' ' ' PRO . 4.6 t -48.88 147.41 4.62 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.139 -0.975 . . . . 0.0 109.606 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.79 ' HD2' ' SG ' ' A' ' 54' ' ' CYS . 44.1 Cg_endo -73.91 -64.65 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.986 1.519 . . . . 0.0 110.509 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.427 ' O ' ' HB2' ' A' ' 57' ' ' GLN . 38.4 t -79.08 -25.02 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.115 -0.99 . . . . 0.0 109.098 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.427 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER 67.38 72.04 0.35 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.277 -0.889 . . . . 0.0 109.755 179.719 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.471 ' SG ' ' HB2' ' A' ' 10' ' ' GLU . 0.7 OUTLIER -89.87 21.89 3.4 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.188 -0.945 . . . . 0.0 109.155 179.571 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 1.038 HD13 ' N ' ' A' ' 60' ' ' HIS . 0.0 OUTLIER -108.65 140.69 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.341 -0.85 . . . . 0.0 109.564 -179.651 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 1.038 ' N ' HD13 ' A' ' 59' ' ' ILE . 2.7 m80 -142.48 -177.47 5.29 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.279 -0.888 . . . . 0.0 109.532 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.562 ' HA ' ' CB ' ' A' ' 4' ' ' PHE . 36.0 m95 -97.84 -179.25 4.36 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.014 -1.054 . . . . 0.0 109.697 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.2 tp10 -150.32 97.15 2.5 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.267 -0.896 . . . . 0.0 109.621 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.7 p-10 -111.77 14.16 21.07 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.225 -0.922 . . . . 0.0 109.338 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 O-C-N 121.268 -0.895 . . . . 0.0 109.546 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' SF4 . . . . . 0.792 ' S1 ' ' OG ' ' A' ' 16' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.215 0.531 . . . . 0.0 109.647 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.73 108.38 13.45 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.295 -0.878 . . . . 0.0 109.533 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.495 ' O ' ' HB3' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -98.17 -155.8 0.51 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.262 -0.899 . . . . 0.0 109.313 -179.99 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.553 ' CB ' ' HA ' ' A' ' 61' ' ' TRP . 53.8 p90 173.06 -176.06 0.06 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.357 -0.839 . . . . 0.0 108.895 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.79 ' HA ' HG11 ' A' ' 36' ' ' VAL . 51.6 p90 175.84 -173.28 0.08 Allowed 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 179.258 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.789 HG13 ' HB ' ' A' ' 59' ' ' ILE . 2.9 t -145.57 166.37 10.0 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.428 0 C-N-CA 117.397 -1.721 . . . . 0.0 112.094 -179.194 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.57 ' H ' HG12 ' A' ' 6' ' ' VAL . 8.5 t0 -105.22 74.56 1.11 Allowed 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.564 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.537 ' O ' ' CD ' ' A' ' 33' ' ' LYS . 3.1 pm0 -53.72 -11.51 0.39 Allowed 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.362 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.42 ' N ' ' C ' ' A' ' 7' ' ' ASP . 0.1 OUTLIER -65.61 -32.8 74.57 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.634 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.578 ' HB3' ' CB ' ' A' ' 58' ' ' CYS . 0.1 OUTLIER -91.16 -16.3 27.97 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.09 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.409 ' HB3' ' O ' ' A' ' 8' ' ' GLN . 7.2 t -43.46 128.41 4.97 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.432 -0.793 . . . . 0.0 110.075 -179.288 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.777 HG12 ' S3 ' ' A' ' 65' ' ' SF4 . 4.5 pt -79.25 -134.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.444 -0.785 . . . . 0.0 109.066 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -119.67 43.55 2.61 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.762 -1.211 . . . . 0.0 110.017 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 1.012 ' SG ' ' OG ' ' A' ' 16' ' ' SER . 0.1 OUTLIER -124.91 156.83 37.33 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.075 -1.016 . . . . 0.0 109.594 179.557 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.437 ' O ' ' C ' ' A' ' 16' ' ' SER . 14.3 mt-10 -117.26 17.75 14.64 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.299 -0.876 . . . . 0.0 109.685 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . 1.012 ' OG ' ' SG ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -44.42 -70.57 0.1 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.245 -0.909 . . . . 0.0 108.996 179.722 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.645 ' SG ' ' N ' ' A' ' 18' ' ' VAL . 8.3 p -44.17 -51.51 8.06 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.262 -0.898 . . . . 0.0 109.325 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.645 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 41.5 t -50.15 -33.31 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.362 -0.836 . . . . 0.0 109.61 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -84.74 -30.93 24.31 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.129 -0.982 . . . . 0.0 109.414 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.841 HD12 ' O ' ' A' ' 16' ' ' SER . 2.7 mp -81.76 9.12 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.206 -0.934 . . . . 0.0 108.646 178.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -169.86 69.41 0.62 Allowed Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.17 -0.956 . . . . 0.0 109.309 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -71.72 76.83 1.9 Allowed 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 124.206 1.635 . . . . 0.0 110.181 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.444 ' C ' ' HA3' ' A' ' 41' ' ' GLY . . . 165.02 -42.55 0.29 Allowed Glycine 0 N--CA 1.488 2.117 0 N-CA-C 108.672 -1.771 . . . . 0.0 108.672 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.487 ' HA ' ' O ' ' A' ' 38' ' ' ASP . . . -92.99 -49.3 6.09 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.415 -1.05 . . . . 0.0 109.046 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.782 ' CZ ' HG21 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -96.06 137.84 34.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.269 -0.894 . . . . 0.0 108.818 179.582 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.445 ' O ' ' CD1' ' A' ' 35' ' ' TYR . . . -174.77 126.66 0.3 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.025 -1.047 . . . . 0.0 109.609 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.596 ' HA ' ' C ' ' A' ' 33' ' ' LYS . 29.3 mtp -58.56 150.86 21.85 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.315 -0.865 . . . . 0.0 109.365 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.615 ' O ' ' N ' ' A' ' 32' ' ' GLU . 1.6 t0 -130.26 163.99 44.03 Favored Pre-proline 0 C--N 1.311 -1.085 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.487 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 43.9 Cg_endo -83.29 -16.44 7.1 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 124.803 1.949 . . . . 0.0 107.571 179.096 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.713 ' HB3' HD13 ' A' ' 31' ' ' ILE . 8.1 tt0 -82.84 -42.38 17.9 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 177.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.745 ' N ' HD13 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -102.14 0.26 10.26 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 178.098 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.615 ' N ' ' O ' ' A' ' 28' ' ' ASP . 2.9 mm-40 35.33 34.55 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -179.016 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.596 ' C ' ' HA ' ' A' ' 27' ' ' MET . 59.4 mttp -163.55 151.16 12.83 Favored 'General case' 0 N--CA 1.499 2.0 0 C-N-CA 119.556 -0.858 . . . . 0.0 110.183 -177.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.539 ' HA ' ' HA ' ' A' ' 27' ' ' MET . . . -59.18 139.97 56.38 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.444 -0.785 . . . . 0.0 110.206 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.647 ' CE2' ' HA ' ' A' ' 37' ' ' LYS . 1.5 p90 -154.06 155.89 36.31 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.79 HG11 ' HA ' ' A' ' 5' ' ' TYR . 14.9 p -67.01 67.19 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 120.905 -1.122 . . . . 0.0 108.933 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.647 ' HA ' ' CE2' ' A' ' 35' ' ' TYR . 0.1 OUTLIER -51.01 -19.05 0.92 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.533 -0.729 . . . . 0.0 110.391 -179.664 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.492 ' N ' ' HG3' ' A' ' 37' ' ' LYS . 11.5 t70 -167.21 103.42 0.53 Allowed 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.996 -1.065 . . . . 0.0 109.674 -179.082 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.543 ' HB ' ' CE1' ' A' ' 4' ' ' PHE . 1.8 m -55.39 -24.39 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.378 -0.826 . . . . 0.0 109.835 -179.475 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -90.89 -0.6 57.77 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.168 -0.958 . . . . 0.0 109.601 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.45 ' N ' ' OD2' ' A' ' 38' ' ' ASP . . . -76.36 -16.05 81.02 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -141.92 161.74 37.21 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.192 -1.181 . . . . 0.0 109.333 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.07 173.89 9.56 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.263 -0.898 . . . . 0.0 109.571 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.457 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 1.0 OUTLIER -70.09 -38.56 75.7 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.363 -0.836 . . . . 0.0 109.233 179.895 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 36.0 mm-40 -66.91 -21.87 65.97 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.143 -0.973 . . . . 0.0 108.875 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -90.2 -43.1 10.65 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 178.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 4.0 t -58.25 -38.11 66.77 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 178.336 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.457 ' HB2' ' O ' ' A' ' 44' ' ' GLN . 0.1 OUTLIER -70.22 -65.93 0.66 Allowed 'General case' 0 C--N 1.308 -1.229 0 O-C-N 121.562 -0.712 . . . . 0.0 109.584 179.715 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.645 ' C ' HG21 ' A' ' 20' ' ' ILE . 16.1 mt-10 -47.5 -42.45 23.0 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.259 -0.9 . . . . 0.0 109.052 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.824 ' N ' HG21 ' A' ' 20' ' ' ILE . . . -68.59 -27.08 65.73 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.356 -0.84 . . . . 0.0 109.024 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.712 ' HG3' HG21 ' A' ' 59' ' ' ILE . 6.6 ttm -83.92 -17.63 40.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.482 -0.761 . . . . 0.0 109.904 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -95.02 -10.36 31.11 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.048 -1.032 . . . . 0.0 109.795 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.745 ' OG1' HD13 ' A' ' 20' ' ' ILE . 12.0 p -91.08 8.05 37.42 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.242 -0.911 . . . . 0.0 109.642 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.518 ' SG ' ' HD2' ' A' ' 55' ' ' PRO . 8.7 t -95.35 140.74 22.51 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.22 -0.925 . . . . 0.0 109.399 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.518 ' HD2' ' SG ' ' A' ' 54' ' ' CYS . 46.1 Cg_endo -75.16 -58.18 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.942 1.496 . . . . 0.0 109.931 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.524 HG21 ' HG2' ' A' ' 10' ' ' GLU . 7.6 p -84.63 -23.19 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.319 -0.863 . . . . 0.0 108.898 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.503 ' CB ' ' O ' ' A' ' 56' ' ' VAL . 1.9 tt0 77.71 -66.44 0.22 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.495 -0.753 . . . . 0.0 110.459 179.557 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.578 ' CB ' ' HB3' ' A' ' 10' ' ' GLU . 2.5 p 43.57 26.41 0.11 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.225 -0.922 . . . . 0.0 109.156 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.789 ' HB ' HG13 ' A' ' 6' ' ' VAL . 9.4 tt -125.77 164.1 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.466 -0.771 . . . . 0.0 110.304 -178.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.665 ' CD2' ' CZ ' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -172.64 173.61 3.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.337 -0.852 . . . . 0.0 109.245 179.987 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.553 ' HA ' ' CB ' ' A' ' 4' ' ' PHE . 50.9 m95 -98.66 164.3 12.29 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.152 -0.968 . . . . 0.0 109.767 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.485 ' N ' ' HA ' ' A' ' 4' ' ' PHE . 20.6 tt0 -121.87 107.25 12.06 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.362 -0.836 . . . . 0.0 109.469 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -110.51 110.87 21.78 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.282 -0.886 . . . . 0.0 109.56 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 . . . . . 0 N--CA 1.491 1.582 0 O-C-N 121.298 -0.876 . . . . 0.0 109.47 179.941 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 65' ' ' SF4 . . . . . 0.914 ' S2 ' ' O ' ' A' ' 14' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.64 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.405 ' HG2' ' CE3' ' A' ' 61' ' ' TRP . 2.1 tpp180 -148.0 105.5 3.67 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.21 -0.931 . . . . 0.0 109.652 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.509 ' HB3' ' HB3' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -86.35 -157.8 0.37 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.205 -0.935 . . . . 0.0 109.137 179.8 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.604 ' CE1' ' HA ' ' A' ' 39' ' ' VAL . 20.7 p90 179.2 -159.05 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.166 -0.959 . . . . 0.0 109.768 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.7 ' HA ' HG21 ' A' ' 36' ' ' VAL . 4.6 p90 168.04 -178.75 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 -179.448 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 1.104 HG23 HG22 ' A' ' 36' ' ' VAL . 1.6 t -121.64 145.07 28.82 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.251 0 C-N-CA 116.914 -1.914 . . . . 0.0 111.954 -179.48 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.495 ' O ' ' N ' ' A' ' 9' ' ' ASP . 0.2 OUTLIER -96.7 38.9 1.19 Allowed 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.718 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.67 ' HG3' HG21 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -38.6 -27.94 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.125 0.488 . . . . 0.0 110.15 -179.689 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.495 ' N ' ' O ' ' A' ' 7' ' ' ASP . 4.8 t0 -46.62 -25.3 0.68 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.159 -0.963 . . . . 0.0 108.822 179.577 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.477 ' HB3' ' HB3' ' A' ' 58' ' ' CYS . 14.7 tt0 -108.04 -15.48 14.51 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.465 -0.772 . . . . 0.0 109.577 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.654 ' SG ' ' HG2' ' A' ' 33' ' ' LYS . 40.6 t -43.37 141.72 1.27 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.17 -0.956 . . . . 0.0 109.661 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.694 ' O ' ' HB2' ' A' ' 13' ' ' ALA . 8.0 pt -98.59 -47.49 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.242 -0.911 . . . . 0.0 109.826 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.694 ' HB2' ' O ' ' A' ' 12' ' ' ILE . . . 166.0 -34.9 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.059 -1.026 . . . . 0.0 110.157 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.956 ' O ' ' S2 ' ' A' ' 65' ' ' SF4 . 0.1 OUTLIER -47.61 159.86 0.14 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.085 -1.01 . . . . 0.0 109.614 -179.488 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -122.13 22.23 10.27 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.321 -0.862 . . . . 0.0 109.854 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.571 ' O ' HD12 ' A' ' 20' ' ' ILE . 0.3 OUTLIER -46.26 -58.33 3.77 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.218 -0.926 . . . . 0.0 109.039 179.728 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.945 ' SG ' ' HD2' ' A' ' 25' ' ' PHE . 19.8 p -52.17 -57.26 10.16 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.37 -0.831 . . . . 0.0 109.239 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.644 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 98.2 t -45.15 -28.14 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.277 -0.89 . . . . 0.0 109.164 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.97 -37.7 23.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.187 -0.946 . . . . 0.0 108.914 179.491 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.841 HD13 ' HA ' ' A' ' 50' ' ' ALA . 1.8 mt -88.33 18.06 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 177.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.522 ' HB2' ' O ' ' A' ' 20' ' ' ILE . . . 172.56 64.6 0.03 OUTLIER Pre-proline 0 N--CA 1.488 1.451 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.65 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -74.25 2.29 6.35 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 124.073 1.565 . . . . 0.0 110.62 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.482 ' O ' ' HB3' ' A' ' 37' ' ' LYS . . . -113.86 -22.7 5.25 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.534 ' O ' ' N ' ' A' ' 37' ' ' LYS . . . -110.66 -30.25 7.68 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.249 -1.147 . . . . 0.0 109.624 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 1.093 ' CE1' HG22 ' A' ' 6' ' ' VAL . 0.8 OUTLIER -114.62 129.84 56.72 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.21 -0.931 . . . . 0.0 108.564 179.762 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.587 ' HA ' HG22 ' A' ' 18' ' ' VAL . . . -158.76 146.83 18.13 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.874 -1.141 . . . . 0.0 110.36 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.55 ' HA ' ' C ' ' A' ' 33' ' ' LYS . 1.3 ttm -74.22 152.38 39.76 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.275 -0.891 . . . . 0.0 109.004 179.637 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.589 ' O ' ' N ' ' A' ' 32' ' ' GLU . 1.2 t0 -133.5 165.77 34.23 Favored Pre-proline 0 C--O 1.211 -0.948 0 O-C-N 120.197 -1.564 . . . . 0.0 108.071 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.508 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 44.8 Cg_endo -84.44 -16.56 5.75 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 124.507 1.793 . . . . 0.0 107.725 179.022 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.491 ' HB3' HD13 ' A' ' 31' ' ' ILE . 0.3 OUTLIER -85.18 -38.95 18.39 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 178.122 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.67 HG21 ' HG3' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -104.29 0.47 10.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 178.068 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.589 ' N ' ' O ' ' A' ' 28' ' ' ASP . 5.2 mt-10 34.97 35.91 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -179.248 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.654 ' HG2' ' SG ' ' A' ' 11' ' ' CYS . 0.1 OUTLIER -172.95 167.26 5.07 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 119.82 -0.752 . . . . 0.0 109.228 -178.367 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.529 ' O ' ' HB3' ' A' ' 8' ' ' GLN . . . -37.45 157.45 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.515 0.674 . . . . 0.0 110.318 -179.139 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.65 ' CZ ' ' HA ' ' A' ' 37' ' ' LYS . 0.2 OUTLIER -162.41 150.26 14.18 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 179.729 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 1.104 HG22 HG23 ' A' ' 6' ' ' VAL . 4.3 t -64.76 88.04 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 120.963 -1.086 . . . . 0.0 109.907 -178.04 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.65 ' HA ' ' CZ ' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -55.56 -26.54 44.01 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.459 -0.776 . . . . 0.0 109.528 179.589 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 39' ' ' VAL . 9.9 t0 175.43 157.99 0.21 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.255 -0.903 . . . . 0.0 109.625 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.604 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 11.6 m -78.22 -21.98 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.321 -0.862 . . . . 0.0 110.111 -179.275 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -117.11 18.95 14.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.12 -0.987 . . . . 0.0 109.422 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.448 ' HA3' ' C ' ' A' ' 23' ' ' GLY . . . -67.7 -15.8 67.04 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 -179.601 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.483 ' HB1' ' HB2' ' A' ' 46' ' ' GLU . . . -148.93 153.72 38.4 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.035 -1.273 . . . . 0.0 109.692 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.469 ' OG ' ' HG3' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -77.12 156.6 31.55 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.349 -0.844 . . . . 0.0 109.944 -179.775 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.489 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -48.47 -48.41 37.83 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.402 -0.811 . . . . 0.0 109.151 179.768 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -57.63 -36.8 72.3 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.209 -0.932 . . . . 0.0 108.979 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.483 ' HB2' ' HB1' ' A' ' 42' ' ' ALA . 14.4 mt-10 -73.06 -57.04 4.31 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.275 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.627 ' CG1' ' CH2' ' A' ' 61' ' ' TRP . 1.2 t -50.87 -32.15 11.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 179.226 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.489 ' HB2' ' O ' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -65.66 -72.89 0.14 Allowed 'General case' 0 C--N 1.309 -1.193 0 O-C-N 121.264 -0.898 . . . . 0.0 109.866 179.966 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -47.22 -39.67 14.63 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.273 -0.892 . . . . 0.0 109.233 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.841 ' HA ' HD13 ' A' ' 20' ' ' ILE . . . -61.03 -39.62 90.49 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.281 -0.887 . . . . 0.0 108.918 179.578 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' MET . . . . . 1.025 ' HE2' HG13 ' A' ' 59' ' ' ILE . 45.0 ttm -74.53 -29.8 61.52 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.443 -0.785 . . . . 0.0 109.169 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -60.99 -45.99 92.57 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.296 -0.877 . . . . 0.0 109.141 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.517 ' O ' ' HB3' ' A' ' 54' ' ' CYS . 65.9 p -68.25 -152.68 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.336 -0.852 . . . . 0.0 109.072 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.941 ' SG ' ' CA ' ' A' ' 57' ' ' GLN . 10.3 t 73.41 122.28 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.268 -0.895 . . . . 0.0 109.779 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -73.51 -44.08 0.58 Allowed 'Trans proline' 0 C--N 1.308 -1.562 0 O-C-N 123.863 1.454 . . . . 0.0 109.083 179.05 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.509 ' O ' ' CB ' ' A' ' 57' ' ' GLN . 1.9 m -96.37 -17.65 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.568 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.998 ' O ' HG22 ' A' ' 59' ' ' ILE . 0.9 OUTLIER 81.34 -59.77 0.24 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.724 -0.61 . . . . 0.0 110.569 179.542 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.962 ' SG ' ' S4 ' ' A' ' 65' ' ' SF4 . 11.9 p 35.88 41.6 0.12 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.641 -0.662 . . . . 0.0 109.51 -179.499 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 1.027 HD12 ' N ' ' A' ' 60' ' ' HIS . 0.1 OUTLIER -148.56 137.44 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.501 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 1.027 ' N ' HD12 ' A' ' 59' ' ' ILE . 31.0 m80 -155.7 163.56 39.74 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.708 -1.245 . . . . 0.0 110.469 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.627 ' CH2' ' CG1' ' A' ' 47' ' ' VAL . 72.2 m95 -87.63 -176.15 5.45 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.381 -0.824 . . . . 0.0 109.216 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.509 ' HB3' ' HB3' ' A' ' 3' ' ' LYS . 7.4 tt0 -150.72 99.8 2.77 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.332 -0.855 . . . . 0.0 109.208 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -90.31 -68.59 0.78 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.264 -0.897 . . . . 0.0 109.557 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.507 0 O-C-N 121.209 -0.932 . . . . 0.0 109.593 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' SF4 . . . . . 0.962 ' S4 ' ' SG ' ' A' ' 58' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 121.331 0.586 . . . . 0.0 109.488 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 67.13 96.46 0.06 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.251 -0.905 . . . . 0.0 109.515 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.459 ' O ' ' HB3' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -114.11 -156.41 0.6 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.32 -0.863 . . . . 0.0 109.524 179.946 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.829 ' CE1' HG12 ' A' ' 39' ' ' VAL . 11.5 p90 176.81 174.49 0.39 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.282 -0.886 . . . . 0.0 109.864 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.8 ' HA ' HG11 ' A' ' 36' ' ' VAL . 1.3 p90 177.15 -171.6 0.09 Allowed 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 179.237 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.982 HG23 ' HB ' ' A' ' 36' ' ' VAL . 0.2 OUTLIER -135.44 177.18 7.01 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 C-N-CA 117.693 -1.603 . . . . 0.0 111.651 179.869 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.583 ' H ' HG12 ' A' ' 6' ' ' VAL . 0.3 OUTLIER -129.35 92.45 3.36 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.786 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.567 ' CG ' ' O ' ' A' ' 34' ' ' ALA . 3.7 mp0 -65.36 45.2 0.02 OUTLIER 'General case' 0 C--N 1.291 -1.945 0 CA-C-O 121.617 0.722 . . . . 0.0 110.669 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.555 ' N ' ' O ' ' A' ' 7' ' ' ASP . 1.0 OUTLIER -110.93 -44.89 3.54 Favored 'General case' 0 C--N 1.285 -2.202 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.214 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.681 ' O ' HG21 ' A' ' 56' ' ' VAL . 0.3 OUTLIER -89.85 -7.35 54.48 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.741 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.671 ' SG ' ' HG2' ' A' ' 33' ' ' LYS . 39.6 t -62.95 144.2 57.02 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.453 -0.779 . . . . 0.0 110.195 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.7 pt -102.0 -113.16 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.293 -0.88 . . . . 0.0 108.798 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -135.27 26.61 3.5 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.778 -1.201 . . . . 0.0 109.043 179.441 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.892 ' O ' ' S2 ' ' A' ' 65' ' ' SF4 . 0.1 OUTLIER -102.1 149.6 24.11 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.28 -0.888 . . . . 0.0 109.905 -179.741 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.48 ' HB2' ' HB ' ' A' ' 18' ' ' VAL . 0.7 OUTLIER -109.13 20.03 18.81 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.468 -0.77 . . . . 0.0 109.645 -179.856 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 15' ' ' GLU . 56.7 m -43.86 -66.78 0.34 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.262 -0.898 . . . . 0.0 109.34 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.969 ' SG ' ' CD2' ' A' ' 25' ' ' PHE . 19.0 p -48.52 -46.49 38.62 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.323 -0.86 . . . . 0.0 109.328 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.48 ' HB ' ' HB2' ' A' ' 15' ' ' GLU . 59.0 t -50.24 -31.28 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.276 -0.89 . . . . 0.0 109.329 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -77.52 -34.56 53.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.244 -0.91 . . . . 0.0 109.395 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.915 HG21 ' N ' ' A' ' 50' ' ' ALA . 2.5 mp -79.95 5.36 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 178.318 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.498 ' HB1' ' HB2' ' A' ' 42' ' ' ALA . . . -172.8 65.15 0.34 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.351 -0.843 . . . . 0.0 109.045 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.37 70.13 2.53 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 O-C-N 124.286 1.677 . . . . 0.0 110.266 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.49 ' O ' ' HB3' ' A' ' 38' ' ' ASP . . . 177.72 -43.51 0.09 OUTLIER Glycine 0 N--CA 1.488 2.105 0 N-CA-C 108.737 -1.745 . . . . 0.0 108.737 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.585 ' HB2' ' O ' ' A' ' 38' ' ' ASP . . . -93.17 -32.25 14.47 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.555 -0.968 . . . . 0.0 109.029 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.969 ' CD2' ' SG ' ' A' ' 17' ' ' CYS . 0.1 OUTLIER -105.58 141.73 36.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.333 -0.855 . . . . 0.0 108.878 179.905 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.49 ' O ' ' CD1' ' A' ' 35' ' ' TYR . . . -174.96 125.32 0.27 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.115 -0.991 . . . . 0.0 109.286 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.579 ' HA ' ' C ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -58.5 154.3 14.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.165 -0.96 . . . . 0.0 109.558 -179.769 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.604 ' O ' ' N ' ' A' ' 32' ' ' GLU . 0.7 OUTLIER -126.18 163.29 40.87 Favored Pre-proline 0 C--N 1.313 -1.005 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 179.295 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.458 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 47.7 Cg_endo -84.19 -16.67 5.98 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 125.055 2.081 . . . . 0.0 108.279 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -88.07 -35.78 17.32 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 178.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.639 HD12 ' HB3' ' A' ' 35' ' ' TYR . 1.3 pt -105.28 -1.32 9.94 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 177.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.604 ' N ' ' O ' ' A' ' 28' ' ' ASP . 0.5 OUTLIER 34.78 36.86 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -179.244 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.671 ' HG2' ' SG ' ' A' ' 11' ' ' CYS . 1.8 mtmt -162.27 148.44 13.13 Favored 'General case' 0 N--CA 1.501 2.083 0 C-N-CA 119.012 -1.075 . . . . 0.0 110.755 -178.187 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.589 ' HB2' ' S2 ' ' A' ' 65' ' ' SF4 . . . -52.76 146.09 11.09 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.548 -0.72 . . . . 0.0 110.201 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.639 ' HB3' HD12 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -149.33 147.54 28.45 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-O 121.77 0.795 . . . . 0.0 109.51 179.219 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.982 ' HB ' HG23 ' A' ' 6' ' ' VAL . 1.3 t -88.84 96.09 5.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.097 -1.002 . . . . 0.0 108.34 -179.376 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.601 ' HB3' ' CE2' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -107.17 -28.12 10.15 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.418 -0.801 . . . . 0.0 110.966 -178.687 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.585 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 22.1 t70 -122.21 78.8 1.53 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.799 -1.188 . . . . 0.0 110.16 -179.1 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.829 HG12 ' CE1' ' A' ' 4' ' ' PHE . 27.2 m -45.25 -46.71 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.248 -0.908 . . . . 0.0 109.266 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.587 ' N ' HG23 ' A' ' 39' ' ' VAL . 6.5 mt-10 -58.51 -24.72 61.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.302 -0.874 . . . . 0.0 109.486 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 38' ' ' ASP . . . -54.08 -26.05 33.73 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.498 ' HB2' ' HB1' ' A' ' 21' ' ' ALA . . . -144.69 144.76 31.39 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.23 -1.159 . . . . 0.0 109.443 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.424 ' OG ' ' CD ' ' A' ' 46' ' ' GLU . 0.1 OUTLIER -67.95 169.14 10.45 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.177 -0.952 . . . . 0.0 109.504 179.988 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.503 ' O ' ' HG2' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -66.15 -47.72 73.11 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.49 -0.756 . . . . 0.0 109.247 179.802 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.721 ' HA ' ' HG2' ' A' ' 48' ' ' GLU . 5.8 mm-40 -61.4 -17.26 53.36 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.284 -0.885 . . . . 0.0 109.185 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.424 ' CD ' ' OG ' ' A' ' 43' ' ' SER . 76.9 mt-10 -91.92 -45.79 8.17 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 178.522 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.811 HG12 ' CH2' ' A' ' 61' ' ' TRP . 6.8 t -55.04 -38.24 45.34 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 178.014 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.721 ' HG2' ' HA ' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -68.14 -56.9 7.13 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.64 -0.663 . . . . 0.0 109.345 178.954 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.457 ' H ' ' HG3' ' A' ' 48' ' ' GLU . 0.3 OUTLIER -43.04 -48.14 6.02 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.167 -0.958 . . . . 0.0 109.085 179.883 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.915 ' N ' HG21 ' A' ' 20' ' ' ILE . . . -60.41 -40.0 89.41 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.213 -0.929 . . . . 0.0 108.65 179.286 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.55 ' CE ' ' CZ3' ' A' ' 61' ' ' TRP . 21.2 ttm -58.7 -37.74 76.76 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.429 -0.794 . . . . 0.0 109.342 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -79.26 -8.07 58.76 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.282 -0.886 . . . . 0.0 109.244 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -115.21 78.36 1.16 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.258 -0.901 . . . . 0.0 109.908 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.792 ' SG ' ' HD2' ' A' ' 55' ' ' PRO . 44.2 t -151.08 148.18 22.16 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.284 -0.885 . . . . 0.0 108.914 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.792 ' HD2' ' SG ' ' A' ' 54' ' ' CYS . 44.1 Cg_endo -72.1 -37.09 5.04 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 123.863 1.454 . . . . 0.0 110.333 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.681 HG21 ' O ' ' A' ' 10' ' ' GLU . 2.9 m -111.83 -29.59 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.27 -0.894 . . . . 0.0 109.232 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.552 ' N ' ' SG ' ' A' ' 54' ' ' CYS . 0.0 OUTLIER 66.57 76.65 0.3 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.305 -0.872 . . . . 0.0 109.722 179.763 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 22.5 p -112.3 17.24 19.59 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.279 -0.888 . . . . 0.0 109.12 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.87 ' CB ' HG13 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -104.09 129.69 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.332 -0.855 . . . . 0.0 109.51 -179.687 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.588 ' N ' HD13 ' A' ' 59' ' ' ILE . 1.8 m80 -136.99 160.42 38.96 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.181 -0.949 . . . . 0.0 109.393 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.811 ' CH2' HG12 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -68.13 -169.68 0.15 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.331 -0.856 . . . . 0.0 109.222 179.884 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.446 ' HB3' ' HB3' ' A' ' 3' ' ' LYS . 26.0 tt0 -159.57 120.37 3.14 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.287 -0.883 . . . . 0.0 109.318 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -66.38 -58.94 4.23 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.31 -0.869 . . . . 0.0 109.321 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 51.2 tt0 . . . . . 0 N--CA 1.489 1.49 0 O-C-N 121.307 -0.871 . . . . 0.0 109.457 179.956 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 65' ' ' SF4 . . . . . 0.892 ' S2 ' ' O ' ' A' ' 14' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 6.5 ptt180 -69.82 166.2 19.88 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.276 -0.89 . . . . 0.0 109.312 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.497 ' O ' ' HB3' ' A' ' 4' ' ' PHE . 0.5 OUTLIER -103.04 -152.58 0.45 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.321 -0.862 . . . . 0.0 109.518 -179.865 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.687 ' CZ ' HG12 ' A' ' 39' ' ' VAL . 39.3 p90 168.8 170.32 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.709 -0.619 . . . . 0.0 109.486 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.508 ' CE1' ' HB2' ' A' ' 62' ' ' GLU . 20.5 p90 176.75 -167.61 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 179.557 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.973 HG21 ' CZ ' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -136.52 -165.36 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 118.44 -1.304 . . . . 0.0 111.517 -179.57 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' A' ' 9' ' ' ASP . 1.5 m-20 -151.23 98.31 2.53 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 114.209 -1.36 . . . . 0.0 107.478 178.317 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.553 ' HG3' ' O ' ' A' ' 34' ' ' ALA . 5.7 mp0 -64.85 43.19 0.02 OUTLIER 'General case' 0 C--N 1.291 -1.939 0 CA-C-O 121.624 0.726 . . . . 0.0 110.664 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 7' ' ' ASP . 0.2 OUTLIER -99.95 -24.52 14.61 Favored 'General case' 0 C--N 1.287 -2.116 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 179.438 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.445 ' HG2' ' HB ' ' A' ' 56' ' ' VAL . 0.6 OUTLIER -115.55 13.13 16.32 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.495 -0.753 . . . . 0.0 109.353 -179.977 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.474 ' HB3' ' HD3' ' A' ' 33' ' ' LYS . 41.9 t -84.23 129.67 34.87 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.155 -0.966 . . . . 0.0 109.7 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.711 ' O ' ' HB2' ' A' ' 13' ' ' ALA . 21.8 pt -102.24 -41.95 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.365 -0.834 . . . . 0.0 109.389 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.711 ' HB2' ' O ' ' A' ' 12' ' ' ILE . . . 163.85 -22.33 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.35 -0.844 . . . . 0.0 109.899 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 1.015 ' O ' ' S2 ' ' A' ' 65' ' ' SF4 . 0.1 OUTLIER -51.23 139.9 17.79 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.037 -1.04 . . . . 0.0 109.443 -179.75 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.487 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 4.0 mp0 -102.51 20.4 17.14 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.107 -0.996 . . . . 0.0 109.501 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.712 ' O ' HD12 ' A' ' 20' ' ' ILE . 7.1 m -44.18 -65.48 0.51 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.25 -0.906 . . . . 0.0 109.063 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.608 ' SG ' ' N ' ' A' ' 18' ' ' VAL . 16.4 p -53.16 -52.16 59.67 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.42 -0.8 . . . . 0.0 109.026 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.608 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 38.5 t -48.32 -24.42 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.354 -0.841 . . . . 0.0 109.161 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -86.22 -33.47 20.73 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.299 -0.876 . . . . 0.0 109.004 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.948 HG21 ' N ' ' A' ' 50' ' ' ALA . 2.7 mp -85.01 12.05 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.27 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.627 ' HB1' ' HB2' ' A' ' 42' ' ' ALA . . . 169.69 65.22 0.02 OUTLIER Pre-proline 0 N--CA 1.486 1.345 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -69.23 -4.85 14.49 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 O-C-N 124.143 1.602 . . . . 0.0 110.298 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.475 ' O ' ' HB3' ' A' ' 38' ' ' ASP . . . -100.44 -39.94 3.1 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.493 ' HA ' ' HB3' ' A' ' 38' ' ' ASP . . . -85.72 -33.76 21.41 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.321 -1.105 . . . . 0.0 109.299 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.973 ' CZ ' HG21 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -103.69 144.25 31.7 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.795 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.487 ' O ' ' CD1' ' A' ' 35' ' ' TYR . . . -170.84 126.48 0.71 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.991 -1.068 . . . . 0.0 109.793 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.57 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 3.7 ppp? -59.91 153.86 20.07 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.082 -1.011 . . . . 0.0 109.323 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.633 ' O ' ' N ' ' A' ' 32' ' ' GLU . 3.0 t0 -123.99 160.21 52.94 Favored Pre-proline 0 C--N 1.31 -1.135 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 179.217 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.461 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 47.2 Cg_endo -84.7 -16.48 5.49 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 124.973 2.039 . . . . 0.0 108.682 -179.28 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.35 -28.21 17.06 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 178.17 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.56 HG12 ' CB ' ' A' ' 28' ' ' ASP . 0.9 OUTLIER -108.83 -2.67 10.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 177.974 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.633 ' N ' ' O ' ' A' ' 28' ' ' ASP . 2.7 mm-40 31.33 38.56 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -179.006 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.546 ' C ' ' HA ' ' A' ' 27' ' ' MET . 70.7 mttt -162.39 148.11 12.76 Favored 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 119.723 -0.791 . . . . 0.0 110.296 -178.432 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.763 ' HB1' ' CD1' ' A' ' 25' ' ' PHE . . . -56.79 147.57 22.83 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.468 -0.77 . . . . 0.0 110.863 -179.423 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.595 ' O ' ' CD1' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -152.44 153.36 33.4 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.576 -0.703 . . . . 0.0 109.316 178.806 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.827 HG23 ' CG2' ' A' ' 6' ' ' VAL . 36.5 t -92.62 103.54 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 120.926 -1.108 . . . . 0.0 109.095 -179.452 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.594 ' HB3' ' CE2' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -119.3 -23.48 6.71 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 119.469 -0.892 . . . . 0.0 110.616 -179.286 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.516 ' N ' ' HG3' ' A' ' 37' ' ' LYS . 45.1 t0 -112.31 98.45 7.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.997 -1.064 . . . . 0.0 109.821 -179.683 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.687 HG12 ' CZ ' ' A' ' 4' ' ' PHE . 27.7 m -63.9 -29.21 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.139 -0.976 . . . . 0.0 109.578 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.534 ' OE1' HG23 ' A' ' 39' ' ' VAL . 0.7 OUTLIER -81.86 -14.26 56.49 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.228 -0.92 . . . . 0.0 109.53 -179.804 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.426 ' HA3' ' C ' ' A' ' 23' ' ' GLY . . . -67.08 -17.85 68.33 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.211 -1.556 . . . . 0.0 109.211 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.627 ' HB2' ' HB1' ' A' ' 21' ' ' ALA . . . -151.34 131.42 13.47 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.431 -1.041 . . . . 0.0 109.278 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.86 167.61 5.92 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.217 -0.927 . . . . 0.0 109.487 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -58.04 -49.01 78.36 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.506 -0.746 . . . . 0.0 109.409 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.742 ' HA ' ' HG2' ' A' ' 48' ' ' GLU . 1.0 OUTLIER -62.77 -14.72 48.33 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.182 -0.949 . . . . 0.0 108.943 179.908 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.439 ' OE1' ' HA ' ' A' ' 42' ' ' ALA . 43.0 mt-10 -90.52 -44.3 9.67 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 178.779 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 8.5 t -57.84 -38.71 67.37 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.343 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.742 ' HG2' ' HA ' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -68.77 -58.21 4.53 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.518 -0.739 . . . . 0.0 109.662 179.672 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.49 ' OE2' HG12 ' A' ' 20' ' ' ILE . 29.0 tt0 -44.13 -53.58 6.32 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.013 -1.054 . . . . 0.0 108.819 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.948 ' N ' HG21 ' A' ' 20' ' ' ILE . . . -54.0 -42.3 68.91 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.057 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.841 ' HA ' HG21 ' A' ' 59' ' ' ILE . 30.3 ttm -61.05 -29.87 69.99 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.052 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -63.56 -32.59 74.09 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.827 HG21 HD11 ' A' ' 20' ' ' ILE . 76.4 p -77.52 -155.03 0.07 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.402 -0.811 . . . . 0.0 109.201 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.507 ' SG ' ' HD2' ' A' ' 55' ' ' PRO . 2.3 t 64.99 140.46 0.06 OUTLIER Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.11 -0.994 . . . . 0.0 109.391 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.507 ' HD2' ' SG ' ' A' ' 54' ' ' CYS . 42.1 Cg_endo -71.37 -86.89 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.006 1.529 . . . . 0.0 110.061 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.445 ' HB ' ' HG2' ' A' ' 10' ' ' GLU . 11.1 t -63.34 -12.68 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.179 -0.951 . . . . 0.0 108.935 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.478 ' HA ' ' HB3' ' A' ' 54' ' ' CYS . 0.0 OUTLIER 58.55 81.08 0.16 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.244 -0.91 . . . . 0.0 109.431 179.863 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.434 ' SG ' HG12 ' A' ' 6' ' ' VAL . 28.0 p -86.64 16.14 4.98 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.2 -0.937 . . . . 0.0 109.399 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.841 HG21 ' HA ' ' A' ' 51' ' ' MET . 7.9 tt -106.16 154.38 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.168 -0.957 . . . . 0.0 109.81 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.425 ' HA ' ' HE1' ' A' ' 51' ' ' MET . 0.2 OUTLIER -166.95 -174.62 2.75 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.49 -0.756 . . . . 0.0 108.986 179.981 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.535 ' HA ' ' HA ' ' A' ' 4' ' ' PHE . 47.1 m95 -104.54 155.16 19.06 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.041 -1.037 . . . . 0.0 109.704 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.508 ' HB2' ' CE1' ' A' ' 5' ' ' TYR . 6.4 tt0 -122.28 96.5 5.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.465 -0.772 . . . . 0.0 109.454 -179.618 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.57 84.49 1.14 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.161 -0.962 . . . . 0.0 109.409 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 . . . . . 0 N--CA 1.489 1.502 0 O-C-N 121.196 -0.94 . . . . 0.0 109.395 -179.998 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 65' ' ' SF4 . . . . . 1.015 ' S2 ' ' O ' ' A' ' 14' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.464 ' O ' ' HG3' ' A' ' 2' ' ' ARG . 9.6 ptt85 -51.27 120.7 5.27 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.224 -0.923 . . . . 0.0 109.45 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.553 ' HB3' ' HB3' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -122.81 -150.18 0.44 Allowed 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.145 -0.972 . . . . 0.0 109.446 -179.965 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.584 ' CB ' ' HA ' ' A' ' 61' ' ' TRP . 24.4 p90 168.54 -179.3 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.508 -0.745 . . . . 0.0 109.551 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.496 ' O ' HG13 ' A' ' 59' ' ' ILE . 30.0 p90 176.71 -175.95 0.13 Allowed 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 179.23 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 1.083 HG21 ' CZ ' ' A' ' 25' ' ' PHE . 0.2 OUTLIER -131.4 169.77 21.08 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.018 0 C-N-CA 117.389 -1.724 . . . . 0.0 111.413 -179.661 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.515 ' O ' ' N ' ' A' ' 9' ' ' ASP . 9.3 t0 -108.99 89.58 3.04 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 178.661 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.559 ' CG ' ' O ' ' A' ' 34' ' ' ALA . 8.4 mp0 -65.36 46.09 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.859 0 CA-C-O 121.578 0.704 . . . . 0.0 110.3 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.515 ' N ' ' O ' ' A' ' 7' ' ' ASP . 0.3 OUTLIER -113.32 -44.65 3.21 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.395 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.657 ' CG ' HG11 ' A' ' 56' ' ' VAL . 0.3 OUTLIER -91.45 17.62 8.33 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.087 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 37.4 t -83.26 111.95 19.43 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.359 -0.838 . . . . 0.0 110.373 -179.169 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.708 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 30.6 pt -78.53 0.59 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.47 -0.768 . . . . 0.0 109.047 179.344 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.708 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . 78.81 50.58 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.452 -0.78 . . . . 0.0 110.294 179.561 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.839 ' SG ' ' OG ' ' A' ' 16' ' ' SER . 3.2 p -105.67 161.51 14.33 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.866 -1.146 . . . . 0.0 109.436 179.297 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.456 ' O ' ' HB2' ' A' ' 19' ' ' GLU . 63.3 mt-10 -87.88 18.38 4.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.277 -0.889 . . . . 0.0 109.832 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' SER . . . . . 1.086 ' OG ' ' S1 ' ' A' ' 65' ' ' SF4 . 52.4 p -60.73 -91.06 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.22 -0.925 . . . . 0.0 109.636 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.523 ' SG ' ' N ' ' A' ' 18' ' ' VAL . 10.8 p -45.34 -47.77 13.3 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.22 -0.925 . . . . 0.0 110.034 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.523 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 78.6 t -53.03 -30.74 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.165 -0.96 . . . . 0.0 109.981 -179.503 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.456 ' HB2' ' O ' ' A' ' 15' ' ' GLU . 2.8 mm-40 -77.35 -41.97 38.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.932 -1.105 . . . . 0.0 109.603 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.768 ' CD1' HG21 ' A' ' 53' ' ' THR . 1.6 mt -84.81 15.57 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.248 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.585 ' HB2' ' O ' ' A' ' 20' ' ' ILE . . . 170.54 63.14 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.452 -0.78 . . . . 0.0 109.281 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.487 ' N ' ' O ' ' A' ' 18' ' ' VAL . 45.9 Cg_endo -74.07 -18.56 21.12 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.08 1.569 . . . . 0.0 110.882 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.401 ' O ' ' HB3' ' A' ' 38' ' ' ASP . . . -79.44 -41.48 13.28 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.489 ' HA ' ' HB3' ' A' ' 38' ' ' ASP . . . -87.32 -34.2 18.93 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.215 -1.168 . . . . 0.0 109.71 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 1.083 ' CZ ' HG21 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -106.04 141.21 37.8 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.324 -0.86 . . . . 0.0 109.326 -179.716 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.49 ' O ' ' CD1' ' A' ' 35' ' ' TYR . . . -170.45 128.69 0.83 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.069 -1.019 . . . . 0.0 109.948 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.572 ' HA ' ' C ' ' A' ' 33' ' ' LYS . 2.7 ptm -62.65 153.98 30.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.917 -1.114 . . . . 0.0 109.222 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.578 ' HB3' ' CD1' ' A' ' 31' ' ' ILE . 1.7 t0 -135.22 165.26 37.82 Favored Pre-proline 0 C--N 1.311 -1.085 0 O-C-N 120.663 -1.273 . . . . 0.0 107.572 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.505 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 43.4 Cg_endo -84.01 -17.1 5.95 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 O-C-N 124.528 1.804 . . . . 0.0 107.867 179.265 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.72 -38.96 19.07 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 177.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.578 ' CD1' ' HB3' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -104.13 3.07 10.58 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 177.885 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.565 ' N ' ' O ' ' A' ' 28' ' ' ASP . 2.5 mm-40 31.62 39.33 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.795 0.807 . . . . 0.0 108.879 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.572 ' C ' ' HA ' ' A' ' 27' ' ' MET . 0.0 OUTLIER -173.7 153.55 2.27 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 119.191 -1.004 . . . . 0.0 110.131 -178.537 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.559 ' O ' ' CG ' ' A' ' 8' ' ' GLN . . . -52.52 149.32 5.95 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.475 -0.766 . . . . 0.0 109.66 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.617 ' O ' ' CD1' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -154.16 146.5 23.9 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.614 0.721 . . . . 0.0 109.267 179.266 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.873 ' HB ' HG23 ' A' ' 6' ' ' VAL . 2.1 t -87.44 99.75 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.103 -0.998 . . . . 0.0 108.49 -179.411 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.597 ' HB3' ' CE2' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -115.56 -27.11 7.24 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.23 -0.919 . . . . 0.0 111.057 -178.699 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.554 ' N ' ' HG3' ' A' ' 37' ' ' LYS . 39.5 t0 -113.21 92.46 4.01 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.897 -1.127 . . . . 0.0 110.026 -179.343 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.457 HG12 ' CE1' ' A' ' 4' ' ' PHE . 25.5 m -61.16 -23.28 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.36 -0.837 . . . . 0.0 109.248 179.657 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -93.13 1.39 57.19 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.418 -0.801 . . . . 0.0 109.561 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -87.2 -0.09 85.37 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.451 ' HA ' ' OE2' ' A' ' 46' ' ' GLU . . . -162.91 131.41 3.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.167 -1.196 . . . . 0.0 109.718 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.609 ' O ' HG23 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -61.52 170.93 1.65 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.348 -0.845 . . . . 0.0 109.943 -179.823 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.486 ' HA ' ' HB ' ' A' ' 47' ' ' VAL . 6.0 tt0 -72.0 -41.05 68.04 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.572 -0.705 . . . . 0.0 109.743 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -67.22 -25.92 66.34 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.108 -0.995 . . . . 0.0 109.41 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.52 ' HG2' ' N ' ' A' ' 43' ' ' SER . 5.1 pt-20 -90.02 -35.29 15.59 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 178.722 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.609 HG23 ' O ' ' A' ' 43' ' ' SER . 4.0 t -64.37 -32.7 58.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 177.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.447 ' HB2' ' O ' ' A' ' 44' ' ' GLN . 0.5 OUTLIER -71.15 -59.35 2.82 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.131 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.687 ' HB3' HG21 ' A' ' 20' ' ' ILE . 0.4 OUTLIER -53.2 -39.22 63.52 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.113 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.709 ' HB2' ' HB ' ' A' ' 20' ' ' ILE . . . -71.59 -17.83 62.27 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.365 -0.834 . . . . 0.0 109.049 179.413 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' MET . . . . . 1.0 ' HG3' HD13 ' A' ' 59' ' ' ILE . 33.4 ttm -92.11 -17.84 24.41 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.483 -0.761 . . . . 0.0 109.939 -179.328 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -100.93 -17.15 16.93 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.054 -1.029 . . . . 0.0 109.784 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.768 HG21 ' CD1' ' A' ' 20' ' ' ILE . 9.6 t -72.58 -11.22 60.56 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.061 -1.025 . . . . 0.0 109.448 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 1.242 ' SG ' ' HD2' ' A' ' 55' ' ' PRO . 9.4 t -71.04 158.61 87.78 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.248 -0.907 . . . . 0.0 109.486 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 1.242 ' HD2' ' SG ' ' A' ' 54' ' ' CYS . 42.1 Cg_endo -72.79 -85.28 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.92 1.484 . . . . 0.0 109.929 179.452 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.657 HG11 ' CG ' ' A' ' 10' ' ' GLU . 4.2 p -68.41 -22.91 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.111 -0.993 . . . . 0.0 108.926 179.358 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.5 ' O ' ' N ' ' A' ' 59' ' ' ILE . 0.6 OUTLIER 69.34 46.63 0.75 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.474 -0.767 . . . . 0.0 109.635 179.741 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.484 ' HB2' ' HB2' ' A' ' 10' ' ' GLU . 0.1 OUTLIER -68.28 62.41 0.09 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.158 -0.964 . . . . 0.0 109.296 179.732 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 1.0 HD13 ' HG3' ' A' ' 51' ' ' MET . 12.0 tt -132.22 160.29 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.297 -0.877 . . . . 0.0 109.418 -179.681 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.582 ' CG ' ' O ' ' A' ' 59' ' ' ILE . 15.7 m80 -159.83 147.54 16.87 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.02 -1.05 . . . . 0.0 109.915 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.584 ' HA ' ' CB ' ' A' ' 4' ' ' PHE . 58.2 m95 -83.74 -175.38 5.78 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.321 -0.862 . . . . 0.0 108.861 179.198 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.553 ' HB3' ' HB3' ' A' ' 3' ' ' LYS . 0.5 OUTLIER -139.47 81.92 1.86 Allowed 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.089 -1.007 . . . . 0.0 109.586 -179.587 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.446 ' O ' ' CB ' ' A' ' 64' ' ' GLU . 11.0 t0 -92.7 90.02 6.9 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.379 -0.825 . . . . 0.0 109.285 179.786 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.446 ' CB ' ' O ' ' A' ' 63' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.244 -0.91 . . . . 0.0 109.48 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' SF4 . . . . . 1.086 ' S1 ' ' OG ' ' A' ' 16' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.445 ' O ' ' HB2' ' A' ' 2' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 121.258 0.551 . . . . 0.0 109.537 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.445 ' HB2' ' O ' ' A' ' 1' ' ' ALA . 10.2 mtt180 64.37 82.14 0.19 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.31 -0.869 . . . . 0.0 109.648 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.42 ' HB3' ' HB3' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -103.3 -153.46 0.47 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.306 -0.871 . . . . 0.0 109.039 179.713 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.654 ' CZ ' HG21 ' A' ' 47' ' ' VAL . 30.9 p90 -178.12 -178.83 0.68 Allowed 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.253 -0.905 . . . . 0.0 109.613 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.759 ' HA ' HG21 ' A' ' 36' ' ' VAL . 45.6 p90 -179.89 -178.15 0.42 Allowed 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 106.012 -1.848 . . . . 0.0 106.012 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 1.104 HG21 ' CE2' ' A' ' 25' ' ' PHE . 2.6 t -142.41 160.95 19.41 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.32 0 C-N-CA 117.487 -1.685 . . . . 0.0 111.228 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.531 ' N ' HG12 ' A' ' 6' ' ' VAL . 4.8 m-20 -114.52 79.26 1.24 Allowed 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.624 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.683 ' OE1' HD13 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -42.07 -22.76 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.564 0.697 . . . . 0.0 109.285 179.359 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.526 ' N ' ' O ' ' A' ' 7' ' ' ASP . 0.5 OUTLIER -48.99 -42.58 38.3 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.545 -0.722 . . . . 0.0 109.332 -179.782 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.489 ' CG ' ' SG ' ' A' ' 58' ' ' CYS . 7.8 tp10 -84.1 -14.53 50.14 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.308 -0.87 . . . . 0.0 109.179 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.415 ' HB3' ' O ' ' A' ' 8' ' ' GLN . 42.8 t -56.68 139.79 49.26 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.243 -0.91 . . . . 0.0 109.492 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.748 ' O ' ' HB2' ' A' ' 13' ' ' ALA . 1.6 pp -101.35 -33.69 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.219 -0.925 . . . . 0.0 109.783 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.748 ' HB2' ' O ' ' A' ' 12' ' ' ILE . . . 155.99 -40.5 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.543 -0.723 . . . . 0.0 109.769 179.544 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 1.154 ' O ' ' S2 ' ' A' ' 65' ' ' SF4 . 0.1 OUTLIER -43.84 153.2 0.13 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.146 -0.971 . . . . 0.0 109.735 -179.39 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.427 ' O ' ' C ' ' A' ' 16' ' ' SER . 3.5 pt-20 -117.49 21.88 12.76 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.277 -0.889 . . . . 0.0 109.559 -179.575 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.825 ' O ' HD12 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -44.43 -55.19 5.23 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.148 -0.97 . . . . 0.0 109.18 179.856 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.49 ' SG ' ' CD1' ' A' ' 25' ' ' PHE . 21.5 p -54.46 -45.31 73.1 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.376 -0.827 . . . . 0.0 109.3 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.461 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 4.8 t -52.26 -26.48 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.34 -0.85 . . . . 0.0 109.466 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -89.82 -32.08 17.08 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.166 -0.959 . . . . 0.0 109.541 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.932 HD13 ' HA ' ' A' ' 50' ' ' ALA . 2.7 mp -84.65 11.8 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.449 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.707 ' HB1' ' HB2' ' A' ' 42' ' ' ALA . . . -168.58 66.28 0.67 Allowed Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.357 -0.84 . . . . 0.0 109.293 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -71.74 83.28 1.12 Allowed 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 123.981 1.516 . . . . 0.0 110.287 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 147.57 -21.01 1.5 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.546 ' CB ' ' O ' ' A' ' 38' ' ' ASP . . . -113.01 -30.68 6.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.314 -1.109 . . . . 0.0 109.102 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 1.104 ' CE2' HG21 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -112.86 140.57 47.54 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.439 -0.788 . . . . 0.0 109.408 -179.972 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.479 ' O ' ' HA ' ' A' ' 34' ' ' ALA . . . -171.59 149.65 2.65 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.544 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 0.2 OUTLIER -82.76 156.51 23.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.874 -1.141 . . . . 0.0 108.652 -179.979 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.622 ' O ' ' N ' ' A' ' 32' ' ' GLU . 1.7 t0 -121.13 160.95 43.16 Favored Pre-proline 0 C--N 1.31 -1.148 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 179.26 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.467 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 48.1 Cg_endo -83.42 -15.97 7.24 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 125.051 2.08 . . . . 0.0 108.157 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -88.56 -35.35 16.96 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 178.31 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.683 HD13 ' OE1' ' A' ' 8' ' ' GLN . 3.8 pt -106.86 0.48 10.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.245 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.622 ' N ' ' O ' ' A' ' 28' ' ' ASP . 51.6 mt-10 32.18 38.34 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -179.247 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.605 ' O ' HD12 ' A' ' 31' ' ' ILE . 83.1 mttt -157.83 146.87 19.55 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 119.262 -0.975 . . . . 0.0 110.93 -177.445 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.76 ' HB1' ' CD1' ' A' ' 25' ' ' PHE . . . -53.31 143.91 17.55 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.737 -0.602 . . . . 0.0 110.634 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.708 ' CE2' ' HA ' ' A' ' 37' ' ' LYS . 6.9 p90 -149.37 169.19 21.4 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 1.062 HG22 HG23 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -86.59 85.09 2.35 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.084 0 CA-C-O 121.624 0.726 . . . . 0.0 109.433 -178.26 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.708 ' HA ' ' CE2' ' A' ' 35' ' ' TYR . 13.4 ptmt -68.89 -10.39 56.79 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.558 -0.714 . . . . 0.0 110.511 -179.344 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.546 ' O ' ' CB ' ' A' ' 24' ' ' ALA . 11.7 t0 178.55 141.07 0.1 Allowed 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 118.611 -1.235 . . . . 0.0 110.424 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.1 m -84.38 -33.54 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.289 -0.882 . . . . 0.0 109.351 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -71.78 -16.08 62.18 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.247 -0.908 . . . . 0.0 109.21 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -69.39 -26.85 74.18 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.707 ' HB2' ' HB1' ' A' ' 21' ' ' ALA . . . -130.7 144.74 51.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.294 -1.121 . . . . 0.0 109.252 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.451 ' OG ' ' OE2' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -89.11 158.24 18.02 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.199 -0.938 . . . . 0.0 109.996 -179.613 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.528 ' HG2' ' N ' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -53.03 -23.06 6.69 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.45 -0.781 . . . . 0.0 109.147 179.811 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.528 ' N ' ' HG2' ' A' ' 44' ' ' GLN . 53.8 mm-40 -85.06 -23.1 28.72 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.4 -0.813 . . . . 0.0 108.837 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.463 ' HB3' ' O ' ' A' ' 20' ' ' ILE . 48.5 mt-10 -88.5 -55.8 3.57 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 106.263 -1.755 . . . . 0.0 106.263 178.44 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.654 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 2.9 t -48.06 -29.35 2.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 177.605 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.519 ' HB2' ' O ' ' A' ' 44' ' ' GLN . 0.3 OUTLIER -70.25 -69.27 0.37 Allowed 'General case' 0 C--N 1.311 -1.083 0 O-C-N 121.565 -0.709 . . . . 0.0 109.41 179.161 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -46.15 -46.72 17.44 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.381 -0.825 . . . . 0.0 109.11 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.932 ' HA ' HD13 ' A' ' 20' ' ' ILE . . . -55.02 -32.49 61.88 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.289 -0.882 . . . . 0.0 109.088 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.679 ' HE2' HG23 ' A' ' 59' ' ' ILE . 34.9 ttm -66.7 -60.2 2.91 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.414 -0.803 . . . . 0.0 109.426 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -46.69 -28.19 1.42 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.223 -0.923 . . . . 0.0 109.689 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.459 ' O ' ' HB2' ' A' ' 54' ' ' CYS . 0.2 OUTLIER -102.08 99.9 10.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.176 -0.953 . . . . 0.0 109.827 -179.763 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.813 ' SG ' ' HD2' ' A' ' 55' ' ' PRO . 53.2 t 176.64 146.43 0.27 Allowed Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.214 -0.929 . . . . 0.0 109.868 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.813 ' HD2' ' SG ' ' A' ' 54' ' ' CYS . 45.1 Cg_endo -75.14 104.04 1.84 Allowed 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 124.061 1.558 . . . . 0.0 109.279 179.178 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.535 HG23 ' C ' ' A' ' 55' ' ' PRO . 3.7 t 77.71 3.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.441 -0.787 . . . . 0.0 109.003 -178.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.489 ' HG2' ' O ' ' A' ' 51' ' ' MET . 41.4 mt-30 44.72 82.65 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.284 -0.885 . . . . 0.0 109.413 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.489 ' SG ' ' CG ' ' A' ' 10' ' ' GLU . 2.3 m -79.93 -12.54 59.72 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.242 -0.911 . . . . 0.0 109.224 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.848 ' HA ' HG13 ' A' ' 6' ' ' VAL . 16.4 tt -83.77 144.19 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.383 -0.823 . . . . 0.0 110.145 -179.588 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.474 ' O ' ' HB2' ' A' ' 4' ' ' PHE . 39.6 m-70 -144.37 172.43 12.94 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.365 -0.834 . . . . 0.0 108.902 179.586 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.532 ' HA ' ' CB ' ' A' ' 4' ' ' PHE . 68.4 m95 -94.69 179.55 5.22 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.029 -1.045 . . . . 0.0 110.037 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.42 ' HB3' ' HB3' ' A' ' 3' ' ' LYS . 13.6 tt0 -155.97 94.36 1.53 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.42 -0.8 . . . . 0.0 109.261 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.88 107.08 0.78 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.189 -0.944 . . . . 0.0 109.413 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 . . . . . 0 N--CA 1.492 1.639 0 O-C-N 121.323 -0.861 . . . . 0.0 109.574 -179.913 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 65' ' ' SF4 . . . . . 1.154 ' S2 ' ' O ' ' A' ' 14' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.271 0.558 . . . . 0.0 109.586 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.2 ttp180 46.56 75.11 0.13 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.187 -0.945 . . . . 0.0 109.715 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.49 ' HB3' ' HB3' ' A' ' 62' ' ' GLU . 1.2 ttmt -80.22 -152.88 0.08 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.216 -0.928 . . . . 0.0 109.188 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.573 ' HA ' ' N ' ' A' ' 62' ' ' GLU . 51.2 p90 175.55 175.69 0.24 Allowed 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.399 -0.813 . . . . 0.0 110.082 179.606 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.845 ' O ' HD12 ' A' ' 59' ' ' ILE . 41.0 p90 179.7 -176.34 0.31 Allowed 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 1.148 HG21 ' CZ ' ' A' ' 25' ' ' PHE . 0.2 OUTLIER -135.48 171.95 16.59 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 C-N-CA 117.816 -1.553 . . . . 0.0 110.94 -179.859 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.58 ' O ' ' N ' ' A' ' 9' ' ' ASP . 2.5 t0 -117.98 92.56 3.86 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.529 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.569 ' CB ' HG21 ' A' ' 31' ' ' ILE . 4.0 mp0 -62.89 42.37 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.93 0 CA-C-O 121.399 0.619 . . . . 0.0 111.039 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.58 ' N ' ' O ' ' A' ' 7' ' ' ASP . 0.4 OUTLIER -104.13 -31.68 9.53 Favored 'General case' 0 C--N 1.287 -2.11 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.432 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.448 ' HB2' ' SG ' ' A' ' 58' ' ' CYS . 0.6 OUTLIER -111.42 22.06 15.53 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.632 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 14.4 t -83.76 126.04 32.51 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.292 -0.88 . . . . 0.0 109.988 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.719 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 23.1 pt -86.21 1.31 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.363 -0.836 . . . . 0.0 109.431 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.719 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . 78.49 32.59 0.32 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.333 -0.854 . . . . 0.0 110.612 179.207 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.494 ' O ' ' S2 ' ' A' ' 65' ' ' SF4 . 1.6 p -88.86 151.52 22.3 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.905 -1.122 . . . . 0.0 109.076 179.216 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.448 ' O ' ' HB2' ' A' ' 19' ' ' GLU . 1.5 mt-10 -88.54 33.97 0.76 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.179 -0.951 . . . . 0.0 110.115 -179.336 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.908 ' OG ' ' S1 ' ' A' ' 65' ' ' SF4 . 75.5 p -75.83 -69.95 0.46 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.086 -1.009 . . . . 0.0 109.326 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.674 ' HB3' ' S1 ' ' A' ' 65' ' ' SF4 . 12.4 p -58.25 -46.55 85.77 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.226 -0.922 . . . . 0.0 109.519 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.533 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 68.7 t -52.69 -41.73 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.364 -0.835 . . . . 0.0 109.916 -179.679 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.448 ' HB2' ' O ' ' A' ' 15' ' ' GLU . 7.4 tm-20 -66.49 -42.7 87.01 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.099 -1.001 . . . . 0.0 109.662 -179.634 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.888 HD11 HG21 ' A' ' 53' ' ' THR . 2.7 mp -82.06 11.76 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.294 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -176.18 68.67 0.25 Allowed Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.29 -0.881 . . . . 0.0 109.237 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -74.09 -0.32 9.4 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 124.076 1.566 . . . . 0.0 110.381 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.468 ' O ' ' HB3' ' A' ' 38' ' ' ASP . . . -112.98 -33.12 2.06 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.442 ' HA ' ' HB3' ' A' ' 38' ' ' ASP . . . -90.1 -46.46 8.46 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.147 -1.208 . . . . 0.0 109.449 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 1.148 ' CZ ' HG21 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -99.26 146.97 25.65 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.273 -0.892 . . . . 0.0 108.901 179.829 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.469 ' O ' ' CD1' ' A' ' 35' ' ' TYR . . . -169.86 125.02 0.8 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.105 -0.997 . . . . 0.0 109.946 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.562 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 6.3 ttp -58.43 152.87 16.94 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.174 -0.954 . . . . 0.0 109.289 179.557 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.637 ' O ' ' N ' ' A' ' 32' ' ' GLU . 0.6 OUTLIER -128.21 163.56 43.25 Favored Pre-proline 0 C--N 1.311 -1.092 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 179.181 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -85.43 -15.62 5.15 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 O-C-N 125.148 2.131 . . . . 0.0 108.513 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -92.41 -29.34 16.34 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 178.359 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.598 HG12 ' HB3' ' A' ' 28' ' ' ASP . 0.2 OUTLIER -103.31 -15.66 7.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 177.557 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.637 ' N ' ' O ' ' A' ' 28' ' ' ASP . 14.1 mt-10 44.08 31.7 0.56 Allowed 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 -177.111 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.537 ' C ' ' HA ' ' A' ' 27' ' ' MET . 2.5 mttp -158.26 152.82 24.64 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 119.344 -0.942 . . . . 0.0 110.483 -177.626 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.612 ' CB ' ' S2 ' ' A' ' 65' ' ' SF4 . . . -59.66 148.97 31.89 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.487 -0.758 . . . . 0.0 109.768 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.635 ' CE2' ' HB3' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -150.75 146.85 26.69 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.624 0.726 . . . . 0.0 109.519 179.296 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.981 ' HB ' HG23 ' A' ' 6' ' ' VAL . 2.4 t -89.57 97.82 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.077 -1.014 . . . . 0.0 108.448 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.635 ' HB3' ' CE2' ' A' ' 35' ' ' TYR . 1.3 pttp -108.08 -23.71 11.87 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.337 -0.852 . . . . 0.0 110.296 -179.26 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.52 ' N ' ' HG3' ' A' ' 37' ' ' LYS . 55.2 t0 -118.36 124.54 47.98 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.125 -0.984 . . . . 0.0 109.884 -179.334 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 15.5 m -86.22 -34.53 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.272 -0.892 . . . . 0.0 109.451 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.439 ' HG2' ' OD1' ' A' ' 38' ' ' ASP . 8.1 pm0 -81.9 -10.31 59.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.198 -0.938 . . . . 0.0 109.519 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -63.54 -18.55 61.41 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.418 ' HB1' ' HB2' ' A' ' 46' ' ' GLU . . . -151.93 132.28 13.72 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.248 -1.148 . . . . 0.0 109.521 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.45 155.09 19.05 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.26 -0.9 . . . . 0.0 109.727 -179.724 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.455 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 4.2 pt20 -49.46 -44.94 46.17 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.479 -0.763 . . . . 0.0 109.565 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.431 ' O ' ' HG3' ' A' ' 49' ' ' GLU . 7.6 mm-40 -64.12 -17.96 63.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.215 -0.928 . . . . 0.0 109.019 179.718 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.418 ' HB2' ' HB1' ' A' ' 42' ' ' ALA . 47.9 mt-10 -90.73 -46.99 7.91 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 179.03 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.459 ' O ' ' HB2' ' A' ' 51' ' ' MET . 2.3 t -57.85 -38.6 66.81 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.438 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.455 ' HB2' ' O ' ' A' ' 44' ' ' GLN . 0.1 OUTLIER -68.19 -60.99 2.06 Favored 'General case' 0 C--N 1.307 -1.257 0 O-C-N 121.534 -0.729 . . . . 0.0 109.629 179.721 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.431 ' HG3' ' O ' ' A' ' 45' ' ' GLU . 2.3 mt-10 -51.5 -40.67 60.01 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.172 -0.955 . . . . 0.0 108.877 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.662 ' HA ' HD13 ' A' ' 20' ' ' ILE . . . -69.28 -20.91 63.91 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.521 -0.737 . . . . 0.0 109.024 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.747 ' HE3' HG12 ' A' ' 59' ' ' ILE . 0.7 OUTLIER -82.86 -51.03 8.0 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.522 -0.736 . . . . 0.0 109.522 -179.482 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -57.32 -32.11 66.36 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.308 -0.87 . . . . 0.0 109.444 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.888 HG21 HD11 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -60.61 -32.05 71.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.341 -0.849 . . . . 0.0 109.804 -179.834 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.478 ' HB3' ' HG3' ' A' ' 57' ' ' GLN . 11.4 t -58.28 128.75 82.7 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.18 -0.95 . . . . 0.0 109.429 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -72.26 -53.94 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 123.931 1.49 . . . . 0.0 109.621 179.589 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 27.9 t -79.63 -15.18 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.478 ' HG3' ' HB3' ' A' ' 54' ' ' CYS . 0.5 OUTLIER 45.84 79.4 0.05 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.413 -0.804 . . . . 0.0 109.789 179.783 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.448 ' SG ' ' HB2' ' A' ' 10' ' ' GLU . 0.9 OUTLIER -92.58 15.86 13.35 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.354 -0.841 . . . . 0.0 109.043 179.517 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.908 ' HA ' HG13 ' A' ' 6' ' ' VAL . 4.0 tp -64.33 159.21 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.34 -0.85 . . . . 0.0 109.448 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.53 ' O ' ' HB2' ' A' ' 61' ' ' TRP . 6.5 m80 -135.73 -32.05 0.92 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.227 -0.921 . . . . 0.0 110.358 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.555 ' HA ' ' CB ' ' A' ' 4' ' ' PHE . 55.7 m95 67.51 163.75 0.2 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.477 -0.764 . . . . 0.0 109.244 -179.025 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.573 ' N ' ' HA ' ' A' ' 4' ' ' PHE . 14.8 tt0 -142.8 95.72 2.82 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.35 -0.844 . . . . 0.0 109.342 -179.462 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -57.99 -42.5 85.3 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.298 -0.876 . . . . 0.0 109.361 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 . . . . . 0 N--CA 1.491 1.578 0 O-C-N 121.316 -0.865 . . . . 0.0 109.388 -179.937 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 65' ' ' SF4 . . . . . 0.908 ' S1 ' ' OG ' ' A' ' 16' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.212 0.53 . . . . 0.0 109.622 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 9.1 ttm180 -92.27 176.85 6.33 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.185 -0.947 . . . . 0.0 109.614 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.501 ' O ' ' HB3' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -140.85 -158.01 0.82 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.215 -0.928 . . . . 0.0 109.443 -179.98 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.644 ' CE1' HG12 ' A' ' 39' ' ' VAL . 33.6 p90 168.0 -175.56 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.469 -0.769 . . . . 0.0 109.323 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.489 ' O ' HG13 ' A' ' 59' ' ' ILE . 28.0 p90 167.6 -175.62 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 106.541 -1.652 . . . . 0.0 106.541 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 1.179 HG21 ' CZ ' ' A' ' 25' ' ' PHE . 0.6 OUTLIER -131.25 176.31 9.2 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.073 0 C-N-CA 117.467 -1.693 . . . . 0.0 110.952 -179.945 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.625 ' H ' HG12 ' A' ' 6' ' ' VAL . 1.1 m-20 -127.1 90.52 3.16 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-O 121.845 0.831 . . . . 0.0 109.118 179.333 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.561 ' CG ' ' O ' ' A' ' 34' ' ' ALA . 1.5 mp0 -63.63 44.1 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.704 179.266 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.541 ' N ' ' O ' ' A' ' 7' ' ' ASP . 0.2 OUTLIER -99.93 -20.75 15.97 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 179.369 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.816 ' OE1' HG21 ' A' ' 56' ' ' VAL . 2.8 mm-40 -121.49 -7.49 9.18 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.663 -0.648 . . . . 0.0 109.468 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.659 ' SG ' ' HG2' ' A' ' 33' ' ' LYS . 45.0 t -54.1 112.41 0.96 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.19 -0.944 . . . . 0.0 109.692 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.699 ' O ' ' HB2' ' A' ' 13' ' ' ALA . 13.8 pt -73.65 -47.61 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.241 -0.912 . . . . 0.0 109.601 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.699 ' HB2' ' O ' ' A' ' 12' ' ' ILE . . . 164.77 -28.92 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.095 -1.003 . . . . 0.0 110.147 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 1.023 ' O ' ' S2 ' ' A' ' 65' ' ' SF4 . 0.1 OUTLIER -46.33 156.52 0.17 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.966 -1.084 . . . . 0.0 109.727 -179.534 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.421 ' O ' ' C ' ' A' ' 16' ' ' SER . 0.7 OUTLIER -120.02 20.45 12.12 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.406 -0.809 . . . . 0.0 109.858 -179.643 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.923 ' O ' HD12 ' A' ' 20' ' ' ILE . 0.5 OUTLIER -43.89 -52.22 7.0 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.199 -0.938 . . . . 0.0 109.414 179.943 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.554 ' SG ' ' N ' ' A' ' 18' ' ' VAL . 19.8 p -59.34 -52.67 64.65 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.308 -0.87 . . . . 0.0 109.453 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.554 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 5.7 t -47.17 -34.92 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.128 -0.983 . . . . 0.0 109.414 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -73.53 -34.67 65.33 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.125 -0.984 . . . . 0.0 109.324 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.929 HD13 ' HA ' ' A' ' 50' ' ' ALA . 2.7 mp -84.9 10.96 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 178.313 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.681 ' HB1' ' HB2' ' A' ' 42' ' ' ALA . . . -174.75 65.71 0.27 Allowed Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 121.377 -0.827 . . . . 0.0 109.2 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -71.81 56.15 2.33 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 O-C-N 124.171 1.616 . . . . 0.0 110.371 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.495 ' O ' ' HB3' ' A' ' 38' ' ' ASP . . . -167.47 -55.09 0.03 OUTLIER Glycine 0 N--CA 1.488 2.109 0 N-CA-C 108.543 -1.823 . . . . 0.0 108.543 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.549 ' HB2' ' O ' ' A' ' 38' ' ' ASP . . . -78.29 -38.87 41.46 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.439 -1.036 . . . . 0.0 109.112 179.402 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 1.179 ' CZ ' HG21 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -97.14 134.23 40.74 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.136 -0.978 . . . . 0.0 108.88 179.693 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.502 ' O ' ' CD1' ' A' ' 35' ' ' TYR . . . -163.55 122.63 2.04 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.173 -0.954 . . . . 0.0 109.8 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.55 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 30.5 ttm -60.32 149.52 33.33 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.187 -0.946 . . . . 0.0 109.235 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.602 ' O ' ' N ' ' A' ' 32' ' ' GLU . 2.4 t0 -126.47 160.73 56.59 Favored Pre-proline 0 C--N 1.311 -1.073 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 179.533 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.489 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 43.9 Cg_endo -84.82 -17.12 5.06 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 O-C-N 124.765 1.929 . . . . 0.0 108.49 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -90.78 -30.45 17.01 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 178.009 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.566 HD12 ' HB3' ' A' ' 35' ' ' TYR . 0.8 OUTLIER -106.74 -0.18 9.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.092 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.602 ' N ' ' O ' ' A' ' 28' ' ' ASP . 8.2 mt-10 27.85 43.43 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.506 0.67 . . . . 0.0 109.983 -179.582 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.659 ' HG2' ' SG ' ' A' ' 11' ' ' CYS . 2.0 mttt -169.19 146.14 3.52 Favored 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 119.475 -0.89 . . . . 0.0 110.273 -179.31 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.561 ' O ' ' CG ' ' A' ' 8' ' ' GLN . . . -58.01 140.87 51.48 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.436 -0.79 . . . . 0.0 109.183 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.619 ' O ' ' CD1' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -146.26 146.49 30.76 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-O 121.902 0.858 . . . . 0.0 110.084 179.742 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.962 ' HB ' HG23 ' A' ' 6' ' ' VAL . 2.7 t -85.67 100.82 9.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -179.581 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.584 ' HG2' ' CZ ' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -116.63 -34.26 4.59 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.456 -0.777 . . . . 0.0 110.103 -179.083 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.549 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 17.0 t0 -104.58 85.56 2.35 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.217 -0.927 . . . . 0.0 109.801 -179.263 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.644 HG12 ' CE1' ' A' ' 4' ' ' PHE . 14.5 m -53.52 -29.21 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.293 -0.879 . . . . 0.0 109.288 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -73.02 -14.45 61.43 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.338 -0.851 . . . . 0.0 109.375 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.435 ' HA3' ' N ' ' A' ' 24' ' ' ALA . . . -71.88 -25.4 74.94 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.681 ' HB2' ' HB1' ' A' ' 21' ' ' ALA . . . -142.24 155.43 45.25 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.317 -1.107 . . . . 0.0 109.2 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -96.05 -166.73 1.47 Allowed 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.064 -1.022 . . . . 0.0 109.875 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.478 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 22.0 tt0 -72.66 -53.7 11.08 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.423 ' OE2' ' NE2' ' A' ' 44' ' ' GLN . 18.7 mm-40 -62.98 -19.63 64.51 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.397 -0.814 . . . . 0.0 109.252 179.581 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -88.25 -45.85 9.72 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 178.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.3 t -62.94 -27.23 42.75 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 178.17 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.478 ' HB2' ' O ' ' A' ' 44' ' ' GLN . 0.2 OUTLIER -71.15 -66.1 0.66 Allowed 'General case' 0 C--N 1.309 -1.192 0 O-C-N 121.635 -0.666 . . . . 0.0 109.302 179.406 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -47.29 -49.0 24.7 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.367 -0.833 . . . . 0.0 109.022 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.929 ' HA ' HD13 ' A' ' 20' ' ' ILE . . . -57.44 -40.18 77.89 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.251 -0.905 . . . . 0.0 108.761 179.429 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.633 ' HE2' HD13 ' A' ' 59' ' ' ILE . 22.4 ttm -69.05 -14.15 62.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.413 -0.804 . . . . 0.0 109.186 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -99.77 -3.99 31.57 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.341 -0.849 . . . . 0.0 109.465 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.437 ' O ' ' HB3' ' A' ' 16' ' ' SER . 2.4 m -113.67 46.01 1.35 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.15 -0.969 . . . . 0.0 109.784 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.789 ' SG ' ' N ' ' A' ' 57' ' ' GLN . 53.6 t -123.05 143.1 39.88 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.225 -0.922 . . . . 0.0 109.142 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.603 ' HD2' ' SG ' ' A' ' 54' ' ' CYS . 44.1 Cg_endo -71.35 -35.33 8.51 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.936 1.493 . . . . 0.0 110.037 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.816 HG21 ' OE1' ' A' ' 10' ' ' GLU . 43.5 t -124.45 -0.98 5.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.426 -0.796 . . . . 0.0 109.185 179.488 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.789 ' N ' ' SG ' ' A' ' 54' ' ' CYS . 6.4 mt-30 60.94 -80.41 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.266 -0.896 . . . . 0.0 109.459 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.5 ' SG ' ' HB3' ' A' ' 10' ' ' GLU . 0.3 OUTLIER 55.59 23.4 6.03 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.075 -1.016 . . . . 0.0 108.825 179.985 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.87 ' CB ' HG13 ' A' ' 6' ' ' VAL . 7.8 tt -124.12 154.31 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.213 -0.929 . . . . 0.0 110.051 -179.313 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.53 ' CG ' ' C ' ' A' ' 59' ' ' ILE . 10.5 m80 -157.36 157.55 34.29 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.426 -0.796 . . . . 0.0 109.241 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.511 ' HA ' ' HA ' ' A' ' 4' ' ' PHE . 40.1 m95 -83.32 179.53 7.66 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.095 -1.003 . . . . 0.0 109.394 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.485 ' O ' ' CB ' ' A' ' 3' ' ' LYS . 1.1 tt0 -149.5 108.04 3.81 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.288 -0.883 . . . . 0.0 109.408 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -104.68 -56.88 2.11 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.178 -0.951 . . . . 0.0 109.546 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 O-C-N 121.328 -0.858 . . . . 0.0 109.508 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' SF4 . . . . . 1.023 ' S2 ' ' O ' ' A' ' 14' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.436 ' O ' ' OD1' ' A' ' 63' ' ' ASP . . . . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.15 76.18 1.53 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.272 -0.893 . . . . 0.0 109.676 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.483 ' O ' ' HB3' ' A' ' 4' ' ' PHE . 1.1 tttt -97.85 -161.81 0.9 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.297 -0.877 . . . . 0.0 109.08 179.68 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.651 ' CE1' HG12 ' A' ' 39' ' ' VAL . 9.3 p90 167.57 179.56 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.283 -0.886 . . . . 0.0 109.307 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.46 ' HB3' ' O ' ' A' ' 4' ' ' PHE . 55.3 p90 176.16 -171.63 0.08 Allowed 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.354 -0.841 . . . . 0.0 109.272 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 1.046 HG21 ' CZ ' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -140.09 152.23 21.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 179.718 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.609 ' O ' ' N ' ' A' ' 9' ' ' ASP . 53.6 t0 -99.56 0.01 41.4 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 118.628 -1.229 . . . . 0.0 111.692 -178.746 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.583 ' NE2' ' O ' ' A' ' 7' ' ' ASP . 1.7 pm0 42.56 14.92 0.01 OUTLIER 'General case' 0 C--N 1.273 -2.753 0 CA-C-O 121.29 0.567 . . . . 0.0 110.935 179.143 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.609 ' N ' ' O ' ' A' ' 7' ' ' ASP . 0.8 OUTLIER -75.98 -50.66 14.25 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.315 -0.866 . . . . 0.0 109.142 -179.295 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.724 ' HB3' HG21 ' A' ' 56' ' ' VAL . 1.1 tp10 -85.66 11.93 9.85 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.457 -0.777 . . . . 0.0 109.041 179.528 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 31.4 t -66.04 111.4 3.35 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.246 -0.909 . . . . 0.0 110.003 -179.482 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.523 HG13 ' N ' ' A' ' 13' ' ' ALA . 11.9 pt -73.53 -139.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.443 -0.786 . . . . 0.0 109.221 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.523 ' N ' HG13 ' A' ' 12' ' ' ILE . . . -102.99 28.34 6.32 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.942 -1.099 . . . . 0.0 110.003 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 1.038 ' O ' ' S2 ' ' A' ' 65' ' ' SF4 . 0.0 OUTLIER -112.0 159.49 18.39 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.922 -1.111 . . . . 0.0 109.78 179.67 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.864 ' HA ' ' S2 ' ' A' ' 65' ' ' SF4 . 0.0 OUTLIER -136.25 20.4 3.19 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.401 -0.812 . . . . 0.0 109.374 -179.995 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.442 ' C ' ' O ' ' A' ' 15' ' ' GLU . 59.6 p -41.83 -44.33 3.29 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.521 -0.737 . . . . 0.0 109.387 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.615 ' SG ' ' CD2' ' A' ' 25' ' ' PHE . 17.4 p -58.33 -42.86 87.75 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.307 -0.871 . . . . 0.0 109.095 179.466 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.444 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 39.8 t -56.8 -30.5 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.33 -0.856 . . . . 0.0 109.493 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -81.58 -38.43 26.13 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.171 -0.955 . . . . 0.0 109.293 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.606 HG21 ' N ' ' A' ' 50' ' ' ALA . 0.3 OUTLIER -74.64 2.98 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.152 -0.967 . . . . 0.0 108.827 178.565 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.79 ' HB1' ' HB2' ' A' ' 42' ' ' ALA . . . -161.86 70.71 2.38 Favored Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.185 -0.947 . . . . 0.0 109.381 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -71.0 68.09 2.42 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 124.133 1.596 . . . . 0.0 110.277 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 165.66 -35.85 0.26 Allowed Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.989 -1.644 . . . . 0.0 108.989 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.525 ' CB ' ' O ' ' A' ' 38' ' ' ASP . . . -91.81 -46.97 7.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.454 -1.027 . . . . 0.0 109.176 179.553 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 1.046 ' CZ ' HG21 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -100.63 139.05 36.86 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.368 -0.832 . . . . 0.0 108.885 179.768 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.499 ' O ' ' CD1' ' A' ' 35' ' ' TYR . . . -169.34 124.03 0.83 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.152 -0.967 . . . . 0.0 109.759 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.554 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER -61.17 152.55 28.34 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.007 -1.058 . . . . 0.0 108.881 179.665 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.6 ' O ' ' N ' ' A' ' 32' ' ' GLU . 2.5 t0 -128.63 159.82 66.01 Favored Pre-proline 0 C--N 1.308 -1.204 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.479 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 44.9 Cg_endo -84.6 -16.23 5.73 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 O-C-N 124.562 1.822 . . . . 0.0 108.346 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -91.96 -27.81 17.63 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 177.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.684 HD12 ' HB3' ' A' ' 35' ' ' TYR . 0.7 OUTLIER -110.46 2.41 9.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.151 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.6 ' N ' ' O ' ' A' ' 28' ' ' ASP . 2.6 mm-40 26.22 44.01 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.466 0.651 . . . . 0.0 110.14 -179.543 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.532 ' CG ' ' O ' ' A' ' 32' ' ' GLU . 0.2 OUTLIER -172.23 149.19 2.24 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 119.175 -1.01 . . . . 0.0 109.999 -179.186 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.554 ' HA ' ' HA ' ' A' ' 27' ' ' MET . . . -56.8 144.67 32.1 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.433 -0.792 . . . . 0.0 110.158 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.684 ' HB3' HD12 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -148.78 140.79 23.85 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.839 0.828 . . . . 0.0 110.173 178.932 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.887 ' HB ' HG23 ' A' ' 6' ' ' VAL . 2.8 t -87.44 90.19 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 120.98 -1.075 . . . . 0.0 108.112 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.606 ' HB3' ' CE2' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -101.28 -7.79 22.7 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.333 -0.854 . . . . 0.0 110.588 -178.75 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.525 ' O ' ' CB ' ' A' ' 24' ' ' ALA . 59.6 t0 -138.16 93.6 2.78 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.991 -1.068 . . . . 0.0 109.952 -179.6 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.651 HG12 ' CE1' ' A' ' 4' ' ' PHE . 17.7 m -58.48 -29.5 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.298 -0.877 . . . . 0.0 109.017 179.459 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -76.28 -17.6 59.38 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.303 -0.873 . . . . 0.0 109.251 179.794 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -69.55 -8.65 60.28 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.79 ' HB2' ' HB1' ' A' ' 21' ' ' ALA . . . -155.09 119.56 4.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.286 -1.126 . . . . 0.0 109.289 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.659 ' O ' HG23 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -49.39 174.99 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.319 -0.863 . . . . 0.0 109.812 -179.747 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.427 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 6.3 tm0? -68.16 -42.48 79.98 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.558 -0.714 . . . . 0.0 109.478 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.6 mm-40 -66.7 -13.8 61.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.101 -0.999 . . . . 0.0 108.963 179.562 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -96.49 -43.48 7.6 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 178.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.67 HG23 ' O ' ' A' ' 42' ' ' ALA . 55.5 t -58.2 -51.61 69.0 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 178.31 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.427 ' HB2' ' O ' ' A' ' 44' ' ' GLN . 0.2 OUTLIER -65.46 -52.6 51.88 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.615 -0.678 . . . . 0.0 109.57 179.387 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -47.73 -48.63 29.59 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.207 -0.933 . . . . 0.0 109.234 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.606 ' N ' HG21 ' A' ' 20' ' ' ILE . . . -65.94 -23.64 66.65 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.199 -0.938 . . . . 0.0 109.001 179.591 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.995 ' CG ' HG21 ' A' ' 59' ' ' ILE . 35.0 ttm -76.16 -14.83 60.15 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.345 -0.847 . . . . 0.0 109.509 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -98.15 -25.32 14.95 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.218 -0.926 . . . . 0.0 109.71 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.75 -19.17 60.33 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.18 -0.95 . . . . 0.0 109.948 -179.617 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.747 ' SG ' ' HD2' ' A' ' 55' ' ' PRO . 9.2 t -70.57 145.03 92.17 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.071 -1.018 . . . . 0.0 109.702 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.747 ' HD2' ' SG ' ' A' ' 54' ' ' CYS . 43.4 Cg_endo -73.44 -86.9 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.004 1.529 . . . . 0.0 109.505 179.247 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.724 HG21 ' HB3' ' A' ' 10' ' ' GLU . 27.8 m -56.03 -31.28 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 120.981 -1.074 . . . . 0.0 108.168 178.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.497 ' O ' ' N ' ' A' ' 59' ' ' ILE . 4.1 tt0 68.97 52.41 0.51 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.566 -0.709 . . . . 0.0 110.361 179.146 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.784 ' O ' HG12 ' A' ' 6' ' ' VAL . 0.5 OUTLIER -68.26 65.5 0.11 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.055 -1.028 . . . . 0.0 108.804 179.166 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.995 HG21 ' CG ' ' A' ' 51' ' ' MET . 0.5 OUTLIER -131.59 148.1 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.229 -0.919 . . . . 0.0 110.219 -179.262 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.505 ' N ' HG13 ' A' ' 59' ' ' ILE . 1.1 m80 -148.74 129.46 14.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.324 -0.86 . . . . 0.0 109.431 179.705 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.57 ' HA ' ' HA ' ' A' ' 4' ' ' PHE . 54.3 m95 -68.27 161.15 27.88 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.266 -0.896 . . . . 0.0 109.256 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.517 ' N ' ' HA ' ' A' ' 4' ' ' PHE . 24.2 tt0 -129.71 119.83 24.13 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.204 -0.935 . . . . 0.0 109.696 -179.262 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 1' ' ' ALA . 4.9 m-20 -112.65 30.47 7.1 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.277 -0.89 . . . . 0.0 109.343 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.337 -0.852 . . . . 0.0 109.452 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' SF4 . . . . . 1.038 ' S2 ' ' O ' ' A' ' 14' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.29 0.566 . . . . 0.0 109.478 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 13.3 mtm180 -59.56 104.01 0.24 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.258 -0.901 . . . . 0.0 109.424 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.48 ' HB3' ' HB3' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -126.28 -152.8 0.53 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.234 -0.916 . . . . 0.0 109.645 -179.879 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.919 ' CZ ' HG12 ' A' ' 39' ' ' VAL . 23.4 p90 175.82 176.67 0.23 Allowed 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.514 ' CE1' ' HB2' ' A' ' 62' ' ' GLU . 17.4 p90 172.45 -168.42 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 105.747 -1.946 . . . . 0.0 105.747 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.854 HG13 ' HA ' ' A' ' 59' ' ' ILE . 4.4 t -146.54 159.72 10.42 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.236 0 C-N-CA 116.724 -1.99 . . . . 0.0 111.739 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.531 ' N ' HG12 ' A' ' 6' ' ' VAL . 39.1 t70 -106.16 78.44 1.31 Allowed 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.342 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.563 ' CG ' ' O ' ' A' ' 34' ' ' ALA . 5.3 mp0 -43.34 -19.24 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.984 179.67 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.525 ' N ' ' O ' ' A' ' 7' ' ' ASP . 0.1 OUTLIER -56.51 -35.56 68.17 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.163 -0.96 . . . . 0.0 108.828 -179.898 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.5 ' HB3' ' HB3' ' A' ' 58' ' ' CYS . 0.6 OUTLIER -81.96 -31.5 31.17 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.656 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.434 ' C ' ' O ' ' A' ' 10' ' ' GLU . 36.5 t -42.65 143.09 0.73 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.362 -0.836 . . . . 0.0 109.503 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.705 ' O ' ' HB2' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -98.14 -45.25 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.27 -0.893 . . . . 0.0 109.675 -179.603 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.705 ' HB2' ' O ' ' A' ' 12' ' ' ILE . . . 162.41 -28.84 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.24 -0.912 . . . . 0.0 109.571 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 1.082 ' O ' ' S2 ' ' A' ' 65' ' ' SF4 . 0.1 OUTLIER -56.09 156.34 5.58 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.16 -0.962 . . . . 0.0 109.499 -179.725 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.436 ' O ' ' C ' ' A' ' 16' ' ' SER . 31.3 mt-10 -116.97 20.94 13.59 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.276 -0.89 . . . . 0.0 109.68 -179.591 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.436 ' C ' ' O ' ' A' ' 15' ' ' GLU . 70.1 m -44.45 -63.79 0.82 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.226 -0.921 . . . . 0.0 109.073 179.755 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.647 ' SG ' ' N ' ' A' ' 18' ' ' VAL . 17.8 p -49.13 -54.33 16.75 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.32 -0.862 . . . . 0.0 109.151 179.585 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.647 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 48.4 t -43.43 -46.1 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.442 -0.786 . . . . 0.0 109.199 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -63.65 -34.5 77.99 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.155 -0.966 . . . . 0.0 109.146 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.592 HG22 ' O ' ' A' ' 20' ' ' ILE . 5.6 mt -87.51 14.42 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.137 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -171.03 65.25 0.43 Allowed Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.486 -0.759 . . . . 0.0 109.257 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -71.15 56.51 2.01 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 124.161 1.611 . . . . 0.0 110.147 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.491 ' C ' ' HB3' ' A' ' 38' ' ' ASP . . . -177.86 -63.35 0.07 OUTLIER Glycine 0 N--CA 1.488 2.148 0 N-CA-C 108.832 -1.707 . . . . 0.0 108.832 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.758 ' HB2' ' O ' ' A' ' 38' ' ' ASP . . . -66.56 -42.04 87.7 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.298 -1.119 . . . . 0.0 108.453 179.443 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.621 ' HZ ' HG11 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -101.23 132.79 46.57 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 118.757 -1.177 . . . . 0.0 108.949 179.45 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.624 ' HB3' ' HE1' ' A' ' 35' ' ' TYR . . . -161.49 130.87 4.64 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.434 -0.791 . . . . 0.0 109.358 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.535 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 4.0 ptt? -71.68 152.2 43.02 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.193 -0.942 . . . . 0.0 109.46 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.632 ' O ' ' N ' ' A' ' 32' ' ' GLU . 2.0 t0 -126.0 161.21 52.88 Favored Pre-proline 0 C--N 1.31 -1.118 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 179.002 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.483 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 45.0 Cg_endo -85.18 -17.9 4.4 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 O-C-N 124.814 1.955 . . . . 0.0 108.596 -179.468 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.3 -28.62 18.64 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 177.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.536 HG12 ' CB ' ' A' ' 28' ' ' ASP . 0.9 OUTLIER -107.17 -3.92 10.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 177.687 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.632 ' N ' ' O ' ' A' ' 28' ' ' ASP . 1.6 mt-10 31.41 37.47 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -179.271 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.548 ' CB ' ' HB3' ' A' ' 8' ' ' GLN . 19.4 mmtp -161.91 148.22 13.68 Favored 'General case' 0 N--CA 1.502 2.17 0 C-N-CA 119.499 -0.881 . . . . 0.0 110.753 -178.673 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.563 ' O ' ' CG ' ' A' ' 8' ' ' GLN . . . -61.58 138.45 58.29 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.416 -0.802 . . . . 0.0 110.167 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.76 ' CE2' ' HG3' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -132.58 144.57 50.48 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-O 122.262 1.029 . . . . 0.0 110.511 179.881 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.655 ' CG2' HG23 ' A' ' 6' ' ' VAL . 2.4 t -86.4 92.26 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 120.303 -1.498 . . . . 0.0 109.242 -178.81 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.76 ' HG3' ' CE2' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -107.55 -53.31 2.64 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.436 -0.79 . . . . 0.0 111.013 -179.006 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.758 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 46.9 t0 -85.77 76.07 9.97 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 119.746 -0.781 . . . . 0.0 110.782 -177.224 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.919 HG12 ' CZ ' ' A' ' 4' ' ' PHE . 27.5 m -49.94 -31.36 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.327 -0.858 . . . . 0.0 109.34 179.279 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -79.55 -6.92 58.02 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.327 -0.858 . . . . 0.0 109.476 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -85.85 5.38 84.01 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -153.35 116.46 4.58 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.179 -1.189 . . . . 0.0 109.644 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.869 ' O ' HG23 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -64.5 163.88 12.65 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.243 -0.911 . . . . 0.0 109.599 179.971 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.46 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 3.4 tt0 -49.8 -44.14 48.89 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.356 -0.84 . . . . 0.0 109.381 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.412 ' O ' ' HB2' ' A' ' 49' ' ' GLU . 72.7 mm-40 -67.87 -8.9 40.29 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.18 -0.95 . . . . 0.0 109.187 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.457 ' OE2' ' OG ' ' A' ' 43' ' ' SER . 14.3 mt-10 -99.58 -43.12 6.62 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 106.66 -1.608 . . . . 0.0 106.66 179.112 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.869 HG23 ' O ' ' A' ' 43' ' ' SER . 1.9 t -61.92 -42.73 95.84 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.398 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.46 ' HB2' ' O ' ' A' ' 44' ' ' GLN . 0.2 OUTLIER -73.49 -50.1 23.25 Favored 'General case' 0 C--N 1.308 -1.236 0 O-C-N 121.59 -0.694 . . . . 0.0 109.282 179.383 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.476 ' HB3' HD13 ' A' ' 20' ' ' ILE . 13.3 mm-40 -53.23 -45.95 68.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.224 -0.923 . . . . 0.0 108.77 179.475 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.554 ' HB2' ' HB ' ' A' ' 20' ' ' ILE . . . -70.29 -13.45 62.17 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.37 -0.831 . . . . 0.0 108.785 179.231 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.53 ' HA ' HG21 ' A' ' 59' ' ' ILE . 0.4 OUTLIER -80.72 -21.9 40.76 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.434 -0.791 . . . . 0.0 109.492 179.98 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -96.37 -34.34 11.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.197 -0.94 . . . . 0.0 109.605 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.477 ' OG1' ' HA ' ' A' ' 50' ' ' ALA . 0.1 OUTLIER -50.71 -54.82 20.11 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.252 -0.905 . . . . 0.0 109.747 179.975 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.535 ' SG ' ' HD2' ' A' ' 55' ' ' PRO . 3.8 t -46.36 140.86 5.21 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.192 -0.943 . . . . 0.0 109.912 -179.61 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.535 ' HD2' ' SG ' ' A' ' 54' ' ' CYS . 44.8 Cg_endo -77.03 -62.99 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 124.123 1.591 . . . . 0.0 109.843 179.33 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 33.0 t -74.4 -20.74 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.335 -0.853 . . . . 0.0 108.868 179.377 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.481 ' NE2' ' O ' ' A' ' 51' ' ' MET . 3.5 mt-30 64.78 94.24 0.06 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.343 -0.848 . . . . 0.0 109.586 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.5 ' HB3' ' HB3' ' A' ' 10' ' ' GLU . 0.1 OUTLIER -100.42 -28.0 13.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.304 -0.872 . . . . 0.0 108.821 179.795 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.854 ' HA ' HG13 ' A' ' 6' ' ' VAL . 5.7 tt -60.88 151.06 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.458 -0.776 . . . . 0.0 109.976 -179.654 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.49 ' NE2' ' CE2' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -159.92 -178.55 7.11 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.454 -0.779 . . . . 0.0 108.9 179.509 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.506 ' HA ' ' HA ' ' A' ' 4' ' ' PHE . 66.7 m95 -101.3 165.02 11.49 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.118 -0.989 . . . . 0.0 109.768 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.514 ' HB2' ' CE1' ' A' ' 5' ' ' TYR . 41.2 tt0 -128.83 107.82 9.95 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.431 -0.793 . . . . 0.0 109.169 -179.629 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -103.07 62.91 0.8 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.263 -0.898 . . . . 0.0 109.508 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 . . . . . 0 N--CA 1.491 1.614 0 O-C-N 121.203 -0.936 . . . . 0.0 109.405 -179.973 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 65' ' ' SF4 . . . . . 1.082 ' S2 ' ' O ' ' A' ' 14' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.479 ' HB3' ' HB3' ' A' ' 62' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.576 ' CB ' ' HA ' ' A' ' 61' ' ' TRP . 31.6 p90 179.78 -167.39 0.09 Allowed 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.173 -0.954 . . . . 0.0 109.208 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.735 ' HA ' HG11 ' A' ' 36' ' ' VAL . 39.3 p90 173.5 -166.79 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 106.87 -1.529 . . . . 0.0 106.87 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.909 HG11 ' HZ ' ' A' ' 25' ' ' PHE . 2.5 t -152.14 166.76 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 C-N-CA 117.532 -1.667 . . . . 0.0 112.119 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.582 ' H ' HG12 ' A' ' 6' ' ' VAL . 0.8 OUTLIER -106.76 68.57 0.74 Allowed 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 178.561 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.531 ' HB3' ' O ' ' A' ' 34' ' ' ALA . 0.6 OUTLIER -47.72 -15.59 0.06 Allowed 'General case' 0 C--N 1.297 -1.701 0 CA-C-O 121.344 0.593 . . . . 0.0 109.495 179.258 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.465 ' N ' ' O ' ' A' ' 7' ' ' ASP . 0.2 OUTLIER -65.17 -33.12 75.25 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.697 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.53 ' HB3' ' HB3' ' A' ' 58' ' ' CYS . 0.3 OUTLIER -93.47 0.74 56.87 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 179.168 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.449 ' HB3' ' O ' ' A' ' 8' ' ' GLN . 10.1 t -66.84 129.32 39.49 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.081 -1.012 . . . . 0.0 110.073 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.493 HG13 ' N ' ' A' ' 13' ' ' ALA . 43.2 pt -88.78 -143.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.486 -0.759 . . . . 0.0 109.639 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.493 ' N ' HG13 ' A' ' 12' ' ' ILE . . . -107.56 52.92 0.7 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.076 -1.015 . . . . 0.0 109.901 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.453 ' SG ' ' OG ' ' A' ' 16' ' ' SER . 0.1 OUTLIER -134.53 155.18 50.86 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.039 -1.038 . . . . 0.0 109.673 179.661 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.42 ' O ' ' C ' ' A' ' 16' ' ' SER . 0.2 OUTLIER -120.46 18.89 12.09 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.319 -0.863 . . . . 0.0 109.798 -179.555 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.671 ' HB3' HG21 ' A' ' 53' ' ' THR . 0.7 OUTLIER -44.15 -51.13 8.34 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.195 -0.941 . . . . 0.0 109.346 179.995 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.823 ' SG ' ' CD2' ' A' ' 25' ' ' PHE . 14.6 p -62.02 -54.93 34.63 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.316 -0.865 . . . . 0.0 109.366 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.626 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 98.7 t -43.92 -34.22 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.279 -0.888 . . . . 0.0 109.501 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.42 -36.78 66.01 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.062 -1.024 . . . . 0.0 109.025 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.572 HD13 ' HB3' ' A' ' 49' ' ' GLU . 5.0 mt -87.37 16.13 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 178.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -174.43 63.64 0.26 Allowed Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.344 -0.848 . . . . 0.0 109.672 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -75.36 51.76 3.0 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 124.04 1.547 . . . . 0.0 110.34 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.428 ' C ' ' HA3' ' A' ' 41' ' ' GLY . . . -166.0 -41.63 0.02 OUTLIER Glycine 0 N--CA 1.489 2.213 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.574 ' HB2' ' H ' ' A' ' 42' ' ' ALA . . . -92.31 -46.8 7.52 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.434 -1.039 . . . . 0.0 108.678 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.909 ' HZ ' HG11 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -89.7 138.09 31.77 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.387 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.45 ' O ' ' CD1' ' A' ' 35' ' ' TYR . . . -173.57 126.31 0.4 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.103 -0.998 . . . . 0.0 109.58 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.565 ' HA ' ' C ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -63.82 153.01 37.98 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.166 -0.959 . . . . 0.0 109.841 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.605 ' O ' ' N ' ' A' ' 32' ' ' GLU . 2.2 t0 -129.59 163.67 45.09 Favored Pre-proline 0 C--O 1.209 -1.061 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.49 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 45.7 Cg_endo -83.63 -18.31 5.73 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 124.619 1.852 . . . . 0.0 107.961 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -84.17 -39.17 19.73 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 178.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.877 HD11 ' CD1' ' A' ' 35' ' ' TYR . 3.0 pt -101.51 -2.05 9.72 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 177.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.605 ' N ' ' O ' ' A' ' 28' ' ' ASP . 65.4 mt-10 34.66 34.53 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -179.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.578 ' O ' HD12 ' A' ' 31' ' ' ILE . 18.5 mttt -163.15 150.3 12.86 Favored 'General case' 0 N--CA 1.499 1.999 0 C-N-CA 119.408 -0.917 . . . . 0.0 110.374 -178.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.562 ' HA ' ' HA ' ' A' ' 27' ' ' MET . . . -62.48 143.88 56.62 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.515 -0.74 . . . . 0.0 110.489 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.877 ' CD1' HD11 ' A' ' 31' ' ' ILE . 1.2 p90 -155.25 158.02 38.18 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.735 HG11 ' HA ' ' A' ' 5' ' ' TYR . 14.5 p -67.51 68.44 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.818 -1.176 . . . . 0.0 108.833 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.679 ' HA ' ' CE2' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -49.95 -19.24 0.66 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.445 -0.785 . . . . 0.0 110.295 -179.691 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -165.95 99.72 0.65 Allowed 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.09 -1.006 . . . . 0.0 109.394 -179.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.503 ' HA ' ' CZ ' ' A' ' 4' ' ' PHE . 11.0 m -48.19 -29.65 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.419 -0.801 . . . . 0.0 109.764 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -85.12 -4.98 59.35 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.207 -0.933 . . . . 0.0 109.711 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.428 ' HA3' ' C ' ' A' ' 23' ' ' GLY . . . -67.02 -32.2 80.11 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.574 ' H ' ' HB2' ' A' ' 24' ' ' ALA . . . -128.24 163.04 25.59 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.212 -1.17 . . . . 0.0 109.279 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.557 ' O ' HG23 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -89.51 171.53 9.64 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.278 -0.889 . . . . 0.0 109.416 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.481 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 17.6 pt20 -68.51 -34.55 76.1 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.326 -0.859 . . . . 0.0 109.38 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -72.4 -23.9 61.17 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.311 -0.868 . . . . 0.0 109.322 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.469 ' OE2' ' OG ' ' A' ' 43' ' ' SER . 33.6 mt-10 -87.55 -41.14 13.69 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 178.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 43' ' ' SER . 38.5 t -63.37 -29.33 46.99 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 177.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.481 ' HB2' ' O ' ' A' ' 44' ' ' GLN . 0.5 OUTLIER -69.37 -64.65 0.83 Allowed 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.262 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.572 ' HB3' HD13 ' A' ' 20' ' ' ILE . 43.1 mt-10 -52.19 -39.76 60.59 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 119.467 -0.893 . . . . 0.0 108.786 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.515 ' HB2' ' HB ' ' A' ' 20' ' ' ILE . . . -62.78 -27.33 69.22 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.571 ' HG3' ' CG2' ' A' ' 59' ' ' ILE . 3.7 ttm -72.82 -43.57 62.53 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -55.36 -42.88 74.49 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.671 HG21 ' HB3' ' A' ' 16' ' ' SER . 0.1 OUTLIER -59.98 -160.23 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.419 -0.801 . . . . 0.0 109.195 179.803 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . 0.593 ' SG ' ' HD2' ' A' ' 55' ' ' PRO . 1.7 t 66.74 144.63 0.09 OUTLIER Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.151 -0.968 . . . . 0.0 109.381 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.593 ' HD2' ' SG ' ' A' ' 54' ' ' CYS . 43.2 Cg_endo -73.57 -61.04 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.97 1.511 . . . . 0.0 109.948 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.456 HG12 ' O ' ' A' ' 56' ' ' VAL . 12.2 t -102.86 14.73 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.368 -0.833 . . . . 0.0 108.778 179.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.578 ' HA ' ' HB3' ' A' ' 54' ' ' CYS . 0.4 OUTLIER 65.08 -73.31 0.06 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.389 -0.819 . . . . 0.0 109.806 -179.891 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.53 ' HB3' ' HB3' ' A' ' 10' ' ' GLU . 1.8 m 63.95 12.98 7.27 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.95 -1.094 . . . . 0.0 108.544 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.571 ' CG2' ' HG3' ' A' ' 51' ' ' MET . 11.3 tt -119.22 152.25 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.432 -0.792 . . . . 0.0 109.463 -179.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.524 ' CD2' ' O ' ' A' ' 59' ' ' ILE . 18.9 m80 -156.11 170.26 22.6 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.104 -0.998 . . . . 0.0 110.007 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.576 ' HA ' ' CB ' ' A' ' 4' ' ' PHE . 60.6 m95 -94.14 175.1 6.83 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.353 -0.842 . . . . 0.0 109.577 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.479 ' HB3' ' HB3' ' A' ' 3' ' ' LYS . 7.3 tt0 . . . . . 0 N--CA 1.488 1.465 0 O-C-N 121.404 -0.81 . . . . 0.0 109.357 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.522 ' HB3' ' HB3' ' A' ' 62' ' ' GLU . 13.6 tptt . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.561 ' CZ ' ' HB ' ' A' ' 39' ' ' VAL . 49.1 p90 176.39 176.38 0.29 Allowed 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.136 -0.977 . . . . 0.0 109.036 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.624 ' HA ' HG11 ' A' ' 36' ' ' VAL . 23.7 p90 175.66 -157.11 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 1.127 HG21 ' CZ ' ' A' ' 25' ' ' PHE . 0.2 OUTLIER -145.6 -170.57 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 C-N-CA 118.101 -1.439 . . . . 0.0 111.175 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.623 ' H ' HG12 ' A' ' 6' ' ' VAL . 0.6 OUTLIER -147.41 96.33 2.68 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.121 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.559 ' CG ' ' HB3' ' A' ' 33' ' ' LYS . 4.5 mp0 -64.67 40.08 0.02 OUTLIER 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.095 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.517 ' N ' ' O ' ' A' ' 7' ' ' ASP . 0.3 OUTLIER -99.03 -18.05 17.96 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.03 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.639 ' O ' HG11 ' A' ' 56' ' ' VAL . 0.5 OUTLIER -116.32 -9.29 11.56 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.701 -0.624 . . . . 0.0 109.621 -179.739 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.777 ' SG ' ' HG2' ' A' ' 33' ' ' LYS . 42.0 t -60.67 129.52 41.96 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.213 -0.929 . . . . 0.0 109.777 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.701 ' O ' ' HB2' ' A' ' 13' ' ' ALA . 14.3 pt -91.38 -45.32 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.413 -0.805 . . . . 0.0 109.271 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.701 ' HB2' ' O ' ' A' ' 12' ' ' ILE . . . 164.4 -29.9 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.279 -0.888 . . . . 0.0 110.024 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.491 ' SG ' ' HB2' ' A' ' 16' ' ' SER . 0.1 OUTLIER -49.16 154.8 0.75 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.938 -1.101 . . . . 0.0 109.377 -179.669 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.593 ' OE1' HG21 ' A' ' 18' ' ' VAL . 5.0 mm-40 -116.74 19.2 14.61 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.215 -0.928 . . . . 0.0 109.277 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.491 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 0.6 OUTLIER -43.93 -46.23 8.04 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.264 -0.897 . . . . 0.0 109.269 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.518 ' SG ' ' N ' ' A' ' 18' ' ' VAL . 19.1 p -66.21 -47.56 73.44 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.394 -0.816 . . . . 0.0 109.274 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.593 HG21 ' OE1' ' A' ' 15' ' ' GLU . 23.7 t -50.65 -38.87 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.261 -0.899 . . . . 0.0 109.305 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -70.19 -37.28 75.08 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.224 -0.922 . . . . 0.0 109.097 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.624 HG22 ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -78.14 5.79 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.316 -0.865 . . . . 0.0 108.696 178.499 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.698 ' HB1' ' HB2' ' A' ' 42' ' ' ALA . . . -179.3 67.55 0.17 Allowed Pre-proline 0 N--CA 1.488 1.426 0 O-C-N 121.116 -0.99 . . . . 0.0 109.292 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -70.78 -2.96 11.74 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.051 1.553 . . . . 0.0 110.49 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.413 ' C ' ' HA3' ' A' ' 41' ' ' GLY . . . -103.52 -33.78 4.07 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.569 ' HB2' ' N ' ' A' ' 42' ' ' ALA . . . -96.95 -51.01 4.41 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.344 -1.092 . . . . 0.0 109.659 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 1.127 ' CZ ' HG21 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -85.54 136.08 33.55 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.307 -0.871 . . . . 0.0 109.572 -179.874 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.435 ' O ' ' CD1' ' A' ' 35' ' ' TYR . . . -163.73 128.83 2.94 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.11 -0.994 . . . . 0.0 109.834 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.56 ' HG2' ' CA ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -61.89 148.39 43.63 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.191 -0.943 . . . . 0.0 109.952 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.584 ' O ' ' N ' ' A' ' 32' ' ' GLU . 1.4 t70 -127.51 160.54 59.94 Favored Pre-proline 0 N--CA 1.478 0.966 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 178.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.48 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 44.2 Cg_endo -84.59 -19.24 4.36 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 O-C-N 124.497 1.788 . . . . 0.0 108.653 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -88.94 -33.99 17.06 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 106.452 -1.685 . . . . 0.0 106.452 177.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.663 HD11 ' CD1' ' A' ' 35' ' ' TYR . 0.5 OUTLIER -101.78 -0.41 10.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 177.9 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.584 ' N ' ' O ' ' A' ' 28' ' ' ASP . 17.0 mt-10 27.91 42.41 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.632 0.729 . . . . 0.0 109.654 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.777 ' HG2' ' SG ' ' A' ' 11' ' ' CYS . 0.2 OUTLIER -171.16 157.52 5.15 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -179.135 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.854 ' HB1' ' HD1' ' A' ' 25' ' ' PHE . . . -70.27 144.16 51.87 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.118 -0.989 . . . . 0.0 110.719 -178.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.665 ' CE2' ' HA ' ' A' ' 37' ' ' LYS . 2.6 p90 -150.24 159.03 44.74 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.801 ' O ' HG13 ' A' ' 36' ' ' VAL . 8.2 p -67.77 67.9 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.814 -1.178 . . . . 0.0 109.219 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.665 ' HA ' ' CE2' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -55.98 -14.8 2.76 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.232 -0.918 . . . . 0.0 110.598 -179.528 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -166.17 92.33 0.49 Allowed 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 119.004 -1.078 . . . . 0.0 109.909 -179.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.6 HG12 HG21 ' A' ' 36' ' ' VAL . 23.7 m -49.72 -26.13 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.389 -0.819 . . . . 0.0 109.703 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -78.86 -9.96 59.64 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.293 -0.879 . . . . 0.0 109.605 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.413 ' HA3' ' C ' ' A' ' 23' ' ' GLY . . . -79.23 -19.43 72.04 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.698 ' HB2' ' HB1' ' A' ' 21' ' ' ALA . . . -127.39 153.78 45.81 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.191 -1.182 . . . . 0.0 109.45 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.455 ' O ' HG23 ' A' ' 47' ' ' VAL . 0.5 OUTLIER -96.77 -168.15 1.67 Allowed 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.181 -0.949 . . . . 0.0 109.961 -179.738 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.481 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 0.4 OUTLIER -73.89 -57.98 3.61 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.609 -0.682 . . . . 0.0 109.196 179.703 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.404 ' O ' ' HB2' ' A' ' 49' ' ' GLU . 49.0 mm-40 -62.49 -14.43 41.37 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.37 -0.831 . . . . 0.0 109.692 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.453 ' HG3' ' HB2' ' A' ' 43' ' ' SER . 20.3 mt-10 -95.21 -46.48 6.75 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 179.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.491 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 5.5 t -59.23 -37.48 69.04 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.526 ' O ' ' N ' ' A' ' 51' ' ' MET . 0.2 OUTLIER -72.92 -55.49 6.52 Favored 'General case' 0 C--N 1.308 -1.218 0 O-C-N 121.58 -0.7 . . . . 0.0 109.813 179.971 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.827 ' O ' HG23 ' A' ' 53' ' ' THR . 2.6 tt0 -45.13 -50.57 11.14 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.196 -0.94 . . . . 0.0 108.862 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.614 ' N ' HG21 ' A' ' 20' ' ' ILE . . . -61.69 -28.37 69.36 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.211 -0.931 . . . . 0.0 108.607 179.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.764 ' HE2' HG23 ' A' ' 59' ' ' ILE . 43.2 ttm -64.7 -20.1 66.13 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.444 -0.785 . . . . 0.0 109.171 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -107.13 -10.03 15.99 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.374 -0.829 . . . . 0.0 109.432 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.827 HG23 ' O ' ' A' ' 49' ' ' GLU . 23.2 p -97.15 36.12 1.49 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.297 -0.877 . . . . 0.0 110.015 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . 0.547 ' SG ' HG22 ' A' ' 56' ' ' VAL . 49.7 t -126.84 132.82 24.48 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.041 -1.037 . . . . 0.0 109.573 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.87 -32.97 8.42 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 123.835 1.44 . . . . 0.0 109.665 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.639 HG11 ' O ' ' A' ' 10' ' ' GLU . 7.3 m -98.82 -16.12 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.502 ' N ' ' SG ' ' A' ' 54' ' ' CYS . 6.9 mt-30 42.39 86.71 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.554 -0.716 . . . . 0.0 109.692 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.494 ' O ' ' CE1' ' A' ' 60' ' ' HIS . 8.9 p -120.33 6.17 10.68 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.318 -0.864 . . . . 0.0 109.23 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.87 HD13 ' N ' ' A' ' 60' ' ' HIS . 0.0 OUTLIER -95.3 127.17 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.268 -0.895 . . . . 0.0 109.931 -179.625 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.87 ' N ' HD13 ' A' ' 59' ' ' ILE . 2.4 m80 -131.91 -160.75 1.07 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.376 -0.828 . . . . 0.0 109.041 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.535 ' HA ' ' CB ' ' A' ' 4' ' ' PHE . 49.3 m95 -111.32 174.11 6.02 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.959 -1.088 . . . . 0.0 109.327 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.522 ' HB3' ' HB3' ' A' ' 3' ' ' LYS . 3.1 tt0 . . . . . 0 C--N 1.301 -1.537 0 O-C-N 121.505 -0.747 . . . . 0.0 109.137 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.486 ' HB3' ' HB3' ' A' ' 62' ' ' GLU . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.46 0.648 . . . . 0.0 109.805 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.578 ' CZ ' ' HB ' ' A' ' 39' ' ' VAL . 8.1 p90 168.59 176.87 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 1.005 ' HA ' HG11 ' A' ' 36' ' ' VAL . 18.9 p90 178.52 -174.2 0.17 Allowed 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 1.14 HG21 ' CZ ' ' A' ' 25' ' ' PHE . 0.4 OUTLIER -132.69 168.45 24.16 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.12 0 C-N-CA 117.546 -1.662 . . . . 0.0 111.333 -179.393 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.541 ' O ' ' N ' ' A' ' 9' ' ' ASP . 9.5 t0 -116.07 89.91 3.21 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.587 ' CG ' ' O ' ' A' ' 34' ' ' ALA . 1.4 mp0 -63.24 42.3 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.949 -0.47 . . . . 0.0 111.004 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.541 ' N ' ' O ' ' A' ' 7' ' ' ASP . 0.4 OUTLIER -101.07 -28.32 12.77 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.177 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -119.53 21.74 11.97 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.485 ' HB3' ' CD ' ' A' ' 33' ' ' LYS . 8.7 t -76.77 122.51 24.86 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.186 -0.946 . . . . 0.0 110.055 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.711 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 37.7 pt -73.39 -5.76 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.405 -0.809 . . . . 0.0 109.436 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.711 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . 79.76 32.78 0.21 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.461 -0.775 . . . . 0.0 110.129 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.776 ' SG ' ' HB2' ' A' ' 16' ' ' SER . 1.3 p -95.78 151.93 18.93 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.097 -1.002 . . . . 0.0 109.178 179.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.468 ' O ' ' HB2' ' A' ' 19' ' ' GLU . 2.1 pt-20 -82.03 5.85 18.05 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.19 -0.944 . . . . 0.0 110.353 -179.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.776 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 3.6 m -43.78 -82.64 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.127 -0.983 . . . . 0.0 109.432 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.75 ' SG ' ' CD2' ' A' ' 25' ' ' PHE . 13.0 p -47.32 -56.83 6.07 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.25 -0.906 . . . . 0.0 109.617 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.666 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 74.1 t -47.29 -27.2 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.394 -0.816 . . . . 0.0 110.186 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.468 ' HB2' ' O ' ' A' ' 15' ' ' GLU . 0.1 OUTLIER -81.03 -40.14 24.72 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.966 -1.084 . . . . 0.0 109.673 -179.685 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.957 ' CD1' HG21 ' A' ' 53' ' ' THR . 2.4 mt -84.18 13.8 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.433 ' HB2' ' O ' ' A' ' 20' ' ' ILE . . . 177.84 65.92 0.09 OUTLIER Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.378 -0.826 . . . . 0.0 109.333 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -74.23 1.62 7.08 Favored 'Trans proline' 0 C--N 1.303 -1.837 0 O-C-N 124.069 1.563 . . . . 0.0 110.718 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.485 ' O ' ' HB3' ' A' ' 38' ' ' ASP . . . -97.77 -45.07 2.54 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' A' ' 38' ' ' ASP . . . -87.78 -47.1 8.89 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.255 -1.144 . . . . 0.0 109.559 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 1.14 ' CZ ' HG21 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -92.62 134.83 34.63 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.263 -0.898 . . . . 0.0 109.121 179.859 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.67 ' HB3' ' HE1' ' A' ' 35' ' ' TYR . . . -157.95 118.63 3.44 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.386 -0.821 . . . . 0.0 109.587 179.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.559 ' HA ' ' C ' ' A' ' 33' ' ' LYS . 14.6 mtm -59.15 149.6 27.64 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.114 -0.991 . . . . 0.0 109.37 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.612 ' O ' ' N ' ' A' ' 32' ' ' GLU . 1.3 t0 -126.95 163.13 43.39 Favored Pre-proline 0 C--N 1.312 -1.031 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 179.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.479 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 43.9 Cg_endo -83.95 -16.76 6.19 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 124.95 2.026 . . . . 0.0 108.086 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.24 -38.83 17.2 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 178.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.606 ' CG1' ' CB ' ' A' ' 28' ' ' ASP . 2.6 pt -102.24 -2.2 9.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.612 ' N ' ' O ' ' A' ' 28' ' ' ASP . 3.9 mm-40 34.35 36.23 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 -178.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.559 ' C ' ' HA ' ' A' ' 27' ' ' MET . 11.1 mttm -161.41 148.64 14.81 Favored 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 119.37 -0.932 . . . . 0.0 110.501 -177.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.587 ' O ' ' CG ' ' A' ' 8' ' ' GLN . . . -58.59 143.99 44.41 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.478 -0.764 . . . . 0.0 109.901 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.67 ' HE1' ' HB3' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -142.31 139.76 31.94 Favored 'General case' 0 N--CA 1.5 2.039 0 CA-C-O 121.803 0.811 . . . . 0.0 110.199 179.461 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 1.005 HG11 ' HA ' ' A' ' 5' ' ' TYR . 7.9 p -74.34 61.61 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.123 -0.986 . . . . 0.0 108.673 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.646 ' HB3' ' CZ ' ' A' ' 35' ' ' TYR . 0.1 OUTLIER -71.4 -18.34 62.35 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.303 -0.873 . . . . 0.0 110.607 -178.992 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.485 ' HB3' ' O ' ' A' ' 23' ' ' GLY . 57.2 t0 -135.21 75.62 1.58 Allowed 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.055 -1.028 . . . . 0.0 109.722 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.578 ' HB ' ' CZ ' ' A' ' 4' ' ' PHE . 6.4 m -51.81 -24.35 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.273 -0.892 . . . . 0.0 108.935 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.521 ' HG3' HG23 ' A' ' 39' ' ' VAL . 2.0 mt-10 -90.16 1.81 56.01 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.335 -0.853 . . . . 0.0 109.365 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.408 ' O ' ' HA3' ' A' ' 23' ' ' GLY . . . -96.04 34.75 4.72 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.435 ' HA ' ' OE2' ' A' ' 46' ' ' GLU . . . -179.66 126.65 0.08 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.251 -1.147 . . . . 0.0 109.615 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.77 ' O ' HG23 ' A' ' 47' ' ' VAL . 0.3 OUTLIER -59.22 165.67 2.52 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.298 -0.876 . . . . 0.0 109.542 179.768 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.496 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 0.1 OUTLIER -71.67 -37.44 70.76 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.333 -0.854 . . . . 0.0 109.467 179.995 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -71.73 -20.26 61.92 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.075 -1.015 . . . . 0.0 109.286 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.531 ' HG2' ' N ' ' A' ' 43' ' ' SER . 5.3 pt-20 -95.08 -34.08 12.44 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 106.517 -1.661 . . . . 0.0 106.517 178.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.77 HG23 ' O ' ' A' ' 43' ' ' SER . 25.1 t -64.25 -46.82 92.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 177.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.496 ' HB2' ' O ' ' A' ' 44' ' ' GLN . 0.2 OUTLIER -64.77 -51.3 63.02 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.615 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.652 ' HB3' HG21 ' A' ' 20' ' ' ILE . 6.6 mt-10 -51.74 -40.57 60.46 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 178.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.769 ' HA ' HD13 ' A' ' 20' ' ' ILE . . . -72.41 -32.73 66.61 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.993 ' HG3' HD13 ' A' ' 59' ' ' ILE . 34.6 ttm -74.41 -24.88 59.17 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.645 -0.659 . . . . 0.0 110.103 -179.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -86.3 -26.35 24.97 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.047 -1.033 . . . . 0.0 109.882 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.957 HG21 ' CD1' ' A' ' 20' ' ' ILE . 13.8 t -73.01 -5.89 41.84 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.137 -0.977 . . . . 0.0 109.772 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . 0.633 ' SG ' ' HD2' ' A' ' 55' ' ' PRO . 19.4 t -79.09 142.61 59.82 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.163 -0.961 . . . . 0.0 109.743 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.633 ' HD2' ' SG ' ' A' ' 54' ' ' CYS . 42.9 Cg_endo -76.35 -72.38 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.07 1.563 . . . . 0.0 109.945 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.424 ' O ' ' HB2' ' A' ' 57' ' ' GLN . 2.5 t -74.5 -18.18 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.096 -1.003 . . . . 0.0 108.761 179.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.451 ' O ' ' C ' ' A' ' 58' ' ' CYS . 0.0 OUTLIER 71.9 -64.57 0.38 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.431 -0.793 . . . . 0.0 110.139 179.582 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.451 ' C ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER 42.05 37.9 0.95 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.334 -0.854 . . . . 0.0 108.799 -179.467 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.993 HD13 ' HG3' ' A' ' 51' ' ' MET . 7.6 tt -121.48 157.46 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.303 -0.873 . . . . 0.0 110.096 -179.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.57 ' CG ' ' O ' ' A' ' 59' ' ' ILE . 23.5 m80 -159.3 132.62 7.14 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.353 -0.842 . . . . 0.0 109.655 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.569 ' HA ' ' HA ' ' A' ' 4' ' ' PHE . 57.3 m95 -71.26 168.72 16.7 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.239 -0.913 . . . . 0.0 109.141 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.505 ' N ' ' HA ' ' A' ' 4' ' ' PHE . 1.4 tt0 . . . . . 0 N--CA 1.488 1.444 0 O-C-N 121.186 -0.946 . . . . 0.0 109.644 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.465 ' HB3' ' HB3' ' A' ' 62' ' ' GLU . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.269 0.557 . . . . 0.0 109.758 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.638 ' CE1' HG21 ' A' ' 47' ' ' VAL . 14.4 p90 167.98 -174.33 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.269 -0.894 . . . . 0.0 109.657 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.527 ' O ' HG13 ' A' ' 59' ' ' ILE . 4.4 p90 176.18 -172.63 0.08 Allowed 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.953 HG21 ' CZ ' ' A' ' 25' ' ' PHE . 0.2 OUTLIER -135.78 164.89 31.25 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 C-N-CA 118.056 -1.458 . . . . 0.0 111.086 179.685 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.569 ' OD2' ' CE1' ' A' ' 60' ' ' HIS . 5.5 m-20 -109.1 90.88 3.43 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.519 ' HG2' ' O ' ' A' ' 34' ' ' ALA . 5.2 mp0 -66.22 48.24 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.66 0 CA-C-O 121.884 0.85 . . . . 0.0 110.002 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.527 ' N ' ' O ' ' A' ' 7' ' ' ASP . 11.0 t0 -110.53 -39.96 4.76 Favored 'General case' 0 C--N 1.285 -2.22 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.426 ' HB2' ' SG ' ' A' ' 58' ' ' CYS . 0.0 OUTLIER -101.25 20.49 15.69 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.307 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.447 ' HB3' ' HG2' ' A' ' 33' ' ' LYS . 11.1 t -86.44 134.99 33.65 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.308 -0.87 . . . . 0.0 110.085 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.692 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 30.3 pt -105.09 -6.15 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.353 -0.842 . . . . 0.0 108.78 179.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.692 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . 76.53 70.85 0.07 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.344 -0.848 . . . . 0.0 109.45 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 1.208 ' SG ' ' OG ' ' A' ' 16' ' ' SER . 27.4 p -103.89 -11.45 17.48 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.124 -0.985 . . . . 0.0 109.697 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.52 ' CB ' ' O ' ' A' ' 14' ' ' CYS . 3.1 tt0 76.29 -1.65 2.88 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.212 -0.93 . . . . 0.0 110.253 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 1.208 ' OG ' ' SG ' ' A' ' 14' ' ' CYS . 0.2 OUTLIER -61.76 -67.11 0.44 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.975 -1.078 . . . . 0.0 109.294 179.89 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.722 ' SG ' ' CD2' ' A' ' 25' ' ' PHE . 14.2 p -54.77 -44.12 73.39 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.21 -0.931 . . . . 0.0 109.103 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.463 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 21.2 t -54.31 -19.69 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.304 -0.872 . . . . 0.0 109.16 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.27 -41.54 14.51 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.172 -0.955 . . . . 0.0 109.107 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.837 HG21 ' HB3' ' A' ' 49' ' ' GLU . 1.9 mt -85.84 16.23 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 177.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.401 ' N ' ' HD3' ' A' ' 22' ' ' PRO . . . -177.54 59.95 0.15 Allowed Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.429 -0.795 . . . . 0.0 109.062 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.401 ' HD3' ' N ' ' A' ' 21' ' ' ALA . 45.4 Cg_endo -74.25 -0.11 9.21 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 124.075 1.566 . . . . 0.0 110.402 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.491 ' O ' ' HB3' ' A' ' 38' ' ' ASP . . . -111.43 -26.88 4.37 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.523 ' CB ' ' O ' ' A' ' 38' ' ' ASP . . . -100.34 -47.25 4.99 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.362 -1.081 . . . . 0.0 109.604 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.953 ' CZ ' HG21 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -90.61 140.4 29.79 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.373 -0.829 . . . . 0.0 109.045 -179.96 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.523 ' O ' ' CD1' ' A' ' 35' ' ' TYR . . . -164.48 119.57 1.45 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.147 -0.97 . . . . 0.0 109.943 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.542 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 5.7 ttm -60.14 152.22 24.94 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.098 -1.001 . . . . 0.0 109.159 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.606 ' O ' ' N ' ' A' ' 32' ' ' GLU . 2.8 t0 -125.97 160.14 58.33 Favored Pre-proline 0 C--N 1.312 -1.06 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 179.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.48 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 43.9 Cg_endo -84.88 -16.15 5.46 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 O-C-N 124.662 1.875 . . . . 0.0 108.585 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.75 -28.0 16.87 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 177.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.596 HD12 ' HB3' ' A' ' 35' ' ' TYR . 0.8 OUTLIER -108.46 -0.81 9.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 177.905 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.606 ' N ' ' O ' ' A' ' 28' ' ' ASP . 19.6 mt-10 28.73 42.73 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.595 0.712 . . . . 0.0 109.625 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.523 ' C ' ' HA ' ' A' ' 27' ' ' MET . 1.0 OUTLIER -169.44 148.19 3.76 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 119.365 -0.934 . . . . 0.0 110.287 -179.051 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.542 ' HA ' ' HA ' ' A' ' 27' ' ' MET . . . -57.2 143.76 37.88 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.453 -0.779 . . . . 0.0 110.67 -179.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.633 ' O ' ' CD1' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -144.03 143.09 31.03 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.732 0.777 . . . . 0.0 109.607 179.094 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.927 ' HB ' HG23 ' A' ' 6' ' ' VAL . 2.1 t -86.2 91.67 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 120.816 -1.178 . . . . 0.0 108.153 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.611 ' HB3' ' CE2' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -104.3 -16.22 15.22 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.343 -0.848 . . . . 0.0 110.605 -178.82 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.523 ' O ' ' CB ' ' A' ' 24' ' ' ALA . 36.9 t70 -129.66 90.92 3.06 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 120.984 -1.072 . . . . 0.0 109.696 -179.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.515 HG12 ' CE1' ' A' ' 4' ' ' PHE . 28.7 m -58.27 -39.77 75.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.22 -0.925 . . . . 0.0 109.578 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.486 ' HG2' ' OD1' ' A' ' 38' ' ' ASP . 1.3 pt-20 -64.6 -16.53 62.86 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.248 -0.907 . . . . 0.0 109.258 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.513 ' N ' ' OD2' ' A' ' 38' ' ' ASP . . . -76.59 0.76 63.86 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.694 -1.363 . . . . 0.0 109.694 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -160.04 103.91 1.49 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.179 -1.189 . . . . 0.0 109.512 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.472 ' OG ' ' OE2' ' A' ' 46' ' ' GLU . 0.4 OUTLIER -50.19 162.65 0.2 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.27 -0.894 . . . . 0.0 109.69 -179.876 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.479 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 15.1 pt20 -48.97 -50.17 36.99 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.434 -0.791 . . . . 0.0 109.43 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.42 ' N ' ' HG3' ' A' ' 44' ' ' GLN . 25.9 mm-40 -63.21 -13.04 33.04 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.298 -0.876 . . . . 0.0 109.359 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.472 ' OE2' ' OG ' ' A' ' 43' ' ' SER . 7.3 mt-10 -93.48 -52.77 4.35 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 179.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.638 HG21 ' CE1' ' A' ' 4' ' ' PHE . 2.5 t -53.67 -38.7 35.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 178.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.479 ' HB2' ' O ' ' A' ' 44' ' ' GLN . 0.1 OUTLIER -69.08 -55.63 10.19 Favored 'General case' 0 C--N 1.309 -1.173 0 O-C-N 121.499 -0.751 . . . . 0.0 109.776 179.775 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.837 ' HB3' HG21 ' A' ' 20' ' ' ILE . 20.3 mm-40 -53.2 -49.77 66.06 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.143 -0.973 . . . . 0.0 108.765 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.72 ' HB2' ' HB ' ' A' ' 20' ' ' ILE . . . -65.6 -11.1 41.32 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.429 -0.794 . . . . 0.0 108.931 179.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.643 ' CG ' HG21 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -83.92 -43.78 14.92 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.453 -0.78 . . . . 0.0 109.938 -179.372 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -76.41 -22.36 54.82 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.335 -0.853 . . . . 0.0 110.205 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.617 HG21 ' CD1' ' A' ' 20' ' ' ILE . 7.6 t -69.95 -6.05 30.43 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.052 -1.03 . . . . 0.0 109.69 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . 0.521 ' SG ' ' HD2' ' A' ' 55' ' ' PRO . 16.1 t -85.95 139.97 34.99 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.152 -0.968 . . . . 0.0 109.557 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.521 ' HD2' ' SG ' ' A' ' 54' ' ' CYS . 46.0 Cg_endo -74.27 -49.52 0.18 Allowed 'Trans proline' 0 C--N 1.303 -1.819 0 O-C-N 124.051 1.553 . . . . 0.0 110.138 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.476 ' O ' ' HB2' ' A' ' 57' ' ' GLN . 5.4 t -97.28 -11.78 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.301 -0.874 . . . . 0.0 109.078 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.476 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 13.6 mt-30 65.43 -85.43 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.464 -0.773 . . . . 0.0 110.028 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.465 ' SG ' ' HB2' ' A' ' 7' ' ' ASP . 7.2 t 58.79 31.99 21.77 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.067 -1.021 . . . . 0.0 108.823 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.845 HD12 HG13 ' A' ' 6' ' ' VAL . 1.2 tt -110.84 156.65 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.354 -0.841 . . . . 0.0 109.724 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.569 ' CE1' ' OD2' ' A' ' 7' ' ' ASP . 13.6 m80 -154.03 136.54 15.07 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.116 -0.99 . . . . 0.0 109.797 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.547 ' HA ' ' CB ' ' A' ' 4' ' ' PHE . 56.8 m95 -78.74 166.88 21.97 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.39 -0.819 . . . . 0.0 109.499 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.526 ' N ' ' HA ' ' A' ' 4' ' ' PHE . 45.2 tt0 . . . . . 0 N--CA 1.489 1.511 0 O-C-N 121.342 -0.849 . . . . 0.0 109.32 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.589 ' CG ' ' CG ' ' A' ' 62' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.041 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.562 ' CB ' ' HA ' ' A' ' 61' ' ' TRP . 28.6 p90 -173.48 -177.59 1.5 Allowed 'General case' 0 C--N 1.296 -1.747 0 O-C-N 121.205 -0.935 . . . . 0.0 109.496 -179.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.609 ' HA ' HG11 ' A' ' 36' ' ' VAL . 14.3 p90 175.1 -172.05 0.06 Allowed 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 1.053 HG21 ' CZ ' ' A' ' 25' ' ' PHE . 0.2 OUTLIER -134.34 172.33 16.38 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 C-N-CA 117.594 -1.642 . . . . 0.0 111.162 179.565 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.567 ' O ' ' N ' ' A' ' 9' ' ' ASP . 13.5 t70 -122.29 90.18 3.25 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.566 ' CG ' ' O ' ' A' ' 34' ' ' ALA . 6.9 mp0 -66.45 48.92 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.748 0.785 . . . . 0.0 109.81 179.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.567 ' N ' ' O ' ' A' ' 7' ' ' ASP . 0.5 OUTLIER -114.08 -25.7 8.41 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.588 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.481 ' HB3' ' SG ' ' A' ' 58' ' ' CYS . 0.1 OUTLIER -110.22 -19.71 12.92 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.649 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.466 ' O ' ' HD3' ' A' ' 33' ' ' LYS . 42.0 t -46.75 141.92 3.62 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.425 -0.797 . . . . 0.0 109.471 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.749 ' O ' ' HB2' ' A' ' 13' ' ' ALA . 11.8 pt -99.34 -51.93 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.068 -1.02 . . . . 0.0 109.545 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.749 ' HB2' ' O ' ' A' ' 12' ' ' ILE . . . 154.91 35.48 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.543 -0.723 . . . . 0.0 110.276 179.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.618 ' SG ' ' HB2' ' A' ' 16' ' ' SER . 0.5 OUTLIER -105.08 158.53 16.5 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.667 -1.271 . . . . 0.0 109.719 179.557 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.455 ' O ' ' N ' ' A' ' 19' ' ' GLU . 11.6 mt-10 -99.07 12.97 34.5 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.306 -0.871 . . . . 0.0 109.833 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.631 ' O ' HD12 ' A' ' 20' ' ' ILE . 3.7 m -45.03 -76.34 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.087 -1.008 . . . . 0.0 109.052 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.984 ' SG ' ' CD2' ' A' ' 25' ' ' PHE . 10.6 p -52.6 -49.15 65.62 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.38 -0.825 . . . . 0.0 109.125 179.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.581 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 60.8 t -52.13 -24.7 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.311 -0.868 . . . . 0.0 109.226 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.455 ' N ' ' O ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -83.61 -36.02 24.21 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.219 -0.926 . . . . 0.0 109.173 179.76 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 1.012 HD13 ' HA ' ' A' ' 50' ' ' ALA . 2.7 mp -83.43 10.56 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.67 ' HB1' ' HB2' ' A' ' 42' ' ' ALA . . . 178.08 68.71 0.1 Allowed Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.393 -0.817 . . . . 0.0 108.879 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -69.93 -1.19 8.21 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 124.166 1.614 . . . . 0.0 110.887 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.497 ' O ' ' HB3' ' A' ' 38' ' ' ASP . . . -105.34 -44.44 1.46 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.53 ' CB ' ' O ' ' A' ' 38' ' ' ASP . . . -83.46 -36.42 24.19 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.374 -1.074 . . . . 0.0 109.844 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 1.053 ' CZ ' HG21 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -105.73 140.71 38.36 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.342 -0.848 . . . . 0.0 109.23 -179.682 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.522 ' O ' ' CD1' ' A' ' 35' ' ' TYR . . . -171.27 120.37 0.5 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.151 -0.968 . . . . 0.0 109.459 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.558 ' HA ' ' C ' ' A' ' 33' ' ' LYS . 10.5 mtp -58.41 153.73 15.16 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.08 -1.013 . . . . 0.0 109.232 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.613 ' O ' ' N ' ' A' ' 32' ' ' GLU . 1.4 t0 -132.97 165.07 39.4 Favored Pre-proline 0 C--N 1.312 -1.063 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.516 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 43.8 Cg_endo -84.59 -15.11 6.29 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 124.654 1.871 . . . . 0.0 107.459 178.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.687 ' HB3' HD13 ' A' ' 31' ' ' ILE . 4.4 tt0 -83.54 -39.24 20.66 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 177.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.7 ' N ' HD13 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -106.2 1.24 10.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.103 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.613 ' N ' ' O ' ' A' ' 28' ' ' ASP . 22.6 mt-10 33.84 36.42 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 -179.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.558 ' C ' ' HA ' ' A' ' 27' ' ' MET . 17.9 mttm -164.72 149.6 9.61 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 119.203 -0.999 . . . . 0.0 110.565 -177.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.566 ' O ' ' CG ' ' A' ' 8' ' ' GLN . . . -53.07 141.83 21.64 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.574 -0.704 . . . . 0.0 109.658 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.642 ' O ' ' CD1' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -144.69 140.67 28.76 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 122.044 0.926 . . . . 0.0 109.901 179.347 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.967 ' HB ' HG23 ' A' ' 6' ' ' VAL . 1.7 t -84.57 97.31 5.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -179.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.564 ' HG2' ' CE1' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -115.87 -10.62 11.65 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.278 -0.889 . . . . 0.0 111.193 -178.604 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.53 ' O ' ' CB ' ' A' ' 24' ' ' ALA . 33.9 t0 -133.03 87.91 2.45 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.792 -1.192 . . . . 0.0 110.098 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.408 HG23 ' N ' ' A' ' 40' ' ' GLU . 24.0 m -54.08 -34.89 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.258 -0.901 . . . . 0.0 109.343 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.408 ' N ' HG23 ' A' ' 39' ' ' VAL . 74.3 mt-10 -69.5 -14.03 62.65 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.4 -0.813 . . . . 0.0 109.601 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.4 ' HA3' ' C ' ' A' ' 23' ' ' GLY . . . -76.44 -2.08 73.0 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.67 ' HB2' ' HB1' ' A' ' 21' ' ' ALA . . . -162.5 135.57 5.92 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.209 -1.171 . . . . 0.0 109.46 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.456 ' OG ' ' HG3' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -77.23 166.43 23.22 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.283 -0.886 . . . . 0.0 109.84 -179.75 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.465 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 5.4 pt20 -54.9 -43.2 73.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.45 -0.781 . . . . 0.0 109.633 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.446 ' N ' ' HG3' ' A' ' 44' ' ' GLN . 33.4 mm-40 -69.18 -11.04 60.45 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.235 -0.916 . . . . 0.0 109.163 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.456 ' HG3' ' OG ' ' A' ' 43' ' ' SER . 18.3 mt-10 -94.72 -44.63 7.7 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 178.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.431 ' O ' ' HB2' ' A' ' 51' ' ' MET . 72.6 t -60.83 -37.26 76.01 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 177.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.465 ' HB2' ' O ' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -67.93 -59.65 3.11 Favored 'General case' 0 C--N 1.31 -1.146 0 O-C-N 121.502 -0.749 . . . . 0.0 109.298 179.108 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.644 ' OE1' HG23 ' A' ' 20' ' ' ILE . 8.8 tt0 -51.59 -47.48 63.55 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.441 -0.903 . . . . 0.0 109.101 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 1.012 ' HA ' HD13 ' A' ' 20' ' ' ILE . . . -61.62 -27.42 68.64 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.3 -0.875 . . . . 0.0 109.204 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.591 ' CG ' ' CG2' ' A' ' 59' ' ' ILE . 0.8 OUTLIER -70.97 -27.14 63.51 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.544 -0.723 . . . . 0.0 110.405 -179.21 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -94.68 -8.45 37.82 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.919 -1.113 . . . . 0.0 110.127 -179.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.474 HG22 ' HB3' ' A' ' 16' ' ' SER . 91.7 m -88.07 -17.96 29.93 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.073 -1.017 . . . . 0.0 110.052 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . 0.818 ' SG ' ' HD2' ' A' ' 55' ' ' PRO . 35.5 t -69.73 147.07 96.24 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.028 -1.045 . . . . 0.0 109.783 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.818 ' HD2' ' SG ' ' A' ' 54' ' ' CYS . 45.0 Cg_endo -77.9 -63.32 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.119 1.589 . . . . 0.0 109.781 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.527 HG12 ' O ' ' A' ' 56' ' ' VAL . 75.9 t -80.65 -6.02 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.287 -0.883 . . . . 0.0 109.081 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.402 ' HA ' ' HB3' ' A' ' 54' ' ' CYS . 44.9 mt-30 45.8 71.46 0.28 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.315 -0.866 . . . . 0.0 109.545 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.481 ' SG ' ' HB3' ' A' ' 10' ' ' GLU . 2.5 m -94.44 21.1 7.5 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.277 -0.889 . . . . 0.0 109.129 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.658 HD12 HG22 ' A' ' 6' ' ' VAL . 1.9 tt -105.19 142.41 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.453 -0.78 . . . . 0.0 109.833 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.436 ' CG ' ' C ' ' A' ' 59' ' ' ILE . 6.5 m80 -149.83 142.31 24.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.471 -0.768 . . . . 0.0 109.118 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.562 ' HA ' ' CB ' ' A' ' 4' ' ' PHE . 64.5 m95 -59.5 175.28 0.35 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.22 -0.925 . . . . 0.0 109.744 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.589 ' CG ' ' CG ' ' A' ' 3' ' ' LYS . 1.4 tp10 . . . . . 0 C--N 1.302 -1.466 0 O-C-N 121.475 -0.766 . . . . 0.0 109.116 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.477 ' O ' ' HB3' ' A' ' 4' ' ' PHE . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.333 0.587 . . . . 0.0 109.677 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.544 ' CB ' ' HA ' ' A' ' 61' ' ' TRP . 12.5 p90 177.07 -163.91 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.453 -0.779 . . . . 0.0 109.175 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.796 ' HA ' HG21 ' A' ' 36' ' ' VAL . 52.2 p90 171.44 -178.32 0.05 Allowed 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.95 HG21 ' CZ ' ' A' ' 25' ' ' PHE . 3.7 t -143.71 155.58 16.13 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.338 0 C-N-CA 117.205 -1.798 . . . . 0.0 111.301 179.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.525 ' O ' ' N ' ' A' ' 9' ' ' ASP . 0.2 OUTLIER -102.14 74.87 1.46 Allowed 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 178.864 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.532 ' HB3' ' O ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER -40.98 -24.43 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.523 0.678 . . . . 0.0 109.372 179.871 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.525 ' N ' ' O ' ' A' ' 7' ' ' ASP . 0.2 OUTLIER -54.27 -31.22 53.14 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.421 -0.799 . . . . 0.0 109.121 179.816 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.484 ' HG2' HG11 ' A' ' 56' ' ' VAL . 1.4 tp10 -100.83 11.27 39.91 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.346 -0.846 . . . . 0.0 109.152 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 6.6 t -76.97 122.03 24.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.242 -0.911 . . . . 0.0 109.905 -179.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.469 HG13 ' N ' ' A' ' 13' ' ' ALA . 16.4 pt -70.96 -145.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.41 -0.806 . . . . 0.0 109.413 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.469 ' N ' HG13 ' A' ' 12' ' ' ILE . . . -111.71 55.77 0.66 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.053 -1.029 . . . . 0.0 109.575 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.414 ' HB3' HD11 ' A' ' 12' ' ' ILE . 0.1 OUTLIER -139.35 155.37 47.72 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.121 -0.987 . . . . 0.0 109.692 179.858 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.43 ' O ' ' C ' ' A' ' 16' ' ' SER . 13.3 pt-20 -118.44 20.36 13.06 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.366 -0.833 . . . . 0.0 109.534 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.64 ' O ' HD12 ' A' ' 20' ' ' ILE . 0.2 OUTLIER -43.65 -60.95 1.56 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.354 -0.841 . . . . 0.0 109.269 179.899 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.533 ' SG ' ' N ' ' A' ' 18' ' ' VAL . 19.5 p -49.17 -48.59 44.92 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.386 -0.821 . . . . 0.0 109.297 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.533 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 5.0 t -49.6 -36.45 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.355 -0.841 . . . . 0.0 109.578 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.426 ' N ' ' OE1' ' A' ' 19' ' ' GLU . 0.2 OUTLIER -73.77 -35.91 65.03 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.041 -1.037 . . . . 0.0 109.321 -179.949 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.942 HD11 HG21 ' A' ' 53' ' ' THR . 2.5 mp -84.84 12.47 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.537 ' HB1' ' HB2' ' A' ' 42' ' ' ALA . . . -171.34 66.48 0.43 Allowed Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.355 -0.84 . . . . 0.0 109.311 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -72.51 56.42 2.77 Favored 'Trans proline' 0 C--N 1.303 -1.842 0 O-C-N 124.091 1.574 . . . . 0.0 110.058 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -179.85 -34.45 0.07 OUTLIER Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.476 ' O ' ' HA ' ' A' ' 36' ' ' VAL . . . -94.72 -25.28 16.77 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.246 -1.149 . . . . 0.0 109.303 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.95 ' CZ ' HG21 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -123.83 135.31 53.69 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.31 -0.869 . . . . 0.0 109.287 179.839 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.49 ' O ' ' HA ' ' A' ' 34' ' ' ALA . . . -163.05 145.15 10.16 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.537 ' HG3' ' CA ' ' A' ' 33' ' ' LYS . 10.7 ttm -77.72 152.7 33.55 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.96 -1.087 . . . . 0.0 109.123 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.636 ' O ' ' N ' ' A' ' 32' ' ' GLU . 1.1 t0 -123.84 162.26 41.98 Favored Pre-proline 0 C--N 1.313 -1.019 0 N-CA-C 106.614 -1.624 . . . . 0.0 106.614 179.067 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.456 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 46.5 Cg_endo -84.29 -15.09 6.67 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 125.06 2.084 . . . . 0.0 108.109 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -88.26 -34.34 17.75 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 178.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.596 ' CG1' ' HB3' ' A' ' 28' ' ' ASP . 1.6 pt -107.72 -2.49 10.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.636 ' N ' ' O ' ' A' ' 28' ' ' ASP . 0.0 OUTLIER 35.25 35.05 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -178.74 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.537 ' CA ' ' HG3' ' A' ' 27' ' ' MET . 23.7 mmtp -157.87 152.92 25.53 Favored 'General case' 0 N--CA 1.499 2.022 0 C-N-CA 119.42 -0.912 . . . . 0.0 110.542 -177.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.532 ' O ' ' HB3' ' A' ' 8' ' ' GLN . . . -61.74 142.75 57.06 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.616 -0.677 . . . . 0.0 110.059 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.651 ' CZ ' ' HB3' ' A' ' 37' ' ' LYS . 11.6 p90 -144.0 168.5 19.83 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 178.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.827 HG22 HG23 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -85.16 78.39 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.272 0 CA-C-O 121.782 0.801 . . . . 0.0 109.04 -178.079 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.651 ' HB3' ' CZ ' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -68.89 -3.74 13.82 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.846 -0.534 . . . . 0.0 110.539 -179.125 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.477 ' HB2' ' O ' ' A' ' 37' ' ' LYS . 36.7 t0 179.87 128.6 0.08 Allowed 'General case' 0 C--N 1.299 -1.611 0 C-N-CA 118.73 -1.188 . . . . 0.0 110.004 -178.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.529 HG12 ' CE1' ' A' ' 4' ' ' PHE . 15.8 m -79.6 -30.66 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.22 -0.925 . . . . 0.0 109.698 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -84.07 -9.75 58.38 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.183 -0.948 . . . . 0.0 109.267 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -61.95 -21.74 61.6 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.537 ' HB2' ' HB1' ' A' ' 21' ' ' ALA . . . -136.21 138.59 42.03 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.235 -1.156 . . . . 0.0 109.737 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.847 ' O ' HG23 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -71.66 158.32 36.38 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.244 -0.91 . . . . 0.0 109.643 -179.957 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.408 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 0.9 OUTLIER -47.53 -46.65 27.8 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.455 -0.778 . . . . 0.0 109.514 179.89 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -67.04 -9.54 40.21 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.292 -0.88 . . . . 0.0 109.449 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.468 ' HB2' ' HB1' ' A' ' 42' ' ' ALA . 27.5 mt-10 -97.91 -41.84 7.82 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 178.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.847 HG23 ' O ' ' A' ' 43' ' ' SER . 2.1 t -62.18 -40.59 88.17 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.924 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 178.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.408 ' HB2' ' O ' ' A' ' 44' ' ' GLN . 0.4 OUTLIER -73.17 -56.17 5.46 Favored 'General case' 0 C--N 1.308 -1.211 0 O-C-N 121.673 -0.642 . . . . 0.0 109.648 179.585 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.543 ' HB3' HG21 ' A' ' 20' ' ' ILE . 34.0 tt0 -52.94 -45.57 67.74 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.172 -0.955 . . . . 0.0 108.806 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.917 ' HA ' HD13 ' A' ' 20' ' ' ILE . . . -64.31 -17.87 64.07 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.32 -0.863 . . . . 0.0 108.93 179.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.79 ' HG3' HG21 ' A' ' 59' ' ' ILE . 2.6 ttm -80.93 -41.61 22.65 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.562 -0.712 . . . . 0.0 109.581 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -69.06 -24.54 64.18 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.282 -0.886 . . . . 0.0 109.704 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.942 HG21 HD11 ' A' ' 20' ' ' ILE . 4.9 p -72.5 -33.24 66.8 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.12 -0.988 . . . . 0.0 109.975 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . 0.798 ' SG ' ' HD2' ' A' ' 55' ' ' PRO . 9.4 t -65.19 146.6 98.91 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.056 -1.028 . . . . 0.0 109.864 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.798 ' HD2' ' SG ' ' A' ' 54' ' ' CYS . 45.2 Cg_endo -79.15 -69.49 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 124.099 1.579 . . . . 0.0 110.105 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.484 HG11 ' HG2' ' A' ' 10' ' ' GLU . 9.8 p -75.44 -16.43 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.201 -0.937 . . . . 0.0 108.791 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 63.94 47.81 3.33 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.449 -0.782 . . . . 0.0 109.837 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.494 ' O ' ' CE1' ' A' ' 60' ' ' HIS . 11.5 p -48.61 -23.57 1.05 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.224 -0.923 . . . . 0.0 109.212 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.869 ' CA ' HG13 ' A' ' 6' ' ' VAL . 6.6 tt -69.32 159.09 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.574 -0.703 . . . . 0.0 110.047 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.527 ' C ' ' CD1' ' A' ' 61' ' ' TRP . 46.9 m80 -149.82 -134.19 0.06 Allowed 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.666 ' CZ2' ' HE3' ' A' ' 51' ' ' MET . 74.4 m95 -151.68 168.74 24.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.835 -1.166 . . . . 0.0 110.062 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.451 ' O ' ' HB3' ' A' ' 3' ' ' LYS . 2.7 tt0 . . . . . 0 N--CA 1.489 1.512 0 O-C-N 121.431 -0.793 . . . . 0.0 109.404 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.513 ' HB3' ' HB3' ' A' ' 62' ' ' GLU . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.608 ' CZ ' ' HB ' ' A' ' 39' ' ' VAL . 29.3 p90 179.08 173.49 0.77 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.203 -0.936 . . . . 0.0 108.506 -179.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.577 ' HA ' HG11 ' A' ' 36' ' ' VAL . 6.4 p90 178.43 -161.63 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 1.051 HG21 ' CZ ' ' A' ' 25' ' ' PHE . 0.2 OUTLIER -139.3 -177.74 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 C-N-CA 117.545 -1.662 . . . . 0.0 112.076 -179.883 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.638 ' H ' HG12 ' A' ' 6' ' ' VAL . 5.6 m-20 -143.3 94.44 2.62 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.073 178.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.566 ' HB3' ' CD ' ' A' ' 33' ' ' LYS . 31.2 mm-40 -65.11 42.54 0.02 OUTLIER 'General case' 0 C--N 1.291 -1.942 0 CA-C-O 121.444 0.64 . . . . 0.0 111.293 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.495 ' N ' ' O ' ' A' ' 7' ' ' ASP . 0.3 OUTLIER -93.57 -16.87 23.95 Favored 'General case' 0 C--N 1.288 -2.094 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.548 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.806 ' CG ' HG11 ' A' ' 56' ' ' VAL . 0.9 OUTLIER -127.15 -1.16 6.44 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.505 -0.747 . . . . 0.0 110.472 -178.944 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.494 ' HB2' ' OE1' ' A' ' 8' ' ' GLN . 49.9 t -63.92 119.11 9.43 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.755 -1.216 . . . . 0.0 109.706 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.713 ' O ' ' HB2' ' A' ' 13' ' ' ALA . 11.8 pt -83.46 -45.1 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 O-C-N 121.364 -0.835 . . . . 0.0 109.481 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.713 ' HB2' ' O ' ' A' ' 12' ' ' ILE . . . 163.92 -27.95 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.163 -0.96 . . . . 0.0 110.033 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.496 ' SG ' ' HB2' ' A' ' 16' ' ' SER . 0.1 OUTLIER -48.24 154.44 0.59 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.011 -1.056 . . . . 0.0 110.041 -179.298 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.426 ' O ' ' C ' ' A' ' 16' ' ' SER . 6.9 mt-10 -113.35 18.25 17.91 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.404 -0.81 . . . . 0.0 109.193 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.8 ' O ' HD12 ' A' ' 20' ' ' ILE . 1.6 m -42.54 -60.17 1.62 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.424 -0.798 . . . . 0.0 109.5 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.682 ' SG ' ' CD2' ' A' ' 25' ' ' PHE . 18.1 p -51.05 -53.88 29.76 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.331 -0.856 . . . . 0.0 109.25 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.575 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 65.7 t -46.33 -37.7 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.334 -0.854 . . . . 0.0 109.207 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.05 -33.16 65.5 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.111 -0.993 . . . . 0.0 109.267 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.942 HG21 ' N ' ' A' ' 50' ' ' ALA . 2.4 mp -85.1 11.99 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.506 ' HB1' ' CB ' ' A' ' 42' ' ' ALA . . . 179.08 62.83 0.1 Allowed Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.429 -0.795 . . . . 0.0 109.49 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -73.34 54.73 2.88 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 124.134 1.597 . . . . 0.0 110.268 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -161.68 -40.57 0.02 OUTLIER Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.756 -1.737 . . . . 0.0 108.756 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.42 ' O ' ' HA ' ' A' ' 36' ' ' VAL . . . -96.41 -36.71 10.73 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.407 -1.055 . . . . 0.0 108.908 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 1.051 ' CZ ' HG21 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -95.17 138.01 33.45 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.301 -0.874 . . . . 0.0 108.835 179.624 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.486 ' C ' ' HA ' ' A' ' 34' ' ' ALA . . . -162.87 121.69 2.13 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.027 -1.046 . . . . 0.0 110.197 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.576 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 6.8 tmm? -62.0 147.81 45.9 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.175 -0.953 . . . . 0.0 109.506 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.624 ' O ' ' N ' ' A' ' 32' ' ' GLU . 0.8 OUTLIER -125.67 161.78 48.8 Favored Pre-proline 0 C--N 1.315 -0.907 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 179.083 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.45 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 46.4 Cg_endo -84.0 -15.79 6.66 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 124.96 2.032 . . . . 0.0 107.958 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.39 -35.89 18.08 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 178.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.639 HD12 ' O ' ' A' ' 33' ' ' LYS . 2.7 pt -105.58 -1.99 9.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.624 ' N ' ' O ' ' A' ' 28' ' ' ASP . 2.1 mt-10 34.75 34.97 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -178.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.639 ' O ' HD12 ' A' ' 31' ' ' ILE . 34.2 mttp -160.49 151.67 19.14 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.213 -178.058 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.594 ' HB1' ' CD1' ' A' ' 25' ' ' PHE . . . -70.09 151.0 45.98 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.249 -0.907 . . . . 0.0 110.658 -179.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.651 ' CZ ' ' HB3' ' A' ' 37' ' ' LYS . 4.3 p90 -148.07 150.41 33.85 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 178.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.724 HG21 HG12 ' A' ' 39' ' ' VAL . 10.6 p -69.59 63.39 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 C-N-CA 119.055 -1.058 . . . . 0.0 108.205 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.651 ' HB3' ' CZ ' ' A' ' 35' ' ' TYR . 13.7 pttp -47.98 -27.49 2.24 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.265 0.555 . . . . 0.0 110.481 -179.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -157.33 92.27 1.23 Allowed 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 119.207 -0.997 . . . . 0.0 109.753 -178.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.724 HG12 HG21 ' A' ' 36' ' ' VAL . 26.8 m -49.11 -21.99 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.425 -0.797 . . . . 0.0 109.773 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.44 -16.79 57.2 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.149 -0.969 . . . . 0.0 109.476 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -77.45 1.38 66.05 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.506 ' CB ' ' HB1' ' A' ' 21' ' ' ALA . . . -157.27 124.0 5.03 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.14 -1.212 . . . . 0.0 109.781 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.554 ' N ' ' HG2' ' A' ' 46' ' ' GLU . 0.3 OUTLIER -53.86 163.0 0.79 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.375 -0.828 . . . . 0.0 109.754 179.708 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.448 ' HG3' ' HG2' ' A' ' 45' ' ' GLU . 11.1 pt20 -67.95 -40.34 83.26 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.351 -0.843 . . . . 0.0 109.853 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.504 ' O ' ' HG2' ' A' ' 48' ' ' GLU . 1.6 mm-40 -72.45 -26.23 61.75 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.075 -1.016 . . . . 0.0 109.53 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.56 ' O ' HG22 ' A' ' 20' ' ' ILE . 5.3 pt-20 -85.0 -31.5 23.45 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 105.476 -2.046 . . . . 0.0 105.476 177.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 43' ' ' SER . 2.5 t -65.28 -34.64 71.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.517 ' O ' ' N ' ' A' ' 51' ' ' MET . 8.4 pt-20 -74.45 -56.84 4.4 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.16 -0.962 . . . . 0.0 109.417 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.581 ' C ' HG21 ' A' ' 20' ' ' ILE . 61.8 tt0 -41.3 -38.32 1.15 Allowed 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.942 ' N ' HG21 ' A' ' 20' ' ' ILE . . . -67.95 -41.63 82.21 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.573 ' HE2' HG22 ' A' ' 59' ' ' ILE . 3.7 ttm -62.93 -47.72 82.04 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.94 -31.61 71.15 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.16 -0.963 . . . . 0.0 109.329 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 70.0 m -98.29 88.22 4.11 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.313 -0.867 . . . . 0.0 109.173 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . 0.536 ' SG ' ' HD2' ' A' ' 55' ' ' PRO . 21.6 t -161.15 145.82 10.38 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.198 -0.939 . . . . 0.0 109.334 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.712 ' O ' HG12 ' A' ' 56' ' ' VAL . 43.3 Cg_endo -71.21 101.3 1.09 Allowed 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 123.858 1.452 . . . . 0.0 109.425 179.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.806 HG11 ' CG ' ' A' ' 10' ' ' GLU . 0.4 OUTLIER 82.41 -9.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 -178.624 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.529 ' HA ' ' HB3' ' A' ' 54' ' ' CYS . 0.1 OUTLIER 63.04 148.38 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.441 -0.787 . . . . 0.0 110.641 179.393 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.585 ' O ' ' CE1' ' A' ' 60' ' ' HIS . 2.4 p -148.87 -34.81 0.2 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.72 -0.613 . . . . 0.0 109.403 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.881 ' HA ' HG13 ' A' ' 6' ' ' VAL . 17.1 mt -58.12 153.67 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.026 -1.046 . . . . 0.0 109.418 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.585 ' CE1' ' O ' ' A' ' 58' ' ' CYS . 45.6 m80 -159.06 125.0 4.41 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.565 ' HA ' ' CB ' ' A' ' 4' ' ' PHE . 87.8 m95 -55.22 171.11 0.17 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.121 -0.987 . . . . 0.0 109.108 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.513 ' HB3' ' HB3' ' A' ' 3' ' ' LYS . 1.3 tt0 . . . . . 0 C--N 1.302 -1.461 0 O-C-N 121.248 -0.907 . . . . 0.0 109.245 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.457 ' O ' ' HB3' ' A' ' 4' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.263 0.554 . . . . 0.0 109.602 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.565 ' CB ' ' HA ' ' A' ' 61' ' ' TRP . 6.1 p90 177.43 -172.12 0.1 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.321 -0.862 . . . . 0.0 109.262 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.623 ' HA ' HG11 ' A' ' 36' ' ' VAL . 46.8 p90 169.2 -177.77 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 1.086 HG21 ' CZ ' ' A' ' 25' ' ' PHE . 3.1 t -139.39 159.5 28.45 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.4 0 C-N-CA 116.962 -1.895 . . . . 0.0 111.417 179.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.544 ' N ' HG12 ' A' ' 6' ' ' VAL . 1.2 m-20 -106.9 72.52 0.89 Allowed 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.521 ' HB3' ' O ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER -41.8 -23.87 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 179.486 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 7' ' ' ASP . 19.5 t0 -50.92 -38.54 50.71 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.562 ' HB3' ' CB ' ' A' ' 58' ' ' CYS . 20.8 tt0 -82.02 -19.99 39.28 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.369 -0.832 . . . . 0.0 108.942 179.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.512 ' HB3' ' O ' ' A' ' 8' ' ' GLN . 36.9 t -51.15 123.92 10.47 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.477 -0.764 . . . . 0.0 109.806 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.683 ' O ' ' HB2' ' A' ' 13' ' ' ALA . 10.0 pt -75.32 -48.7 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.376 -0.827 . . . . 0.0 109.541 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.683 ' HB2' ' O ' ' A' ' 12' ' ' ILE . . . 166.13 -33.03 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.028 -1.045 . . . . 0.0 110.132 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -52.32 159.6 0.95 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.073 -1.017 . . . . 0.0 109.519 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.407 ' O ' ' C ' ' A' ' 16' ' ' SER . 13.6 pt-20 -123.75 21.85 9.1 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.31 -0.869 . . . . 0.0 109.505 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.428 ' O ' HD12 ' A' ' 20' ' ' ILE . 0.6 OUTLIER -44.53 -58.57 2.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.175 -0.953 . . . . 0.0 109.023 179.797 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.674 ' SG ' ' N ' ' A' ' 18' ' ' VAL . 17.6 p -49.96 -58.77 4.76 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.433 -0.792 . . . . 0.0 109.166 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.674 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 59.4 t -45.26 -34.41 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.224 -0.922 . . . . 0.0 109.044 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.39 -39.53 71.13 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.162 -0.961 . . . . 0.0 108.897 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.728 ' HB ' ' HB2' ' A' ' 50' ' ' ALA . 1.9 mt -87.1 17.77 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 177.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.639 ' HB1' ' HB2' ' A' ' 42' ' ' ALA . . . 172.31 65.42 0.03 OUTLIER Pre-proline 0 N--CA 1.489 1.482 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.503 ' N ' ' O ' ' A' ' 18' ' ' VAL . 43.8 Cg_endo -72.14 -2.09 11.07 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.108 1.583 . . . . 0.0 110.65 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.506 ' O ' ' HB3' ' A' ' 38' ' ' ASP . . . -92.2 -71.85 1.2 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.763 ' HB2' ' O ' ' A' ' 38' ' ' ASP . . . -66.82 -30.15 70.26 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.353 -1.087 . . . . 0.0 109.364 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 1.086 ' CZ ' HG21 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -105.42 133.75 49.66 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 118.821 -1.152 . . . . 0.0 109.904 -179.734 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.553 ' O ' ' CD1' ' A' ' 35' ' ' TYR . . . -166.27 123.97 1.42 Allowed 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.478 -0.764 . . . . 0.0 109.156 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.56 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER -62.17 155.63 23.91 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.169 -0.957 . . . . 0.0 109.092 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.589 ' O ' ' HA ' ' A' ' 32' ' ' GLU . 4.0 t0 -128.2 161.99 53.02 Favored Pre-proline 0 C--N 1.309 -1.166 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.477 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 43.9 Cg_endo -85.0 -18.16 4.42 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 124.428 1.752 . . . . 0.0 108.562 -179.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -89.32 -32.75 17.19 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 177.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.635 HD12 ' HB3' ' A' ' 35' ' ' TYR . 0.8 OUTLIER -104.79 2.19 10.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 178.071 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.589 ' HA ' ' O ' ' A' ' 28' ' ' ASP . 9.9 mt-10 26.34 43.68 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.51 0.672 . . . . 0.0 110.212 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.53 ' O ' ' HA ' ' A' ' 27' ' ' MET . 6.2 mttt -172.13 148.46 2.2 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 119.134 -1.027 . . . . 0.0 110.653 -179.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.56 ' HA ' ' HA ' ' A' ' 27' ' ' MET . . . -54.71 142.21 29.44 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.684 -0.635 . . . . 0.0 110.634 -179.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.71 ' CE2' ' HG3' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -143.91 151.01 39.26 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-O 121.764 0.792 . . . . 0.0 109.95 179.156 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.805 ' HB ' HG23 ' A' ' 6' ' ' VAL . 0.9 OUTLIER -91.04 109.19 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.424 -1.422 . . . . 0.0 109.563 -178.637 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.71 ' HG3' ' CE2' ' A' ' 35' ' ' TYR . 23.5 mmtt -125.75 -53.25 1.56 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.423 -0.798 . . . . 0.0 110.445 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.763 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 61.6 t0 -86.98 71.94 10.17 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.599 -0.688 . . . . 0.0 110.462 -177.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.523 HG23 ' N ' ' A' ' 40' ' ' GLU . 24.8 m -46.58 -40.59 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.322 -0.861 . . . . 0.0 109.194 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.523 ' N ' HG23 ' A' ' 39' ' ' VAL . 11.0 mm-40 -66.33 -17.71 64.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.352 -0.842 . . . . 0.0 109.499 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' A' ' 38' ' ' ASP . . . -72.43 -21.13 79.58 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.639 ' HB2' ' HB1' ' A' ' 21' ' ' ALA . . . -132.02 134.67 45.83 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.277 -1.131 . . . . 0.0 109.296 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.692 ' O ' HG23 ' A' ' 47' ' ' VAL . 0.4 OUTLIER -79.29 -166.99 1.04 Allowed 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.224 -0.922 . . . . 0.0 109.775 -179.8 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.477 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 1.9 mt-30 -71.44 -49.58 40.27 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.664 -0.647 . . . . 0.0 109.56 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.459 ' O ' ' HB2' ' A' ' 49' ' ' GLU . 1.8 pm0 -72.77 -12.84 61.16 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.175 -0.953 . . . . 0.0 109.298 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.476 ' HG3' ' HB2' ' A' ' 43' ' ' SER . 29.9 mt-10 -90.71 -42.01 10.96 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 178.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.692 HG23 ' O ' ' A' ' 43' ' ' SER . 24.2 t -63.95 -47.53 90.12 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 CA-C-N 114.789 -1.096 . . . . 0.0 108.093 178.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.526 ' O ' ' N ' ' A' ' 51' ' ' MET . 0.3 OUTLIER -67.97 -62.23 1.5 Allowed 'General case' 0 C--N 1.307 -1.243 0 O-C-N 121.584 -0.697 . . . . 0.0 109.591 179.583 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.628 ' HB3' HG21 ' A' ' 20' ' ' ILE . 34.6 mt-10 -43.23 -52.01 5.86 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 119.44 -0.904 . . . . 0.0 108.918 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.728 ' HB2' ' HB ' ' A' ' 20' ' ' ILE . . . -65.53 -27.86 68.76 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 1.029 ' CG ' HG21 ' A' ' 59' ' ' ILE . 22.5 ttm -76.88 -21.68 54.58 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.627 -0.67 . . . . 0.0 110.35 -179.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.81 -15.78 26.11 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.085 -1.009 . . . . 0.0 109.759 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.527 ' OG1' ' CD1' ' A' ' 20' ' ' ILE . 76.2 p -91.91 73.63 5.66 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.189 -0.944 . . . . 0.0 109.455 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 19.0 t -151.65 128.49 5.43 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.219 -0.926 . . . . 0.0 109.684 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.596 ' C ' HG12 ' A' ' 56' ' ' VAL . 47.1 Cg_endo -75.48 53.73 3.64 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 123.857 1.451 . . . . 0.0 109.912 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.596 HG12 ' C ' ' A' ' 55' ' ' PRO . 1.5 p 160.42 -26.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 60.19 72.96 0.5 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.569 -0.707 . . . . 0.0 109.933 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.562 ' CB ' ' HB3' ' A' ' 10' ' ' GLU . 29.7 p -84.6 7.98 18.31 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.108 -0.995 . . . . 0.0 109.198 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 1.029 HG21 ' CG ' ' A' ' 51' ' ' MET . 1.0 OUTLIER -75.87 155.62 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.348 -0.845 . . . . 0.0 110.505 -179.232 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.56 ' CD2' ' O ' ' A' ' 59' ' ' ILE . 39.7 m80 -155.52 125.36 6.51 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.565 ' HA ' ' CB ' ' A' ' 4' ' ' PHE . 62.5 m95 -73.05 173.89 8.69 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.194 -0.941 . . . . 0.0 109.652 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.453 ' HB3' ' HB3' ' A' ' 3' ' ' LYS . 9.6 tp10 . . . . . 0 N--CA 1.49 1.526 0 O-C-N 121.327 -0.858 . . . . 0.0 109.333 -179.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.475 ' O ' ' HB3' ' A' ' 4' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.562 ' CB ' ' HA ' ' A' ' 61' ' ' TRP . 2.5 p90 177.9 -178.73 0.24 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.293 -0.879 . . . . 0.0 110.007 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.463 ' HA ' HG11 ' A' ' 36' ' ' VAL . 20.3 p90 174.68 -167.0 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 1.088 HG21 ' CZ ' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -137.03 -166.36 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 C-N-CA 118.406 -1.318 . . . . 0.0 111.066 179.713 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.532 ' O ' ' N ' ' A' ' 9' ' ' ASP . 0.3 OUTLIER -151.65 98.98 2.55 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 114.413 -1.267 . . . . 0.0 108.056 177.784 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.6 ' CG ' ' HB3' ' A' ' 33' ' ' LYS . 2.9 mp0 -65.15 43.3 0.02 OUTLIER 'General case' 0 C--N 1.29 -2.001 0 CA-C-O 121.367 0.603 . . . . 0.0 110.392 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.532 ' N ' ' O ' ' A' ' 7' ' ' ASP . 0.5 OUTLIER -99.42 -29.68 12.62 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.265 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.471 ' HB2' ' SG ' ' A' ' 58' ' ' CYS . 0.0 OUTLIER -118.31 25.59 10.2 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.859 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.712 ' SG ' ' HG2' ' A' ' 33' ' ' LYS . 14.3 t -90.22 119.07 30.22 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.225 -0.922 . . . . 0.0 110.432 -179.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.439 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 12.2 pt -88.61 5.01 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . 61.76 65.26 0.94 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.367 -0.833 . . . . 0.0 109.665 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.783 ' SG ' ' OG ' ' A' ' 16' ' ' SER . 31.7 p -102.22 -9.89 20.06 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.082 -1.011 . . . . 0.0 109.678 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.447 ' OE1' ' HG3' ' A' ' 19' ' ' GLU . 0.0 OUTLIER 70.7 4.29 4.93 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.24 -0.913 . . . . 0.0 109.84 179.591 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.783 ' OG ' ' SG ' ' A' ' 14' ' ' CYS . 29.6 p -62.15 -69.77 0.23 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.068 -1.02 . . . . 0.0 109.335 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.634 ' SG ' ' N ' ' A' ' 18' ' ' VAL . 19.4 p -49.33 -55.87 11.43 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.328 -0.857 . . . . 0.0 109.385 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.634 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 59.6 t -46.32 -33.14 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.199 -0.938 . . . . 0.0 109.012 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.447 ' HG3' ' OE1' ' A' ' 15' ' ' GLU . 5.3 mt-10 -71.05 -34.78 71.57 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.999 -1.063 . . . . 0.0 108.592 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.633 HG22 ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -81.16 6.05 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.252 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.59 ' HB1' ' HB2' ' A' ' 42' ' ' ALA . . . 176.82 65.47 0.07 OUTLIER Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.274 -0.891 . . . . 0.0 109.009 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.54 ' N ' ' O ' ' A' ' 18' ' ' VAL . 46.0 Cg_endo -71.92 0.12 7.62 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.039 1.547 . . . . 0.0 110.783 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -96.3 -31.66 7.09 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.679 ' HB1' ' O ' ' A' ' 38' ' ' ASP . . . -109.4 -53.65 2.63 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.333 -1.098 . . . . 0.0 109.99 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 1.088 ' CZ ' HG21 ' A' ' 6' ' ' VAL . 0.3 OUTLIER -75.22 139.43 42.59 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 118.561 -1.256 . . . . 0.0 107.689 179.727 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.574 ' O ' ' CD1' ' A' ' 35' ' ' TYR . . . -172.13 140.84 1.22 Allowed 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.263 -0.898 . . . . 0.0 109.561 -179.217 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.554 ' HA ' ' C ' ' A' ' 33' ' ' LYS . 5.1 mtp -71.55 158.35 36.39 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.292 -0.88 . . . . 0.0 109.94 -179.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.613 ' O ' ' N ' ' A' ' 32' ' ' GLU . 3.9 t0 -126.31 161.52 51.74 Favored Pre-proline 0 C--N 1.309 -1.154 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.489 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 44.3 Cg_endo -85.19 -16.13 5.15 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 O-C-N 124.691 1.89 . . . . 0.0 108.626 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -91.53 -29.7 16.83 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 178.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.575 ' CD1' ' HB3' ' A' ' 35' ' ' TYR . 1.0 OUTLIER -106.2 -5.25 10.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.25 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.613 ' N ' ' O ' ' A' ' 28' ' ' ASP . 6.9 mm-40 33.59 41.52 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 121.433 0.635 . . . . 0.0 109.303 -179.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.712 ' HG2' ' SG ' ' A' ' 11' ' ' CYS . 0.2 OUTLIER -169.74 146.3 3.22 Favored 'General case' 0 N--CA 1.501 2.109 0 C-N-CA 119.601 -0.839 . . . . 0.0 110.365 -179.176 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.742 ' HB1' ' CD1' ' A' ' 25' ' ' PHE . . . -47.99 146.54 2.47 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.425 -0.797 . . . . 0.0 111.564 -178.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.676 ' CE2' ' CG ' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -135.83 -174.29 3.61 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.965 -1.085 . . . . 0.0 110.086 179.075 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.784 HG23 ' CG2' ' A' ' 6' ' ' VAL . 2.5 t -125.98 92.44 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.676 ' CG ' ' CE2' ' A' ' 35' ' ' TYR . 18.5 mmtt -103.87 -46.07 4.59 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 119.567 -0.853 . . . . 0.0 111.286 -178.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.679 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 62.8 t0 -93.59 118.24 31.11 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 119.207 -0.997 . . . . 0.0 110.564 -177.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.2 m -80.52 -17.11 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.338 -0.851 . . . . 0.0 109.268 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.424 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -103.01 2.39 34.87 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.355 -0.841 . . . . 0.0 109.558 -179.994 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.569 ' HA3' ' HB2' ' A' ' 24' ' ' ALA . . . -78.24 -7.64 87.71 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.674 -1.371 . . . . 0.0 109.674 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.59 ' HB2' ' HB1' ' A' ' 21' ' ' ALA . . . -149.08 127.84 12.51 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.229 -1.159 . . . . 0.0 109.566 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.927 ' O ' HG23 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -67.61 166.79 14.28 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.235 -0.916 . . . . 0.0 109.43 179.951 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.463 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -51.66 -45.28 63.32 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.412 -0.805 . . . . 0.0 109.438 179.979 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.414 ' O ' ' CG ' ' A' ' 49' ' ' GLU . 50.0 mm-40 -67.54 -8.4 33.63 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.362 -0.836 . . . . 0.0 109.646 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.528 ' HB2' ' HB1' ' A' ' 42' ' ' ALA . 11.9 mt-10 -100.32 -43.88 6.11 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 179.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.927 HG23 ' O ' ' A' ' 43' ' ' SER . 1.9 t -60.49 -40.54 84.63 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 178.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.463 ' HB2' ' O ' ' A' ' 44' ' ' GLN . 0.2 OUTLIER -74.86 -48.43 25.0 Favored 'General case' 0 C--N 1.308 -1.227 0 O-C-N 121.527 -0.733 . . . . 0.0 109.198 179.293 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.527 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . 34.1 mt-10 -53.5 -54.01 43.26 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.189 -0.944 . . . . 0.0 109.096 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.522 ' HB2' ' CG2' ' A' ' 20' ' ' ILE . . . -63.83 -18.04 63.73 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.143 -0.973 . . . . 0.0 108.945 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.595 ' HE3' HD12 ' A' ' 59' ' ' ILE . 38.6 ttm -77.87 -18.31 56.37 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.416 -0.802 . . . . 0.0 109.208 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -105.35 -23.73 12.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.32 -0.863 . . . . 0.0 109.599 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -62.39 -48.02 81.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.23 -0.919 . . . . 0.0 109.768 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . 0.79 ' SG ' ' HD2' ' A' ' 55' ' ' PRO . 4.6 t -48.88 147.41 4.62 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.139 -0.975 . . . . 0.0 109.606 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.79 ' HD2' ' SG ' ' A' ' 54' ' ' CYS . 44.1 Cg_endo -73.91 -64.65 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.986 1.519 . . . . 0.0 110.509 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.427 ' O ' ' HB2' ' A' ' 57' ' ' GLN . 38.4 t -79.08 -25.02 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.115 -0.99 . . . . 0.0 109.098 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.427 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER 67.38 72.04 0.35 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.277 -0.889 . . . . 0.0 109.755 179.719 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.471 ' SG ' ' HB2' ' A' ' 10' ' ' GLU . 0.7 OUTLIER -89.87 21.89 3.4 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.188 -0.945 . . . . 0.0 109.155 179.571 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 1.038 HD13 ' N ' ' A' ' 60' ' ' HIS . 0.0 OUTLIER -108.65 140.69 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.341 -0.85 . . . . 0.0 109.564 -179.651 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 1.038 ' N ' HD13 ' A' ' 59' ' ' ILE . 2.7 m80 -142.48 -177.47 5.29 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.279 -0.888 . . . . 0.0 109.532 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.562 ' HA ' ' CB ' ' A' ' 4' ' ' PHE . 36.0 m95 -97.84 -179.25 4.36 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.014 -1.054 . . . . 0.0 109.697 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.2 tp10 . . . . . 0 N--CA 1.49 1.541 0 O-C-N 121.267 -0.896 . . . . 0.0 109.621 -179.561 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.495 ' O ' ' HB3' ' A' ' 4' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.464 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.553 ' CB ' ' HA ' ' A' ' 61' ' ' TRP . 53.8 p90 173.06 -176.06 0.06 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.357 -0.839 . . . . 0.0 108.895 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.79 ' HA ' HG11 ' A' ' 36' ' ' VAL . 51.6 p90 175.84 -173.28 0.08 Allowed 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 179.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.789 HG13 ' HB ' ' A' ' 59' ' ' ILE . 2.9 t -145.57 166.37 10.0 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.428 0 C-N-CA 117.397 -1.721 . . . . 0.0 112.094 -179.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.57 ' H ' HG12 ' A' ' 6' ' ' VAL . 8.5 t0 -105.22 74.56 1.11 Allowed 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.537 ' O ' ' CD ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -53.72 -11.51 0.39 Allowed 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.362 179.576 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.42 ' N ' ' C ' ' A' ' 7' ' ' ASP . 0.1 OUTLIER -65.61 -32.8 74.57 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.634 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.578 ' HB3' ' CB ' ' A' ' 58' ' ' CYS . 0.1 OUTLIER -91.16 -16.3 27.97 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.09 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.409 ' HB3' ' O ' ' A' ' 8' ' ' GLN . 7.2 t -43.46 128.41 4.97 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.432 -0.793 . . . . 0.0 110.075 -179.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.585 HD11 ' HB3' ' A' ' 14' ' ' CYS . 4.5 pt -79.25 -134.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.444 -0.785 . . . . 0.0 109.066 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -119.67 43.55 2.61 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.762 -1.211 . . . . 0.0 110.017 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 1.009 ' SG ' ' OG ' ' A' ' 16' ' ' SER . 0.1 OUTLIER -124.91 156.83 37.33 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.075 -1.016 . . . . 0.0 109.594 179.557 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.437 ' O ' ' C ' ' A' ' 16' ' ' SER . 14.3 mt-10 -117.26 17.75 14.64 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.299 -0.876 . . . . 0.0 109.685 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 1.009 ' OG ' ' SG ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -44.42 -70.57 0.1 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.245 -0.909 . . . . 0.0 108.996 179.722 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.645 ' SG ' ' N ' ' A' ' 18' ' ' VAL . 8.3 p -44.17 -51.51 8.06 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.262 -0.898 . . . . 0.0 109.325 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.645 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 41.5 t -50.15 -33.31 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.362 -0.836 . . . . 0.0 109.61 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -84.74 -30.93 24.31 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.129 -0.982 . . . . 0.0 109.414 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.841 HD12 ' O ' ' A' ' 16' ' ' SER . 2.7 mp -81.76 9.12 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.206 -0.934 . . . . 0.0 108.646 178.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -169.86 69.41 0.62 Allowed Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.17 -0.956 . . . . 0.0 109.309 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -71.72 76.83 1.9 Allowed 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 124.206 1.635 . . . . 0.0 110.181 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.444 ' C ' ' HA3' ' A' ' 41' ' ' GLY . . . 165.02 -42.55 0.29 Allowed Glycine 0 N--CA 1.488 2.117 0 N-CA-C 108.672 -1.771 . . . . 0.0 108.672 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.487 ' HA ' ' O ' ' A' ' 38' ' ' ASP . . . -92.99 -49.3 6.09 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.415 -1.05 . . . . 0.0 109.046 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.782 ' CZ ' HG21 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -96.06 137.84 34.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.269 -0.894 . . . . 0.0 108.818 179.582 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.445 ' O ' ' CD1' ' A' ' 35' ' ' TYR . . . -174.77 126.66 0.3 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.025 -1.047 . . . . 0.0 109.609 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.596 ' HA ' ' C ' ' A' ' 33' ' ' LYS . 29.3 mtp -58.56 150.86 21.85 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.315 -0.865 . . . . 0.0 109.365 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.615 ' O ' ' N ' ' A' ' 32' ' ' GLU . 1.6 t0 -130.26 163.99 44.03 Favored Pre-proline 0 C--N 1.311 -1.085 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.487 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 43.9 Cg_endo -83.29 -16.44 7.1 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 124.803 1.949 . . . . 0.0 107.571 179.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.713 ' HB3' HD13 ' A' ' 31' ' ' ILE . 8.1 tt0 -82.84 -42.38 17.9 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 177.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.745 ' N ' HD13 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -102.14 0.26 10.26 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 178.098 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.615 ' N ' ' O ' ' A' ' 28' ' ' ASP . 2.9 mm-40 35.33 34.55 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -179.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.596 ' C ' ' HA ' ' A' ' 27' ' ' MET . 59.4 mttp -163.55 151.16 12.83 Favored 'General case' 0 N--CA 1.499 2.0 0 C-N-CA 119.556 -0.858 . . . . 0.0 110.183 -177.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.539 ' HA ' ' HA ' ' A' ' 27' ' ' MET . . . -59.18 139.97 56.38 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.444 -0.785 . . . . 0.0 110.206 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.647 ' CE2' ' HA ' ' A' ' 37' ' ' LYS . 1.5 p90 -154.06 155.89 36.31 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.79 HG11 ' HA ' ' A' ' 5' ' ' TYR . 14.9 p -67.01 67.19 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 120.905 -1.122 . . . . 0.0 108.933 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.647 ' HA ' ' CE2' ' A' ' 35' ' ' TYR . 0.1 OUTLIER -51.01 -19.05 0.92 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.533 -0.729 . . . . 0.0 110.391 -179.664 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.492 ' N ' ' HG3' ' A' ' 37' ' ' LYS . 11.5 t70 -167.21 103.42 0.53 Allowed 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.996 -1.065 . . . . 0.0 109.674 -179.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.543 ' HB ' ' CE1' ' A' ' 4' ' ' PHE . 1.8 m -55.39 -24.39 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.378 -0.826 . . . . 0.0 109.835 -179.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -90.89 -0.6 57.77 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.168 -0.958 . . . . 0.0 109.601 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.45 ' N ' ' OD2' ' A' ' 38' ' ' ASP . . . -76.36 -16.05 81.02 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -141.92 161.74 37.21 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.192 -1.181 . . . . 0.0 109.333 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.07 173.89 9.56 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.263 -0.898 . . . . 0.0 109.571 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.457 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 1.0 OUTLIER -70.09 -38.56 75.7 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.363 -0.836 . . . . 0.0 109.233 179.895 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 36.0 mm-40 -66.91 -21.87 65.97 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.143 -0.973 . . . . 0.0 108.875 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -90.2 -43.1 10.65 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 178.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 4.0 t -58.25 -38.11 66.77 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 178.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.457 ' HB2' ' O ' ' A' ' 44' ' ' GLN . 0.1 OUTLIER -70.22 -65.93 0.66 Allowed 'General case' 0 C--N 1.308 -1.229 0 O-C-N 121.562 -0.712 . . . . 0.0 109.584 179.715 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.645 ' C ' HG21 ' A' ' 20' ' ' ILE . 16.1 mt-10 -47.5 -42.45 23.0 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.259 -0.9 . . . . 0.0 109.052 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.824 ' N ' HG21 ' A' ' 20' ' ' ILE . . . -68.59 -27.08 65.73 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.356 -0.84 . . . . 0.0 109.024 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.712 ' HG3' HG21 ' A' ' 59' ' ' ILE . 6.6 ttm -83.92 -17.63 40.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.482 -0.761 . . . . 0.0 109.904 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -95.02 -10.36 31.11 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.048 -1.032 . . . . 0.0 109.795 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.745 ' OG1' HD13 ' A' ' 20' ' ' ILE . 12.0 p -91.08 8.05 37.42 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.242 -0.911 . . . . 0.0 109.642 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . 0.518 ' SG ' ' HD2' ' A' ' 55' ' ' PRO . 8.7 t -95.35 140.74 22.51 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.22 -0.925 . . . . 0.0 109.399 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.518 ' HD2' ' SG ' ' A' ' 54' ' ' CYS . 46.1 Cg_endo -75.16 -58.18 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.942 1.496 . . . . 0.0 109.931 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.524 HG21 ' HG2' ' A' ' 10' ' ' GLU . 7.6 p -84.63 -23.19 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.319 -0.863 . . . . 0.0 108.898 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.503 ' CB ' ' O ' ' A' ' 56' ' ' VAL . 1.9 tt0 77.71 -66.44 0.22 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.495 -0.753 . . . . 0.0 110.459 179.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.578 ' CB ' ' HB3' ' A' ' 10' ' ' GLU . 2.5 p 43.57 26.41 0.11 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.225 -0.922 . . . . 0.0 109.156 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.789 ' HB ' HG13 ' A' ' 6' ' ' VAL . 9.4 tt -125.77 164.1 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.466 -0.771 . . . . 0.0 110.304 -178.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.665 ' CD2' ' CZ ' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -172.64 173.61 3.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.337 -0.852 . . . . 0.0 109.245 179.987 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.553 ' HA ' ' CB ' ' A' ' 4' ' ' PHE . 50.9 m95 -98.66 164.3 12.29 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.152 -0.968 . . . . 0.0 109.767 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.485 ' N ' ' HA ' ' A' ' 4' ' ' PHE . 20.6 tt0 . . . . . 0 N--CA 1.489 1.524 0 O-C-N 121.362 -0.836 . . . . 0.0 109.469 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.509 ' HB3' ' HB3' ' A' ' 62' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.604 ' CE1' ' HA ' ' A' ' 39' ' ' VAL . 20.7 p90 179.2 -159.05 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.166 -0.959 . . . . 0.0 109.768 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.7 ' HA ' HG21 ' A' ' 36' ' ' VAL . 4.6 p90 168.04 -178.75 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 -179.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 1.104 HG23 HG22 ' A' ' 36' ' ' VAL . 1.6 t -121.64 145.07 28.82 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.251 0 C-N-CA 116.914 -1.914 . . . . 0.0 111.954 -179.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.495 ' O ' ' N ' ' A' ' 9' ' ' ASP . 0.2 OUTLIER -96.7 38.9 1.19 Allowed 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.718 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.67 ' HG3' HG21 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -38.6 -27.94 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.125 0.488 . . . . 0.0 110.15 -179.689 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.495 ' N ' ' O ' ' A' ' 7' ' ' ASP . 4.8 t0 -46.62 -25.3 0.68 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.159 -0.963 . . . . 0.0 108.822 179.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.477 ' HB3' ' HB3' ' A' ' 58' ' ' CYS . 14.7 tt0 -108.04 -15.48 14.51 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.465 -0.772 . . . . 0.0 109.577 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.654 ' SG ' ' HG2' ' A' ' 33' ' ' LYS . 40.6 t -43.37 141.72 1.27 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.17 -0.956 . . . . 0.0 109.661 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.694 ' O ' ' HB2' ' A' ' 13' ' ' ALA . 8.0 pt -98.59 -47.49 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.242 -0.911 . . . . 0.0 109.826 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.694 ' HB2' ' O ' ' A' ' 12' ' ' ILE . . . 166.0 -34.9 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.059 -1.026 . . . . 0.0 110.157 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -47.61 159.86 0.14 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.085 -1.01 . . . . 0.0 109.614 -179.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -122.13 22.23 10.27 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.321 -0.862 . . . . 0.0 109.854 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.571 ' O ' HD12 ' A' ' 20' ' ' ILE . 0.3 OUTLIER -46.26 -58.33 3.77 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.218 -0.926 . . . . 0.0 109.039 179.728 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.945 ' SG ' ' HD2' ' A' ' 25' ' ' PHE . 19.8 p -52.17 -57.26 10.16 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.37 -0.831 . . . . 0.0 109.239 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.644 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 98.2 t -45.15 -28.14 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.277 -0.89 . . . . 0.0 109.164 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.97 -37.7 23.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.187 -0.946 . . . . 0.0 108.914 179.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.841 HD13 ' HA ' ' A' ' 50' ' ' ALA . 1.8 mt -88.33 18.06 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 177.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.522 ' HB2' ' O ' ' A' ' 20' ' ' ILE . . . 172.56 64.6 0.03 OUTLIER Pre-proline 0 N--CA 1.488 1.451 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -74.25 2.29 6.35 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 124.073 1.565 . . . . 0.0 110.62 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.482 ' O ' ' HB3' ' A' ' 37' ' ' LYS . . . -113.86 -22.7 5.25 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.534 ' O ' ' N ' ' A' ' 37' ' ' LYS . . . -110.66 -30.25 7.68 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.249 -1.147 . . . . 0.0 109.624 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 1.093 ' CE1' HG22 ' A' ' 6' ' ' VAL . 0.8 OUTLIER -114.62 129.84 56.72 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.21 -0.931 . . . . 0.0 108.564 179.762 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.587 ' HA ' HG22 ' A' ' 18' ' ' VAL . . . -158.76 146.83 18.13 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.874 -1.141 . . . . 0.0 110.36 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.55 ' HA ' ' C ' ' A' ' 33' ' ' LYS . 1.3 ttm -74.22 152.38 39.76 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.275 -0.891 . . . . 0.0 109.004 179.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.589 ' O ' ' N ' ' A' ' 32' ' ' GLU . 1.2 t0 -133.5 165.77 34.23 Favored Pre-proline 0 C--O 1.211 -0.948 0 O-C-N 120.197 -1.564 . . . . 0.0 108.071 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.508 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 44.8 Cg_endo -84.44 -16.56 5.75 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 124.507 1.793 . . . . 0.0 107.725 179.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.491 ' HB3' HD13 ' A' ' 31' ' ' ILE . 0.3 OUTLIER -85.18 -38.95 18.39 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 178.122 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.67 HG21 ' HG3' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -104.29 0.47 10.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 178.068 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.589 ' N ' ' O ' ' A' ' 28' ' ' ASP . 5.2 mt-10 34.97 35.91 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -179.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.654 ' HG2' ' SG ' ' A' ' 11' ' ' CYS . 0.1 OUTLIER -172.95 167.26 5.07 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 119.82 -0.752 . . . . 0.0 109.228 -178.367 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.529 ' O ' ' HB3' ' A' ' 8' ' ' GLN . . . -37.45 157.45 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.515 0.674 . . . . 0.0 110.318 -179.139 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.65 ' CZ ' ' HA ' ' A' ' 37' ' ' LYS . 0.2 OUTLIER -162.41 150.26 14.18 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 179.729 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 1.104 HG22 HG23 ' A' ' 6' ' ' VAL . 4.3 t -64.76 88.04 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 120.963 -1.086 . . . . 0.0 109.907 -178.04 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.65 ' HA ' ' CZ ' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -55.56 -26.54 44.01 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.459 -0.776 . . . . 0.0 109.528 179.589 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 39' ' ' VAL . 9.9 t0 175.43 157.99 0.21 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.255 -0.903 . . . . 0.0 109.625 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.604 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 11.6 m -78.22 -21.98 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.321 -0.862 . . . . 0.0 110.111 -179.275 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -117.11 18.95 14.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.12 -0.987 . . . . 0.0 109.422 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.448 ' HA3' ' C ' ' A' ' 23' ' ' GLY . . . -67.7 -15.8 67.04 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 -179.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.483 ' HB1' ' HB2' ' A' ' 46' ' ' GLU . . . -148.93 153.72 38.4 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.035 -1.273 . . . . 0.0 109.692 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.469 ' OG ' ' HG3' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -77.12 156.6 31.55 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.349 -0.844 . . . . 0.0 109.944 -179.775 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.489 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -48.47 -48.41 37.83 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.402 -0.811 . . . . 0.0 109.151 179.768 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -57.63 -36.8 72.3 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.209 -0.932 . . . . 0.0 108.979 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.483 ' HB2' ' HB1' ' A' ' 42' ' ' ALA . 14.4 mt-10 -73.06 -57.04 4.31 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.275 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.627 ' CG1' ' CH2' ' A' ' 61' ' ' TRP . 1.2 t -50.87 -32.15 11.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 179.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.489 ' HB2' ' O ' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -65.66 -72.89 0.14 Allowed 'General case' 0 C--N 1.309 -1.193 0 O-C-N 121.264 -0.898 . . . . 0.0 109.866 179.966 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -47.22 -39.67 14.63 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.273 -0.892 . . . . 0.0 109.233 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.841 ' HA ' HD13 ' A' ' 20' ' ' ILE . . . -61.03 -39.62 90.49 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.281 -0.887 . . . . 0.0 108.918 179.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 1.025 ' HE2' HG13 ' A' ' 59' ' ' ILE . 45.0 ttm -74.53 -29.8 61.52 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.443 -0.785 . . . . 0.0 109.169 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -60.99 -45.99 92.57 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.296 -0.877 . . . . 0.0 109.141 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.517 ' O ' ' HB3' ' A' ' 54' ' ' CYS . 65.9 p -68.25 -152.68 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.336 -0.852 . . . . 0.0 109.072 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . 0.941 ' SG ' ' CA ' ' A' ' 57' ' ' GLN . 10.3 t 73.41 122.28 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.268 -0.895 . . . . 0.0 109.779 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -73.51 -44.08 0.58 Allowed 'Trans proline' 0 C--N 1.308 -1.562 0 O-C-N 123.863 1.454 . . . . 0.0 109.083 179.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.509 ' O ' ' CB ' ' A' ' 57' ' ' GLN . 1.9 m -96.37 -17.65 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.998 ' O ' HG22 ' A' ' 59' ' ' ILE . 0.9 OUTLIER 81.34 -59.77 0.24 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.724 -0.61 . . . . 0.0 110.569 179.542 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.523 ' O ' HG12 ' A' ' 6' ' ' VAL . 11.9 p 35.88 41.6 0.12 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.641 -0.662 . . . . 0.0 109.51 -179.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 1.027 HD12 ' N ' ' A' ' 60' ' ' HIS . 0.1 OUTLIER -148.56 137.44 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.501 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 1.027 ' N ' HD12 ' A' ' 59' ' ' ILE . 31.0 m80 -155.7 163.56 39.74 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.708 -1.245 . . . . 0.0 110.469 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.627 ' CH2' ' CG1' ' A' ' 47' ' ' VAL . 72.2 m95 -87.63 -176.15 5.45 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.381 -0.824 . . . . 0.0 109.216 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.509 ' HB3' ' HB3' ' A' ' 3' ' ' LYS . 7.4 tt0 . . . . . 0 N--CA 1.489 1.5 0 O-C-N 121.332 -0.855 . . . . 0.0 109.208 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.459 ' O ' ' HB3' ' A' ' 4' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.829 ' CE1' HG12 ' A' ' 39' ' ' VAL . 11.5 p90 176.81 174.49 0.39 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.282 -0.886 . . . . 0.0 109.864 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.8 ' HA ' HG11 ' A' ' 36' ' ' VAL . 1.3 p90 177.15 -171.6 0.09 Allowed 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 179.237 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.982 HG23 ' HB ' ' A' ' 36' ' ' VAL . 0.2 OUTLIER -135.44 177.18 7.01 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 C-N-CA 117.693 -1.603 . . . . 0.0 111.651 179.869 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.583 ' H ' HG12 ' A' ' 6' ' ' VAL . 0.3 OUTLIER -129.35 92.45 3.36 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.786 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.567 ' CG ' ' O ' ' A' ' 34' ' ' ALA . 3.7 mp0 -65.36 45.2 0.02 OUTLIER 'General case' 0 C--N 1.291 -1.945 0 CA-C-O 121.617 0.722 . . . . 0.0 110.669 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.555 ' N ' ' O ' ' A' ' 7' ' ' ASP . 1.0 OUTLIER -110.93 -44.89 3.54 Favored 'General case' 0 C--N 1.285 -2.202 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.214 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.681 ' O ' HG21 ' A' ' 56' ' ' VAL . 0.3 OUTLIER -89.85 -7.35 54.48 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.741 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.671 ' SG ' ' HG2' ' A' ' 33' ' ' LYS . 39.6 t -62.95 144.2 57.02 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.453 -0.779 . . . . 0.0 110.195 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.7 pt -102.0 -113.16 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.293 -0.88 . . . . 0.0 108.798 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -135.27 26.61 3.5 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.778 -1.201 . . . . 0.0 109.043 179.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -102.1 149.6 24.11 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.28 -0.888 . . . . 0.0 109.905 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.48 ' HB2' ' HB ' ' A' ' 18' ' ' VAL . 0.7 OUTLIER -109.13 20.03 18.81 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.468 -0.77 . . . . 0.0 109.645 -179.856 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 15' ' ' GLU . 56.7 m -43.86 -66.78 0.34 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.262 -0.898 . . . . 0.0 109.34 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.969 ' SG ' ' CD2' ' A' ' 25' ' ' PHE . 19.0 p -48.52 -46.49 38.62 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.323 -0.86 . . . . 0.0 109.328 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.48 ' HB ' ' HB2' ' A' ' 15' ' ' GLU . 59.0 t -50.24 -31.28 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.276 -0.89 . . . . 0.0 109.329 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -77.52 -34.56 53.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.244 -0.91 . . . . 0.0 109.395 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.915 HG21 ' N ' ' A' ' 50' ' ' ALA . 2.5 mp -79.95 5.36 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 178.318 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.498 ' HB1' ' HB2' ' A' ' 42' ' ' ALA . . . -172.8 65.15 0.34 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.351 -0.843 . . . . 0.0 109.045 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.37 70.13 2.53 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 O-C-N 124.286 1.677 . . . . 0.0 110.266 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.49 ' O ' ' HB3' ' A' ' 38' ' ' ASP . . . 177.72 -43.51 0.09 OUTLIER Glycine 0 N--CA 1.488 2.105 0 N-CA-C 108.737 -1.745 . . . . 0.0 108.737 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.585 ' HB2' ' O ' ' A' ' 38' ' ' ASP . . . -93.17 -32.25 14.47 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.555 -0.968 . . . . 0.0 109.029 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.969 ' CD2' ' SG ' ' A' ' 17' ' ' CYS . 0.1 OUTLIER -105.58 141.73 36.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.333 -0.855 . . . . 0.0 108.878 179.905 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.49 ' O ' ' CD1' ' A' ' 35' ' ' TYR . . . -174.96 125.32 0.27 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.115 -0.991 . . . . 0.0 109.286 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.579 ' HA ' ' C ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -58.5 154.3 14.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.165 -0.96 . . . . 0.0 109.558 -179.769 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.604 ' O ' ' N ' ' A' ' 32' ' ' GLU . 0.7 OUTLIER -126.18 163.29 40.87 Favored Pre-proline 0 C--N 1.313 -1.005 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 179.295 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.458 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 47.7 Cg_endo -84.19 -16.67 5.98 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 125.055 2.081 . . . . 0.0 108.279 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -88.07 -35.78 17.32 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 178.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.639 HD12 ' HB3' ' A' ' 35' ' ' TYR . 1.3 pt -105.28 -1.32 9.94 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 177.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.604 ' N ' ' O ' ' A' ' 28' ' ' ASP . 0.5 OUTLIER 34.78 36.86 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -179.244 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.671 ' HG2' ' SG ' ' A' ' 11' ' ' CYS . 1.8 mtmt -162.27 148.44 13.13 Favored 'General case' 0 N--CA 1.501 2.083 0 C-N-CA 119.012 -1.075 . . . . 0.0 110.755 -178.187 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.567 ' O ' ' CG ' ' A' ' 8' ' ' GLN . . . -52.76 146.09 11.09 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.548 -0.72 . . . . 0.0 110.201 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.639 ' HB3' HD12 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -149.33 147.54 28.45 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-O 121.77 0.795 . . . . 0.0 109.51 179.219 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.982 ' HB ' HG23 ' A' ' 6' ' ' VAL . 1.3 t -88.84 96.09 5.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.097 -1.002 . . . . 0.0 108.34 -179.376 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.601 ' HB3' ' CE2' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -107.17 -28.12 10.15 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.418 -0.801 . . . . 0.0 110.966 -178.687 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.585 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 22.1 t70 -122.21 78.8 1.53 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.799 -1.188 . . . . 0.0 110.16 -179.1 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.829 HG12 ' CE1' ' A' ' 4' ' ' PHE . 27.2 m -45.25 -46.71 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.248 -0.908 . . . . 0.0 109.266 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.587 ' N ' HG23 ' A' ' 39' ' ' VAL . 6.5 mt-10 -58.51 -24.72 61.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.302 -0.874 . . . . 0.0 109.486 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 38' ' ' ASP . . . -54.08 -26.05 33.73 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.498 ' HB2' ' HB1' ' A' ' 21' ' ' ALA . . . -144.69 144.76 31.39 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.23 -1.159 . . . . 0.0 109.443 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.424 ' OG ' ' CD ' ' A' ' 46' ' ' GLU . 0.1 OUTLIER -67.95 169.14 10.45 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.177 -0.952 . . . . 0.0 109.504 179.988 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.503 ' O ' ' HG2' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -66.15 -47.72 73.11 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.49 -0.756 . . . . 0.0 109.247 179.802 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.721 ' HA ' ' HG2' ' A' ' 48' ' ' GLU . 5.8 mm-40 -61.4 -17.26 53.36 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.284 -0.885 . . . . 0.0 109.185 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.424 ' CD ' ' OG ' ' A' ' 43' ' ' SER . 76.9 mt-10 -91.92 -45.79 8.17 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 178.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.811 HG12 ' CH2' ' A' ' 61' ' ' TRP . 6.8 t -55.04 -38.24 45.34 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 178.014 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.721 ' HG2' ' HA ' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -68.14 -56.9 7.13 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.64 -0.663 . . . . 0.0 109.345 178.954 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.457 ' H ' ' HG3' ' A' ' 48' ' ' GLU . 0.3 OUTLIER -43.04 -48.14 6.02 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.167 -0.958 . . . . 0.0 109.085 179.883 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.915 ' N ' HG21 ' A' ' 20' ' ' ILE . . . -60.41 -40.0 89.41 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.213 -0.929 . . . . 0.0 108.65 179.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.55 ' CE ' ' CZ3' ' A' ' 61' ' ' TRP . 21.2 ttm -58.7 -37.74 76.76 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.429 -0.794 . . . . 0.0 109.342 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -79.26 -8.07 58.76 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.282 -0.886 . . . . 0.0 109.244 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -115.21 78.36 1.16 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.258 -0.901 . . . . 0.0 109.908 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . 0.792 ' SG ' ' HD2' ' A' ' 55' ' ' PRO . 44.2 t -151.08 148.18 22.16 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.284 -0.885 . . . . 0.0 108.914 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.792 ' HD2' ' SG ' ' A' ' 54' ' ' CYS . 44.1 Cg_endo -72.1 -37.09 5.04 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 123.863 1.454 . . . . 0.0 110.333 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.681 HG21 ' O ' ' A' ' 10' ' ' GLU . 2.9 m -111.83 -29.59 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.27 -0.894 . . . . 0.0 109.232 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.552 ' N ' ' SG ' ' A' ' 54' ' ' CYS . 0.0 OUTLIER 66.57 76.65 0.3 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.305 -0.872 . . . . 0.0 109.722 179.763 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 22.5 p -112.3 17.24 19.59 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.279 -0.888 . . . . 0.0 109.12 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.87 ' CB ' HG13 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -104.09 129.69 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.332 -0.855 . . . . 0.0 109.51 -179.687 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.588 ' N ' HD13 ' A' ' 59' ' ' ILE . 1.8 m80 -136.99 160.42 38.96 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.181 -0.949 . . . . 0.0 109.393 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.811 ' CH2' HG12 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -68.13 -169.68 0.15 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.331 -0.856 . . . . 0.0 109.222 179.884 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.446 ' HB3' ' HB3' ' A' ' 3' ' ' LYS . 26.0 tt0 . . . . . 0 N--CA 1.489 1.521 0 O-C-N 121.287 -0.883 . . . . 0.0 109.318 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.497 ' O ' ' HB3' ' A' ' 4' ' ' PHE . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.687 ' CZ ' HG12 ' A' ' 39' ' ' VAL . 39.3 p90 168.8 170.32 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.709 -0.619 . . . . 0.0 109.486 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.508 ' CE1' ' HB2' ' A' ' 62' ' ' GLU . 20.5 p90 176.75 -167.61 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 179.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.973 HG21 ' CZ ' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -136.52 -165.36 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 118.44 -1.304 . . . . 0.0 111.517 -179.57 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' A' ' 9' ' ' ASP . 1.5 m-20 -151.23 98.31 2.53 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 114.209 -1.36 . . . . 0.0 107.478 178.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.553 ' HG3' ' O ' ' A' ' 34' ' ' ALA . 5.7 mp0 -64.85 43.19 0.02 OUTLIER 'General case' 0 C--N 1.291 -1.939 0 CA-C-O 121.624 0.726 . . . . 0.0 110.664 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 7' ' ' ASP . 0.2 OUTLIER -99.95 -24.52 14.61 Favored 'General case' 0 C--N 1.287 -2.116 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 179.438 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.445 ' HG2' ' HB ' ' A' ' 56' ' ' VAL . 0.6 OUTLIER -115.55 13.13 16.32 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.495 -0.753 . . . . 0.0 109.353 -179.977 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.474 ' HB3' ' HD3' ' A' ' 33' ' ' LYS . 41.9 t -84.23 129.67 34.87 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.155 -0.966 . . . . 0.0 109.7 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.711 ' O ' ' HB2' ' A' ' 13' ' ' ALA . 21.8 pt -102.24 -41.95 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.365 -0.834 . . . . 0.0 109.389 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.711 ' HB2' ' O ' ' A' ' 12' ' ' ILE . . . 163.85 -22.33 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.35 -0.844 . . . . 0.0 109.899 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -51.23 139.9 17.79 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.037 -1.04 . . . . 0.0 109.443 -179.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.487 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 4.0 mp0 -102.51 20.4 17.14 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.107 -0.996 . . . . 0.0 109.501 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.712 ' O ' HD12 ' A' ' 20' ' ' ILE . 7.1 m -44.18 -65.48 0.51 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.25 -0.906 . . . . 0.0 109.063 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.608 ' SG ' ' N ' ' A' ' 18' ' ' VAL . 16.4 p -53.16 -52.16 59.67 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.42 -0.8 . . . . 0.0 109.026 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.608 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 38.5 t -48.32 -24.42 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.354 -0.841 . . . . 0.0 109.161 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -86.22 -33.47 20.73 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.299 -0.876 . . . . 0.0 109.004 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.948 HG21 ' N ' ' A' ' 50' ' ' ALA . 2.7 mp -85.01 12.05 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.27 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.627 ' HB1' ' HB2' ' A' ' 42' ' ' ALA . . . 169.69 65.22 0.02 OUTLIER Pre-proline 0 N--CA 1.486 1.345 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -69.23 -4.85 14.49 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 O-C-N 124.143 1.602 . . . . 0.0 110.298 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.475 ' O ' ' HB3' ' A' ' 38' ' ' ASP . . . -100.44 -39.94 3.1 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.493 ' HA ' ' HB3' ' A' ' 38' ' ' ASP . . . -85.72 -33.76 21.41 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.321 -1.105 . . . . 0.0 109.299 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.973 ' CZ ' HG21 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -103.69 144.25 31.7 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.795 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.487 ' O ' ' CD1' ' A' ' 35' ' ' TYR . . . -170.84 126.48 0.71 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.991 -1.068 . . . . 0.0 109.793 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.57 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 3.7 ppp? -59.91 153.86 20.07 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.082 -1.011 . . . . 0.0 109.323 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.633 ' O ' ' N ' ' A' ' 32' ' ' GLU . 3.0 t0 -123.99 160.21 52.94 Favored Pre-proline 0 C--N 1.31 -1.135 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 179.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.461 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 47.2 Cg_endo -84.7 -16.48 5.49 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 124.973 2.039 . . . . 0.0 108.682 -179.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.35 -28.21 17.06 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 178.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.56 HG12 ' CB ' ' A' ' 28' ' ' ASP . 0.9 OUTLIER -108.83 -2.67 10.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 177.974 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.633 ' N ' ' O ' ' A' ' 28' ' ' ASP . 2.7 mm-40 31.33 38.56 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -179.006 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.546 ' C ' ' HA ' ' A' ' 27' ' ' MET . 70.7 mttt -162.39 148.11 12.76 Favored 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 119.723 -0.791 . . . . 0.0 110.296 -178.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.763 ' HB1' ' CD1' ' A' ' 25' ' ' PHE . . . -56.79 147.57 22.83 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.468 -0.77 . . . . 0.0 110.863 -179.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.595 ' O ' ' CD1' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -152.44 153.36 33.4 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.576 -0.703 . . . . 0.0 109.316 178.806 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.827 HG23 ' CG2' ' A' ' 6' ' ' VAL . 36.5 t -92.62 103.54 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 120.926 -1.108 . . . . 0.0 109.095 -179.452 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.594 ' HB3' ' CE2' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -119.3 -23.48 6.71 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 119.469 -0.892 . . . . 0.0 110.616 -179.286 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.516 ' N ' ' HG3' ' A' ' 37' ' ' LYS . 45.1 t0 -112.31 98.45 7.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.997 -1.064 . . . . 0.0 109.821 -179.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.687 HG12 ' CZ ' ' A' ' 4' ' ' PHE . 27.7 m -63.9 -29.21 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.139 -0.976 . . . . 0.0 109.578 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.534 ' OE1' HG23 ' A' ' 39' ' ' VAL . 0.7 OUTLIER -81.86 -14.26 56.49 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.228 -0.92 . . . . 0.0 109.53 -179.804 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.426 ' HA3' ' C ' ' A' ' 23' ' ' GLY . . . -67.08 -17.85 68.33 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.211 -1.556 . . . . 0.0 109.211 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.627 ' HB2' ' HB1' ' A' ' 21' ' ' ALA . . . -151.34 131.42 13.47 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.431 -1.041 . . . . 0.0 109.278 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.86 167.61 5.92 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.217 -0.927 . . . . 0.0 109.487 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -58.04 -49.01 78.36 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.506 -0.746 . . . . 0.0 109.409 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.742 ' HA ' ' HG2' ' A' ' 48' ' ' GLU . 1.0 OUTLIER -62.77 -14.72 48.33 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.182 -0.949 . . . . 0.0 108.943 179.908 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.439 ' OE1' ' HA ' ' A' ' 42' ' ' ALA . 43.0 mt-10 -90.52 -44.3 9.67 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 178.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 8.5 t -57.84 -38.71 67.37 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.742 ' HG2' ' HA ' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -68.77 -58.21 4.53 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.518 -0.739 . . . . 0.0 109.662 179.672 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.49 ' OE2' HG12 ' A' ' 20' ' ' ILE . 29.0 tt0 -44.13 -53.58 6.32 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.013 -1.054 . . . . 0.0 108.819 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.948 ' N ' HG21 ' A' ' 20' ' ' ILE . . . -54.0 -42.3 68.91 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.057 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.841 ' HA ' HG21 ' A' ' 59' ' ' ILE . 30.3 ttm -61.05 -29.87 69.99 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.052 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -63.56 -32.59 74.09 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.827 HG21 HD11 ' A' ' 20' ' ' ILE . 76.4 p -77.52 -155.03 0.07 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.402 -0.811 . . . . 0.0 109.201 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . 0.507 ' SG ' ' HD2' ' A' ' 55' ' ' PRO . 2.3 t 64.99 140.46 0.06 OUTLIER Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.11 -0.994 . . . . 0.0 109.391 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.507 ' HD2' ' SG ' ' A' ' 54' ' ' CYS . 42.1 Cg_endo -71.37 -86.89 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.006 1.529 . . . . 0.0 110.061 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.445 ' HB ' ' HG2' ' A' ' 10' ' ' GLU . 11.1 t -63.34 -12.68 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.179 -0.951 . . . . 0.0 108.935 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.478 ' HA ' ' HB3' ' A' ' 54' ' ' CYS . 0.0 OUTLIER 58.55 81.08 0.16 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.244 -0.91 . . . . 0.0 109.431 179.863 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.434 ' SG ' HG12 ' A' ' 6' ' ' VAL . 28.0 p -86.64 16.14 4.98 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.2 -0.937 . . . . 0.0 109.399 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.841 HG21 ' HA ' ' A' ' 51' ' ' MET . 7.9 tt -106.16 154.38 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.168 -0.957 . . . . 0.0 109.81 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.425 ' HA ' ' HE1' ' A' ' 51' ' ' MET . 0.2 OUTLIER -166.95 -174.62 2.75 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.49 -0.756 . . . . 0.0 108.986 179.981 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.535 ' HA ' ' HA ' ' A' ' 4' ' ' PHE . 47.1 m95 -104.54 155.16 19.06 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.041 -1.037 . . . . 0.0 109.704 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.508 ' HB2' ' CE1' ' A' ' 5' ' ' TYR . 6.4 tt0 . . . . . 0 N--CA 1.49 1.548 0 O-C-N 121.465 -0.772 . . . . 0.0 109.454 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.553 ' HB3' ' HB3' ' A' ' 62' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.36 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.584 ' CB ' ' HA ' ' A' ' 61' ' ' TRP . 24.4 p90 168.54 -179.3 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.508 -0.745 . . . . 0.0 109.551 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.496 ' O ' HG13 ' A' ' 59' ' ' ILE . 30.0 p90 176.71 -175.95 0.13 Allowed 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 179.23 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 1.083 HG21 ' CZ ' ' A' ' 25' ' ' PHE . 0.2 OUTLIER -131.4 169.77 21.08 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.018 0 C-N-CA 117.389 -1.724 . . . . 0.0 111.413 -179.661 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.515 ' O ' ' N ' ' A' ' 9' ' ' ASP . 9.3 t0 -108.99 89.58 3.04 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 178.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.559 ' CG ' ' O ' ' A' ' 34' ' ' ALA . 8.4 mp0 -65.36 46.09 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.859 0 CA-C-O 121.578 0.704 . . . . 0.0 110.3 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.515 ' N ' ' O ' ' A' ' 7' ' ' ASP . 0.3 OUTLIER -113.32 -44.65 3.21 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.395 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.657 ' CG ' HG11 ' A' ' 56' ' ' VAL . 0.3 OUTLIER -91.45 17.62 8.33 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.087 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 37.4 t -83.26 111.95 19.43 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.359 -0.838 . . . . 0.0 110.373 -179.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.708 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 30.6 pt -78.53 0.59 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.47 -0.768 . . . . 0.0 109.047 179.344 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.708 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . 78.81 50.58 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.452 -0.78 . . . . 0.0 110.294 179.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.82 ' SG ' ' OG ' ' A' ' 16' ' ' SER . 3.2 p -105.67 161.51 14.33 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.866 -1.146 . . . . 0.0 109.436 179.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.456 ' O ' ' HB2' ' A' ' 19' ' ' GLU . 63.3 mt-10 -87.88 18.38 4.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.277 -0.889 . . . . 0.0 109.832 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.82 ' OG ' ' SG ' ' A' ' 14' ' ' CYS . 52.4 p -60.73 -91.06 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.22 -0.925 . . . . 0.0 109.636 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.523 ' SG ' ' N ' ' A' ' 18' ' ' VAL . 10.8 p -45.34 -47.77 13.3 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.22 -0.925 . . . . 0.0 110.034 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.523 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 78.6 t -53.03 -30.74 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.165 -0.96 . . . . 0.0 109.981 -179.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.456 ' HB2' ' O ' ' A' ' 15' ' ' GLU . 2.8 mm-40 -77.35 -41.97 38.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.932 -1.105 . . . . 0.0 109.603 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.768 ' CD1' HG21 ' A' ' 53' ' ' THR . 1.6 mt -84.81 15.57 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.248 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.585 ' HB2' ' O ' ' A' ' 20' ' ' ILE . . . 170.54 63.14 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.452 -0.78 . . . . 0.0 109.281 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.487 ' N ' ' O ' ' A' ' 18' ' ' VAL . 45.9 Cg_endo -74.07 -18.56 21.12 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.08 1.569 . . . . 0.0 110.882 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.401 ' O ' ' HB3' ' A' ' 38' ' ' ASP . . . -79.44 -41.48 13.28 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.489 ' HA ' ' HB3' ' A' ' 38' ' ' ASP . . . -87.32 -34.2 18.93 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.215 -1.168 . . . . 0.0 109.71 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 1.083 ' CZ ' HG21 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -106.04 141.21 37.8 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.324 -0.86 . . . . 0.0 109.326 -179.716 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.49 ' O ' ' CD1' ' A' ' 35' ' ' TYR . . . -170.45 128.69 0.83 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.069 -1.019 . . . . 0.0 109.948 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.572 ' HA ' ' C ' ' A' ' 33' ' ' LYS . 2.7 ptm -62.65 153.98 30.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.917 -1.114 . . . . 0.0 109.222 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.578 ' HB3' ' CD1' ' A' ' 31' ' ' ILE . 1.7 t0 -135.22 165.26 37.82 Favored Pre-proline 0 C--N 1.311 -1.085 0 O-C-N 120.663 -1.273 . . . . 0.0 107.572 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.505 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 43.4 Cg_endo -84.01 -17.1 5.95 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 O-C-N 124.528 1.804 . . . . 0.0 107.867 179.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.72 -38.96 19.07 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 177.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.578 ' CD1' ' HB3' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -104.13 3.07 10.58 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 177.885 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.565 ' N ' ' O ' ' A' ' 28' ' ' ASP . 2.5 mm-40 31.62 39.33 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.795 0.807 . . . . 0.0 108.879 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.572 ' C ' ' HA ' ' A' ' 27' ' ' MET . 0.0 OUTLIER -173.7 153.55 2.27 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 119.191 -1.004 . . . . 0.0 110.131 -178.537 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.559 ' O ' ' CG ' ' A' ' 8' ' ' GLN . . . -52.52 149.32 5.95 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.475 -0.766 . . . . 0.0 109.66 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.617 ' O ' ' CD1' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -154.16 146.5 23.9 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.614 0.721 . . . . 0.0 109.267 179.266 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.873 ' HB ' HG23 ' A' ' 6' ' ' VAL . 2.1 t -87.44 99.75 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.103 -0.998 . . . . 0.0 108.49 -179.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.597 ' HB3' ' CE2' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -115.56 -27.11 7.24 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.23 -0.919 . . . . 0.0 111.057 -178.699 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.554 ' N ' ' HG3' ' A' ' 37' ' ' LYS . 39.5 t0 -113.21 92.46 4.01 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.897 -1.127 . . . . 0.0 110.026 -179.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.457 HG12 ' CE1' ' A' ' 4' ' ' PHE . 25.5 m -61.16 -23.28 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.36 -0.837 . . . . 0.0 109.248 179.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -93.13 1.39 57.19 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.418 -0.801 . . . . 0.0 109.561 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -87.2 -0.09 85.37 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.451 ' HA ' ' OE2' ' A' ' 46' ' ' GLU . . . -162.91 131.41 3.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.167 -1.196 . . . . 0.0 109.718 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.609 ' O ' HG23 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -61.52 170.93 1.65 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.348 -0.845 . . . . 0.0 109.943 -179.823 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.486 ' HA ' ' HB ' ' A' ' 47' ' ' VAL . 6.0 tt0 -72.0 -41.05 68.04 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.572 -0.705 . . . . 0.0 109.743 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -67.22 -25.92 66.34 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.108 -0.995 . . . . 0.0 109.41 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.52 ' HG2' ' N ' ' A' ' 43' ' ' SER . 5.1 pt-20 -90.02 -35.29 15.59 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 178.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.609 HG23 ' O ' ' A' ' 43' ' ' SER . 4.0 t -64.37 -32.7 58.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 177.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.447 ' HB2' ' O ' ' A' ' 44' ' ' GLN . 0.5 OUTLIER -71.15 -59.35 2.82 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.131 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.687 ' HB3' HG21 ' A' ' 20' ' ' ILE . 0.4 OUTLIER -53.2 -39.22 63.52 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.113 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.709 ' HB2' ' HB ' ' A' ' 20' ' ' ILE . . . -71.59 -17.83 62.27 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.365 -0.834 . . . . 0.0 109.049 179.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 1.0 ' HG3' HD13 ' A' ' 59' ' ' ILE . 33.4 ttm -92.11 -17.84 24.41 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.483 -0.761 . . . . 0.0 109.939 -179.328 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -100.93 -17.15 16.93 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.054 -1.029 . . . . 0.0 109.784 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.768 HG21 ' CD1' ' A' ' 20' ' ' ILE . 9.6 t -72.58 -11.22 60.56 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.061 -1.025 . . . . 0.0 109.448 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . 1.242 ' SG ' ' HD2' ' A' ' 55' ' ' PRO . 9.4 t -71.04 158.61 87.78 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.248 -0.907 . . . . 0.0 109.486 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 1.242 ' HD2' ' SG ' ' A' ' 54' ' ' CYS . 42.1 Cg_endo -72.79 -85.28 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.92 1.484 . . . . 0.0 109.929 179.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.657 HG11 ' CG ' ' A' ' 10' ' ' GLU . 4.2 p -68.41 -22.91 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.111 -0.993 . . . . 0.0 108.926 179.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.5 ' O ' ' N ' ' A' ' 59' ' ' ILE . 0.6 OUTLIER 69.34 46.63 0.75 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.474 -0.767 . . . . 0.0 109.635 179.741 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.484 ' HB2' ' HB2' ' A' ' 10' ' ' GLU . 0.1 OUTLIER -68.28 62.41 0.09 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.158 -0.964 . . . . 0.0 109.296 179.732 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 1.0 HD13 ' HG3' ' A' ' 51' ' ' MET . 12.0 tt -132.22 160.29 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.297 -0.877 . . . . 0.0 109.418 -179.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.582 ' CG ' ' O ' ' A' ' 59' ' ' ILE . 15.7 m80 -159.83 147.54 16.87 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.02 -1.05 . . . . 0.0 109.915 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.584 ' HA ' ' CB ' ' A' ' 4' ' ' PHE . 58.2 m95 -83.74 -175.38 5.78 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.321 -0.862 . . . . 0.0 108.861 179.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.553 ' HB3' ' HB3' ' A' ' 3' ' ' LYS . 0.5 OUTLIER . . . . . 0 C--N 1.301 -1.53 0 O-C-N 121.089 -1.007 . . . . 0.0 109.586 -179.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.42 ' HB3' ' HB3' ' A' ' 62' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.654 ' CZ ' HG21 ' A' ' 47' ' ' VAL . 30.9 p90 -178.12 -178.83 0.68 Allowed 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.253 -0.905 . . . . 0.0 109.613 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.759 ' HA ' HG21 ' A' ' 36' ' ' VAL . 45.6 p90 -179.89 -178.15 0.42 Allowed 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 106.012 -1.848 . . . . 0.0 106.012 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 1.104 HG21 ' CE2' ' A' ' 25' ' ' PHE . 2.6 t -142.41 160.95 19.41 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.32 0 C-N-CA 117.487 -1.685 . . . . 0.0 111.228 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.531 ' N ' HG12 ' A' ' 6' ' ' VAL . 4.8 m-20 -114.52 79.26 1.24 Allowed 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.683 ' OE1' HD13 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -42.07 -22.76 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.564 0.697 . . . . 0.0 109.285 179.359 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.526 ' N ' ' O ' ' A' ' 7' ' ' ASP . 0.5 OUTLIER -48.99 -42.58 38.3 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.545 -0.722 . . . . 0.0 109.332 -179.782 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.489 ' CG ' ' SG ' ' A' ' 58' ' ' CYS . 7.8 tp10 -84.1 -14.53 50.14 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.308 -0.87 . . . . 0.0 109.179 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.415 ' HB3' ' O ' ' A' ' 8' ' ' GLN . 42.8 t -56.68 139.79 49.26 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.243 -0.91 . . . . 0.0 109.492 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.748 ' O ' ' HB2' ' A' ' 13' ' ' ALA . 1.6 pp -101.35 -33.69 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.219 -0.925 . . . . 0.0 109.783 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.748 ' HB2' ' O ' ' A' ' 12' ' ' ILE . . . 155.99 -40.5 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.543 -0.723 . . . . 0.0 109.769 179.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.43 ' C ' ' O ' ' A' ' 13' ' ' ALA . 0.1 OUTLIER -43.84 153.2 0.13 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.146 -0.971 . . . . 0.0 109.735 -179.39 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.427 ' O ' ' C ' ' A' ' 16' ' ' SER . 3.5 pt-20 -117.49 21.88 12.76 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.277 -0.889 . . . . 0.0 109.559 -179.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.825 ' O ' HD12 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -44.43 -55.19 5.23 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.148 -0.97 . . . . 0.0 109.18 179.856 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.461 ' SG ' ' N ' ' A' ' 18' ' ' VAL . 21.5 p -54.46 -45.31 73.1 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.376 -0.827 . . . . 0.0 109.3 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.461 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 4.8 t -52.26 -26.48 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.34 -0.85 . . . . 0.0 109.466 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -89.82 -32.08 17.08 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.166 -0.959 . . . . 0.0 109.541 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.932 HD13 ' HA ' ' A' ' 50' ' ' ALA . 2.7 mp -84.65 11.8 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.707 ' HB1' ' HB2' ' A' ' 42' ' ' ALA . . . -168.58 66.28 0.67 Allowed Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.357 -0.84 . . . . 0.0 109.293 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -71.74 83.28 1.12 Allowed 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 123.981 1.516 . . . . 0.0 110.287 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 147.57 -21.01 1.5 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.546 ' CB ' ' O ' ' A' ' 38' ' ' ASP . . . -113.01 -30.68 6.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.314 -1.109 . . . . 0.0 109.102 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 1.104 ' CE2' HG21 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -112.86 140.57 47.54 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.439 -0.788 . . . . 0.0 109.408 -179.972 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.479 ' O ' ' HA ' ' A' ' 34' ' ' ALA . . . -171.59 149.65 2.65 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.544 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 0.2 OUTLIER -82.76 156.51 23.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.874 -1.141 . . . . 0.0 108.652 -179.979 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.622 ' O ' ' N ' ' A' ' 32' ' ' GLU . 1.7 t0 -121.13 160.95 43.16 Favored Pre-proline 0 C--N 1.31 -1.148 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 179.26 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.467 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 48.1 Cg_endo -83.42 -15.97 7.24 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 125.051 2.08 . . . . 0.0 108.157 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -88.56 -35.35 16.96 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 178.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.683 HD13 ' OE1' ' A' ' 8' ' ' GLN . 3.8 pt -106.86 0.48 10.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.622 ' N ' ' O ' ' A' ' 28' ' ' ASP . 51.6 mt-10 32.18 38.34 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -179.247 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.605 ' O ' HD12 ' A' ' 31' ' ' ILE . 83.1 mttt -157.83 146.87 19.55 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 119.262 -0.975 . . . . 0.0 110.93 -177.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.76 ' HB1' ' CD1' ' A' ' 25' ' ' PHE . . . -53.31 143.91 17.55 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.737 -0.602 . . . . 0.0 110.634 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.708 ' CE2' ' HA ' ' A' ' 37' ' ' LYS . 6.9 p90 -149.37 169.19 21.4 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 1.062 HG22 HG23 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -86.59 85.09 2.35 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.084 0 CA-C-O 121.624 0.726 . . . . 0.0 109.433 -178.26 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.708 ' HA ' ' CE2' ' A' ' 35' ' ' TYR . 13.4 ptmt -68.89 -10.39 56.79 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.558 -0.714 . . . . 0.0 110.511 -179.344 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.546 ' O ' ' CB ' ' A' ' 24' ' ' ALA . 11.7 t0 178.55 141.07 0.1 Allowed 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 118.611 -1.235 . . . . 0.0 110.424 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.1 m -84.38 -33.54 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.289 -0.882 . . . . 0.0 109.351 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -71.78 -16.08 62.18 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.247 -0.908 . . . . 0.0 109.21 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -69.39 -26.85 74.18 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.707 ' HB2' ' HB1' ' A' ' 21' ' ' ALA . . . -130.7 144.74 51.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.294 -1.121 . . . . 0.0 109.252 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.451 ' OG ' ' OE2' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -89.11 158.24 18.02 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.199 -0.938 . . . . 0.0 109.996 -179.613 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.528 ' HG2' ' N ' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -53.03 -23.06 6.69 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.45 -0.781 . . . . 0.0 109.147 179.811 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.528 ' N ' ' HG2' ' A' ' 44' ' ' GLN . 53.8 mm-40 -85.06 -23.1 28.72 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.4 -0.813 . . . . 0.0 108.837 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.463 ' HB3' ' O ' ' A' ' 20' ' ' ILE . 48.5 mt-10 -88.5 -55.8 3.57 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 106.263 -1.755 . . . . 0.0 106.263 178.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.654 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 2.9 t -48.06 -29.35 2.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 177.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.519 ' HB2' ' O ' ' A' ' 44' ' ' GLN . 0.3 OUTLIER -70.25 -69.27 0.37 Allowed 'General case' 0 C--N 1.311 -1.083 0 O-C-N 121.565 -0.709 . . . . 0.0 109.41 179.161 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -46.15 -46.72 17.44 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.381 -0.825 . . . . 0.0 109.11 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.932 ' HA ' HD13 ' A' ' 20' ' ' ILE . . . -55.02 -32.49 61.88 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.289 -0.882 . . . . 0.0 109.088 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.679 ' HE2' HG23 ' A' ' 59' ' ' ILE . 34.9 ttm -66.7 -60.2 2.91 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.414 -0.803 . . . . 0.0 109.426 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -46.69 -28.19 1.42 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.223 -0.923 . . . . 0.0 109.689 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.459 ' O ' ' HB2' ' A' ' 54' ' ' CYS . 0.2 OUTLIER -102.08 99.9 10.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.176 -0.953 . . . . 0.0 109.827 -179.763 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . 0.813 ' SG ' ' HD2' ' A' ' 55' ' ' PRO . 53.2 t 176.64 146.43 0.27 Allowed Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.214 -0.929 . . . . 0.0 109.868 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.813 ' HD2' ' SG ' ' A' ' 54' ' ' CYS . 45.1 Cg_endo -75.14 104.04 1.84 Allowed 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 124.061 1.558 . . . . 0.0 109.279 179.178 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.535 HG23 ' C ' ' A' ' 55' ' ' PRO . 3.7 t 77.71 3.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.441 -0.787 . . . . 0.0 109.003 -178.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.489 ' HG2' ' O ' ' A' ' 51' ' ' MET . 15.5 mt-30 44.72 82.65 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.284 -0.885 . . . . 0.0 109.413 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.538 ' O ' ' CE1' ' A' ' 60' ' ' HIS . 2.3 m -79.93 -12.54 59.72 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.242 -0.911 . . . . 0.0 109.224 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.848 ' HA ' HG13 ' A' ' 6' ' ' VAL . 16.4 tt -83.77 144.19 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.383 -0.823 . . . . 0.0 110.145 -179.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.538 ' CE1' ' O ' ' A' ' 58' ' ' CYS . 14.0 m80 -144.37 172.43 12.94 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.365 -0.834 . . . . 0.0 108.902 179.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.532 ' HA ' ' CB ' ' A' ' 4' ' ' PHE . 68.4 m95 -94.69 179.55 5.22 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.029 -1.045 . . . . 0.0 110.037 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.42 ' HB3' ' HB3' ' A' ' 3' ' ' LYS . 13.6 tt0 . . . . . 0 N--CA 1.49 1.53 0 O-C-N 121.42 -0.8 . . . . 0.0 109.261 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.49 ' HB3' ' HB3' ' A' ' 62' ' ' GLU . 1.2 ttmt . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.573 ' HA ' ' N ' ' A' ' 62' ' ' GLU . 51.2 p90 175.55 175.69 0.24 Allowed 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.399 -0.813 . . . . 0.0 110.082 179.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.845 ' O ' HD12 ' A' ' 59' ' ' ILE . 41.0 p90 179.7 -176.34 0.31 Allowed 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 1.148 HG21 ' CZ ' ' A' ' 25' ' ' PHE . 0.2 OUTLIER -135.48 171.95 16.59 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 C-N-CA 117.816 -1.553 . . . . 0.0 110.94 -179.859 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.58 ' O ' ' N ' ' A' ' 9' ' ' ASP . 2.5 t0 -117.98 92.56 3.86 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.569 ' CB ' HG21 ' A' ' 31' ' ' ILE . 4.0 mp0 -62.89 42.37 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.93 0 CA-C-O 121.399 0.619 . . . . 0.0 111.039 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.58 ' N ' ' O ' ' A' ' 7' ' ' ASP . 0.4 OUTLIER -104.13 -31.68 9.53 Favored 'General case' 0 C--N 1.287 -2.11 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.432 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.448 ' HB2' ' SG ' ' A' ' 58' ' ' CYS . 0.6 OUTLIER -111.42 22.06 15.53 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.632 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 14.4 t -83.76 126.04 32.51 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.292 -0.88 . . . . 0.0 109.988 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.719 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 23.1 pt -86.21 1.31 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.363 -0.836 . . . . 0.0 109.431 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.719 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . 78.49 32.59 0.32 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.333 -0.854 . . . . 0.0 110.612 179.207 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.6 p -88.86 151.52 22.3 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.905 -1.122 . . . . 0.0 109.076 179.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.448 ' O ' ' HB2' ' A' ' 19' ' ' GLU . 1.5 mt-10 -88.54 33.97 0.76 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.179 -0.951 . . . . 0.0 110.115 -179.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.786 ' O ' HD12 ' A' ' 20' ' ' ILE . 75.5 p -75.83 -69.95 0.46 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.086 -1.009 . . . . 0.0 109.326 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.576 ' SG ' ' CD2' ' A' ' 25' ' ' PHE . 12.4 p -58.25 -46.55 85.77 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.226 -0.922 . . . . 0.0 109.519 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.533 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 68.7 t -52.69 -41.73 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.364 -0.835 . . . . 0.0 109.916 -179.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.448 ' HB2' ' O ' ' A' ' 15' ' ' GLU . 7.4 tm-20 -66.49 -42.7 87.01 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.099 -1.001 . . . . 0.0 109.662 -179.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.888 HD11 HG21 ' A' ' 53' ' ' THR . 2.7 mp -82.06 11.76 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.294 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -176.18 68.67 0.25 Allowed Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.29 -0.881 . . . . 0.0 109.237 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -74.09 -0.32 9.4 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 124.076 1.566 . . . . 0.0 110.381 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.468 ' O ' ' HB3' ' A' ' 38' ' ' ASP . . . -112.98 -33.12 2.06 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.442 ' HA ' ' HB3' ' A' ' 38' ' ' ASP . . . -90.1 -46.46 8.46 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.147 -1.208 . . . . 0.0 109.449 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 1.148 ' CZ ' HG21 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -99.26 146.97 25.65 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.273 -0.892 . . . . 0.0 108.901 179.829 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.469 ' O ' ' CD1' ' A' ' 35' ' ' TYR . . . -169.86 125.02 0.8 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.105 -0.997 . . . . 0.0 109.946 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.562 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 6.3 ttp -58.43 152.87 16.94 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.174 -0.954 . . . . 0.0 109.289 179.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.637 ' O ' ' N ' ' A' ' 32' ' ' GLU . 0.6 OUTLIER -128.21 163.56 43.25 Favored Pre-proline 0 C--N 1.311 -1.092 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 179.181 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -85.43 -15.62 5.15 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 O-C-N 125.148 2.131 . . . . 0.0 108.513 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -92.41 -29.34 16.34 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 178.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.598 HG12 ' HB3' ' A' ' 28' ' ' ASP . 0.2 OUTLIER -103.31 -15.66 7.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 177.557 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.637 ' N ' ' O ' ' A' ' 28' ' ' ASP . 14.1 mt-10 44.08 31.7 0.56 Allowed 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 -177.111 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.537 ' C ' ' HA ' ' A' ' 27' ' ' MET . 2.5 mttp -158.26 152.82 24.64 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 119.344 -0.942 . . . . 0.0 110.483 -177.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.562 ' HA ' ' HA ' ' A' ' 27' ' ' MET . . . -59.66 148.97 31.89 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.487 -0.758 . . . . 0.0 109.768 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.635 ' CE2' ' HB3' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -150.75 146.85 26.69 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.624 0.726 . . . . 0.0 109.519 179.296 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.981 ' HB ' HG23 ' A' ' 6' ' ' VAL . 2.4 t -89.57 97.82 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.077 -1.014 . . . . 0.0 108.448 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.635 ' HB3' ' CE2' ' A' ' 35' ' ' TYR . 1.3 pttp -108.08 -23.71 11.87 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.337 -0.852 . . . . 0.0 110.296 -179.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.52 ' N ' ' HG3' ' A' ' 37' ' ' LYS . 55.2 t0 -118.36 124.54 47.98 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.125 -0.984 . . . . 0.0 109.884 -179.334 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 15.5 m -86.22 -34.53 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.272 -0.892 . . . . 0.0 109.451 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.439 ' HG2' ' OD1' ' A' ' 38' ' ' ASP . 8.1 pm0 -81.9 -10.31 59.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.198 -0.938 . . . . 0.0 109.519 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -63.54 -18.55 61.41 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.418 ' HB1' ' HB2' ' A' ' 46' ' ' GLU . . . -151.93 132.28 13.72 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.248 -1.148 . . . . 0.0 109.521 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.45 155.09 19.05 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.26 -0.9 . . . . 0.0 109.727 -179.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.455 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 4.2 pt20 -49.46 -44.94 46.17 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.479 -0.763 . . . . 0.0 109.565 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.431 ' O ' ' HG3' ' A' ' 49' ' ' GLU . 7.6 mm-40 -64.12 -17.96 63.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.215 -0.928 . . . . 0.0 109.019 179.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.418 ' HB2' ' HB1' ' A' ' 42' ' ' ALA . 47.9 mt-10 -90.73 -46.99 7.91 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 179.03 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.459 ' O ' ' HB2' ' A' ' 51' ' ' MET . 2.3 t -57.85 -38.6 66.81 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.438 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.455 ' HB2' ' O ' ' A' ' 44' ' ' GLN . 0.1 OUTLIER -68.19 -60.99 2.06 Favored 'General case' 0 C--N 1.307 -1.257 0 O-C-N 121.534 -0.729 . . . . 0.0 109.629 179.721 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.431 ' HG3' ' O ' ' A' ' 45' ' ' GLU . 2.3 mt-10 -51.5 -40.67 60.01 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.172 -0.955 . . . . 0.0 108.877 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.662 ' HA ' HD13 ' A' ' 20' ' ' ILE . . . -69.28 -20.91 63.91 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.521 -0.737 . . . . 0.0 109.024 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.747 ' HE3' HG12 ' A' ' 59' ' ' ILE . 0.7 OUTLIER -82.86 -51.03 8.0 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.522 -0.736 . . . . 0.0 109.522 -179.482 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -57.32 -32.11 66.36 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.308 -0.87 . . . . 0.0 109.444 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.888 HG21 HD11 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -60.61 -32.05 71.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.341 -0.849 . . . . 0.0 109.804 -179.834 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . 0.478 ' HB3' ' HG3' ' A' ' 57' ' ' GLN . 11.4 t -58.28 128.75 82.7 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.18 -0.95 . . . . 0.0 109.429 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -72.26 -53.94 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 123.931 1.49 . . . . 0.0 109.621 179.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 27.9 t -79.63 -15.18 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.478 ' HG3' ' HB3' ' A' ' 54' ' ' CYS . 0.5 OUTLIER 45.84 79.4 0.05 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.413 -0.804 . . . . 0.0 109.789 179.783 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.448 ' SG ' ' HB2' ' A' ' 10' ' ' GLU . 0.9 OUTLIER -92.58 15.86 13.35 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.354 -0.841 . . . . 0.0 109.043 179.517 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.908 ' HA ' HG13 ' A' ' 6' ' ' VAL . 4.0 tp -64.33 159.21 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.34 -0.85 . . . . 0.0 109.448 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.53 ' O ' ' HB2' ' A' ' 61' ' ' TRP . 6.5 m80 -135.73 -32.05 0.92 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.227 -0.921 . . . . 0.0 110.358 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.555 ' HA ' ' CB ' ' A' ' 4' ' ' PHE . 55.7 m95 67.51 163.75 0.2 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.477 -0.764 . . . . 0.0 109.244 -179.025 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.573 ' N ' ' HA ' ' A' ' 4' ' ' PHE . 14.8 tt0 . . . . . 0 N--CA 1.488 1.441 0 O-C-N 121.35 -0.844 . . . . 0.0 109.342 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.501 ' O ' ' HB3' ' A' ' 4' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.644 ' CE1' HG12 ' A' ' 39' ' ' VAL . 33.6 p90 168.0 -175.56 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.469 -0.769 . . . . 0.0 109.323 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.489 ' O ' HG13 ' A' ' 59' ' ' ILE . 28.0 p90 167.6 -175.62 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 106.541 -1.652 . . . . 0.0 106.541 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 1.179 HG21 ' CZ ' ' A' ' 25' ' ' PHE . 0.6 OUTLIER -131.25 176.31 9.2 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.073 0 C-N-CA 117.467 -1.693 . . . . 0.0 110.952 -179.945 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.625 ' H ' HG12 ' A' ' 6' ' ' VAL . 1.1 m-20 -127.1 90.52 3.16 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-O 121.845 0.831 . . . . 0.0 109.118 179.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.561 ' CG ' ' O ' ' A' ' 34' ' ' ALA . 1.5 mp0 -63.63 44.1 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.704 179.266 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.541 ' N ' ' O ' ' A' ' 7' ' ' ASP . 0.2 OUTLIER -99.93 -20.75 15.97 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 179.369 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.816 ' OE1' HG21 ' A' ' 56' ' ' VAL . 2.8 mm-40 -121.49 -7.49 9.18 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.663 -0.648 . . . . 0.0 109.468 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.659 ' SG ' ' HG2' ' A' ' 33' ' ' LYS . 45.0 t -54.1 112.41 0.96 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.19 -0.944 . . . . 0.0 109.692 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.699 ' O ' ' HB2' ' A' ' 13' ' ' ALA . 13.8 pt -73.65 -47.61 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.241 -0.912 . . . . 0.0 109.601 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.699 ' HB2' ' O ' ' A' ' 12' ' ' ILE . . . 164.77 -28.92 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.095 -1.003 . . . . 0.0 110.147 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -46.33 156.52 0.17 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.966 -1.084 . . . . 0.0 109.727 -179.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.421 ' O ' ' C ' ' A' ' 16' ' ' SER . 0.7 OUTLIER -120.02 20.45 12.12 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.406 -0.809 . . . . 0.0 109.858 -179.643 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.923 ' O ' HD12 ' A' ' 20' ' ' ILE . 0.5 OUTLIER -43.89 -52.22 7.0 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.199 -0.938 . . . . 0.0 109.414 179.943 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.554 ' SG ' ' N ' ' A' ' 18' ' ' VAL . 19.8 p -59.34 -52.67 64.65 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.308 -0.87 . . . . 0.0 109.453 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.554 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 5.7 t -47.17 -34.92 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.128 -0.983 . . . . 0.0 109.414 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -73.53 -34.67 65.33 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.125 -0.984 . . . . 0.0 109.324 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.929 HD13 ' HA ' ' A' ' 50' ' ' ALA . 2.7 mp -84.9 10.96 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 178.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.681 ' HB1' ' HB2' ' A' ' 42' ' ' ALA . . . -174.75 65.71 0.27 Allowed Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 121.377 -0.827 . . . . 0.0 109.2 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -71.81 56.15 2.33 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 O-C-N 124.171 1.616 . . . . 0.0 110.371 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.495 ' O ' ' HB3' ' A' ' 38' ' ' ASP . . . -167.47 -55.09 0.03 OUTLIER Glycine 0 N--CA 1.488 2.109 0 N-CA-C 108.543 -1.823 . . . . 0.0 108.543 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.549 ' HB2' ' O ' ' A' ' 38' ' ' ASP . . . -78.29 -38.87 41.46 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.439 -1.036 . . . . 0.0 109.112 179.402 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 1.179 ' CZ ' HG21 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -97.14 134.23 40.74 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.136 -0.978 . . . . 0.0 108.88 179.693 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.502 ' O ' ' CD1' ' A' ' 35' ' ' TYR . . . -163.55 122.63 2.04 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.173 -0.954 . . . . 0.0 109.8 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.55 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 30.5 ttm -60.32 149.52 33.33 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.187 -0.946 . . . . 0.0 109.235 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.602 ' O ' ' N ' ' A' ' 32' ' ' GLU . 2.4 t0 -126.47 160.73 56.59 Favored Pre-proline 0 C--N 1.311 -1.073 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 179.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.489 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 43.9 Cg_endo -84.82 -17.12 5.06 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 O-C-N 124.765 1.929 . . . . 0.0 108.49 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -90.78 -30.45 17.01 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 178.009 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.566 HD12 ' HB3' ' A' ' 35' ' ' TYR . 0.8 OUTLIER -106.74 -0.18 9.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.092 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.602 ' N ' ' O ' ' A' ' 28' ' ' ASP . 8.2 mt-10 27.85 43.43 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.506 0.67 . . . . 0.0 109.983 -179.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.659 ' HG2' ' SG ' ' A' ' 11' ' ' CYS . 2.0 mttt -169.19 146.14 3.52 Favored 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 119.475 -0.89 . . . . 0.0 110.273 -179.31 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.561 ' O ' ' CG ' ' A' ' 8' ' ' GLN . . . -58.01 140.87 51.48 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.436 -0.79 . . . . 0.0 109.183 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.619 ' O ' ' CD1' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -146.26 146.49 30.76 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-O 121.902 0.858 . . . . 0.0 110.084 179.742 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.962 ' HB ' HG23 ' A' ' 6' ' ' VAL . 2.7 t -85.67 100.82 9.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -179.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.584 ' HG2' ' CZ ' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -116.63 -34.26 4.59 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.456 -0.777 . . . . 0.0 110.103 -179.083 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.549 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 17.0 t0 -104.58 85.56 2.35 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.217 -0.927 . . . . 0.0 109.801 -179.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.644 HG12 ' CE1' ' A' ' 4' ' ' PHE . 14.5 m -53.52 -29.21 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.293 -0.879 . . . . 0.0 109.288 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -73.02 -14.45 61.43 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.338 -0.851 . . . . 0.0 109.375 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.435 ' HA3' ' N ' ' A' ' 24' ' ' ALA . . . -71.88 -25.4 74.94 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.681 ' HB2' ' HB1' ' A' ' 21' ' ' ALA . . . -142.24 155.43 45.25 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.317 -1.107 . . . . 0.0 109.2 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -96.05 -166.73 1.47 Allowed 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.064 -1.022 . . . . 0.0 109.875 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.478 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 22.0 tt0 -72.66 -53.7 11.08 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.423 ' OE2' ' NE2' ' A' ' 44' ' ' GLN . 18.7 mm-40 -62.98 -19.63 64.51 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.397 -0.814 . . . . 0.0 109.252 179.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -88.25 -45.85 9.72 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 178.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.3 t -62.94 -27.23 42.75 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 178.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.478 ' HB2' ' O ' ' A' ' 44' ' ' GLN . 0.2 OUTLIER -71.15 -66.1 0.66 Allowed 'General case' 0 C--N 1.309 -1.192 0 O-C-N 121.635 -0.666 . . . . 0.0 109.302 179.406 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -47.29 -49.0 24.7 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.367 -0.833 . . . . 0.0 109.022 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.929 ' HA ' HD13 ' A' ' 20' ' ' ILE . . . -57.44 -40.18 77.89 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.251 -0.905 . . . . 0.0 108.761 179.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.633 ' HE2' HD13 ' A' ' 59' ' ' ILE . 22.4 ttm -69.05 -14.15 62.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.413 -0.804 . . . . 0.0 109.186 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -99.77 -3.99 31.57 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.341 -0.849 . . . . 0.0 109.465 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.437 ' O ' ' HB3' ' A' ' 16' ' ' SER . 2.4 m -113.67 46.01 1.35 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.15 -0.969 . . . . 0.0 109.784 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . 0.789 ' SG ' ' N ' ' A' ' 57' ' ' GLN . 53.6 t -123.05 143.1 39.88 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.225 -0.922 . . . . 0.0 109.142 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.603 ' HD2' ' SG ' ' A' ' 54' ' ' CYS . 44.1 Cg_endo -71.35 -35.33 8.51 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.936 1.493 . . . . 0.0 110.037 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.816 HG21 ' OE1' ' A' ' 10' ' ' GLU . 43.5 t -124.45 -0.98 5.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.426 -0.796 . . . . 0.0 109.185 179.488 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.789 ' N ' ' SG ' ' A' ' 54' ' ' CYS . 6.4 mt-30 60.94 -80.41 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.266 -0.896 . . . . 0.0 109.459 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.5 ' SG ' ' HB3' ' A' ' 10' ' ' GLU . 0.3 OUTLIER 55.59 23.4 6.03 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.075 -1.016 . . . . 0.0 108.825 179.985 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.87 ' CB ' HG13 ' A' ' 6' ' ' VAL . 7.8 tt -124.12 154.31 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.213 -0.929 . . . . 0.0 110.051 -179.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.53 ' CG ' ' C ' ' A' ' 59' ' ' ILE . 10.5 m80 -157.36 157.55 34.29 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.426 -0.796 . . . . 0.0 109.241 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.511 ' HA ' ' HA ' ' A' ' 4' ' ' PHE . 40.1 m95 -83.32 179.53 7.66 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.095 -1.003 . . . . 0.0 109.394 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.485 ' O ' ' CB ' ' A' ' 3' ' ' LYS . 1.1 tt0 . . . . . 0 N--CA 1.489 1.476 0 O-C-N 121.288 -0.883 . . . . 0.0 109.408 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.483 ' O ' ' HB3' ' A' ' 4' ' ' PHE . 1.1 tttt . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.651 ' CE1' HG12 ' A' ' 39' ' ' VAL . 9.3 p90 167.57 179.56 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.283 -0.886 . . . . 0.0 109.307 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.46 ' HB3' ' O ' ' A' ' 4' ' ' PHE . 55.3 p90 176.16 -171.63 0.08 Allowed 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.354 -0.841 . . . . 0.0 109.272 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 1.046 HG21 ' CZ ' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -140.09 152.23 21.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 179.718 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.609 ' O ' ' N ' ' A' ' 9' ' ' ASP . 53.6 t0 -99.56 0.01 41.4 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 118.628 -1.229 . . . . 0.0 111.692 -178.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.506 ' HB2' ' HB3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER 42.56 14.92 0.01 OUTLIER 'General case' 0 C--N 1.273 -2.753 0 CA-C-O 121.29 0.567 . . . . 0.0 110.935 179.143 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.609 ' N ' ' O ' ' A' ' 7' ' ' ASP . 0.8 OUTLIER -75.98 -50.66 14.25 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.315 -0.866 . . . . 0.0 109.142 -179.295 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.724 ' HB3' HG21 ' A' ' 56' ' ' VAL . 1.1 tp10 -85.66 11.93 9.85 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.457 -0.777 . . . . 0.0 109.041 179.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 31.4 t -66.04 111.4 3.35 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.246 -0.909 . . . . 0.0 110.003 -179.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.523 HG13 ' N ' ' A' ' 13' ' ' ALA . 11.9 pt -73.53 -139.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.443 -0.786 . . . . 0.0 109.221 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.523 ' N ' HG13 ' A' ' 12' ' ' ILE . . . -102.99 28.34 6.32 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.942 -1.099 . . . . 0.0 110.003 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -112.0 159.49 18.39 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.922 -1.111 . . . . 0.0 109.78 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.442 ' O ' ' C ' ' A' ' 16' ' ' SER . 0.0 OUTLIER -136.25 20.4 3.19 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.401 -0.812 . . . . 0.0 109.374 -179.995 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.442 ' C ' ' O ' ' A' ' 15' ' ' GLU . 59.6 p -41.83 -44.33 3.29 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.521 -0.737 . . . . 0.0 109.387 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.605 ' SG ' ' CD2' ' A' ' 25' ' ' PHE . 17.4 p -58.33 -42.86 87.75 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.307 -0.871 . . . . 0.0 109.095 179.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.444 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 39.8 t -56.8 -30.5 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.33 -0.856 . . . . 0.0 109.493 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -81.58 -38.43 26.13 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.171 -0.955 . . . . 0.0 109.293 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.606 HG21 ' N ' ' A' ' 50' ' ' ALA . 0.3 OUTLIER -74.64 2.98 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.152 -0.967 . . . . 0.0 108.827 178.565 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.79 ' HB1' ' HB2' ' A' ' 42' ' ' ALA . . . -161.86 70.71 2.38 Favored Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.185 -0.947 . . . . 0.0 109.381 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -71.0 68.09 2.42 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 124.133 1.596 . . . . 0.0 110.277 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 165.66 -35.85 0.26 Allowed Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.989 -1.644 . . . . 0.0 108.989 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.525 ' CB ' ' O ' ' A' ' 38' ' ' ASP . . . -91.81 -46.97 7.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.454 -1.027 . . . . 0.0 109.176 179.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 1.046 ' CZ ' HG21 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -100.63 139.05 36.86 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.368 -0.832 . . . . 0.0 108.885 179.768 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.499 ' O ' ' CD1' ' A' ' 35' ' ' TYR . . . -169.34 124.03 0.83 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.152 -0.967 . . . . 0.0 109.759 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.554 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER -61.17 152.55 28.34 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.007 -1.058 . . . . 0.0 108.881 179.665 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.6 ' O ' ' N ' ' A' ' 32' ' ' GLU . 2.5 t0 -128.63 159.82 66.01 Favored Pre-proline 0 C--N 1.308 -1.204 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.479 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 44.9 Cg_endo -84.6 -16.23 5.73 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 O-C-N 124.562 1.822 . . . . 0.0 108.346 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -91.96 -27.81 17.63 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 177.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.684 HD12 ' HB3' ' A' ' 35' ' ' TYR . 0.7 OUTLIER -110.46 2.41 9.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.151 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.6 ' N ' ' O ' ' A' ' 28' ' ' ASP . 2.6 mm-40 26.22 44.01 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.466 0.651 . . . . 0.0 110.14 -179.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.532 ' CG ' ' O ' ' A' ' 32' ' ' GLU . 0.2 OUTLIER -172.23 149.19 2.24 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 119.175 -1.01 . . . . 0.0 109.999 -179.186 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.554 ' HA ' ' HA ' ' A' ' 27' ' ' MET . . . -56.8 144.67 32.1 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.433 -0.792 . . . . 0.0 110.158 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.684 ' HB3' HD12 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -148.78 140.79 23.85 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.839 0.828 . . . . 0.0 110.173 178.932 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.887 ' HB ' HG23 ' A' ' 6' ' ' VAL . 2.8 t -87.44 90.19 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 120.98 -1.075 . . . . 0.0 108.112 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.606 ' HB3' ' CE2' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -101.28 -7.79 22.7 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.333 -0.854 . . . . 0.0 110.588 -178.75 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.525 ' O ' ' CB ' ' A' ' 24' ' ' ALA . 59.6 t0 -138.16 93.6 2.78 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.991 -1.068 . . . . 0.0 109.952 -179.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.651 HG12 ' CE1' ' A' ' 4' ' ' PHE . 17.7 m -58.48 -29.5 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.298 -0.877 . . . . 0.0 109.017 179.459 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -76.28 -17.6 59.38 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.303 -0.873 . . . . 0.0 109.251 179.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -69.55 -8.65 60.28 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.79 ' HB2' ' HB1' ' A' ' 21' ' ' ALA . . . -155.09 119.56 4.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.286 -1.126 . . . . 0.0 109.289 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.659 ' O ' HG23 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -49.39 174.99 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.319 -0.863 . . . . 0.0 109.812 -179.747 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.427 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 6.3 tm0? -68.16 -42.48 79.98 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.558 -0.714 . . . . 0.0 109.478 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.6 mm-40 -66.7 -13.8 61.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.101 -0.999 . . . . 0.0 108.963 179.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -96.49 -43.48 7.6 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 178.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.67 HG23 ' O ' ' A' ' 42' ' ' ALA . 55.5 t -58.2 -51.61 69.0 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 178.31 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.427 ' HB2' ' O ' ' A' ' 44' ' ' GLN . 0.2 OUTLIER -65.46 -52.6 51.88 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.615 -0.678 . . . . 0.0 109.57 179.387 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -47.73 -48.63 29.59 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.207 -0.933 . . . . 0.0 109.234 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.606 ' N ' HG21 ' A' ' 20' ' ' ILE . . . -65.94 -23.64 66.65 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.199 -0.938 . . . . 0.0 109.001 179.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.995 ' CG ' HG21 ' A' ' 59' ' ' ILE . 35.0 ttm -76.16 -14.83 60.15 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.345 -0.847 . . . . 0.0 109.509 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -98.15 -25.32 14.95 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.218 -0.926 . . . . 0.0 109.71 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.75 -19.17 60.33 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.18 -0.95 . . . . 0.0 109.948 -179.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . 0.747 ' SG ' ' HD2' ' A' ' 55' ' ' PRO . 9.2 t -70.57 145.03 92.17 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.071 -1.018 . . . . 0.0 109.702 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.747 ' HD2' ' SG ' ' A' ' 54' ' ' CYS . 43.4 Cg_endo -73.44 -86.9 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.004 1.529 . . . . 0.0 109.505 179.247 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.724 HG21 ' HB3' ' A' ' 10' ' ' GLU . 27.8 m -56.03 -31.28 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 120.981 -1.074 . . . . 0.0 108.168 178.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.497 ' O ' ' N ' ' A' ' 59' ' ' ILE . 4.1 tt0 68.97 52.41 0.51 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.566 -0.709 . . . . 0.0 110.361 179.146 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.784 ' O ' HG12 ' A' ' 6' ' ' VAL . 0.5 OUTLIER -68.26 65.5 0.11 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.055 -1.028 . . . . 0.0 108.804 179.166 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.995 HG21 ' CG ' ' A' ' 51' ' ' MET . 0.5 OUTLIER -131.59 148.1 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.229 -0.919 . . . . 0.0 110.219 -179.262 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.505 ' N ' HG13 ' A' ' 59' ' ' ILE . 1.1 m80 -148.74 129.46 14.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.324 -0.86 . . . . 0.0 109.431 179.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.57 ' HA ' ' HA ' ' A' ' 4' ' ' PHE . 54.3 m95 -68.27 161.15 27.88 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.266 -0.896 . . . . 0.0 109.256 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.517 ' N ' ' HA ' ' A' ' 4' ' ' PHE . 24.2 tt0 . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.204 -0.935 . . . . 0.0 109.696 -179.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.48 ' HB3' ' HB3' ' A' ' 62' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.48 0 CA-C-O 121.346 0.593 . . . . 0.0 109.645 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.919 ' CZ ' HG12 ' A' ' 39' ' ' VAL . 23.4 p90 175.82 176.67 0.23 Allowed 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.514 ' CE1' ' HB2' ' A' ' 62' ' ' GLU . 17.4 p90 172.45 -168.42 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 105.747 -1.946 . . . . 0.0 105.747 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.854 HG13 ' HA ' ' A' ' 59' ' ' ILE . 4.4 t -146.54 159.72 10.42 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.236 0 C-N-CA 116.724 -1.99 . . . . 0.0 111.739 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.531 ' N ' HG12 ' A' ' 6' ' ' VAL . 39.1 t70 -106.16 78.44 1.31 Allowed 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.563 ' CG ' ' O ' ' A' ' 34' ' ' ALA . 5.3 mp0 -43.34 -19.24 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.984 179.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.525 ' N ' ' O ' ' A' ' 7' ' ' ASP . 0.1 OUTLIER -56.51 -35.56 68.17 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.163 -0.96 . . . . 0.0 108.828 -179.898 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.5 ' HB3' ' HB3' ' A' ' 58' ' ' CYS . 0.6 OUTLIER -81.96 -31.5 31.17 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.656 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.434 ' C ' ' O ' ' A' ' 10' ' ' GLU . 36.5 t -42.65 143.09 0.73 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.362 -0.836 . . . . 0.0 109.503 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.705 ' O ' ' HB2' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -98.14 -45.25 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.27 -0.893 . . . . 0.0 109.675 -179.603 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.705 ' HB2' ' O ' ' A' ' 12' ' ' ILE . . . 162.41 -28.84 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.24 -0.912 . . . . 0.0 109.571 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -56.09 156.34 5.58 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.16 -0.962 . . . . 0.0 109.499 -179.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.436 ' O ' ' C ' ' A' ' 16' ' ' SER . 31.3 mt-10 -116.97 20.94 13.59 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.276 -0.89 . . . . 0.0 109.68 -179.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.436 ' C ' ' O ' ' A' ' 15' ' ' GLU . 70.1 m -44.45 -63.79 0.82 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.226 -0.921 . . . . 0.0 109.073 179.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.647 ' SG ' ' N ' ' A' ' 18' ' ' VAL . 17.8 p -49.13 -54.33 16.75 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.32 -0.862 . . . . 0.0 109.151 179.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.647 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 48.4 t -43.43 -46.1 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.442 -0.786 . . . . 0.0 109.199 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -63.65 -34.5 77.99 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.155 -0.966 . . . . 0.0 109.146 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.592 HG22 ' O ' ' A' ' 20' ' ' ILE . 5.6 mt -87.51 14.42 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.137 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -171.03 65.25 0.43 Allowed Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.486 -0.759 . . . . 0.0 109.257 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -71.15 56.51 2.01 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 124.161 1.611 . . . . 0.0 110.147 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.491 ' C ' ' HB3' ' A' ' 38' ' ' ASP . . . -177.86 -63.35 0.07 OUTLIER Glycine 0 N--CA 1.488 2.148 0 N-CA-C 108.832 -1.707 . . . . 0.0 108.832 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.758 ' HB2' ' O ' ' A' ' 38' ' ' ASP . . . -66.56 -42.04 87.7 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.298 -1.119 . . . . 0.0 108.453 179.443 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.621 ' HZ ' HG11 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -101.23 132.79 46.57 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 118.757 -1.177 . . . . 0.0 108.949 179.45 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.624 ' HB3' ' HE1' ' A' ' 35' ' ' TYR . . . -161.49 130.87 4.64 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.434 -0.791 . . . . 0.0 109.358 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.535 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 4.0 ptt? -71.68 152.2 43.02 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.193 -0.942 . . . . 0.0 109.46 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.632 ' O ' ' N ' ' A' ' 32' ' ' GLU . 2.0 t0 -126.0 161.21 52.88 Favored Pre-proline 0 C--N 1.31 -1.118 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 179.002 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.483 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 45.0 Cg_endo -85.18 -17.9 4.4 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 O-C-N 124.814 1.955 . . . . 0.0 108.596 -179.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.3 -28.62 18.64 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 177.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.536 HG12 ' CB ' ' A' ' 28' ' ' ASP . 0.9 OUTLIER -107.17 -3.92 10.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 177.687 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.632 ' N ' ' O ' ' A' ' 28' ' ' ASP . 1.6 mt-10 31.41 37.47 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -179.271 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.548 ' CB ' ' HB3' ' A' ' 8' ' ' GLN . 19.4 mmtp -161.91 148.22 13.68 Favored 'General case' 0 N--CA 1.502 2.17 0 C-N-CA 119.499 -0.881 . . . . 0.0 110.753 -178.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.563 ' O ' ' CG ' ' A' ' 8' ' ' GLN . . . -61.58 138.45 58.29 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.416 -0.802 . . . . 0.0 110.167 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.76 ' CE2' ' HG3' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -132.58 144.57 50.48 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-O 122.262 1.029 . . . . 0.0 110.511 179.881 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.655 ' CG2' HG23 ' A' ' 6' ' ' VAL . 2.4 t -86.4 92.26 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 120.303 -1.498 . . . . 0.0 109.242 -178.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.76 ' HG3' ' CE2' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -107.55 -53.31 2.64 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.436 -0.79 . . . . 0.0 111.013 -179.006 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.758 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 46.9 t0 -85.77 76.07 9.97 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 119.746 -0.781 . . . . 0.0 110.782 -177.224 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.919 HG12 ' CZ ' ' A' ' 4' ' ' PHE . 27.5 m -49.94 -31.36 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.327 -0.858 . . . . 0.0 109.34 179.279 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -79.55 -6.92 58.02 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.327 -0.858 . . . . 0.0 109.476 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -85.85 5.38 84.01 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -153.35 116.46 4.58 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.179 -1.189 . . . . 0.0 109.644 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.869 ' O ' HG23 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -64.5 163.88 12.65 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.243 -0.911 . . . . 0.0 109.599 179.971 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.46 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 3.4 tt0 -49.8 -44.14 48.89 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.356 -0.84 . . . . 0.0 109.381 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.412 ' O ' ' HB2' ' A' ' 49' ' ' GLU . 72.7 mm-40 -67.87 -8.9 40.29 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.18 -0.95 . . . . 0.0 109.187 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.457 ' OE2' ' OG ' ' A' ' 43' ' ' SER . 14.3 mt-10 -99.58 -43.12 6.62 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 106.66 -1.608 . . . . 0.0 106.66 179.112 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.869 HG23 ' O ' ' A' ' 43' ' ' SER . 1.9 t -61.92 -42.73 95.84 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.398 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.46 ' HB2' ' O ' ' A' ' 44' ' ' GLN . 0.2 OUTLIER -73.49 -50.1 23.25 Favored 'General case' 0 C--N 1.308 -1.236 0 O-C-N 121.59 -0.694 . . . . 0.0 109.282 179.383 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.476 ' HB3' HD13 ' A' ' 20' ' ' ILE . 13.3 mm-40 -53.23 -45.95 68.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.224 -0.923 . . . . 0.0 108.77 179.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.554 ' HB2' ' HB ' ' A' ' 20' ' ' ILE . . . -70.29 -13.45 62.17 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.37 -0.831 . . . . 0.0 108.785 179.231 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.53 ' HA ' HG21 ' A' ' 59' ' ' ILE . 0.4 OUTLIER -80.72 -21.9 40.76 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.434 -0.791 . . . . 0.0 109.492 179.98 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -96.37 -34.34 11.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.197 -0.94 . . . . 0.0 109.605 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.477 ' OG1' ' HA ' ' A' ' 50' ' ' ALA . 0.1 OUTLIER -50.71 -54.82 20.11 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.252 -0.905 . . . . 0.0 109.747 179.975 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . 0.535 ' SG ' ' HD2' ' A' ' 55' ' ' PRO . 3.8 t -46.36 140.86 5.21 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.192 -0.943 . . . . 0.0 109.912 -179.61 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.535 ' HD2' ' SG ' ' A' ' 54' ' ' CYS . 44.8 Cg_endo -77.03 -62.99 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 124.123 1.591 . . . . 0.0 109.843 179.33 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 33.0 t -74.4 -20.74 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.335 -0.853 . . . . 0.0 108.868 179.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.481 ' NE2' ' O ' ' A' ' 51' ' ' MET . 3.5 mt-30 64.78 94.24 0.06 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.343 -0.848 . . . . 0.0 109.586 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.5 ' HB3' ' HB3' ' A' ' 10' ' ' GLU . 0.1 OUTLIER -100.42 -28.0 13.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.304 -0.872 . . . . 0.0 108.821 179.795 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.854 ' HA ' HG13 ' A' ' 6' ' ' VAL . 5.7 tt -60.88 151.06 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.458 -0.776 . . . . 0.0 109.976 -179.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.49 ' NE2' ' CE2' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -159.92 -178.55 7.11 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.454 -0.779 . . . . 0.0 108.9 179.509 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.506 ' HA ' ' HA ' ' A' ' 4' ' ' PHE . 66.7 m95 -101.3 165.02 11.49 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.118 -0.989 . . . . 0.0 109.768 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.514 ' HB2' ' CE1' ' A' ' 5' ' ' TYR . 41.2 tt0 . . . . . 0 N--CA 1.489 1.491 0 O-C-N 121.431 -0.793 . . . . 0.0 109.169 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.7 tpt180 -137.03 114.31 10.83 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.231 -0.918 . . . . 0.0 109.451 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.479 ' HB3' ' HB3' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -101.19 -156.47 0.56 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.165 -0.959 . . . . 0.0 109.522 -179.884 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.576 ' CB ' ' HA ' ' A' ' 61' ' ' TRP . 31.6 p90 179.78 -167.39 0.09 Allowed 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.173 -0.954 . . . . 0.0 109.208 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.735 ' HA ' HG11 ' A' ' 36' ' ' VAL . 39.3 p90 173.5 -166.79 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 106.87 -1.529 . . . . 0.0 106.87 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.909 HG11 ' HZ ' ' A' ' 25' ' ' PHE . 2.5 t -152.14 166.76 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 C-N-CA 117.532 -1.667 . . . . 0.0 112.119 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.582 ' H ' HG12 ' A' ' 6' ' ' VAL . 0.8 OUTLIER -106.76 68.57 0.74 Allowed 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 178.561 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.531 ' HB3' ' O ' ' A' ' 34' ' ' ALA . 0.6 OUTLIER -47.72 -15.59 0.06 Allowed 'General case' 0 C--N 1.297 -1.701 0 CA-C-O 121.344 0.593 . . . . 0.0 109.495 179.258 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.465 ' N ' ' O ' ' A' ' 7' ' ' ASP . 0.2 OUTLIER -65.17 -33.12 75.25 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.697 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.53 ' HB3' ' HB3' ' A' ' 58' ' ' CYS . 0.3 OUTLIER -93.47 0.74 56.87 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 179.168 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.449 ' HB3' ' O ' ' A' ' 8' ' ' GLN . 10.1 t -66.84 129.32 39.49 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.081 -1.012 . . . . 0.0 110.073 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.773 HG12 ' S3 ' ' A' ' 65' ' ' SF4 . 43.2 pt -88.78 -143.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.486 -0.759 . . . . 0.0 109.639 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.493 ' N ' HG13 ' A' ' 12' ' ' ILE . . . -107.56 52.92 0.7 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.076 -1.015 . . . . 0.0 109.901 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.947 ' O ' ' S2 ' ' A' ' 65' ' ' SF4 . 0.1 OUTLIER -134.53 155.18 50.86 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.039 -1.038 . . . . 0.0 109.673 179.661 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.42 ' O ' ' C ' ' A' ' 16' ' ' SER . 0.2 OUTLIER -120.46 18.89 12.09 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.319 -0.863 . . . . 0.0 109.798 -179.555 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.671 ' HB3' HG21 ' A' ' 53' ' ' THR . 0.7 OUTLIER -44.15 -51.13 8.34 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.195 -0.941 . . . . 0.0 109.346 179.995 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.826 ' SG ' ' CD2' ' A' ' 25' ' ' PHE . 14.6 p -62.02 -54.93 34.63 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.316 -0.865 . . . . 0.0 109.366 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.626 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 98.7 t -43.92 -34.22 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.279 -0.888 . . . . 0.0 109.501 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.42 -36.78 66.01 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.062 -1.024 . . . . 0.0 109.025 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.572 HD13 ' HB3' ' A' ' 49' ' ' GLU . 5.0 mt -87.37 16.13 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 178.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -174.43 63.64 0.26 Allowed Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.344 -0.848 . . . . 0.0 109.672 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -75.36 51.76 3.0 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 124.04 1.547 . . . . 0.0 110.34 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.428 ' C ' ' HA3' ' A' ' 41' ' ' GLY . . . -166.0 -41.63 0.02 OUTLIER Glycine 0 N--CA 1.489 2.213 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.574 ' HB2' ' H ' ' A' ' 42' ' ' ALA . . . -92.31 -46.8 7.52 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.434 -1.039 . . . . 0.0 108.678 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.909 ' HZ ' HG11 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -89.7 138.09 31.77 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.387 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.45 ' O ' ' CD1' ' A' ' 35' ' ' TYR . . . -173.57 126.31 0.4 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.103 -0.998 . . . . 0.0 109.58 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.565 ' HA ' ' C ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -63.82 153.01 37.98 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.166 -0.959 . . . . 0.0 109.841 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.605 ' O ' ' N ' ' A' ' 32' ' ' GLU . 2.2 t0 -129.59 163.67 45.09 Favored Pre-proline 0 C--O 1.209 -1.061 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.49 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 45.7 Cg_endo -83.63 -18.31 5.73 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 124.619 1.852 . . . . 0.0 107.961 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -84.17 -39.17 19.73 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 178.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.877 HD11 ' CD1' ' A' ' 35' ' ' TYR . 3.0 pt -101.51 -2.05 9.72 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 177.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.605 ' N ' ' O ' ' A' ' 28' ' ' ASP . 65.4 mt-10 34.66 34.53 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -179.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.578 ' O ' HD12 ' A' ' 31' ' ' ILE . 18.5 mttt -163.15 150.3 12.86 Favored 'General case' 0 N--CA 1.499 1.999 0 C-N-CA 119.408 -0.917 . . . . 0.0 110.374 -178.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.562 ' HA ' ' HA ' ' A' ' 27' ' ' MET . . . -62.48 143.88 56.62 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.515 -0.74 . . . . 0.0 110.489 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.877 ' CD1' HD11 ' A' ' 31' ' ' ILE . 1.2 p90 -155.25 158.02 38.18 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.735 HG11 ' HA ' ' A' ' 5' ' ' TYR . 14.5 p -67.51 68.44 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.818 -1.176 . . . . 0.0 108.833 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.679 ' HA ' ' CE2' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -49.95 -19.24 0.66 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.445 -0.785 . . . . 0.0 110.295 -179.691 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -165.95 99.72 0.65 Allowed 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.09 -1.006 . . . . 0.0 109.394 -179.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.503 ' HA ' ' CZ ' ' A' ' 4' ' ' PHE . 11.0 m -48.19 -29.65 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.419 -0.801 . . . . 0.0 109.764 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -85.12 -4.98 59.35 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.207 -0.933 . . . . 0.0 109.711 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.428 ' HA3' ' C ' ' A' ' 23' ' ' GLY . . . -67.02 -32.2 80.11 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.574 ' H ' ' HB2' ' A' ' 24' ' ' ALA . . . -128.24 163.04 25.59 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.212 -1.17 . . . . 0.0 109.279 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.557 ' O ' HG23 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -89.51 171.53 9.64 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.278 -0.889 . . . . 0.0 109.416 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.481 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 17.6 pt20 -68.51 -34.55 76.1 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.326 -0.859 . . . . 0.0 109.38 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -72.4 -23.9 61.17 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.311 -0.868 . . . . 0.0 109.322 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.469 ' OE2' ' OG ' ' A' ' 43' ' ' SER . 33.6 mt-10 -87.55 -41.14 13.69 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 178.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 43' ' ' SER . 38.5 t -63.37 -29.33 46.99 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 177.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.481 ' HB2' ' O ' ' A' ' 44' ' ' GLN . 0.5 OUTLIER -69.37 -64.65 0.83 Allowed 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.262 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.572 ' HB3' HD13 ' A' ' 20' ' ' ILE . 43.1 mt-10 -52.19 -39.76 60.59 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 119.467 -0.893 . . . . 0.0 108.786 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.515 ' HB2' ' HB ' ' A' ' 20' ' ' ILE . . . -62.78 -27.33 69.22 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.571 ' HG3' ' CG2' ' A' ' 59' ' ' ILE . 3.7 ttm -72.82 -43.57 62.53 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -55.36 -42.88 74.49 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.671 HG21 ' HB3' ' A' ' 16' ' ' SER . 0.1 OUTLIER -59.98 -160.23 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.419 -0.801 . . . . 0.0 109.195 179.803 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.593 ' SG ' ' HD2' ' A' ' 55' ' ' PRO . 1.7 t 66.74 144.63 0.09 OUTLIER Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.151 -0.968 . . . . 0.0 109.381 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.593 ' HD2' ' SG ' ' A' ' 54' ' ' CYS . 43.2 Cg_endo -73.57 -61.04 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.97 1.511 . . . . 0.0 109.948 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.456 HG12 ' O ' ' A' ' 56' ' ' VAL . 12.2 t -102.86 14.73 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.368 -0.833 . . . . 0.0 108.778 179.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.578 ' HA ' ' HB3' ' A' ' 54' ' ' CYS . 0.4 OUTLIER 65.08 -73.31 0.06 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.389 -0.819 . . . . 0.0 109.806 -179.891 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.53 ' HB3' ' HB3' ' A' ' 10' ' ' GLU . 1.8 m 63.95 12.98 7.27 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.95 -1.094 . . . . 0.0 108.544 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.571 ' CG2' ' HG3' ' A' ' 51' ' ' MET . 11.3 tt -119.22 152.25 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.432 -0.792 . . . . 0.0 109.463 -179.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.524 ' CD2' ' O ' ' A' ' 59' ' ' ILE . 18.9 m80 -156.11 170.26 22.6 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.104 -0.998 . . . . 0.0 110.007 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.576 ' HA ' ' CB ' ' A' ' 4' ' ' PHE . 60.6 m95 -94.14 175.1 6.83 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.353 -0.842 . . . . 0.0 109.577 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.479 ' HB3' ' HB3' ' A' ' 3' ' ' LYS . 7.3 tt0 -136.8 89.23 2.43 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.404 -0.81 . . . . 0.0 109.357 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.41 ' O ' ' C ' ' A' ' 64' ' ' GLU . 22.2 p-10 -54.93 155.41 4.46 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.317 -0.864 . . . . 0.0 109.666 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 63' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.363 -0.835 . . . . 0.0 109.571 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SF4 . . . . . 0.947 ' S2 ' ' O ' ' A' ' 14' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.505 ' O ' ' CB ' ' A' ' 2' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.2 0.524 . . . . 0.0 109.614 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.505 ' CB ' ' O ' ' A' ' 1' ' ' ALA . 10.6 tpp85 79.0 37.85 0.14 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.407 -0.808 . . . . 0.0 109.723 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.522 ' HB3' ' HB3' ' A' ' 62' ' ' GLU . 13.6 tptt -99.25 -154.37 0.47 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.246 -0.909 . . . . 0.0 109.286 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.561 ' CZ ' ' HB ' ' A' ' 39' ' ' VAL . 49.1 p90 176.39 176.38 0.29 Allowed 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.136 -0.977 . . . . 0.0 109.036 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.624 ' HA ' HG11 ' A' ' 36' ' ' VAL . 23.7 p90 175.66 -157.11 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 1.127 HG21 ' CZ ' ' A' ' 25' ' ' PHE . 0.2 OUTLIER -145.6 -170.57 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 C-N-CA 118.101 -1.439 . . . . 0.0 111.175 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.623 ' H ' HG12 ' A' ' 6' ' ' VAL . 0.6 OUTLIER -147.41 96.33 2.68 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.121 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.559 ' CG ' ' HB3' ' A' ' 33' ' ' LYS . 4.5 mp0 -64.67 40.08 0.02 OUTLIER 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.095 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.517 ' N ' ' O ' ' A' ' 7' ' ' ASP . 0.3 OUTLIER -99.03 -18.05 17.96 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.03 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.639 ' O ' HG11 ' A' ' 56' ' ' VAL . 0.5 OUTLIER -116.32 -9.29 11.56 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.701 -0.624 . . . . 0.0 109.621 -179.739 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.777 ' SG ' ' HG2' ' A' ' 33' ' ' LYS . 42.0 t -60.67 129.52 41.96 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.213 -0.929 . . . . 0.0 109.777 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.701 ' O ' ' HB2' ' A' ' 13' ' ' ALA . 14.3 pt -91.38 -45.32 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.413 -0.805 . . . . 0.0 109.271 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.701 ' HB2' ' O ' ' A' ' 12' ' ' ILE . . . 164.4 -29.9 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.279 -0.888 . . . . 0.0 110.024 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 1.164 ' O ' ' S2 ' ' A' ' 65' ' ' SF4 . 0.1 OUTLIER -49.16 154.8 0.75 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.938 -1.101 . . . . 0.0 109.377 -179.669 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.593 ' OE1' HG21 ' A' ' 18' ' ' VAL . 5.0 mm-40 -116.74 19.2 14.61 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.215 -0.928 . . . . 0.0 109.277 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.491 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 0.6 OUTLIER -43.93 -46.23 8.04 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.264 -0.897 . . . . 0.0 109.269 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.562 ' HB3' ' S1 ' ' A' ' 65' ' ' SF4 . 19.1 p -66.21 -47.56 73.44 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.394 -0.816 . . . . 0.0 109.274 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.593 HG21 ' OE1' ' A' ' 15' ' ' GLU . 23.7 t -50.65 -38.87 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.261 -0.899 . . . . 0.0 109.305 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -70.19 -37.28 75.08 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.224 -0.922 . . . . 0.0 109.097 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.624 HG22 ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -78.14 5.79 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.316 -0.865 . . . . 0.0 108.696 178.499 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.698 ' HB1' ' HB2' ' A' ' 42' ' ' ALA . . . -179.3 67.55 0.17 Allowed Pre-proline 0 N--CA 1.488 1.426 0 O-C-N 121.116 -0.99 . . . . 0.0 109.292 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -70.78 -2.96 11.74 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.051 1.553 . . . . 0.0 110.49 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.413 ' C ' ' HA3' ' A' ' 41' ' ' GLY . . . -103.52 -33.78 4.07 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.569 ' HB2' ' N ' ' A' ' 42' ' ' ALA . . . -96.95 -51.01 4.41 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.344 -1.092 . . . . 0.0 109.659 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 1.127 ' CZ ' HG21 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -85.54 136.08 33.55 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.307 -0.871 . . . . 0.0 109.572 -179.874 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.435 ' O ' ' CD1' ' A' ' 35' ' ' TYR . . . -163.73 128.83 2.94 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.11 -0.994 . . . . 0.0 109.834 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.56 ' HG2' ' CA ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -61.89 148.39 43.63 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.191 -0.943 . . . . 0.0 109.952 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.584 ' O ' ' N ' ' A' ' 32' ' ' GLU . 1.4 t70 -127.51 160.54 59.94 Favored Pre-proline 0 N--CA 1.478 0.966 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 178.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.48 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 44.2 Cg_endo -84.59 -19.24 4.36 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 O-C-N 124.497 1.788 . . . . 0.0 108.653 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -88.94 -33.99 17.06 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 106.452 -1.685 . . . . 0.0 106.452 177.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.663 HD11 ' CD1' ' A' ' 35' ' ' TYR . 0.5 OUTLIER -101.78 -0.41 10.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 177.9 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.584 ' N ' ' O ' ' A' ' 28' ' ' ASP . 17.0 mt-10 27.91 42.41 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.632 0.729 . . . . 0.0 109.654 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.777 ' HG2' ' SG ' ' A' ' 11' ' ' CYS . 0.2 OUTLIER -171.16 157.52 5.15 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -179.135 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.854 ' HB1' ' HD1' ' A' ' 25' ' ' PHE . . . -70.27 144.16 51.87 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.118 -0.989 . . . . 0.0 110.719 -178.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.665 ' CE2' ' HA ' ' A' ' 37' ' ' LYS . 2.6 p90 -150.24 159.03 44.74 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.801 ' O ' HG13 ' A' ' 36' ' ' VAL . 8.2 p -67.77 67.9 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.814 -1.178 . . . . 0.0 109.219 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.665 ' HA ' ' CE2' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -55.98 -14.8 2.76 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.232 -0.918 . . . . 0.0 110.598 -179.528 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -166.17 92.33 0.49 Allowed 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 119.004 -1.078 . . . . 0.0 109.909 -179.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.6 HG12 HG21 ' A' ' 36' ' ' VAL . 23.7 m -49.72 -26.13 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.389 -0.819 . . . . 0.0 109.703 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -78.86 -9.96 59.64 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.293 -0.879 . . . . 0.0 109.605 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.413 ' HA3' ' C ' ' A' ' 23' ' ' GLY . . . -79.23 -19.43 72.04 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.698 ' HB2' ' HB1' ' A' ' 21' ' ' ALA . . . -127.39 153.78 45.81 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.191 -1.182 . . . . 0.0 109.45 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.455 ' O ' HG23 ' A' ' 47' ' ' VAL . 0.5 OUTLIER -96.77 -168.15 1.67 Allowed 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.181 -0.949 . . . . 0.0 109.961 -179.738 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.481 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 0.4 OUTLIER -73.89 -57.98 3.61 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.609 -0.682 . . . . 0.0 109.196 179.703 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.404 ' O ' ' HB2' ' A' ' 49' ' ' GLU . 49.0 mm-40 -62.49 -14.43 41.37 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.37 -0.831 . . . . 0.0 109.692 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.453 ' HG3' ' HB2' ' A' ' 43' ' ' SER . 20.3 mt-10 -95.21 -46.48 6.75 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 179.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.491 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 5.5 t -59.23 -37.48 69.04 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.526 ' O ' ' N ' ' A' ' 51' ' ' MET . 0.2 OUTLIER -72.92 -55.49 6.52 Favored 'General case' 0 C--N 1.308 -1.218 0 O-C-N 121.58 -0.7 . . . . 0.0 109.813 179.971 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.827 ' O ' HG23 ' A' ' 53' ' ' THR . 2.6 tt0 -45.13 -50.57 11.14 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.196 -0.94 . . . . 0.0 108.862 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.614 ' N ' HG21 ' A' ' 20' ' ' ILE . . . -61.69 -28.37 69.36 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.211 -0.931 . . . . 0.0 108.607 179.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.764 ' HE2' HG23 ' A' ' 59' ' ' ILE . 43.2 ttm -64.7 -20.1 66.13 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.444 -0.785 . . . . 0.0 109.171 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -107.13 -10.03 15.99 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.374 -0.829 . . . . 0.0 109.432 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.827 HG23 ' O ' ' A' ' 49' ' ' GLU . 23.2 p -97.15 36.12 1.49 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.297 -0.877 . . . . 0.0 110.015 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.547 ' SG ' HG22 ' A' ' 56' ' ' VAL . 49.7 t -126.84 132.82 24.48 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.041 -1.037 . . . . 0.0 109.573 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.87 -32.97 8.42 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 123.835 1.44 . . . . 0.0 109.665 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.639 HG11 ' O ' ' A' ' 10' ' ' GLU . 7.3 m -98.82 -16.12 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.502 ' N ' ' SG ' ' A' ' 54' ' ' CYS . 6.9 mt-30 42.39 86.71 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.554 -0.716 . . . . 0.0 109.692 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.494 ' O ' ' CE1' ' A' ' 60' ' ' HIS . 8.9 p -120.33 6.17 10.68 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.318 -0.864 . . . . 0.0 109.23 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.87 HD13 ' N ' ' A' ' 60' ' ' HIS . 0.0 OUTLIER -95.3 127.17 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.268 -0.895 . . . . 0.0 109.931 -179.625 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.87 ' N ' HD13 ' A' ' 59' ' ' ILE . 2.4 m80 -131.91 -160.75 1.07 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.376 -0.828 . . . . 0.0 109.041 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.535 ' HA ' ' CB ' ' A' ' 4' ' ' PHE . 49.3 m95 -111.32 174.11 6.02 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.959 -1.088 . . . . 0.0 109.327 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.522 ' HB3' ' HB3' ' A' ' 3' ' ' LYS . 3.1 tt0 -136.43 78.78 1.73 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.505 -0.747 . . . . 0.0 109.137 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -92.21 -19.02 22.65 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.43 -0.794 . . . . 0.0 109.442 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.29 -0.881 . . . . 0.0 109.442 179.98 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' SF4 . . . . . 1.164 ' S2 ' ' O ' ' A' ' 14' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.426 ' O ' ' HG2' ' A' ' 2' ' ' ARG . 0.0 OUTLIER -86.63 101.38 13.19 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.358 -0.839 . . . . 0.0 109.407 179.998 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.486 ' HB3' ' HB3' ' A' ' 62' ' ' GLU . 0.6 OUTLIER -96.82 -153.41 0.41 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.182 -0.949 . . . . 0.0 109.805 -179.739 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.578 ' CZ ' ' HB ' ' A' ' 39' ' ' VAL . 8.1 p90 168.59 176.87 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 1.005 ' HA ' HG11 ' A' ' 36' ' ' VAL . 18.9 p90 178.52 -174.2 0.17 Allowed 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 1.14 HG21 ' CZ ' ' A' ' 25' ' ' PHE . 0.4 OUTLIER -132.69 168.45 24.16 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.12 0 C-N-CA 117.546 -1.662 . . . . 0.0 111.333 -179.393 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.541 ' O ' ' N ' ' A' ' 9' ' ' ASP . 9.5 t0 -116.07 89.91 3.21 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.587 ' CG ' ' O ' ' A' ' 34' ' ' ALA . 1.4 mp0 -63.24 42.3 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.949 -0.47 . . . . 0.0 111.004 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.541 ' N ' ' O ' ' A' ' 7' ' ' ASP . 0.4 OUTLIER -101.07 -28.32 12.77 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.177 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -119.53 21.74 11.97 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.485 ' HB3' ' CD ' ' A' ' 33' ' ' LYS . 8.7 t -76.77 122.51 24.86 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.186 -0.946 . . . . 0.0 110.055 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.913 HG12 ' S3 ' ' A' ' 65' ' ' SF4 . 37.7 pt -73.39 -5.76 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.405 -0.809 . . . . 0.0 109.436 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.711 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . 79.76 32.78 0.21 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.461 -0.775 . . . . 0.0 110.129 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.782 ' O ' ' S2 ' ' A' ' 65' ' ' SF4 . 1.3 p -95.78 151.93 18.93 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.097 -1.002 . . . . 0.0 109.178 179.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.468 ' O ' ' HB2' ' A' ' 19' ' ' GLU . 2.1 pt-20 -82.03 5.85 18.05 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.19 -0.944 . . . . 0.0 110.353 -179.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.776 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 3.6 m -43.78 -82.64 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.127 -0.983 . . . . 0.0 109.432 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.751 ' SG ' ' CD2' ' A' ' 25' ' ' PHE . 13.0 p -47.32 -56.83 6.07 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.25 -0.906 . . . . 0.0 109.617 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.666 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 74.1 t -47.29 -27.2 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.394 -0.816 . . . . 0.0 110.186 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.468 ' HB2' ' O ' ' A' ' 15' ' ' GLU . 0.1 OUTLIER -81.03 -40.14 24.72 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.966 -1.084 . . . . 0.0 109.673 -179.685 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.957 ' CD1' HG21 ' A' ' 53' ' ' THR . 2.4 mt -84.18 13.8 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.433 ' HB2' ' O ' ' A' ' 20' ' ' ILE . . . 177.84 65.92 0.09 OUTLIER Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.378 -0.826 . . . . 0.0 109.333 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -74.23 1.62 7.08 Favored 'Trans proline' 0 C--N 1.303 -1.837 0 O-C-N 124.069 1.563 . . . . 0.0 110.718 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.485 ' O ' ' HB3' ' A' ' 38' ' ' ASP . . . -97.77 -45.07 2.54 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' A' ' 38' ' ' ASP . . . -87.78 -47.1 8.89 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.255 -1.144 . . . . 0.0 109.559 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 1.14 ' CZ ' HG21 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -92.62 134.83 34.63 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.263 -0.898 . . . . 0.0 109.121 179.859 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.67 ' HB3' ' HE1' ' A' ' 35' ' ' TYR . . . -157.95 118.63 3.44 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.386 -0.821 . . . . 0.0 109.587 179.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.559 ' HA ' ' C ' ' A' ' 33' ' ' LYS . 14.6 mtm -59.15 149.6 27.64 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.114 -0.991 . . . . 0.0 109.37 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.612 ' O ' ' N ' ' A' ' 32' ' ' GLU . 1.3 t0 -126.95 163.13 43.39 Favored Pre-proline 0 C--N 1.312 -1.031 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 179.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.479 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 43.9 Cg_endo -83.95 -16.76 6.19 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 124.95 2.026 . . . . 0.0 108.086 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.24 -38.83 17.2 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 178.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.606 ' CG1' ' CB ' ' A' ' 28' ' ' ASP . 2.6 pt -102.24 -2.2 9.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.612 ' N ' ' O ' ' A' ' 28' ' ' ASP . 3.9 mm-40 34.35 36.23 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 -178.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.559 ' C ' ' HA ' ' A' ' 27' ' ' MET . 11.1 mttm -161.41 148.64 14.81 Favored 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 119.37 -0.932 . . . . 0.0 110.501 -177.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.587 ' O ' ' CG ' ' A' ' 8' ' ' GLN . . . -58.59 143.99 44.41 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.478 -0.764 . . . . 0.0 109.901 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.67 ' HE1' ' HB3' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -142.31 139.76 31.94 Favored 'General case' 0 N--CA 1.5 2.039 0 CA-C-O 121.803 0.811 . . . . 0.0 110.199 179.461 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 1.005 HG11 ' HA ' ' A' ' 5' ' ' TYR . 7.9 p -74.34 61.61 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.123 -0.986 . . . . 0.0 108.673 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.646 ' HB3' ' CZ ' ' A' ' 35' ' ' TYR . 0.1 OUTLIER -71.4 -18.34 62.35 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.303 -0.873 . . . . 0.0 110.607 -178.992 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.485 ' HB3' ' O ' ' A' ' 23' ' ' GLY . 57.2 t0 -135.21 75.62 1.58 Allowed 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.055 -1.028 . . . . 0.0 109.722 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.578 ' HB ' ' CZ ' ' A' ' 4' ' ' PHE . 6.4 m -51.81 -24.35 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.273 -0.892 . . . . 0.0 108.935 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.521 ' HG3' HG23 ' A' ' 39' ' ' VAL . 2.0 mt-10 -90.16 1.81 56.01 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.335 -0.853 . . . . 0.0 109.365 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.408 ' O ' ' HA3' ' A' ' 23' ' ' GLY . . . -96.04 34.75 4.72 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.435 ' HA ' ' OE2' ' A' ' 46' ' ' GLU . . . -179.66 126.65 0.08 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.251 -1.147 . . . . 0.0 109.615 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.77 ' O ' HG23 ' A' ' 47' ' ' VAL . 0.3 OUTLIER -59.22 165.67 2.52 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.298 -0.876 . . . . 0.0 109.542 179.768 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.496 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 0.1 OUTLIER -71.67 -37.44 70.76 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.333 -0.854 . . . . 0.0 109.467 179.995 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -71.73 -20.26 61.92 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.075 -1.015 . . . . 0.0 109.286 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.531 ' HG2' ' N ' ' A' ' 43' ' ' SER . 5.3 pt-20 -95.08 -34.08 12.44 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 106.517 -1.661 . . . . 0.0 106.517 178.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.77 HG23 ' O ' ' A' ' 43' ' ' SER . 25.1 t -64.25 -46.82 92.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 177.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.496 ' HB2' ' O ' ' A' ' 44' ' ' GLN . 0.2 OUTLIER -64.77 -51.3 63.02 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.615 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.652 ' HB3' HG21 ' A' ' 20' ' ' ILE . 6.6 mt-10 -51.74 -40.57 60.46 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 178.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.769 ' HA ' HD13 ' A' ' 20' ' ' ILE . . . -72.41 -32.73 66.61 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.993 ' HG3' HD13 ' A' ' 59' ' ' ILE . 34.6 ttm -74.41 -24.88 59.17 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.645 -0.659 . . . . 0.0 110.103 -179.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -86.3 -26.35 24.97 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.047 -1.033 . . . . 0.0 109.882 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.957 HG21 ' CD1' ' A' ' 20' ' ' ILE . 13.8 t -73.01 -5.89 41.84 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.137 -0.977 . . . . 0.0 109.772 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.633 ' SG ' ' HD2' ' A' ' 55' ' ' PRO . 19.4 t -79.09 142.61 59.82 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.163 -0.961 . . . . 0.0 109.743 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.633 ' HD2' ' SG ' ' A' ' 54' ' ' CYS . 42.9 Cg_endo -76.35 -72.38 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.07 1.563 . . . . 0.0 109.945 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.424 ' O ' ' HB2' ' A' ' 57' ' ' GLN . 2.5 t -74.5 -18.18 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.096 -1.003 . . . . 0.0 108.761 179.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.451 ' O ' ' C ' ' A' ' 58' ' ' CYS . 0.0 OUTLIER 71.9 -64.57 0.38 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.431 -0.793 . . . . 0.0 110.139 179.582 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.451 ' C ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER 42.05 37.9 0.95 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.334 -0.854 . . . . 0.0 108.799 -179.467 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.993 HD13 ' HG3' ' A' ' 51' ' ' MET . 7.6 tt -121.48 157.46 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.303 -0.873 . . . . 0.0 110.096 -179.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.57 ' CG ' ' O ' ' A' ' 59' ' ' ILE . 23.5 m80 -159.3 132.62 7.14 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.353 -0.842 . . . . 0.0 109.655 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.569 ' HA ' ' HA ' ' A' ' 4' ' ' PHE . 57.3 m95 -71.26 168.72 16.7 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.239 -0.913 . . . . 0.0 109.141 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.505 ' N ' ' HA ' ' A' ' 4' ' ' PHE . 1.4 tt0 -135.5 112.57 10.37 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.186 -0.946 . . . . 0.0 109.644 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -106.04 36.52 2.54 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.335 -0.853 . . . . 0.0 109.375 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 O-C-N 121.21 -0.931 . . . . 0.0 109.457 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' SF4 . . . . . 0.913 ' S3 ' HG12 ' A' ' 12' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 23.9 mtm180 -150.56 153.63 36.1 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.171 -0.956 . . . . 0.0 109.602 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.465 ' HB3' ' HB3' ' A' ' 62' ' ' GLU . 0.2 OUTLIER -101.55 -163.25 1.0 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.226 -0.921 . . . . 0.0 109.758 -179.968 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.638 ' CE1' HG21 ' A' ' 47' ' ' VAL . 14.4 p90 167.98 -174.33 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.269 -0.894 . . . . 0.0 109.657 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.527 ' O ' HG13 ' A' ' 59' ' ' ILE . 4.4 p90 176.18 -172.63 0.08 Allowed 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.953 HG21 ' CZ ' ' A' ' 25' ' ' PHE . 0.2 OUTLIER -135.78 164.89 31.25 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 C-N-CA 118.056 -1.458 . . . . 0.0 111.086 179.685 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.569 ' OD2' ' CE1' ' A' ' 60' ' ' HIS . 5.5 m-20 -109.1 90.88 3.43 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.519 ' HG2' ' O ' ' A' ' 34' ' ' ALA . 5.2 mp0 -66.22 48.24 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.66 0 CA-C-O 121.884 0.85 . . . . 0.0 110.002 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.527 ' N ' ' O ' ' A' ' 7' ' ' ASP . 11.0 t0 -110.53 -39.96 4.76 Favored 'General case' 0 C--N 1.285 -2.22 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.426 ' HB2' ' SG ' ' A' ' 58' ' ' CYS . 0.0 OUTLIER -101.25 20.49 15.69 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.307 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.447 ' HB3' ' HG2' ' A' ' 33' ' ' LYS . 11.1 t -86.44 134.99 33.65 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.308 -0.87 . . . . 0.0 110.085 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.692 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 30.3 pt -105.09 -6.15 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.353 -0.842 . . . . 0.0 108.78 179.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.692 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . 76.53 70.85 0.07 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.344 -0.848 . . . . 0.0 109.45 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 1.214 ' SG ' ' OG ' ' A' ' 16' ' ' SER . 27.4 p -103.89 -11.45 17.48 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.124 -0.985 . . . . 0.0 109.697 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.52 ' CB ' ' O ' ' A' ' 14' ' ' CYS . 3.1 tt0 76.29 -1.65 2.88 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.212 -0.93 . . . . 0.0 110.253 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 1.214 ' OG ' ' SG ' ' A' ' 14' ' ' CYS . 0.2 OUTLIER -61.76 -67.11 0.44 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.975 -1.078 . . . . 0.0 109.294 179.89 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.723 ' SG ' ' CD2' ' A' ' 25' ' ' PHE . 14.2 p -54.77 -44.12 73.39 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.21 -0.931 . . . . 0.0 109.103 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.463 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 21.2 t -54.31 -19.69 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.304 -0.872 . . . . 0.0 109.16 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.27 -41.54 14.51 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.172 -0.955 . . . . 0.0 109.107 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.837 HG21 ' HB3' ' A' ' 49' ' ' GLU . 1.9 mt -85.84 16.23 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 177.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.401 ' N ' ' HD3' ' A' ' 22' ' ' PRO . . . -177.54 59.95 0.15 Allowed Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.429 -0.795 . . . . 0.0 109.062 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.401 ' HD3' ' N ' ' A' ' 21' ' ' ALA . 45.4 Cg_endo -74.25 -0.11 9.21 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 124.075 1.566 . . . . 0.0 110.402 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.491 ' O ' ' HB3' ' A' ' 38' ' ' ASP . . . -111.43 -26.88 4.37 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.523 ' CB ' ' O ' ' A' ' 38' ' ' ASP . . . -100.34 -47.25 4.99 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.362 -1.081 . . . . 0.0 109.604 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.953 ' CZ ' HG21 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -90.61 140.4 29.79 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.373 -0.829 . . . . 0.0 109.045 -179.96 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.523 ' O ' ' CD1' ' A' ' 35' ' ' TYR . . . -164.48 119.57 1.45 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.147 -0.97 . . . . 0.0 109.943 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.542 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 5.7 ttm -60.14 152.22 24.94 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.098 -1.001 . . . . 0.0 109.159 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.606 ' O ' ' N ' ' A' ' 32' ' ' GLU . 2.8 t0 -125.97 160.14 58.33 Favored Pre-proline 0 C--N 1.312 -1.06 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 179.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.48 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 43.9 Cg_endo -84.88 -16.15 5.46 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 O-C-N 124.662 1.875 . . . . 0.0 108.585 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.75 -28.0 16.87 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 177.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.596 HD12 ' HB3' ' A' ' 35' ' ' TYR . 0.8 OUTLIER -108.46 -0.81 9.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 177.905 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.606 ' N ' ' O ' ' A' ' 28' ' ' ASP . 19.6 mt-10 28.73 42.73 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.595 0.712 . . . . 0.0 109.625 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.523 ' C ' ' HA ' ' A' ' 27' ' ' MET . 1.0 OUTLIER -169.44 148.19 3.76 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 119.365 -0.934 . . . . 0.0 110.287 -179.051 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.542 ' HA ' ' HA ' ' A' ' 27' ' ' MET . . . -57.2 143.76 37.88 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.453 -0.779 . . . . 0.0 110.67 -179.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.633 ' O ' ' CD1' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -144.03 143.09 31.03 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.732 0.777 . . . . 0.0 109.607 179.094 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.927 ' HB ' HG23 ' A' ' 6' ' ' VAL . 2.1 t -86.2 91.67 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 120.816 -1.178 . . . . 0.0 108.153 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.611 ' HB3' ' CE2' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -104.3 -16.22 15.22 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.343 -0.848 . . . . 0.0 110.605 -178.82 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.523 ' O ' ' CB ' ' A' ' 24' ' ' ALA . 36.9 t70 -129.66 90.92 3.06 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 120.984 -1.072 . . . . 0.0 109.696 -179.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.515 HG12 ' CE1' ' A' ' 4' ' ' PHE . 28.7 m -58.27 -39.77 75.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.22 -0.925 . . . . 0.0 109.578 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.486 ' HG2' ' OD1' ' A' ' 38' ' ' ASP . 1.3 pt-20 -64.6 -16.53 62.86 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.248 -0.907 . . . . 0.0 109.258 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.513 ' N ' ' OD2' ' A' ' 38' ' ' ASP . . . -76.59 0.76 63.86 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.694 -1.363 . . . . 0.0 109.694 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -160.04 103.91 1.49 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.179 -1.189 . . . . 0.0 109.512 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.472 ' OG ' ' OE2' ' A' ' 46' ' ' GLU . 0.4 OUTLIER -50.19 162.65 0.2 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.27 -0.894 . . . . 0.0 109.69 -179.876 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.479 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 15.1 pt20 -48.97 -50.17 36.99 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.434 -0.791 . . . . 0.0 109.43 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.42 ' N ' ' HG3' ' A' ' 44' ' ' GLN . 25.9 mm-40 -63.21 -13.04 33.04 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.298 -0.876 . . . . 0.0 109.359 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.472 ' OE2' ' OG ' ' A' ' 43' ' ' SER . 7.3 mt-10 -93.48 -52.77 4.35 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 179.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.638 HG21 ' CE1' ' A' ' 4' ' ' PHE . 2.5 t -53.67 -38.7 35.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 178.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.479 ' HB2' ' O ' ' A' ' 44' ' ' GLN . 0.1 OUTLIER -69.08 -55.63 10.19 Favored 'General case' 0 C--N 1.309 -1.173 0 O-C-N 121.499 -0.751 . . . . 0.0 109.776 179.775 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.837 ' HB3' HG21 ' A' ' 20' ' ' ILE . 20.3 mm-40 -53.2 -49.77 66.06 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.143 -0.973 . . . . 0.0 108.765 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.72 ' HB2' ' HB ' ' A' ' 20' ' ' ILE . . . -65.6 -11.1 41.32 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.429 -0.794 . . . . 0.0 108.931 179.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.643 ' CG ' HG21 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -83.92 -43.78 14.92 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.453 -0.78 . . . . 0.0 109.938 -179.372 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -76.41 -22.36 54.82 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.335 -0.853 . . . . 0.0 110.205 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.617 HG21 ' CD1' ' A' ' 20' ' ' ILE . 7.6 t -69.95 -6.05 30.43 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.052 -1.03 . . . . 0.0 109.69 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.521 ' SG ' ' HD2' ' A' ' 55' ' ' PRO . 16.1 t -85.95 139.97 34.99 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.152 -0.968 . . . . 0.0 109.557 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.521 ' HD2' ' SG ' ' A' ' 54' ' ' CYS . 46.0 Cg_endo -74.27 -49.52 0.18 Allowed 'Trans proline' 0 C--N 1.303 -1.819 0 O-C-N 124.051 1.553 . . . . 0.0 110.138 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.476 ' O ' ' HB2' ' A' ' 57' ' ' GLN . 5.4 t -97.28 -11.78 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.301 -0.874 . . . . 0.0 109.078 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.476 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 13.6 mt-30 65.43 -85.43 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.464 -0.773 . . . . 0.0 110.028 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.465 ' SG ' ' HB2' ' A' ' 7' ' ' ASP . 7.2 t 58.79 31.99 21.77 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.067 -1.021 . . . . 0.0 108.823 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.845 HD12 HG13 ' A' ' 6' ' ' VAL . 1.2 tt -110.84 156.65 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.354 -0.841 . . . . 0.0 109.724 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.569 ' CE1' ' OD2' ' A' ' 7' ' ' ASP . 13.6 m80 -154.03 136.54 15.07 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.116 -0.99 . . . . 0.0 109.797 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.547 ' HA ' ' CB ' ' A' ' 4' ' ' PHE . 56.8 m95 -78.74 166.88 21.97 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.39 -0.819 . . . . 0.0 109.499 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.526 ' N ' ' HA ' ' A' ' 4' ' ' PHE . 45.2 tt0 -132.65 116.83 17.13 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.342 -0.849 . . . . 0.0 109.32 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -106.14 -39.14 6.05 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.285 -0.885 . . . . 0.0 109.611 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 . . . . . 0 N--CA 1.49 1.548 0 O-C-N 121.207 -0.933 . . . . 0.0 109.507 179.984 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' SF4 . . . . . 0.595 ' S1 ' ' HB3' ' A' ' 17' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.433 ' O ' ' C ' ' A' ' 2' ' ' ARG . . . . . . . . 0 N--CA 1.492 1.627 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.433 ' C ' ' O ' ' A' ' 1' ' ' ALA . 18.9 mtm180 43.9 33.06 0.69 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.267 -0.895 . . . . 0.0 109.159 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.589 ' CG ' ' CG ' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -81.44 -145.01 0.05 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.506 -0.746 . . . . 0.0 109.538 -179.82 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.562 ' CB ' ' HA ' ' A' ' 61' ' ' TRP . 28.6 p90 -173.48 -177.59 1.5 Allowed 'General case' 0 C--N 1.296 -1.747 0 O-C-N 121.205 -0.935 . . . . 0.0 109.496 -179.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.609 ' HA ' HG11 ' A' ' 36' ' ' VAL . 14.3 p90 175.1 -172.05 0.06 Allowed 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 1.053 HG21 ' CZ ' ' A' ' 25' ' ' PHE . 0.2 OUTLIER -134.34 172.33 16.38 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 C-N-CA 117.594 -1.642 . . . . 0.0 111.162 179.565 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.567 ' O ' ' N ' ' A' ' 9' ' ' ASP . 13.5 t70 -122.29 90.18 3.25 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.566 ' CG ' ' O ' ' A' ' 34' ' ' ALA . 6.9 mp0 -66.45 48.92 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.748 0.785 . . . . 0.0 109.81 179.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.567 ' N ' ' O ' ' A' ' 7' ' ' ASP . 0.5 OUTLIER -114.08 -25.7 8.41 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.588 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.481 ' HB3' ' SG ' ' A' ' 58' ' ' CYS . 0.1 OUTLIER -110.22 -19.71 12.92 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.649 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.466 ' O ' ' HD3' ' A' ' 33' ' ' LYS . 42.0 t -46.75 141.92 3.62 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.425 -0.797 . . . . 0.0 109.471 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.749 ' O ' ' HB2' ' A' ' 13' ' ' ALA . 11.8 pt -99.34 -51.93 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.068 -1.02 . . . . 0.0 109.545 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.749 ' HB2' ' O ' ' A' ' 12' ' ' ILE . . . 154.91 35.48 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.543 -0.723 . . . . 0.0 110.276 179.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.673 ' O ' ' S2 ' ' A' ' 65' ' ' SF4 . 0.5 OUTLIER -105.08 158.53 16.5 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.667 -1.271 . . . . 0.0 109.719 179.557 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.455 ' O ' ' N ' ' A' ' 19' ' ' GLU . 11.6 mt-10 -99.07 12.97 34.5 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.306 -0.871 . . . . 0.0 109.833 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.631 ' O ' HD12 ' A' ' 20' ' ' ILE . 3.7 m -45.03 -76.34 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.087 -1.008 . . . . 0.0 109.052 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.995 ' SG ' ' CD2' ' A' ' 25' ' ' PHE . 10.6 p -52.6 -49.15 65.62 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.38 -0.825 . . . . 0.0 109.125 179.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.581 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 60.8 t -52.13 -24.7 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.311 -0.868 . . . . 0.0 109.226 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.455 ' N ' ' O ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -83.61 -36.02 24.21 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.219 -0.926 . . . . 0.0 109.173 179.76 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 1.012 HD13 ' HA ' ' A' ' 50' ' ' ALA . 2.7 mp -83.43 10.56 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.67 ' HB1' ' HB2' ' A' ' 42' ' ' ALA . . . 178.08 68.71 0.1 Allowed Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.393 -0.817 . . . . 0.0 108.879 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -69.93 -1.19 8.21 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 124.166 1.614 . . . . 0.0 110.887 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.497 ' O ' ' HB3' ' A' ' 38' ' ' ASP . . . -105.34 -44.44 1.46 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.53 ' CB ' ' O ' ' A' ' 38' ' ' ASP . . . -83.46 -36.42 24.19 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.374 -1.074 . . . . 0.0 109.844 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 1.053 ' CZ ' HG21 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -105.73 140.71 38.36 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.342 -0.848 . . . . 0.0 109.23 -179.682 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.522 ' O ' ' CD1' ' A' ' 35' ' ' TYR . . . -171.27 120.37 0.5 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.151 -0.968 . . . . 0.0 109.459 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.558 ' HA ' ' C ' ' A' ' 33' ' ' LYS . 10.5 mtp -58.41 153.73 15.16 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.08 -1.013 . . . . 0.0 109.232 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.613 ' O ' ' N ' ' A' ' 32' ' ' GLU . 1.4 t0 -132.97 165.07 39.4 Favored Pre-proline 0 C--N 1.312 -1.063 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.516 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 43.8 Cg_endo -84.59 -15.11 6.29 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 124.654 1.871 . . . . 0.0 107.459 178.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.687 ' HB3' HD13 ' A' ' 31' ' ' ILE . 4.4 tt0 -83.54 -39.24 20.66 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 177.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.7 ' N ' HD13 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -106.2 1.24 10.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.103 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.613 ' N ' ' O ' ' A' ' 28' ' ' ASP . 22.6 mt-10 33.84 36.42 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 -179.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.558 ' C ' ' HA ' ' A' ' 27' ' ' MET . 17.9 mttm -164.72 149.6 9.61 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 119.203 -0.999 . . . . 0.0 110.565 -177.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.566 ' O ' ' CG ' ' A' ' 8' ' ' GLN . . . -53.07 141.83 21.64 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.574 -0.704 . . . . 0.0 109.658 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.642 ' O ' ' CD1' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -144.69 140.67 28.76 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 122.044 0.926 . . . . 0.0 109.901 179.347 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.967 ' HB ' HG23 ' A' ' 6' ' ' VAL . 1.7 t -84.57 97.31 5.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -179.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.564 ' HG2' ' CE1' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -115.87 -10.62 11.65 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.278 -0.889 . . . . 0.0 111.193 -178.604 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.53 ' O ' ' CB ' ' A' ' 24' ' ' ALA . 33.9 t0 -133.03 87.91 2.45 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.792 -1.192 . . . . 0.0 110.098 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.408 HG23 ' N ' ' A' ' 40' ' ' GLU . 24.0 m -54.08 -34.89 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.258 -0.901 . . . . 0.0 109.343 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.408 ' N ' HG23 ' A' ' 39' ' ' VAL . 74.3 mt-10 -69.5 -14.03 62.65 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.4 -0.813 . . . . 0.0 109.601 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.4 ' HA3' ' C ' ' A' ' 23' ' ' GLY . . . -76.44 -2.08 73.0 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.67 ' HB2' ' HB1' ' A' ' 21' ' ' ALA . . . -162.5 135.57 5.92 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.209 -1.171 . . . . 0.0 109.46 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.456 ' OG ' ' HG3' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -77.23 166.43 23.22 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.283 -0.886 . . . . 0.0 109.84 -179.75 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.465 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 5.4 pt20 -54.9 -43.2 73.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.45 -0.781 . . . . 0.0 109.633 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.446 ' N ' ' HG3' ' A' ' 44' ' ' GLN . 33.4 mm-40 -69.18 -11.04 60.45 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.235 -0.916 . . . . 0.0 109.163 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.456 ' HG3' ' OG ' ' A' ' 43' ' ' SER . 18.3 mt-10 -94.72 -44.63 7.7 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 178.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.431 ' O ' ' HB2' ' A' ' 51' ' ' MET . 72.6 t -60.83 -37.26 76.01 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 177.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.465 ' HB2' ' O ' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -67.93 -59.65 3.11 Favored 'General case' 0 C--N 1.31 -1.146 0 O-C-N 121.502 -0.749 . . . . 0.0 109.298 179.108 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.644 ' OE1' HG23 ' A' ' 20' ' ' ILE . 8.8 tt0 -51.59 -47.48 63.55 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.441 -0.903 . . . . 0.0 109.101 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 1.012 ' HA ' HD13 ' A' ' 20' ' ' ILE . . . -61.62 -27.42 68.64 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.3 -0.875 . . . . 0.0 109.204 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.591 ' CG ' ' CG2' ' A' ' 59' ' ' ILE . 0.8 OUTLIER -70.97 -27.14 63.51 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.544 -0.723 . . . . 0.0 110.405 -179.21 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -94.68 -8.45 37.82 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.919 -1.113 . . . . 0.0 110.127 -179.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.474 HG22 ' HB3' ' A' ' 16' ' ' SER . 91.7 m -88.07 -17.96 29.93 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.073 -1.017 . . . . 0.0 110.052 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.818 ' SG ' ' HD2' ' A' ' 55' ' ' PRO . 35.5 t -69.73 147.07 96.24 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.028 -1.045 . . . . 0.0 109.783 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.818 ' HD2' ' SG ' ' A' ' 54' ' ' CYS . 45.0 Cg_endo -77.9 -63.32 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.119 1.589 . . . . 0.0 109.781 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.527 HG12 ' O ' ' A' ' 56' ' ' VAL . 75.9 t -80.65 -6.02 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.287 -0.883 . . . . 0.0 109.081 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.402 ' HA ' ' HB3' ' A' ' 54' ' ' CYS . 44.9 mt-30 45.8 71.46 0.28 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.315 -0.866 . . . . 0.0 109.545 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.481 ' SG ' ' HB3' ' A' ' 10' ' ' GLU . 2.5 m -94.44 21.1 7.5 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.277 -0.889 . . . . 0.0 109.129 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.658 HD12 HG22 ' A' ' 6' ' ' VAL . 1.9 tt -105.19 142.41 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.453 -0.78 . . . . 0.0 109.833 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.436 ' CG ' ' C ' ' A' ' 59' ' ' ILE . 6.5 m80 -149.83 142.31 24.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.471 -0.768 . . . . 0.0 109.118 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.562 ' HA ' ' CB ' ' A' ' 4' ' ' PHE . 64.5 m95 -59.5 175.28 0.35 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.22 -0.925 . . . . 0.0 109.744 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.589 ' CG ' ' CG ' ' A' ' 3' ' ' LYS . 1.4 tp10 -127.81 103.74 7.44 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.475 -0.766 . . . . 0.0 109.116 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -108.36 104.04 13.33 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.0 -1.063 . . . . 0.0 109.485 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.5 0 O-C-N 121.274 -0.891 . . . . 0.0 109.486 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' SF4 . . . . . 0.673 ' S2 ' ' O ' ' A' ' 14' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.5 ptt-85 -74.01 114.18 12.04 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.165 -0.959 . . . . 0.0 109.379 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.477 ' O ' ' HB3' ' A' ' 4' ' ' PHE . 0.5 OUTLIER -111.58 -168.01 1.25 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.279 -0.888 . . . . 0.0 109.677 -179.882 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.544 ' CB ' ' HA ' ' A' ' 61' ' ' TRP . 12.5 p90 177.07 -163.91 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.453 -0.779 . . . . 0.0 109.175 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.796 ' HA ' HG21 ' A' ' 36' ' ' VAL . 52.2 p90 171.44 -178.32 0.05 Allowed 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.95 HG21 ' CZ ' ' A' ' 25' ' ' PHE . 3.7 t -143.71 155.58 16.13 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.338 0 C-N-CA 117.205 -1.798 . . . . 0.0 111.301 179.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.525 ' O ' ' N ' ' A' ' 9' ' ' ASP . 0.2 OUTLIER -102.14 74.87 1.46 Allowed 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 178.864 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.532 ' HB3' ' O ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER -40.98 -24.43 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.523 0.678 . . . . 0.0 109.372 179.871 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.525 ' N ' ' O ' ' A' ' 7' ' ' ASP . 0.2 OUTLIER -54.27 -31.22 53.14 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.421 -0.799 . . . . 0.0 109.121 179.816 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.484 ' HG2' HG11 ' A' ' 56' ' ' VAL . 1.4 tp10 -100.83 11.27 39.91 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.346 -0.846 . . . . 0.0 109.152 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 6.6 t -76.97 122.03 24.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.242 -0.911 . . . . 0.0 109.905 -179.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 1.001 HG12 ' S3 ' ' A' ' 65' ' ' SF4 . 16.4 pt -70.96 -145.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.41 -0.806 . . . . 0.0 109.413 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.469 ' N ' HG13 ' A' ' 12' ' ' ILE . . . -111.71 55.77 0.66 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.053 -1.029 . . . . 0.0 109.575 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 1.044 ' O ' ' S2 ' ' A' ' 65' ' ' SF4 . 0.1 OUTLIER -139.35 155.37 47.72 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.121 -0.987 . . . . 0.0 109.692 179.858 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.43 ' O ' ' C ' ' A' ' 16' ' ' SER . 13.3 pt-20 -118.44 20.36 13.06 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.366 -0.833 . . . . 0.0 109.534 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.64 ' O ' HD12 ' A' ' 20' ' ' ILE . 0.2 OUTLIER -43.65 -60.95 1.56 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.354 -0.841 . . . . 0.0 109.269 179.899 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.533 ' SG ' ' N ' ' A' ' 18' ' ' VAL . 19.5 p -49.17 -48.59 44.92 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.386 -0.821 . . . . 0.0 109.297 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.533 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 5.0 t -49.6 -36.45 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.355 -0.841 . . . . 0.0 109.578 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.426 ' N ' ' OE1' ' A' ' 19' ' ' GLU . 0.2 OUTLIER -73.77 -35.91 65.03 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.041 -1.037 . . . . 0.0 109.321 -179.949 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.942 HD11 HG21 ' A' ' 53' ' ' THR . 2.5 mp -84.84 12.47 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.537 ' HB1' ' HB2' ' A' ' 42' ' ' ALA . . . -171.34 66.48 0.43 Allowed Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.355 -0.84 . . . . 0.0 109.311 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -72.51 56.42 2.77 Favored 'Trans proline' 0 C--N 1.303 -1.842 0 O-C-N 124.091 1.574 . . . . 0.0 110.058 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -179.85 -34.45 0.07 OUTLIER Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.476 ' O ' ' HA ' ' A' ' 36' ' ' VAL . . . -94.72 -25.28 16.77 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.246 -1.149 . . . . 0.0 109.303 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.95 ' CZ ' HG21 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -123.83 135.31 53.69 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.31 -0.869 . . . . 0.0 109.287 179.839 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.49 ' O ' ' HA ' ' A' ' 34' ' ' ALA . . . -163.05 145.15 10.16 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.537 ' HG3' ' CA ' ' A' ' 33' ' ' LYS . 10.7 ttm -77.72 152.7 33.55 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.96 -1.087 . . . . 0.0 109.123 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.636 ' O ' ' N ' ' A' ' 32' ' ' GLU . 1.1 t0 -123.84 162.26 41.98 Favored Pre-proline 0 C--N 1.313 -1.019 0 N-CA-C 106.614 -1.624 . . . . 0.0 106.614 179.067 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.456 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 46.5 Cg_endo -84.29 -15.09 6.67 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 125.06 2.084 . . . . 0.0 108.109 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -88.26 -34.34 17.75 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 178.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.596 ' CG1' ' HB3' ' A' ' 28' ' ' ASP . 1.6 pt -107.72 -2.49 10.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.636 ' N ' ' O ' ' A' ' 28' ' ' ASP . 0.0 OUTLIER 35.25 35.05 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -178.74 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.537 ' CA ' ' HG3' ' A' ' 27' ' ' MET . 23.7 mmtp -157.87 152.92 25.53 Favored 'General case' 0 N--CA 1.499 2.022 0 C-N-CA 119.42 -0.912 . . . . 0.0 110.542 -177.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.532 ' O ' ' HB3' ' A' ' 8' ' ' GLN . . . -61.74 142.75 57.06 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.616 -0.677 . . . . 0.0 110.059 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.651 ' CZ ' ' HB3' ' A' ' 37' ' ' LYS . 11.6 p90 -144.0 168.5 19.83 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 178.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.827 HG22 HG23 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -85.16 78.39 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.272 0 CA-C-O 121.782 0.801 . . . . 0.0 109.04 -178.079 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.651 ' HB3' ' CZ ' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -68.89 -3.74 13.82 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.846 -0.534 . . . . 0.0 110.539 -179.125 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.477 ' HB2' ' O ' ' A' ' 37' ' ' LYS . 36.7 t0 179.87 128.6 0.08 Allowed 'General case' 0 C--N 1.299 -1.611 0 C-N-CA 118.73 -1.188 . . . . 0.0 110.004 -178.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.529 HG12 ' CE1' ' A' ' 4' ' ' PHE . 15.8 m -79.6 -30.66 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.22 -0.925 . . . . 0.0 109.698 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -84.07 -9.75 58.38 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.183 -0.948 . . . . 0.0 109.267 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -61.95 -21.74 61.6 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.537 ' HB2' ' HB1' ' A' ' 21' ' ' ALA . . . -136.21 138.59 42.03 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.235 -1.156 . . . . 0.0 109.737 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.847 ' O ' HG23 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -71.66 158.32 36.38 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.244 -0.91 . . . . 0.0 109.643 -179.957 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.408 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 0.9 OUTLIER -47.53 -46.65 27.8 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.455 -0.778 . . . . 0.0 109.514 179.89 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -67.04 -9.54 40.21 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.292 -0.88 . . . . 0.0 109.449 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.468 ' HB2' ' HB1' ' A' ' 42' ' ' ALA . 27.5 mt-10 -97.91 -41.84 7.82 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 178.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.847 HG23 ' O ' ' A' ' 43' ' ' SER . 2.1 t -62.18 -40.59 88.17 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.924 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 178.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.408 ' HB2' ' O ' ' A' ' 44' ' ' GLN . 0.4 OUTLIER -73.17 -56.17 5.46 Favored 'General case' 0 C--N 1.308 -1.211 0 O-C-N 121.673 -0.642 . . . . 0.0 109.648 179.585 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.543 ' HB3' HG21 ' A' ' 20' ' ' ILE . 34.0 tt0 -52.94 -45.57 67.74 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.172 -0.955 . . . . 0.0 108.806 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.917 ' HA ' HD13 ' A' ' 20' ' ' ILE . . . -64.31 -17.87 64.07 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.32 -0.863 . . . . 0.0 108.93 179.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.79 ' HG3' HG21 ' A' ' 59' ' ' ILE . 2.6 ttm -80.93 -41.61 22.65 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.562 -0.712 . . . . 0.0 109.581 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -69.06 -24.54 64.18 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.282 -0.886 . . . . 0.0 109.704 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.942 HG21 HD11 ' A' ' 20' ' ' ILE . 4.9 p -72.5 -33.24 66.8 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.12 -0.988 . . . . 0.0 109.975 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.798 ' SG ' ' HD2' ' A' ' 55' ' ' PRO . 9.4 t -65.19 146.6 98.91 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.056 -1.028 . . . . 0.0 109.864 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.798 ' HD2' ' SG ' ' A' ' 54' ' ' CYS . 45.2 Cg_endo -79.15 -69.49 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 124.099 1.579 . . . . 0.0 110.105 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.484 HG11 ' HG2' ' A' ' 10' ' ' GLU . 9.8 p -75.44 -16.43 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.201 -0.937 . . . . 0.0 108.791 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 63.94 47.81 3.33 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.449 -0.782 . . . . 0.0 109.837 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.541 ' SG ' ' S4 ' ' A' ' 65' ' ' SF4 . 11.5 p -48.61 -23.57 1.05 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.224 -0.923 . . . . 0.0 109.212 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.869 ' CA ' HG13 ' A' ' 6' ' ' VAL . 6.6 tt -69.32 159.09 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.574 -0.703 . . . . 0.0 110.047 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.527 ' C ' ' CD1' ' A' ' 61' ' ' TRP . 46.9 m80 -149.82 -134.19 0.06 Allowed 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.666 ' CZ2' ' HE3' ' A' ' 51' ' ' MET . 74.4 m95 -151.68 168.74 24.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.835 -1.166 . . . . 0.0 110.062 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.451 ' O ' ' HB3' ' A' ' 3' ' ' LYS . 2.7 tt0 -147.83 114.5 6.03 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.431 -0.793 . . . . 0.0 109.404 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -137.79 -67.12 0.49 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.222 -0.924 . . . . 0.0 109.395 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 . . . . . 0 N--CA 1.489 1.513 0 O-C-N 121.254 -0.904 . . . . 0.0 109.423 -179.986 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' SF4 . . . . . 1.044 ' S2 ' ' O ' ' A' ' 14' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 15.4 mmm-85 58.94 90.75 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.173 -0.954 . . . . 0.0 109.403 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.513 ' HB3' ' HB3' ' A' ' 62' ' ' GLU . 0.5 OUTLIER -110.28 -158.34 0.64 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.142 -0.974 . . . . 0.0 109.606 -179.925 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.608 ' CZ ' ' HB ' ' A' ' 39' ' ' VAL . 29.3 p90 179.08 173.49 0.77 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.203 -0.936 . . . . 0.0 108.506 -179.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.577 ' HA ' HG11 ' A' ' 36' ' ' VAL . 6.4 p90 178.43 -161.63 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 1.051 HG21 ' CZ ' ' A' ' 25' ' ' PHE . 0.2 OUTLIER -139.3 -177.74 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 C-N-CA 117.545 -1.662 . . . . 0.0 112.076 -179.883 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.638 ' H ' HG12 ' A' ' 6' ' ' VAL . 5.6 m-20 -143.3 94.44 2.62 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.073 178.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.566 ' HB3' ' CD ' ' A' ' 33' ' ' LYS . 31.2 mm-40 -65.11 42.54 0.02 OUTLIER 'General case' 0 C--N 1.291 -1.942 0 CA-C-O 121.444 0.64 . . . . 0.0 111.293 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.495 ' N ' ' O ' ' A' ' 7' ' ' ASP . 0.3 OUTLIER -93.57 -16.87 23.95 Favored 'General case' 0 C--N 1.288 -2.094 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.548 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.806 ' CG ' HG11 ' A' ' 56' ' ' VAL . 0.9 OUTLIER -127.15 -1.16 6.44 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.505 -0.747 . . . . 0.0 110.472 -178.944 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.494 ' HB2' ' OE1' ' A' ' 8' ' ' GLN . 49.9 t -63.92 119.11 9.43 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.755 -1.216 . . . . 0.0 109.706 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.713 ' O ' ' HB2' ' A' ' 13' ' ' ALA . 11.8 pt -83.46 -45.1 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 O-C-N 121.364 -0.835 . . . . 0.0 109.481 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.713 ' HB2' ' O ' ' A' ' 12' ' ' ILE . . . 163.92 -27.95 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.163 -0.96 . . . . 0.0 110.033 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 1.079 ' O ' ' S2 ' ' A' ' 65' ' ' SF4 . 0.1 OUTLIER -48.24 154.44 0.59 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.011 -1.056 . . . . 0.0 110.041 -179.298 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.426 ' O ' ' C ' ' A' ' 16' ' ' SER . 6.9 mt-10 -113.35 18.25 17.91 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.404 -0.81 . . . . 0.0 109.193 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.8 ' O ' HD12 ' A' ' 20' ' ' ILE . 1.6 m -42.54 -60.17 1.62 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.424 -0.798 . . . . 0.0 109.5 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.682 ' SG ' ' CD2' ' A' ' 25' ' ' PHE . 18.1 p -51.05 -53.88 29.76 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.331 -0.856 . . . . 0.0 109.25 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.575 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 65.7 t -46.33 -37.7 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.334 -0.854 . . . . 0.0 109.207 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.05 -33.16 65.5 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.111 -0.993 . . . . 0.0 109.267 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.942 HG21 ' N ' ' A' ' 50' ' ' ALA . 2.4 mp -85.1 11.99 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.506 ' HB1' ' CB ' ' A' ' 42' ' ' ALA . . . 179.08 62.83 0.1 Allowed Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.429 -0.795 . . . . 0.0 109.49 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -73.34 54.73 2.88 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 124.134 1.597 . . . . 0.0 110.268 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -161.68 -40.57 0.02 OUTLIER Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.756 -1.737 . . . . 0.0 108.756 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.42 ' O ' ' HA ' ' A' ' 36' ' ' VAL . . . -96.41 -36.71 10.73 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.407 -1.055 . . . . 0.0 108.908 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 1.051 ' CZ ' HG21 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -95.17 138.01 33.45 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.301 -0.874 . . . . 0.0 108.835 179.624 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.486 ' C ' ' HA ' ' A' ' 34' ' ' ALA . . . -162.87 121.69 2.13 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.027 -1.046 . . . . 0.0 110.197 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.576 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 6.8 tmm? -62.0 147.81 45.9 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.175 -0.953 . . . . 0.0 109.506 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.624 ' O ' ' N ' ' A' ' 32' ' ' GLU . 0.8 OUTLIER -125.67 161.78 48.8 Favored Pre-proline 0 C--N 1.315 -0.907 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 179.083 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.45 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 46.4 Cg_endo -84.0 -15.79 6.66 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 124.96 2.032 . . . . 0.0 107.958 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.39 -35.89 18.08 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 178.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.639 HD12 ' O ' ' A' ' 33' ' ' LYS . 2.7 pt -105.58 -1.99 9.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.624 ' N ' ' O ' ' A' ' 28' ' ' ASP . 2.1 mt-10 34.75 34.97 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -178.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.639 ' O ' HD12 ' A' ' 31' ' ' ILE . 34.2 mttp -160.49 151.67 19.14 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.213 -178.058 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.594 ' HB1' ' CD1' ' A' ' 25' ' ' PHE . . . -70.09 151.0 45.98 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.249 -0.907 . . . . 0.0 110.658 -179.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.651 ' CZ ' ' HB3' ' A' ' 37' ' ' LYS . 4.3 p90 -148.07 150.41 33.85 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 178.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.724 HG21 HG12 ' A' ' 39' ' ' VAL . 10.6 p -69.59 63.39 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 C-N-CA 119.055 -1.058 . . . . 0.0 108.205 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.651 ' HB3' ' CZ ' ' A' ' 35' ' ' TYR . 13.7 pttp -47.98 -27.49 2.24 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.265 0.555 . . . . 0.0 110.481 -179.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -157.33 92.27 1.23 Allowed 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 119.207 -0.997 . . . . 0.0 109.753 -178.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.724 HG12 HG21 ' A' ' 36' ' ' VAL . 26.8 m -49.11 -21.99 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.425 -0.797 . . . . 0.0 109.773 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.44 -16.79 57.2 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.149 -0.969 . . . . 0.0 109.476 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -77.45 1.38 66.05 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.506 ' CB ' ' HB1' ' A' ' 21' ' ' ALA . . . -157.27 124.0 5.03 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.14 -1.212 . . . . 0.0 109.781 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.554 ' N ' ' HG2' ' A' ' 46' ' ' GLU . 0.3 OUTLIER -53.86 163.0 0.79 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.375 -0.828 . . . . 0.0 109.754 179.708 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.448 ' HG3' ' HG2' ' A' ' 45' ' ' GLU . 11.1 pt20 -67.95 -40.34 83.26 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.351 -0.843 . . . . 0.0 109.853 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.504 ' O ' ' HG2' ' A' ' 48' ' ' GLU . 1.6 mm-40 -72.45 -26.23 61.75 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.075 -1.016 . . . . 0.0 109.53 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.56 ' O ' HG22 ' A' ' 20' ' ' ILE . 5.3 pt-20 -85.0 -31.5 23.45 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 105.476 -2.046 . . . . 0.0 105.476 177.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 43' ' ' SER . 2.5 t -65.28 -34.64 71.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.517 ' O ' ' N ' ' A' ' 51' ' ' MET . 8.4 pt-20 -74.45 -56.84 4.4 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.16 -0.962 . . . . 0.0 109.417 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.581 ' C ' HG21 ' A' ' 20' ' ' ILE . 61.8 tt0 -41.3 -38.32 1.15 Allowed 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.942 ' N ' HG21 ' A' ' 20' ' ' ILE . . . -67.95 -41.63 82.21 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.573 ' HE2' HG22 ' A' ' 59' ' ' ILE . 3.7 ttm -62.93 -47.72 82.04 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.94 -31.61 71.15 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.16 -0.963 . . . . 0.0 109.329 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 70.0 m -98.29 88.22 4.11 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.313 -0.867 . . . . 0.0 109.173 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.536 ' SG ' ' HD2' ' A' ' 55' ' ' PRO . 21.6 t -161.15 145.82 10.38 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.198 -0.939 . . . . 0.0 109.334 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.758 ' CG ' ' S3 ' ' A' ' 65' ' ' SF4 . 43.3 Cg_endo -71.21 101.3 1.09 Allowed 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 123.858 1.452 . . . . 0.0 109.425 179.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.806 HG11 ' CG ' ' A' ' 10' ' ' GLU . 0.4 OUTLIER 82.41 -9.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 -178.624 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.529 ' HA ' ' HB3' ' A' ' 54' ' ' CYS . 0.1 OUTLIER 63.04 148.38 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.441 -0.787 . . . . 0.0 110.641 179.393 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.749 ' SG ' ' S4 ' ' A' ' 65' ' ' SF4 . 2.4 p -148.87 -34.81 0.2 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.72 -0.613 . . . . 0.0 109.403 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.881 ' HA ' HG13 ' A' ' 6' ' ' VAL . 17.1 mt -58.12 153.67 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.026 -1.046 . . . . 0.0 109.418 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.585 ' CE1' ' O ' ' A' ' 58' ' ' CYS . 45.6 m80 -159.06 125.0 4.41 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.565 ' HA ' ' CB ' ' A' ' 4' ' ' PHE . 87.8 m95 -55.22 171.11 0.17 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.121 -0.987 . . . . 0.0 109.108 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.513 ' HB3' ' HB3' ' A' ' 3' ' ' LYS . 1.3 tt0 -136.22 93.55 2.92 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.248 -0.907 . . . . 0.0 109.245 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -90.23 135.26 33.78 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.189 -0.945 . . . . 0.0 109.424 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 O-C-N 121.23 -0.919 . . . . 0.0 109.479 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' SF4 . . . . . 1.079 ' S2 ' ' O ' ' A' ' 14' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.276 0.56 . . . . 0.0 109.529 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 17.0 mtt180 -63.52 172.04 2.26 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.263 -0.898 . . . . 0.0 109.35 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.457 ' O ' ' HB3' ' A' ' 4' ' ' PHE . 0.2 OUTLIER -132.26 -164.36 1.45 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.132 -0.98 . . . . 0.0 109.602 -179.955 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.565 ' CB ' ' HA ' ' A' ' 61' ' ' TRP . 6.1 p90 177.43 -172.12 0.1 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.321 -0.862 . . . . 0.0 109.262 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.623 ' HA ' HG11 ' A' ' 36' ' ' VAL . 46.8 p90 169.2 -177.77 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 1.086 HG21 ' CZ ' ' A' ' 25' ' ' PHE . 3.1 t -139.39 159.5 28.45 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.4 0 C-N-CA 116.962 -1.895 . . . . 0.0 111.417 179.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.544 ' N ' HG12 ' A' ' 6' ' ' VAL . 1.2 m-20 -106.9 72.52 0.89 Allowed 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.521 ' HB3' ' O ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER -41.8 -23.87 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 179.486 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 7' ' ' ASP . 19.5 t0 -50.92 -38.54 50.71 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.562 ' HB3' ' CB ' ' A' ' 58' ' ' CYS . 20.8 tt0 -82.02 -19.99 39.28 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.369 -0.832 . . . . 0.0 108.942 179.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.512 ' HB3' ' O ' ' A' ' 8' ' ' GLN . 36.9 t -51.15 123.92 10.47 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.477 -0.764 . . . . 0.0 109.806 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.683 ' O ' ' HB2' ' A' ' 13' ' ' ALA . 10.0 pt -75.32 -48.7 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.376 -0.827 . . . . 0.0 109.541 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.683 ' HB2' ' O ' ' A' ' 12' ' ' ILE . . . 166.13 -33.03 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.028 -1.045 . . . . 0.0 110.132 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 1.119 ' O ' ' S2 ' ' A' ' 65' ' ' SF4 . 0.1 OUTLIER -52.32 159.6 0.95 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.073 -1.017 . . . . 0.0 109.519 -179.59 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.476 ' HA ' ' S2 ' ' A' ' 65' ' ' SF4 . 13.6 pt-20 -123.75 21.85 9.1 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.31 -0.869 . . . . 0.0 109.505 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.428 ' O ' HD12 ' A' ' 20' ' ' ILE . 0.6 OUTLIER -44.53 -58.57 2.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.175 -0.953 . . . . 0.0 109.023 179.797 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.674 ' SG ' ' N ' ' A' ' 18' ' ' VAL . 17.6 p -49.96 -58.77 4.76 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.433 -0.792 . . . . 0.0 109.166 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.674 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 59.4 t -45.26 -34.41 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.224 -0.922 . . . . 0.0 109.044 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.39 -39.53 71.13 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.162 -0.961 . . . . 0.0 108.897 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.728 ' HB ' ' HB2' ' A' ' 50' ' ' ALA . 1.9 mt -87.1 17.77 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 177.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.639 ' HB1' ' HB2' ' A' ' 42' ' ' ALA . . . 172.31 65.42 0.03 OUTLIER Pre-proline 0 N--CA 1.489 1.482 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.503 ' N ' ' O ' ' A' ' 18' ' ' VAL . 43.8 Cg_endo -72.14 -2.09 11.07 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.108 1.583 . . . . 0.0 110.65 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.506 ' O ' ' HB3' ' A' ' 38' ' ' ASP . . . -92.2 -71.85 1.2 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.763 ' HB2' ' O ' ' A' ' 38' ' ' ASP . . . -66.82 -30.15 70.26 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.353 -1.087 . . . . 0.0 109.364 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 1.086 ' CZ ' HG21 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -105.42 133.75 49.66 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 118.821 -1.152 . . . . 0.0 109.904 -179.734 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.553 ' O ' ' CD1' ' A' ' 35' ' ' TYR . . . -166.27 123.97 1.42 Allowed 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.478 -0.764 . . . . 0.0 109.156 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.56 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER -62.17 155.63 23.91 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.169 -0.957 . . . . 0.0 109.092 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.589 ' O ' ' HA ' ' A' ' 32' ' ' GLU . 4.0 t0 -128.2 161.99 53.02 Favored Pre-proline 0 C--N 1.309 -1.166 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.477 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 43.9 Cg_endo -85.0 -18.16 4.42 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 124.428 1.752 . . . . 0.0 108.562 -179.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -89.32 -32.75 17.19 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 177.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.635 HD12 ' HB3' ' A' ' 35' ' ' TYR . 0.8 OUTLIER -104.79 2.19 10.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 178.071 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.589 ' HA ' ' O ' ' A' ' 28' ' ' ASP . 9.9 mt-10 26.34 43.68 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.51 0.672 . . . . 0.0 110.212 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.53 ' O ' ' HA ' ' A' ' 27' ' ' MET . 6.2 mttt -172.13 148.46 2.2 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 119.134 -1.027 . . . . 0.0 110.653 -179.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.56 ' HA ' ' HA ' ' A' ' 27' ' ' MET . . . -54.71 142.21 29.44 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.684 -0.635 . . . . 0.0 110.634 -179.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.71 ' CE2' ' HG3' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -143.91 151.01 39.26 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-O 121.764 0.792 . . . . 0.0 109.95 179.156 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.805 ' HB ' HG23 ' A' ' 6' ' ' VAL . 0.9 OUTLIER -91.04 109.19 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.424 -1.422 . . . . 0.0 109.563 -178.637 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.71 ' HG3' ' CE2' ' A' ' 35' ' ' TYR . 23.5 mmtt -125.75 -53.25 1.56 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.423 -0.798 . . . . 0.0 110.445 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.763 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 61.6 t0 -86.98 71.94 10.17 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.599 -0.688 . . . . 0.0 110.462 -177.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.523 HG23 ' N ' ' A' ' 40' ' ' GLU . 24.8 m -46.58 -40.59 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.322 -0.861 . . . . 0.0 109.194 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.523 ' N ' HG23 ' A' ' 39' ' ' VAL . 11.0 mm-40 -66.33 -17.71 64.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.352 -0.842 . . . . 0.0 109.499 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' A' ' 38' ' ' ASP . . . -72.43 -21.13 79.58 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.639 ' HB2' ' HB1' ' A' ' 21' ' ' ALA . . . -132.02 134.67 45.83 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.277 -1.131 . . . . 0.0 109.296 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.692 ' O ' HG23 ' A' ' 47' ' ' VAL . 0.4 OUTLIER -79.29 -166.99 1.04 Allowed 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.224 -0.922 . . . . 0.0 109.775 -179.8 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.477 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 1.9 mt-30 -71.44 -49.58 40.27 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.664 -0.647 . . . . 0.0 109.56 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.459 ' O ' ' HB2' ' A' ' 49' ' ' GLU . 1.8 pm0 -72.77 -12.84 61.16 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.175 -0.953 . . . . 0.0 109.298 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.476 ' HG3' ' HB2' ' A' ' 43' ' ' SER . 29.9 mt-10 -90.71 -42.01 10.96 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 178.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.692 HG23 ' O ' ' A' ' 43' ' ' SER . 24.2 t -63.95 -47.53 90.12 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 CA-C-N 114.789 -1.096 . . . . 0.0 108.093 178.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.526 ' O ' ' N ' ' A' ' 51' ' ' MET . 0.3 OUTLIER -67.97 -62.23 1.5 Allowed 'General case' 0 C--N 1.307 -1.243 0 O-C-N 121.584 -0.697 . . . . 0.0 109.591 179.583 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.628 ' HB3' HG21 ' A' ' 20' ' ' ILE . 34.6 mt-10 -43.23 -52.01 5.86 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 119.44 -0.904 . . . . 0.0 108.918 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.728 ' HB2' ' HB ' ' A' ' 20' ' ' ILE . . . -65.53 -27.86 68.76 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 1.029 ' CG ' HG21 ' A' ' 59' ' ' ILE . 22.5 ttm -76.88 -21.68 54.58 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.627 -0.67 . . . . 0.0 110.35 -179.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.81 -15.78 26.11 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.085 -1.009 . . . . 0.0 109.759 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.527 ' OG1' ' CD1' ' A' ' 20' ' ' ILE . 76.2 p -91.91 73.63 5.66 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.189 -0.944 . . . . 0.0 109.455 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 19.0 t -151.65 128.49 5.43 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.219 -0.926 . . . . 0.0 109.684 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.596 ' C ' HG12 ' A' ' 56' ' ' VAL . 47.1 Cg_endo -75.48 53.73 3.64 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 123.857 1.451 . . . . 0.0 109.912 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.596 HG12 ' C ' ' A' ' 55' ' ' PRO . 1.5 p 160.42 -26.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 60.19 72.96 0.5 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.569 -0.707 . . . . 0.0 109.933 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.562 ' CB ' ' HB3' ' A' ' 10' ' ' GLU . 29.7 p -84.6 7.98 18.31 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.108 -0.995 . . . . 0.0 109.198 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 1.029 HG21 ' CG ' ' A' ' 51' ' ' MET . 1.0 OUTLIER -75.87 155.62 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.348 -0.845 . . . . 0.0 110.505 -179.232 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.56 ' CD2' ' O ' ' A' ' 59' ' ' ILE . 39.7 m80 -155.52 125.36 6.51 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.565 ' HA ' ' CB ' ' A' ' 4' ' ' PHE . 62.5 m95 -73.05 173.89 8.69 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.194 -0.941 . . . . 0.0 109.652 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.453 ' HB3' ' HB3' ' A' ' 3' ' ' LYS . 9.6 tp10 -145.1 106.25 4.18 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.327 -0.858 . . . . 0.0 109.333 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -118.97 99.29 6.64 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.379 -0.825 . . . . 0.0 109.301 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 . . . . . 0 N--CA 1.489 1.503 0 O-C-N 121.325 -0.86 . . . . 0.0 109.379 -179.99 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' SF4 . . . . . 1.119 ' S2 ' ' O ' ' A' ' 14' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -94.08 102.39 14.44 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.228 -0.92 . . . . 0.0 109.41 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.475 ' O ' ' HB3' ' A' ' 4' ' ' PHE . 0.2 OUTLIER -101.9 -154.9 0.5 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.181 -0.949 . . . . 0.0 109.441 -179.999 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.562 ' CB ' ' HA ' ' A' ' 61' ' ' TRP . 2.5 p90 177.9 -178.73 0.24 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.293 -0.879 . . . . 0.0 110.007 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.463 ' HA ' HG11 ' A' ' 36' ' ' VAL . 20.3 p90 174.68 -167.0 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 1.088 HG21 ' CZ ' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -137.03 -166.36 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 C-N-CA 118.406 -1.318 . . . . 0.0 111.066 179.713 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.532 ' O ' ' N ' ' A' ' 9' ' ' ASP . 0.3 OUTLIER -151.65 98.98 2.55 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 114.413 -1.267 . . . . 0.0 108.056 177.784 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.6 ' CG ' ' HB3' ' A' ' 33' ' ' LYS . 2.9 mp0 -65.15 43.3 0.02 OUTLIER 'General case' 0 C--N 1.29 -2.001 0 CA-C-O 121.367 0.603 . . . . 0.0 110.392 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.532 ' N ' ' O ' ' A' ' 7' ' ' ASP . 0.5 OUTLIER -99.42 -29.68 12.62 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.265 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.471 ' HB2' ' SG ' ' A' ' 58' ' ' CYS . 0.0 OUTLIER -118.31 25.59 10.2 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.859 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.712 ' SG ' ' HG2' ' A' ' 33' ' ' LYS . 14.3 t -90.22 119.07 30.22 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.225 -0.922 . . . . 0.0 110.432 -179.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.439 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 12.2 pt -88.61 5.01 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . 61.76 65.26 0.94 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.367 -0.833 . . . . 0.0 109.665 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.783 ' SG ' ' OG ' ' A' ' 16' ' ' SER . 31.7 p -102.22 -9.89 20.06 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.082 -1.011 . . . . 0.0 109.678 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.447 ' OE1' ' HG3' ' A' ' 19' ' ' GLU . 0.0 OUTLIER 70.7 4.29 4.93 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.24 -0.913 . . . . 0.0 109.84 179.591 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.792 ' OG ' ' S1 ' ' A' ' 65' ' ' SF4 . 29.6 p -62.15 -69.77 0.23 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.068 -1.02 . . . . 0.0 109.335 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.634 ' SG ' ' N ' ' A' ' 18' ' ' VAL . 19.4 p -49.33 -55.87 11.43 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.328 -0.857 . . . . 0.0 109.385 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.634 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 59.6 t -46.32 -33.14 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.199 -0.938 . . . . 0.0 109.012 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.447 ' HG3' ' OE1' ' A' ' 15' ' ' GLU . 5.3 mt-10 -71.05 -34.78 71.57 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.999 -1.063 . . . . 0.0 108.592 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.633 HG22 ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -81.16 6.05 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.252 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.59 ' HB1' ' HB2' ' A' ' 42' ' ' ALA . . . 176.82 65.47 0.07 OUTLIER Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.274 -0.891 . . . . 0.0 109.009 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.54 ' N ' ' O ' ' A' ' 18' ' ' VAL . 46.0 Cg_endo -71.92 0.12 7.62 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.039 1.547 . . . . 0.0 110.783 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -96.3 -31.66 7.09 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.679 ' HB1' ' O ' ' A' ' 38' ' ' ASP . . . -109.4 -53.65 2.63 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.333 -1.098 . . . . 0.0 109.99 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 1.088 ' CZ ' HG21 ' A' ' 6' ' ' VAL . 0.3 OUTLIER -75.22 139.43 42.59 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 118.561 -1.256 . . . . 0.0 107.689 179.727 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.574 ' O ' ' CD1' ' A' ' 35' ' ' TYR . . . -172.13 140.84 1.22 Allowed 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.263 -0.898 . . . . 0.0 109.561 -179.217 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.554 ' HA ' ' C ' ' A' ' 33' ' ' LYS . 5.1 mtp -71.55 158.35 36.39 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.292 -0.88 . . . . 0.0 109.94 -179.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.613 ' O ' ' N ' ' A' ' 32' ' ' GLU . 3.9 t0 -126.31 161.52 51.74 Favored Pre-proline 0 C--N 1.309 -1.154 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.489 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 44.3 Cg_endo -85.19 -16.13 5.15 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 O-C-N 124.691 1.89 . . . . 0.0 108.626 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -91.53 -29.7 16.83 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 178.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.575 ' CD1' ' HB3' ' A' ' 35' ' ' TYR . 1.0 OUTLIER -106.2 -5.25 10.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.25 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.613 ' N ' ' O ' ' A' ' 28' ' ' ASP . 6.9 mm-40 33.59 41.52 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 121.433 0.635 . . . . 0.0 109.303 -179.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.712 ' HG2' ' SG ' ' A' ' 11' ' ' CYS . 0.2 OUTLIER -169.74 146.3 3.22 Favored 'General case' 0 N--CA 1.501 2.109 0 C-N-CA 119.601 -0.839 . . . . 0.0 110.365 -179.176 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.742 ' HB1' ' CD1' ' A' ' 25' ' ' PHE . . . -47.99 146.54 2.47 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.425 -0.797 . . . . 0.0 111.564 -178.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.676 ' CE2' ' CG ' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -135.83 -174.29 3.61 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.965 -1.085 . . . . 0.0 110.086 179.075 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.784 HG23 ' CG2' ' A' ' 6' ' ' VAL . 2.5 t -125.98 92.44 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.676 ' CG ' ' CE2' ' A' ' 35' ' ' TYR . 18.5 mmtt -103.87 -46.07 4.59 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 119.567 -0.853 . . . . 0.0 111.286 -178.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.679 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 62.8 t0 -93.59 118.24 31.11 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 119.207 -0.997 . . . . 0.0 110.564 -177.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.2 m -80.52 -17.11 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.338 -0.851 . . . . 0.0 109.268 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.424 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -103.01 2.39 34.87 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.355 -0.841 . . . . 0.0 109.558 -179.994 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.569 ' HA3' ' HB2' ' A' ' 24' ' ' ALA . . . -78.24 -7.64 87.71 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.674 -1.371 . . . . 0.0 109.674 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.59 ' HB2' ' HB1' ' A' ' 21' ' ' ALA . . . -149.08 127.84 12.51 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.229 -1.159 . . . . 0.0 109.566 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.927 ' O ' HG23 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -67.61 166.79 14.28 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.235 -0.916 . . . . 0.0 109.43 179.951 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.463 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -51.66 -45.28 63.32 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.412 -0.805 . . . . 0.0 109.438 179.979 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.414 ' O ' ' CG ' ' A' ' 49' ' ' GLU . 50.0 mm-40 -67.54 -8.4 33.63 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.362 -0.836 . . . . 0.0 109.646 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.528 ' HB2' ' HB1' ' A' ' 42' ' ' ALA . 11.9 mt-10 -100.32 -43.88 6.11 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 179.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.927 HG23 ' O ' ' A' ' 43' ' ' SER . 1.9 t -60.49 -40.54 84.63 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 178.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.463 ' HB2' ' O ' ' A' ' 44' ' ' GLN . 0.2 OUTLIER -74.86 -48.43 25.0 Favored 'General case' 0 C--N 1.308 -1.227 0 O-C-N 121.527 -0.733 . . . . 0.0 109.198 179.293 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.527 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . 34.1 mt-10 -53.5 -54.01 43.26 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.189 -0.944 . . . . 0.0 109.096 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.522 ' HB2' ' CG2' ' A' ' 20' ' ' ILE . . . -63.83 -18.04 63.73 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.143 -0.973 . . . . 0.0 108.945 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.595 ' HE3' HD12 ' A' ' 59' ' ' ILE . 38.6 ttm -77.87 -18.31 56.37 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.416 -0.802 . . . . 0.0 109.208 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -105.35 -23.73 12.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.32 -0.863 . . . . 0.0 109.599 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -62.39 -48.02 81.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.23 -0.919 . . . . 0.0 109.768 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.79 ' SG ' ' HD2' ' A' ' 55' ' ' PRO . 4.6 t -48.88 147.41 4.62 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.139 -0.975 . . . . 0.0 109.606 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.79 ' HD2' ' SG ' ' A' ' 54' ' ' CYS . 44.1 Cg_endo -73.91 -64.65 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.986 1.519 . . . . 0.0 110.509 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.427 ' O ' ' HB2' ' A' ' 57' ' ' GLN . 38.4 t -79.08 -25.02 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.115 -0.99 . . . . 0.0 109.098 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.427 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER 67.38 72.04 0.35 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.277 -0.889 . . . . 0.0 109.755 179.719 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.471 ' SG ' ' HB2' ' A' ' 10' ' ' GLU . 0.7 OUTLIER -89.87 21.89 3.4 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.188 -0.945 . . . . 0.0 109.155 179.571 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 1.038 HD13 ' N ' ' A' ' 60' ' ' HIS . 0.0 OUTLIER -108.65 140.69 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.341 -0.85 . . . . 0.0 109.564 -179.651 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 1.038 ' N ' HD13 ' A' ' 59' ' ' ILE . 2.7 m80 -142.48 -177.47 5.29 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.279 -0.888 . . . . 0.0 109.532 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.562 ' HA ' ' CB ' ' A' ' 4' ' ' PHE . 36.0 m95 -97.84 -179.25 4.36 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.014 -1.054 . . . . 0.0 109.697 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.2 tp10 -150.32 97.15 2.5 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.267 -0.896 . . . . 0.0 109.621 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.7 p-10 -111.77 14.16 21.07 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.225 -0.922 . . . . 0.0 109.338 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 O-C-N 121.268 -0.895 . . . . 0.0 109.546 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' SF4 . . . . . 0.792 ' S1 ' ' OG ' ' A' ' 16' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.215 0.531 . . . . 0.0 109.647 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.73 108.38 13.45 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.295 -0.878 . . . . 0.0 109.533 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.495 ' O ' ' HB3' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -98.17 -155.8 0.51 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.262 -0.899 . . . . 0.0 109.313 -179.99 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.553 ' CB ' ' HA ' ' A' ' 61' ' ' TRP . 53.8 p90 173.06 -176.06 0.06 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.357 -0.839 . . . . 0.0 108.895 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.79 ' HA ' HG11 ' A' ' 36' ' ' VAL . 51.6 p90 175.84 -173.28 0.08 Allowed 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 179.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.789 HG13 ' HB ' ' A' ' 59' ' ' ILE . 2.9 t -145.57 166.37 10.0 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.428 0 C-N-CA 117.397 -1.721 . . . . 0.0 112.094 -179.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.57 ' H ' HG12 ' A' ' 6' ' ' VAL . 8.5 t0 -105.22 74.56 1.11 Allowed 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.537 ' O ' ' CD ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -53.72 -11.51 0.39 Allowed 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.362 179.576 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.42 ' N ' ' C ' ' A' ' 7' ' ' ASP . 0.1 OUTLIER -65.61 -32.8 74.57 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.634 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.578 ' HB3' ' CB ' ' A' ' 58' ' ' CYS . 0.1 OUTLIER -91.16 -16.3 27.97 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.09 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.409 ' HB3' ' O ' ' A' ' 8' ' ' GLN . 7.2 t -43.46 128.41 4.97 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.432 -0.793 . . . . 0.0 110.075 -179.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.777 HG12 ' S3 ' ' A' ' 65' ' ' SF4 . 4.5 pt -79.25 -134.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.444 -0.785 . . . . 0.0 109.066 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -119.67 43.55 2.61 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.762 -1.211 . . . . 0.0 110.017 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 1.012 ' SG ' ' OG ' ' A' ' 16' ' ' SER . 0.1 OUTLIER -124.91 156.83 37.33 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.075 -1.016 . . . . 0.0 109.594 179.557 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.437 ' O ' ' C ' ' A' ' 16' ' ' SER . 14.3 mt-10 -117.26 17.75 14.64 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.299 -0.876 . . . . 0.0 109.685 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 1.012 ' OG ' ' SG ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -44.42 -70.57 0.1 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.245 -0.909 . . . . 0.0 108.996 179.722 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.645 ' SG ' ' N ' ' A' ' 18' ' ' VAL . 8.3 p -44.17 -51.51 8.06 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.262 -0.898 . . . . 0.0 109.325 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.645 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 41.5 t -50.15 -33.31 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.362 -0.836 . . . . 0.0 109.61 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -84.74 -30.93 24.31 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.129 -0.982 . . . . 0.0 109.414 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.841 HD12 ' O ' ' A' ' 16' ' ' SER . 2.7 mp -81.76 9.12 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.206 -0.934 . . . . 0.0 108.646 178.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -169.86 69.41 0.62 Allowed Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.17 -0.956 . . . . 0.0 109.309 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -71.72 76.83 1.9 Allowed 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 124.206 1.635 . . . . 0.0 110.181 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.444 ' C ' ' HA3' ' A' ' 41' ' ' GLY . . . 165.02 -42.55 0.29 Allowed Glycine 0 N--CA 1.488 2.117 0 N-CA-C 108.672 -1.771 . . . . 0.0 108.672 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.487 ' HA ' ' O ' ' A' ' 38' ' ' ASP . . . -92.99 -49.3 6.09 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.415 -1.05 . . . . 0.0 109.046 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.782 ' CZ ' HG21 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -96.06 137.84 34.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.269 -0.894 . . . . 0.0 108.818 179.582 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.445 ' O ' ' CD1' ' A' ' 35' ' ' TYR . . . -174.77 126.66 0.3 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.025 -1.047 . . . . 0.0 109.609 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.596 ' HA ' ' C ' ' A' ' 33' ' ' LYS . 29.3 mtp -58.56 150.86 21.85 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.315 -0.865 . . . . 0.0 109.365 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.615 ' O ' ' N ' ' A' ' 32' ' ' GLU . 1.6 t0 -130.26 163.99 44.03 Favored Pre-proline 0 C--N 1.311 -1.085 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.487 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 43.9 Cg_endo -83.29 -16.44 7.1 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 124.803 1.949 . . . . 0.0 107.571 179.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.713 ' HB3' HD13 ' A' ' 31' ' ' ILE . 8.1 tt0 -82.84 -42.38 17.9 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 177.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.745 ' N ' HD13 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -102.14 0.26 10.26 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 178.098 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.615 ' N ' ' O ' ' A' ' 28' ' ' ASP . 2.9 mm-40 35.33 34.55 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -179.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.596 ' C ' ' HA ' ' A' ' 27' ' ' MET . 59.4 mttp -163.55 151.16 12.83 Favored 'General case' 0 N--CA 1.499 2.0 0 C-N-CA 119.556 -0.858 . . . . 0.0 110.183 -177.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.539 ' HA ' ' HA ' ' A' ' 27' ' ' MET . . . -59.18 139.97 56.38 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.444 -0.785 . . . . 0.0 110.206 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.647 ' CE2' ' HA ' ' A' ' 37' ' ' LYS . 1.5 p90 -154.06 155.89 36.31 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.79 HG11 ' HA ' ' A' ' 5' ' ' TYR . 14.9 p -67.01 67.19 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 120.905 -1.122 . . . . 0.0 108.933 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.647 ' HA ' ' CE2' ' A' ' 35' ' ' TYR . 0.1 OUTLIER -51.01 -19.05 0.92 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.533 -0.729 . . . . 0.0 110.391 -179.664 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.492 ' N ' ' HG3' ' A' ' 37' ' ' LYS . 11.5 t70 -167.21 103.42 0.53 Allowed 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.996 -1.065 . . . . 0.0 109.674 -179.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.543 ' HB ' ' CE1' ' A' ' 4' ' ' PHE . 1.8 m -55.39 -24.39 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.378 -0.826 . . . . 0.0 109.835 -179.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -90.89 -0.6 57.77 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.168 -0.958 . . . . 0.0 109.601 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.45 ' N ' ' OD2' ' A' ' 38' ' ' ASP . . . -76.36 -16.05 81.02 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -141.92 161.74 37.21 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.192 -1.181 . . . . 0.0 109.333 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.07 173.89 9.56 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.263 -0.898 . . . . 0.0 109.571 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.457 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 1.0 OUTLIER -70.09 -38.56 75.7 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.363 -0.836 . . . . 0.0 109.233 179.895 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 36.0 mm-40 -66.91 -21.87 65.97 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.143 -0.973 . . . . 0.0 108.875 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -90.2 -43.1 10.65 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 178.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 4.0 t -58.25 -38.11 66.77 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 178.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.457 ' HB2' ' O ' ' A' ' 44' ' ' GLN . 0.1 OUTLIER -70.22 -65.93 0.66 Allowed 'General case' 0 C--N 1.308 -1.229 0 O-C-N 121.562 -0.712 . . . . 0.0 109.584 179.715 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.645 ' C ' HG21 ' A' ' 20' ' ' ILE . 16.1 mt-10 -47.5 -42.45 23.0 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.259 -0.9 . . . . 0.0 109.052 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.824 ' N ' HG21 ' A' ' 20' ' ' ILE . . . -68.59 -27.08 65.73 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.356 -0.84 . . . . 0.0 109.024 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.712 ' HG3' HG21 ' A' ' 59' ' ' ILE . 6.6 ttm -83.92 -17.63 40.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.482 -0.761 . . . . 0.0 109.904 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -95.02 -10.36 31.11 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.048 -1.032 . . . . 0.0 109.795 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.745 ' OG1' HD13 ' A' ' 20' ' ' ILE . 12.0 p -91.08 8.05 37.42 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.242 -0.911 . . . . 0.0 109.642 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.518 ' SG ' ' HD2' ' A' ' 55' ' ' PRO . 8.7 t -95.35 140.74 22.51 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.22 -0.925 . . . . 0.0 109.399 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.518 ' HD2' ' SG ' ' A' ' 54' ' ' CYS . 46.1 Cg_endo -75.16 -58.18 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.942 1.496 . . . . 0.0 109.931 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.524 HG21 ' HG2' ' A' ' 10' ' ' GLU . 7.6 p -84.63 -23.19 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.319 -0.863 . . . . 0.0 108.898 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.503 ' CB ' ' O ' ' A' ' 56' ' ' VAL . 1.9 tt0 77.71 -66.44 0.22 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.495 -0.753 . . . . 0.0 110.459 179.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.578 ' CB ' ' HB3' ' A' ' 10' ' ' GLU . 2.5 p 43.57 26.41 0.11 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.225 -0.922 . . . . 0.0 109.156 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.789 ' HB ' HG13 ' A' ' 6' ' ' VAL . 9.4 tt -125.77 164.1 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.466 -0.771 . . . . 0.0 110.304 -178.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.665 ' CD2' ' CZ ' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -172.64 173.61 3.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.337 -0.852 . . . . 0.0 109.245 179.987 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.553 ' HA ' ' CB ' ' A' ' 4' ' ' PHE . 50.9 m95 -98.66 164.3 12.29 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.152 -0.968 . . . . 0.0 109.767 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.485 ' N ' ' HA ' ' A' ' 4' ' ' PHE . 20.6 tt0 -121.87 107.25 12.06 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.362 -0.836 . . . . 0.0 109.469 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -110.51 110.87 21.78 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.282 -0.886 . . . . 0.0 109.56 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 . . . . . 0 N--CA 1.491 1.582 0 O-C-N 121.298 -0.876 . . . . 0.0 109.47 179.941 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' SF4 . . . . . 0.914 ' S2 ' ' O ' ' A' ' 14' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.64 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.405 ' HG2' ' CE3' ' A' ' 61' ' ' TRP . 2.1 tpp180 -148.0 105.5 3.67 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.21 -0.931 . . . . 0.0 109.652 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.509 ' HB3' ' HB3' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -86.35 -157.8 0.37 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.205 -0.935 . . . . 0.0 109.137 179.8 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.604 ' CE1' ' HA ' ' A' ' 39' ' ' VAL . 20.7 p90 179.2 -159.05 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.166 -0.959 . . . . 0.0 109.768 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.7 ' HA ' HG21 ' A' ' 36' ' ' VAL . 4.6 p90 168.04 -178.75 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 -179.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 1.104 HG23 HG22 ' A' ' 36' ' ' VAL . 1.6 t -121.64 145.07 28.82 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.251 0 C-N-CA 116.914 -1.914 . . . . 0.0 111.954 -179.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.495 ' O ' ' N ' ' A' ' 9' ' ' ASP . 0.2 OUTLIER -96.7 38.9 1.19 Allowed 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.718 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.67 ' HG3' HG21 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -38.6 -27.94 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.125 0.488 . . . . 0.0 110.15 -179.689 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.495 ' N ' ' O ' ' A' ' 7' ' ' ASP . 4.8 t0 -46.62 -25.3 0.68 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.159 -0.963 . . . . 0.0 108.822 179.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.477 ' HB3' ' HB3' ' A' ' 58' ' ' CYS . 14.7 tt0 -108.04 -15.48 14.51 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.465 -0.772 . . . . 0.0 109.577 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.654 ' SG ' ' HG2' ' A' ' 33' ' ' LYS . 40.6 t -43.37 141.72 1.27 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.17 -0.956 . . . . 0.0 109.661 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.694 ' O ' ' HB2' ' A' ' 13' ' ' ALA . 8.0 pt -98.59 -47.49 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.242 -0.911 . . . . 0.0 109.826 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.694 ' HB2' ' O ' ' A' ' 12' ' ' ILE . . . 166.0 -34.9 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.059 -1.026 . . . . 0.0 110.157 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.956 ' O ' ' S2 ' ' A' ' 65' ' ' SF4 . 0.1 OUTLIER -47.61 159.86 0.14 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.085 -1.01 . . . . 0.0 109.614 -179.488 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -122.13 22.23 10.27 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.321 -0.862 . . . . 0.0 109.854 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.571 ' O ' HD12 ' A' ' 20' ' ' ILE . 0.3 OUTLIER -46.26 -58.33 3.77 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.218 -0.926 . . . . 0.0 109.039 179.728 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.945 ' SG ' ' HD2' ' A' ' 25' ' ' PHE . 19.8 p -52.17 -57.26 10.16 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.37 -0.831 . . . . 0.0 109.239 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.644 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 98.2 t -45.15 -28.14 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.277 -0.89 . . . . 0.0 109.164 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.97 -37.7 23.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.187 -0.946 . . . . 0.0 108.914 179.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.841 HD13 ' HA ' ' A' ' 50' ' ' ALA . 1.8 mt -88.33 18.06 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 177.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.522 ' HB2' ' O ' ' A' ' 20' ' ' ILE . . . 172.56 64.6 0.03 OUTLIER Pre-proline 0 N--CA 1.488 1.451 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -74.25 2.29 6.35 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 124.073 1.565 . . . . 0.0 110.62 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.482 ' O ' ' HB3' ' A' ' 37' ' ' LYS . . . -113.86 -22.7 5.25 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.534 ' O ' ' N ' ' A' ' 37' ' ' LYS . . . -110.66 -30.25 7.68 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.249 -1.147 . . . . 0.0 109.624 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 1.093 ' CE1' HG22 ' A' ' 6' ' ' VAL . 0.8 OUTLIER -114.62 129.84 56.72 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.21 -0.931 . . . . 0.0 108.564 179.762 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.587 ' HA ' HG22 ' A' ' 18' ' ' VAL . . . -158.76 146.83 18.13 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.874 -1.141 . . . . 0.0 110.36 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.55 ' HA ' ' C ' ' A' ' 33' ' ' LYS . 1.3 ttm -74.22 152.38 39.76 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.275 -0.891 . . . . 0.0 109.004 179.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.589 ' O ' ' N ' ' A' ' 32' ' ' GLU . 1.2 t0 -133.5 165.77 34.23 Favored Pre-proline 0 C--O 1.211 -0.948 0 O-C-N 120.197 -1.564 . . . . 0.0 108.071 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.508 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 44.8 Cg_endo -84.44 -16.56 5.75 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 124.507 1.793 . . . . 0.0 107.725 179.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.491 ' HB3' HD13 ' A' ' 31' ' ' ILE . 0.3 OUTLIER -85.18 -38.95 18.39 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 178.122 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.67 HG21 ' HG3' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -104.29 0.47 10.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 178.068 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.589 ' N ' ' O ' ' A' ' 28' ' ' ASP . 5.2 mt-10 34.97 35.91 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -179.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.654 ' HG2' ' SG ' ' A' ' 11' ' ' CYS . 0.1 OUTLIER -172.95 167.26 5.07 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 119.82 -0.752 . . . . 0.0 109.228 -178.367 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.529 ' O ' ' HB3' ' A' ' 8' ' ' GLN . . . -37.45 157.45 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.515 0.674 . . . . 0.0 110.318 -179.139 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.65 ' CZ ' ' HA ' ' A' ' 37' ' ' LYS . 0.2 OUTLIER -162.41 150.26 14.18 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 179.729 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 1.104 HG22 HG23 ' A' ' 6' ' ' VAL . 4.3 t -64.76 88.04 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 120.963 -1.086 . . . . 0.0 109.907 -178.04 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.65 ' HA ' ' CZ ' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -55.56 -26.54 44.01 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.459 -0.776 . . . . 0.0 109.528 179.589 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 39' ' ' VAL . 9.9 t0 175.43 157.99 0.21 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.255 -0.903 . . . . 0.0 109.625 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.604 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 11.6 m -78.22 -21.98 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.321 -0.862 . . . . 0.0 110.111 -179.275 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -117.11 18.95 14.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.12 -0.987 . . . . 0.0 109.422 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.448 ' HA3' ' C ' ' A' ' 23' ' ' GLY . . . -67.7 -15.8 67.04 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 -179.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.483 ' HB1' ' HB2' ' A' ' 46' ' ' GLU . . . -148.93 153.72 38.4 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.035 -1.273 . . . . 0.0 109.692 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.469 ' OG ' ' HG3' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -77.12 156.6 31.55 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.349 -0.844 . . . . 0.0 109.944 -179.775 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.489 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -48.47 -48.41 37.83 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.402 -0.811 . . . . 0.0 109.151 179.768 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -57.63 -36.8 72.3 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.209 -0.932 . . . . 0.0 108.979 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.483 ' HB2' ' HB1' ' A' ' 42' ' ' ALA . 14.4 mt-10 -73.06 -57.04 4.31 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.275 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.627 ' CG1' ' CH2' ' A' ' 61' ' ' TRP . 1.2 t -50.87 -32.15 11.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 179.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.489 ' HB2' ' O ' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -65.66 -72.89 0.14 Allowed 'General case' 0 C--N 1.309 -1.193 0 O-C-N 121.264 -0.898 . . . . 0.0 109.866 179.966 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -47.22 -39.67 14.63 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.273 -0.892 . . . . 0.0 109.233 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.841 ' HA ' HD13 ' A' ' 20' ' ' ILE . . . -61.03 -39.62 90.49 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.281 -0.887 . . . . 0.0 108.918 179.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 1.025 ' HE2' HG13 ' A' ' 59' ' ' ILE . 45.0 ttm -74.53 -29.8 61.52 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.443 -0.785 . . . . 0.0 109.169 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -60.99 -45.99 92.57 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.296 -0.877 . . . . 0.0 109.141 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.517 ' O ' ' HB3' ' A' ' 54' ' ' CYS . 65.9 p -68.25 -152.68 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.336 -0.852 . . . . 0.0 109.072 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.941 ' SG ' ' CA ' ' A' ' 57' ' ' GLN . 10.3 t 73.41 122.28 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.268 -0.895 . . . . 0.0 109.779 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -73.51 -44.08 0.58 Allowed 'Trans proline' 0 C--N 1.308 -1.562 0 O-C-N 123.863 1.454 . . . . 0.0 109.083 179.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.509 ' O ' ' CB ' ' A' ' 57' ' ' GLN . 1.9 m -96.37 -17.65 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.998 ' O ' HG22 ' A' ' 59' ' ' ILE . 0.9 OUTLIER 81.34 -59.77 0.24 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.724 -0.61 . . . . 0.0 110.569 179.542 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.962 ' SG ' ' S4 ' ' A' ' 65' ' ' SF4 . 11.9 p 35.88 41.6 0.12 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.641 -0.662 . . . . 0.0 109.51 -179.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 1.027 HD12 ' N ' ' A' ' 60' ' ' HIS . 0.1 OUTLIER -148.56 137.44 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.501 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 1.027 ' N ' HD12 ' A' ' 59' ' ' ILE . 31.0 m80 -155.7 163.56 39.74 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.708 -1.245 . . . . 0.0 110.469 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.627 ' CH2' ' CG1' ' A' ' 47' ' ' VAL . 72.2 m95 -87.63 -176.15 5.45 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.381 -0.824 . . . . 0.0 109.216 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.509 ' HB3' ' HB3' ' A' ' 3' ' ' LYS . 7.4 tt0 -150.72 99.8 2.77 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.332 -0.855 . . . . 0.0 109.208 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -90.31 -68.59 0.78 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.264 -0.897 . . . . 0.0 109.557 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.507 0 O-C-N 121.209 -0.932 . . . . 0.0 109.593 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' SF4 . . . . . 0.962 ' S4 ' ' SG ' ' A' ' 58' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 121.331 0.586 . . . . 0.0 109.488 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 67.13 96.46 0.06 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.251 -0.905 . . . . 0.0 109.515 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.459 ' O ' ' HB3' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -114.11 -156.41 0.6 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.32 -0.863 . . . . 0.0 109.524 179.946 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.829 ' CE1' HG12 ' A' ' 39' ' ' VAL . 11.5 p90 176.81 174.49 0.39 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.282 -0.886 . . . . 0.0 109.864 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.8 ' HA ' HG11 ' A' ' 36' ' ' VAL . 1.3 p90 177.15 -171.6 0.09 Allowed 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 179.237 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.982 HG23 ' HB ' ' A' ' 36' ' ' VAL . 0.2 OUTLIER -135.44 177.18 7.01 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 C-N-CA 117.693 -1.603 . . . . 0.0 111.651 179.869 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.583 ' H ' HG12 ' A' ' 6' ' ' VAL . 0.3 OUTLIER -129.35 92.45 3.36 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.786 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.567 ' CG ' ' O ' ' A' ' 34' ' ' ALA . 3.7 mp0 -65.36 45.2 0.02 OUTLIER 'General case' 0 C--N 1.291 -1.945 0 CA-C-O 121.617 0.722 . . . . 0.0 110.669 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.555 ' N ' ' O ' ' A' ' 7' ' ' ASP . 1.0 OUTLIER -110.93 -44.89 3.54 Favored 'General case' 0 C--N 1.285 -2.202 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.214 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.681 ' O ' HG21 ' A' ' 56' ' ' VAL . 0.3 OUTLIER -89.85 -7.35 54.48 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.741 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.671 ' SG ' ' HG2' ' A' ' 33' ' ' LYS . 39.6 t -62.95 144.2 57.02 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.453 -0.779 . . . . 0.0 110.195 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.7 pt -102.0 -113.16 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.293 -0.88 . . . . 0.0 108.798 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -135.27 26.61 3.5 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.778 -1.201 . . . . 0.0 109.043 179.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.892 ' O ' ' S2 ' ' A' ' 65' ' ' SF4 . 0.1 OUTLIER -102.1 149.6 24.11 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.28 -0.888 . . . . 0.0 109.905 -179.741 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.48 ' HB2' ' HB ' ' A' ' 18' ' ' VAL . 0.7 OUTLIER -109.13 20.03 18.81 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.468 -0.77 . . . . 0.0 109.645 -179.856 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 15' ' ' GLU . 56.7 m -43.86 -66.78 0.34 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.262 -0.898 . . . . 0.0 109.34 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.969 ' SG ' ' CD2' ' A' ' 25' ' ' PHE . 19.0 p -48.52 -46.49 38.62 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.323 -0.86 . . . . 0.0 109.328 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.48 ' HB ' ' HB2' ' A' ' 15' ' ' GLU . 59.0 t -50.24 -31.28 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.276 -0.89 . . . . 0.0 109.329 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -77.52 -34.56 53.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.244 -0.91 . . . . 0.0 109.395 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.915 HG21 ' N ' ' A' ' 50' ' ' ALA . 2.5 mp -79.95 5.36 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 178.318 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.498 ' HB1' ' HB2' ' A' ' 42' ' ' ALA . . . -172.8 65.15 0.34 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.351 -0.843 . . . . 0.0 109.045 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.37 70.13 2.53 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 O-C-N 124.286 1.677 . . . . 0.0 110.266 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.49 ' O ' ' HB3' ' A' ' 38' ' ' ASP . . . 177.72 -43.51 0.09 OUTLIER Glycine 0 N--CA 1.488 2.105 0 N-CA-C 108.737 -1.745 . . . . 0.0 108.737 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.585 ' HB2' ' O ' ' A' ' 38' ' ' ASP . . . -93.17 -32.25 14.47 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.555 -0.968 . . . . 0.0 109.029 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.969 ' CD2' ' SG ' ' A' ' 17' ' ' CYS . 0.1 OUTLIER -105.58 141.73 36.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.333 -0.855 . . . . 0.0 108.878 179.905 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.49 ' O ' ' CD1' ' A' ' 35' ' ' TYR . . . -174.96 125.32 0.27 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.115 -0.991 . . . . 0.0 109.286 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.579 ' HA ' ' C ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -58.5 154.3 14.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.165 -0.96 . . . . 0.0 109.558 -179.769 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.604 ' O ' ' N ' ' A' ' 32' ' ' GLU . 0.7 OUTLIER -126.18 163.29 40.87 Favored Pre-proline 0 C--N 1.313 -1.005 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 179.295 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.458 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 47.7 Cg_endo -84.19 -16.67 5.98 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 125.055 2.081 . . . . 0.0 108.279 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -88.07 -35.78 17.32 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 178.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.639 HD12 ' HB3' ' A' ' 35' ' ' TYR . 1.3 pt -105.28 -1.32 9.94 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 177.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.604 ' N ' ' O ' ' A' ' 28' ' ' ASP . 0.5 OUTLIER 34.78 36.86 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -179.244 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.671 ' HG2' ' SG ' ' A' ' 11' ' ' CYS . 1.8 mtmt -162.27 148.44 13.13 Favored 'General case' 0 N--CA 1.501 2.083 0 C-N-CA 119.012 -1.075 . . . . 0.0 110.755 -178.187 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.589 ' HB2' ' S2 ' ' A' ' 65' ' ' SF4 . . . -52.76 146.09 11.09 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.548 -0.72 . . . . 0.0 110.201 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.639 ' HB3' HD12 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -149.33 147.54 28.45 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-O 121.77 0.795 . . . . 0.0 109.51 179.219 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.982 ' HB ' HG23 ' A' ' 6' ' ' VAL . 1.3 t -88.84 96.09 5.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.097 -1.002 . . . . 0.0 108.34 -179.376 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.601 ' HB3' ' CE2' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -107.17 -28.12 10.15 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.418 -0.801 . . . . 0.0 110.966 -178.687 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.585 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 22.1 t70 -122.21 78.8 1.53 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.799 -1.188 . . . . 0.0 110.16 -179.1 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.829 HG12 ' CE1' ' A' ' 4' ' ' PHE . 27.2 m -45.25 -46.71 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.248 -0.908 . . . . 0.0 109.266 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.587 ' N ' HG23 ' A' ' 39' ' ' VAL . 6.5 mt-10 -58.51 -24.72 61.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.302 -0.874 . . . . 0.0 109.486 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 38' ' ' ASP . . . -54.08 -26.05 33.73 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.498 ' HB2' ' HB1' ' A' ' 21' ' ' ALA . . . -144.69 144.76 31.39 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.23 -1.159 . . . . 0.0 109.443 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.424 ' OG ' ' CD ' ' A' ' 46' ' ' GLU . 0.1 OUTLIER -67.95 169.14 10.45 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.177 -0.952 . . . . 0.0 109.504 179.988 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.503 ' O ' ' HG2' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -66.15 -47.72 73.11 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.49 -0.756 . . . . 0.0 109.247 179.802 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.721 ' HA ' ' HG2' ' A' ' 48' ' ' GLU . 5.8 mm-40 -61.4 -17.26 53.36 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.284 -0.885 . . . . 0.0 109.185 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.424 ' CD ' ' OG ' ' A' ' 43' ' ' SER . 76.9 mt-10 -91.92 -45.79 8.17 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 178.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.811 HG12 ' CH2' ' A' ' 61' ' ' TRP . 6.8 t -55.04 -38.24 45.34 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 178.014 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.721 ' HG2' ' HA ' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -68.14 -56.9 7.13 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.64 -0.663 . . . . 0.0 109.345 178.954 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.457 ' H ' ' HG3' ' A' ' 48' ' ' GLU . 0.3 OUTLIER -43.04 -48.14 6.02 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.167 -0.958 . . . . 0.0 109.085 179.883 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.915 ' N ' HG21 ' A' ' 20' ' ' ILE . . . -60.41 -40.0 89.41 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.213 -0.929 . . . . 0.0 108.65 179.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.55 ' CE ' ' CZ3' ' A' ' 61' ' ' TRP . 21.2 ttm -58.7 -37.74 76.76 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.429 -0.794 . . . . 0.0 109.342 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -79.26 -8.07 58.76 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.282 -0.886 . . . . 0.0 109.244 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -115.21 78.36 1.16 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.258 -0.901 . . . . 0.0 109.908 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.792 ' SG ' ' HD2' ' A' ' 55' ' ' PRO . 44.2 t -151.08 148.18 22.16 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.284 -0.885 . . . . 0.0 108.914 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.792 ' HD2' ' SG ' ' A' ' 54' ' ' CYS . 44.1 Cg_endo -72.1 -37.09 5.04 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 123.863 1.454 . . . . 0.0 110.333 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.681 HG21 ' O ' ' A' ' 10' ' ' GLU . 2.9 m -111.83 -29.59 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.27 -0.894 . . . . 0.0 109.232 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.552 ' N ' ' SG ' ' A' ' 54' ' ' CYS . 0.0 OUTLIER 66.57 76.65 0.3 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.305 -0.872 . . . . 0.0 109.722 179.763 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 22.5 p -112.3 17.24 19.59 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.279 -0.888 . . . . 0.0 109.12 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.87 ' CB ' HG13 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -104.09 129.69 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.332 -0.855 . . . . 0.0 109.51 -179.687 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.588 ' N ' HD13 ' A' ' 59' ' ' ILE . 1.8 m80 -136.99 160.42 38.96 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.181 -0.949 . . . . 0.0 109.393 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.811 ' CH2' HG12 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -68.13 -169.68 0.15 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.331 -0.856 . . . . 0.0 109.222 179.884 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.446 ' HB3' ' HB3' ' A' ' 3' ' ' LYS . 26.0 tt0 -159.57 120.37 3.14 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.287 -0.883 . . . . 0.0 109.318 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -66.38 -58.94 4.23 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.31 -0.869 . . . . 0.0 109.321 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 51.2 tt0 . . . . . 0 N--CA 1.489 1.49 0 O-C-N 121.307 -0.871 . . . . 0.0 109.457 179.956 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' SF4 . . . . . 0.892 ' S2 ' ' O ' ' A' ' 14' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 6.5 ptt180 -69.82 166.2 19.88 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.276 -0.89 . . . . 0.0 109.312 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.497 ' O ' ' HB3' ' A' ' 4' ' ' PHE . 0.5 OUTLIER -103.04 -152.58 0.45 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.321 -0.862 . . . . 0.0 109.518 -179.865 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.687 ' CZ ' HG12 ' A' ' 39' ' ' VAL . 39.3 p90 168.8 170.32 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.709 -0.619 . . . . 0.0 109.486 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.508 ' CE1' ' HB2' ' A' ' 62' ' ' GLU . 20.5 p90 176.75 -167.61 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 179.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.973 HG21 ' CZ ' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -136.52 -165.36 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 118.44 -1.304 . . . . 0.0 111.517 -179.57 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' A' ' 9' ' ' ASP . 1.5 m-20 -151.23 98.31 2.53 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 114.209 -1.36 . . . . 0.0 107.478 178.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.553 ' HG3' ' O ' ' A' ' 34' ' ' ALA . 5.7 mp0 -64.85 43.19 0.02 OUTLIER 'General case' 0 C--N 1.291 -1.939 0 CA-C-O 121.624 0.726 . . . . 0.0 110.664 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 7' ' ' ASP . 0.2 OUTLIER -99.95 -24.52 14.61 Favored 'General case' 0 C--N 1.287 -2.116 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 179.438 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.445 ' HG2' ' HB ' ' A' ' 56' ' ' VAL . 0.6 OUTLIER -115.55 13.13 16.32 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.495 -0.753 . . . . 0.0 109.353 -179.977 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.474 ' HB3' ' HD3' ' A' ' 33' ' ' LYS . 41.9 t -84.23 129.67 34.87 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.155 -0.966 . . . . 0.0 109.7 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.711 ' O ' ' HB2' ' A' ' 13' ' ' ALA . 21.8 pt -102.24 -41.95 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.365 -0.834 . . . . 0.0 109.389 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.711 ' HB2' ' O ' ' A' ' 12' ' ' ILE . . . 163.85 -22.33 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.35 -0.844 . . . . 0.0 109.899 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 1.015 ' O ' ' S2 ' ' A' ' 65' ' ' SF4 . 0.1 OUTLIER -51.23 139.9 17.79 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.037 -1.04 . . . . 0.0 109.443 -179.75 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.487 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 4.0 mp0 -102.51 20.4 17.14 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.107 -0.996 . . . . 0.0 109.501 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.712 ' O ' HD12 ' A' ' 20' ' ' ILE . 7.1 m -44.18 -65.48 0.51 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.25 -0.906 . . . . 0.0 109.063 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.608 ' SG ' ' N ' ' A' ' 18' ' ' VAL . 16.4 p -53.16 -52.16 59.67 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.42 -0.8 . . . . 0.0 109.026 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.608 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 38.5 t -48.32 -24.42 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.354 -0.841 . . . . 0.0 109.161 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -86.22 -33.47 20.73 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.299 -0.876 . . . . 0.0 109.004 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.948 HG21 ' N ' ' A' ' 50' ' ' ALA . 2.7 mp -85.01 12.05 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.27 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.627 ' HB1' ' HB2' ' A' ' 42' ' ' ALA . . . 169.69 65.22 0.02 OUTLIER Pre-proline 0 N--CA 1.486 1.345 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -69.23 -4.85 14.49 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 O-C-N 124.143 1.602 . . . . 0.0 110.298 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.475 ' O ' ' HB3' ' A' ' 38' ' ' ASP . . . -100.44 -39.94 3.1 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.493 ' HA ' ' HB3' ' A' ' 38' ' ' ASP . . . -85.72 -33.76 21.41 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.321 -1.105 . . . . 0.0 109.299 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.973 ' CZ ' HG21 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -103.69 144.25 31.7 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.795 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.487 ' O ' ' CD1' ' A' ' 35' ' ' TYR . . . -170.84 126.48 0.71 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.991 -1.068 . . . . 0.0 109.793 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.57 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 3.7 ppp? -59.91 153.86 20.07 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.082 -1.011 . . . . 0.0 109.323 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.633 ' O ' ' N ' ' A' ' 32' ' ' GLU . 3.0 t0 -123.99 160.21 52.94 Favored Pre-proline 0 C--N 1.31 -1.135 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 179.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.461 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 47.2 Cg_endo -84.7 -16.48 5.49 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 124.973 2.039 . . . . 0.0 108.682 -179.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.35 -28.21 17.06 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 178.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.56 HG12 ' CB ' ' A' ' 28' ' ' ASP . 0.9 OUTLIER -108.83 -2.67 10.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 177.974 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.633 ' N ' ' O ' ' A' ' 28' ' ' ASP . 2.7 mm-40 31.33 38.56 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -179.006 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.546 ' C ' ' HA ' ' A' ' 27' ' ' MET . 70.7 mttt -162.39 148.11 12.76 Favored 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 119.723 -0.791 . . . . 0.0 110.296 -178.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.763 ' HB1' ' CD1' ' A' ' 25' ' ' PHE . . . -56.79 147.57 22.83 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.468 -0.77 . . . . 0.0 110.863 -179.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.595 ' O ' ' CD1' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -152.44 153.36 33.4 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.576 -0.703 . . . . 0.0 109.316 178.806 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.827 HG23 ' CG2' ' A' ' 6' ' ' VAL . 36.5 t -92.62 103.54 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 120.926 -1.108 . . . . 0.0 109.095 -179.452 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.594 ' HB3' ' CE2' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -119.3 -23.48 6.71 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 119.469 -0.892 . . . . 0.0 110.616 -179.286 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.516 ' N ' ' HG3' ' A' ' 37' ' ' LYS . 45.1 t0 -112.31 98.45 7.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.997 -1.064 . . . . 0.0 109.821 -179.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.687 HG12 ' CZ ' ' A' ' 4' ' ' PHE . 27.7 m -63.9 -29.21 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.139 -0.976 . . . . 0.0 109.578 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.534 ' OE1' HG23 ' A' ' 39' ' ' VAL . 0.7 OUTLIER -81.86 -14.26 56.49 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.228 -0.92 . . . . 0.0 109.53 -179.804 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.426 ' HA3' ' C ' ' A' ' 23' ' ' GLY . . . -67.08 -17.85 68.33 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.211 -1.556 . . . . 0.0 109.211 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.627 ' HB2' ' HB1' ' A' ' 21' ' ' ALA . . . -151.34 131.42 13.47 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.431 -1.041 . . . . 0.0 109.278 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.86 167.61 5.92 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.217 -0.927 . . . . 0.0 109.487 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -58.04 -49.01 78.36 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.506 -0.746 . . . . 0.0 109.409 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.742 ' HA ' ' HG2' ' A' ' 48' ' ' GLU . 1.0 OUTLIER -62.77 -14.72 48.33 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.182 -0.949 . . . . 0.0 108.943 179.908 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.439 ' OE1' ' HA ' ' A' ' 42' ' ' ALA . 43.0 mt-10 -90.52 -44.3 9.67 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 178.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 8.5 t -57.84 -38.71 67.37 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.742 ' HG2' ' HA ' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -68.77 -58.21 4.53 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.518 -0.739 . . . . 0.0 109.662 179.672 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.49 ' OE2' HG12 ' A' ' 20' ' ' ILE . 29.0 tt0 -44.13 -53.58 6.32 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.013 -1.054 . . . . 0.0 108.819 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.948 ' N ' HG21 ' A' ' 20' ' ' ILE . . . -54.0 -42.3 68.91 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.057 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.841 ' HA ' HG21 ' A' ' 59' ' ' ILE . 30.3 ttm -61.05 -29.87 69.99 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.052 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -63.56 -32.59 74.09 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.827 HG21 HD11 ' A' ' 20' ' ' ILE . 76.4 p -77.52 -155.03 0.07 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.402 -0.811 . . . . 0.0 109.201 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.507 ' SG ' ' HD2' ' A' ' 55' ' ' PRO . 2.3 t 64.99 140.46 0.06 OUTLIER Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.11 -0.994 . . . . 0.0 109.391 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.507 ' HD2' ' SG ' ' A' ' 54' ' ' CYS . 42.1 Cg_endo -71.37 -86.89 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.006 1.529 . . . . 0.0 110.061 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.445 ' HB ' ' HG2' ' A' ' 10' ' ' GLU . 11.1 t -63.34 -12.68 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.179 -0.951 . . . . 0.0 108.935 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.478 ' HA ' ' HB3' ' A' ' 54' ' ' CYS . 0.0 OUTLIER 58.55 81.08 0.16 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.244 -0.91 . . . . 0.0 109.431 179.863 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.434 ' SG ' HG12 ' A' ' 6' ' ' VAL . 28.0 p -86.64 16.14 4.98 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.2 -0.937 . . . . 0.0 109.399 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.841 HG21 ' HA ' ' A' ' 51' ' ' MET . 7.9 tt -106.16 154.38 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.168 -0.957 . . . . 0.0 109.81 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.425 ' HA ' ' HE1' ' A' ' 51' ' ' MET . 0.2 OUTLIER -166.95 -174.62 2.75 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.49 -0.756 . . . . 0.0 108.986 179.981 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.535 ' HA ' ' HA ' ' A' ' 4' ' ' PHE . 47.1 m95 -104.54 155.16 19.06 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.041 -1.037 . . . . 0.0 109.704 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.508 ' HB2' ' CE1' ' A' ' 5' ' ' TYR . 6.4 tt0 -122.28 96.5 5.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.465 -0.772 . . . . 0.0 109.454 -179.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.57 84.49 1.14 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.161 -0.962 . . . . 0.0 109.409 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 . . . . . 0 N--CA 1.489 1.502 0 O-C-N 121.196 -0.94 . . . . 0.0 109.395 -179.998 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' SF4 . . . . . 1.015 ' S2 ' ' O ' ' A' ' 14' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.464 ' O ' ' HG3' ' A' ' 2' ' ' ARG . 9.6 ptt85 -51.27 120.7 5.27 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.224 -0.923 . . . . 0.0 109.45 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.553 ' HB3' ' HB3' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -122.81 -150.18 0.44 Allowed 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.145 -0.972 . . . . 0.0 109.446 -179.965 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.584 ' CB ' ' HA ' ' A' ' 61' ' ' TRP . 24.4 p90 168.54 -179.3 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.508 -0.745 . . . . 0.0 109.551 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.496 ' O ' HG13 ' A' ' 59' ' ' ILE . 30.0 p90 176.71 -175.95 0.13 Allowed 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 179.23 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 1.083 HG21 ' CZ ' ' A' ' 25' ' ' PHE . 0.2 OUTLIER -131.4 169.77 21.08 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.018 0 C-N-CA 117.389 -1.724 . . . . 0.0 111.413 -179.661 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.515 ' O ' ' N ' ' A' ' 9' ' ' ASP . 9.3 t0 -108.99 89.58 3.04 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 178.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.559 ' CG ' ' O ' ' A' ' 34' ' ' ALA . 8.4 mp0 -65.36 46.09 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.859 0 CA-C-O 121.578 0.704 . . . . 0.0 110.3 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.515 ' N ' ' O ' ' A' ' 7' ' ' ASP . 0.3 OUTLIER -113.32 -44.65 3.21 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.395 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.657 ' CG ' HG11 ' A' ' 56' ' ' VAL . 0.3 OUTLIER -91.45 17.62 8.33 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.087 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 37.4 t -83.26 111.95 19.43 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.359 -0.838 . . . . 0.0 110.373 -179.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.708 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 30.6 pt -78.53 0.59 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.47 -0.768 . . . . 0.0 109.047 179.344 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.708 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . 78.81 50.58 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.452 -0.78 . . . . 0.0 110.294 179.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.839 ' SG ' ' OG ' ' A' ' 16' ' ' SER . 3.2 p -105.67 161.51 14.33 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.866 -1.146 . . . . 0.0 109.436 179.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.456 ' O ' ' HB2' ' A' ' 19' ' ' GLU . 63.3 mt-10 -87.88 18.38 4.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.277 -0.889 . . . . 0.0 109.832 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 1.086 ' OG ' ' S1 ' ' A' ' 65' ' ' SF4 . 52.4 p -60.73 -91.06 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.22 -0.925 . . . . 0.0 109.636 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.523 ' SG ' ' N ' ' A' ' 18' ' ' VAL . 10.8 p -45.34 -47.77 13.3 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.22 -0.925 . . . . 0.0 110.034 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.523 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 78.6 t -53.03 -30.74 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.165 -0.96 . . . . 0.0 109.981 -179.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.456 ' HB2' ' O ' ' A' ' 15' ' ' GLU . 2.8 mm-40 -77.35 -41.97 38.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.932 -1.105 . . . . 0.0 109.603 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.768 ' CD1' HG21 ' A' ' 53' ' ' THR . 1.6 mt -84.81 15.57 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.248 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.585 ' HB2' ' O ' ' A' ' 20' ' ' ILE . . . 170.54 63.14 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.452 -0.78 . . . . 0.0 109.281 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.487 ' N ' ' O ' ' A' ' 18' ' ' VAL . 45.9 Cg_endo -74.07 -18.56 21.12 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.08 1.569 . . . . 0.0 110.882 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.401 ' O ' ' HB3' ' A' ' 38' ' ' ASP . . . -79.44 -41.48 13.28 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.489 ' HA ' ' HB3' ' A' ' 38' ' ' ASP . . . -87.32 -34.2 18.93 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.215 -1.168 . . . . 0.0 109.71 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 1.083 ' CZ ' HG21 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -106.04 141.21 37.8 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.324 -0.86 . . . . 0.0 109.326 -179.716 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.49 ' O ' ' CD1' ' A' ' 35' ' ' TYR . . . -170.45 128.69 0.83 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.069 -1.019 . . . . 0.0 109.948 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.572 ' HA ' ' C ' ' A' ' 33' ' ' LYS . 2.7 ptm -62.65 153.98 30.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.917 -1.114 . . . . 0.0 109.222 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.578 ' HB3' ' CD1' ' A' ' 31' ' ' ILE . 1.7 t0 -135.22 165.26 37.82 Favored Pre-proline 0 C--N 1.311 -1.085 0 O-C-N 120.663 -1.273 . . . . 0.0 107.572 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.505 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 43.4 Cg_endo -84.01 -17.1 5.95 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 O-C-N 124.528 1.804 . . . . 0.0 107.867 179.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.72 -38.96 19.07 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 177.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.578 ' CD1' ' HB3' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -104.13 3.07 10.58 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 177.885 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.565 ' N ' ' O ' ' A' ' 28' ' ' ASP . 2.5 mm-40 31.62 39.33 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.795 0.807 . . . . 0.0 108.879 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.572 ' C ' ' HA ' ' A' ' 27' ' ' MET . 0.0 OUTLIER -173.7 153.55 2.27 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 119.191 -1.004 . . . . 0.0 110.131 -178.537 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.559 ' O ' ' CG ' ' A' ' 8' ' ' GLN . . . -52.52 149.32 5.95 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.475 -0.766 . . . . 0.0 109.66 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.617 ' O ' ' CD1' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -154.16 146.5 23.9 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.614 0.721 . . . . 0.0 109.267 179.266 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.873 ' HB ' HG23 ' A' ' 6' ' ' VAL . 2.1 t -87.44 99.75 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.103 -0.998 . . . . 0.0 108.49 -179.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.597 ' HB3' ' CE2' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -115.56 -27.11 7.24 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.23 -0.919 . . . . 0.0 111.057 -178.699 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.554 ' N ' ' HG3' ' A' ' 37' ' ' LYS . 39.5 t0 -113.21 92.46 4.01 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.897 -1.127 . . . . 0.0 110.026 -179.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.457 HG12 ' CE1' ' A' ' 4' ' ' PHE . 25.5 m -61.16 -23.28 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.36 -0.837 . . . . 0.0 109.248 179.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -93.13 1.39 57.19 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.418 -0.801 . . . . 0.0 109.561 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -87.2 -0.09 85.37 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.451 ' HA ' ' OE2' ' A' ' 46' ' ' GLU . . . -162.91 131.41 3.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.167 -1.196 . . . . 0.0 109.718 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.609 ' O ' HG23 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -61.52 170.93 1.65 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.348 -0.845 . . . . 0.0 109.943 -179.823 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.486 ' HA ' ' HB ' ' A' ' 47' ' ' VAL . 6.0 tt0 -72.0 -41.05 68.04 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.572 -0.705 . . . . 0.0 109.743 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -67.22 -25.92 66.34 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.108 -0.995 . . . . 0.0 109.41 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.52 ' HG2' ' N ' ' A' ' 43' ' ' SER . 5.1 pt-20 -90.02 -35.29 15.59 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 178.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.609 HG23 ' O ' ' A' ' 43' ' ' SER . 4.0 t -64.37 -32.7 58.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 177.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.447 ' HB2' ' O ' ' A' ' 44' ' ' GLN . 0.5 OUTLIER -71.15 -59.35 2.82 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.131 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.687 ' HB3' HG21 ' A' ' 20' ' ' ILE . 0.4 OUTLIER -53.2 -39.22 63.52 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.113 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.709 ' HB2' ' HB ' ' A' ' 20' ' ' ILE . . . -71.59 -17.83 62.27 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.365 -0.834 . . . . 0.0 109.049 179.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 1.0 ' HG3' HD13 ' A' ' 59' ' ' ILE . 33.4 ttm -92.11 -17.84 24.41 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.483 -0.761 . . . . 0.0 109.939 -179.328 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -100.93 -17.15 16.93 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.054 -1.029 . . . . 0.0 109.784 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.768 HG21 ' CD1' ' A' ' 20' ' ' ILE . 9.6 t -72.58 -11.22 60.56 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.061 -1.025 . . . . 0.0 109.448 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 1.242 ' SG ' ' HD2' ' A' ' 55' ' ' PRO . 9.4 t -71.04 158.61 87.78 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.248 -0.907 . . . . 0.0 109.486 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 1.242 ' HD2' ' SG ' ' A' ' 54' ' ' CYS . 42.1 Cg_endo -72.79 -85.28 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.92 1.484 . . . . 0.0 109.929 179.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.657 HG11 ' CG ' ' A' ' 10' ' ' GLU . 4.2 p -68.41 -22.91 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.111 -0.993 . . . . 0.0 108.926 179.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.5 ' O ' ' N ' ' A' ' 59' ' ' ILE . 0.6 OUTLIER 69.34 46.63 0.75 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.474 -0.767 . . . . 0.0 109.635 179.741 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.484 ' HB2' ' HB2' ' A' ' 10' ' ' GLU . 0.1 OUTLIER -68.28 62.41 0.09 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.158 -0.964 . . . . 0.0 109.296 179.732 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 1.0 HD13 ' HG3' ' A' ' 51' ' ' MET . 12.0 tt -132.22 160.29 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.297 -0.877 . . . . 0.0 109.418 -179.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.582 ' CG ' ' O ' ' A' ' 59' ' ' ILE . 15.7 m80 -159.83 147.54 16.87 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.02 -1.05 . . . . 0.0 109.915 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.584 ' HA ' ' CB ' ' A' ' 4' ' ' PHE . 58.2 m95 -83.74 -175.38 5.78 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.321 -0.862 . . . . 0.0 108.861 179.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.553 ' HB3' ' HB3' ' A' ' 3' ' ' LYS . 0.5 OUTLIER -139.47 81.92 1.86 Allowed 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.089 -1.007 . . . . 0.0 109.586 -179.587 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.446 ' O ' ' CB ' ' A' ' 64' ' ' GLU . 11.0 t0 -92.7 90.02 6.9 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.379 -0.825 . . . . 0.0 109.285 179.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.446 ' CB ' ' O ' ' A' ' 63' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.244 -0.91 . . . . 0.0 109.48 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' SF4 . . . . . 1.086 ' S1 ' ' OG ' ' A' ' 16' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.445 ' O ' ' HB2' ' A' ' 2' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 121.258 0.551 . . . . 0.0 109.537 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.445 ' HB2' ' O ' ' A' ' 1' ' ' ALA . 10.2 mtt180 64.37 82.14 0.19 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.31 -0.869 . . . . 0.0 109.648 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.42 ' HB3' ' HB3' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -103.3 -153.46 0.47 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.306 -0.871 . . . . 0.0 109.039 179.713 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.654 ' CZ ' HG21 ' A' ' 47' ' ' VAL . 30.9 p90 -178.12 -178.83 0.68 Allowed 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.253 -0.905 . . . . 0.0 109.613 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.759 ' HA ' HG21 ' A' ' 36' ' ' VAL . 45.6 p90 -179.89 -178.15 0.42 Allowed 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 106.012 -1.848 . . . . 0.0 106.012 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 1.104 HG21 ' CE2' ' A' ' 25' ' ' PHE . 2.6 t -142.41 160.95 19.41 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.32 0 C-N-CA 117.487 -1.685 . . . . 0.0 111.228 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.531 ' N ' HG12 ' A' ' 6' ' ' VAL . 4.8 m-20 -114.52 79.26 1.24 Allowed 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.683 ' OE1' HD13 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -42.07 -22.76 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.564 0.697 . . . . 0.0 109.285 179.359 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.526 ' N ' ' O ' ' A' ' 7' ' ' ASP . 0.5 OUTLIER -48.99 -42.58 38.3 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.545 -0.722 . . . . 0.0 109.332 -179.782 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.489 ' CG ' ' SG ' ' A' ' 58' ' ' CYS . 7.8 tp10 -84.1 -14.53 50.14 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.308 -0.87 . . . . 0.0 109.179 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.415 ' HB3' ' O ' ' A' ' 8' ' ' GLN . 42.8 t -56.68 139.79 49.26 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.243 -0.91 . . . . 0.0 109.492 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.748 ' O ' ' HB2' ' A' ' 13' ' ' ALA . 1.6 pp -101.35 -33.69 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.219 -0.925 . . . . 0.0 109.783 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.748 ' HB2' ' O ' ' A' ' 12' ' ' ILE . . . 155.99 -40.5 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.543 -0.723 . . . . 0.0 109.769 179.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 1.154 ' O ' ' S2 ' ' A' ' 65' ' ' SF4 . 0.1 OUTLIER -43.84 153.2 0.13 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.146 -0.971 . . . . 0.0 109.735 -179.39 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.427 ' O ' ' C ' ' A' ' 16' ' ' SER . 3.5 pt-20 -117.49 21.88 12.76 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.277 -0.889 . . . . 0.0 109.559 -179.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.825 ' O ' HD12 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -44.43 -55.19 5.23 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.148 -0.97 . . . . 0.0 109.18 179.856 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.49 ' SG ' ' CD1' ' A' ' 25' ' ' PHE . 21.5 p -54.46 -45.31 73.1 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.376 -0.827 . . . . 0.0 109.3 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.461 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 4.8 t -52.26 -26.48 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.34 -0.85 . . . . 0.0 109.466 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -89.82 -32.08 17.08 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.166 -0.959 . . . . 0.0 109.541 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.932 HD13 ' HA ' ' A' ' 50' ' ' ALA . 2.7 mp -84.65 11.8 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.707 ' HB1' ' HB2' ' A' ' 42' ' ' ALA . . . -168.58 66.28 0.67 Allowed Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.357 -0.84 . . . . 0.0 109.293 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -71.74 83.28 1.12 Allowed 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 123.981 1.516 . . . . 0.0 110.287 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 147.57 -21.01 1.5 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.546 ' CB ' ' O ' ' A' ' 38' ' ' ASP . . . -113.01 -30.68 6.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.314 -1.109 . . . . 0.0 109.102 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 1.104 ' CE2' HG21 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -112.86 140.57 47.54 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.439 -0.788 . . . . 0.0 109.408 -179.972 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.479 ' O ' ' HA ' ' A' ' 34' ' ' ALA . . . -171.59 149.65 2.65 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.544 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 0.2 OUTLIER -82.76 156.51 23.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.874 -1.141 . . . . 0.0 108.652 -179.979 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.622 ' O ' ' N ' ' A' ' 32' ' ' GLU . 1.7 t0 -121.13 160.95 43.16 Favored Pre-proline 0 C--N 1.31 -1.148 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 179.26 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.467 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 48.1 Cg_endo -83.42 -15.97 7.24 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 125.051 2.08 . . . . 0.0 108.157 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -88.56 -35.35 16.96 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 178.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.683 HD13 ' OE1' ' A' ' 8' ' ' GLN . 3.8 pt -106.86 0.48 10.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.622 ' N ' ' O ' ' A' ' 28' ' ' ASP . 51.6 mt-10 32.18 38.34 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -179.247 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.605 ' O ' HD12 ' A' ' 31' ' ' ILE . 83.1 mttt -157.83 146.87 19.55 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 119.262 -0.975 . . . . 0.0 110.93 -177.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.76 ' HB1' ' CD1' ' A' ' 25' ' ' PHE . . . -53.31 143.91 17.55 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.737 -0.602 . . . . 0.0 110.634 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.708 ' CE2' ' HA ' ' A' ' 37' ' ' LYS . 6.9 p90 -149.37 169.19 21.4 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 1.062 HG22 HG23 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -86.59 85.09 2.35 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.084 0 CA-C-O 121.624 0.726 . . . . 0.0 109.433 -178.26 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.708 ' HA ' ' CE2' ' A' ' 35' ' ' TYR . 13.4 ptmt -68.89 -10.39 56.79 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.558 -0.714 . . . . 0.0 110.511 -179.344 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.546 ' O ' ' CB ' ' A' ' 24' ' ' ALA . 11.7 t0 178.55 141.07 0.1 Allowed 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 118.611 -1.235 . . . . 0.0 110.424 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.1 m -84.38 -33.54 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.289 -0.882 . . . . 0.0 109.351 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -71.78 -16.08 62.18 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.247 -0.908 . . . . 0.0 109.21 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -69.39 -26.85 74.18 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.707 ' HB2' ' HB1' ' A' ' 21' ' ' ALA . . . -130.7 144.74 51.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.294 -1.121 . . . . 0.0 109.252 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.451 ' OG ' ' OE2' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -89.11 158.24 18.02 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.199 -0.938 . . . . 0.0 109.996 -179.613 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.528 ' HG2' ' N ' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -53.03 -23.06 6.69 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.45 -0.781 . . . . 0.0 109.147 179.811 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.528 ' N ' ' HG2' ' A' ' 44' ' ' GLN . 53.8 mm-40 -85.06 -23.1 28.72 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.4 -0.813 . . . . 0.0 108.837 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.463 ' HB3' ' O ' ' A' ' 20' ' ' ILE . 48.5 mt-10 -88.5 -55.8 3.57 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 106.263 -1.755 . . . . 0.0 106.263 178.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.654 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 2.9 t -48.06 -29.35 2.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 177.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.519 ' HB2' ' O ' ' A' ' 44' ' ' GLN . 0.3 OUTLIER -70.25 -69.27 0.37 Allowed 'General case' 0 C--N 1.311 -1.083 0 O-C-N 121.565 -0.709 . . . . 0.0 109.41 179.161 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -46.15 -46.72 17.44 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.381 -0.825 . . . . 0.0 109.11 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.932 ' HA ' HD13 ' A' ' 20' ' ' ILE . . . -55.02 -32.49 61.88 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.289 -0.882 . . . . 0.0 109.088 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.679 ' HE2' HG23 ' A' ' 59' ' ' ILE . 34.9 ttm -66.7 -60.2 2.91 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.414 -0.803 . . . . 0.0 109.426 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -46.69 -28.19 1.42 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.223 -0.923 . . . . 0.0 109.689 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.459 ' O ' ' HB2' ' A' ' 54' ' ' CYS . 0.2 OUTLIER -102.08 99.9 10.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.176 -0.953 . . . . 0.0 109.827 -179.763 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.813 ' SG ' ' HD2' ' A' ' 55' ' ' PRO . 53.2 t 176.64 146.43 0.27 Allowed Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.214 -0.929 . . . . 0.0 109.868 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.813 ' HD2' ' SG ' ' A' ' 54' ' ' CYS . 45.1 Cg_endo -75.14 104.04 1.84 Allowed 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 124.061 1.558 . . . . 0.0 109.279 179.178 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.535 HG23 ' C ' ' A' ' 55' ' ' PRO . 3.7 t 77.71 3.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.441 -0.787 . . . . 0.0 109.003 -178.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.489 ' HG2' ' O ' ' A' ' 51' ' ' MET . 15.5 mt-30 44.72 82.65 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.284 -0.885 . . . . 0.0 109.413 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.538 ' O ' ' CE1' ' A' ' 60' ' ' HIS . 2.3 m -79.93 -12.54 59.72 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.242 -0.911 . . . . 0.0 109.224 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.848 ' HA ' HG13 ' A' ' 6' ' ' VAL . 16.4 tt -83.77 144.19 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.383 -0.823 . . . . 0.0 110.145 -179.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.538 ' CE1' ' O ' ' A' ' 58' ' ' CYS . 14.0 m80 -144.37 172.43 12.94 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.365 -0.834 . . . . 0.0 108.902 179.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.532 ' HA ' ' CB ' ' A' ' 4' ' ' PHE . 68.4 m95 -94.69 179.55 5.22 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.029 -1.045 . . . . 0.0 110.037 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.42 ' HB3' ' HB3' ' A' ' 3' ' ' LYS . 13.6 tt0 -155.97 94.36 1.53 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.42 -0.8 . . . . 0.0 109.261 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.88 107.08 0.78 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.189 -0.944 . . . . 0.0 109.413 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 . . . . . 0 N--CA 1.492 1.639 0 O-C-N 121.323 -0.861 . . . . 0.0 109.574 -179.913 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' SF4 . . . . . 1.154 ' S2 ' ' O ' ' A' ' 14' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.271 0.558 . . . . 0.0 109.586 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.2 ttp180 46.56 75.11 0.13 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.187 -0.945 . . . . 0.0 109.715 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.49 ' HB3' ' HB3' ' A' ' 62' ' ' GLU . 1.2 ttmt -80.22 -152.88 0.08 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.216 -0.928 . . . . 0.0 109.188 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.573 ' HA ' ' N ' ' A' ' 62' ' ' GLU . 51.2 p90 175.55 175.69 0.24 Allowed 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.399 -0.813 . . . . 0.0 110.082 179.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.845 ' O ' HD12 ' A' ' 59' ' ' ILE . 41.0 p90 179.7 -176.34 0.31 Allowed 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 1.148 HG21 ' CZ ' ' A' ' 25' ' ' PHE . 0.2 OUTLIER -135.48 171.95 16.59 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 C-N-CA 117.816 -1.553 . . . . 0.0 110.94 -179.859 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.58 ' O ' ' N ' ' A' ' 9' ' ' ASP . 2.5 t0 -117.98 92.56 3.86 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.569 ' CB ' HG21 ' A' ' 31' ' ' ILE . 4.0 mp0 -62.89 42.37 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.93 0 CA-C-O 121.399 0.619 . . . . 0.0 111.039 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.58 ' N ' ' O ' ' A' ' 7' ' ' ASP . 0.4 OUTLIER -104.13 -31.68 9.53 Favored 'General case' 0 C--N 1.287 -2.11 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.432 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.448 ' HB2' ' SG ' ' A' ' 58' ' ' CYS . 0.6 OUTLIER -111.42 22.06 15.53 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.632 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 14.4 t -83.76 126.04 32.51 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.292 -0.88 . . . . 0.0 109.988 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.719 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 23.1 pt -86.21 1.31 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.363 -0.836 . . . . 0.0 109.431 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.719 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . 78.49 32.59 0.32 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.333 -0.854 . . . . 0.0 110.612 179.207 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.494 ' O ' ' S2 ' ' A' ' 65' ' ' SF4 . 1.6 p -88.86 151.52 22.3 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.905 -1.122 . . . . 0.0 109.076 179.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.448 ' O ' ' HB2' ' A' ' 19' ' ' GLU . 1.5 mt-10 -88.54 33.97 0.76 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.179 -0.951 . . . . 0.0 110.115 -179.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.908 ' OG ' ' S1 ' ' A' ' 65' ' ' SF4 . 75.5 p -75.83 -69.95 0.46 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.086 -1.009 . . . . 0.0 109.326 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.674 ' HB3' ' S1 ' ' A' ' 65' ' ' SF4 . 12.4 p -58.25 -46.55 85.77 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.226 -0.922 . . . . 0.0 109.519 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.533 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 68.7 t -52.69 -41.73 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.364 -0.835 . . . . 0.0 109.916 -179.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.448 ' HB2' ' O ' ' A' ' 15' ' ' GLU . 7.4 tm-20 -66.49 -42.7 87.01 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.099 -1.001 . . . . 0.0 109.662 -179.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.888 HD11 HG21 ' A' ' 53' ' ' THR . 2.7 mp -82.06 11.76 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.294 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -176.18 68.67 0.25 Allowed Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.29 -0.881 . . . . 0.0 109.237 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -74.09 -0.32 9.4 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 124.076 1.566 . . . . 0.0 110.381 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.468 ' O ' ' HB3' ' A' ' 38' ' ' ASP . . . -112.98 -33.12 2.06 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.442 ' HA ' ' HB3' ' A' ' 38' ' ' ASP . . . -90.1 -46.46 8.46 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.147 -1.208 . . . . 0.0 109.449 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 1.148 ' CZ ' HG21 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -99.26 146.97 25.65 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.273 -0.892 . . . . 0.0 108.901 179.829 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.469 ' O ' ' CD1' ' A' ' 35' ' ' TYR . . . -169.86 125.02 0.8 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.105 -0.997 . . . . 0.0 109.946 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.562 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 6.3 ttp -58.43 152.87 16.94 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.174 -0.954 . . . . 0.0 109.289 179.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.637 ' O ' ' N ' ' A' ' 32' ' ' GLU . 0.6 OUTLIER -128.21 163.56 43.25 Favored Pre-proline 0 C--N 1.311 -1.092 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 179.181 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -85.43 -15.62 5.15 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 O-C-N 125.148 2.131 . . . . 0.0 108.513 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -92.41 -29.34 16.34 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 178.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.598 HG12 ' HB3' ' A' ' 28' ' ' ASP . 0.2 OUTLIER -103.31 -15.66 7.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 177.557 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.637 ' N ' ' O ' ' A' ' 28' ' ' ASP . 14.1 mt-10 44.08 31.7 0.56 Allowed 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 -177.111 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.537 ' C ' ' HA ' ' A' ' 27' ' ' MET . 2.5 mttp -158.26 152.82 24.64 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 119.344 -0.942 . . . . 0.0 110.483 -177.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.612 ' CB ' ' S2 ' ' A' ' 65' ' ' SF4 . . . -59.66 148.97 31.89 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.487 -0.758 . . . . 0.0 109.768 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.635 ' CE2' ' HB3' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -150.75 146.85 26.69 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.624 0.726 . . . . 0.0 109.519 179.296 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.981 ' HB ' HG23 ' A' ' 6' ' ' VAL . 2.4 t -89.57 97.82 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.077 -1.014 . . . . 0.0 108.448 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.635 ' HB3' ' CE2' ' A' ' 35' ' ' TYR . 1.3 pttp -108.08 -23.71 11.87 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.337 -0.852 . . . . 0.0 110.296 -179.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.52 ' N ' ' HG3' ' A' ' 37' ' ' LYS . 55.2 t0 -118.36 124.54 47.98 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.125 -0.984 . . . . 0.0 109.884 -179.334 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 15.5 m -86.22 -34.53 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.272 -0.892 . . . . 0.0 109.451 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.439 ' HG2' ' OD1' ' A' ' 38' ' ' ASP . 8.1 pm0 -81.9 -10.31 59.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.198 -0.938 . . . . 0.0 109.519 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -63.54 -18.55 61.41 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.418 ' HB1' ' HB2' ' A' ' 46' ' ' GLU . . . -151.93 132.28 13.72 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.248 -1.148 . . . . 0.0 109.521 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.45 155.09 19.05 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.26 -0.9 . . . . 0.0 109.727 -179.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.455 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 4.2 pt20 -49.46 -44.94 46.17 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.479 -0.763 . . . . 0.0 109.565 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.431 ' O ' ' HG3' ' A' ' 49' ' ' GLU . 7.6 mm-40 -64.12 -17.96 63.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.215 -0.928 . . . . 0.0 109.019 179.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.418 ' HB2' ' HB1' ' A' ' 42' ' ' ALA . 47.9 mt-10 -90.73 -46.99 7.91 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 179.03 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.459 ' O ' ' HB2' ' A' ' 51' ' ' MET . 2.3 t -57.85 -38.6 66.81 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.438 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.455 ' HB2' ' O ' ' A' ' 44' ' ' GLN . 0.1 OUTLIER -68.19 -60.99 2.06 Favored 'General case' 0 C--N 1.307 -1.257 0 O-C-N 121.534 -0.729 . . . . 0.0 109.629 179.721 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.431 ' HG3' ' O ' ' A' ' 45' ' ' GLU . 2.3 mt-10 -51.5 -40.67 60.01 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.172 -0.955 . . . . 0.0 108.877 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.662 ' HA ' HD13 ' A' ' 20' ' ' ILE . . . -69.28 -20.91 63.91 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.521 -0.737 . . . . 0.0 109.024 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.747 ' HE3' HG12 ' A' ' 59' ' ' ILE . 0.7 OUTLIER -82.86 -51.03 8.0 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.522 -0.736 . . . . 0.0 109.522 -179.482 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -57.32 -32.11 66.36 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.308 -0.87 . . . . 0.0 109.444 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.888 HG21 HD11 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -60.61 -32.05 71.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.341 -0.849 . . . . 0.0 109.804 -179.834 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.478 ' HB3' ' HG3' ' A' ' 57' ' ' GLN . 11.4 t -58.28 128.75 82.7 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.18 -0.95 . . . . 0.0 109.429 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -72.26 -53.94 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 123.931 1.49 . . . . 0.0 109.621 179.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 27.9 t -79.63 -15.18 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.478 ' HG3' ' HB3' ' A' ' 54' ' ' CYS . 0.5 OUTLIER 45.84 79.4 0.05 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.413 -0.804 . . . . 0.0 109.789 179.783 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.448 ' SG ' ' HB2' ' A' ' 10' ' ' GLU . 0.9 OUTLIER -92.58 15.86 13.35 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.354 -0.841 . . . . 0.0 109.043 179.517 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.908 ' HA ' HG13 ' A' ' 6' ' ' VAL . 4.0 tp -64.33 159.21 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.34 -0.85 . . . . 0.0 109.448 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.53 ' O ' ' HB2' ' A' ' 61' ' ' TRP . 6.5 m80 -135.73 -32.05 0.92 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.227 -0.921 . . . . 0.0 110.358 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.555 ' HA ' ' CB ' ' A' ' 4' ' ' PHE . 55.7 m95 67.51 163.75 0.2 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.477 -0.764 . . . . 0.0 109.244 -179.025 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.573 ' N ' ' HA ' ' A' ' 4' ' ' PHE . 14.8 tt0 -142.8 95.72 2.82 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.35 -0.844 . . . . 0.0 109.342 -179.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -57.99 -42.5 85.3 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.298 -0.876 . . . . 0.0 109.361 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 . . . . . 0 N--CA 1.491 1.578 0 O-C-N 121.316 -0.865 . . . . 0.0 109.388 -179.937 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' SF4 . . . . . 0.908 ' S1 ' ' OG ' ' A' ' 16' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.212 0.53 . . . . 0.0 109.622 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 9.1 ttm180 -92.27 176.85 6.33 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.185 -0.947 . . . . 0.0 109.614 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.501 ' O ' ' HB3' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -140.85 -158.01 0.82 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.215 -0.928 . . . . 0.0 109.443 -179.98 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.644 ' CE1' HG12 ' A' ' 39' ' ' VAL . 33.6 p90 168.0 -175.56 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.469 -0.769 . . . . 0.0 109.323 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.489 ' O ' HG13 ' A' ' 59' ' ' ILE . 28.0 p90 167.6 -175.62 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 106.541 -1.652 . . . . 0.0 106.541 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 1.179 HG21 ' CZ ' ' A' ' 25' ' ' PHE . 0.6 OUTLIER -131.25 176.31 9.2 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.073 0 C-N-CA 117.467 -1.693 . . . . 0.0 110.952 -179.945 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.625 ' H ' HG12 ' A' ' 6' ' ' VAL . 1.1 m-20 -127.1 90.52 3.16 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-O 121.845 0.831 . . . . 0.0 109.118 179.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.561 ' CG ' ' O ' ' A' ' 34' ' ' ALA . 1.5 mp0 -63.63 44.1 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.704 179.266 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.541 ' N ' ' O ' ' A' ' 7' ' ' ASP . 0.2 OUTLIER -99.93 -20.75 15.97 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 179.369 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.816 ' OE1' HG21 ' A' ' 56' ' ' VAL . 2.8 mm-40 -121.49 -7.49 9.18 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.663 -0.648 . . . . 0.0 109.468 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.659 ' SG ' ' HG2' ' A' ' 33' ' ' LYS . 45.0 t -54.1 112.41 0.96 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.19 -0.944 . . . . 0.0 109.692 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.699 ' O ' ' HB2' ' A' ' 13' ' ' ALA . 13.8 pt -73.65 -47.61 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.241 -0.912 . . . . 0.0 109.601 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.699 ' HB2' ' O ' ' A' ' 12' ' ' ILE . . . 164.77 -28.92 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.095 -1.003 . . . . 0.0 110.147 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 1.023 ' O ' ' S2 ' ' A' ' 65' ' ' SF4 . 0.1 OUTLIER -46.33 156.52 0.17 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.966 -1.084 . . . . 0.0 109.727 -179.534 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.421 ' O ' ' C ' ' A' ' 16' ' ' SER . 0.7 OUTLIER -120.02 20.45 12.12 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.406 -0.809 . . . . 0.0 109.858 -179.643 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.923 ' O ' HD12 ' A' ' 20' ' ' ILE . 0.5 OUTLIER -43.89 -52.22 7.0 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.199 -0.938 . . . . 0.0 109.414 179.943 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.554 ' SG ' ' N ' ' A' ' 18' ' ' VAL . 19.8 p -59.34 -52.67 64.65 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.308 -0.87 . . . . 0.0 109.453 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.554 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 5.7 t -47.17 -34.92 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.128 -0.983 . . . . 0.0 109.414 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -73.53 -34.67 65.33 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.125 -0.984 . . . . 0.0 109.324 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.929 HD13 ' HA ' ' A' ' 50' ' ' ALA . 2.7 mp -84.9 10.96 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 178.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.681 ' HB1' ' HB2' ' A' ' 42' ' ' ALA . . . -174.75 65.71 0.27 Allowed Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 121.377 -0.827 . . . . 0.0 109.2 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -71.81 56.15 2.33 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 O-C-N 124.171 1.616 . . . . 0.0 110.371 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.495 ' O ' ' HB3' ' A' ' 38' ' ' ASP . . . -167.47 -55.09 0.03 OUTLIER Glycine 0 N--CA 1.488 2.109 0 N-CA-C 108.543 -1.823 . . . . 0.0 108.543 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.549 ' HB2' ' O ' ' A' ' 38' ' ' ASP . . . -78.29 -38.87 41.46 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.439 -1.036 . . . . 0.0 109.112 179.402 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 1.179 ' CZ ' HG21 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -97.14 134.23 40.74 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.136 -0.978 . . . . 0.0 108.88 179.693 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.502 ' O ' ' CD1' ' A' ' 35' ' ' TYR . . . -163.55 122.63 2.04 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.173 -0.954 . . . . 0.0 109.8 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.55 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 30.5 ttm -60.32 149.52 33.33 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.187 -0.946 . . . . 0.0 109.235 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.602 ' O ' ' N ' ' A' ' 32' ' ' GLU . 2.4 t0 -126.47 160.73 56.59 Favored Pre-proline 0 C--N 1.311 -1.073 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 179.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.489 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 43.9 Cg_endo -84.82 -17.12 5.06 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 O-C-N 124.765 1.929 . . . . 0.0 108.49 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -90.78 -30.45 17.01 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 178.009 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.566 HD12 ' HB3' ' A' ' 35' ' ' TYR . 0.8 OUTLIER -106.74 -0.18 9.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.092 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.602 ' N ' ' O ' ' A' ' 28' ' ' ASP . 8.2 mt-10 27.85 43.43 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.506 0.67 . . . . 0.0 109.983 -179.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.659 ' HG2' ' SG ' ' A' ' 11' ' ' CYS . 2.0 mttt -169.19 146.14 3.52 Favored 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 119.475 -0.89 . . . . 0.0 110.273 -179.31 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.561 ' O ' ' CG ' ' A' ' 8' ' ' GLN . . . -58.01 140.87 51.48 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.436 -0.79 . . . . 0.0 109.183 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.619 ' O ' ' CD1' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -146.26 146.49 30.76 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-O 121.902 0.858 . . . . 0.0 110.084 179.742 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.962 ' HB ' HG23 ' A' ' 6' ' ' VAL . 2.7 t -85.67 100.82 9.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -179.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.584 ' HG2' ' CZ ' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -116.63 -34.26 4.59 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.456 -0.777 . . . . 0.0 110.103 -179.083 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.549 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 17.0 t0 -104.58 85.56 2.35 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.217 -0.927 . . . . 0.0 109.801 -179.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.644 HG12 ' CE1' ' A' ' 4' ' ' PHE . 14.5 m -53.52 -29.21 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.293 -0.879 . . . . 0.0 109.288 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -73.02 -14.45 61.43 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.338 -0.851 . . . . 0.0 109.375 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.435 ' HA3' ' N ' ' A' ' 24' ' ' ALA . . . -71.88 -25.4 74.94 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.681 ' HB2' ' HB1' ' A' ' 21' ' ' ALA . . . -142.24 155.43 45.25 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.317 -1.107 . . . . 0.0 109.2 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -96.05 -166.73 1.47 Allowed 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.064 -1.022 . . . . 0.0 109.875 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.478 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 22.0 tt0 -72.66 -53.7 11.08 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.423 ' OE2' ' NE2' ' A' ' 44' ' ' GLN . 18.7 mm-40 -62.98 -19.63 64.51 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.397 -0.814 . . . . 0.0 109.252 179.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -88.25 -45.85 9.72 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 178.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.3 t -62.94 -27.23 42.75 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 178.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.478 ' HB2' ' O ' ' A' ' 44' ' ' GLN . 0.2 OUTLIER -71.15 -66.1 0.66 Allowed 'General case' 0 C--N 1.309 -1.192 0 O-C-N 121.635 -0.666 . . . . 0.0 109.302 179.406 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -47.29 -49.0 24.7 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.367 -0.833 . . . . 0.0 109.022 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.929 ' HA ' HD13 ' A' ' 20' ' ' ILE . . . -57.44 -40.18 77.89 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.251 -0.905 . . . . 0.0 108.761 179.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.633 ' HE2' HD13 ' A' ' 59' ' ' ILE . 22.4 ttm -69.05 -14.15 62.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.413 -0.804 . . . . 0.0 109.186 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -99.77 -3.99 31.57 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.341 -0.849 . . . . 0.0 109.465 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.437 ' O ' ' HB3' ' A' ' 16' ' ' SER . 2.4 m -113.67 46.01 1.35 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.15 -0.969 . . . . 0.0 109.784 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.789 ' SG ' ' N ' ' A' ' 57' ' ' GLN . 53.6 t -123.05 143.1 39.88 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.225 -0.922 . . . . 0.0 109.142 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.603 ' HD2' ' SG ' ' A' ' 54' ' ' CYS . 44.1 Cg_endo -71.35 -35.33 8.51 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.936 1.493 . . . . 0.0 110.037 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.816 HG21 ' OE1' ' A' ' 10' ' ' GLU . 43.5 t -124.45 -0.98 5.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.426 -0.796 . . . . 0.0 109.185 179.488 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.789 ' N ' ' SG ' ' A' ' 54' ' ' CYS . 6.4 mt-30 60.94 -80.41 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.266 -0.896 . . . . 0.0 109.459 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.5 ' SG ' ' HB3' ' A' ' 10' ' ' GLU . 0.3 OUTLIER 55.59 23.4 6.03 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.075 -1.016 . . . . 0.0 108.825 179.985 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.87 ' CB ' HG13 ' A' ' 6' ' ' VAL . 7.8 tt -124.12 154.31 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.213 -0.929 . . . . 0.0 110.051 -179.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.53 ' CG ' ' C ' ' A' ' 59' ' ' ILE . 10.5 m80 -157.36 157.55 34.29 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.426 -0.796 . . . . 0.0 109.241 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.511 ' HA ' ' HA ' ' A' ' 4' ' ' PHE . 40.1 m95 -83.32 179.53 7.66 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.095 -1.003 . . . . 0.0 109.394 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.485 ' O ' ' CB ' ' A' ' 3' ' ' LYS . 1.1 tt0 -149.5 108.04 3.81 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.288 -0.883 . . . . 0.0 109.408 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -104.68 -56.88 2.11 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.178 -0.951 . . . . 0.0 109.546 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 O-C-N 121.328 -0.858 . . . . 0.0 109.508 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' SF4 . . . . . 1.023 ' S2 ' ' O ' ' A' ' 14' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.436 ' O ' ' OD1' ' A' ' 63' ' ' ASP . . . . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.15 76.18 1.53 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.272 -0.893 . . . . 0.0 109.676 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.483 ' O ' ' HB3' ' A' ' 4' ' ' PHE . 1.1 tttt -97.85 -161.81 0.9 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.297 -0.877 . . . . 0.0 109.08 179.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.651 ' CE1' HG12 ' A' ' 39' ' ' VAL . 9.3 p90 167.57 179.56 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.283 -0.886 . . . . 0.0 109.307 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.46 ' HB3' ' O ' ' A' ' 4' ' ' PHE . 55.3 p90 176.16 -171.63 0.08 Allowed 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.354 -0.841 . . . . 0.0 109.272 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 1.046 HG21 ' CZ ' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -140.09 152.23 21.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 179.718 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.609 ' O ' ' N ' ' A' ' 9' ' ' ASP . 53.6 t0 -99.56 0.01 41.4 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 118.628 -1.229 . . . . 0.0 111.692 -178.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.506 ' HB2' ' HB3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER 42.56 14.92 0.01 OUTLIER 'General case' 0 C--N 1.273 -2.753 0 CA-C-O 121.29 0.567 . . . . 0.0 110.935 179.143 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.609 ' N ' ' O ' ' A' ' 7' ' ' ASP . 0.8 OUTLIER -75.98 -50.66 14.25 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.315 -0.866 . . . . 0.0 109.142 -179.295 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.724 ' HB3' HG21 ' A' ' 56' ' ' VAL . 1.1 tp10 -85.66 11.93 9.85 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.457 -0.777 . . . . 0.0 109.041 179.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 31.4 t -66.04 111.4 3.35 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.246 -0.909 . . . . 0.0 110.003 -179.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.523 HG13 ' N ' ' A' ' 13' ' ' ALA . 11.9 pt -73.53 -139.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.443 -0.786 . . . . 0.0 109.221 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.523 ' N ' HG13 ' A' ' 12' ' ' ILE . . . -102.99 28.34 6.32 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.942 -1.099 . . . . 0.0 110.003 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 1.038 ' O ' ' S2 ' ' A' ' 65' ' ' SF4 . 0.0 OUTLIER -112.0 159.49 18.39 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.922 -1.111 . . . . 0.0 109.78 179.67 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.864 ' HA ' ' S2 ' ' A' ' 65' ' ' SF4 . 0.0 OUTLIER -136.25 20.4 3.19 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.401 -0.812 . . . . 0.0 109.374 -179.995 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.442 ' C ' ' O ' ' A' ' 15' ' ' GLU . 59.6 p -41.83 -44.33 3.29 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.521 -0.737 . . . . 0.0 109.387 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.615 ' SG ' ' CD2' ' A' ' 25' ' ' PHE . 17.4 p -58.33 -42.86 87.75 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.307 -0.871 . . . . 0.0 109.095 179.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.444 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 39.8 t -56.8 -30.5 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.33 -0.856 . . . . 0.0 109.493 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -81.58 -38.43 26.13 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.171 -0.955 . . . . 0.0 109.293 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.606 HG21 ' N ' ' A' ' 50' ' ' ALA . 0.3 OUTLIER -74.64 2.98 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.152 -0.967 . . . . 0.0 108.827 178.565 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.79 ' HB1' ' HB2' ' A' ' 42' ' ' ALA . . . -161.86 70.71 2.38 Favored Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.185 -0.947 . . . . 0.0 109.381 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -71.0 68.09 2.42 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 124.133 1.596 . . . . 0.0 110.277 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 165.66 -35.85 0.26 Allowed Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.989 -1.644 . . . . 0.0 108.989 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.525 ' CB ' ' O ' ' A' ' 38' ' ' ASP . . . -91.81 -46.97 7.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.454 -1.027 . . . . 0.0 109.176 179.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 1.046 ' CZ ' HG21 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -100.63 139.05 36.86 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.368 -0.832 . . . . 0.0 108.885 179.768 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.499 ' O ' ' CD1' ' A' ' 35' ' ' TYR . . . -169.34 124.03 0.83 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.152 -0.967 . . . . 0.0 109.759 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.554 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER -61.17 152.55 28.34 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.007 -1.058 . . . . 0.0 108.881 179.665 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.6 ' O ' ' N ' ' A' ' 32' ' ' GLU . 2.5 t0 -128.63 159.82 66.01 Favored Pre-proline 0 C--N 1.308 -1.204 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.479 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 44.9 Cg_endo -84.6 -16.23 5.73 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 O-C-N 124.562 1.822 . . . . 0.0 108.346 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -91.96 -27.81 17.63 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 177.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.684 HD12 ' HB3' ' A' ' 35' ' ' TYR . 0.7 OUTLIER -110.46 2.41 9.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.151 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.6 ' N ' ' O ' ' A' ' 28' ' ' ASP . 2.6 mm-40 26.22 44.01 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.466 0.651 . . . . 0.0 110.14 -179.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.532 ' CG ' ' O ' ' A' ' 32' ' ' GLU . 0.2 OUTLIER -172.23 149.19 2.24 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 119.175 -1.01 . . . . 0.0 109.999 -179.186 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.554 ' HA ' ' HA ' ' A' ' 27' ' ' MET . . . -56.8 144.67 32.1 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.433 -0.792 . . . . 0.0 110.158 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.684 ' HB3' HD12 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -148.78 140.79 23.85 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.839 0.828 . . . . 0.0 110.173 178.932 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.887 ' HB ' HG23 ' A' ' 6' ' ' VAL . 2.8 t -87.44 90.19 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 120.98 -1.075 . . . . 0.0 108.112 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.606 ' HB3' ' CE2' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -101.28 -7.79 22.7 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.333 -0.854 . . . . 0.0 110.588 -178.75 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.525 ' O ' ' CB ' ' A' ' 24' ' ' ALA . 59.6 t0 -138.16 93.6 2.78 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.991 -1.068 . . . . 0.0 109.952 -179.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.651 HG12 ' CE1' ' A' ' 4' ' ' PHE . 17.7 m -58.48 -29.5 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.298 -0.877 . . . . 0.0 109.017 179.459 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -76.28 -17.6 59.38 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.303 -0.873 . . . . 0.0 109.251 179.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -69.55 -8.65 60.28 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.79 ' HB2' ' HB1' ' A' ' 21' ' ' ALA . . . -155.09 119.56 4.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.286 -1.126 . . . . 0.0 109.289 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.659 ' O ' HG23 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -49.39 174.99 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.319 -0.863 . . . . 0.0 109.812 -179.747 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.427 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 6.3 tm0? -68.16 -42.48 79.98 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.558 -0.714 . . . . 0.0 109.478 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.6 mm-40 -66.7 -13.8 61.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.101 -0.999 . . . . 0.0 108.963 179.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -96.49 -43.48 7.6 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 178.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.67 HG23 ' O ' ' A' ' 42' ' ' ALA . 55.5 t -58.2 -51.61 69.0 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 178.31 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.427 ' HB2' ' O ' ' A' ' 44' ' ' GLN . 0.2 OUTLIER -65.46 -52.6 51.88 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.615 -0.678 . . . . 0.0 109.57 179.387 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -47.73 -48.63 29.59 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.207 -0.933 . . . . 0.0 109.234 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.606 ' N ' HG21 ' A' ' 20' ' ' ILE . . . -65.94 -23.64 66.65 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.199 -0.938 . . . . 0.0 109.001 179.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.995 ' CG ' HG21 ' A' ' 59' ' ' ILE . 35.0 ttm -76.16 -14.83 60.15 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.345 -0.847 . . . . 0.0 109.509 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -98.15 -25.32 14.95 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.218 -0.926 . . . . 0.0 109.71 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.75 -19.17 60.33 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.18 -0.95 . . . . 0.0 109.948 -179.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.747 ' SG ' ' HD2' ' A' ' 55' ' ' PRO . 9.2 t -70.57 145.03 92.17 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.071 -1.018 . . . . 0.0 109.702 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.747 ' HD2' ' SG ' ' A' ' 54' ' ' CYS . 43.4 Cg_endo -73.44 -86.9 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.004 1.529 . . . . 0.0 109.505 179.247 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.724 HG21 ' HB3' ' A' ' 10' ' ' GLU . 27.8 m -56.03 -31.28 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 120.981 -1.074 . . . . 0.0 108.168 178.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.497 ' O ' ' N ' ' A' ' 59' ' ' ILE . 4.1 tt0 68.97 52.41 0.51 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.566 -0.709 . . . . 0.0 110.361 179.146 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.784 ' O ' HG12 ' A' ' 6' ' ' VAL . 0.5 OUTLIER -68.26 65.5 0.11 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.055 -1.028 . . . . 0.0 108.804 179.166 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.995 HG21 ' CG ' ' A' ' 51' ' ' MET . 0.5 OUTLIER -131.59 148.1 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.229 -0.919 . . . . 0.0 110.219 -179.262 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.505 ' N ' HG13 ' A' ' 59' ' ' ILE . 1.1 m80 -148.74 129.46 14.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.324 -0.86 . . . . 0.0 109.431 179.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.57 ' HA ' ' HA ' ' A' ' 4' ' ' PHE . 54.3 m95 -68.27 161.15 27.88 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.266 -0.896 . . . . 0.0 109.256 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.517 ' N ' ' HA ' ' A' ' 4' ' ' PHE . 24.2 tt0 -129.71 119.83 24.13 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.204 -0.935 . . . . 0.0 109.696 -179.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 1' ' ' ALA . 4.9 m-20 -112.65 30.47 7.1 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.277 -0.89 . . . . 0.0 109.343 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.337 -0.852 . . . . 0.0 109.452 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' SF4 . . . . . 1.038 ' S2 ' ' O ' ' A' ' 14' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.29 0.566 . . . . 0.0 109.478 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 13.3 mtm180 -59.56 104.01 0.24 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.258 -0.901 . . . . 0.0 109.424 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.48 ' HB3' ' HB3' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -126.28 -152.8 0.53 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.234 -0.916 . . . . 0.0 109.645 -179.879 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.919 ' CZ ' HG12 ' A' ' 39' ' ' VAL . 23.4 p90 175.82 176.67 0.23 Allowed 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.514 ' CE1' ' HB2' ' A' ' 62' ' ' GLU . 17.4 p90 172.45 -168.42 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 105.747 -1.946 . . . . 0.0 105.747 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.854 HG13 ' HA ' ' A' ' 59' ' ' ILE . 4.4 t -146.54 159.72 10.42 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.236 0 C-N-CA 116.724 -1.99 . . . . 0.0 111.739 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.531 ' N ' HG12 ' A' ' 6' ' ' VAL . 39.1 t70 -106.16 78.44 1.31 Allowed 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.563 ' CG ' ' O ' ' A' ' 34' ' ' ALA . 5.3 mp0 -43.34 -19.24 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.984 179.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.525 ' N ' ' O ' ' A' ' 7' ' ' ASP . 0.1 OUTLIER -56.51 -35.56 68.17 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.163 -0.96 . . . . 0.0 108.828 -179.898 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.5 ' HB3' ' HB3' ' A' ' 58' ' ' CYS . 0.6 OUTLIER -81.96 -31.5 31.17 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.656 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.434 ' C ' ' O ' ' A' ' 10' ' ' GLU . 36.5 t -42.65 143.09 0.73 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.362 -0.836 . . . . 0.0 109.503 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.705 ' O ' ' HB2' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -98.14 -45.25 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.27 -0.893 . . . . 0.0 109.675 -179.603 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.705 ' HB2' ' O ' ' A' ' 12' ' ' ILE . . . 162.41 -28.84 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.24 -0.912 . . . . 0.0 109.571 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 1.082 ' O ' ' S2 ' ' A' ' 65' ' ' SF4 . 0.1 OUTLIER -56.09 156.34 5.58 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.16 -0.962 . . . . 0.0 109.499 -179.725 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.436 ' O ' ' C ' ' A' ' 16' ' ' SER . 31.3 mt-10 -116.97 20.94 13.59 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.276 -0.89 . . . . 0.0 109.68 -179.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.436 ' C ' ' O ' ' A' ' 15' ' ' GLU . 70.1 m -44.45 -63.79 0.82 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.226 -0.921 . . . . 0.0 109.073 179.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.647 ' SG ' ' N ' ' A' ' 18' ' ' VAL . 17.8 p -49.13 -54.33 16.75 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.32 -0.862 . . . . 0.0 109.151 179.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.647 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 48.4 t -43.43 -46.1 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.442 -0.786 . . . . 0.0 109.199 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -63.65 -34.5 77.99 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.155 -0.966 . . . . 0.0 109.146 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.592 HG22 ' O ' ' A' ' 20' ' ' ILE . 5.6 mt -87.51 14.42 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.137 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -171.03 65.25 0.43 Allowed Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.486 -0.759 . . . . 0.0 109.257 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -71.15 56.51 2.01 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 124.161 1.611 . . . . 0.0 110.147 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.491 ' C ' ' HB3' ' A' ' 38' ' ' ASP . . . -177.86 -63.35 0.07 OUTLIER Glycine 0 N--CA 1.488 2.148 0 N-CA-C 108.832 -1.707 . . . . 0.0 108.832 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.758 ' HB2' ' O ' ' A' ' 38' ' ' ASP . . . -66.56 -42.04 87.7 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.298 -1.119 . . . . 0.0 108.453 179.443 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.621 ' HZ ' HG11 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -101.23 132.79 46.57 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 118.757 -1.177 . . . . 0.0 108.949 179.45 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.624 ' HB3' ' HE1' ' A' ' 35' ' ' TYR . . . -161.49 130.87 4.64 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.434 -0.791 . . . . 0.0 109.358 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.535 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 4.0 ptt? -71.68 152.2 43.02 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.193 -0.942 . . . . 0.0 109.46 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.632 ' O ' ' N ' ' A' ' 32' ' ' GLU . 2.0 t0 -126.0 161.21 52.88 Favored Pre-proline 0 C--N 1.31 -1.118 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 179.002 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.483 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 45.0 Cg_endo -85.18 -17.9 4.4 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 O-C-N 124.814 1.955 . . . . 0.0 108.596 -179.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.3 -28.62 18.64 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 177.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.536 HG12 ' CB ' ' A' ' 28' ' ' ASP . 0.9 OUTLIER -107.17 -3.92 10.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 177.687 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.632 ' N ' ' O ' ' A' ' 28' ' ' ASP . 1.6 mt-10 31.41 37.47 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -179.271 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.548 ' CB ' ' HB3' ' A' ' 8' ' ' GLN . 19.4 mmtp -161.91 148.22 13.68 Favored 'General case' 0 N--CA 1.502 2.17 0 C-N-CA 119.499 -0.881 . . . . 0.0 110.753 -178.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.563 ' O ' ' CG ' ' A' ' 8' ' ' GLN . . . -61.58 138.45 58.29 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.416 -0.802 . . . . 0.0 110.167 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.76 ' CE2' ' HG3' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -132.58 144.57 50.48 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-O 122.262 1.029 . . . . 0.0 110.511 179.881 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.655 ' CG2' HG23 ' A' ' 6' ' ' VAL . 2.4 t -86.4 92.26 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 120.303 -1.498 . . . . 0.0 109.242 -178.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.76 ' HG3' ' CE2' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -107.55 -53.31 2.64 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.436 -0.79 . . . . 0.0 111.013 -179.006 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.758 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 46.9 t0 -85.77 76.07 9.97 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 119.746 -0.781 . . . . 0.0 110.782 -177.224 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.919 HG12 ' CZ ' ' A' ' 4' ' ' PHE . 27.5 m -49.94 -31.36 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.327 -0.858 . . . . 0.0 109.34 179.279 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -79.55 -6.92 58.02 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.327 -0.858 . . . . 0.0 109.476 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -85.85 5.38 84.01 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -153.35 116.46 4.58 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.179 -1.189 . . . . 0.0 109.644 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.869 ' O ' HG23 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -64.5 163.88 12.65 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.243 -0.911 . . . . 0.0 109.599 179.971 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.46 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 3.4 tt0 -49.8 -44.14 48.89 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.356 -0.84 . . . . 0.0 109.381 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.412 ' O ' ' HB2' ' A' ' 49' ' ' GLU . 72.7 mm-40 -67.87 -8.9 40.29 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.18 -0.95 . . . . 0.0 109.187 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.457 ' OE2' ' OG ' ' A' ' 43' ' ' SER . 14.3 mt-10 -99.58 -43.12 6.62 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 106.66 -1.608 . . . . 0.0 106.66 179.112 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.869 HG23 ' O ' ' A' ' 43' ' ' SER . 1.9 t -61.92 -42.73 95.84 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.398 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.46 ' HB2' ' O ' ' A' ' 44' ' ' GLN . 0.2 OUTLIER -73.49 -50.1 23.25 Favored 'General case' 0 C--N 1.308 -1.236 0 O-C-N 121.59 -0.694 . . . . 0.0 109.282 179.383 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.476 ' HB3' HD13 ' A' ' 20' ' ' ILE . 13.3 mm-40 -53.23 -45.95 68.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.224 -0.923 . . . . 0.0 108.77 179.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.554 ' HB2' ' HB ' ' A' ' 20' ' ' ILE . . . -70.29 -13.45 62.17 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.37 -0.831 . . . . 0.0 108.785 179.231 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.53 ' HA ' HG21 ' A' ' 59' ' ' ILE . 0.4 OUTLIER -80.72 -21.9 40.76 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.434 -0.791 . . . . 0.0 109.492 179.98 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -96.37 -34.34 11.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.197 -0.94 . . . . 0.0 109.605 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.477 ' OG1' ' HA ' ' A' ' 50' ' ' ALA . 0.1 OUTLIER -50.71 -54.82 20.11 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.252 -0.905 . . . . 0.0 109.747 179.975 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.535 ' SG ' ' HD2' ' A' ' 55' ' ' PRO . 3.8 t -46.36 140.86 5.21 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.192 -0.943 . . . . 0.0 109.912 -179.61 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.535 ' HD2' ' SG ' ' A' ' 54' ' ' CYS . 44.8 Cg_endo -77.03 -62.99 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 124.123 1.591 . . . . 0.0 109.843 179.33 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 33.0 t -74.4 -20.74 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.335 -0.853 . . . . 0.0 108.868 179.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.481 ' NE2' ' O ' ' A' ' 51' ' ' MET . 3.5 mt-30 64.78 94.24 0.06 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.343 -0.848 . . . . 0.0 109.586 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.5 ' HB3' ' HB3' ' A' ' 10' ' ' GLU . 0.1 OUTLIER -100.42 -28.0 13.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.304 -0.872 . . . . 0.0 108.821 179.795 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.854 ' HA ' HG13 ' A' ' 6' ' ' VAL . 5.7 tt -60.88 151.06 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.458 -0.776 . . . . 0.0 109.976 -179.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.49 ' NE2' ' CE2' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -159.92 -178.55 7.11 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.454 -0.779 . . . . 0.0 108.9 179.509 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.506 ' HA ' ' HA ' ' A' ' 4' ' ' PHE . 66.7 m95 -101.3 165.02 11.49 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.118 -0.989 . . . . 0.0 109.768 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.514 ' HB2' ' CE1' ' A' ' 5' ' ' TYR . 41.2 tt0 -128.83 107.82 9.95 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.431 -0.793 . . . . 0.0 109.169 -179.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -103.07 62.91 0.8 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.263 -0.898 . . . . 0.0 109.508 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 . . . . . 0 N--CA 1.491 1.614 0 O-C-N 121.203 -0.936 . . . . 0.0 109.405 -179.973 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' SF4 . . . . . 1.082 ' S2 ' ' O ' ' A' ' 14' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_